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The bacterium Streptococcus pneumoniae is a leading cause of human morbidity and 
mortality. With ever increasing antibiotic resistance rates and poor coverage of current 
vaccines, novel therapeutics and vaccines are urgently required. However, the mechanisms 
underlying the differences between capacity of individual strains to cause localised vs 
invasive pneumococcal diseases are poorly understood. This is largely due to vast genetic 
diversity of strains, which can be subdivided into 100 serotypes based on the capsular 
polysaccharide they produce, superimposed on >12000 clonal sequence types (ST) 
distinguished by multi-locus sequence typing. This poor understanding of underlying 
disease mechanisms is impeding novel treatment design. 
Previous studies have shown that even closely related strains within the same serotype and 
clonal type can display variations in virulence, corresponding to their isolation site in 
humans. In murine intranasal challenge models, serotype 14 ST15 and serotype 3 ST 180 
clinical isolates from the blood tended to cause invasive disease, while corresponding ear 
isolates instead caused more localised disease. Focusing on the relatively few differences 
between these closely related strains offers an opportunity to bypass the large genetic 
diversity of S. pneumoniae.   
To determine the mechanisms that dictate their progression to specific sites of the body, 
the blood and ear isolates pairs had their genomes and transcriptomes sequenced and 
compared. No significant findings came out of the transcriptomic studies, but the genomic 
analyses found single nucleotide polymorphisms (SNPs) in rafR and rafK, respectively, 
that drastically alter pneumococcal disease progression. These genes encode proteins 
involved in the uptake and/or metabolism of the sugar raffinose. Growth assays with 
raffinose as the sole carbon source showed that blood isolates grew better than ear isolates, 
whereas there were no differences in growth in the presence of glucose. Finally, the 




and ear isolates led to a concomitant swap in virulence phenotype in mice. These results 
suggest the ability to utilise raffinose plays a significant role in dictating pneumococcal 
tissue tropism and disease progression. 
Using in vivo dual RNA sequencing on infected murine lungs in the early stages of 
infection, it was established that the rafR SNP extensively impacts both bacterial and host 
transcriptomes. A crucial role for IL-17 induced neutrophil recruitment was predicted, with 
IL-17 pathway genes upregulated in the strains cleared from the lungs. Indeed, single cell 
flow cytometry analysis showed the rafR SNP leads to increased recruitment of neutrophils 
in the lungs of mice infected with the strains that were subsequently cleared. Importantly, 
in the murine intranasal challenge models, mice depleted of neutrophils or IL-17A had 
significantly higher bacterial loads in the lungs 24h post-challenge. Strikingly, the strains 
originally cleared from the lungs were now able to persist in this niche after neutrophil 
depletion, at similar levels at the non-neutrophil depleted invasive strains. The findings 
provide novel insights into the mechanisms underlying differences in virulence phenotype 
among S. pneumoniae clinical isolates and demonstrate the wide impact of a single 
bacterial SNP on both bacteria metabolism and host innate immune responses.  







1.1 The Pneumococcus  
Streptococcus pneumoniae (the pneumococcus) is a Gram-positive, alpha haemolytic 
diplococcal shaped bacterial pathogen, responsible for significant human morbidity and 
mortality. S. pneumoniae is a leading cause of invasive diseases including pneumonia, 
bacteraemia and meningitis (Luna-Muschi et al., 2019), as well as localised diseases, such 
as otitis media and sinusitis (Danishyar and Ashurst, 2019). The pneumococcus is a human 
pathogen that transmits from human to human via secretory droplets (Weiser et al., 2018), 
with colonisation of the nasopharynx required for both transmission and invasion deeper 
into the body to cause disease (Weiser et al., 2018).The capsular polysaccharide (CPS) is 
the major virulence factor of S. pneumoniae and is used to classify the pneumococcus into 
at least 100 structurally distinct serotypes (Ganaie et al., 2020; Paton and Trappetti, 2019). 
1.1.1 Historical background  
The first recorded visualisation of the pneumococcus was in 1875 by Edwin Klebs, and in 
1881 it was independently isolated by French chemist Louis Pasteur (Note de L. Pasteur, 
1881) and U.S. Army physician George Sternberg (Sternberg, 1881). This bacterium was 
isolated by injecting saliva into rabbits; Pasteur using saliva from a child with rabies and 
Sternberg using his own, allowing the bacteria to be isolated from the rabbit’s blood. 
Pasteur named the bacteria Microbe septicemique du salive, while Sternberg named it 
Micrococcus pasteuri. It was latter named Diplococcus pneumoniae in the 1920s, due to 
its ability to cause pneumonia and its tendency to form pairs (Austrian, 1981), then renamed 




again as Streptococcus pneumoniae in the 1970s because of its chain-like morphology 
(Watson et al., 1993).       
Many important contributions to science and medicine have been made due to research on 
S. pneumoniae. For instance, in 1882 the Gram stain was discovered accidentally from 
research aimed at elucidating the cause(s) of pneumonia. It was observed that certain 
bacteria were able to retain the crystal violet stain while others could not, leading to 
classification of organisms as either Gram positive or Gram negative (Gram, 1884). 
Additionally, the Quellung reaction, which allows the determination of capsular serotype 
of human isolates, was established after an observation that pneumococci swell when 
exposed to particular antisera (Neufeld, 1902). This reaction is also used for other bacteria, 
including Haemophilus, Klebsiella and Neisseria spp. S. pneumoniae has also played an 
important role in understanding humoral immunity and phagocytosis. It was demonstrated 
in the 1920s that the capsular polysaccharide (CPS) of the pneumococcus was capable of 
eliciting serological activity (Heidelberger and Avery, 1923) and strain specific protection 
in mice (Heidelberger, 1927).   
Finally, the elucidation of DNA as genetic material, one of the biggest discoveries in 
molecular biology, was achieved using S. pneumoniae. Frederick Griffith observed two 
different types of pneumococcal colonies present on blood agar (BA) plates: smooth (S) 
colonies, which possessed CPS and caused lethal infections, and rough (R) colonies, which 
didn’t possess CPS nor the ability to cause lethal infections. It was shown that R strain, 
incapable of naturally reverting to the S form in vivo, was able to acquire S morphology 
after injecting the R strain into mice along with a heat-killed S strain (Griffith, 1928). 
Subsequent isolated colonies produced CPS that was identical to the CPS produced by the 
S strain. This suggested that the pneumococcus was capable of taking up and incorporating 
genetic material from the environment, a process known as natural transformation. It was 
then shown that this genetic transformation could be achieved in vitro (Alloway, 1932). A 




few years later, Oswald Avery and colleagues showed that DNA was the heredity material, 
by demonstrating that the capsular transformation reaction was abrogated when lysates 
from the smooth donor were first digested with DNAse (Avery et al., 1944).                
1.1.2 Disease burden 
Pneumococcal infections are most prevalent in the immunocompromised, children under 
five years of age and the elderly. The human nasopharynx is its main ecological niche, 
where it can remain asymptomatically in over 50% of children and up to 10% of adults 
(Bogaert, De Groot, et al., 2004; Regev-Yochay et al., 2004; Weiser et al., 2018). From the 
nasopharynx, certain strains of pneumococci can spread deeper into normally sterile sites 
of the body, such as the lungs, blood or cerebrospinal fluid, to cause invasive pneumococcal 
disease (IPD) (Figure 1.1) (Weiser et al., 2018). An estimated 1 million people die annually 
due to IPD, the majority of which are children less than 5 years old in developing countries 
(Iroh Tam et al., 2017; Kadioglu et al., 2008; WHO | Pneumococcal disease, 2014). From 
2010-2011, an estimated 120 million pneumonia episodes occurred, of which 14 million 
progressed to severe disease (Walker et al., 2013). S. pneumoniae also causes highly 
prevalent localised diseases such as otitis media (OM) and sinusitis, with the 
pneumococcus being the primary causative agent of OM (Brook, 2013; Danishyar and 
Ashurst, 2019). Australian Aboriginal children have the highest rates of OM in the world, 
up to 10 times higher than the world average (Organization, 1998). IPD in Indigenous 
populations has also been reported at rates up to 75 times higher than non-indigenous 
groups (Forrest et al., 2000).  
Risk factors for pneumococcal carriage in the nasopharynx include poverty, malnutrition, 
poor access to medical care, crowded areas such as day care centres and having younger 
siblings (Lynch and Zhanel, 2010). In adults, smoking cigarettes, asthma, old age, immuno-  
 












Figure 1.1. S. pneumoniae colonises the mucosal layer of the nasopharynx, which is a prerequisite 
for invasive disease and for its transmission to other hosts. From the nasopharynx, S. pneumoniae 
can be shed in nasal secretions, allowing for transmission. Dissemination from the nasopharynx 
along the nasal epithelium via aspiration, bacteraemia or localised spread, leads to pneumonia, 
meningitis or otitis media, respectively. Figure reproduced from Weiser et al (2018). 
compromising afflictions and prior acute respiratory infections increase the risk of 
nasopharyngeal carriage (Lynch and Zhanel, 2010). In Australia, the mortality rate from 
IPD for both children less than five years of age and for people over 65 years is less than 
5% (Australian Institute of Health and Welfare, 2018). In contrast, the IPD mortality rate 
of children under 5 years of age in developing countries is between 10-40%, which may be 
in part due limited access to treatments, relatively poor healthcare systems and co-
morbidities, such as malnutrition and Human immunodeficiency virus (HIV) infections 
(Bogaert, Hermans, et al., 2004; Harboe et al., 2009; Madeddu et al., 2010). Other 
respiratory pathogens, such as the influenza virus, can lead to enhanced pneumococcal 
infections which results in increased morbidity and mortality. An epitomised example is 
the 1918-19 Spanish influenza pandemic, where a significant proportion of deaths (about 
50 million) were due to secondary bacterial (principally pneumococcal) infections (Morens 
et al., 2008). More recently, a study during the H1N1 swine flu pandemic in 2009 found 




that 33% of all cases involved secondary bacterial coinfection and 62% of these were due 
to S. pneumoniae (Cillóniz et al., 2012).  
1.2 Vaccine and Therapeutic Strategies 
1.2.1 Antibiotics resistance  
Since the introduction of penicillin in the 1940s, antibiotics have readily been used in the 
treatment of pneumococcal infections. However, since the detection of penicillin-resistant 
isolates in the 1970s, antibiotic resistance rates have increased dramatically (Cherazard et 
al., 2017; Lynch and Zhanel, 2009). Penicillin resistance primarily comes about through 
penicillin-binding protein mutations such that penicillin can no longer bind and inhibit 
peptidoglycan production (van der Poll and Opal, 2009). Rates of pneumococcal penicillin 
resistance vary greatly between regions with non-susceptibility rates surpassing 50% of 
isolates in East Asia and the Middle East, and 30% in Spain. Conversely, rates remain 
under 5% in Finland, Germany and Sweden (Bruinsma et al., 2004; Cherazard et al., 2017; 
El Moujaber et al., 2017; Lynch and Zhanel, 2009; Mamishi et al., 2014). It has also been 
shown that pneumococcal macrolide antibiotic resistance has increased in correlation with 
penicillin resistance, along with resistance to fluoroquinolones and tetracycline (Cherazard 
et al., 2017; Lynch and Zhanel, 2009). Rates of pneumococcal macrolide resistance range 
from 10% to over 70% around the globe (Zhanel et al., 2014), and the SENTRY 
Antimicrobial Surveillance Program showed that pneumococcal resistance rates in the 
United States against erythromycin and clindamycin have been steadily increasing since 
1998 (Jones et al., 2013).   
The proficient genetic transformability of S. pneumoniae likely mediates the rapid spread 
of antibiotic resistance through lateral transfer of antibiotic resistance genes and cassettes, 
with heavy antibiotic use also providing strong selective pressure. The escalation of 
antibiotic resistance globally is predominately due to the global dissemination of a handful 




of serotypes, for example, serotypes 6A, 6B, 9V, 14, 14F and 23F account for the majority 
of macrolide resistance in S. pneumoniae (Lynch and Zhanel, 2009). These six serotypes, 
plus 15A, 19A and 19F, also accounted for the highest rates of penicillin and erythromycin 
resistance (Liñares et al., 2010). Increasing levels of antibiotic resistance lead to a greater 
reliance on preventative strategies such as vaccination programs as an alternative to 
reliance on antibiotics.    
1.2.2 Polysaccharide vaccines and serotype replacement  
A limited number of vaccines are currently utilised to prevent pneumococcal disease. As 
the CPS of S. pneumoniae is critical in pneumococcal colonisation and virulence, and is 
highly immunogenic in adults, it has become the major antigen target in current vaccine 
formulations (Bogaert, Hermans, et al., 2004). In 1977, a 14-valent purified CPS vaccine 
was released in the United States, providing protection against 14 of the most common 
invasive pneumococcal serotypes. This vaccine lessened morbidity and mortality in the 
healthy adult population, though unfortunately, overall pneumonia rates were unaffected 
(Riley et al., 1977). In 1983, a 23-valent CPS vaccine (PPSV23) was developed that 
provided 80-90% protection against the covered virulent serotypes. IPD rates were 
significantly reduced in the target population after the implementation of PPSV23, but 
overall rates of carriage and pneumonia have not been reduced (Fine et al., 1994; Stanek et 
al., 2016). Importantly, PPSV23 does not elicit immunogenicity in the groups with the 
greatest pneumococcal disease burden, the immunocompromised and children under 2 
years old,.This is due to the inability of these populations to mount effective T-cell 
independent immune responses (Heilmann, 1990; Shapiro et al., 1991). To overcome this, 
a seven valent CPS vaccine (PCV7), covering serotypes 4, 6B, 9V, 14, 18C, 19F and 23F 
was developed that conjugated CPS to a protein carrier CRM197 (a non-toxic variant of 
diphtheria toxin). PCV7 elicits a T-cell-dependant antibody response even in infants, 
significantly reducing IPD and carriage in vaccinated children under 2 years old, as well 




as in adult populations, due to herd immunity. However, rates of OM did not decrease (von 
Gottberg et al., 2014; Hammitt et al., 2006; Whitney et al., 2003). A 13-valent conjugate 
vaccine (PCV13), containing all 7 serotype from PCV7 plus 6 additional invasive serotypes 
(1, 3, 5, 6A, 7F and 19A), was later developed to increase serotype coverage (Bryant et al., 
2010).  
Despite the effectiveness of the CPS conjugate vaccines against the included capsular 
serotypes, the overall serotype coverage is limited. This facilitates the emergence of non-
vaccine serotypes, which fill the unoccupied nasopharyngeal niche, and subsequently cause 
disease. This is termed serotype replacement and evidence for this phenomenon is clear. 
For example, a few years after the introduction of PCV7, pneumococcal carriage and 
disease due to serotypes not covered in PCV7 were shown to increase (Ghaffar et al., 2004; 
van Gils et al., 2009; Grivea et al., 2008; Lipsitch et al., 2007). Moreover, infection rates 
returned to almost pre-vaccine levels in high risk groups and antibiotic resistance in non-
vaccine serotype isolates also increased (Hsu et al., 2009; Singleton et al., 2007). The 
continual emergence of new non-vaccine serotypes causing pneumococcal disease after 
introduction of PCV13 has also been observed (Corcoran et al., 2019; Kandasamy et al., 
2019).   
1.2.3 Protein and whole cell vaccines    
Given the ongoing serotype replacement seen in pneumococcal carriage and IPD, paired 
with increased antibiotic resistance rates, broader preventive strategies are urgently 
required. Colonisation acts as a natural immunisation event by increasing anti-capsular and 
anti-protein antibody levels (Ferreira et al., 2013; McCool et al., 2002; Richards et al., 
2010), while more recent studies have shown that anti-protein antibodies against S. 
pneumoniae are largely responsible for natural immunity (Ramos-Sevillano et al., 2019; 
Wilson et al., 2017). Hence, protein antigens that are highly conserved among many 




pneumococcal serotypes potentially offer serotype-independent protection from IPD, thus 
mitigating the risk of serotype replacement (Stanek et al., 2016). In fact, recent research 
has shown protein antigens, such as pneumolysin (Ply), choline binding protein A (CbpA), 
or pneumococcal surface protein A (PspA), in multivalent combinations confer broad and 
strong protection (Chen et al., 2015; Olafsdottir et al., 2012). Several pneumococcal protein 
vaccines are undergoing or have recently undergone clinical trials. These include 
formulations containing Ply and pneumococcal histidine triad protein D (PhtD) 
(Pichichero, 2017).   
Another strategy to elicit non-serotype dependant protection is the use of whole cell 
vaccines (WCV), e.g. immunising with killed non-encapsulated pneumococci with 
exposed surface protein antigens. A lytA-deletion mutant of S. pneumoniae Rx1 that 
expressed non-toxic Ply has been shown to elicit protection against nasopharyngeal 
carriage and sepsis in murine models (Babb et al., 2016, 2017; Lu et al., 2010; Malley et 
al., 2001). WCVs have many cost advantages over purified protein or conjugate vaccines, 
making them more suitable for widespread use in developing countries. Chemically killed 
(Moffitt and Malley, 2016) and γ-irradiated (Babb et al., 2016, 2017; David et al., 2019) 
pneumococcal WCVs have been developed and are in the process of undergoing pre-
clinical and clinical trials to test their safety and efficacy in providing serotype independent 
protection.  
1.3 Pneumococcal Pathogenesis  
1.3.1 Colonisation and transmission  
Despite the massive morbidity and mortality associated with pneumococcal disease, S. 
pneumoniae is more commonly carried asymptomatically as a commensal of the human 
nasopharynx, with carriage a perquisite step for pneumococcal disease. In fact, the human 
nasopharynx is the primary reservoir for S. pneumoniae. Asymptomatic carriage rates vary 




markedly with age and geographic region, but are estimated to occur in 18% to >50% of 
healthy children and 4-10% of adults, with peak rates occurring at 2-3 years of age 
(Bogaert, De Groot, et al., 2004; Hosseini et al., 2015; Regev-Yochay et al., 2004; Wang 
et al., 2017).  
Other potentially pathogenic bacterial species, including Moraxella catarrhalis and 
Haemophilus influenzae may co-reside in the human nasopharynx, as well as multiple 
serotypes/strains of pneumococci (Shiri et al., 2013; Xu and Pichichero, 2014). Intraspecies 
competition between pneumococcal strains has been reported to affect nasopharyngeal 
colonisation (Dawid et al., 2009). A study using mouse models showed that pre-existing 
pneumococcal colonisation prevents acquisition by a new strain (Kono et al., 2016). 
Passive immunisation of infant mice with anti-capsular immunoglobulin G (IgG) was also 
sufficient to prevent colonisation by pneumococcal strains in a serotype-specific fashion 
(Roche et al., 2015). Host IgA1 additionally contributes to pneumococcal clearance from 
mucosal surfaces of the human upper respiratory tract (URT). However, S. pneumoniae is 
believed to evade this by secretion of an IgA1 protease which cleaves the antibody hinge 
region, thus preventing coagulation of pneumococci (Janoff et al., 2014; Roche et al., 
2015). Interactions with nasopharyngeal microflora also influence the success of 
pneumococcal colonisation (Shak et al., 2013). Greater microbial diversity is associated 
with increased acquisition of S. pneumoniae after intranasal (I.N.) challenge (Lysenko et 
al., 2007), while detection by neutrophils of Gram-negative peptidoglycan via the 
nucleotide-binding oligomerization domain-containing protein 1 (NOD1) triggers 
enhanced killing of S. pneumoniae (Cremers et al., 2014).       
S. pneumoniae transmits from human to human mainly through contaminated secretory 
aerosol droplets. Crowded areas such as day care centres and hospitals help facilitate spread 
(Mandigers et al., 1994; Pessoa et al., 2013), as do colder months when airway secretions 
are more likely to occur in conjunction with viral infection of the URT (Musher, 2003; 




Numminen et al., 2015). It has been shown that influenza A virus (IAV) co-infection 
induces higher rates of pneumococcal transmission and colonisation in mouse pups, due to 
increased inflammatory conditions (Nakamura et al., 2011; Richard et al., 2014). 
Moreover, increases in mucosal flow and secretion volume have been shown to increase 
pneumococcal transmission (Rodrigues et al., 2013). Pro-inflammatory affects caused by 
S. pneumoniae (induced by Ply) also lead to increases in transmission (Zafar et al., 2017). 
Indeed, dampening inflammation has been shown to reduce shedding and transmission in 
infant mice (Zafar et al., 2017). 
Contact-dependant transmission of pneumococci, through secretions from infected hosts, 
could involve direct contact from person to person or through contact with contaminated 
surfaces. Transmission between littermates has been shown in the infant mouse study 
above, where the mouse dam was not colonised but had large numbers of pneumococci 
present on her teats (Zafar et al., 2017). S. pneumoniae can also be readily cultured from 
objects such as toys that colonised children recently handled (Marks et al., 2014). Bacteria 
can survive for days in nutrient-sufficient conditions, such as human saliva (Verhagen et 
al., 2014). For nutrient poor conditions such as in airway surfaces, capsule polysaccharide 
(CPS) and Ply expression have also been shown to promote pneumococcal survival 
(Hamaguchi et al., 2018; Zafar et al., 2017).  Additionally, S. pneumoniae is able to survive 
desiccation for several days, while biofilm bacteria are able to retain viability more so than 
planktonic bacteria (Marks et al., 2014; Walsh and Camilli, 2011).   
Upon entering the nasopharynx, S. pneumoniae is subject to entrapment by URT mucus, 
made up of gel like mucin glycoproteins and containing antimicrobial peptides as well as 
immunoglobulins (Rose and Voynow, 2006). This mucus layer acts as a barrier that 
prevents microorganisms from reaching the surface epithelium. These epithelial cells also 
provide a protective barrier for underlying tissues and organs (Brooks and Mias, 2018). 
Epithelial cells and mucus work in conjunction, resulting in mucociliary clearance. Here, 




the negatively charged mucus traps invaders while the cilia on epithelial cells move 
simultaneously, directing trapped pathogens and mucus towards the mouth for expulsion 
(Antunes and Cohen, 2007; Nelson, Roche, et al., 2007). 
For pneumococcal colonisation to successfully establish, the bacteria must adhere to the 
epithelial cells that line the upper respiratory tract. This adherence occurs via specific 
binding of pneumococcal adhesins to ligands on host receptors, e.g. choline binding 
proteins of pneumococci can adhere to host cell glycoconjugates (Rosenow et al., 1997). 
Non-specific physio-chemical interactions, such as hydrophobic interactions, between host 
mucosa and bacterial cells also aid adherence (Swiatlo et al., 2002). Other pneumococcal 
factors that aid in colonisation include phosphorylcholine (ChoP) present in the cell wall, 
which has affinity for the platelet activating factor receptor (PAFR) of host cells. 
Neuraminidase (NanA), β-galactosidase (BgaA) and N-acetylglucosaminidase (SrtH) may 
also unmask adhesin receptors through the cleavage of terminal sugars from host cell 
surface glycoconjugates (Kadioglu et al., 2008). Furthermore, S. pneumoniae can combat 
the lytic action of host lysozyme via two key enzymes; peptidoglycan-N-
acetylglucosamine deacetylase (PgdA) and attenuator of drug resistance (Adr) (Davis et 
al., 2008).  
1.3.2 Invasive pneumococcal disease    
Stable colonisation of the nasopharynx is the ideal lifestyle for S. pneumoniae, as this 
allows transmission to new hosts. However, increased pneumococcal loads in the 
nasopharynx and loss of epithelial barrier integrity, increases the probability of invasion 
into deeper host tissues. IPD occurs when the pneumococcus penetrates tissues by crossing 
these epithelial and/or endothelial barriers, and enters the lungs, blood and/or cerebrospinal 
fluid (CSF) (Figure 1.2). 




Similar to the colonisation of the nasopharynx, invasion of the respiratory tract requires the 
evasion of mucus entrapment and mucociliary clearance by the CPS, and proteolytic 
degradation of IgA1. NanA, BgaA and StrH unmask glycan targets for adhesins, and Ply 
inhibits ciliary beating (Kadioglu et al., 2008). Upon contact with lung epithelial cells, 
apical surface adherence is mediated by ChoP, choline-binding protein A (CbpA), the 
ancillary pilus subunit (RrgA), adherence and virulence protein A (PavA) and large 
surface-exposed glycoprotein (PsrP). Adherence can occur through interaction of ChoP 
with PAFR and CbpA with polymeric immunoglobulin receptor (PIGR) (Zhang et al., 
2000). S. pneumoniae is then able to induce endocytosis into the lung epithelial cells by 
subverting host receptor recycling pathways, facilitating release to the basolateral surface 
(Cundell et al., 1995). S. pneumoniae can also penetrate the lung epithelium via an 
alternative paracellular route. Here, Ply and hydrogen peroxide (H2O2) damage the 
epithelium, while hyaluronate lyase (Hy1) and plasmin, bound to the surface of 
pneumococci via enolase (Eno), glyceralde-hyde-3-phosphate dehydrogenase (GAPDH) 
or CbpE, degrade the extracellular matrix. Interactions between ChoP-PAFR and CbpA-
PIGR also allow pneumococci to cross the endothelium and enter the bloodstream (Cundell 
et al., 1995; Zhang et al., 2000).  
To cross the blood-brain barrier (BBB), S. pneumoniae utilise ChoP-PAFR, CbpA-PIGR 
and CbpA-laminin receptor binding on the brain microvascular endothelium (Brown et al., 
2014; Orihuela et al., 2009). Strains that express pili use RrgA, the tip adhesin of 
pneumococcal pilus 1, to bind to PIGR and platelet endothelial cell adhesion molecule 1 
(PECAM1) on the brain microvascular endothelium. Blockade of these two receptors 
lessened brain invasion rates in a mouse meningitis model (Iovino et al., 2017). Similar to 
respiratory tract invasion, Ply, H2O2 generated by α-glycerophosphate oxidase (GlpO) and 
activated plasmin bound to the pneumococcal surface proteins Eno, GAPDH and CbpE can 
lead to the compromise of the BBB (Attali, Durmort, et al., 2008; Mahdi et al., 2012; 




Rayner et al., 1995). Meningitis may also occur through localised infections, or through 
retrograde axonal transport when pneumococci bind to gangliosides on olfactory neurons 
on the nasopharyngeal mucosa (van Ginkel et al., 2003). Exogenous sialic acid also 











Figure 1.2. To cause Invasive Pneumococcal Disease, S. pneumoniae utilises a range of surface 
proteins and other molecules to bind to and penetrate host tissue. (a) Pneumococci cross 
respiratory epithelium via inducing endocytosis, providing access to the interstitium. S. pneumoniae 
can then bind to and transverse capillary endothelium, allowing access to the bloodstream, which 
results in haematogenous spread. From here, pneumococci can bind to and cross the blood-brain 
barrier (b), allowing invasion of the Cerebrospinal fluid.  Figure reproduced from Weiser et al. 
(2018). 
1.3.3 Otitis media 
Many strains of S. pneumoniae are able to ascend the Eustachian tube to cause OM, which 
is a disorder resulting in inflammation of the middle ear. Infection of the middle ear is 
facilitated by two neuraminidases, NanA and NanB, which can cleave N-acetylneuraminic 
acid from glycoproteins and glycolipids on host cell surfaces, as well as cleaving mucins 
(Loughran et al., 2019). This reduces overall viscosity, improving access to the epithelial 
surfaces. Oligosaccharides on epithelial surfaces can then be cleaved by NanA and NanB, 




exposing receptors for pneumococcal adherence (Berry et al., 1996; Stahl and O’Toole, 
1972). These enzymes are evidently critical to development of OM. In a chinchilla 
infection model, a neuraminidase-deficient mutant was cleared twice as quickly from the 
middle ear compared to the wild-type S. pneumoniae (Tong et al., 2000). Once within the 
middle ear, the pneumococcus induces inflammation through cell surface proteins and Ply 
which contributes to hearing loss and cochlear damage (Comis et al., 1993; Tuomanen, 
2000; Winter et al., 1997).    
OM can be divided into 3 categories depending on the symptoms and severity of disease, 
acute OM, OM with effusion and chronic OM with effusion (Taylor et al., 2009). OM with 
effusion in the presence of signs of an infection is defined as acute OM. There are 2 
subtypes of acute OM; without perforation, which usually involves the bulging of the 
tympanic membrane, and with perforation, which involves perforation of the tympanic 
membrane. When effusion discharges through a tympanic membrane perforation 
persistently for at least 6 weeks, it is then classified as chronic suppurative otitis media 
(Bergenfelz and Hakansson, 2017).      
1.4 Host immune responses  
1.4.1 Innate immunity 
The first line of defence against S. pneumoniae infection is the innate immune system, 
which involves a non-specific and rapid response initiated against anything recognised as 
foreign or ‘non-self’. Pathogens are recognised by innate pattern recognition receptors 
(PRRs) which are located on host cell surfaces or intracellularly. These will recognise 
pathogen-associated molecular patterns (PAMPS), such as viral dsRNA, and bacterial LPS 
or lipoteichoic acid, and initiate a signalling cascade leading to innate immune activation 
(Murphy and Weaver, 2017; Paterson and Mitchell, 2006a). Among all the PRRs identified, 
Toll like receptors (TLRs) are one of the largest and most well-characterised families. 




TLRs are typically membrane-bound, with TLR2, TLR4 and TLR9 being the most 
important for recognition of S. pneumoniae (Richard et al., 2014; Srivastava et al., 2005; 
Tomlinson et al., 2014). These will recognise pneumococcal lipoproteins, the 
pneumococcal toxin Ply, and CpG-DNA for TLR2, 4, and 9 respectively. TLRs also play 
roles in the adaptive immune response as they facilitate the release of co-stimulatory 
molecules required for T-cell activation (Rahman et al., 2009).  
Nucleotide-binding oligomerization domain-like receptors (NLRs) are another class of 
PRRs that recognise bacterial cell wall components. In response to ligand binding, NLRs 
will stimulate NF-κB, activate the inflammasome, promote cytokine production and induce 
inflammation (Franchi et al., 2009; Murray, 2009; Rabes et al., 2016). The protein CD14 
has also been identified as a PRR through recognition of bacterial cell wall components 
(Anas et al., 2010). However, during S. pneumoniae infection, CD14 has instead been 
shown to facilitate pneumococcal dissemination into the respiratory tract (Dessing et al., 
2007). 
In response to production of inflammatory mediators, innate immune cells will be directed 
to the site of pathogen encounter. These cells include basophils, dendritic cells, eosinophils, 
Langerhans cells, mast cells, monocytes and macrophages, neutrophils and natural killer 
(NK) cells. Neutrophils and macrophages are critical innate immune cells for clearance of 
pneumococcal infection. (Craig et al., 2009; Dockrell and Brown, 2015; Murphy and 
Weaver, 2017; Paterson and Mitchell, 2006a; Standish and Weiser, 2009). Neutrophils are 
the most abundant innate cell types and are usually the first cells that travel to the site of 
infection (Craig et al., 2009; Kolaczkowska and Kubes, 2013). They are phagocytic cells 
that produce granules which break down pathogen cell walls (Falloon and Gallin, 1986; 
Kolaczkowska and Kubes, 2013) and can also trap S. pneumoniae extracellularly though 
fibres made from DNA (Gardiner and Andrews, 2012). Macrophages also function as 
phagocytic cells that engulf and kill pneumococci (Murphy and Weaver, 2017; Paterson 




and Mitchell, 2006a). They target cells that have been opsonised via the complement 
system and Fcγ receptors (Dockrell and Brown, 2015), but they can also phagocytose non-
opsonised antigens through their receptor MARCO, macrophage receptor with collagenous 
structure (Kraal et al., 2000).  
In addition, respiratory epithelial cells are able to kill pneumococci through secretion of 
antimicrobial peptides such as apolactoferrin and lysozyme, that lyse cells, prevent growth, 
and/or sequester iron (André et al., 2015; Whitsett and Alenghat, 2015). Respiratory 
epithelial cells can also release cytokines and chemokines to recruit additional immune 
cells to the site of infection (Whitsett and Alenghat, 2015).  
1.4.2 Adaptive immunity 
The adaptive or acquired immune response takes longer to initiate, but is pathogen specific 
and highly effective. It also results in immunological memory of encountered antigens, 
with each subsequent response being faster and larger in magnitude. There are two types 
of adaptive responses, cell-mediated immunity involving T-cells and humoral immunity 
involving the production of antigen-specific antibodies via B-cells. Activation of B-cells 
and subsequent class switching results in production of functional and highly specific 
antibodies, mainly IgG and IgA. S. pneumoniae infections are controlled at mucosal sites 
through secretory IgA, which opsonises the bacteria to promote phagocytosis (Mook-
Kanamori et al., 2011).  
T-cells also play a crucial role in clearance of pneumococcal infection. These cells are split 
into two broad classes, helper CD4+ and cytotoxic CD8+ T-cells. T-cells become activated 
when they recognise their cognate antigen presented on the major histocompatibility 
complex proteins of professional antigen presenting cells (APCs). APCs include 
macrophages, B-cells, and dendritic cells. (Brooks and Mias, 2018). After T-cell activation, 
helper T cells can differentiate into either the Th1 or Th2 cell subsets. Th1 cells mainly 




produce cytokines that drive inflammation and recruit additional immune cells, whilst Th2 
cells interact with B-cells to promote class switching and production of antibodies 
(Romagnani, 1999). Research has shown that CD4+ T-cells are crucial for antibody-
dependent immunity to pneumococci (Malley et al., 2005).  
The IL-17 producing T-helper cells (Th17) cells are an additional class of CD4+ T-cell that 
function in anti-pneumococcal immunity. Th17 cells release IL-17 which recruits 
neutrophils, monocytes and macrophages to infection sites, leading to pneumococcal 
clearance. Th17 responses are also linked to reduced S. pneumoniae carriage (Hoe et al., 
2017). In contrast, CD8+ T-cells directly kill infected host cells, similar to natural killer T-
cells (van der Poll and Opal, 2009). Moreover, a protective role for CD8+ T-cell-mediated 
IFN-gamma production against S. pneumoniae has been suggested (Weber et al., 2011). 
Following resolution of infection, subsets of both T-cells and B-cells will differentiate into 
memory cells and remain in circulation. These memory cells are able to undergo rapid re-
activation upon pathogen re-encounter, facilitating faster activation of the adaptive immune 
response for enhanced pathogen clearance (Sprent, 1994). 
1.4.3 Other immune system factors 
Cytokines are a broad category of small proteins, ~5-20 kDa, involved in cell signalling. 
Chemokines are a family of cytokines secreted by cells that direct immune cells to sites of 
infections and promote inflammation (Arango Duque and Descoteaux, 2014). Well studied 
examples are the cytokines TNF-α, produced by T-cells, monocytes and macrophages, and 
IFN-γ, produced by NK cells and T-cells in response to IL-12. These cytokines have been 
shown to be vital in controlling pneumococcal infections (Jeong et al., 2015; O’Brien et 
al., 1999; van der Poll et al., 1997; Rubins and Pomeroy, 1997; Wellmer et al., 2001; 
Yamamoto et al., 2004), though IFN-γ was shown in another study to instead promote 
pneumococcal meningitis (Mitchell et al., 2012). Moreover, S. pneumoniae autolysis has 




been shown to prevent the production of phagocyte-activating cytokines (Martner et al., 
2009).  
The inflammasome is a complex of proteins, consisting of caspase 1 (a sensor protein) and 
an apoptosis associated Speck-like protein with a caspase recruitment domain, that 
indirectly identifies pathogenic molecules and subsequently regulates cytokine production 
(Baroja-Mazo et al., 2014; Rabes et al., 2016). The NLRP3 inflammasome has been shown 
to aid in the identification of S. pneumoniae infection, directly interacting with Ply and 
leading to macrophage activation and IL-1β and IL-18 release (McNeela et al., 2010; 
Witzenrath et al., 2011).  
The complement system is a made up of small proteins that when activated enhance 
phagocytosis of pathogens and other invaders by coating them with opsonins (Paterson and 
Mitchell, 2006a). Complement can be activated through three cascade pathways: classical, 
alternative, and mannose-lectin pathways. The classical pathway involves complement 
proteins binding to antibody-antigen complexes, while the alternative and mannose-lectin 
pathways bind directly to PAMPs (Kadioglu and Andrew, 2004). Both the complement and 
mannose-lectin pathways have been shown to play important roles in host immunity to 
pneumococcal infection in mouse models (Ali et al., 2012; Brown, Hussell, et al., 2002). 
Moreover, mice lacking complement component C3 were not able to clear pneumococcal 
infection and had lower survival compared to wild type mice (Kerr et al., 2005). 
Acute phase serum proteins are able to bind to bacterial surfaces, and they increase in the 
blood during acute inflammatory infection due to cytokine secretions from innate immune 
cells (Pepys, 1998). The three major proteins that have been linked with pneumococcal 
infection are C-reactive protein, serum amyloid P and mannose-binding lectin. C-reactive 
protein and serum amyloid P have been shown to bind to pneumococcal cell surface 
phosphocholine, allowing complement deposition through the classical pathway (Mukerji 
et al., 2012), while mannose-binding lectin has been shown to attach to pneumococcal cell 




surface sugars (van Emmerik et al., 1994); low levels of this protein in serum increases the 
chance of death due to pneumococcal infection (Eisen et al., 2008). 
1.4.4 Evasion and subversion of host defences   
In order to survive in the human host, S. pneumoniae must be able to evade and subvert the 
host immune system. Acute inflammation occurs as a result of pneumococcal tissue 
damage, which leads to neutrophil migration to the inflamed sites. Neutrophil granules can 
then kill phagocytised S. pneumoniae, as highlighted in section 1.4.1, through the release 
of serine proteases (Standish and Weiser, 2009), hence immune evasion and subversion is 
critical. Pneumococcal CbpE aids in the prevention of neutrophil recruitment by cleaving 
ChoP moieties on host derived platelet-activating factor (PAF), a potent neutrophil 
activator (Hergott et al., 2015). 
S. pneumoniae employs a range of proteins for the evasion of complement-mediated 
immunity, e.g. CbpA binds to factor H, a protein that inhibits activation of the alternative 
complement pathway (Andre et al., 2017). PspA has also been shown to obstruct 
complement deposition through factor B binding and preventing the formation, or 
increasing the dissociation rate of the alternative pathway C3 convertase (Tu et al., 1999). 
Released Ply also activates the classical complement pathway as it contains a domain 
structurally similar to the IgG Fc component, depleting serum complement components 
and opsonic activity (Mitchell and Dalziel, 2014; Paton et al., 1984). In fact, both Ply and 
PspA have been shown to be crucial for pneumococci in causing septicaemia through 
complement inhibition (Yuste et al., 2005). NanA, BgaA and StrH also disrupt 
opsonophagocytosis, likely through the deglycosylation of  human proteins needed for 
complement deposition (Dalia et al., 2010).         
S. pneumoniae can grow in both long-chains and short-chains. The long-chain forms have 
greater surface area and hence are more likely to induce complement activation, thus short-




chain forms are more likely to evade opsonophagocytic clearance during IPD (Dalia and 
Weiser, 2011). The CPS also plays critical roles in the evasion of host immunity as the 
negative charge of most pneumococcal CPSs also repel similarly charged sialic acid 
terminal glycans present in the mucosa. This aids in avoiding nasal mucus entrapment 
allowing pneumococci to transit and attach to epithelial cells (Nelson et al., 2007). 
Additionally, CPS conceals underlying bacterial surface structures,preventing the binding 
of immunoglobulins, C-reactive protein and complement components. For example, CPS 
prevents interactions of Fc and C3b bound to deeper structures in the cell wall with 
receptors on phagocytic cells (Hyams et al., 2010). Moreover, downregulation/shedding of 
CPS, together with the D-alanine present in pneumococcal cell wall decreases bacterial 
negative charge, which aids in evasion of positively charged antimicrobial proteins 
(Kietzman et al., 2016; Kovács et al., 2006; Nawrocki et al., 2014).  
1.5 Pneumococcal Virulence Determinants  
1.5.1 The capsular polysaccharide  
The polysaccharide capsule forms the outer layer of S. pneumoniae, and is approximately 
200-400nm thick (Skov Sørensen et al., 1988). With the exception of serotypes 3 and 37, 
CPS is covalently attached to the cell wall peptidoglycan (Sørensen et al., 1990). Section 
1.3 outlined the roles that a few pneumococcal factors play in disease, with the CPS being 
the most prominent virulence factor. Indeed, within a given serotype, virulence has been 
shown to be directly related to capsular thickness (MacLeod and Krauss, 1950). 
Furthermore, although non-encapsulated pneumococci are able to colonise the upper 
respiratory tract and cause superficial eye infections, they rarely cause IPD (Keller et al., 
2016). Nevertheless, the CPS of S. pneumoniae impedes adherence and thereby the 
invasion of host cells, as it sterically hinders interactions between cell wall surface proteins 




and cognate host receptors (Talbot et al., 1996). However, pneumococci can greatly reduce 
CPS thickness during invasion of host cells (Hammerschmidt et al., 2005). 
The 100 structurally distinct CPS serotypes differ in capacity to inhibit opsonophagocytosis 
and switching of the CPS of a given S. pneumoniae strain results in marked differences in 
virulence for mice (Kelly et al., 1994). Such capsule switching occurs naturally, with 
elevated rates of recombination and substitution occurring within the cps locus compared 
to the rest of the genome (Mostowy et al., 2017). Despite the importance of the CPS during 
pathogenesis, it is likely disadvantageous during colonisation. This is because colonisation 
involves direct interaction between pneumococcal surface adhesins and receptors on host 
epithelial cells. Hence, the pneumococcal adhesins need the CPS to be downregulated in 
order to interact with host receptors. Indeed, progression from colonisation to disease 
involves major changes in the expression of a range of virulence determinants in order to 
adapt to the different host environments (Ogunniyi et al., 2012; Orihuela, Radin, et al., 
2004).  
1.5.2 Virulence proteins  
Virulence refers to the degree of pathology an organism is able to inflict on the host. The 
degree of virulence of a pathogen is often correlated with its ability to replicate in the host 
and may also be affected by other conditional factors. For example, pathogens encounter 
dynamic and varied nutritional host microenvironments that are altered during the course 
of disease. Hence, pathogens contain metabolic adaptations to nutrients such as 
carbohydrates (see section 1.5.6) that aid in virulence. S. pneumoniae possesses many 
surface and non-surface proteins that aid in virulence, and hence these are known as 
virulence proteins. A general overview of virulence proteins is given in Table 1.1. Well 
characterised examples include Pneumolysin, Choline-binding proteins such as PspA, 




PspC/CbpA and LytA, transporters such as PsaA, PiaA and PiuA, and various LPXTG-
anchored proteins (Figure 1.3).   
Pneumolysin (Ply) is a 52 kDa soluble protein that is a potent and broad acting virulence 
factor belonging to the family of cholesterol-dependant cytolysins, synthesised by Gram-
positive bacteria. Ply is present in essentially all pneumococcal isolates and its amino 
sequence is very conserved (Mitchell et al., 1990; Yun et al., 2015). However a few Ply 
variants have been found (Lock et al., 1996). Ply oligomorises within the membranes of 
target cells in groups of approximately 40 monomer subunits, forming large ring-shaped 
transmembrane pores roughly 260 Å in diameter. These oligomers are likely responsible 
for the cytolytic cell-modulatory activities of Ply, which include: inhibition of ciliary 
beating on respiratory epithelium and brain ependyma, inhibition of the phagocyte 
respiratory burst, and induction of cytokine synthesis and resultant CD4+ T-cell activation 
and chemotaxis (Hirst et al., 2004; Kadioglu et al., 2004). Ply has also been shown, via 
site-directed mutagenesis, to activate the classical complement pathway independently of 
its cell-modulatory activities (Mitchell et al., 1991). Numerous studies have shown that 
both complement-activation and cell-modulatory functions of Ply impact pneumococcal 
virulence (Alexander et al., 1998; Berry et al., 1995; Canvin et al., 1995; Jounblat et al., 
2003; Rubins et al., 1996). However, particular isolates of S. pneumoniae lacking 
haemolytic activity and complement-activating activity have been shown to be at least as 
virulent, if not more virulent, than isolates containing fully functional Ply, indicating 
additional unknown functions of this virulence factor (Alexander et al., 1998; Kirkham et 
al., 2006). Isolates without haemolytic activity of Ply are still able to cause TLR4 or IFN-
γ responses, which suggests that there are additional unknown functions of Ply (Baba et 
al., 2002; Malley et al., 2003).       
The Choline-binding proteins PspA, PspC/CbpA and LytA are well-characterised 
pneumococcal virulence factors, present on the cell wall, anchored to phosphorylcholine 




(ChoP) moieties on cell wall teichoic acid and lipoteichoic acid. These proteins contain 
approximately 20 amino acid repeat sequences that allow for attachment to the cell surface 
via ChoP. PspA is highly variable between pneumococci strains; based on its N-terminal 
sequence it can be grouped into three families, subdivided into 6 clades (Hollingshead et 
al., 2000). PspA inhibits complement component C3 from binding to the pneumococcal 
cell surface, likely through its highly electronegative properties (Jedrzejas et al., 2001). 
This protein also binds lactoferrin; hence it protects S. pneumoniae from apolactoferrin 
bactericidal activity (Shaper et al., 2004). PspC/CbpA is a cell-surface multifunctional 
protein, with pspC knock out (KO) mutants showing reduced adherence to epithelial cells 
and sialic acid in vitro, as well as reduced colonisation, compared to a wild type control 
(Rosenow et al., 1997). PspC can also bind the polymeric immunoglobulin receptor that 
transports secretory IgA (Hammerschmidt et al., 2000; Zhang et al., 2000). This function 
may allow the first stage of translocation across respiratory epithelium by subversion of 
the receptor recycling pathway (Asmat et al., 2014). Additionally, PspC is able to bind 
factor H (Dave et al., 2004; Janulczyk et al., 2000), preventing C3b formation via the 
alternative pathway of the complement system, thereby inhibiting opsonisation (Quin et 
al., 2005). Indeed, pspC KO mutants have reduced virulence in mouse pneumonia and 
sepsis models (Iannelli et al., 2004; Jounblat et al., 2003; Quin et al., 2005). LytA is an 
amidase that cleaves pneumococcal peptidoglycan N-acetylmuramoyl-L-alanine bonds, 
leading to cell autolysis, a hallmark feature when growing pneumococci in batch culture 
(Lysbo Svendsen et al., 1979). However, LytA also aids in cell-wall growth and turnover. 
LytA KO mutants had reduced virulence in pneumonia and sepsis murine models (Berry et 
al., 1989; Berry and Paton, 2000; Canvin et al., 1995; Orihuela, Gao, et al., 2004). LytA’s 
influence on virulence is likely due in part to the release of Ply and lipoteichoic acids and 
inflammatory peptidoglycan fragments from lysed pneumococci (Kadioglu et al., 2008; 
Mellroth et al., 2012).        




Cell-surface lipoproteins that have been shown to be essential for pneumococcal virulence 
include the metal-binding lipoproteins pneumococcal surface antigen A (PsaA), 
pneumococcal iron acquisition A (PiaA) and pneumococcal iron uptake A (PiuA). PsaA is 
a divalent metal-ion binding component of a manganese uptake ATP-binding cassette 
(ABC) transport system, which accommodates both zinc and manganese ions (Dintilhac et 
al., 1997; Lawrence et al., 1998). PsaA KO mutants were unable to grow without the 
addition of manganese (Dintilhac et al., 1997), were deficient in adherence to mammalian 
cells in vitro (Berry and Paton, 1996; Briles et al., 2000) and were avirulent in murine 
pneumonia, sepsis and colonisation models (Berry and Paton, 1996; Johnson et al., 2002; 
Marra et al., 2002; McAllister et al., 2004). Studies with psaA mutants suggest that 
manganese uptake is essential for resistance to oxidative stress due to the production of 
hydrogen peroxide during pneumococcal metabolism and generation of reactive oxygen 
species during host innate immune responses (McAllister et al., 2004; Tseng et al., 2002). 
PiaA and PiuA are the lipoprotein metal-binding proteins of two ABC iron and iron-carrier 
uptake transporters (Cheng et al., 2013; Whalan et al., 2005). Redundancy is seen between 
the transporters, as both must be deleted to induce significant reduction in growth in iron-
deficient medium. However, mutations in either of these transporters leads to decreases in 
virulence in murine pneumonia and sepsis models, while a double mutant showed the 
greatest decrease in virulence (Brown, Gilliland, et al., 2002).     
The pneumococcal sortase transpeptidase (StrA) recognises the LPXTG amino acid motif 
in certain surface proteins, covalently anchoring them to the peptidoglycan. S. pneumoniae 
strains can contain either a single or multiple sortase-like genes (Bergmann and 
Hammerschmidt, 2006). Murine, chinchilla and in vitro adhesion models show SrtA plays 
roles in pneumococcal colonisation, pneumonia and septicaemia (Chen et al., 2005; Kharat 
and Tomasz, 2003; Paterson and Mitchell, 2006b). Up to 20 pneumococcal proteins, 
including neuraminidases and Hic, in some serotypes, are believed to be anchored by an 




LPXTG motif (Bergmann and Hammerschmidt, 2006; Iannelli et al., 2002). 
Neuraminidases, known also as sialidases, cleave terminal sialic acid residues off 
glycoproteins, glycolipids, cell surface oligosaccharides and even soluble proteins such as 
lactoferrin and IgA2 (King et al., 2004). The pneumococcus produces at least three 
neuraminidases: NanA, NanB and NanC. NanA is present in all strains, NanB in most, 
while NanC is present in an estimated 50% of strains (Pettigrew et al., 2006). All these 
neuraminidases are secreted, though only NanA contains an LPXTG sequence, suggesting 
differing allele locations and functions, which is supported by the observation that NanB 
has a drastically lower optimum pH than NanA (Berry et al., 1996). Loss of function 
neuraminidase mutants in an acute pneumonia murine model demonstrated that both NanA 
and NanB play roles in pneumococcal persistence in the respiratory tract and bloodstream 
(Manco et al., 2006). NanC, with its primary reaction product being a nonspecific sialidase 
inhibitor (Owen et al., 2015), was found to be more common in isolates from cerebrospinal 
fluid compared to carriage isolates (Pettigrew et al., 2006).  
 
 
Figure 1.3. Virulence of Streptococcus 
pneumoniae is impacted by many 
different factors. Important and well 
characterised virulence factors include: 
the capsule; the cell wall; choline-binding 
proteins; pneumococcal surface proteins 
A and C (PspA and PspC); the LPXTG-
anchored neuraminidase proteins; 
hyaluronate lyase (Hyl); pneumococcal 
adhesion and virulence A (PavA); 
enolase (Eno); pneumolysin; autolysin A 
(LytA); and the metal-binding proteins 
pneumococcal surface antigen A (PsaA), 
pneumococcal iron acquisition A (PiaA) 
and pneumococcal iron uptake A (PiuA). 









Table 1.1. Major pneumococcal virulence factors. Adapted from Weiser et al. (2018). 




Prevents entrapment by mucus during 
colonization 
A. L. Nelson 
et al, 2007 
100 structurally 
distinct serotypes 
Inhibits opsonophagocytosis by preventing 
the interaction of iC3b and the Fc fragment 
of IgG bound to deeper bacterial surface 
structures with receptors on phagocytic cells 
Hyams et al, 
2010 
ChoP on teichoic 
acid PAFR ligand 
Binds PAFR on surface of epithelial and 













et al, 1999; 
Seo et al, 
2008 
Ply 
Pore-forming toxin Cytotoxic and pro-apoptotic for a wide variety of host cells 
Rubins et al, 
1996 
TLR4 ligand Activates classical complement pathway and depletes serum opsonic activity 
Andre et al, 
2017 
 
Highly pro-inflammatory at sub-lytic levels 
García-
Suárez et al, 
2007  




PspA Choline binding protein 
Limits C3 deposition on pneumococcal 
surface 
Tu et al, 
1999 
Protects against bactericidal effects of free 
lactoferrin 
Shaper et al, 
2004 
CbpA (also 
known as PspC) 
Choline binding 
protein 
Binds C3 and factor H and limits C3b 
deposition on pneumococcal surface 
Lu et al, 
2006 
Binds PIGR and laminin receptor through 
separate domains 
Lu et al, 
2003 
Facilitates adherence and invasion of 
respiratory epithelium and blood–brain 
barrier 








Autolysin Releases Ply and pro-inflammatory cell wall fragments 
López et al, 
1997  











Murein hydrolase Promotes biofilm formation Moscoso et al, 2006 
CbpE (also 
known as Pce) 
Choline binding 
protein 
Decreases neutrophil activity by inactivation 
of host PAF 
Hergott et al. 
2015 
Phosphorylcholine 
esterase Binds plasminogen 






Cell-attached form promotes adherence Mann et al, 2006 
Extracellular form degrades fibronectin Mann et al, 2006 
Important for mucosal and invasive disease Mann et al, 2006 
CbpL Choline binding protein 









Promotes dissemination from nasopharynx 






Neuraminidase A Cleaves terminal sialic acid from host mucin and cell surface glycoconjugates 
Manco et al, 
2006 
LPXTG binding 
domain Unmasks receptors for adhesins 
Manco et al, 
2006  
Important role in otitis media Wren et al, 2017  
Triggers TGF-β signalling to facilitate 
endothelial invasion 
Gratz et al, 
2017 
BgaA 
β-Galactosidase Sequentially cleaves sugars from host 
glycoconjugates 
Singh et al, 





ase Sequentially cleaves sugars from host glycoconjugates 







ase Sequentially cleaves sugars from host glycoconjugates 
Muramatsu 











known as IgA1 
protease) 
Zinc 













Binds fibronectin and plasminogen and 
Facilitates adherence and invasion 
Agarwal et 
al, 2013 







rich repeat protein Adhesin, bind to lung cells via keratin 10 
Shivshankar 
et al. 2009 
LPXTG binding 
domain Mediates bacterial aggregation and biofilm 
formation in lung tissue 
Blanchette-
Cain et al. 
2013 
RrgA, RrgB and 
RrgC 
LPXTG proteins 
Adhesins, bind to a range of glycans 
Gentile et al, 
2011; A L 
Nelson et al, 
2007; Shaik 
et al, 2014 
Structural 





Facilitate colonization and biofilm formation 
LeMieux et 
al, 2006 
RrgA is tip adhesin 
RrgA also binds PIGR and PECAM1 on 
endothelium of the blood–brain barrier, 
which promotes brain invasion 
Iovino et al, 
2017 











Essential for pneumococcal resistance to 
oxidative stress in vivo 
Johnston et 
al. 2004 
AdcA and AdcAII 
Lipoproteins 
Zn acquisition in vivo 
Bayle et al, 
2011 Solute-binding 
components of a 
single Zn-specific 
ABC transporter 
PiuA, PiaA and 
PitA 
Lipoprotein 







SlrA and PpmA 
Lipoproteins 
Contribute to nasopharyngeal colonization 






PhtA, PhtB, PhtD 
and PhtE 





Kallio et al, 
2014 




PavA and PavB 
Fibronectin-binding 
proteins Adhere to host surfaces and important 
during sepsis and meningitis 
Jensch et al, 
2010; Pracht 
et al, 2005 NCSP 







Binds and activates plasminogen 
Bergmann et 
al. 2004 




GlpO α-Glycerophosphate oxidase 
Generates H2O2 and is important during 
sepsis and meningitis 






Resistance to oxidative stress 
Yesilkaya et 
al, 2000 




Resistance to oxidative stress 
Saleh et al, 
2013 
SpMsrAB2 Methionine sulfoxide reductase Redox partner of Etrx1 and Etrx2 
Saleh et al, 
2013 
 
1.5.3 Competence and natural transformation    
Competence is the ability of bacterial cells to take up extracellular DNA (eDNA) and 
integrate it into their genomes via recombination, allowing the reparation of damaged DNA 
or the acquisition of new traits such as antibiotic resistance or virulence proteins (Alloing 




et al., 1996; Johnston et al., 2014). Homologous recombination is required for successful 
integration of eDNA, hence the more similar eDNA is to the genome, the more likely 
recombination will occur (Mell and Redfield, 2014). The proteins synthesised from the 
comABCDE operon control competence in pneumococci. ComC encoded pre-CSP is 
exported via the ComAB ABC transporter/protease, where it’s cleaved into the 
competence-stimulating peptide (CSP) upon entering the extracellular matrix (Håvarstein 
et al., 1995). CSP then accumulates extracellularly and subsequently binds and activates 
the ComD histidine kinase receptor, which is part of the ComDE two component signal 
transduction system. This results in ComD auto-phosphorylation, and subsequent transfer 
of this phosphoryl group on ComD to ComE. ComE-P binds to and activates early 
competence genes containing the Ceb promoter sequence. These include the comABCDE 
genes, comM, which provides cellular immunity against lytic enzymes, and comX encoding 
an alternative sigma factor (Håvarstein et al., 2006; Martin et al., 2013; Peterson et al., 
2004). ComX controls activation of the late competence genes needed for DNA-uptake, 
transformation and fratricide. Fratricide is the targeted lysis of non-competent 
pneumococci by competent siblings, and is one method pneumococci use to access highly 
homologous DNA (Steinmoen et al., 2002). This process also aids in pathogenicity by 
regulating the release of virulence factors such as Ply (Claverys and Håvarstein, 2007). The 
murein hydrolase choline binding protein D (CbpD) and the early immunity protein ComM 
play key roles in lysing target cells (Eldholm et al., 2009; Kausmally et al., 2005). It was 
originally thought that fratricide only enables gene integration between pneumococci, but 
it has been shown that CbpD results in DNA release by closely related species, including 
S. mitis and S. oralis, by binding to choline containing teichoic acids (Eldholm et al., 2010; 
Johnsborg et al., 2008). Meanwhile, bacteriocins, the small ribosomal peptide antibiotics, 
facilitate antagonistic affects to differing bacterial species within the same ecological 
niches, providing a competitive advantage for pneumococci (Wang and Kuramitsu, 2005). 




Competence in Streptococci has been shown to be tightly linked with bacteriocin 
production, mediated through a variety of regulatory pathways (Shanker and Federle, 
2017). Indeed, lysis of non-competent S. pneumoniae relies on the two peptide bacteriocin 
CibAB, which targets cells lacking the corresponding immunity factor CibC (Guiral et al., 
2005). 
1.5.4 Biofilms 
Biofilms are highly structured collections of cells that adhere together embedded within 
extracellular polymeric substances comprised of extracellular DNA, proteins and 
polysaccharides produced by the bacteria (Hall-Stoodley et al., 2004). S. pneumoniae 
colonise the nasopharynx as biofilms as part of microbial communities, which is recognised 
as a crucial step in pneumococcal pathogenesis (Hall-Stoodley et al., 2004). Biofilms are 
complex structures that facilitate bacterial persistence by providing protection from 
antimicrobial drugs and contain channels through which nutrients and signalling molecules 
can circulate, also enabling pneumococcal genetic exchange to take place (Cho et al., 2007; 
Costerton et al., 1999; Donlan and Costerton, 2002; Lewis, 2008; Marks et al., 2012). 
Increased antibiotic-resistance of biofilm bacteria is attributed to lower penetration of the 
selected drug into biofilm structures, and with corresponding phenotype shifts of biofilm 
bacteria (de la Fuente-Núñez et al., 2013; Nguyen et al., 2011). In fact, majority of bacterial 
species within the nasopharynx are not cleared from patients after antibiotic treatment 
(Cohen et al., 1997; Dabernat et al., 1998; Dagan et al., 1998; García-Rodríguez and 
Fresnadillo Martínez, 2002). Biofilms present during OM or chronic rhinosinusitis provide 
potential reservoirs from whence virulent bacteria can seed under the right conditions 
(Oggioni et al., 2006; Sanchez et al., 2011; Weimer et al., 2010). 
Bacterial cells in biofilms are very close to each other, as well as to surrounding DNA. This 
provides an optimum environment for the exchange of genetic material, promoting survival 




and adaptation to the host environment. Moreover, studies suggest that pneumococci 
dispersed from biofilms have distinct phenotypes. In vivo murine models of colonisation 
and dissemination have shown biofilm dispersed S. pneumoniae were able to colonise the 
nasopharynx at higher levels than broth-grown pneumococci (Trappetti et al., 2011) and 
disseminate to the middle ear and lungs at higher levels as well (Marks et al., 2013). 
Histological examination showed that mice infected with biofilm-dispersed S. pneumoniae 
had higher levels of inflammation and leukocyte infiltrates in the lungs, blood and middle 
ear, compared to planktonic S. pneumoniae-infected counterparts (Blanchette-Cain et al., 
2013). These differences in virulence between biofilm, planktonic and biofilm dispersed 
bacteria suggest key transcriptomic differences, as another study showed virulence genes 
are down regulated in biofilm bacteria compared to broth-grown (Sanchez et al., 2011). 
Moreover, environmental changes that influence transcriptional changes, such as fever, ion 
concentrations, nutrient availability and pro-inflammatory cytokines (Grebe et al., 2010; 
Weiser, 2010), can trigger biofilm dispersal (Marks et al., 2013).      
1.5.5 Quorum sensing 
Quorum sensing (QS) is a communication process used by both Gram-negative and Gram-
positive bacteria to coordinate population-wide responses. Three types of known QS 
systems in bacteria are; LuxI/LuxR-type QS in Gram-negative bacteria, oligopeptide-two 
component-type QS in Gram-positive bacteria and LuxS-mediated autoinducer 2 (AI-2) 
QS. Pneumococcal QS systems are classified into general groups based on the small 
peptide signals known as pheromones and their receptors; the RNPP family of regulators, 
double glycine peptides and Lanthinonine-containing cyclic peptides. Pheremones are 
released by Gram-positive bacteria and sensed in a concentration depended manner by 
neighbouring cells, eliciting a response such as competence regulation, biofilm 
development, symbiosis, sporulation and virulence factor expression (Johnston et al., 
2014). As this process is based on concentrations of peptides, conditions that alter peptide 




concentration (e.g. diffusion, signal degradation, sequestration, etc) impact the ability of 
bacteria to communicate.     
The oligopeptide QS ComABCDE pathway and associated fratricide, as described in 
section 1.5.3, is one of the most well characterised examples of QS in S. pneumoniae. 
Another QS system in the pneumococcus is the BlpABCSRH pathway, which is similar to 
the Com pathway, as it regulates the production of class II bacteriocins and their 
corresponding immunity proteins (Knutsen et al., 2004). The Peptide BlpC activates the 
histidine kinase receptor BlpH, which in turn phosphorylates the response regulator BlpR 
(de Saizieu et al., 2000). Upon BlpC induction, blpABC, blpXYZ, and blpSRH, as well as 
several putative bacteriocins and related immunity protein genes that constitute the 
Bacteriocin Immunity Region (BIR), are upregulated (Dawid et al., 2007, 2009; de Saizieu 
et al., 2000). It has been demonstrated that the the ComABCDE and BlpABCSRH QS 
systems are linked, as exogenous CSP upregulated the blp operon, even when the comAB 
locus was deleted (Wholey et al., 2016).  
The LuxS/AI-2 QS system is present in both Gram-positive and Gram-negative bacteria. 
Here AI-2 synthesis is catalysed by the metabolic enzyme LuxS, which generates the 
precursor to AI-2, 4,5-dihydroxy-2,3-pentanedione (DPD) as a by-product of the 
conversion of S-ribosylhomocysteine into homocysteine, an integral reaction of the 
activated methyl cycle (Winzer et al., 2003). Pneumococcal strains lacking luxS showed 
significant decreases in biofilm formation and virulence after murine intranasal challenge 
(Stroeher et al., 2003; Trappetti et al., 2017; Yadav et al., 2018) 
1.5.6 Carbohydrate metabolism  
S. pneumoniae is a fermentative bacterium, relying solely on glycolysis for energy, as it 
lacks an entire set of genes involved in the tricarboxylic acid cycle and an electron transport 
chain (Hoskins et al., 2001; Tettelin et al., 2001). This critical role for carbohydrates is 




highlighted by the large number of sugar transporter genes present in the pneumococcal 
genome with more than 30% of all encoded transporters involved in carbohydrate uptake 
(Bidossi et al., 2012; Tettelin et al., 2001). At least 32 different carbohydrates are imported 
through 21 phosphotransferase systems (PTS) and 8 ABC transporters (Bidossi et al., 
2012).  
Carbohydrates imported into pneumococcal cells undergo glycolysis, where two ATP 
molecules and two NADH molecules are gained from the conversion of one molecule of 
glucose to two molecules of pyruvate. Pyruvate is then metabolised primarily to lactate via 
a lactate dehydrogenase, which regenerates NAD+ (Harris and Harper, 2015). The 
oxidation of NADH to NAD+ maintains redox balance, and this NADH-NAD+ balance 
appears to regulate pneumococcal fermentation. An excess of easily convertible sugars, 
such as glucose, as well as low oxygen tension, leads to a high NADH-NAD+ ratio, which 
results in homolactic fermentation, where two molecules of lactic acid are generated 
(Gänzle, 2015). Contrastingly, low glycolytic flux, such as during an excess of non-readily 
convertible sugars, and high oxygen tension, results in pneumococci undergoing mixed 
acid fermentation where ethanol, acetate and formate are produced (Kandler, 1983; 
Yesilkaya et al., 2009).    
Glucose is S. pneumoniae’s preferred source of carbon and energy (Carvalho et al., 2011) 
and is transported into the cell largely through PTS MalN-MalLM system. If glucose is 
transported via an ABC transporter, it is phosphorylated by a glucokinase Gki before 
entering the glycolytic pathway. However, free sugars are scarce in the human respiratory 
tract where the pneumococcus principally lives, with concentrations of glucose under 1 
mM (Philips et al., 2003). To overcome this limitation, the pneumococcus employs a range 
of extracellular glycosidases, such as NanA, BgaA and StrH, that are able to cleave sugars 
from N-linked glycoconjugates present on epithelial surfaces (King, 2010). The sugars are 
then able to be taken up by the appropriate ABC or PTS transporters. Many glycosidases 




that pneumococci possess target specific structures of sugars. For example, the β-
galactosidase activity of BgaA only targets galactose β1-4 linked to N-acetylglucosamine, 
which is generally found in N-linked glycaoconjugates, while NanA cleaves α2-3- and α2-
6-linked sialic acid. In fact, S. pneumoniae is able to grow solely on mucins, which are 
glycosylated macromolecules with a majority make up of carbohydrates, as a carbon source 
(Rose and Voynow, 2006).  It has also been shown that pneumococci can alter capsule 
structures of certain other bacteria such as Neisseria meningitidis and Haemophilus 
influenzae to scavenge surface carbohydrates (Shakhnovich et al., 2002) and are able to 
grow on solely purified Group A Streptococcus capsule as a carbon source (Marion et al., 
2012).     
During pathogenesis, S. pneumoniae encounters several distinct environmental niches that 
contain various constituent nutrients, including carbohydrates, at differing levels. Hence, 
it is vital for pneumococci to be able to ferment a diverse range of carbohydrates. Indeed, 
genes encoding for 20 carbohydrate transporters are present in S. pneumoniae’s core 
genome (Obert et al., 2006). In comparison, other airway commensal and pathogenic 
bacteria, sharing the same ecological niche, such as N. meningitidis, H.influenzae and 
Morxaella catarrhalis have much more limited carbohydrate utilisation capabilities, 
though Staphylococcus aureus is an exception (Egan and Morse, 1966; Leighton et al., 
2001; Macfadyen et al., 1996; de Vries et al., 2010). These other bacterial species do not 
solely rely on carbohydrates for carbon and energy. Nevertheless, it is likely that the ability 
of S. pneumoniae to utilize a wider variety of carbohydrates provides a competitive 
advantage against other bacteria in human host niches.  
Additionally, as the pneumococcus encounters a wide variety of carbon sources, it opts to 
preferentially use glucose or sucrose over other sugars, in order to maintain optimal growth 
via the catabolite control protein A (CcpA). This process is referred as carbon catabolite 
control, and prevents simultaneous utilisation of sugars, which would be metabolically less 




efficient (Iyer et al., 2005). When there is excess glucose, the kinase HPrK phosphorylates 
the phosphoprotein HPr which mediates carbon catabolite repression via CcpA dependant 
and independent mechanisms. (Carvalho et al., 2011; Fleming et al., 2015; Iyer et al., 
2005). Moreover, a mouse study found that ccpA deletion mutants were severely attenuated  
in both nasopharyngeal colonisation and lung infection, suggesting a link between 
carbohydrate metabolism and pneumococcal virulence (Iyer et al., 2005). 
It has been shown that the metabolic capabilities of Streptococci are highly adapted to the 
environments in which they live (Price et al., 2012). Nevertheless, the pneumococcus is a 
human adapted bacterium, which is able to take up and metabolize a range of plant-derived 
sugars (Bidossi et al., 2012; Hiss, 1905; McKessar and Hakenbeck, 2007; Rosenow et al., 
1999; Shafeeq et al., 2011). The metabolism of S. pneumoniae seems to be closer to oral 
streptococci than other human airway pathogens (Sitkiewicz, 2018). Hence, there is the 
possibility that the pneumococcus evolved from an ancestral oral streptococcal lineage, 
which also had wide carbohydrate metabolic capabilities. Though it is also possible that S. 
pneumoniae along with other members of the Mitis groups evolved from an ancestral 
lineage presumed to be pathogenic to hominoids (Kilian et al., 2008).   
1.6 Genomic Diversity  
S. pneumoniae’s genome is incredibly diverse, as this species can be divided into over 
12000 different clonal clusters, recognised through multi locus sequence typing (ST) 
(Enright and Spratt, 1998).  Moreover, pneumococcal genes are distributed across the 
population (referred to as the pangenome). At least 20% of the coding sequences in any 
single pneumococcal isolate are not present in all strains, but rather make up part of the 
accessory genome, which is unevenly distributed across all isolates (Donati et al., 2010; 
Hiller et al., 2007). This provides the pneumococcus additional sets of accessory genes to 
draw from, for optimum adaptation to its environment. TIGR4, the first pneumococcal 




genome to be sequenced, is approximately 2 megabases in length and contains roughly 
2200 coding sequences (Tettelin et al., 2001). The pneumococcal genome has been 
estimated to encode 500-1100 clusters of orthologous genes, while the pangenome encodes 
between 5000-7000 orthologous clusters (Croucher, Finkelstein, et al., 2013; Donati et al., 
2010; Gladstone et al., 2015; Tonder et al., 2017). Hence, approximately three quarters of 
all pneumococcal genes are distributed differentially across the species.  
The accessory genome allows pneumococci to exchange DNA in settings such as biofilms 
in the nasopharynx, leading to strains with novel combinations of genes that may provide 
advantages to evade host immune responses, outcompete other colonisers or escape 
antibiotics (Ehrlich et al., 2005). However, the accessory genome is not solely derived from 
pneumococcal genes, as other colonisers of the upper respiratory tract such as S. mitis, S. 
pseudopneumoniae, S. oralis and S. infantis can contribute considerably to the 
pneumococcal pangenome (Donati et al., 2010; Kilian et al., 2008). Plasmids also 
contribute to the genetic variation seen within pneumococci, as the plasmid pDP1 was 
found in approximately 3% of all tested isolates (Sibold et al., 1991; Smith and Guild, 
1979). However, no specific function has been described for this plasmid, or other 
unrelated plasmids (Santoro et al., 2019).      
Many factors contribute to S. pneumoniae’s striking ability to undergo genetic exchange, 
including their natural competence and biofilm lifestyle in the upper respiratory tract, as 
detailed above. Human intervention has also been shown to activate competence, as 
multiple classes of antibiotics are able to indirectly increase local CSP concentrations 
(Domenech et al., 2018; Prudhomme et al., 2006; Stevens et al., 2011). Additionally, 
pneumococci are able to protect internalised ssDNA through the production of single 
stranded DNA binding proteins (SsbB), which can protect the equivalent of half a genome 
of intracellular DNA. These resulting ssDNA-SsbB complexes can be used in subsequent 
recombination events, serving as DNA reservoirs (Attaiech et al., 2011). Moreover, the 




recombination machinery of S. pneumoniae allows for highly divergent alleles or novel 
genes to be inserted, as it does not require extended runs of identical sequences for 
recombination to occur (Prudhomme et al., 2002).       
S. pneumoniae is also able to perform genetic exchange through transduction, which is the 
horizontal gene transfer mediated by prophages that undergo lytic and lysogenic life cycles. 
During the lysogenic phase, these prophages are integrated into the pneumococcal genome. 
In the lytic phase, prophages are excised from the host genome, which then replicate and 
lyse the host cell in order to infect other bacterial cells. Prophages are ubiquitous and 
heavily present within pneumococcal genomes, present in up to 76% of tested strains 
(Ramirez et al., 1999). The phage integrase dictates the location where a phage integrates 
into the genome, with most pneumococcal prophages located within one of a few conserved 
locations (Brueggemann et al., 2017). Studies have highlighted the importance of prophage 
genes in the pneumococcal genome, with the ϕMM1-like phage increasing adherence to 
pharyngeal cells and inert surfaces (Loeffler and Fischetti, 2006). Additionally, the phage 
tail protein PblB promotes pneumococcal adherence to human epithelial cells, while also 
increasing nasopharyngeal colonisation and lung infection in murine pneumococcal disease 
models (Harvey et al., 2011; Hsieh et al., 2015). The Spn1 prophage also leads to defects 
in pneumococcal autolysis, increased chain length of pneumococci, decreased fitness in 
murine colonisation models and increased resistance to penicillin-mediated lysis 
(DeBardeleben et al., 2014). The genomes of S. pneumoniae also encode phage-related 
chromosomal islands (PRCIs) that are presumed to hitchhike with prophages as they are 
incapable of lytic cycles (Novick et al., 2010). However, the distribution of PRCIs is much 
less diverse than prophages, likely due to limited lateral transfer or the high specificities 
between PRCIs and subsets of prophages. 
Conjugation, which is the process of one bacterium transferring genetic material to another 
through direct contact, is another method used by S. pneumoniae for horizontal gene 




transfer of integrative and conjugative elements (ICEs). ICEs consist of conjugative 
transposons or integrative plasmids and undergo vertical transfer once inserted into the 
genome. They can alternatively undergo horizontal transfer between strains after being 
excised from the recipient genome (Burrus et al., 2002). ICEs can contain several kilobases 
of genomic material, hence allowing for significant genetic diversity to emerge from even 
one transfer event. Moreover, ICEs have a propensity to carry drug resistance genes and 
cassettes that confer resistance to antibiotics such as macrolides, tetracycline and 
chloramphenicol (Ayoubi et al., 1991; Chancey et al., 2015; Croucher et al., 2009).  
To summarise, recombination, transformation, transduction and conjugation all play 
important roles that drive S. pneumoniae’s genetic diversity and evolution. The great extent 
of pneumococcal genetic diversity is highlighted in its separation into 100 structurally 
distinct capsular serotypes, which is superimposed onto over 12000 different clonal 
lineages/ sequence types distinguished by multi-locus sequence typing (ST).  
1.7 Research Project 
1.7.1 Rationale for project 
Previous studies have independently shown that strains within the same CPS serotype and 
clonal lineage/ST display distinct niche adaptation in mice, depending on their original site 
of isolation in humans (Amin et al., 2015; Croucher, Mitchell, et al., 2013; Silva et al., 
2006; Trappetti et al., 2013). In the studies from the Paton lab, murine intranasal challenge 
models were used which mimic the natural route of infection. Serotype 3 (ST180, ST232 
and ST233) blood isolates did not stably colonise the nasopharynx, but spread to the blood 
in 10/15 mice, while none spread to the ear. In contrast, ear isolates belonging to the same 
STs colonised the nasopharynx at higher levels and also spread to the ear in 7/15 mice; 
none caused bacteraemia (Trappetti et al., 2013). Meanwhile, serotype 14 (ST15) clinical 
blood isolates exhibited higher tendencies to infect the lungs compared to serotype/ST 




matched ear isolates. On the other hand, the serotype 14 ST15 ear isolates infected the ear 
and brain at higher levels than their corresponding blood isolates, while both colonised the 
nasopharynx stably and neither caused bacteraemia (Amin et al., 2015). Both the serotype 
3 and 14 isolates are clinically relevant as these serotypes are common causes of invasive 
disease. Moreover, Serotype 3 is a common cause of OM and serotype 14 is highly 
prevalent in children (Grabenstein and Musey, 2014; Weinberger et al., 2010). 
This project was initiated to investigate the molecular differences that determine in vivo 
behaviour of blood and ear isolate pairs from each of the serotype 3 and 14 S. pneumoniae 
strains mentioned above. Although members of the same ST type have very closely related 
genetic backbones, they are not necessarily identical as they may have acquired distinct 
accessory regions, random mutations from replication errors or other genetic changes 
through horizontal gene transfer, which may account for differences seen in the niche 
adaption/virulence phenotype. The distinct phenotypes could also be due to differential 
expression patterns of core virulence-related or metabolic genes, post-transcriptional 
modifications, or a combination of scenarios. This project was designed to benefit from the 
involvement of our laboratory with the Antibiotic Resistant Sepsis Pathogens Framework 
Initiative consortium, coordinated by Bioplatforms Australia, which aimed to provide 
multi-omic analyses of various sepsis pathogens, including S. pneumoniae. It had been 
predetermined that omic analyses would be carried out in chemically defined media (CDM) 
+ Glucose (Glc) or Galactose (Gal) or in human serum.  
1.7.2 Hypothesis, aims and strategy 
Hypothesis: Strains of S. pneumoniae of the same serotype and sequence type that spread 
to the different sites of the body (e.g. ear vs blood), although very similar, may contain 
distinct molecular differences that result in their varied disease progression. Genomic and 
transcriptomic comparisons of these serotype- and sequence type-matched strains, will 




elucidate key molecular mechanisms that drive pneumococcal progression into specific 
sites of the body. 
Aim 1: Investigate the genomic features that distinguish ear and blood isolates within a 
given clonal lineage and examine their impacts on in vitro and in vivo phenotypes.  
Aim 2: Investigate which transcriptomic features that distinguish ear and blood isolates 
within a given clonal lineage and examine their impacts on in vitro and in vivo phenotypes. 
Aim 3: Investigate both the pneumococcal and host transcriptomic features that determine 
the virulence/pathogenic phenotype of S. pneumoniae in vivo. 
Strategy: As this project generated an immense amount of data, the following strategy was 
followed to prioritise the research. Genomic and transcriptomic differences found 
commonly within both the blood and ear isolate pairs will firstly be examined, as these 
findings are more likely to be widespread across S. pneumoniae strains. However, as the 
pneumococcus is a genetically diverse species there may not be many, if any common 
differences between the isolate pairs. If this is the case, examinations will begin on 
differences present within each of the pairs separately, with differences that have been 
shown to impact pneumococcal disease to be prioritised. The following Chapters detail the 
experimental techniques used to examine and analyse the findings. 





Genomic Comparisons of S. 
pneumoniae Clonal Clinical Isolates 
 
2.1 Introduction  
This Chapter incorporates data published in mBio (Minhas et al., 2019),which focuses 
mainly on mutations within the raffinose transport operon, and their impacts on 
pneumococcal disease progression. Additional data and discussion have been included in 
order to provide more detail on the work that was undertaken regarding the genomic 
comparison analyses as a whole.  
As detailed in Chapter 1, S. pneumoniae is one of the world’s foremost bacterial pathogens, 
yet it can asymptomatically colonise the nasopharynx. This provides a reservoir for 
pneumococcal transmission in the community (Kadioglu et al., 2008; Weiser et al., 2018). 
In a small proportion of carriers, which nevertheless translates into globally significant 
numbers, S. pneumoniae invades from its nasopharyngeal reservoir around the body to 
cause disease (section 1.3) (Kadioglu et al., 2008; Weiser et al., 2018). However, the 
molecular mechanisms whereby pneumococci transition from a commensal lifestyle to 
cause either localized or invasive disease are poorly understood. 
 
The pneumococcus is a genetically plastic and diverse species, comprising at least 100 
capsular serotypes, superimposed on more than 12,000 clonal lineages (sequence types 
[STs]) recognizable by multilocus sequence typing (Enright and Spratt, 1998). 
Individual S. pneumoniae strains can differ markedly in their virulence phenotypes, 
including their capacity to colonise the nasopharynx, spread from person to person, or 
progress to either localised or invasive infections. Capsule switching experiments have 
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shown that both serotype and genetic background (i.e., ST) influence virulence (Kelly et 
al., 1994; McAllister et al., 2011), but strain complexity has complicated attempts to 
examine whether there is any association between a given clonal lineage or serotype and 
propensity to cause localized rather than invasive infections.    
 
To determine potential disease mechanisms of S. pneumoniae, the serotype 3 ST180 and 
serotype 14 ST15 blood and ear isolate pairs were utilised in a multi-omics study in 
collaboration with Bioplatforms Australia as explained in section 1.6.1. Here, these strains 
were subjected to comprehensive analyses, including Illumina MiSeq and PacBio SMRT 
genome sequencing, to obtain fully closed genomes, as well as transcriptomic (RNAseq) 
sequencing. To address aim 1 of this project, the genomic sequences between each serotype 
and ST matched pair were compared to identify any differences present. Analysis of this 
data allowed a thorough examination of the molecular mechanisms of serotype 3 and 14 
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2.2 Materials and Methods  
 2.2.1 Bacterial strains and growth conditions  
The bacterial strains used in this Chapter are listed in Table 2.1. S. pneumoniae strains 
were routinely grown in casein-based, semisynthetic liquid medium (C+Y) (Lacks and 
Hotchkiss, 1960) or serum broth (SB) (10 g/l peptone [Oxoid], 10 g/l Lab Lemco poweder 
[Oxoid]. 5 g/l NaCl and 10% (v/v) heat –inactivated horse serum [Gibco®, Auckland, New 
Zealand]) as required. Growth assays were performed using a chemically defined medium 
(CDM) comprising RPMI 1640 medium (Sigma-Aldrich, St. Louis, United States), 
supplemented with amino acids, vitamins, choline, and catalase as described previously 
(Kloosterman et al., 2006), supplemented with either 0.5% glucose or 0.5% raffinose. 
Bacteria were routinely plated on Columbia agar (39 g/l [Oxoid]) supplemented with 5% 
(vol/vol) defibrinated horse blood (BA) with or without gentamicin (40 µg/ml), kanamycin 
(500 µg/ml), or streptomycin (150 µg/ml) (as required) and incubated at 37°C in 5% 
CO2 overnight. For gene expression analyses, strains were grown in CDM + glucose (Glc) 
medium to an Optical Density at 600 nm (OD600) of 0.2, before being incubated in CDM + 
raffinose (Raf) for 30 min. E. coli strain were routinely grown in Luria-Bertani (LB) broth 
or agar (10 g/l trypton, 5 g/l yeast extract and 5 g/l NaCl), with or without 1.5% Bacto 
Agar. 
2.2.2 Genome sequencing  
S. pneumoniae strains were grown to mid-exponential phase in Todd-Hewitt (THY) broth 
supplemented with 1% yeast extract (Becton, Dickinson and Company, New Jersey, USA). 
Genomic DNA (gDNA) was extracted using the Qiagen genomic DNA buffer set with 
100/g Genomic Tips according to the manufacturer’s instructions, except mutanolysin 
(20 U) and sodium deoxycholate (0.1%) were included to aid cell lysis. The gDNA was 
sequenced at the Ramaciotti Centre for Genomics (University of New South Wales, 
Sydney, Australia). Illumina MiSeq (250-bp paired-end reads), as well as a PacBio RSII 
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instrument using one SMRT cell per strain, a 20-kb insert library, and the P6 polymerase 
and C4 sequencing chemistry were used for genomic sequencing before de novo assembly 
(Gladman, 2018). 
Table 2.1. Bacterial strains used in this Chapter. 
Strain Description Source Reference 
4559 S. pneumoniae serotype 14 ST15 Blood Amin et al., 2015 
947 S. pneumoniae serotype 14 ST15 Ear Amin et al. 2015 
4534 S. pneumoniae serotype 14 ST15 Blood Amin et al, 2015 
51742 S. pneumoniae serotype 14 ST15 Ear Amin et al, 2015 
4559947rafR 4559 expressing 947 rafR gene  This study 
9474559rafR 947 expressing 4559 rafR gene  This study 
180/15 S. pneumoniae serotype 3 ST180 Blood Trappetti et al, 2013 
180/2 S. pneumoniae serotype 3 ST180 Ear Trappetti et al, 2013 
180/15 ΔrafK 180/15 with rafK deletion  This study 
180/2 ΔrafK 180/2 with rafK deletion  This study 
5076 S. pneumoniae serotype 23F ST81 Blood This study 
9725241 S. pneumoniae serotype 23F ST81 Ear This study 
XL10pAL2  
E. coli XL10 containing the empty T7 
vector pAL2  Chai, 2016 
947pAL2 
947 containing the empty T7 vector 
pAL2  This Study 
51742pAL2 
51742 containing the empty T7 vector 
pAL2  This Study 
XL10pAL2:4559rafR 
E. coli XL10 containing pAL2 with 
rafR from 4559 inserted  This Study 
947pAL2:4559rafR 
947 containing pAL2 with rafR from 
4559 inserted  This Study 
51742pAL2:4559rafR 
51742 containing pAL2 with rafR 
from 4559 inserted  This Study 
4559RafE RGD→HAE 
4559 with the RGD motif of RafE 
mutated to HAE  This Study 
947RafE RGD→HAE 
947 with the RGD motif of RafE 
mutated to HAE  This Study 
 
 2.2.3 Bioinformatic analyses  
The Artemis Comparison Tool was used to compare genomes (Carver et al., 2005). MiSeq 
reads of 4559 and 947 and 180/15 and 180/2 were mapped to the assembled reference 
genome of the opposing strain with BOWTIE2 version 2.2.6 (Langmead and Salzberg, 
2012). Variant calling was then performed using SAMTools version 0.1.18 (Li et al., 2009), 
and variants were mapped to coding sequences of the reference strain using BEDTools 
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version 2.25.0 (Quinlan and Hall, 2010). Single nucleotide polymorphisms (SNPs) and 
insertions/deletions (indels) were filtered for those with scores of 100 or greater. Artemis 
was used to visualize SNPs and indels (Rutherford et al., 2000). Sanger sequencing was 
performed to confirm the SNPs in rafR and rafK (Australian Genome Research Facility, 
Adelaide). 
 2.2.4 Phenotypic microarrays 
Carbon phenotype microarray analysis was performed on the serotype 14 ST 15 strains, 
using the PM microplates PM1 and PM2A (Biolog, Inc.), which tested for the catabolism 
of 190 different carbon sources. Each well of the microarrays contained a different carbon 
source. Briefly, cells were suspended in the provided buffer (as per the manufacturer’s 
instructions) to an Absorbance 590 nm (A590) of 0.37. 100 µl of this suspension was added 
to the wells, and the A590 was measured after 17 h of incubation at 37°C on a SpectraMax 
M2 Microplate Reader (Molecular Devices, California, USA). Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 
activity. Absorbance values above 0.65 after subtraction from the zero carbon source blank 
were considered positive. 
 2.2.5 Growth assays 
Each tested strain was grown in CDM supplemented with either 0.5% Glc (CDM+Glc), 
0.5% Raf (CDM+Raf), or no sugar (CDM) from an OD600 of 0.05. 200 µl of inoculated 
culture was then incubated at 37°C for 12 h in a Costar® 96-well Flat-bottomed Cell 
Culture Plate (Corning Incoporated, New York, United States). The OD600 was measured 
every 15 min a SpectraMax M2 Microplate Reader (Molecular Devices). All experiments 
were conducted in triplicate and repeated at least two times. 
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 2.2.6 Quantitative real-time RT-PCR 
Differences in levels of gene expression were assayed by one-step relative quantitative 
real-time RT-PCR (qRT-PCR) in a LightCycler® 480 II cycler (Roche) essentially as 
described previously (Mahdi et al., 2008). The specific primers used for the various genes 
are listed in Table 2.2 and were used at a final concentration of 200 nM per reaction. As 
an internal control, primers specific for 16S rRNA were employed. Amplification data were 
analysed using the comparative critical threshold cycle (2−ΔΔCT) method (Livak and 
Schmittgen, 2001). For analysis of raffinose operon expression in vivo, groups of 4 mice 
were challenged I.N. with 50 μl of bacterial suspension containing approximately 1 × 108 
colony forming units (CFU) of 4559, 947, 4559947rafR or 9474559rafR. 6 h post-infection, the 
lungs were harvested and placed in 1ml Trizol (Ambion), left at RT for 5 min then 
subsequently homogenised using a Precellys® 24 tissue homogeniser (Bertin 
Technologies, France) before storage at -80oC. The following day, 200 μl chloroform was 
added to the samples and inverted to mix well, then centrifuged at 12,000 x g for 15 min at 
4oC. The resulting aqueous phase was removed and RNA extracted using the Qiagen 
RNeasy RNA isolation kit.  
2.2.7 Polymerase chain reaction 
PCR reactions were performed on a Mastercycler Flexilid thermal cycler (Eppendorf, 
NSW, Australia). Reactions were carried out using 2 × Phusion Flash PCR Master Mix 
(Thermo Fisher Scientific, Victoria, Australia), according to manufacturer’s instructions. 
Typical reaction conditions comprised 25 cycles of denaturation at 95oC for 30 s, annealing 
at 55oC for 30 s and extension at 68oC for 15 s per kb of expected PCR product. PCR 
products were then purified using a MiniElute PCR Purification Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. To analyse PCR products or 
chromosomal  and  plasmid  DNA  preparations,  gel  electrophoresis  was  performed using   
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Table 2.2. Oligonucleotide primers used in this study. All primers used in this Chapter and 
subsequent Chapters were purchased from Sigma Aldrich.  
Primer Sequence (5′→3′) Reference 
rafR Flank F GCGAACGTAGGTTACAATCGT This study 
rafR R j tail 
GGAAAGGGGCCCAGGTCTCTCTAGCATGTG
CTACCTCCTACC This study 
rafR F j tail 
CATTATCCATTAAAAATCAAAGGGGAAATC
CTACCAAGCTGTCTACC This study 
rafR Flank R CGAACGTAGTTCAGTGGTAGAA This study 
Janus F CCGTTTGATTTTTAATGGATAATG Sung et al, 2001 
Janus R AGAGACCTGGGCCCCTTTCC Sung et al., 2001 
aga F AAGGTCAGAATGGTCCACAG This study 
aga R GCTGGAAAATCAGCCATAAA This study 
rafG F CCTATGGCAGCCTACTCCATC This study 
rafG R GGGTCTGTGGAATCGCATAGG This study 
rafK F AACGACGTAGCTCCAAAAGA This study 
rafK R GCTGGTTTACGTTCCAAGAA This study 
16s rRNA F GGTGAGTAACGCGTAGGTAA Trappetti et al, 2017 
16s rRNA R ACGATCCGAAAACCTTCTTC Trappetti et al, 2017 
rafR sanger AGTAGAAGAGCTGGTGTTTG This study 
rafR sanger TCTGTGACTAAGCCAGTTTC This study 
rafK Flank F AGGACTTGGTTCTTGTTGAG This study 
rafK Rery tail 
TTGTTCATGTAATCACTCCTTCCTACCATGA
GGTGAACTCC This study 
rafK Fery tail 
CGGGAGGAAATAATTCTATGAGATCAGTTA
ATCTAGGGAGAG This study 
rafK Flank R CTCAAAGGCAACTGGACAAC This study 
EcoRI-rafR F GCGCGAATTCCCATTTACTTCACCTCATCAC This study 
EcoRI-rafR R GCGCGAATTCGGATTTGGTAGACAGCTTGG This study 
pAL2 BamHI F CTACTTGGAGCCACTATCGAC This study 
rafE Flank F TGAAGTTCGGGTGGCTATTG This study 
rafE RGD R 
CCAAGACCCATTTGGTGTCATGAGGACCTC
CGCATGTGCGAAGGCTCCGATAACATCGGT This study 
rafE R j tail 
GGAAAGGGGCCCAGGTCTCTCCATTCCATT
AGAAAGCCTC This study 
rafE RGD F 
ACCGATGTTATCGGAGCCTTCGCACATGCG
GAGGTCCTCATGACACCAAATGGGTCTTGG This study 
rafE F j tail 
CATTATCCATTAAAAATCAAAGGGTGGATT
AGGAGTAGAGAGAC This study 
rafE Flank R GGCCTGCGTAGTTGTATTGG This study 
0.8% (w/v) agarose (Agarose low EEO [AppliChem, Germany]) in TBE buffer (44.5 mM 
Tris, 44.5 mM boric acid, 1.25 mM EDTA, pH 8.4). Prior to loading, DNA was mixed with 
1/10th volume of loading buffer (15% [w/v] Ficoll, 0.1% [w/v] bromophenol dye, 100 
ng/ml RNAse A) and 0.5 µl/10ml GelRedTM (Biotium, California, United States). Gels 
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were electrophoresed in 0.5 × TBE buffer at 180 V for at least 30 min. DNA bands were 
visualised by transillumination with short wavelength ultraviolet light using a Gel/Chemi 
Doc XR system (Bio-Rad, NSW, Australia) and analysed using Quantity One v 4.6.9 
software. 
 2.2.8 Mutagenesis 
The rafR gene swap between serotype 14 ST15 strains 4559 and 947, to produce 
4559947rafR and 9474559rafR, was achieved via allelic exchange mutagenesis utilising the 
Janus cassette, as described previously (Harvey et al., 2014; Sung et al., 2001). This 
involved a three-step process in which endogenous rpsL (which confers streptomycin 
sensitivity) was first replaced with the streptomycin-resistant rpsL1 allele by direct 
transformation of the blood and ear isolates. The Janus cassette (comprising a kanamycin 
resistance marker and a dominant counterselectable rpsL+ marker) was then used to replace 
the native rafR gene by direct transformation with a linear PCR product comprising the 
Janus cassette flanked by sequences 5′ and 3′ to rafR (selecting on kanamycin). In the final 
step, the Janus cassette in Kanr/Streps transformants is replaced by transformation with the 
alternative rafR allele and flanking sequences, counter selecting on streptomycin (loss of 
the Janus cassette reinstates the Strepr phenotype). Gene swap constructs were confirmed 
by Sanger DNA sequencing (AGRF, Adelaide). The rafK gene was also deleted from 
serotype 3 ST180/2 and ST180/15 by direct transformation with a linear DNA fragment 
comprising an erythromycin resistance cassette flanked by sequences 5′ and 3′ 
to rafK generated by overlap PCR, essentially as previously described (Trappetti et al., 
2017). The rafR and rafK primers used are listed in Table 2.2. Mutant constructs were 
confirmed by Sanger sequencing (AGRF). Introduction of the RafE RGD to HAE amino 
acid mutation in the serotype 14 ST15 4559 and 947 strains, to produce 4559RafE RGD→HAE 
and 947RafE RGD→HAE, utilised the Janus cassette method as well. After the Janus cassette 
replaced rafE, the rafE RGD primers (Table 2.2) incorporating the RGD→HAE mutation, 
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were constructed into a linear PCR product by overlap PCR and transformed into 4559 and 
947. 
2.2.9 Construction and integration of pAL2:4559rafR 
The plasmid pAL2 was extracted from an E. coli XL10 strain by using a Qiagen Plasmid 
Mini Kit (Hilden, Germany). RafR was PCR amplified from the S. pneumoniae strain 4559, 
using the EcoRI-rafR primers listed in Table 2.2, then purified using the MiniElute PCR 
Purification Kit (Qiagen). The pAL2 plasmid (Addgene, Massachusetts, United States)  
and rafR PCR product were digested with EcoRI, using Shrimp Alkaline Phosphatase 
(rSAP) and CutSmart buffer, then ligated with T4 DNA ligase (New England Biolabs, 
Massachusetts, United States), creating the pAL2:4559rafR plasmid. Correct ligation was 
checked for via PCR using the pAL2 BamHI F and EcoRI-rafR R primers listed in Table 
2.2. The pAL2:4559rafR plasmid was then transformed into the E. coli strain XL10 via the 
following method (Jechlinger et al., 1999). XL10 cells were prepared by growing cells in 
LB medium to roughly OD600 0.60 at 37oC, followed by incubation at 4oC for 30 min. Cells 
were then centrifuged and the resulting pellet resuspended in ice cold 100 mM MgCl2, 
followed by another centrifugation and resuspension in 100 mM CaCl2, then incubation for 
a further 30 min at 4oC. 30% (v/v) glycerol was added to competent cells and 100 µl 
aliquots were stored at -80oC. For transformation of the plasmid DNA into competent 
XL10, equal volumes of KCM (100 mM KCl, 30 mM CaCl2, 50mM MgCl2) and competent 
cells were mixed together with the pAL2:4559rafR plasmid, then placed on ice for 30 min, 
followed by heat-shock at 42oC for 90 s. The cells were then placed into 1 ml LB and 
incubated at 37oC for 1 h with shaking. Successfully transformed cells were plated onto 
LB agar + 500 μg/ml erythromycin and incubated overnight at 37oC. XL10 containing 
pAL2:4559rafR plasmid was grown up in LB broth to OD600 of 0.6 and plasmid DNA was 
purified using the QIAprep spin Miniprep Kit (Qiagen). Purified pAL2:4559rafR was then 
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transformed into the S. pneumoniae serotype 14 ST 15 ear isolates 947 and 51742, by 
growing the strains to an OD600 of 0.2 in C+Y + 0.2% glucose media, then adding 10 μl of 
10 mg/ml competence stimulating peptides (CSP) 1 and 2. After 10 minutes, 200 ng of the 
pAL2:4559rafR plasmid was added then plated onto blood agar + 0.2 μg/ml erythromycin. 
Successful transformation was confirmed by PCR.  
2.2.10 Animal studies 
Animal experiments were approved by the University of Adelaide Animal Ethics 
Committee. Groups of outbred 6-week-old female Swiss (CD-1) mice were anesthetized 
by intraperitoneal injection of 10 µl/g pentobarbital sodium (Nembutal; Rhone-Merieux) 
and challenged intranasally (I.N.) with 50 µl of bacterial suspension containing 
approximately 1 × 108 CFU in SB (Amin et al., 2015). The challenge dose was confirmed 
retrospectively by serial dilution and plating on BA. Mice were euthanized by 
CO2 asphyxiation at 24 h, and then tissue samples (lungs, nasopharynx, brain, ear, and 
blood) were harvested and pneumococci enumerated in tissue homogenates as described 
previously via serial dilution and spreading on plates containing BA plus gentamicin 
(Trappetti et al., 2011). 
 2.2.11 Adherence assays 
A549 human lung alveolar carcinoma (type II pneumocyte) and Detroit 562 human 
nasopharyngeal cell lines were used for adherence assays. Cells were grown in CDM 
supplemented with 10% fetal calf serum (FCS) and 0.5% glucose, in 75cm2 tissue culture 
bottles (Becton Dickinson) at 37oC in a 5% CO2 atmosphere. 2 × 105 cells were seeded into 
each well of 24-well tissue culture trays (Becton Dickinson) for use in the adherence 
assays. The day prior to inoculation of pneumococcal cells to the tissue culture, CDM 
media was replaced with CDM + 10% FCS + 0.5% Glc or CDM + 10% FCS + 0.5% Raf 
in the 24-well seeded trays. S. pneumoniae serotype 14 ST15 strains were used for 
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adherence assays. 500 µl of each strain was inoculated onto washed A549 or Detroit 562 
cells, to an OD600 of 0.2 in CDM + 0.5% Glc or Raf in triplicate. After incubation for 2 
hours at 37oC, the wells were washed three times with PBS and cells were detached from 
the plate by treatment with 100 µl of 0.25% trypsin-0.02% EDTA and 400µl of 0.1% triton 
x-100. Appropriate dilutions of the cultures were plated on BA to determine the number of 
adherent bacteria. Assays were performed in triplicate from two independent experiments. 
 2.2.12 ELISA for capsule quantification  
Total capsular polysaccharide (CPS) produced by strains was quantified by enzyme-linked 
immunosorbent assay (ELISA) using a modification of the method described previously 
(Trappetti et al., 2011). Briefly, serial 2-fold dilutions of either purified type 14 CPS 
standard (American Type Culture Collection, USA) at a starting concentration of 10 µg/ml 
or total CPS preparations of the strains included in this study were coated on poly-L-lysine-
treated Nunc MaxiSorp (Roskilde, Denmark) flat-bottom 96-well plates overnight at 4°C. 
After blocking with 1% fetal calf serum, the samples were reacted with a 1:10,000 dilution 
of S. pneumoniae serotype 14 typing sera (Statens Seruminstitut, Copenhagen, Denmark) 
for 2 h. The plates were washed five times in wash buffer (0.05% Tween 20 –phosphate-
buffered saline (PBS)) and then reacted with a 1:20,000 dilution of goat anti-rabbit IgG 
alkaline phosphatase conjugate (Sigma-Aldrich) overnight at 4°C. After extensive 
washing, the plates were developed using alkaline phosphatase substrate (Sigma) in 
diethanolamine buffer, and the Absorbance at 405 nm was read in a Spectramax M2 
spectrometer (Molecular Devices, CA, USA). 
2.2.13 Gas chromatography mass spectrometry of infected murine 
lungs 
Presence of raffinose in murine lung extracts was assayed by gas chromatography mass 
spectrometry (GC MS). Groups of 4 mice were I.N. challenged with 50 µl containing 
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1 × 108 CFU of 4559, 947 or SB. 24 h post-infection, lungs were harvested and flash frozen 
before being stored at -80°C, then sent to Metabolomics Australia for metabolite extraction 
and analysis. Here 20 mg of infected lungs were pulverised using a CryoMill cryogenic 
grinder and suspended in 600 µl in 3:1 MeOH:Water; 0.1 nM 13C Sorbitol (ISTD). Samples 
then underwent GC MS analysis as previously described, in order to detect and quantify 
monosaccharides, disaccharides and trisaccharides (Fiehn, 2016).  
2.2.14 Data availability  
Genome sequences have been deposited with European Nucleotide Archive (ENA) under 
the accession numbers SAMEA5092021, SAMEA5092022, SAMEA5092023, 

















2.3.1 Genetic differences between serotype/ST-matched blood and 
ear isolates 
In the first instance, draft genomes of serotype 14 ST15 strains 4559 (blood isolate) and 
947 (ear isolate) were assembled from PacBio and MiSeq data and then compared (see 
Sections 2.2.3). The only differences in ARs were the presence of a 35-kb prophage and a 
3.2-kb plasmid in 4559 and not 947, but these ARs were not present in other serotype 14 
ST15 blood isolates in our collection and hence were not examined further. Seventeen 
SNPs and indels present within protein coding sequences of 4559 and 947 resulting in a 
change in the predicted amino acid sequence are listed in Table 2.3. The genes affected 
included those predicted to be involved in metabolism and energy production, 
transcriptional regulation, transporters, and putative virulence factors. Among the latter 
category, a SNP resulting in a L43P substitution was identified in cpsE, which encodes the 
glycosyl transferase that initiates assembly of the capsular polysaccharide (CPS) repeat 
unit. However, it has previously been shown that there is no difference in total CPS 
production between 4559 and 947 (Amin et al., 2015). The SNP in the putative plasmin 
and fibronectin-binding protein gene pfbA is also a conservative T318M substitution. The 
protein encoded by iga is truncated in 4559 compared to 947, but only by four amino acids. 
On the other hand, the nanB sequence in 947 has a premature stop codon that truncates the 
protein by 330 amino acids (47% of the 4559 protein), presumably inactivating the gene 
product. Mutagenesis studies have previously shown that NanB contributes to colonization 
of both the upper and lower respiratory tract of mice, albeit to a lesser extent than the major 
neuraminidase NanA (Manco et al., 2006). Nevertheless, 4559 and 947 colonize the 
nasopharynx equally well (Amin et al., 2015). Interestingly, SNPs were identified in two 
metabolic genes, coding for ATP-dependent 6-phosphofructokinase (pfkA) and a glycogen 
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synthase (glgA), as well as in two helix-turn-helix (HTH)-type transcriptional 
regulators, scrR and rafR, involved in metabolism of sucrose and raffinose, respectively. 
Given the importance of carbohydrate metabolism to S. pneumoniae (Buckwalter and 
King, 2012), a phenotypic microarray was employed to compare the capacity of 4559 and 
947 to metabolize over 100 different carbohydrates (see Section 2.2.4). The only difference 
observed between the ear and blood isolates was a reduced capacity of the former (947) to 
induce reduction of colourless tetrazolium dye by NADH,in medium containing raffinose 
as the sole carbon source (Appendices A, B, E and F). Moreover, the SNP in rafR was 
within a functionally important conserved signature sequence for the AraC/XylS family of 
transcriptional regulators (Rosenow et al., 1999), hence further examination was 
warranted.  
Table 2.3. Genes containing indels or SNPs that led to amino acid changes, identified from the 
whole-genome variant calling analysis between 4559 and 947 (results for the raffinose pathway 
gene rafR are in bold face). 
Locus tag 
in 947 Gene Product 
Change in aa sequence in 
4559 relative to 947 
0862 pfkA ATP-dependent 6-phosphofructokinase S212G 
1153 glgA Glycogen synthase E174G 
1345 pncB Nicotinate phosphoribosyltransferase N434D 
1631 scrR HTH-type transcriptional regulator ΔL27-G28 
1803 rafR HTH-type transcriptional regulator D249G 
1255 pyrP Uracil permease V65A 
1737 piuA Fe3+ import ATP-binding protein G141V 
2020  ABC transporter ATP-binding protein Y508N 
0330 cpsE CPS glycosyltransferase L43P 
1139 iga Immunoglobulin A1 protease 
Premature stop 1905 (4559) 
due to indel 
1594 nanB Sialidase B 
Premature stop 362 (947) 
due to indel 
1741 pfbA 
Plasmin and fibronectin-binding protein 
A T318M 
0945 coiA Competence protein E78K 
1141 addA 
ATP-dependent helicase/nuclease subunit 
A I980M 
1060  Acetyl transferase C101G 
1194  
Cytosolic protein containing multiple 
CBS domains 
Premature stop 104 (947) 
due to SNP 
1731  Hypothetical protein (no Pfam match) H32P 
 
2 | Genomic Comparisons of S. pneumoniae Clonal Clinical Isolates 
55 
 
Genetic differences between ear/blood isolate pairs that are common to two unrelated 
serotypes/ST lineages would be strong candidates for determinants of tissue tropism. 
Genomic comparisons were therefore also made between two serotype 3 ST180 ear and 
blood isolates (strains 180/2 and 180/15, respectively), which like the serotype 14 ST15 
isolates, have previously been shown to exhibit distinct tissue tropism in mice in 
accordance with clinical isolation site (Trappetti et al., 2013). There were no differences in 
ARs between the two strains, while SNPs and indels impacting the deduced amino acid 
sequence for 27 genes were identified (Table 2.4). Interestingly, there were no affected 
genes in common with those in Table 2.3. However, an I227T SNP was detected in the 
serotype 3 rafK gene, encoding the ATP-binding protein component of the raffinose ABC 
transporter. RafK is known to be essential for activation of other raf operon genes, and the 
SNP identified in ST180 isolates is located in the conserved regulatory domain motif 1 
(Tyx et al., 2011). This compares with a SNP in the raffinose pathway regulatory gene rafR 
between the serotype 14 strains. Thus, potential defects in raffinose uptake/metabolism 
appear to be a common feature of ear isolates from both serotypes/lineages. 
2.3.2 Blood isolates utilise raffinose more efficiently than ear 
isolates 
In view of the SNPs in genes associated with raffinose metabolism between ear and blood 
isolates in two unrelated serotypes/STs and the fact that the serotype 14 ear and blood 
isolates differed only in their ability to metabolize raffinose on phenotypic microarray 
analysis, in vitro growth phenotypes were further investigated. Strains 4559 and 947, as 
well as another pair of serotype 14 ST15 blood and ear isolates (4534 and 51742, 
respectively), were grown in a chemically defined medium (CDM) with either glucose or 
raffinose as the sole carbon source (designated CDM+Glc and CDM+Raf, respectively) 
(see section 2.2.5) (Figure 2.1).  In CDM+Glc, there were no significant differences in 
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growth rates between blood and ear isolates. However, in CDM+Raf, the two blood isolates 
grew at a higher rate and to a higher final culture density OD600 than either of the serotype  
Table 2.4. Genes containing indels or SNPs that led to amino acid changes, identified from the 
whole-genome variant calling analysis between 180/2 and 180/15 (results for the raffinose pathway 
gene rafK are in bold face). 
Locus tag 
in 180/2 Gene Product 
Change in aa sequence of 
180/15 relative to 180/2 
100 purN Phosphoribosyl-glycinamide G81A 
254 rpsJ 30S ribosomal protein S10 Y58D 
285  Hypothetical protein A81S 
314 cdsA Phosphatidate cytidylyltransferase M14I 
335 adhP Alcohol dehydrogenase 1 M210V 
403 fabK Enoyl-[acyl-carrier-protein] reductase I1029T 
449  Nitronate monooxygenase I55M 
512 glnA Glutamine synthetase F22L 
645 nhaK 
Sodium, potassium, lithium and 
rubidium/H+ antiporter G190D 
741  VanZ family protein C149W 
996  Hypothetical protein H38R 
1121 clcA H+/Cl− exchange transporter M131I 
1138 ptsH Phosphocarrier protein HPr I14V 
1172  Formate/nitrate transporter A211E 
1194 glnP 
Glutamine transport system permease 
protein S662A 
1234  SpF43_sRNA Y31C 
1306 alaS Alanine-tRNA ligase E18A 
1387 apbE FAD:protein FMN transferase* M52I 
1404  
LPXTG cell wall anchor domain-
containing protein 
ΔK112-Q119; G125K, 
E126T, P127E, E130V, 
K131N, I133D; ΔQ135-
P178 
1491 rafK Raffinose import ATP-binding protein I227T 
1616 dnaB DNA helicase C375R 
1760 fepD_2 
Ferric enterobactin transport system 
permease protein S248G 
1863 rpoC 
DNA-directed RNA polymerase subunit 
beta D76E 
1878 acyP Acylphosphatase V4I 
1887 rsgA Small ribosomal subunit biogenesis G40S 
2045 aspS Aspartate tRNA ligase E51V 
2100 dltD 
D-Alanyl-lipoteichoic acid biosynthesis 
protein D151E 
*FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide. 
14 ST15 ear isolates. Similarly, there was no significant difference in growth rates of the 
serotype 3 ST180 ear and blood isolates (180/15 and 180/2, respectively) in CDM+Glc, 
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but the blood isolate grew better than the ear isolate in CDM+Raf (Figure 2.1). Thus, 
defective growth in raffinose appears to be a common defect in ear isolates relative to 
serotype/ST-matched blood isolates. 
The raffinose uptake/utilization operon in S. pneumoniae comprises genes encoding 
transcriptional regulators (rafR and rafS), an α-galactosidase (aga), the ABC transporter 
substrate-binding protein and two cognate permeases (rafE, rafF, and rafG), a sucrose 
phosphorylase (gtfA), and a protein of unknown function (rafX), as well as the ATP binding 
protein component of the transporter (rafK), which is separately located in the genome 





Figure 2.1. Differential growth of blood and ear isolates in raffinose. S. pneumoniae serotype 14 
ST15 blood isolates 4559 and 4534 and ear isolates 947 and 51742 were grown in 200 µl CDM 
supplemented with 0.5% glucose (CDM+Glc) or 0.5% raffinose (CDM+Raf). Similar growth studies 
were also performed for serotype 3 ST180 strains 180/15 (blood isolate) and 180/2 (ear isolate). 
OD600 was measured every hour for 12 h. Data are mean OD600 ± standard deviation (SD) from a 
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Figure 2.2. Genetic loci encoding raffinose uptake and utilization in S. pneumoniae. The numbers 
below each gene refer to the locus tags in the serotype 14 ST15 947 genome. The locations of 
SNPs in serotype 14 ST15 and serotype 3 ST180 isolates are indicated with asterisks; horizontal 
arrows show the locations of promoters. 
 
To determine if the difference in ability to utilize raffinose between the blood and ear 
isolates corresponded with raffinose operon gene expression, S. pneumoniae serotype 14 
ST15 strains 4559, 947, 4534, and 51742 and serotype 3 ST180 strains 180/2 and 180/15 
were grown to the same OD600 (0.2) in CDM+Glc and then washed and resuspended in 
CDM+Raf and incubated for a further 30 min. RNA was then extracted, and levels 
of aga, rafG and rafK mRNA, representative of each of the three rafR-regulated 
transcriptional units, were then measured relative to 16S rRNA by quantitative real-time 
reverse transcription-PCR (qRT-PCR). In every case, expression levels for all three genes 
were significantly greater in the blood isolates than in the respective ear isolates 
(Figure 2.3). 
As further confirmation, blood and ear isolates belonging to serotype 23F ST81 were also 
tested for growth in CDM+Glc and CDM+Raf, as well as for expression of aga, rafG, 
and rafK (Figure 2.4). Again, the blood isolate grew to a higher OD600 than the ear isolate 
in CDM+Raf, but not in CDM+Glc. Moreover, expression of all three raf genes were 
significantly higher in the blood isolate than in the ear isolate. 
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Figure 2.3. Expression of raffinose pathway genes by serotype 14 and 3 blood and ear isolates. 
The indicated strains were grown in CDM+Glc to an OD600 of 0.2, washed and resuspended in 
CDM+Raf, and then incubated at 37°C for a further 30 min. RNA was then extracted, and levels 
of aga, rafG, and rafK mRNA were analysed by qRT-PCR using 16S rRNA as an internal control 
(see Section 2.2.6). The data presented are the means ± SD from three independent experiments. 
*, p < 0.05, **, p < 0.01, and ****, p < 0.0001, by unpaired t test. 
Figure 2.4. Growth phenotype and raffinose pathway gene expression in serotype 23F ST81 blood 
and ear isolates. (A) Growth of blood isolate 5076 and ear isolate 9725241 in CDM+Glc or 
CDM+Raf was monitored by OD600 for 12 h. Data are mean OD600 ± SD from a representative assay 
that was performed in triplicate. (B) The indicated strains were grown in CDM+Glc to an OD600 of 
0.2, washed and resuspended in CDM+Raf, and then incubated at 37°C for a further 30 min. RNA 
was then extracted, and levels of aga, rafG, and rafK mRNA were analysed by qRT-PCR using 
16S rRNA as an internal control. The data presented are the means ± SD from three independent 
experiments. ***, p < 0.001 by unpaired t test. 
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2.3.3 The SNP in 947 rafR is responsible for its raffinose phenotype 
In order to test whether the distinct in vitro and in vivo phenotype of 947 relative to 4559 
was attributable to the SNP in rafR, allelic-exchange mutagenesis was performed in 4559 
and 947, generating a 4559 derivative with its rafR allele replaced by that from 947 
(designated 4559947rafR) and a 947 derivative expressing the 4559 rafR allele (9474559rafR) 
(see Section 2.2.8). Growth assays in CDM+Glc showed no significant differences in 
growth rates between 4559, 947, 4559947rafR, and 9474559rafR. However, in CDM+Raf, 
growth of 4559947rafR was at least as poor as that of 947, while growth of 9474559rafR was 
similar to that of 4559 (Figure 2.5A). Expression of aga, rafG, and rafK was then 
examined in 4559, 947, 4559947rafR, and 9474559rafR by qRT-PCR after 30 min of growth in 
CDM+Raf. For all three genes, expression levels in 9474559rafR were indistinguishable from 
those in 4559, while expression in 4559947rafR was essentially the same as that in 947 
(Figure 2.5B). Thus, exchange of rafR alleles between 4559 and 947 significantly impacts 
both growth phenotype and raf operon gene expression in CDM+Raf. 
To further confirm the observed raffinose phenotype, that is 4559’s rafR leads to greater 
raffinose utilisation, rafR from the blood isolate 4559 was inserted into the plasmid pAL2, 
creating the new plasmid pAL2:4559rafR (Figure 2.6), which was then introduced into the 
ear isolates 947 and 51742 (see Section 2.2.8). Successful insertion of rafR into pAL2 was 
confirmed by Sanger sequencing. Growth assays in CDM+Glc showed no significant 
differences in growth rates between 947pAL2, 51742pAL2, 947pAL2:4559rafR and 
51742pAL2:4559rafR. However, in CDM+Raf, 947pAL2:4559rafR and 51742 pAL2:4559rafR grew to 
higher optical densities more efficiently than their respective wild type strains, with effect 
more pronounced in the 947 background (Figure 2.7A). Expression of aga, rafG, 
and rafK was then examined in 947pAL2, 51742pAL2, 947pAL2:4559rafR and 51742 
pAL2:4559rafR by qRT-PCR after 30 min of growth in CDM+Raf. For all three genes, 
expression levels in 947pAL2:4559rafR and 51742 pAL2:4559rafR was significantly greater than 
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their respective empty vector wild types, corresponding to the results seen in the growth 
curves (Figure 2.7B). This suggests that the rafR allele in 4559 allows for greater raffinose 
utilisation compared to the rafR of 947. 
Figure 2.5. Growth phenotype and raffinose operon gene expression in rafR exchange mutants. 
(A) S. pneumoniae strains 4559, 947, 4559947rafR, and 9474559rafR were grown in CDM+Glc or 
CDM+Raf, and OD600 was monitored for 12 h. Data are mean OD600 ± SD from a representative 
assay that was performed in triplicate. (B) The indicated strains were grown in CDM+Glc to an 
OD600 of 0.2, washed and resuspended in CDM+Raf, and then incubated at 37°C for a further 
30 min. RNA was then extracted, and levels of aga, rafG, and rafK mRNA were analysed by qRT-
PCR. Data are the means ± SD from three independent experiments. *, p < 0.05, ***, p < 0.001, 







Figure 2.6. Insertion of rafR from 4559 into the pAL3 plasmid. Visualisation of PCRs through gel 
electrophoresis with 1kb plus ladder (Invitrogen) (lane 1, all images). (A) The rafR of 4559 was 
PCR amplified, then purified, with EcoRI sites placed at edges of the rafR sequence (lanes 2-5). 
(B) EcoRI digest of pAL3 (lane 2) and undigested control (lane 3). EcoRI digested pAL3 was then 
ligated with EcoRI digested 4559 rafR, and transformed into E. coli XL10 (see Section 2.2.9). (C) 
PCR amplification of DNA from a successfully transformed colony, using rafR EcoRI F and R 
primers (lane 2) and pAL2 bamHI F – rafR EcoRI R primers (lane 3). DNA from 4559 was used 
with rafR EcoRI F and R primers as a positive control (lane 4). 
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 Figure 2.7. Growth phenotype and raffinose operon gene expression in serotype 14 ST 15 ear 
isolates mutants with 4559 rafR containing expression plasmid. (A) S. pneumoniae strains 947pAL2, 
51742pAL2, 947pAL2:4559rafR and 51742 pAL2:4559rafR were grown in CDM+Glc or CDM+Raf, and OD600 
was monitored for 12 h. Data are mean OD600 ± SD from a representative assay that was performed 
in triplicate. (B) The indicated strains were grown in CDM+Glc to an OD600 of 0.2, washed and 
resuspended in CDM+Raf, and then incubated at 37°C for a further 30 min. RNA was then 
extracted, and levels of aga, rafG, and rafK mRNA were analysed by qRT-PCR. Data are the 
means ± SD from three independent experiments. *, p < 0.05, **, p < 0.001, ***, p < 0.001, and 
****, p < 0.0001, by unpaired t test 
2.3.4 Virulence phenotypes of 4559 and 947 and 
their rafR exchange mutants  
To determine whether the marked difference in virulence phenotypes of 4559 and 947 is 
also directly attributable to the SNP in rafR, 4559, 947, 4559947rafR and 9474559rafR were 
tested in a murine intranasal challenge model. Groups of Swiss mice were challenged with 
108 CFU of each strain, and bacterial loads were quantitated in various tissues 24 h post 
challenge (Figure 2.8). No significant differences in bacterial numbers in the nasopharynx 
were seen between any groups (Figure 2.8), and no bacteria were detected in the blood of 
any mice (data not presented). However, 4559 was better able than 947 to persist in the 
lungs of infected mice, with significantly higher geometric mean (GM) bacterial load 
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(p < 0.0001) and a significantly greater proportion of infected animals (14/16 versus 
6/16; p < 0.01) (Figure 2.8). On the other hand, bacterial loads of 947 in the ear were 
significantly greater than that for mice challenged with 4559 (p < 0.01), and the proportion 
of infected mice was also significantly greater (16/16 versus 7/16; p < 0.001) (Figure 2.8). 










Figure 2.8. Virulence phenotype of rafR exchange mutants. Groups of 16 mice were infected 
intranasally with 108 CFU of the indicated strain. At 24 h, all mice from each group were euthanized 
and numbers of pneumococci in the indicated tissues/sites were quantitated (see Section 2.2.10). 
Viable counts (total CFU per tissue) are shown for each mouse at each site; horizontal bars indicate 
the geometric mean (GM) CFU for each group; the broken line indicates the threshold for detection. 
Differences in GM bacterial loads between groups are indicated by asterisks *, p < 0.05, **, p 
< 0.01, and ****, p < 0.0001, by unpaired t test. 
Exchanging the rafR alleles has a striking impact on virulence phenotype. In the lungs, 
both the GM CFU and proportion of infected mice for the group challenged with 
4559947rafR were significantly lower than those for the 4559 group (p < 0.0001 
and p < 0.001, respectively). Indeed, the virulence phenotype of 4559947rafR was 
indistinguishable from that of 947. Conversely, the GM lung bacterial load and proportion 
of infected mice for the 9474559rafR group were significantly greater than those for the 947 
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group (P < 0.01 and P < 0.05, respectively); there were no significant differences in these 
parameters between the 9474559rafR and 4559 groups. In the ear, both the GM CFU and 
proportion of infected mice for the group challenged with 4559947rafR were significantly 
greater than those for the 4559 group (P < 0.05 and P < 0.01, respectively). On the other 
hand, both the GM CFU and proportion of infected mice for the group challenged with 
9474559rafR were significantly lower than those for the 947 group (P < 0.01 in both cases). 
Moreover, there was no significant difference in either GM bacterial loads or proportions 
of infected mice between the 4559947rafR and 947 groups or between the 9474559rafR and 4559 
groups (Figure 2.8). A similar pattern is seen in the brain; the GM CFU for the 
4559947rafR group was significantly greater than those for either the 4559 or 
9474559rafR groups (P < 0.01 in both cases). Moreover, there was no significant difference 
in either GM bacterial loads or proportions of infected mice between the 4559947rafR and 
947 groups or between the 9474559rafR and 4559 group (Figure 2.8). Collectively, these data 
show that swapping the rafR allele between 4559 and 947 leads to a switch in their 
respective virulence profiles, and thus, the D49G SNP in rafR is entirely responsible for 
the observed differences in tissue tropism between the serotype 14 ST15 blood and ear 
isolates. 
2.3.5 Mutagenesis of rafK in serotype 3 ST180 blood and ear 
isolates 
Attempts to construct rafK exchange mutants of serotype 3 ST180 blood and ear isolates 
(180/15 and 180/2, respectively) analogous to the rafR exchange mutants constructed for 
the serotype 14 strains were not successful. Thus, the impact of the SNP in RafK could not 
be directly tested. However, the native rafK genes from both type 3 strains were 
successfully deleted (designated 180/15 ΔrafK and 180/2 ΔrafK, respectively). Both 
mutants were incapable of growth in CDM+Raf, and expression of aga and rafG was 
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virtually undetectable by qRT-PCR; rafK expression was also undetectable, as expected 
(Figure 2.9). Thus, the ear isolate 180/2 exhibits a phenotype that is intermediate between 
that of the blood isolate 180/15 and either of the two ΔrafK mutants, consistent with partial 
functionality of the ear isolate RafK. S. pneumoniae rafK deletion mutants have previously 
been shown to be outcompeted by the wild type in the murine lung and nasopharynx 
(Marion et al., 2011; Tyx et al., 2011). Similarly, in the present study, bacterial loads in the 
lungs, blood, ear, and brain were also lower for mice challenged with the 180/2 and 180/15 
ΔrafK mutants relative to those challenged with the respective wild types at 24 h after 
intranasal challenge (Figure 2.10). This indicates that even the intermediate level of 
raffinose pathway gene expression exhibited by ear isolate 180/2 contributes to virulence. 
Figure 2.9. Growth phenotype and raffinose operon gene expression in ΔrafK mutants. (A) S. 
pneumoniae serotype 3 strains 180/15, 180/2, 180/15ΔrafK, and 180/2ΔrafK were grown in 
CDM+Glc or CDM+Raf, and OD600 was monitored for 12 h. Data are mean OD600 ± SD from a 
representative assay that was performed in triplicate. (B) The indicated strains were grown in 
CDM+Glc to an OD600 of 0.2, washed and resuspended in CDM+Raf, and then incubated at 37°C 
for a further 30 min. RNA was then extracted, and levels of aga, rafG, and rafK mRNA were 
analysed by qRT-PCR. Data are the means ± SD from three independent experiments. *, p < 0.05, 
**, p < 0.01, and ***, p < 0.001, by unpaired t test. 
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Figure 2.10. Virulence phenotype of serotype 3 ST 180 rafK knockout mutants. Groups of 16 mice 
were infected I.N. with 108 CFU of the indicated strain. At 24 h, all mice from each group were 
euthanized and numbers of pneumococci in the indicated tissues/sites were quantitated (see 
Section 2.2.9). Viable counts (total CFU per tissue) are shown for each mouse at each site; 
horizontal bars indicate the geometric mean (GM) CFU for each group; the broken line indicates 
the threshold for detection. Statistically significant differences in GM bacterial loads between 
groups are indicated by asterisks: *, p < 0.05 and **, p < 0.01, by unpaired t test. 
 
2.3.6 Effects of raf mutations on adherence to lung epithelial cells 
 Given that exchanging rafR between 4559 and 947 had such stark impacts on murine 
disease progression, whether this impact was at least partly due to a direct impact of rafR 
on adherence to respiratory epithelial cell lines was investigated. Here 4559, 947, 
4559947rafR, and 9474559rafR were assessed for their adherence to A549 and Detroit 562 cell 
lines, in both CDM+Glc and CDM+Raf (see Section 2.2.11). The adherence of 4559 was 
greater than both 947 and 4559947rafR to A549 cells, in CDM+Glc (p < 0.01) and CDM+Raf 
(p < 0.0001) (Figure 2.11). Similarly, 9474559rafR showed significantly greater adherence 
to A549 cells than 947 and 4559947rafR in CDM+Glc (p < 0.01 and p < 0.001, respectively) 
and CDM+Raf (p < 0.0001) (Figure 2.11). Conversely, there was no significant difference 
between the ability of any of the strains to adhere to Detroit 562 cells, in both CDM+Glc 
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and CDM+Raf (Figure 2.11). These results are compatible with the in vivo mouse 
virulence data, as both 4559 and 9474559rafR were able to persist in the lungs significantly 
more so than 947 and 4559947rafR, while there was no significant difference between the 









Figure 2.11. Impact of rafR exchange on adherence to A549 (lung epithelial) and Detroit 562 
(nasopharyngeal) cells. S. pneumoniae strains 4559, 947, 4559947rafR and 9474559rafR were 
inoculated at OD600 = 0.2 onto A549 or Detroit 562 monolayers in CDM + 10% FCS + 0.5% glucose 
(A) or 0.5% raffinose (B), in triplicate, then tested for adherence after 2 h at 37 °C (see Section 
2.2.11). Each adherence assay was performed twice, with similar results. Data presented are the 
means ± standard deviations from two independent experiments (*, p < 0.05; **, p < 0.01;***, p < 
0.001;****, p < 0.0001; unpaired t-test). 
To confirm that the virulence and adherence impacts of the rafR exchange was not due to 
any corresponding effects on CPS production, CPS ELISA assays were performed (see 
section 2.2.12). No significant difference in total CPS production was observed between  
4559, 947, 4559947rafR, and 9474559rafR (Figure 2.12). 
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Figure 2.12. Total CPS production in serotype 14 ST 15 strains 4559, 947, 4559947rafR, and 
9474559rafR was measured by ELISA (see section 2.2.12). Serial 2-fold dilutions of a serotype 14 
CPS standard and total CPS preparations of the above strains were performed, then serotype 14 
typing sera (1o antibody) and goat anti-rabbit IgG (2o antibody) were used to detect CPS levels. 
Absorbance was read at 405nm and a resulting standard curve was generated.  
RafE, the substrate binding protein of the raffinose ABC uptake system under regulation 
of RafR, contains a RGD motif, Arg-Gly-Asp (263-RGD-265) (Rosenow et al., 1999). The 
RGD motif has been reported to promote eukaryotic cell attachment (D’Souza et al., 1991) 
and to be crucial for interactions with the cell surface receptor integrin (Ruoslahti and 
Pierschbacher, 1986). To determine whether the RGD motif in RafE plays a role in 
pneumococcal adherence, the RGD motif was mutated to HAE (conservative amino acid 
changes) in 4559 and 947, generating 4559RafE RGD→HAE and 947RafE RGD→HAE (see Section 
2.2.8). These strains were then assessed for their adherence to A549 and Detroit 562 
epithelial monolayers, in both CDM+Glc and CDM+Raf. The adherence to A549 cells of 
both 4559 and 4559RafE RGD→HAE were significantly greater than of 947 (p < 0.001 and p < 
0.01, respectively) and 947RafE RGD→HAE (p < 0.05 and p < 0.05, respectively) in CDM+Glc, 
while 4559 and 4559RafE RGD→HAE also had significantly greater adherence than 947 (p < 
0.05) in CDM+Raf. There was no significant sidffrence in adherence to A549 cells between 
4559 and 4559RafE RGD→HAE or between 947 and 947RafE RGD→HAE (Figure 2.13). As 
observed in the previous experiment, there were no significant differences between any of 
the strains in adherence to Detroit 562 cells in either CDM+Glc and CDM+Raf (Figure 
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2.13). Thus, the RafE RGD motif is not directly affecting pneumococcal adherence to either 
A549 or Detroit 562 cells. 
Figure 2.13. Impact of RafE RGD→HAE mutation on adherence to A549 and Detroit 562 cells. S. 
pneumoniae strains 4559, 947, 4559RafE RGD→HAE and 947RafE RGD→HAE were inoculated at OD600 = 
0.2 onto A549 or Detroit 562 monolayers in CDM + 10% FCS + 0.5% glucose (A) or 0.5% raffinose 
(B), in triplicate, then tested for adherence after 2 h at 37 °C (see Section 2.2.10). Each adherence 
assay was performed twice, with similar results. Data presented are the means ± standard 
deviations from two independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.001; unpaired t-
test). 
2.3.7 Detection of raffinose and raf operon expression in mouse 
lungs 
Despite the apparent involvement of raffinose in pneumococcal disease progression, 
raffinose, a plant derived sugar, has not been directly detected in mammalian tissues. To 
determine raffinose’s presence in murine lungs, groups of 4 mice were challenged with 108 
CFU of either 4559, 947 or SB (mock), the lungs were then harvested 24 h post-infection. 
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The infected murine lungs were sent to Metabolomics Australia, where Gas 
chromatography-mass spectrometry (GC MS) was performed on these samples (see 
Section 2.2.13). This technique is capable of detecting raffinose down to a minimum of 
0.01 mg/g in tissue. Sucrose was also examined in the GC MS as a positive control. 
Selected-ion monitoring (SIM) chromatograms of all tested samples showed detectable 
levels of sucrose (Appendix I), but levels of raffinose were under the limit of detection 
(Appendix J).  Overlaid SIM chromatograms of the murine lung samples and sucrose and 
raffinose analytical standards, show no peak/detection of raffinose in the lungs (Figure 2.14). 
Figure 2.14. GC MS was performed at Metabolomics Australia on lungs extracted from groups of 
4 mice after infectiom with 4559, 947 or SB. Lungs were harvested 24 h post-infection and 
underwent CryoMill extraction for polar metabolites (see section 2.2.13). Overlaid SIM 
chromatograms show selected-ion intensity (Y-axis) and the acquisition time (X-axis) of the 12 
murine lung samples and raffinose analytical standards (STD).   
As raffinose was unable to be detected in murine lungs, the activation of the raffinose 
operon was examined in vivo, in order to confirm the biological relevance of the rafR 
switch. Here murine lungs were harvested 6 h after infection with either 4559, 947, 
4559947rafR, and 9474559rafR. RNA was then extracted and levels of aga, rafG, and rafK 
mRNA were then measured relative to 16S rRNA by qRT-PCR. Importantly, differential 
expression of these genes was observed, with aga expression greater in 4559 than 947 and 
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4559947rafR (p < 0.05, in both cases). 9474559rafR also showed significantly greater aga 
expression than 4559947rafR (p < 0.05) (Figure 2.16). Expression of rafG was also 
statistically significantly greater in both 4559 and 9474559rafR than in either 947 or 
4559947rafR (p < 0.05, in all cases). Hence expression of the pneumococcal raffinose operon 
does occur in vivo after infection of murine lungs. These findings for aga and rafG 
expression are similar to that seen in cells grown in vitro in CDM+Raf, and implies the 
presence of raffinose or similar saccharides able to activate the raf operon within lung 
tissue. RafK expression was also detected in all infected lung extracts, but unlike the case 
with in vitro grown cells in CDM+Raf, there was no significant difference in rafK 
expression between strains. 
Figure 2.16. Expression of raffinose pathway genes in murine lungs. Mice were challenged I.N. 
with 108 cfu of indicated strains, then lungs were harvested 6 h post-infection. RNA was then 
extracted, and levels of aga, rafG, and rafK mRNA were analysed the means ± SD from three 
















Utilising both PacBio and Illumina MiSeq genomic sequencing allowed the de novo 
assembly of the serotype 14 ST15 and serotype 3 ST 180 blood and ear isolate genomes. 
PacBio produces long reads with high error rates while MiSeq yields much shorter reads 
with lower error rates (Quail et al., 2012). Thus, combining these two sequencing 
technologies allowed the consolidation of their advantages (long reads for PacBio and low 
error rate for MiSeq) whilst removing their disadvantages (high error rate for PacBio and 
short reads for MiSeq). Given that each sequenced blood and ear isolate pair were from the 
same serotype and sequence type, the low number of significant genetic differences within 
each pair was expected. The serotype 3 ST 180 pair had 27 indels or SNPs that lead to 
amino acid changes, while the serotype 14 ST 15 pair had 17 amino acid altering mutations, 
along with a prophage and plasmid present in 4559 but not 947 (section 2.3.1).  
It was initially hoped that consistent genetic differences between blood and ear isolates 
might be identified for the two distinct lineages, pointing to candidate polymorphisms that 
are directly responsible for virulence phenotype. However, the serotype 14 ST15 and 
serotype 3 ST 180 blood and ear isolate pairs shared no common genetic differences. 
Nevertheless, SNPs in rafR and rafK within the raffinose utilisation locus were present in 
the ST15 and ST180 isolate pairs, respectively. As there were no other common differences 
between the clonal isolate pairs, the potential impact of raffinose utilisation on differential 
disease progression/niche adaptation was examined. 
Pneumococci are strictly fermentative bacteria, relying solely on carbohydrate metabolism 
for energy and growth (Paixão et al., 2015). However, carbohydrate availability differs 
between host niches, and so the ability to respond to and utilize distinct carbohydrates is 
crucial for pneumococcal fitness in vivo. The S. pneumoniae genome encodes 21 
phosphotransferase systems (PTSs) and up to 8 ATP binding cassette (ABC) transporters 
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for the import of carbohydrates (Bidossi et al., 2012; Buckwalter and King, 2012), 
accounting for roughly 30% of all transport systems (section 1.5.3). Previous studies have 
shown that several of these carbohydrate transporters, present in both the core and 
accessory genome, impact pneumococcal virulence. For example, a sucrose PTS and ABC 
transporter system of serotype 4 pneumococci have both been shown to play roles in murine 
colonisation and pneumonia, respectively (Iyer and Camilli, 2007), while transporters for 
carbohydrates such as glucose, galactose and mannose were shown to impact invasive 
pneumococcal disease (Hava and Camilli, 2002; Ogunniyi et al., 2012; Orihuela, Radin, et 
al., 2004). 
Results from this Chapter further underscore the critical role played by differential 
carbohydrate metabolism in pneumococcal pathogenesis. It demonstrates that reduced 
capacity to utilise raffinose does not simply reduce pneumococcal virulence, but rather 
changes the nature of disease caused. In multiple serotypes/ST lineages, ear isolates had 
defective growth in CDM+Raf and reduced expression of raffinose pathway genes relative 
to their serotype/ST-matched blood isolates (section 2.3.2). Exchange of rafR alleles 
between ear and blood isolates of serotype 14 ST15 reversed these in vitro phenotypes 
(section 2.3.4). Moreover, rafR exchange caused blood isolates to now cause otitis media 
and meningitis rather than pneumonia after intranasal challenge, and conversely caused ear 
isolates to now target the lungs. This striking switch in in vitro and in vivo behaviours was 
attributable to a single, nonconservative SNP (D249G) in RafR, identifying this residue as 
one of critical functional importance. Significantly, the region of RafR from amino acids 
226 to 268 comprises a conserved signature sequence for the AraC/XylS family of 
transcriptional regulators (Rosenow et al., 1999). 
 
Interestingly, in spite of exhibiting similarly distinct in vitro and in vivo phenotypes, the 
serotype 3 ST180 blood and ear isolates did not share the SNP in rafR, but rather had a 
SNP in rafK, which encodes the ATPase required for raffinose uptake via the ABC 
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transport system encoded by rafEFG. RafK-mediated uptake of raffinose has previously 
been shown to be essential for induction of the raf operons in S. pneumoniae D39 (Tyx et 
al., 2011). Attempts to construct rafK exchange mutants in this lineage (analogous to the 
serotype 14 ST15 rafR exchange mutants) were not successful, likely due to the low 
transformability reported with serotype 3 strains (Croucher, Mitchell, et al., 2013). 
However, rafK deletion mutants of both 180/2 and 180/15 were obtained. Whereas the 
wild-type ear isolate 180/2 exhibited reduced growth in CDM+Raf and expression 
of aga, rafG and rafK relative to the wild-type blood isolate 180/15, both rafK deletion 
mutants were unable to grow in CDM+Raf at all, and expression of any of the raf operon 
transcripts was undetectable (section 2.3.5). Clearly, the RafK allele carried by 180/2 
retains partial function. The I227T SNP that distinguishes the RafK alleles of 180/2 and 
180/15 is located in the conserved regulatory domain motif 1. This domain is believed to 
be involved in the interaction between RafK and the enzyme dihydrolipoamide 
dehydrogenase (DLDH), which has been shown to modulate raffinose uptake 
and raf operon expression in S. pneumoniae D39 (Tyx et al., 2011). In the murine model, 
both rafK deletion mutants exhibited reduced bacterial loads in multiple host niches 
relative to their respective wild-type strains (section 2.3.5), consistent with previous reports 
(Marion et al., 2011; Tyx et al., 2011). 
 
These findings provide an interesting example of convergent evolution, whereby 
pneumococci belonging to two unrelated serotypes/lineages exhibit SNPs in separate 
genes, each affecting raffinose uptake and utilisation, which in turn correlate with distinct 
pathogenic profiles in both mice and humans (the latter by inference from the clinical 
isolation site). In S. pneumoniae D39, induction of expression of the raf operon 
gene aga required the presence of raffinose; reduced but nevertheless 
significant aga expression also occurred in a rafR knockout mutant (Rosenow et al., 1999). 
Thus, raf operon expression in pneumococci can be impacted either by defects in raffinose 
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import (e.g., due to a defective RafK), such that insufficient exogenous raffinose (if 
present) is internalised to induce raf expression, or by functional defects in the 
transcriptional activator RafR, such that baseline levels of expression induced by the 
presence of raffinose are not further upregulated. The raf operons are part of the core 
genome of S. pneumoniae, and BLASTX analysis of available genomes shows that there 
is between 1% and 3% deduced amino acid sequence variation within any of the raf genes. 
Thus, SNPs are widespread, but it is not known which (if any) of these other SNPs impact 
the capacity to import or utilize raffinose or the virulence phenotype. 
 
Notwithstanding the results presented above, the precise mechanism whereby differential 
raffinose uptake/utilization determines the virulence phenotype is uncertain. Raffinose is a 
plant-derived trisaccharide present in many staple foods, particularly beans and soy (Díaz-
Batalla et al., 2006; Kumar et al., 2010). A potential complicating factor is that RafEFG is 
reported to be also capable of importing stachyose (Bidossi et al., 2012), while RafK has 
been reported to also energize uptake of sialic acid and maltotetraose via unrelated 
transporters (Marion et al., 2011). Thus, the SNPs observed in the present study could have 
pleiotropic effects. However, no differences in metabolism of these sugars between the 
serotype 14 ST15 blood and ear isolates were observed using phenotypic microarray 
analysis (Appendices A-H), and the serotype 3 ST180 strains were unable to grow in CDM 
with stachyose or sialic acid as the sole carbon source. Moreover, there was no significant 
difference in the growth rates of the ST180 blood and ear isolates when grown in CDM 
with maltotetraose. 
A particularly intriguing finding of the present study was that lower raffinose 
uptake/utilisation by the ear isolates provided an advantage over blood isolates in the ear 
compartment. Interestingly, exogenous raffinose has recently been shown to promote 
biofilm formation by Streptococcus mutans by promoting aggregation of extracellular 
DNA into the biofilm matrix. Biofilm formation was unaffected by deletion of the α-
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galactosidase gene agaL, indicating that the effect was unrelated to metabolism of any 
internalized raffinose (Nagasawa et al., 2017). Thus, it is conceivable that the reduced 
capacity of S. pneumoniae ear isolates to assimilate (and thereby deplete) raffinose from 
the middle ear mucosa may similarly promote pneumococcal biofilm formation in that 
niche, leading to otitis media. 
 
Although humans are unable to metabolise it, dietary raffinose is known to be absorbed by 
the intestinal epithelium (Lobley et al., 1990), raising the possibility of at least small 
amounts being present on mucosal surfaces. Expression of aga, rafG and rafK was detected 
in RNA extracts of mouse lung tissue 6 h after intranasal challenge with either of the 
serotype 14 ST15 blood or ear isolates. Since raffinose is the only known inducer of 
the raf operon in S. pneumoniae, this finding is strongly indicative of the presence of 
bioavailable raffinose in the murine lung. However, GC MS analysis of infected lung 
extracts failed to detect the presence of raffinose. This may be due to the limit of detection 
for raffinose by GC MS. Raffinose uptake by pneumococci may be very efficient, leading 
to free raffinose being kept below the detection threshold of the GC MS. However, 
raffinose was not detected in the mock infected lung extracts. Whether this raffinose operon 
upregulation is due to raffinose or induced by other saccharides that are similar in structure 
to raffinose, capable of interacting with RafR and present in the lungs, remains to be seen.   
 
Adherence assays showed the rafR mutation affect the ability of the serotype 14 ST 15 
blood and ear isolates to adhere to lung epithelial cells. However, conservative mutation of 
a putative RGD binding motif of the raffinose ABC uptake system’s substrate binding 
protein, RafE, did not abrogate adherence. Whether RafE could moonlight as a 
pneumococcal adhesin would seem unlikely given its cellular location attached to the cell 
membrane, beneath the cell wall and capsule, making interactions with host receptors 
problematic. There is also the issue of adherence occurring in CDM+Glc (Figure 2.13), in 
which raffinose gene expression, including rafE, would be expected to be repressed. Thus, 
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the raffinose operon’s impact on lung epithelial adherence, and potentially on virulence as 
a whole, may be indirect. As rafR acts as the regulator for the raffinose operon, it is possible 
that it also acts as a regulator for other genes that in turn impact pneumococcal virulence 
and disease progression. Further studies looking into the impact of rafR on both the 
pneumococcal and host genome in vivo are needed to elucidate the precise molecular 
mechanisms whereby fine-tuning of levels of expression of rafR can have such a profound 

























Transcriptomic Comparisons of S. 
pneumoniae Clonal Clinical Isolates 
 
3.1 Introduction 
In the previous Chapter, the potential effects of the genetic differences within the serotype 
14 ST 15 and serotype 3 ST 180 blood and ear isolate pairs were explored, in an attempt to 
explain their differential disease phenotypes. Indeed, SNPs present within the genes rafR 
and rafK were shown in Chapter 2 to influence disease progression for the serotype 14 ST 
15 and serotype 3 ST 180 blood and ear isolates, respectively (Minhas et al., 2019). Whilst 
there is strong evidence for the involvement of the raffinose operon in disease progression 
of both the examined serotype/lineages, it was unclear whether this was strictly via effects 
on raffinose metabolism or indirect effects on unrelated parameters. Transcriptomic 
analyses of the clonally-related blood and ear isolates may therefore provide insights into 
the underlying mechanisms.  
In this Chapter, the serotype 14 ST15 and serotype 3 ST180 strains were grown in either 
CDM with Glc or galactose (Gal) as the sole carbon sources, or in human serum, and RNA 
extracts were subjected to RNA sequencing. The strains exposed to human serum 
mimicked the human blood environment as closely as possible without the need to infect 
live patients. CDM+Glc similarly mimicked this blood environment, at least in terms of 
carbohydrate source, as glucose is the major sugar found in the blood (McMillin, 1990). 
Identification of similarities between these two growth media may provide insights into 
how pneumococci typically behave upon invading the blood stream. Conversely, galactose 
is the major sugar present in the nasopharynx (Blanchette et al., 2016), thus CDM+Gal 
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sought to mimic the nasopharyngeal environment, which may help to elucidate the 
behaviour of pneumococci during colonisation.  
Clearly, transcriptomic analyses of cells grown in CDM+Raf would have been highly 
informative in light of the findings in Chapter 2. However, the decision to use CDM+Glc 
and CDM+Gal was made before the genomic analyses were performed. Hence, there was 
no capacity in this current chapter to thoroughly expand on the raffinose related findings 
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3.2 Materials and Methods 
 3.2.1 Preparation of S. pneumoniae strains  
The bacterial strains used in this Chapter are listed in Table 3.1. Cells were routinely 
grown in C+Y medium (Lacks and Hotchkiss, 1960) or on BA plates with or without 
gentamicin (40 µg/ml), kanamycin (500 µg/ml), or spectinomycin (200 µg/ml) (as 
required) and incubated at 37°C in 5% CO2 overnight (section 2.2.1). The strains 4559, 
947, 180/15 and 180/2 were prepared for RNA sequencing in human serum or CDM 
(Kloosterman et al., 2006), with either 0.5% Glc or 0.5% galactose, in 6  biological 
replicates. Each strain was inoculated into CDM+Glc or CDM+Gal at an OD600 of 0.05, 
and grown to 0.25 OD600. Pneumococci are unable to grow in human serum, hence strains 
were instead incubated in this media at 0.5 OD600 for 2 hours. Each sample was then 
pelleted and RNA extracted by the addition of 400 µl of  Acid Phenol: Chloroform (5:1, 
pH 4.5) (Ambion), and 400 µl of 65oC NAES (50mM NaAC pH 5.1 + 1% SDS) at 65oC, 
essentially as previously described (Ogunniyi et al., 2002), except that the resulting 
aqueous phase was extracted using the Qiagen RNeasy RNA isolation kit. For gene 
expression validations, strains were similarly grown in CDM+Gal or CDM+Gal to an 
OD600 of 0.5, before RNA extraction.  
3.2.2 Transcriptomic sequencing  
Purified pneumococcal RNA samples were assessed by the Bioanalyzer (Agilent, Sant 
Clara, United States) for a RIN (RNA Integrity Number) value > 8.0, then sent to AGRF 
for sequencing. Then rRNA was depleted using the Ribo-Zero rRNA Removal Kit 
(Bacteria) and prepared for RNAseq using the TruSeq Stranded mRNA Library Prep Kit 
(not including the poly(A) RNA purification step) (Illumina). RNA sequencing was 
performed on a single Hiseq2500 lane with 100 PE chemistry and dual indexing. 
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Table 3.1. Bacterial strains used in this Chapter.  
Strain Description Source Reference 
4559 S. pneumoniae serotype 14 ST15 Blood Amin et al, 2015 
947 S. pneumoniae serotype 14 ST15 Ear Amin et al, 2015 
4534 S. pneumoniae serotype 14 ST15 Blood Amin et al. 2015 
51742 S. pneumoniae serotype 14 ST15 Ear Amin et al, 2015 
180/15 S. pneumoniae serotype 3 ST180 Blood Trappetti et al, 2013 
180/2 S. pneumoniae serotype 3 ST180 Ear Trappetti et al, 2013 
D39 ΔadhE 
S. pneumoniae serotype 2 with adhE 
deletion  This study 
180/15 ΔadhE 
S. pneumoniae serotype 3 ST180 with 
adhE deletion  This study 
180/2 ΔadhE 
S. pneumoniae serotype 3 ST180 with 
adhE deletion  This study 
180/4 S. pneumoniae serotype 3 ST180 Blood This study 
180/9 S. pneumoniae serotype 3 ST180 Ear This study 
232/1 S. pneumoniae serotype 3 ST232 Blood Trappetti et al, 2013 
232/11 S. pneumoniae serotype 3 ST232 Ear Trappetti et al, 2013 
 
Demultiplexing was then performed, assigning reads to their corresponding samples, 
generating one FASTQ sequence file per sample. Finally, a quality check was performed 
on the FASTQ files using FASTQC (Andrews and Babraham Bioinformatics, 2010).  
 3.2.3 Bioinformatics analysis 
Read counts were obtained utilising Galaxy Australia provided by the Research Computing 
Centre, University of Queensland, Australia. FASTQ reads of 4559 and 947 and 180/15 
and 180/2 were mapped to the assembled reference genome of the other strain within each 
clonal lineage, using BWA-MEM version 1.1.3 (Li, 2013). Read counts for each gene were 
then determined using SAMTools version 0.1.18 (Li et al., 2009), and differentially 
expressed genes (DEG) were quantified using Degust version 4.1.1 (Powell et al., 2019). 
Genes were filtered for DEG Fold Change (FC) > 2 and FDR (false discovery rate) < 0.01.   
 3.2.4 Quantitative real time RT-PCR 
Differences in levels of gene expression were validated by qRT-PCR in a Roche LC480 
real-time cycler essentially as described previously (Mahdi et al., 2008). The specific 
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primers used for the various genes are listed in Table 3.2 and were used at a final 
concentration of 200 nM per reaction. As an internal control, primers specific for 16S 
rRNA were employed. Amplification data were analysed using the comparative critical 
threshold cycle (2−ΔΔCT) method (Livak and Schmittgen, 2001). 
Table 3.2. Oligonucleotide primers used in this Chapter.  
Primer Sequence (5′→3′) Reference 
TreP F CCAGTCCTTGTTGCAGTCTG This study 
TreP R CGCATCAGACACAACCAACA This study 
WbbI F ATCCAGCTGATGAGGAGGAC This study 
WbbI R CGATTGGCTTCCTCCAAACT This study 
Gtf2 F  GTCACTTTCCGTATTGCAGC This study 
Gtf2 R GCCTGTAGCAACTCATTACTGT This study 
EpsJ_4 F  CGCTTTGATGATGAAGCAAC This study 
EpsJ_4 R CCTGTAGGATATCCTGTACCCA This study 
ScrB F  CGACCGTACTGCCTACATGA This study 
ScrB R GAAGGCTTGAGTTGCATAGG This study 
TreR F CTGTCTCTCCTCCAAGAGGA This study 
TreR R GGACCACCTTCCAAACCATC This study 
NanA_3 F ATGTTCCCAGAAGGTCGAGC This study 
NanA_3 R CTATAGCCAGGTTCTGTTGG This study 
GmuE F CGTGCCAATGTACTTCACAA This study 
GmuE R CCACACCACCGATAAACTCA This study 
BioY2 F  TCCAATTGGACCTGTTCCCT This study 
BioY2 R CCTGCAGTAGGGCCAACTAA This study 
SpxB F CCGTGTTGGTTGGAAACCAG This study 
SpxB R CTTGACCAGCATCACCAAGG This study 
lytA_7 F CTCGCTGAGTGTTGCTTATG This study 
lytA_7 R CCTGAGCCAGAAGAAACAGC This study 
Dus F GGATAATGAAATGCTTGCTCG This study 
Dus R AGCACCAGTTGCTGCACCTT This study 
AcpB F TTGATCCACGGACAAGTAGC This study 
AcpB R GCAAGAATATTGGCTGCAGC This study 
NanE F GCATTCGCGCAAATTCTGTG This study 
NanE R GACTGTTGTTCCGCATTCTAC This study 
ArcC1 F CTGTTGTAACGCAAGTTGTCG This study 
ArcC1 R TGGTGAGGCAACGACCTTAC This study 
SorC F CGTGTGGATGCTGCAATCGA This study 
SorC R CAAGTGTCAAGCCATCTGCA This study 
RpiR F CCAAGAGATGATTCGTGAGA This study 
RpiR R CACGCTCAGCAGTTTCTATC This study 
NatA F GAGTATTGAATGGCTGGATGG This study 
NatA R CGTTGCTTCATGCCTAAGGA This study 
BoGH2 F CGTTGGTATTCAGGAAGTGG This study 
BoGH2 R CCTGTTACAGCATGACCACC This study 
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PflB F GGACGTATCATCGGTGTTTACG This study 
PflB R CCAGGCGAACAACTTGTTGC This study 
Gtf F GGTCATTCTCGATAGGGAGA This study 
Gtf R AGTCAACCTTATCTGCATTGG This study 
BglH_2 F ATCAAGGCCATGCGAGATGC This study 
BglH_2 R CTTGCTACGTTTGAGAGTCC This study 
LacD F TTGCCAGACTGCTTGGATGT Trappetti et al, 2017 
LacD R ACTCAGAACCGATGCGTTCG Trappetti et al, 2017 
GalT F GGTGTAGGAGCAATCAGTCT Trappetti et al, 2017 
GalT R GCATCACCAATTGACATCCA Trappetti et al, 2017 
AdhR F GCAGGAATTGGTGAGATAAA This study 
AdhR R GTCCGATAAATTCGAGCAAT This study 
GlnP F ACGTTCCCAACCTTCTCTGG This study 
GlnP F CCGCCTCGAATAATCTCAGC This study 
Zwf F GGTGTAGAAGAACGTGGTGG This study 
Zwf R TCATCAGTTGGATGATAGAGG This study 
GlnR F GACATGGATCGTCTGCTTGA This study 
GlnR R GAGGAGTTCATTGTGAAGTGC This study 
AlsT F GGAACCTTCACCCAAGTCAA This study 
AlsT R GAGTCCACCAAAGACTGCAA This study 
LytN F TGTAGCGCCTGTTGCAACAC This study 
LytN R GGCTTCTGCTTCAGATCCGC This study 
ComF F CTAACTCATTGGTCGAAGTCG This study 
ComF R GCAACAACCCATCAGTTATTG This study 
GroL F GCCAATAAAGAAGCTATCGC This study 
GroL R TACTGTGAAAGGTAACCACGG This study 
PatB F AACCCTCACAATCCTGGTGG This study 
PatB R GGCACTGCTCAAGACGATAGC This study 
ArgG F TGTCATTGATGTCAAGGACG This study 
ArgG R GGTACAGCCATGAGCAATTG This study 
Ugd_2 F CGCATAGTTGTTGGAGATGAG This study 
Ugd_2 R GCTTAATTGCTTCTGCTTCAG This study 
SpeA F CCTGCAAGGCAGGAGATAAG This study 
SpeA R CCTTAGCATCTGGATGGTCC This study 
GmuA F GTGGAGCAGCCAAATCATCC This study 
GmuA R TGTGCGCTTCTACTAAGGAG This study 
PdhC F CCAATGCGTAAGGTTATTGC This study 
PdhC R CCAGTTGCTTCCATGATTGG This study 
Fhs1 F CCATGTGACTGTTGGTCTTG This study 
Fhs1 R GGCGTACGGTCATAGCGATA This study 
LytA_3 F CCTGAGCAATCATCTATTCCT This study 
LytA_3 R CGTTGCTGTTGAGGTAGTACC This study 
GuaA F GAGACAGTAGAAGGAAGCGTG This study 
GuaA R GGTGCTCGTCGATAGACTCA This study 
YusV F GAGTCTTGGAAAAGATGACCTTG This study 
YusV R CCAAGTAAGTAGTTGGCTCATC This study 
ComE F CCTGTAGGTAGTCGAGTCAATG This study 
ComE R GGCTAACTGCTTCTTCTCCA This study 
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Eno_2 F CTCGTGCTGCTGCTGACTAC This study 
Eno_2 R CCAACTGGCAAGATCATGAAC This study 
PbpF_1 F CATACCATGCAGTATGACAGC This study 
PbpF_1 R CCAAGAACACGGTCAACCTT This study 
PurH F CCGTGATGCAGATGCTGCTA This study 
PurH R CTCACGGTTGAGGACGACAA This study 
ApbE F GGTGCTGCCTCTAATCAATC This study 
ApbE R CAGATTGATCAAGGCAGAAGT This study 
PaaI F CGACCAAAGTAGTGAACTCG This study 
PaaI R TGGTCAATACATCGTCGAGTT This study 
PspC F TCGTCAAGTTCAGGCTCCTC This study 
PspC R GGCTCTGGTTTAACCTCTGG This study 
Fba F AGCTATCCACCTTGACCACG This study 
Fba R CCACCGATAGTACCAACTTCA This study 
Nfr1 F GCAGCAATCACTGGTGCTGT This study 
Nfr1 R TGTCTGGATCTTGGTGAGCG This study 
RibF F TGTTCCACCTGTAGAAGATGAG This study 
RibF R GTACGACCACGAGCATTACC This study 
HemH F CCAACACTTGGCAGAGTGAG This study 
HemH R GTGGACGATGGTAGTTTACC This study 
DLDH F ATGCTGCAAATCGTGGTATC This study 
DLDH R CCGTAGCTACGAAGAAGTCC This study 
CapA F  CAGATGGGTGTTGAGTATCG This study 
CapA R TTCAACCGTTTCAGATGGCT This study 
Pgk F CCATTCGTGGCTATCCTTGG This study 
Pgk R GAGTTACCGATTTCGATACC This study 
YdaF F GTTAAGATAGACGAGGCTGA This study 
YdaF R CCATGACACGACCTGAAGCT This study 
YbiV F GGATGAATTAACATCTGACCTC This study 
YbiV R GGAGGATATCAATGCAACCA This study 
CtsR F GCTACATTCGTATAGGACGGA This study 
CtsR R CCTGCTTGGTCATCAATTCC This study 
AdhB F  GCTGGTCTTGGTTATGTTCA This study 
AdhB R CCAAGGCTTTGGCAACATTG This study 
PurL F CGGTTATCGAAGCAACTGCT This study 
PurL R ACCACCGATAGATGGCAAGC This study 
AdhE F CCATGCCATGGTAGAGCTTG This study 
AdhE R TGGCAGCATCCATTGGAGAC This study 
GapN F ATTGGAGAACGTATTGGTCG This study 
GapN R TGCAACGTTGTCCTGAGTAG This study 
PncB2 F TACCAGACCTTGGTGGCGAC This study 
PncB2 R CACGTTGCTGGTTCCATTGG This study 
Aadh_2 F GCTCACTGTGAAGACGAAGG This study 
Aadh_2 R TAGGCAGAATGTCTGACAGC This study 
PurC F GCAGGTAAGGGAGTCTTGAA This study 
PurC R GGAACCAGCAGTATAGTTGC This study 
Peb1A F GGTCAAGATTCACTATGTGC This study 
Peb1A R CCAGAAGCGTCTGTGTAGTA This study 
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Rex F CTTGGTCGTCGTGGTTTTGG This study 
Rex R CAGGATGGTCGTCTAGGTCA This study 
CopY F GCAGAGCGGTTTGACTGGTC This study 
CopY R TCCCGACTTTGGTCTAGAG This study 
lmrA_1 F CTTTGTCTCGGTTTGAATCG This study 
lmrA_1 R CGTTCACCAACTTCAGTATCT This study 
CelA_3 F GCAACAAAGTGCGACTGAAC This study 
CelA_3 R CCTGCAATTTCTTTCACAGC This study 
TruC F CCTGGAGATGTTTGCCAGTT This study 
TruC R CGTTTGGTTGATTACCATGC This study 
MscL F GGTGTTGTCATTGCCTCTGC This study 
MscL R AGTTGAGCGATACGTTCGAC This study 
GlxK F GTCTTGCCTGCTTCCGATCA This study 
GlxK R GCAAACATAGTCGGATGTAGACC This study 
ManZ F CAGCAACTATGGCTATCGCT This study 
ManZ R AGCACCCATCATGAAGACAC This study 
YesO F GCACAAGTCATGTGGGTTAG This study 
YesO R CCTCCACCACTACGTACGTA This study 
UbiE F CATATGCCTGATTTGGATGC This study 
UbiE R CAGGTCTTCAGCGCTATAGAGA This study 
AgaC F GGTGATCTGCCTACTGCTCT This study 
AgaC R TCTGGACTGACTTTACCAGC This study 
lacE_1 F  GAATTCAGGAGCGTACGGAG This study 
lacE_1 R  CCATTCCTCTGGTAGCAACT This study 
CzcD F GTAGCTGTTATCCTGATGGC This study 
CzcD R CCACATTGTCCAATCGTTCC This study 
NanB F GCACGTTATGGTGGGACTCA This study 
NanB R CTCGTGGCCAGTAAACTAACT This study 
TabA F CGAAGAAGCCATGGCTGTTAC This study 
TabA R CGAACCTTGGGTTGATGTAA This study 
YxlF F ACTGCGTCCATGGATACCTC This study 
YxlF R CTCGCTACGCATAGCTAGAG This study 
J253 GAGGAGGATATATTTGAATACATACG Trappetti et al, 2017 
J254 
TTATAATTTTTTTAATCTGTTATTTAAATA
GTTTATAGTTA Trappetti et al, 2017 
adhE for GAGATTCCTTATGACAAGAA Trappetti et al, 2017 
adhE Rev TACTAGCTTATTATTCTAG Trappetti et al, 2017 
adhE spec for 
AAATAACAGATTGAAGAAGGTATAATGTT
TATCAGTCTAGAAG Trappetti et al, 2017 
adhE spec Rev 
ACAAAGGATATCGTTCCTGAGGAGGATAT
ATATGAATACATA Trappetti et al, 2017 
 
3.2.5 Mutagenesis 
Transformation of the serotype 3 ST180 clinical isolates, 180/15 and 180/2, requires 
chromosomal DNA as the template, as previously described (Harvey et al., 2014, 2016). 
Hence in order to delete rafK in these strains, this mutation was first introduced into the 
3 | Transcriptomic Comparisons of S. pneumoniae Clonal Clinical Isolates 
86 
 
laboratory adapted D39 strain. A spectinomycin cassette PCR product flanked by rafK 
adjacent regions, was generated by overlap extension PCR as previously described 
(Morona et al., 2000). To achieve this, the relevant primers listed in Table 3.2 were used 
to amplify rafK flanking products from 180/2 template DNA and to amplify the 
spectinomycin resistance cassette. D39 was transformed with the overlap extension PCR 
product, as previously described (Giammarinaro and Paton, 2002; Martin et al., 1995), and 
selected on spectinomycin containing BA plates. Transformants were confirmed by PCR 
and Sanger Sequencing. The construct used to make the 180/2 and 180/15 ΔrafK mutants 
were then generated in a two-step process, commencing with transformation with genomic 
DNA (gDNA) from D39 ΔrafK. After selection on BA plus spectinomycin, genomic DNA 
was extracted from one of the transformants for each of 180/2 and 180/15, and used as the 
donor in a second round of transformation of these strains. The transformation procedure 
itself was a modification of that developed previously for type 1 ST306 (Harvey et al., 
2014). Strains 180/2 and 180/15 were grown overnight on BA and then inoculated into a 
1:1 mixture of C+Y medium and Dulbecco’s modified Eagle’s medium (DMEM; Gibco, 
Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum (FCS). After 
1 h at 37°C, the culture was diluted into fresh medium and incubated for a further 2 h at 
37°C. Competence-stimulating peptide 1 (CSP-1) was added to achieve a concentration of 
50 ng/ml, followed 15 min later by donor DNA (approximately 1 μg) of the appropriate 
180/2 and 180/15 wild type strains. After a further 2 h of incubation at 37°C, transformation 
mixes were plated on BA plus spectinomycin. 
 3.2.6 Acetaldehyde assay 
S. pneumoniae 180/15, 180/2 and respective ΔrafK strains were assessed for acetaldehyde 
production. Strains were cultured in C+Y medium until they reached an OD600 of 0.3, then 
acetaldehyde levels were measured using an aldehyde quantification kit (Abcam, England), 
according to the manufacturer's instructions. C+Y medium was used as a blank control. 
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 3.2.7 Adherence and invasion assays   
A549 and Detroit 562 cell lines were used for adherence assays. Cells were grown in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum 
(FCS), in 75 cm2 tissue culture bottles (Becton Dickinson) at 37oC in a 5% CO2 
atmosphere. 2 × 105 cells were seeded into each well of a 24-well tissue culture trays 
(Becton Dickinson) for use in the adherence assays. The day prior to inoculation of 
pneumococcal cells to the tissue culture, the media was replaced with DMEM + 1% FCS 
in the 24-well seeded trays. S. pneumoniae strains 180/15, 180/2, 180/15 ΔrafK and 180/2 
ΔrafK were used for adherence and invasion assays. 500 µl of each strain was inoculated 
onto washed A549 or Detroit 562 cells, at an OD600 of 0.2 in DMEM + 1% FCS in triplicate. 
After incubation for 2 hours at 37oC, the wells were washed three times with PBS and cells 
were detached from the plate by treatment with 100 µl of 0.25% trypsin-0.02% EDTA and 
400 µl of 0.1% triton x-100. Appropriate dilutions of the cultures were plated on BA to 
determine the number of adherent bacteria. Assays were performed in triplicate from two 
independent experiments. For quantitation of pneumococci that had invaded A549 and 
Detroit 562 cells, extracellular bacteria were killed through treatment with gentamicin (200 
μg/ml) and penicillin G (10 μg/ml), before the addition of trypsin. Any intracellular 
pneumococci were then recovered after eukaryotic cell lysis, mediated by washing with 
100µl of 0.25% trypsin-0.02% EDTA and 400µl of 0.1% triton x-100. 100 µl of neat 









3.3.1 Transcriptomic differences between serotype/ST-matched 
isolates 
RNAseq analysis was performed on the serotype 14 ST15 blood and ear isolate (4559 and 
947) and serotype 3 ST180 blood and ear isolate pairs (180/2 and 180/15). Strains were 
grown to mid-exponential phase in CDM+Glc and CDM+Gal, or exposed to human serum 
for 2 h. 6 replicates for each blood and ear isolate strain were sequenced after growth in 
each of three media (see Section 3.2.1 and 3.2.2). Multidimensional scaling (MDS) plots 
indicate the level of variation (i.e. pairwise distance between the fold change values for 
each gene) between each sample of the blood and ear isolates. The first dimension of each 
MDS plot represents a greater amount of the total variation than the second dimension, 
which represents more variation than the third dimension, and so on (Figure 3.1). 
Essentially, the MDS plots provide a visual representation of the similarities or distances 
in the FC of each gene, between samples. Each sample in the MDS plot is signified as a 
coloured dot, with increasing transcriptomic variation between samples represented the 
further apart samples are from each other. In CDM+Glc, the serotype 14 ST15 947 samples 
were grouped mostly together except for one replicate, and the same was the case for 4559 
(Figure 3.1A), while over 45% of the variation was represented in the 1st MDS dimension 
(Figure 3.1B). All 947 replicates were closely grouped together in CDM+Gal while only 
1 replicate for 4559 differed extensively from the rest (Figure 3.1C). Almost 90% of all 
variation seen between these samples were represented in the 1st MDS dimension (Figure 
3.1D). In human serum, 2 replicates from 947 showed more variation compared to the rest, 
while for 4559 all but 1 of the replicates were grouped close together (Figure 3.1E). Here, 
over 55% of all the variation between these samples is represented in the 1st dimension 
(Figure 3.1F).  
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Appendices K and L list the pneumococcal genes that were significantly differentially 
expressed (fold change (FC) > 2, false discovery rate (FDR) < 0.01) between each of the 
blood and ear isolate pairs, in the 3 different media. No genes were found to be commonly 
differentially expressed between both the serotype 14 ST15 and serotype 3 ST180 blood 
and ear isolate pairs, with a FDR cut off of < 0.01. The differentially expressed gene (DEG) 
analysis between the serotype 14 ST15 4559 and 947 strains (Appendix K), found 21 genes 
to be significantly upregulated for 947, in CDM+Glc, including nanA (FC = 2.19, FDR = 
0.0012) and a Sucrose-6-phosphate hydrolase (scrB) (FC = 2.9, FDR = 0.00025). 
Conversely, 7 genes were significantly upregulated for 4559 in this media, including 
pyruvate oxidase (spxB) (FC = 6.95, FDR = 4.27 × 10-8). In CDM+Gal, 19 genes were 
upregulated for 947, including scrB (FC = 2.85, FDR = 0.00015) and a CPS synthesis 
positive regulator (acpB) (FC = 2.38, FDR < 0.0027).  For 4559, 30 genes were upregulated 
in CDM+Gal, including spxB (FC = 6.01, FDR = 2.2 × 10-6) and the Galactose-1-phosphate 
uridylyltransferase (galT) (FC = 4.15, FDR = 0.00021). Lastly, in human serum, 18 genes 
were upregulated in 947 which included scrB (FC = 6.66, FDR = 2.49 × 10-8), while 4559 
contained 5 genes that were upregulated, including spxB (FC = 3.44 FDR = 2.87 × 10-7). 
This analysis shows that metabolic genes were heavily differentially regulated between 
4559 and 947, highlighting the role of metabolism in influencing the variation seen between 
these two clonally matched strains. 
For the serotype 3 ST180 samples grown in CDM+Glc, 180/2 replicates were grouped 
together within dimension 1 but were separated in dimension 2, while 180/15 had two 
replicates that varied from the rest on dimension 2 (Figure 3.2A). Almost 50% of its 
variation was represented in the 1st MDS dimension (Figure 3.2B). The replicates for both 
180/2 and 180/15 were closely grouped together in the 1st dimension, respectively, but were 
separated along the 2nd dimension (Figure 3.2C). Over 40% of the variation seen between 
these samples were represented in the 1st MDS dimension (Figure 3.2D). In human serum, 
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both 180/2 and 180/15 samples were grouped closely together in both dimensions, except 
for 1 sample from both groups (Figure 3.2E). Over 45% of all the variation between these 
samples were represented in the 1st dimension (Figure 3.2F). Outliers within the 1st MDS 
dimension for each group may need to be excluded to increase chances of obtaining 
























Figure 3.1. MDS plots illustrate the variation between each individual sample used in the RNA 
sequencing of the serotype 14 ST 15 blood and ear isolate pair, 4559 and 947. (A, C, E) Each dot 
represents a sample, with the dots closer together indicating less variation. 947 samples are 
represented as 947glu1-6, 947gal1-6 and 947s1-6, while 4559 samples are represented as 
4559glu1-6, 4559gal1-6 and 4559s1-6.  (B, D, F) The percentage of variance that each dimension 
represents is indicated in each column.  
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For the serotype 3 ST180 strains, the DEG analysis between the blood and ear isolate 
(Appendix L) showed that in CDM+Glc, 44 genes were upregulated in 180/2, including 
the Glucose-6-phosphate 1-dehydrogenase (zwf) (FC = 3.25, FDR = 1.32 × 10-6). For 
180/15 in CDM+Glc, 52 genes were upregulated including the dihydrolipoamide 
dehydrogenase DLDH (FC = 2.52, FDR = 1.44 × 10-7) and the alcohol dehydrogenase 
(adhE) (FC = 3.51, FDR = 4.23 × 10-5). In CDM+Gal 35 genes were upregulated in 180/2, 
which included the transcriptional repressor of the cop operon (copY) (FC = 2.48, FDR = 
0.0070) and zwf (FC = 2.24, FDR = 5.80 × 10-5). On the other hand, 180/15 in CDM+Gal 
contained 61 upregulated genes, including the penicillin binding protein (pbpF_1) (FC = 
2.08, FDR = 5.48 × 10-8), DLDH (FC = 2.21, FDR = 0.00052) and adhE (FC = 4.64, FDR 
= 2.09 × 10-6). In human serum, 180/2 contained 88 genes that were upregulated which 
included the autolysin (lytA) (FC = 2.27, FDR = 0.00039). 180/15 had 55 genes upregulated 
in human serum, including the catabolite control protein A (ccpA) (FC = 2.19, FDR = 
0.0052) and DLDH (FC = 6.61, FDR = 6.42 × 10-9). Similar to the serotype 14 ST 15 DEG 
data, this analysis shows that metabolic genes were heavily differentially regulated 
between 180/2 and 180/15, again highlighting the role of metabolism in influencing the 
variation seen between these two clonally matched strains. 
3.3.2 Serotype 14 ST 15 blood and ear isolate validation 
To validate the data from the RNA sequencing analysis of the serotype 14 ST15 isolates, 
qRT-PCR (4559 and 947) was performed on fresh sample preparations, on genes that were 
significantly differentially expressed (FC > 2, FDR < 0.01) (Table 3.3). Similar to the 
RNAseq analysis, a FC > 2 and p value < 0.01 cut off was used to categorise genes 
significantly differentially expressed for the qRT-PCR validations. Hypothetical genes 
were omitted from the qRT-PCR validations, while only a single gene from an operon was 
validated if more than one gene from an operon was significantly differentially expressed  
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Figure 3.2. MDS plots illustrate the variation between each individual sample used in the RNA 
sequencing of the serotype 3 ST180 blood and ear isolate pair 180/15 and 180/2. (A, C, E) Each 
dot represents a sample, with the dots closer together indicating less variation. 180/2 samples are 
represented as 2glu1-6, 2gal1-6 and 2s1-6, while 180/15 samples are represented as 15glu1-6, 
15gal1-6 and 15s1-6. (B, D, F) The percentage of variance that each dimension represents is 
indicated in each column. 
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in the RNASeq data.  In CDM+Glc, 5 genes were significantly upregulated in the ear isolate 
947 (treP, wbbI, gtf2, scrB and treR) while 3 genes were significantly upregulated in the 
blood isolate 4559 (pflB, bglH_2, spxB) which corresponded with the RNAseq data. In 
CDM+Gal, 5 genes were significantly upregulated in 947 (treP, lytA_7, dus, acpB and 
arcC1) while 7 genes were significantly upregulated in 4559 (pflB, gtf, lacD, galT, exoA, 
adhR and spxB).  
The metabolic genes wbbi, treR and gtf2 were significantly upregulated in 947 in 
CDM+Glc (Table 3.3) and human serum (only wbbi and gtf2) (Appendix K), but not in 
CDM+Gal. Hence, these genes are only upregulated in the blood mimicking environments. 
Conversely, lytA_7, dus, acpB and arcC1 were significantly upregulated in 947, while gtf1, 
lacD, galT, exoA and adgR were significantly upregulated in 4559, in the nasopharynx 
mimicking environment CDM+Gal but not in CDM+Glc 
Table 3.3. Fold change and significance (FDR or p value, for RNAseq and qRT-PCR, respectively) 
of 947 vs 4559 genes after growth in CDM+Glc or CDM+Gal for 2 h. Genes with FC greater than 2 
and FDR < 0.01 in RNAseq are shown, with genes upregulated in the ear isolate 947 indicated by 
grayscale. For qRT-PCR, genes highlighted in blue = statistically significantly (p < 0.01) 
upregulated (FC > 2) in 947, while values highlighted in pink = statistically significantly (p < 0.01) 
upregulated (FC > 2) in 4559. 








Sp947_chr_01629 TreP Glu 4.99E-07 10.16 0.000643 7.65 
Sp947_chr_01671 WbbI Glu 3.30E-08 4.57 0.000931 3.25 
Sp947_chr_01664 Gtf2 Glu 4.31E-09 4.56 0.008975 3.98 
Sp947_chr_01674 EpsJ_4 Glu 3.84E-08 3.74 0.005638 1.76 
Sp947_chr_01630 ScrB Glu 0.000246 2.90 0.007442 2.34 
Sp947_chr_01788 TreR Glu 0.001066 2.61 0.029658 2.11 
Sp947_chr_01600 NanA_3 Glu 0.001146 2.19 0.063962 1.66 
Sp947_chr_01628 GmuE Glu 0.007833 2.14 0.034275 1.83 
Sp947_chr_00722 BioY2 Glu 0.005284 2.49 0.045262 2.27 
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Sp947_chr_00440 PflB Glu 2.96E-05 3.16 0.003386 2.96 
Sp947_chr_00679 BglH_2 Glu 0.002146 3.97 0.007221 2.68 
Sp947_chr_00675 SpxB Glu 4.72E-08 6.95 0.000848 7.49 
       
Sp947_chr_01629 TreP Gal 0.002858 24.5 7.63E-05 19.71 
Sp947_chr_00502 lytA_7 Gal 0.002688 7.40 0.004363 8.62 
Sp947_chr_00491 Dus Gal 0.004584 7.14 0.000024 5.49 
Sp947_chr_01630 ScrB Gal 0.000152 2.85 0.076927 2.36 
Sp947_chr_00065 AcpB Gal 0.002688 2.38 0.003604 2.73 
Sp947_chr_00840 NanE Gal 9.87E-05 2.25 0.037128 1.65 
Sp947_chr_02095 ArcC1 Gal 0.002442 2.21 0.009428 2.19 
Sp947_chr_00066 SorC Gal 0.004824 2.07 0.036572 1.77 
Sp947_chr_00839 RpiR Gal 0.000128 2.03 0.083943 1.32 
Sp947_chr_00924 NatA Gal 0.00857 2.00 0.053629 1.93 
Sp947_chr_00594 BoGH2 Gal 0.000211 2.11 0.146262 1.28 
Sp947_chr_00440 PflB Gal 0.000229 2.21 0.001242 2.53 
Sp947_chr_00023 Gtf Gal 0.00102 2.46 0.008316 2.44 
Sp947_chr_00679 BglH_2 Gal 0.001418 2.9 0.052783 2.64 
Sp947_chr_01104 LacD Gal 6.09E-06 3.74 0.003901 4.32 
Sp947_chr_00119 GalT Gal 3.93E-05 4.15 0.009235 3.67 
Sp947_chr_00111 ExoA Gal 0.000229 4.58 0.000372 3.65 
Sp947_chr_00123 AdhR Gal 8.98E-05 4.78 0.004718 4.93 
Sp947_chr_00675 SpxB Gal 2.18E-06 6.01 0.000272 5.88 
 
To determine if other serotype 14 blood and ear isolate pairs shared the same expression 
differences, another serotype 14 ST15 blood (4534) and ear (51742) isolate pair, which 
showed similar differential virulence profiles as 4559 and 947 (Amin et al., 2015), were 
grown in CDM+Glc and CDM+Gal and tested via qRT-PCR for differential expression 
(Table 3.4). The scale of expression differences between this strain pair was much lower 
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than for 4559 vs 947. None of the tested genes showed significant differential expression 
at p < 0.01 that corresponded with the genes differentially expressed between 947 and 4559. 
Nevertheless, wbbI, scrB, spxB, dus, pflB, lacD, galT and adhR all showed consistent trends 
in common with 947 and 4559, without reaching statistical significance or FC cut off. 
Table 3.4. Fold change and significance (p value) of 51742 vs 4534 genes after growth in CDM+Glc 
or CDM+Gal for 2 h. Genes with FC greater than 2 and p value < 0.01, as determined by qRT-PCR, 
are shown. FC values highlighted in blue = upregulated (not significantly) in the ear isolate 51742, 
while values highlighted in pink = upregulated (not significantly) in the blood isolate 4534. Genes 
upregulated in the ear isolate 947, compared to 4559 in the RNAseq data, indicated by grayscale. 
Locus tag in 947 Product Media qRT-PCR p value qRT-PCR FC 
Sp947_chr_01629 TreP Glu 0.185306 0.44 
Sp947_chr_01671 WbbI Glu 0.062863 1.53 
Sp947_chr_01664 Gtf2 Glu 0.092957 0.79 
Sp947_chr_01630 ScrB Glu 0.038215 1.71 
Sp947_chr_00440 PflB Glu 0.375024 0.28 
Sp947_chr_00679 BglH_2 Glu 0.145827 0.55 
Sp947_chr_00675 SpxB Glu 0.035284 1.42 
     
Sp947_chr_01629 TreP Gal 0.074102 1.01 
Sp947_chr_00502 lytA_7 Gal 0.255832 0.32 
Sp947_chr_00491 Dus Gal 0.061592 1.48 
Sp947_chr_00065 AcpB Gal 0.072358 1.23 
Sp947_chr_02095 ArcC1 Gal 0.345923 0.26 
Sp947_chr_00440 PflB Gal 0.084772 1.62 
Sp947_chr_00023 Gtf Gal 0.468193 0.04 
Sp947_chr_01104 LacD Gal 0.042957 1.73 
Sp947_chr_00119 GalT Gal 0.086372 0.85 
Sp947_chr_00111 ExoA Gal 0.152735 0.74 
Sp947_chr_00123 AdhR Gal 0.096313 0.49 
Sp947_chr_00675 SpxB Gal 0.077948 1.12 
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3.3.3 Serotype 3 ST 180 blood and ear isolate validation 
To validate the data from the RNA sequencing analysis of the serotype 3 ST180 isolates, 
qRT-PCR (180/2 and 180/15) was performed on genes that were significantly differentially 
expressed (FC > 2, FDR < 0.01) (Table 3.5). Similar to the RNAseq analysis, a FC > 2 and 
p value < 0.01 cut off was used to categorise genes as significantly differentially expressed 
for the qRT-PCR validations. As with the serotype  14 ST 15 qRT-PCR validations, 
hypothetical genes were omitted from the qRT-PCR validations, while only a single gene 
from an operon was validated if more than one gene from an operon was significantly 
differentially expressed in the RNASeq data. In CDM+Glc, 6 genes were significantly 
upregulated in the ear isolate 180/2 (glnP, zwf, lytN, comF, argG and speA) while 16 genes 
were significantly upregulated in the blood isolate 180/15 (guaA, pbpF_1, pspC, nfr1, 
hemH, DLDH, pgk, ydaF, ctsR, adhB, purL, adhE, gapN, pncB2, aadh_2 and purC) which 
corresponded with the RNAseq data. In CDM+Gal, 6 genes were significantly upregulated 
in 180/2 (peb1A, glnR, groL, copY, gmuA and glnP) while 14 genes were significantly 
upregulated in 180/15 (pbpF_1, ribF, DLDH, agaC, adhB, czcD, nanB, comE, nadE, walK, 
yxlF, hemH, adhE and adh_2).  
For 180/2, comF, speA and argG were upregulated in CDM+Glc but not in CDM+Gal, 
while argG was also upregulated in human serum. For 180/15, genes that were upregulated 
in both CDM+Glc and human serum, but not in CDM+Gal, include; guaA, aadH_2 (only 
in CDM+Glc), and purL. On the other hand, the solitary gene upregulated in only 
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Table 3.5. Fold change and significance (FDR or p value, for RNAseq and qRT-PCR, respectively) 
of 180/2 vs 180/15 genes after growth in CDM+Glc or CDM+Gal for 2 h. Genes with FC greater 
than 2 and FDR < 0.01 in RNAseq are shown, with genes upregulated in the ear isolate 947 
indicated by grayscale. For qRT-PCR, genes highlighted in blue = statistically significantly (p < 
0.01) upregulated (FC > 2) in 180/2, while values highlighted in pink = statistically significantly (p < 
0.01) upregulated (FC > 2) in 180/15. 










Sp180_2_chr_00600 GlnP Glu 1.71E-07 6.28 0.000048 7.89 
Sp180_2_chr_01196 Zwf Glu 1.3E-06 3.25 0.004621 3.22 
Sp180_2_chr_00511 GlnR Glu 8.7E-05 2.93 0.008513 1.76 
Sp180_2_chr_00438 AlsT Glu 7.43E-07 2.92 0.038602 2.48 
Sp180_2_chr_00152 LytN Glu 0.00266 2.76 0.002837 2.42 
Sp180_2_chr_02133 ComF Glu 0.01515 2.55 0.007522 3.27 
Sp180_2_chr_01821 GroL Glu 0.00056 2.47 0.039636 1.36 
Sp180_2_chr_01433 PatB Glu 2.7E-05 2.31 0.017834 1.82 
Sp180_2_chr_00159 ArgG Glu 0.00826 2.3 0.005287 3.44 
Sp180_2_chr_00203 Ugd_2 Glu 0.02178 2.08 0.023661 2.27 
Sp180_2_chr_00888 SpeA Glu 0.01817 2.03 0.008254 2.18 
Sp180_2_chr_01941 GmuA Glu 0.00399 2.02 0.037288 1.74 
Sp180_2_chr_01125 PdhC Glu 1.3E-06 2.01 0.019579 2.65 
Sp180_2_chr_01183 Fhs1 Glu 0.00297 2.01 0.074643 1.83 
Sp180_2_chr_01339 LytA_3 Glu 3.90E-08 2.02 0.052788 1.55 
Sp180_2_chr_02004 GuaA Glu 0.00279 2.03 0.006742 3.46 
Sp180_2_chr_01740 PucK Glu 0.00032 2.04 0.088329 1.42 
Sp180_2_chr_01007 YusV Glu 1.58E-07 2.05 0.029335 2.12 
Sp180_2_chr_00925 ComE Glu 0.00145 2.07 0.009186 1.89 
Sp180_2_chr_01113 Eno_2 Glu 0.00309 2.07 0.061145 1.47 
Sp180_2_chr_01928 PbpF_1 Glu 6.29E-07 2.08 0.007493 3.91 
Sp180_2_chr_00102 PurH Glu 0.02127 2.08 0.026429 2.12 
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Sp180_2_chr_01387 ApbE Glu 2.1E-05 2.16 0.057617 1.86 
Sp180_2_chr_01743 PaaI Glu 0.00011 2.26 0.082825 1.39 
Sp180_2_chr_02116 PspC Glu 1.4E-06 2.33 0.006519 2.04 
Sp180_2_chr_00598 Fba Glu 0.0002 2.45 0.016345 2.37 
Sp180_2_chr_01389 Nfr1 Glu 0.00017 2.47 0.001527 4.82 
Sp180_2_chr_01095 RibF Glu 2.37E-07 2.48 0.026611 1.93 
Sp180_2_chr_00979 HemH Glu 2.37E-07 2.48 0.008274 2.31 
Sp180_2_chr_01124 DLDH Glu 1.44E-07 2.52 0.003621 2.59 
Sp180_2_chr_01372 CapA Glu 3.66E-07 2.53 0.022548 2.04 
Sp180_2_chr_00509 Pgk Glu 0.00031 2.62 0.005369 3.36 
Sp180_2_chr_01341 YdaF Glu 3.90E-09 2.73 0.001582 2.42 
Sp180_2_chr_01371 YbiV Glu 1.51E-07 2.88 0.046273 2.25 
Sp180_2_chr_02121 CtsR Glu 1.19E-09 2.97 0.000739 3.86 
Sp180_2_chr_02082 AdhB Glu 2.6E-05 3.24 0.005783 3.02 
Sp180_2_chr_00097 PurL Glu 0.0002 3.36 0.009825 2.81 
Sp180_2_chr_01942 AdhE Glu 4.2E-05 3.51 0.006623 2.44 
Sp180_2_chr_01105 GapN Glu 9.7E-06 3.60 0.005982 3.17 
Sp180_2_chr_01343 PncB2 Glu 1.13E-09 3.60 0.000417 3.52 
Sp180_2_chr_01971 Adh_2 Glu 1.3E-06 4.57 0.003821 3.96 
Sp180_2_chr_00096 PurC Glu 5.12E-07 4.75 0.000832 5.11 
       
Sp180_2_chr_01194 GlnP Gal 2.2E-05 3.42 0.007189 2.86 
Sp180_2_chr_00602 Peb1A Gal 2.5E-05 3.42 0.000351 3.30 
Sp180_2_chr_00511 GlnR Gal 7.65E-07 3.15 0.004724 2.73 
Sp180_2_chr_01077 Rex Gal 1.3E-05 2.83 0.032782 2.15 
Sp180_2_chr_01821 GroL Gal 1.8E-05 2.69 0.001753 3.09 
Sp180_2_chr_00152 LytN Gal 0.004 2.54 0.026168 2.36 
Sp180_2_chr_00706 CopY Gal 0.007 2.48 0.008249 2.79 
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Sp180_2_chr_01435 lmrA_1 Gal 1.8E-05 2.37 0.026822 1.84 
Sp180_2_chr_01941 GmuA Gal 0.00192 2.27 0.009302 2.69 
Sp180_2_chr_01196 Zwf Gal 5.8E-05 2.24 0.047295 2.13 
Sp180_2_chr_00600 
putative
GlnP Gal 0.0009 2.24 
0.009327 2.67 
Sp180_2_chr_01940 CelA_3 Gal 0.00101 2.23 0.016280 2.08 
Sp180_2_chr_01433 PatB Gal 1.2E-06 2.02 0.072602 1.93 
Sp180_2_chr_00980 MscL Gal 0.0002 2.03 0.037278 1.88 
Sp180_2_chr_00509 Pgk Gal 0.01028 2.03 0.089768 1.63 
Sp180_2_chr_01007 YusV Gal 3.7E-05 2.05 0.016229 2.21 
Sp180_2_chr_01111 GlxK Gal 0.00011 2.05 0.012267 1.92 
Sp180_2_chr_01928 PbpF_1 Gal 5.48E-08 2.08 0.006411 2.49 
Sp180_2_chr_00924 YdaF Gal 7.65E-07 2.08 0.052721 2.13 
Sp180_2_chr_00373 ManZ Gal 0.00069 2.1 0.029983 2.02 
Sp180_2_chr_01595 YesO Gal 0.01301 2.11 0.061589 1.77 
Sp180_2_chr_01372 CapA Gal 0.00011 2.15 0.014671 2.14 
Sp180_2_chr_01095 RibF Gal 0.00044 2.15 0.008216 2.50 
Sp180_2_chr_00598 Fba Gal 0.00321 2.15 0.026180 1.84 
Sp180_2_chr_02116 PspC Gal 3.9E-06 2.16 0.016522 2.11 
Sp180_2_chr_01961 UbiE Gal 0.00167 2.19 0.036111 1.73 
Sp180_2_chr_01124 DLDH Gal 0.00052 2.21 0.006184 2.35 
Sp180_2_chr_00372 AgaC Gal 0.00969 2.26 0.003357 3.18 
Sp180_2_chr_00490 lacE_1 Gal 0.00254 2.42 0.027915 2.04 
Sp180_2_chr_02082 AdhB Gal 3.4E-06 2.45 0.002418 2.52 
Sp180_2_chr_01389 Nfr1 Gal 0.00096 2.53 0.012671 2.13 
Sp180_2_chr_01749 CzcD Gal 0.02412 2.54 0.006828 3.44 
Sp180_2_chr_01592 NanB Gal 0.0018 2.64 0.009716 2.78 
Sp180_2_chr_00925 ComE Gal 2.05E-07 2.70 0.004162 2.46 
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Sp180_2_chr_01105 GapN Gal 0.00037 2.73 0.024617 2.22 
Sp180_2_chr_01342 NadE Gal 1.5E-05 2.78 0.000883 3.49 
Sp180_2_chr_01596 TabA Gal 0.00399 2.81 0.016712 2.31 
Sp180_2_chr_02121 CtsR Gal 1.16E-08 2.96 0.010593 2.53 
Sp180_2_chr_02118 WalK Gal 5.48E-08 3.09 0.005344 3.05 
Sp180_2_chr_01908 YxlF Gal 1.5E-06 3.53 0.008625 3.18 
Sp180_2_chr_00979 HemH Gal 4.45E-07 4.25 0.009259 3.66 
Sp180_2_chr_01942 AdhE Gal 2.1E-06 4.64 0.000723 5.21 
Sp180_2_chr_01971 Adh_2 Gal 0.00714 4.84 0.003782 4.87 
 
To further validate the genes that were shown to be consistently significantly differentially 
expressed between 180/2 and 180/15 in both the RNAseq and qRT-PCR analyses, two 
other serotype 3 blood (180/4 and 232/1) and ear (180/9 and 232/11) isolate pairs, which 
showed similar differential virulence profiles as 180/2 and 180/15 (Trappetti et al., 2013), 
were grown in CDM+Glc or CDM+Gal and tested by qRT-PCR for differential expression 
(Table 3.6). From all tested genes, only adhE showed significant differential expression 
that corresponded for all three of the tested serotype 3 blood and ear isolate pairs.  
Table 3.6. Fold change and significance (p value) of 180/4 vs 180/9 and 232/1 vs 232/11 genes, 
detected by qRT-PCR after growth in CDM+Glc or CDM+Gal for 2 h. FC values highlighted in blue 
= upregulated (not significantly) in the ear isolates 180/9 (A) or 232/11 (B), while values highlighted 
in pink = upregulated (not significantly) in the blood isolates 180/4 (A) or 232/1 (B). Genes 
upregulated in the ear isolate 180/2, compared to 180/15 in the RNAseq data, indicated by 
grayscale. Genes highlighted in yellow = statistically significantly (p < 0.01) upregulated (FC > 2) 
in 180/15 from the qRT-PCR. 
Locus tag in 180/2 Product Medi
a 
(A) 180/4 vs 180/9 (B) 232/1 vs 232/11 
p value FC p value FC 
Sp180_2_chr_00600 GlnP Glu 0.082274 0.97 0.023831 1.42 
Sp180_2_chr_01196 Zwf Glu 0.016376 1.51 0.009782 1.86 
Sp180_2_chr_00152 LytN Glu 0.096385 0.71 0.62467 0.28 
Sp180_2_chr_02133 ComF Glu 0.082755 2.26 0.271744 0.81 
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Sp180_2_chr_00159 ArgG Glu 0.064521 1.32 0.002352 2.36 
Sp180_2_chr_00888 SpeA Glu 0.218174 0.63 0.582124 0.21 
Sp180_2_chr_02004 GuaA Glu 0.072628 0.93 0.008176 2.22 
Sp180_2_chr_01928 PbpF_1 Glu 0.817126 0.13 0.325177 0.42 
Sp180_2_chr_02116 PspC Glu 0.042722 1.54 0.072823 1.19 
Sp180_2_chr_01389 Nfr1 Glu 0.082659 1.08 0.021746 2.51 
Sp180_2_chr_00979 HemH Glu 0.271933 0.74 0.045171 1.23 
Sp180_2_chr_01124 DLDH Glu 0.046268 1.61 0.082796 0.85 
Sp180_2_chr_00509 Pgk Glu 0.019518 2.25 0.41677 1.42 
Sp180_2_chr_01341 YdaF Glu 0.152167 0.32 0.612871 0.05 
Sp180_2_chr_02121 CtsR Glu 0.093514 0.63 0.000739 1.14 
Sp180_2_chr_02082 AdhB Glu 0.036162 1.84 0.061884 1.42 
Sp180_2_chr_00097 PurL Glu 0.0002 3.36 0.009825 2.81 
Sp180_2_chr_01942 AdhE Glu 0.008192 2.47 0.0024728 3.13 
Sp180_2_chr_01105 GapN Glu 0.453829 0.11 0.062516 1.28 
Sp180_2_chr_01343 PncB2 Glu 0.071599 1.78 0.129332 0.59 
Sp180_2_chr_01971 Adh_2 Glu 0.246621 0.26 0.092687 0.94 
Sp180_2_chr_00096 PurC Glu 0.073928 1.16 0.076928 1.63 
       
Sp180_2_chr_01194 GlnP Gal 0.021559 2.06 0.056222 1.32 
Sp180_2_chr_00602 Peb1A Gal 0.092147 0.44 0.855186 0.03 
Sp180_2_chr_00511 GlnR Gal 0.023577 1.26 0.062774 0.75 
Sp180_2_chr_01821 GroL Gal 0.015825 1.84 0.249019 0.21 
Sp180_2_chr_00706 CopY Gal 0.007343 1.49 0.039582 0.93 
Sp180_2_chr_01941 GmuA Gal 0.100693 0.26 0.266912 0.31 
Sp180_2_chr_00600 
putative
GlnP Gal 0.098687 0.51 
0.620516 0.16 
Sp180_2_chr_01928 PbpF_1 Gal 0.007684 1.92 0.045814 1.76 
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Sp180_2_chr_01095 RibF Gal 0.081599 0.42 0.040014 1.04 
Sp180_2_chr_01124 DLDH Gal 0.252068 0.17 0.089226 0.86 
Sp180_2_chr_00372 AgaC Gal 0.015967 2.14 0.023458 1.49 
Sp180_2_chr_02082 AdhB Gal 0.063882 1.14 0.092444 0.77 
Sp180_2_chr_01749 CzcD Gal 0.866832 0.06 0.351451 0.36 
Sp180_2_chr_01592 NanB Gal 0.039282 1.18 0.016399 1.25 
Sp180_2_chr_00925 ComE Gal 0.000816 3.17 0.032617 1.83 
Sp180_2_chr_01342 NadE Gal 0.184993 0.42 0.0012561 2.32 
Sp180_2_chr_02118 WalK Gal 0.062882 1.16 0.042771 0.98 
Sp180_2_chr_01908 YxlF Gal 0.872816 0.08 0.096838 0.55 
Sp180_2_chr_00979 HemH Gal 0.025683 1.93 0.004651 1.22 
Sp180_2_chr_01942 AdhE Gal 0.006122 3.62 0.003103 2.79 
 
3.3.4 Effect of adhE deletion on serotype 3 ST180 pneumococci 
As the serotype 14 ST15 qRT-PCR validation failed to show any consistently differentially 
regulated genes under the stringent conditions, and aldehyde-alcohol dehydrogenase E 
(adhE) was the only gene to be shown to be consistently differentially expressed between 
the tested serotype 3 ST 180 and ST 232 blood and ear isolate pairs, adhE was analysed 
for its effect on these strains. Subsequently, adhE was deleted from 180/15 and 180/2 (see 
Section 3.2.5). AdhE has previously been shown to catalyse the reaction between ethanol 
and NAD+ to form acetaldehyde and NADH in the serotype 2 strain D39 (Luong et al., 
2015). To test if AdhE levels impacted the ability of the serotype 3 ST180 strains to produce 
acetaldehyde, an acetaldehyde assay was performed on 180/15, 180/2 and their respective 
adhE deletion mutants, with or without ethanol supplementation. In the presence of 
ethanol, acetaldehyde levels were significantly higher compared to when no ethanol was 
added (180/15, p < 0.05; 180/2, p < 0.001; 180/15 ΔadhE, p < 0.001; 180/2 ΔadhE, p < 
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0.0001). However, there was no significant difference in acetaldehyde production between 
the wild type and adhE deletion strains (Figure 3.3).  
Figure 3.3. S. pneumoniae 180/15, 180/2 and respective ΔadhE strains were cultured until 
an OD600 of 0.3, and then adhE was induced through supplementation with 100 mM ethanol for 30 
min. Bacterial cultures were analysed for acetaldehyde (sees section 3.2.6). Data are representative 
of two independent experiments and were analysed by one-way ANOVA (*, p < 0.05; ***, p < 
0.001; ****, p < 0.0001).  
Figure 3.4. Impact of adhE deletion on adherence to A549 and Detroit 562 cells. S. pneumoniae 
strains 180/15, 180/2, 180/15 ΔadhE and 180/2 ΔadhE were inoculated at OD600 = 0.2 onto A549 
or Detroit 562 monolayers in DMEM + 10% FCS, in triplicate, then tested for adherence after 2 h 
at 37 °C (see Section 3.2.7). Invasion assays were also performed on these cell lines and bacterial 
strains, although no bacteria were recovered after eukaryotic cell lysis (see section 3.2.7). Data 
presented are the means ± standard deviations from two independent experiments. 
It has previously been shown that LAP, the alcohol acetaldehyde dehydrogenase of Listeria 
monocytogenes increases adherence by binding to the host-cell receptor HSP60 
(Burkholder et al., 2009; Jagadeesan et al., 2010). Consequently, AdhE was examined for 
potential effects on host adherence and invasion. Adherence assays were performed on 
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human lung epithelial A549 and nasopharyngeal Detroit 562 cells. No significant 
difference was found in the adherence of 180/15 or 180/2 when compared to their 
respective adhE deletion mutants to either A549 or Detroit 562 cell lines (Figure 3.4), 
































The S. pneumoniae serotype 14 ST15 and serotype 3 ST 180 blood and ear isolate pairs 
were subjected to Illumina HiSeq 2500 transcriptomic sequencing after growth and/or 
incubation in CDM+Glc, CDM+Gal or human serum media. Each medium was selected to 
represent a particular biological niche, with CDM+Glc and human serum both mimicking 
conditions in the blood (McMillin, 1990), while CDM+Gal mimicked conditions in the 
nasopharynx (Blanchette et al., 2016). Hence, performing RNAseq in these media was 
intended to provide clues as to which pathways might be upregulated in these particular 
niches in vivo. Under each of these conditions, the transcriptomes of each of the isolate 
pairs were aligned to identify any DEGs, as these genes may be influencing the capacity of 
the bacteria to spread to distinct sites in the body. It is worth noting that the variation in 
levels of complement proteins and antibodies in the human sera was not provided, which 
could have potentially affected transcription levels. 
Similar to the genomic analysis in Chapter 2, the serotype 14 ST15 and serotype 3 ST180 
blood and ear isolates shared no common differentially regulated genes or pathways. This 
underscores the vast genetic and transcriptomic diversity between the unrelated serotype 
and sequence type matched pairs. However, the stringent FC (> 2) and FDR (< 0.01) 
conditions and sample outliers from the RNAseq analysis highlighted in the MDS plots 
(Figures 3.1 and 3.2) may have excluded many DEGs from consideration. Future analyses 
of these data should consider easing the FDR cut off to < 0.05 and removing data from the 
1st dimension sample outliers identified in the MDS plots (see section 3.3.1). 
For each blood and ear isolate pair, several genes were found to be significantly 
differentially regulated within one or more of the tested media. This suggests that there are 
large amounts of transcriptomic variation between strains, even within the same serotype 
and ST, which underscores the transcriptomic complexity and diversity of S. pneumoniae. 
3 | Transcriptomic Comparisons of S. pneumoniae Clonal Clinical Isolates 
106 
 
Many of the identified differentially expressed genes are involved in carbohydrate and 
amino acid metabolism, including scrB, galT, zwf, ccpA, glnP, purC and artM. This further 
highlights the importance of pneumococcal metabolic activity as a potential driver of 
virulence capabilities.  
A handful of genes were found to be significantly differentially regulated in media that 
mimicked one anatomical niche only; either the blood mimicking conditions (CDM+Glc 
and human serum) or the nasopharyngeal mimicking condition (CDM+Gal). For example, 
the metabolic genes wbbi, treR and gtf were significantly upregulated in 947 in the blood 
mimicking conditions, and may play adverse roles for survival in the blood, as 947 is 
unable to invade the blood via the respiratory tract. Gtf genes have been identified in other 
Streptococcus species to promote and modify biofilm structures, presupposing a tendency 
for sessile growth not suitable in the blood (Xu et al., 2018), and hence gtf may be worth 
examining in the future. This may also be the case for comF, speA, zwf and glnP in the 
serotype 3 ST 180 background, as these genes were upregulated in blood mimicking 
conditions in the ear isolate 180/2. Indeed, glnP and zwf have been shown to be important 
for pneumococcal spread into the blood in IN murine models via glnR regulation, which 
was also shown to be upregulated in 180/2 in CDM+Glc, though this gene was under the 
FC > 2 cut-off (Härtel et al., 2011; Hendriksen et al., 2008). 
Conversely, guaA, aadH_2 and purL may be beneficial for the survival of 180/15 in the 
blood as these genes were upregulated in the blood isolate in both blood mimicking 
conditions. Accordingly, purL has been identified as a virulence gene through signature-
tagged mutagenesis and invasive murine models (Polissi et al., 1998) potentially 
warranting further examination. CDM+Gal is a nasopharynx mimicking medium, hence 
any genes upregulated by the blood and ear isolate pairs may aid in colonisation of the 
nasopharynx. However, this is unlikely, as there is not any significant difference between 
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the blood and ear isolates in terms of capacity to colonise the nasopharynx (see section 
2.3.4).  
Genes that were found to be significantly differentially expressed in the RNAseq data were 
independently validated in fresh RNA extracts using qRT-PCR. However, this analysis was 
confined to CDM+Glc and CDM+Gal owing to limited availability of human serum. 
Probability value was used to determine significance here, rather than false discovery rate, 
as was previously used in the RNAseq analysis, as the qRT-PCR validated individual genes 
separately rather than in groups. Of the 31 genes that were found to be significantly 
differentially expressed in CDM+Glc or CDM+Gal for the serotype 14 ST15 pair in the 
RNAseq data, 19 of these genes were also consistently significantly differentially 
expressed in the independent qRT-PCR dataset. Similarly, for the serotype 3 ST180 pair, 
of the 85 genes that were significantly differentially expressed in the RNAseq data, 42 
genes were also significantly differentially expressed in the independent qRT-PCR dataset. 
It is worth noting that many of the genes that were not significantly differentially expressed 
in the qRT-PCR dataset, still showed the same trends in relative gene expression to the 
RNAseq data set, just without passing the FC > 2 and/or p < 0.01 thresholds. Hence, the 
RNAseq data matches up closely with the qRT-PCR, further validating the whole 
transcriptome sequencing approach.  
A limitation of this study is that only specific individual clinical isolates were used in the 
RNAseq analysis, with no certainty that any significant differences found between the 
blood and ear isolates would be representative of other S. pneumoniae blood and ear isolate 
pairs. Therefore, to further validate the gene regulation patterns found in the RNAseq data, 
qRT-PCR tested the expression of these genes in different blood and ear isolate pairs of the 
same serotype and sequence type. This ensured that any significant gene regulatory patterns 
found in the RNAseq data were widespread and present among other pneumococci that 
occupy the same virulence niche (i.e. blood or ear isolate). These additional strains tested 
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were the serotype 14 ST15 blood isolate 4534 and ear isolate 51742, serotype 3 ST180 
blood isolate 180/4 and ear isolate 180/9, and the serotype 3 ST232 blood isolate 232/1 and 
ear isolate 232/11. Of all the genes that were tested with qRT-PCR in these other serotype- 
and sequence type-matched blood and ear isolate pairs, only acetaldehyde alcohol 
dehydrogenase (adhE) was found to be consistently significantly upregulated in the 
serotype 3 blood isolate 180/15 compared to the ear isolate 180/2, in the RNAseq and qRT-
PCR analyses. This was found in both CDM+Glc and CDM+Gal.  
AdhE is an alcohol dehydrogenase which plays a role in ethanol oxidation, allowing the 
conversion of alcohol to aldehyde through the reduction of NAD+ to NADH (Walker, 
1992). In serotype 2 S. pneumoniae D39, AdhE has been shown to catalyse the reaction 
between ethanol and NAD+ to form acetaldehyde and NADH (Luong et al., 2015). Hence 
adhE was deleted in 180/2 and 180/15 in frame, then an acetaldehyde assay was performed 
to examine the role of this gene in acetaldehyde production (Figure 3.3). No significant 
difference was found between the adhE deletion mutants relative to their respective wild 
type strains. This suggests that there may be another complementary or redundant alcohol 
dehydrogenase present within the serotype 3 ST180 blood and ear isolate pair sequences. 
Indeed, there are four other annotated alcohol dehydrogenases present in the 180/2 and 
180/15 genomes; Sp180_2_chr_00335, Sp180_2_chr_01747, Sp180_2_chr_01971 and 
Sp180_2_chr_02082. Although it would be interesting to test the impact of these other 
alcohol dehydrogenase genes on acetaldehyde production, this is beyond the scope of the 
project. 
The lack of difference in acetaldehyde production between the wild-type and adhE deletion 
mutants above also suggests AdhE could serve an alternative role in these strains. For 
example, an alcohol acetaldehyde dehydrogenase in the Gram-positive pathogen Listeria 
monocytogenes increases adherence by binding to the host-cell receptor HSP60 
(Burkholder et al., 2009; Jagadeesan et al., 2010). Thus, alcohol dehydrogenases in S. 
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pneumoniae may contribute to pneumococcal virulence by aiding adherence to respiratory 
epithelium. Accordingly, A549 and Detroit 562 adherence and invasion assays were 
performed on the 180/2 and 180/15 adhE deletion mutants. However, no significant 
differences in either parameter were found in either of the adhE mutants compared to their 
respective wild types. It is important to note however, that the thick CPS of these serotype 
3 strains (Geno et al., 2015) likely impedes pneumococcal adherence to host cells in vitro 
as adherence factors may be masked. Any potential effects of adhE deletion in vivo, where 
the CPS could be differentially regulated, remains to be investigated. However, given the 
lack of evidence that AdhE effects acetaldehyde production and adherence in vitro, there 
was not sufficient justification to perform in vivo murine experiments as part of this study.  
The raffinose pathway genes that were affected by the rafR and rafK SNPs found in 
Chapter 2 (see also Minhas et al. (2019), were not found to be significantly differentially 
expressed in the RNAseq data for both serotypes. However, this is expected due to the 
carbon catabolite control that silences expression of lesser utilised sugar pathways when 
preferred carbohydrate sources, such as glucose or galactose, are present (Iyer et al., 2005). 
Nevertheless DLDH, which has been found to interact with RafK to potentially regulate 
raffinose transport (Tyx et al., 2011), was significantly upregulated in the blood isolate 
180/15 relative to the ear isolate 180/2 in both CDM+Glc and CDM+Gal. This may 
potentially contribute to 180/15’s superior ability to utilise raffinose. Only 7 differentially 
expressed genes from the serotype 3 ST180 and 1 gene from serotype 14 ST15 RNAseq 
analyses contained SNPs that were highlighted in the genomic variant analyses in Chapter 
2 (Sp180_2_chr_00100, Sp180_2_chr_00449, Sp180_2_chr_00512, Sp180_2_chr_01172, 
Sp180_2_chr_01194, Sp180_2_chr_01387, Sp180_2_chr_01404 and Sp947_chr_01631). 
Therefore, the majority of genes that were significantly differentially expressed according 
to the RNAseq data were not impacted by inherent differences in coding regions between 
the blood and ear isolates. This is not surprising, as it would not be expected for a SNP in 
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a given gene to impact transcription, unless present within regulatory regions or genes, 
although the protein product itself may be compromised.  
As adhE was the only gene found to be commonly significantly differentially expressed 
between multiple serotype 3 blood and ear isolate pairs, and none were found for the 
serotype 14 ST 15 pairs, additional omics analyses should be used to elucidate differences 
between the blood and ear isolate pairs that were not picked up in the RNAseq data. Indeed, 
metabolomic and proteomic profiling for the serotype 14 ST15 and serotype 3 ST180 blood 
and ear isolates is currently being conducted by the Antibiotic Resistant Sepsis Pathogens 
Framework Initiative consortium. Future analysis of these data sets may uncover other 
mechanisms that influence how pneumococci survive in and spread around the body. 
Moreover, it may be worth revisiting virulence factor genes that showed differential 
expression without reaching statistical significance in the transcriptomic analyses, such as 
nanA for the serotype 14 ST 15 isolate pair (section 3.3.2) or lytA for the serotype 3 ST 180 
isolate pair (section 3.3.3), if future analyses also highlight the products of these genes as 
potential determients of pneumococcal tissue tropism. Unfortunately, all related 
metabolomic and proteomic data, and associated analyses, are scheduled to be completed 
after the time frame of this PhD project.






In vivo dual RNA analysis of S. 
pneumoniae Clonal Clinical Isolates 
 
4.1 Introduction 
This Chapter incorporates data published in Communications Biology (Minhas et al., 
2020). This work was done in collaboration with the laboratory of Jan-Willem Veening at 
the University of Lausanne, Switzerland, who carried out the dual RNAseq analyses.  
Chapter 2 of this thesis highlighted the impact of rafR regulation on disease progression in 
the serotype 14 ST15 blood and ear isolate pair, 4559 and 947. However, the mechanisms 
causing the rafR SNP to alter tissue tropism were not elucidated. These mechanisms 
presumably involve a combination of altered bacterial gene expression patterns and 
differences in host response elicited by such alterations. Unfortunately, the data in Chapter 
3 enabled only limited conclusions to be drawn, as in vitro RNAseq analyses of cells grown 
in CDM+Raf were not performed, as the in vitro transcriptomic sequencing was carried out 
prior to identification of raffinose regulation as an important factor in pneumococcal 
disease progression. Due to catabolite repression of the raffinose operon in CDM+Glc or 
CM+Gal media (used for the in vitro RNAseq analyses), any impact of differential 
expression of the raf genes between isolate pairs would have been masked, and thus the 
data did not show any consistent results in terms of raffinose related genes.  This highlights 
the pitfalls associated with trying to mimic conditions of distinct in vivo niches by growth 
of bacteria in different defined media or in human serum, rather than using the in vivo 
niches themselves. In order to circumvent this, Chapter 4 describes the application of a 




novel RNA sequencing approach involving bacterial RNA isolation directly from in vivo 
niches. 
Our laboratory has developed significant expertise in extraction of bacterial RNA from 
various infected mouse tissues, permitting transcriptional analysis under genuine in vivo 
conditions, initially using qRT-PCR and microarray analysis, and more recently by 
RNAseq (Mahdi et al., 2008; Minhas et al., 2020; Ogunniyi et al., 2012; Trappetti et al., 
2011). Through initial discussion with Professor Veening, it became apparent that the yield 
and quality of in vivo RNA extracts, at least for lung tissue, should be sufficient to apply 
the newly developed dual RNAseq technology, which applies deep sequencing to 
simultaneously quantify genome-wide transcriptional responses of host and pathogen 
(Westermann et al., 2017; Wolf et al., 2018). This approach offers higher efficiency and 
more restricted technical bias compared to conventional approaches, such as assaying 
single species or array-based methods. Here, dual RNAseq analysis has been used to 
examine host-pathogen transcriptional cross-talk in the blood and ear isolates and rafR-














4.2 Materials and Methods 
4.2.1 Bacterial strains and growth conditions 
 S. pneumoniae strains used in this Chapter are listed in Table 4.1. Cells were routinely 
grown in SB or plated on BA as required, then incubated at 37oC in 5% CO2 overnight (see 
section 2.2.1). 
Table 4.1. Bacterial strains used in this Chapter. 
Strain Description Source Reference 
4559 S. pneumoniae serotype 14 ST15 Blood Amin et al, 2015 
947 S. pneumoniae serotype 14 ST15 Ear Amin et al, 2015 
4559947rafR 4559 expressing 947 rafR gene Blood Minhas et al, 2019 
9474559rafR 947 expressing 4559 rafR gene Ear Minhas et al, 2019 
4559947rafR = 4559M | 9474559rafR= 947M 
4.2.2 Intranasal challenge of mice and extraction of RNA 
Animal experiments were approved by the University of Adelaide Animal Ethics 
Committee. Groups of 12 outbred 5-6-week-old female Swiss (CD-1) mice (48 in total), 
were anesthetized by intraperitoneal injection of pentobarbital sodium (Nembutal) and 
challenged intranasally (IN) with 50 µl of bacterial suspension containing approximately 1 
× 108 CFU in SB of 4559, 947, 4559947rafR (designated 4559M) or 9474559rafR (designated 
947M). The challenge dose was confirmed retrospectively by serial dilution and plating on 
BA. Mice were euthanized by CO2 asphyxiation at 6 h and lungs placed in 1 ml TRIzol 
(Thermo Fisher). RNA was then extracted using acid-phenol-chloroform-isoamyl alcohol 
(125:21:1; pH 4.5; Ambion) and purified using the RNeasy minikit (Qiagen). For 
subsequent dual RNAseq analyses, there were three replicates per strain, with each 
replicate derived from the lungs of four mice. 
4.2.3 RNA library preparation and sequencing 
RNA quality was checked using chip-based capillary electrophoresis. Samples were then 
simultaneously depleted of murine and pneumococcal ribosomal RNAs by dual rRNA-




depletion as previously described (Aprianto et al., 2016). Stranded cDNA library 
preparation was performed according to the prescribed protocol (Illumina, US). 
Sequencing was performed for twelve samples in one lane of an Illumina NextSeq 500, 
High Output Flowcell in 85 single end mode. Libraries were demultiplexed and analysed 
further. Raw libraries are accessible at https://www.ncbi.nlm.nih.gov/geo/ with the 
accession number GSE123982. 
4.2.4 Sequence data analysis 
Quality of raw libraries was checked (FastQC v0.11.8, Babraham Bioinformatics, UK) 
(Andrews and Babraham Bioinformatics, 2010). In order to improve the quality of 
alignment, reads were trimmed using the following criteria: (i) removal of adapter 
sequence, if any, based on TruSeq3-SE library, (ii) removal of low quality leading and 
trailing nucleotides, (iii) a five-nucleotide sliding window was created for surviving reads, 
in which the average quality score must be above 20 and (iv) minimum remaining length 
must be above 50 (Trimmomatic v0.38) (Bolger et al., 2014). The quality of trimmed reads 
was confirmed using FastQC (Andrews and Babraham Bioinformatics, 2010).  
As reference genomes, chimeric genomes were created by concatenating the in-house 
generated S. pneumoniae strain 947 or 4559 circular genomes (deposited with ENA under 
the accession numbers SAMEA5092021 and SAMEA5092022) into the genome of Mus 
musculus (ENSEMBL, release 94, downloaded 9 October 2018). The corresponding 
annotation file was downloaded at the same time. The chimeric mouse/947 genome was 
used as reference to align libraries from lungs infected by strain 947 (and its corresponding 
swap mutant 947M), while the mouse/4559 chimeric genome was used to align 4559 and 
4559M libraries. Alignment was performed by RNA-STAR (v2.6.0a) (Dobin et al., 2013) 
with the following options: (i) alignIntronMax 1 and (ii) sjdbOverhang 84. The aligned 
reads were then summarized (featureCount v1.6.3) according to the chimeric annotation 




file in stranded, multimapping (-M), fractionized (--fraction) and overlapping (-O) modes 
(Liao et al., 2014). In order to compare gene expression between strains from ear and blood 
isolate backgrounds, we prepared a common pneumococcal annotation file using Mauve 
v20150226 (Darling et al., 2004). Common genes between 947 and 4559 were defined as 
having common coverage at least 90% and identity at least 90%. This single-pass alignment 
was selected to minimise false discovery rate. However, due to this approach, the 
summarising process had to be adjusted, taking into account the overlapping nature of 
bacterial genes and their organisation into operon structures. 
Pathogen and host libraries were then analysed separately in R (R v3.5.2). Since reads 
coming from pneumococcal genes encoding bacterial rRNA dominate the pathogen 
libraries (average 64.5%; range 61.4 to 67.3%), these pneumococcal ribosomal RNA reads 
were excluded from downstream analysis, but this was not required for murine ribosomal 
RNA reads due to effective eukaryotic rRNA depletion. Differential gene analysis was 
performed by DESeq2 v1.22.1 (Love et al., 2014) and genome-wide fold change was 
calculated within host and pathogen libraries for the pairwise comparisons: strains 947 to 
947M, strains 947 to 4559, strains 947 to 4559M, strains 947M to 4559, strains 947M to 
4559M and strains 4559 to 4559M. The value of fold change was set to zero if the 
corresponding adjusted p-value (padj) was reported to be not available (NA).  
4.2.5 Quantitative real time RT-PCR 
Differences in levels of gene expression observed in the dual RNAseq data were validated 
by one-step relative quantitative real-time RT-PCR (qRT-PCR) in a Roche LC480 real-
time cycler essentially as previously described (Mahdi et al., 2008). The same RNA that 
was used for the dual RNAseq was used in the qRT-PCR experimental validation. 19 
pneumococcal genes and 18 murine genes were chosen for the experimental validation. 
The murine intranasal challenge and RNA isolation was also repeated to test the 




reproducibility of the dual RNAseq data. 6 pneumococcal and 6 murine genes were chosen 
for the reproducibility validation. The specific primers used for the various genes are listed 
in Table 4.2 and were used at a final concentration of 200 nM per reaction. As an internal 
control, primers specific for gyrA for pneumococcal genes, and GAPDH for murine genes, 
were employed. Amplification data were analysed using the comparative critical threshold 
(2−ΔΔCT ) method (Livak and Schmittgen, 2001).  
Table 4.2. Oligonucleotide primers used in this Chapter. 
Primer Sequence (5’  3’) Reference 
rafR F:  CCAGCCATTCGTGATACATA Minhas et al, 2019 
rafR R:  CCTCCAGTGATTCCTAACCA Minhas et al, 2019 
aga F:  AAGGTCAGAATGGTCCACAG Minhas et al, 2019 
aga R:  GCTGGAAAATCAGCCATAAA Minhas et al, 2019 
rafG F:  CCTATGGCAGCCTACTCCATC Minhas et al, 2019 
rafG R:  GGGTCTGTGGAATCGCATAGG Minhas et al, 2019 
rafK F:  GCTGGTTTACGTTCCAAGAA Minhas et al, 2019 
rafK R:  GCTGGTTTACGTTCCAAGAA Minhas et al, 2019 
Sp947_00054 F:  GCAAGACAGACTACGAAGCAG This study 
Sp947_00054 R:  TCCTCAATCCCATGAGCTC This study 
Sp947_00279 F:  GTGGCACTTGCGAATACTGT This study 
Sp947_00279 R:  GGATCAAGTCCGTCAGGAAC This study 
Sp947_00544 F:  CTGTTCGAGCCTCGTAACTC This study 
Sp947_00544 R:  CGTGGAAGGTGGATATTCTC This study 
Sp947_00675 F:  CCGTGTTGGTTGGAAACCAG This study 
Sp947_00675 R:  CTTGACCAGCATCACCAAGG This study 
Sp947_00841 F:  GGTTGCGTTGACTGGTAGTT This study 
Sp947_00841 R:  CCAATACCAGCTTCTGCTCC This study 
Sp947_01448 F:  ACAGCTCCAGCTATGAAGGG This study 
Sp947_01448 R:  AGACTGAGCCCCATAAGATG This study 
Sp947_01582 F:  GTCAACTGTGCAGGTCTTGC This study 
Sp947_01582 R:  GCTCCATCCTGCATATGCAT This study 
Sp947_01598 F:  GTTCGATTGCTATCGATGGT This study 
Sp947_01598 R:  CATCATATTCTTGGGTAACGC This study 
Sp947_01629 F:  CCAGTCCTTGTTGCAGTCTG This study 
Sp947_01629 R:  CGCATCAGACACAACCAACA This study 
Sp947_01798 F:  CGAGATATCGCTGCTGAGTA This study 
Sp947_01798 R:  CAAACGCTCTGTTCTGGAAC This study 
Sp947_01920 F:  TCCATGGATACCTCAACTCG This study 
Sp947_01920 R:  CTAGAGGCGTCGTATCTCGA This study 
Sp947_01951 F:  AATGGTCATTCCAGAAGCAG This study 
Sp947_01951 R:  CTTCTTGGATAAGCAGGTGTC This study 
Sp947_01955 F:  CCATGCCATGGTAGAGCTTG This study 
Sp947_01955 R:  TGGCAGCATCCATTGGAGAC This study 
Sp947_01982 F:  AGGCAAGCAGTACAGGCAAC This study 
Sp947_01982 R:  GTCCTGCTTGATTTCGACAG This study 
Sp947_02097 F:  CATTCTTGCTCCTCTCCAAG This study 




Sp947_02097 R:  GATTGATCATGAGACCTGCG This study 
ENSMUSG00000063021 F:  CTGCTTGCCTCTTCCTGACAT This study 
ENSMUSG00000063021 R:  ATTGGTCTAGGTGCAATGCTTC This study 
ENSMUSG00000068855 F:  AAGTGACGATCGCACAGGG This study 
ENSMUSG00000068855 R:  CGTGTTGAGTTTCACTTGCTCT This study 
ENSMUSG00000063954 F:  AACTACGCGGAGCGTGTGG This study 
ENSMUSG00000063954 R:  CGCGTCTTCTTGTTGTCGC This study 
ENSMUSG00000034855 F:  TAAACTCATGGCACCGGCAT This study 
ENSMUSG00000034855 R:  GGCATTTGGCAGCTTTACCC This study 
ENSMUSG00000048806 F:  GCACTGGGTGGAATGAGACT This study 
ENSMUSG00000048806 R:  GTGGAGAGCAGTTGAGGACA This study 
ENSMUSG00000074695 F:  AGCTGCTTGGGCTTCATAAC This study 
ENSMUSG00000074695 R:  CCCCTGCAATCACCTAATCC This study 
ENSMUSG00000000157 F:  CACCTGGCTCCTTGGAGAG This study 
ENSMUSG00000000157 R:  AGCCAAGTGGAAATCGTTGT This study 
ENSMUSG00000017300 F:  AGGAACTGGCTGAGTGCTTC This study 
ENSMUSG00000017300 R:  GCTCCATCTGCTCTCAGGTC This study 
ENSMUSG00000030730 F:  CCTCCCTACCTTGATGCCAG This study 
ENSMUSG00000030730 R:  GGAAGGGTCAAGGCTTCAGG This study 
ENSMUSG00000026407 F:  CATGAGGACCTGAGGTGCAG This study 
ENSMUSG00000026407 R:  CTGGTTTGACTCTGCTGGCT This study 
ENSMUSG00000026985 F:  GCCATGTCTTCTCAAAGCAAT This study 
ENSMUSG00000026985 R:  TGAACCCTGTAGTTTCTGGGAG This study 
ENSMUSG00000061928 F:  GGCACTGGCATAGCCTCATA This study 
ENSMUSG00000061928 R:  TTCCAGAGACTACCCCACCC This study 
ENSMUSG00000063130 F:  CCCTCCACGGGACTTTGTC This study 
ENSMUSG00000063130 R:  CAATGACCCCCAGCTCTACT This study 
ENSMUSG00000030046 F:  GCATGACCCTTTGCTGGTTG This study 
ENSMUSG00000030046 R:  CCAGATCCTGCTCATGGGTG This study 
ENSMUSG00000033765 F:  ACAAGCTCCAACTCGTCGTC This study 
ENSMUSG00000033765 R:  CTCCAGATGGCACAGCATCC This study 
ENSMUSG00000028001 F:  CTGCACCCGTTTCCTAACCT This study 
ENSMUSG00000028001 R:  CACATGGTCAAGTCCCTGCC This study 
ENSMUSG00000033860 F:  TGGAGAGACTCCAGGGATAC This study 
ENSMUSG00000033860 R:  GTTTGTCTGACAGCGCATGA This study 
ENSMUSG00000033831 F:  TGGACAGTCATACAGAACCGT This study 
ENSMUSG00000033831 R:   TTCACTCGCAGTCTTTACCTG This study 
 
4.2.6 Flow cytometry analysis of infected murine lungs 
Groups of 8 outbred 6-week-old female Swiss (CD-1) mice (32 in total) were anesthetized 
and challenged with the bacterial suspension as outlined above in section 4.2.2. Mice were 
euthanized by CO2 asphyxiation at 6 h, then lungs were finely macerated in 1 mL 
prewarmed digestion medium (DMEM + 5% FCS, 10 mM HEPES, 2.5 mM CaCl2, 
0.2 U/ml penicillin/gentamicin, 1 mg/ml collagenase IA, 30 U/ml DNase) and incubated at 
37°C for 1 h with mixing every 20 min. The single cell suspensions were stained and fixed 




using antibodies against surface markers listed in Table 4.3, allowing the enumeration of 
a number of immune cell subsets, as previously described (Yu et al., 2016). Single cells 
were then processed for data acquisition on a BD LSRFortessa X20 flow cytometer as 
previously described (David et al., 2019).  
Table 4.3. List of antibodies used in this study. 
 
4.2.7 Neutrophil depletion, IL-17A blockade and bacterial loads  
Groups of 8 outbred 6-week-old female Swiss (CD-1) mice (64 in total) were 
intraperitoneally administered with either 350 μg of rat anti-mouse Ly6G or rat IgG2a 
isotype control antibodies, one and two days prior to pneumococcal challenge, or 200 μg 
of either monoclonal anti-mouse IL-17A or mouse IgG1 isotype control antibodies one day 
prior to, 2 h before and 6 h after pneumococcal challenge. Mice were also cheek bled on 
the day of challenge for confirmation of depletion of Ly6G-positive cells via flow 
Antibodies Source Identifier 
Anti-mouse/human CD11b-PE (clone 
M1/70) 
BioLegend Cat# 101208, RRID: 
AB_312791 
Anti-mouse CD11c-BV786 (clone HL3) BD Biosciences Cat# 563735, RRID: 
AB_2738394 
Anti-mouse CD24-BV711 (clone M1/69) BD Biosciences Cat# 563450, RRID: 
AB_2738213 
Anti-mouse CD45-FITC (clone 30-F11) BioLegend Cat# 103107, RRID: 
AB_312972 
Anti-mouse CD64-BV421 (clone X54-
5/7.1) 
BioLegend Cat# 139309, RRID: 
AB_2562694 
Anti-mouse Ly6C-PerCP/Cy5.5 (clone 
HK1.4) 
BioLegend Cat# 128011, RRID: 
AB_1659242 
Anti-mouse Ly6G-BUV395 (clone 1A8) BD Biosicences Cat# 563978, RRID: 
AB_2716852 
Anti-mouse I-A/I-E-BV650 (clone 
M5/114.15.2) 
BD Biosicences Cat# 563415, RRID: 
AB_2738192 
Anti-mouse Ly6G (clone 1A8) Bio X Cell Cat# BE0075-1, RRID: 
AB_1107721 
Rat IgG2A Isotype Control (clone 54447) R and D 
Systems 
Cat# MAB006, RRID: 
AB_357349 
Anti-mouse Ly-6G, Ly-6C-Biotin (clone 
RB6-8C5) 
BD Biosicences Cat# 553125, RRID: 
AB_394641 
Anti-mouse IL-17A (clone 17F3) Bio X Cell Cat# BE0173, RRID: 
AB_10950102 
Mouse IgG1 Isotype Control (clone MOPC-
21) 
Bio X Cell Cat# BE0083, RRID: 
AB_1107784 




cytometry, as previously described (Faget et al., 2018). Mice were then anesthetized and 
challenged with the bacterial suspension for each treatment group as outlined in section 
4.2.2. Mice were euthanized by CO2 asphyxiation at 24 h, then nasopharynx and lung tissue 
samples were harvested, and pneumococci enumerated in tissue homogenates as described 
previously via serial dilution and plating on BA containing gentamicin (section 2.2.10). 
4.2.8 Neutrophil and IL-17A levels after IL-17A neutralization 
Groups of 3 outbred 6-week-old female Swiss (CD-1) mice were intraperitoneally 
administered with 200 μg of either monoclonal anti-mouse IL-17A or mouse IgG1 isotype 
control antibodies one day prior to and 2 h before intranasal challenge with 9-47, as 
described above. 6 h post-infection, lung tissue and bronchoalveolar lavage (BAL) were 
harvested. To quantify IL-17 levels, a mouse IL-17 DuoSet® ELISA (R&D Systems) was 
performed on BAL samples in duplicate, according to the manufacturer’s instructions. 
Flow cytometry was performed on lung tissue samples, as described above, to quantify 
neutrophil levels after anti-mouse IL-17A treatment.        
4.2.9 Statistics and reproducibility  
For the RNAseq data, enrichment tests to assess enrichment were performed by the built-
in function, fisher.test(). Corresponding p-values of the enrichment test were adjusted by 
Bonferroni correction. Resultant figures encompass data derived from three replicates per 
group, with each replicate derived from lungs of four mice. All other data are presented as 
mean ± standard error of mean (SEM) or geometric mean, and were analysed by two-tailed 
unpaired Student’s t-test, one way ANOVA or Pearson correlation coefficient, using Prism 
v8.0d (GraphPad). Statistical significance was defined as p < 0.05. Data presented in 
figures are representative of at least two independent in vivo experiments, or at least 3 
independent in vitro experiments.  





4.3.1 Comparative host/pathogen transcriptomics 
Previous studies have shown that at 6 h after IN challenge with serotype 14 ST15 S. 
pneumoniae, numbers of blood and ear isolates (strains 4559 and 947, respectively) in 
murine lungs are similar (106 – 107 CFU per lung) (Amin et al., 2015). However, by 24 h, 
the ear isolate had been cleared from the lungs, instead spreading to the ear and brain. In 
contrast, the blood isolate persisted in the lungs at 24 h, but did not spread to the ear or 
brain (Amin et al., 2015). Thus, 6 h post infection is a critical decision point in the 
pathogenic process, and the similar bacterial loads in the lung at this time enables 
examination of host/pathogen transcriptional crosstalk without the complication of 
bacterial dose effects. Accordingly, groups of 12 mice were anaesthetized and challenged 
IN with 108 CFU of 4559, 947 or their respective rafR-swapped mutants (4559M and 
947M); at 6 h, mice were euthanised, and total RNA was extracted from perfused lungs 
and purified. RNA from lungs of 4 mice was pooled for dual RNAseq analysis in triplicate 
(see section 4.2.2). 
Within the sequencing libraries, an overwhelming majority of reads originate from the host 
genome (average 99.5%; range 99.1-99.7%), which translates into an average depth of 1.3 
times (range 0.8-1.8 times). Conversely, 0.52% of the total reads originated from the 
pathogen genome (0.33-0.93%) (Table 4.4). Of these pneumococcal reads, 64.5% (61.4-
67.3%) mapped onto rRNA genes and 35.5% (32.7-38.6%) mapped onto non-rRNA genes. 
Previous data indicate that non-depleted libraries only contain 5% non-ribosomal RNA 
reads; thus, this treatment enriched the non-ribosomal RNAs sevenfold. Non-ribosomal 
read depth was 2.7 times (1.4-4.6 times) for the pathogen genome. Further downstream 
analysis, including differential gene expression, excluded ribosomal reads from the 
pathogen library. Appendices M-R list pneumococcal genes that are significantly 




differentially expressed (fold change (FC) > 2, p < 0.05) for each of the six pairwise 
comparisons between the four strains. Appendices S-X list murine genes that are 
significantly differentially expressed (FC > 1.5, p < 0.05) for the same pairwise 
comparisons. The lower FC cut-off for murine genes was chosen to strike a balance 
between simplicity of analysis and sensitivity. Heat maps displaying the top 50 murine and 
top 50 pneumococcal genes (Fig. 4.1) showcase the breadth of transcriptomic rewiring due 
to the rafR SNP.  
Table 4.4. Host and pneumococcal read counts of RNA isolated from murine lungs 6 h post-












947 46316502 46141193 175309 99.621% 0.379% 
947 59564884 59248907 315977 99.470% 0.530% 
947 40204707 40059925 144782 99.640% 0.360% 
947M 30056978 29956541 100437 99.666% 0.334% 
947M 47479606 47290932 188674 99.603% 0.397% 
947M 48752703 48544160 208543 99.572% 0.428% 
4559 40887116 40652817 234299 99.427% 0.573% 
4559 42418850 42218273 200577 99.527% 0.473% 
4559 36017301 35853955 163346 99.546% 0.454% 
4559M 25210330 25045001 165329 99.344% 0.656% 
4559M 52201495 51833174 368321 99.294% 0.706% 
4559M 34141985 33825643 316342 99.073% 0.927% 
 
4.3.2 RafR fine tunes carbohydrate metabolism during infection 
In order to directly compare correlations in pathogen transcriptional responses in murine 
lungs between samples, homologous genes between the wild type ear and blood isolates 
were listed and used to visualise the transcriptional response in a principal component 
analysis (PCA) plot (Fig. 4.2a). Here, the pneumococcal transcriptional response of the ear 
isolate (strain 947, dark orange) to murine lung infection diverges considerably from the 
response of the blood isolate (strain 4559, dark purple). Specifically, 76 homologous genes 
are significantly upregulated in the ear isolate, while 40 are upregulated in the blood isolate.  



















Figure 4.1. Heat maps 
displaying differentially 
expressed genes from the dual 
RNAseq data in murine lungs 6 
h after infection with either 9-
47-Ear (947), 4559-Blood 
(4559), 947M or 4559M. Purple 
indicates relatively low 
expression, while orange 
indicates relatively higher 
expression values. Top 50 
differentially expressed 
pneumococcal (A) and murine 
lung (B) genes are shown. Fold 
change values of all 
significantly expressed genes 











Upregulated genes in strain 947 include genes involved in carbohydrate metabolism, 
general stress response and nutrient transporters, while upregulated genes in 4559 include 
genes encoding small molecule permeases and nisin biosynthesis orthologous proteins.  
Furthermore, replacing rafR of 947 with the allele from the 4559 (designated strain 947M) 
dissociates its transcriptional response considerably from its parental strain (Fig. 4.2a; 947, 
dark orange to 947M, light orange). These large-scale transcriptomic differences between 
947 and 947M may explain the impact of the rafR SNP on in vivo tissue tropism. 
Specifically, 87 genes were upregulated in the wild type strain (947) while 36 genes were 
upregulated in the otherwise isogenic rafR swap strain (947M, Fig. 4.2b), with 
differentially expressed genes spread across the pneumococcal genome. Presence of the 
blood isolate rafR allele in 947 activates the expression of major genes pertaining to 
carbohydrate metabolism, including adhA (alcohol dehydrogenase) and spxB (pyruvate 
oxidase), as well as genes encoding permeases, including glnH6P6 (transporting arginine, 
cysteine) and ycjOP-yesO (transporting multiple sugars). Also, a subset of genes with 
function in carbohydrate metabolism are repressed in the rafR-swap strain, such as 
glycogen synthesis (glgACD), sucrose metabolism (scrB) and ribulose metabolism 
(ulaDEF). Expression of seven genes encoding ATPase subunits (ntpABCDEGK) and 
genes for iron (piuB) and sugar (scrA, satABC, gadEW) permeases are also repressed.  
On the other hand, replacing the blood isolate rafR with the ear allele (strain 4559M) does 
not noticeably interrupt pneumococcal transcriptional response to murine lung (Fig. 4.2a; 
4559, dark purple to 4559M, light purple), despite the different in vivo behaviours of 4559 
and 4559M. Essentially, the rafR swap activated only two genes: yxlF, encoding a putative 
subunit of an ABC transporter and phoU1 encoding a phosphate transporter; and repressed 
35 genes, mostly contained in a single genomic island (Fig. 4.2c, upregulated in 4559). The 
genomic island consists of 28 consecutive genes encoding subunits of bacteriophage(s), 
interspaced by dnaC, encoding a DNA replication protein and lytA, encoding autolysin. 




The activation of bacteriophage-associated genes indicates that the original isolate (strain 
4559) endures host-derived stress, unlike the rafR swap mutant (strain 4559M). Other 
genes repressed in 4559M include adhAE (alcohol dehydrogenases), gtfA (sucrose 
phosphorylase) and rafEG (raffinose transporter). Conversely, 947M and 4559 showcased 
similar in vivo behaviours yet displayed varied transcriptomes in murine lungs post-
infection (Fig. 4.2a). Hence, transcriptional profiling was unable to predict tissue tropism 
in this case. Taken together, the single D249G SNP in rafR interferes with global gene 
expression within the already transcriptionally-distinct parental clinical isolates. This effect 
was more pronounced in 947 than 4559.  
Figure 4.2. Pathogen transcriptional responses in murine lung. (a). PCA plot showing divergence 
of transcriptional response to lung infection within the ear (947) and blood isolates (4559). rafR 
swap (947M) rewires pneumococcal transcriptional response only in the ear isolate background but 
not in the blood isolate. (b). Differential expression due to the rafR swap in the ear isolate 
background is spread throughout the pneumococcal genome, (c) while in the blood isolate 
background, differential expression due to the rafR swap is limited to a genomic island. Functional 
enrichment showed specific function being differentially expressed, including carbohydrate 
metabolism (d), ABC transporters (e) and sugar transporters (f). A: comparison of 947 to 947M; B: 
947 to 4559; C: 947 to 4559M; D: 947M to 4559; E: 947M to 4559M and F: 4559 to 4559M. * 
denotes statistically significant functional enrichment for the indicated strain-strain comparison. 




Next, quantified enrichment analyses were performed on specific gene functions. 
Carbohydrate metabolism is enriched in the differentially expressed genes between the 
strains, particularly when comparing the ear isolate to its cognate rafR swap (Fig. 4.2d; 
comparison A, 947 vs 947M, p = 0.03), comparing the two clinical isolates (comparison B, 
947 vs 4559, p = 0.017) and comparing the swap cognates (comparison E, 947M vs. 
4559M, p = 0.041). Another function, ABC transporters, is also enriched in the comparison 
within the ear isolates (Fig. 4.2e; comparison A, 947 vs. 947M, p = 0.049), between the 
original isolates (comparison B, 947 vs 4559, p = 0.014), between the ear isolate and the 
blood isolate with the rafR 746G (comparison C, 947 vs. 4559M, p = 0.01) and between 
the rafR cognates (comparison E, 947M vs. 4559M, p = 1.8 ×10-4). 
Additionally, since the pneumococcal genome has an exceptionally high number of sugar 
transporters (Bidossi et al., 2012), we quantified enrichment for this function (Fig. 4.2f). 
Sugar transporters are enriched in almost all comparisons (except between 4559 and 
4559M), highlighting the role of rafR in the widespread regulation of pneumococcal sugar 
importers. Specifically, ear and blood isolates behave differently in regard to sugar 
transporter expression (947 vs. 4559; Fig. 4.2f, comparison B). The ear isolate upregulated 
scrA (encoding a mannose and trehalose transporter) and ulaA (ascorbate transporter), 
while the blood isolate upregulated ycjOP-yesO (alternative sugar transporters), rafE 
(raffinose transporter) and malFG (maltose transporter). Furthermore, rafR swap in the ear 
isolate background (947 vs. 947M; Fig. 4.2f, comparison A) reduced the expression of 
gadEW (encoding sorbose and mannose transporter), satABC (arabinose and lactose 
transporter), ulaAC and glpF (glycerol transporter), while the swap activated the expression 
of ycjOP-yesO and bguD (encoding complex polysaccharide transporters). In contrast, rafR 
swap in the blood isolate background (4559 vs. 4559M; Fig. 4.2f, comparison F) 
downregulated the expression of rafEG and malD (maltose transporter). The enrichment 
analysis reveals that the D249G SNP in rafR directly and indirectly affects the expression 




of genes encoding sugar transporters, other (ABC) transporters and carbohydrate 
metabolism. 
Genes that were commonly up or down regulated between the strains with a given virulence 
phenotype were also identified (Table 4.5). adhP (Sp947_00279) was significantly 
upregulated in both strains that persisted in lungs (947M and 4559), while 8 genes from 
the genomic region Sp947_0842 to Sp947_0855, as well as Sp947_00631 and 
Sp947_02096, were significantly upregulated in strains that were cleared from lungs by 24 
h (947 and 4559M). These genes include neuraminidase nanB, and alpha-glycerophosphate 
oxidase glpO (Table 4.5). All other differentially expressed pneumococcal genes are listed 
in Appendices M-R.  
Table 4.5. Pneumococcal genes that were consistently up or down regulated between strains that 
persisted in murine lungs (4559 and 947M) or between the strains that were cleared from the lungs 
(947 and 4559M).  
 
4.3.3 RafR-specific rewiring of host transcriptional responses 
The measured murine transcriptional response represents aggregate gene expression of all 
(host) cells present during pneumococcal lung infection. These include epithelial cells, 
endothelial cells of lung vasculature, smooth muscle cells, fibroblasts, activated and non-
activated immune cells. The host transcriptional response was specific to the infecting 
pneumococcal strain (Fig. 4.3a). Specifically, there was a diverging host response to the 
ear isolate (947, dark orange) and blood isolate (4559, dark purple). Interestingly, rafR 
swap in blood isolate background (4559M, light purple) mimicked the lung response to the 
Gene (locus tag) Comparison Fold Change padj 
adhP (Sp947_00279) 947 vs 947M 0.48 0.004 
adhP (Sp947_00279) 947 vs 4559 0.32 5.38 ×10-7 
adhP (Sp947_00279) 947M vs 4559M 2.39 0.00018 
adhP (Sp947_00279) 4559 vs 4559M 3.53 2.23×10-8 
nanB (Sp947_00844) 947 vs 947M 313 3.08×10-1 
nanB (Sp947_00844) 947 vs 4559 2.53 1.14×10-8 
nanB (Sp947_00844) 947M vs 4559M 0.01 4.59×10-8 
glpO (Sp947_02129) 947 vs 947M 5.86 1.19×10-37 
glpO (Sp947_02129) 947 vs 4559 1.89 2.26×10-7 
glpO (Sp947_02129) 947M vs 4559M 0.25 3.55×10-23 




wild type ear isolate (947, dark orange); these two strains harbour the D249 rafR allele. 
Surprisingly, the rafR swap in the 947 background (947M, light orange) which harbours 
the G249 allele, did not drive the host response to mimic those of the wild type 4559 strain 
(dark purple) that also has the G249 allele, but rather towards a new, third position of 
genome-wide expression. 
Genome-wide plotting of murine transcriptional responses to S. pneumoniae strains 947 
and 4559 showed extensive rewiring of gene expression across the murine chromosomes, 
consistent with their different tissue tropisms in vivo (Fig. 4.3b). Specifically, 433 murine 
genes are activated upon infection by 947 (FC > 1.5, p < 0.05), while 787 genes are 
activated by infection with 4559 (FC > 1.5, p < 0.05). Of the 947-upregulated murine 
genes, only 37% were protein-coding, with the majority encoding pseudogenes and small 
RNAs. Conversely, of the 787 4559-upregulated murine genes, 80% were protein-coding, 
while the rest encoded small RNAs. The 4559-upregulated genes encode proteins involved 
in multiple pathways such as general metabolism, peroxisome proliferator-activated 
receptor (PPAR) signalling, steroid hormone biosynthesis and cAMP signalling. Although 
both strains belong to the same capsular serotype and ST (Amin et al., 2015) the data 
strongly suggests wildly diverging isolate-specific host responses during early infection, 
with the rafR SNP varying the host response considerably. Interestingly, the host 
transcriptional response to 4559M closely resembles that of 947 (Fig. 4.3a), suggesting 
that the rafR SNP plays a crucial role in the distinct response to 947 vs 4559. However, the 
host transcriptional response to 4559 does not closely resemble the response to 947M, 
despite the similar in vivo tissue tropism these strains display. This suggests, 
unsurprisingly, that the host transcriptional response to pneumococcal infection does not 
perfectly correlate with in vivo outcomes.  
 




Figure 4.3. Single nucleotide polymorphism in pneumococcal rafR drives diverging host response. 
(a). PCA plot illustrates murine lung response to the pneumococcal strains. Interestingly, host 
transcriptional response to rafR swap in blood isolate (4559M, light purple) is similar to the murine 
response to the original ear strain (947, dark orange). (b). Differential gene expression of 
transcriptional response to pneumococcal ear and blood isolates shows a widespread 
transcriptional rewiring. Specifically, 433 genes are activated in response to infection by ear isolate 
(947) while 787 genes are activated (FC > 1.5, p < 0.05) by blood isolate (4559). Specific gene 
ontology terms are enriched in differentially expressed host genes in response to pneumococcal 
infection: cytokine-cytokine receptor interaction (c), interleukin-17 signalling pathway (d) and 
necroptosis (e). A: comparison between 947 to 947M; B: 947 to 4559; C: 947 to 4559M; D: 947M 
to 4559; E: 947M to 4559M and F: 4559 to 4559M. * denotes statistically significant functional 
enrichment for the indicated strain-strain comparison. 
In addition, rafR swap in the ear isolate background (947M) expressing the G249 rafR 
allele activated 271 murine genes (FC > 1.5, p < 0.05), while it repressed 479 genes. The 
G249 rafR-activated genes include those involved in the Wnt signalling pathway (Fzd2, 
Lgr6, Rspo1, Sost, Sox17, Wnt3a, Wnt7a) and general calcium signalling pathway (Adra1a, 
Adra1b, Adrb3, Cckar, Grin2c, P2rx6, Tacr1, Tacr2). Conversely, 52% of the G249 rafR-
repressed genes in lungs infected with 947M encode RNA features and 18 chemokines, 
chemokine ligands, interferons and interleukins. On the other hand, rafR swap in the blood 
isolate background (4559M) expressing the D249 rafR allele activated 328 murine genes 




(FC > 1.5, p < 0.05), and repressed 472 genes. 73% of the D249 rafR-activated murine 
genes encode RNA features and 33 encode histone proteins. The activation of these histone 
proteins suggests a massive reorganisation of gene regulation with numerous potential 
downstream impacts. In contrast, D249 rafR-repressed genes include genes encoding 
calmodulins (Calm4, Calm13 and Camk2a) and phospholipases A2 (Pla2g4b, Pla2g4d and 
Pla2g4f).  
Moreover, there are only 132 differentially expressed host genes in response to wild type 
947 compared to the response to strain 4559M (both having the D249 rafR allele), with 38 
genes upregulated in strain 947 and 94 in strain 4559M. Fascinatingly, the D249 rafR allele 
(strains 947 and 4559M) is associated with a significant upregulation of RNA features, 
including antisense, intronic, long intergenic non-coding RNAs (lincRNAs) and micro 
RNAs (miRNAs). The resulting abundance of RNA species in murine cells upon 
pneumococcal infection has the potential for even more widespread transcriptional 
rewiring and fine-tuning of gene products later in the infection. 
A quantified functional enrichment showed that certain gene functions are enriched in the 
murine response to pneumococcal strains. In particular, cytokine-cytokine receptor 
interaction is enriched in differentially expressed host genes because of rafR swap in the 
ear isolate background (Fig. 4.3c, comparison A, 947 vs. 947M, p = 9.5×10-4). 
Concurrently, this function is enriched in differentially expressed genes between mice 
infected with 947M and those infected with 4559 (comparison D, p = 1.8 ×10-4). Since 
both strains harbour the G249 rafR allele, the differentially expressed genes encoding 
cytokines and cytokine receptors are most likely attributable to unrelated genetic 
differences between the clinical isolates. Interestingly, this function is not enriched in 
differentially expressed genes between the rafR swap in the blood isolate background 
(4559M) and the wild type 947 (comparison C), both of which have the D249 rafR allele. 
Genes encoding chemokine ligands (Cxcl2, Cxcl3, Cxcl10 and Ccl20), interleukin 17F 




(Il17f), interferon beta (Ifnb1) and a receptor of TNF (Tnfrsf18) are the common 
differentially expressed genes in lungs of mice infected with 947, 947M and 4559, with 
ascending expression from responses to 947M, 947 and 4559. Other genes encoding 
chemokine ligands (Ccl3, Ccl4, Ccl17, Ccl24, Cxcl5, Cxcl11 and Xcl1), interleukins (Il1rn 
and Il13ra2) and interferon gamma (Ifng) are more highly expressed in the ear isolate-
infected lung (947) than in lungs infected by the rafR swap ear isolate (947M). Finally, 
genes encoding chemokine receptors (Ccr1 and Ccr6), interleukin receptors (Il1r2, Il10ra, 
Il17a, Il18rap, Il20ra, Il20rb, Il22 and Il23r), and interleukins (Il1f5, Il1f6, Il1f8 and Il6) 
are more highly expressed in lungs infected by 4559 compared to the rafR swap in in the 
ear isolate background (947M). 
Interleukin 17, as part of the cytokine response, activates multitudes of downstream targets 
in defence against infectious agents (Onishi and Gaffen, 2010), and thus plays a central role 
in host response to pneumococcal infection. Here, we observe the same pattern of diverging 
activation among murine responses to the pneumococcal strains (Fig. 4.3d), with IL-17-
associated genes being enriched in differentially expressed genes among the host 
transcriptional response to the rafR swap in the ear isolate background (comparison A, 947 
vs. 947M, p = 9.5×10-4). These genes are also enriched amongst the host response to 
pneumococcal strains with the G249 rafR allele (comparison D, 947M vs. 4559, p = 
7.5×10-4) and to the rafR swap cognates (comparison E, 947M vs. 4559M, p = 0.022). 
However, there was no enrichment of IL-17 associated genes amongst the host response to 
pneumococcal strains with the D249 rafR allele (comparison C, 947 vs. 4559M). Common 
differentially expressed genes of this function include genes encoding interleukin 17F 
(Il17f) and chemokine ligands (Cxcl2, Cxcl3 and Ccl20), with ascending expression level 
of response to 947M, 947 and 4559. Specifically, the products of these genes regulate the 
recruitment of neutrophils and activate immune responses to extracellular pathogens.  




In addition to the above, necroptosis, a programmed cell death, is almost significantly 
enriched (p = 0.07) in differentially expressed murine genes because of the rafR swap in 
the blood isolate background (Fig. 4.3e, comparison F, 4559 vs. 4559M). Genes encoding 
histone cluster 2 (Hist2h2ac, Hisr2h2aa1, Hist2h2aa2 and H2afx) are more highly 
expressed in murine lungs infected with 4559, while those encoding phospholipases A2 
(Pla2g4b, Pla2g4f and Pla2g4d) and a subunit of calcium/calmodulin-dependent protein 
kinase II (Camk2a) are more highly expressed in the transcriptional response to the rafR 
swap in the blood isolate background (4559M).  
4.3.4 Validation of host/pathogen transcriptomics 
To validate the findings from the dual RNAseq, qRT-PCR was performed on the same 
RNA samples from the lungs 6 h post-infection. 19 pneumococcal and 18 murine genes 
were chosen for this validation, with the primers used listed in Table 4.2. A total of 76 
pneumococcal and 72 murine gene Log2 FC comparisons were performed, with a high 
degree of correlation observed for both pneumococcal (R2 > 0.73, Pearson) and murine 
genes (R2 > 0.81, Pearson) (Fig. 4.4A). To validate the reproducibility of the dual RNAseq 
data, lung RNA samples 6 h post-infection from a different experiment were analysed with 
qRT-PCR. Here, 6 pneumococcal and 6 murine genes were chosen, and 24 pneumococcal 
and 24 murine gene log2 FC comparisons were performed. A high degree of correlation 
was also observed here, for both pneumococcal (R2 > 0.77, Pearson) and murine genes 
(R2 > 0.73, Pearson) (Fig. 4.4B).  
4.3.5 Immune cell subsets present in infected lung tissue  
The host RNAseq data represent the pooled transcriptional responses of all cell types 
present in the lungs at the time of RNA extraction. Thus, some of the transcriptomic 
differences may be attributable to alterations in the relative abundance of given cell types,  




Figure 4.4. Gene expression values from the dual RNAseq were confirmed by qRT-PCR, using (A) 
the same isolated RNA used for the dual RNAseq or (B) isolated RNA from a repeated experiment. 
(A) 18 murine and 19 pneumococcal genes were chosen as experimental validation targets. Log2 
fold changes were plotted from qRT-PCR against dual RNAseq log fold changes for 947 vs 4559, 
947 vs 947M, 947M vs 4559M and 4559 vs 4559M comparisons. A total of 72 murine and 76 
pneumococcal comparisons were plotted, with a high degree of correlation observed for both 
species (R2 > 0.73, Pearson). (B) 6 murine and 6 pneumococcal genes were chosen as targets to 
test the reproducibility of the dual RNAseq data. Log2 fold changes were plotted from qRT-PCR 
against dual RNAseq log fold changes for 947 vs 4559, 947 vs 947M, 947M vs 4559M and 4559 
vs 4559M comparisons. A total of 24 murine and 24 pneumococcal comparisons were plotted, with 
a high degree of correlation observed for both species (R2 > 0.73, Pearson).   
for example, by differential recruitment of immune cell subsets to the site of infection. 
Accordingly, flow cytometry was used to quantify immune cell subsets present in lung 
tissue 6 h after infection with either 947, 4559, 947M or 4559M. The surface marker 
staining panel used (Table 4.3) and appropriate gating strategy (Appendix Y) allowed the 
identification and enumeration of natural killer (NK) cells, neutrophils, eosinophils, 
inflammatory monocytes (iMono), resident monocytes (rMono), alveolar macrophages 
(AMФ), interstitial macrophages (iMФ), CD11b-negative dendritic cells (CD11b-DC), 
CD11b-positive dendritic cells (CD11b+ DC), T cells and B cells (Yu et al., 2016). Of 
these, neutrophils, by far the most abundant cell type, were present in significantly higher 
numbers in murine lungs infected with 947 (vs 4559, p < 0.01; vs 947M, p < 0.05) and 
4559M (vs 4559, p < 0.05) (Fig. 4.5), both of which have the D249 rafR allele and were 
cleared from the lungs 24 h post-infection. NK cells were also found to be significantly 
higher in lungs infected with 947 (vs 4559, p < 0.01; vs 947M, p < 0.05), while eosinophils 
were raised in 4559M infected lungs (vs 4559, p < 0.05) (Fig. 4.5). However, since the 




numbers of NK cells and eosinophils were much lower than neutrophils, their contribution 
to total lung mRNA and their impact on tissue tropism may be less pronounced. Moreover, 
the large difference in neutrophil recruitment to the lungs 6 post-infection aligns with the 
differential IL-17 response highlighted in the dual RNAseq data. The higher number of 
neutrophils in murine lungs infected with 947 and 4559M is likely to facilitate their 
clearance from this niche.  
Fig. 4.5. Quantification of immune cell subsets in murine lungs 6 h post infection. Groups of 8 
mice per strain were challenged with either 947, 4559, 947M or 4559M. Single cell lung 
suspensions were prepared and stained with antibodies against various surface markers (Table 4.3) 
then analysed by flow cytometry. Populations enumerated include: natural killer (NK) cells, 
neutrophils, eosinophils, inflammatory monocytes (iMono), resident monocytes (rMono), alveolar 
macrophages (AMФ), interstitial macrophages (iMФ), CD11b-negative dendritic cells (CD11b-
DC), CD11b-positive dendritic cells (CD11b+ DC), T cells and B cells. Graphs shown represent 
pooled data from two independent experiments. All quantitative data are presented as 
mean ± S.E.M (n = 16 for each group), analysed by one-way ANOVA (*p < 0.05; **p < 0.01). 




4.3.6 Impact of neutrophil depletion and IL-17A neutralization 
The greater abundance of neutrophils in lungs infected with strains containing the D249 
rafR allele that are cleared from the lungs by 24 h suggests that the recruitment and 
presence of neutrophils is crucial for bacterial clearance from the lung. Thus, differential 
neutrophil recruitment might be the underlying mechanism for the observed RafR-
dependent tropism. To test this, we investigated the importance of neutrophils for 
persistence of pneumococci in the lungs in the IN challenge model. Injection of anti-mouse 
Ly6G was used to deplete neutrophils in 32 mice, alongside an isotype control group 
treated with rat IgG2a. Neutrophil depletion was confirmed in the blood prior to challenge 
using flow cytometry (Appendix Z), with a 76.35% decrease in neutrophils in the anti-
mouse Ly6G treated mice, relative to the isotype control-treated group (p < 0.0001) (Fig. 
4.6A). Mice were then challenged with 108 CFU of each strain, for both treatment groups. 
Bacterial loads were quantified in the nasopharynx and lungs 24 h post-challenge. No 
significant differences in bacterial numbers in the nasopharynx were seen between strains 
within each treatment group (Fig. 4.7A). Also, for both treatments, the numbers of bacteria 
in the lungs infected with 4559 and 947M were significantly higher than 947 and 4559M 
(Fig. 4.7B), which is consistent with our previous findings (Minhas et al., 2019).  However, 
the anti-Ly6G-treated groups showed significantly higher lung bacterial loads compared to 
their respective isotype controls: 4559 anti-Ly6G vs 4559 control (p < 0.001), 947-Blood 
anti-Ly6G vs 947-Blood control (p < 0.01), 4559M anti-Ly6G vs 4559M control (p < 0.01) 
and 947M anti-Ly6G vs 947M control (p < 0.05) (Fig. 4.7B). Importantly, the lung 
bacterial loads of anti-Ly6G-treated 947 and 4559M groups were not significantly different 
to the isotype control-treated 4559 group (Fig. 4.7B). Thus, restriction of neutrophil 
infiltration into the lungs by depleting circulating neutrophils in mice challenged with the 
strains expressing the D249 rafR allele resulted in enhanced lung bacterial loads at 24 h 




similar to that seen in untreated mice challenged with the strains expressing the G249 rafR 
allele. 
Figure 4.6.  Effect of anti-mouse Ly6G and anti-mouse IL-17A treatment on neutrophil and IL-
17A levels. A Groups of 8 mice per strain were treated with either 350 μg of rat anti-mouse Ly6G 
or rat IgG2a isotype control antibodies (see section 4.2.7) Percentage of circulating neutrophils 
relative to live (CD45+) cells were calculated. Differences in circulating neutrophils between groups 
are indicated by asterisks: ****, p < 0.0001, by one-way ANOVA. B & C Groups of 3 outbred 6-
week-old female Swiss (CD-1) mice were treated with either monoclonal anti-mouse IL-17A or 
mouse IgG1 isotype control antibodies (see section 4.2.8). B BAL was harvested 6 h post-infection 
and an IL-17 ELISA was performed to calculate IL-17 levels after anti-mouse IL-17A treatment. 
Differences in BAL IL-17 levels between groups are indicated by asterisks: ****, p < 0.0001, by 
two-tailed unpaired Student’s t-test. C Lung tissue was also harvested 6 h post-infection and stained 
with antibodies against neutrophil surface markers (Table 3), then analysed by flow cytometry. 
Differences in lung neutrophil levels between groups are indicated by asterisks: *, p < 0.05, by two-
tailed unpaired Student’s t-test. 
Given the known involvement of IL-17 in neutrophil recruitment into the lungs after 
infection (Lindén et al., 2005; McCarthy et al., 2014; Ritchie et al., 2018; Stoppelenburg et 
al., 2013), we also investigated the in vivo significance of the rafR-mediated differential 
expression of IL-17-associated genes between the various S. pneumoniae strains.  Groups 
of mice were injected with anti-mouse IL-17A, or a control murine IgG1 antibody, before 
and after pneumococcal challenge. IL-17A depletion was confirmed by ELISA on separate 
9-47-infected bronchoalveolar lavage (BAL) samples, with a 55.63% reduction in IL-17A 
levels seen in anti-mouse IL-17A treated mice relative to the isotype control group (p < 
0.0001) (Fig. 4.6B). The effect of this IL-17A depletion on neutrophil levels was also tested 
using flow cytometry on infected 9-47 lung tissue, with a 22.23% decrease in neutrophils 




seen in the anti-mouse IL-17A-treated mice, relative to the isotype control-treated group (p 
< 0.05) (Fig. 4.6C).  
Figure 4.7. Impact of neutrophil depletion or anti-IL-17A on pneumococcal virulence. Groups of 8 
mice were treated with either 350 μg of rat anti-mouse Ly6G or rat IgG2a isotype control, one and 
two days prior to pneumococcal challenge (A & B), or with IL-17A or mouse IgG1 isotype control 
(C & D), one day before, 2 h before and 6 h after intranasal challenge (A, B, C & D). 24 h post-
infection, numbers of pneumococci in the nasopharynx and lungs were quantitated (see section 
4.2.8). NB: n is <8 for some groups because didn’t survive the challenge procedure, or until the 
time of harvest. Viable counts (total CFU per tissue) are shown for each mouse at each site; 
horizontal bars indicate the geometric mean (GM) CFU for each group; the broken line indicates 
the threshold for detection. Differences in GM bacterial loads between groups are indicated by 
asterisks: *, p < 0.05, **, p < 0.01, ***, p < 0.001, by unpaired t-test.  
Bacterial loads were quantified in the nasopharynx and lungs 24 h post-challenge. Again, 
no significant differences between strains in bacterial numbers in the nasopharynx were 
seen within each treatment group (Fig. 4.7C). However, similar to the results obtained 
using anti-Ly6G, groups treated with anti-IL-17A showed significantly higher bacterial 
numbers in the lungs compared to their respective isotype controls; 4559 anti-IL-17A vs 
4559 control (p < 0.05); 947-Blood anti-IL-17A vs 947-Blood control (p < 0.05); 4559M 




anti-IL-17A vs 4559M control (p < 0.05); and 947M anti-IL-17A vs 947M control (p < 
0.01) (Fig. 4.7D). Nevertheless, the impact of anti-IL-17 treatment on lung bacterial loads 
was not quite as dramatic as that of anti-Ly6G, as the number of bacteria in the lungs of 
anti-IL-17A-treated 947 and 4559M groups remained significantly lower relative to the 
isotype control treated 4559 group (both p < 0.05) (Fig. 4.7D).  Together, these results 
show that pneumococcal strains carrying the D249 rafR allele caused a rapid influx of 
neutrophils, partly controlled by IL-17 expression in the host, leading to clearance from the 



















In this Chapter, a dual RNAseq approach was used, validated by qRT-PCR, to elucidate 
the complex interspecies interactions between murine lung cells and infecting S. 
pneumoniae blood and ear isolates that are closely related (same capsular serotype and ST 
type), but exhibit distinct virulence phenotypes in accordance with their original clinical 
isolation site. These differences are largely, but not completely, driven by a D249G SNP 
in the raffinose pathway transcriptional regulator gene rafR, which extensively impacts the 
bacterial transcriptome in the lung environment. The SNP affects expression of genes 
encoding multiple transmembrane transporters, including those for various sugars, and 
fine-tunes pneumococcal carbohydrate metabolism (section 4.3.2). This indicates that the 
differential expression of sugar catabolism pathways provides specific advantages in 
distinct host niches, implying differential niche-specific availability of one carbohydrate 
source versus another.  
Free sugars are in low abundance in the upper respiratory tract, but S. pneumoniae 
expresses a range of surface-associated exoglycosidases that enable it to scavenge 
constituent sugars (including galactose, N-acetylglucosamine, sialic acid and mannose) 
from complex host glycans present in respiratory secretions and on the epithelial surface 
(Andreassen et al., 2020; Buckwalter and King, 2012; King et al., 2006; Paixão et al., 2015; 
Robb et al., 2017; Shelburne et al., 2008).  Conversely, glucose is readily available in the 
blood and also in inflamed tissues, implying a marked alteration in the availability of this 
preferred carbohydrate source as invasive disease progresses (Philips et al., 2003). All these 
variations, and the downstream consequences thereof, are ultimately sensed by host cells, 
including epithelial and immune cells, resulting in the observed divergence of host 
responses to the various strains, particularly with respect to expression of genes encoding 
cytokine and chemokine ligands and receptors, as well as those associated with 




programmed cell death (section 4.3.3).Examination of the nature of the host response 
provided important clues regarding the mechanism whereby the rafR SNP impacts 
virulence phenotype. By way of example, the dual RNAseq data showed that expression 
of IL-17 related genes were enriched in mice infected with 947 and 4559M. These strains 
express the D249 rafR allele and are cleared from the lungs by 24 h post-challenge. It is 
well known that IL-17 drives neutrophil recruitment into the lungs after infection (Lindén 
et al., 2005; McCarthy et al., 2014; Ritchie et al., 2018; Stoppelenburg et al., 2013). Indeed, 
the results in this Chapter showed that neutrophils were present in the lungs 6 h post 
challenge at significantly higher numbers in mice infected with 947 and 4559M compared 
with the strains expressing the G249 rafR allele (Fig. 4.5), as predicted by the dual RNAseq 
data. Moreover, it was shown that neutrophil depletion by treatment with anti-Ly6G 
increased bacterial numbers in the lungs of mice, relative to the isotype controls. Strikingly, 
pneumococcal numbers in the lungs of anti-Ly6G treated mice infected with 947 and 
4559M were not significantly different to that of isotype control-treated 4559 infected mice 
(Fig. 4.7B), underscoring the impact of RafR-mediated neutrophil recruitment on murine 
lung clearance. In vivo neutralization of IL-17A also resulted in an increase in bacterial 
loads in the lungs of mice, relative to the isotype controls, for all challenge strains (Fig. 
4.7D), although not to the same extent as seen for neutrophil-depleted mice (Fig. 4.7B). 
The difference between the impact of IL-17A neutralization vs neutrophil depletion is 
likely due to the action of alternative neutrophil recruitment pathways (Craig et al., 2009; 
Peñaloza et al., 2015).  
These findings demonstrate that the rafR SNP examined in this study has a wide-spread 
effect on both the bacterial and host transcriptomes, with the strains expressing the G249 
allele triggering a strong pro-inflammatory IL-17 response in the lungs post-infection. This 
response leads to an influx of neutrophils to the lungs, resulting in the clearance of bacteria. 
Conversely, expression of the G249 rafR allele results in a more subdued IL-17 host 




response, allowing for bacterial persistence in the lungs. Thus, the findings clearly indicate 
that modulation of neutrophil recruitment during the early stage of infection plays a key 
role in the capacity of a given S. pneumoniae strain to persist in the lungs, and the nature 
of disease ultimately caused by it.  
The downstream experimental analyses of the dual RNAseq data in this chapter were 
confined predominately to examining the impact of neutrophil recruitment and IL-17 on 
ability to persist in murine lungs, largely due to compatability with the results of the flow 
cytometry analyses of cells from infected lung tissue. As the data sets that arise from dual 
RNAseq experiments are so large, the functional enrichment analyses provided a strategy 
to focus on classes of genes that are over-represented within the data. This allows focus to 
be placed on genes that are more likely to be playing roles in the behaviour of the strains, 
but also results in the focus of analysis being narrow. Beyond IL-17 signalling, the host 
functional enrichment analyses also identified cytokine-cytokine receptor interactions and 
necroptosis pathways as being differentially regulated between the serotype 14 ST 15 
strains. Further analysis of these additional host-specific areas was outside the scope of the 
current project, but could be explored in future studies.   
In fact, recent studies have shown that necroptosis influences the outcome of pneumococcal 
infection, through the loss of immune cells or by controlling excessive proinflammatory 
signalling  (Ahn and Prince, 2017; Hakansson and Bergenfelz, 2017; Riegler et al., 2019). 
Moreover, pore forming toxins such Ply are known to induce necroptosis during  
pneumonia (Gonzalez-Juarbe et al., 2018, p.; González-Juarbe et al., 2015), though ply was 
not highlighted as significantly differentially expressed in the dual RNAseq data shown in 
this Chapter. Validation of an impact of RafR on necroptosis could follow a similar route 
to the flow cytometry experiments of murine lungs 6 h post-infection detailed in this 
Chapter (section 4.2.6).  Necroptotic cells can be identified by staining with Annexin V or 
propidium iodide (Battaglia, 2017). Moreover, cell death kinetic and morphology assays 




and live imaging can be used to distinguish necroptotic and apoptotic cells (Shlomovitz et 
al., 2018). 
The bacterial genes that were commonly up or down regulated between the strains that 
persisted in murine lungs (4559 and 947M) or between the strains that were cleared from 
the lungs (947 and 4559M), may be determinants of the distinct virulence phenotypes of 
the blood and ear isolates (section 4.3.2). Hence their examination through KO or 
overexpression experiments in murine models is warranted in the future. Both adhP and 
glpO were upregulated in the strains that persisted in the lungs, and hence may play roles 
in preventing neutrophil recruitment to this niche. Other studies have shown that these 
genes play roles in pneumococcal virulence; GlpO aids in nasopharyngeal colonisation and 
meningitis (Mahdi et al., 2012, 2017), while AdhP potentiated Ply and infection in a murine 
infection model (Luong et al., 2015). In contrast, the data showed nanB was upregulated in 
the strains that were cleared from the lungs compared to the strains that persisted, thus this 
gene may play a role in neutrophil recruitment. Additionally, NanB functions in sialic acid 
acquisition, and this sugar has been shown to contribute towards biofilm formation (Parker 
et al., 2009; Trappetti et al., 2009). Therefore, it is possible that the upregulation of nanB 
in 947 and 4559M may result in their increased propensity to infect and persist the middle 
ear.  
NK cells were shown to be present at significantly higher numbers in murine lungs infected 
with 947 (which were cleared from the lungs) compared to 4559 and 947M (that persisted 
in the lungs), whereas a similar significant result was seen for eosinophils in 4559M  
compared to 4559 (section 4.3.5). Hence, heightened NK cell and eosinophil responses 
may also contribute towards the clearance of these pneumococcal strains from the lungs. 
To examine if this is the case, future experiments could take a similar approach as the 
murine neutrophil depletion experiments detailed in this Chapter (section 4.2.7), using the 




Siglec-F antibody to deplete eosinophils (Zimmermann et al., 2008) and NK1.1 to deplete 
NK cells (Waggoner et al., 2014). 
Chapter 2 of this thesis showed that in spite of early clearance from the lung, ear isolate 
947 and rafR-swapped 4559M, both expressing the D249 rafR allele, have an enhanced 
capacity to spread to and/or proliferate in the ear and brain compartments (Minhas et al., 
2019). It is not known whether differential carbohydrate metabolism better adapts these 
strains to utilise alternative carbohydrate sources in these niches, or whether altered host 
pro-inflammatory responses contribute to ascension of the Eustachian tube and/or 
penetration of the blood-brain barrier. Unfortunately, the total numbers of pneumococci 
present in these niches are too low for pathogen-host transcriptomic analyses to be 
conducted using available technologies. 
Intra-species variation in virulence phenotype is a common feature of pathogenic 
microorganisms, which by nature are genetically diverse. S. pneumoniae is an exemplar of 
such diversity comprising at least 100 capsular serotypes superimposed on over 12,000 
MLST types, and with a core genome that accounts for only 70% of genes (Weiser et al., 
2018). Nevertheless, stark differences in pathogenic profile can result from the smallest of 
genetic differences between strains, as exemplified by the profound impact of a single SNP 











The work described in this thesis circumvented issues regarding pneumococcal genomic 
diversity that have complicated previous attempts to pinpoint factors responsible for the 
spread of pneumococci into specific sites of the body. This was done by examining closely 
related strains of the same serotype and ST that have been shown to display distinct tissue 
tropism in mice that appear to correlate with their initial isolation site in the human body 
(Amin et al., 2015; Trappetti et al., 2013). It was hypothesised that by examining the 
relatively few differences within the closely related blood and ear isolate pairs from the 
serotype 3 ST180 and serotype 14 ST15 clonal lineages, mechanisms dictating their spread 
to specific sites in the body could be elucidated.  
Chapter 2 of this thesis examined genomic differences between the blood and ear isolate 
pairs. Among other genetic differences, SNPs leading to non-conserved amino acid 
substitutions were found in the raf genes rafR (for serotype 14) and rafK (for serotype 3), 
which were subsequently highlighted as potential determinants of tissue tropism. It was not 
possible to directly attribute the distinct virulence phenotypes of the serotype 3 ST180 
blood and ear isolates to the SNP in rafK, due to the inability to swap their rafK alleles. 
However, through IN murine challenges with rafK KO mutants (section 2.3.5), it is clear 
that the ability to utilise raffinose and/or downstream consequences thereof, strongly 
impact the capacity of these strains to cause disease. For the serotype 14 ST 15 isolate pair, 
swapping the rafR alleles between the blood and ear isolate led to concurrent switches in 
their disease progression following IN murine challenge (section 2.3.4). This was a 
significant finding for the research field of S. pneumoniae disease, as it showed how a 




single SNP could alter the tissue tropism of pneumococcal strains while also highlighting 
the major impact of raffinose regulation on disease progression.  
An interesting observation from Chapter 2 was that adherence assays with the serotype 14 
ST 15 isolates, and their respective rafR swapped mutants, showed the strains able survive 
in the lung exhibited significantly greater adherence to A549 cells than the strains that were 
cleared (section 2.3.6), suggesting a role for RafR in adherence. However, this phenotype 
was seen in CDM media with either Raf or Glc as sole carbon source. In CDM+Glc, the 
raffinose operon would have been repressed to due to catabolite repression (Carvalho et 
al., 2011; Fleming et al., 2015; Iyer et al., 2005), suggesting there are additional unknown 
factors at play. Indeed, analysis of the dual RNAseq data from chapter 4 revealed that 
exchanging rafR alleles led to major alteration in transcriptional patterns in both host and 
pathogen (sections 4.3.2 and 4.3.3), including bacterial genes that are not related to 
carbohydrate metabolism.  
Notably, the disease progression phenotypes of the serotype 14 ST15 blood and ear isolates 
were not completely switched after rafR allelic exchange. At 24 h post-challenge, the 
numbers of the rafR-swapped 947 strain present in the lungs were roughly one log lower 
than that for the wild type blood isolate 4559, while the rafR-swapped 4559 strain displayed 
slightly lower spread to the ear than the wild type ear isolate 947 (section 2.3.4). This 
suggests that there are additional unknown factors outside the raf operon that are 
contributing to the differential virulence phenotype of these otherwise closely related 
pneumococcal isolates.  
Despite the apparent importance of raffinose utilisation in the disease progression of S. 
pneumoniae, GC MS was unable to detect the presence of free raffinose in murine lungs 
post-infection. However, qRT-PCR analysis of infected lung tissue found that the raffinose 
operon was activated, indicative of the presence of the sugar (section 2.3.7). Activation of 




the raffinose operon early in the course of infection may have led to consumption of much 
of the free raffinose present in the lungs, resulting in levels below the detectable threshold. 
Additional GC MS analyses of uninfected lung tissue and at earlier timepoints may 
therefore be informative. Another possibility is that there may be other carbohydrates 
present in lung mucus that mimic raffinose sufficiently to induce raffinose operon 
expression. Nevertheless, the precise mechanisms underlying the effect of the raffinose 
operon on disease progression remain to be elucidated.  
As explored in the section 2.4, the findings of Chapter 2 suggest an example of convergent 
evolution, where unrelated serotypes/lineages exhibit SNPs in separate genes affecting 
raffinose utilisation, which impacts their virulence phenotype. BLASTX analysis of 
available S. pneumoniae genomes highlighted that SNPs are widespread in the raf genes. 
Whether these other SNPs impact raffinose utilisation or virulence phenotype is unknown, 
but is clearly worthy of investigation. 
Finally, in addition to the aforementioned SNPs,  the serotype 3 ST180 isolate pair had 26 
other SNPs or indels, while the serotype 14 ST15 pair had 16 other SNPs or indels, as well 
as a 35-kb prophage and a 3.2-kb plasmid in 4559 but not in 947 (section 2.3.1). Many of 
these genomic differences were not within recognised virulence factor genes. Future work 
should include examination of these other genomic differences, using a similar approach 
to that used in Chapter 2, namely construction of gene-swap mutants in both blood and ear 
isolate backgrounds. To further determine the effect of raffinose utilization on 
pneumococcal virulence in different tissues, future experiments could be performed with 
the addition of external raffinose in in vivo and ex vivo assays or using inoculum prepared 
in the presence of raffinose. Additionally, given the potential impact of carbohydrate 
metabolism on pneumococcal virulence phenotype, it would make sense to target other 
metabolic related genes in the first instance, such as pfkA and nanB for the serotype 14 
isolate pair and adhP and glnP for the serotype 3 isolate pair. However, as there are no 




other common SNPs between the serotype 3 and 14 blood and ear isolate pairs, the general 
applicability of any findings to other pneumococcal strains may be more limited. 
The transcriptomic comparisons detailed in Chapter 3 followed a similar line of analysis 
as the genomic comparisons in Chapter 2. The transcriptomes of each isolate pair were 
analysed for differentially expressed genes in the three media types, followed by qRT-PCR 
validations in the sequenced isolate pairs and other corresponding isolate pairs of the same 
serotype and/or ST. Of all the qRT-PCR validations conducted, only the aldehyde-alcohol 
dehydrogenase E (adhE) was found to be commonly significantly differentially expressed 
within the tested serotype 3 ST 180 strains (section 3.3.3). Unfortunately, adhE KO 
mutants were unable to show any significant impact of acetaldehyde production or 
adherence to lung epithelial or nasopharyngeal cells (section 3.3.4), hence in vivo 
experiments were not performed. 
The stringent cut off conditions utilised in the differential gene expression analyses may 
have excluded important gene regulation patterns that influence tissue tropism of the 
pneumococcal isolate pairs. Therefore, changing the p value cut off to < 0.05, then 
performing function enrichment analyses (Hawkins et al., 2010) may uncover determinants 
of pneumococcal disease progression that were overlooked in Chapter 3. Moreover, as the 
ST180 and ST232 clonal lineages are not from the same lineage, it may be worth examining 
differences common to only the ST180 blood and ear isolate pairs in the future. 
The sequence of genes and their expression patterns do not represent the only potential 
factors that could differentiate blood and ear isolate pairs. Hence, it is likely that the other 
omics platforms may uncover other candidate virulence-related factors that the genomic 
and transcriptomic analyses missed. The PacBio genomic sequencing contains the 
methylome data of the sequenced pneumococcal strains, but this was not analysed due to 
time constraints. Importantly, epigenetic changes have been shown to influence 




pneumococcal virulence phenotype, resulting from recombinational exchanges at the locus 
encoding a Type I restriction/modification (RM) system. In strain D39, switching between 
six possible restriction site target specificities for the enzyme SpnD39III, generated six 
alternative genome-wide methylation patterns, which was shown to influence both gene 
expression profiles and in vivo virulence phenotype (Manso et al., 2014). Hence, future 
experiments should compare the methylome data within the blood and ear isolates. 
Nevertheless, it would be predicted that if epigenetic phase variation was the basis for the 
distinct phenotypes of blood and ear isolates, this would be reflected in transcriptomic 
patterns. Thus, it seems improbable that such a mechanism is a predominant underlying 
cause of the observed phenotypic variation of these blood and ear isolate pairs.  
The comprehensive multi-omics program conducted under the auspices of Bioplatforms 
Australia that generated the data analysed in Chapers 2 and 3 also includes metabolomic 
and proteomic analyses of the blood and ear isolates under the same three media conditions 
as the transcriptomic analyses. It is plausible that potentially significant differences in the 
cellular levels of proteins and/or metabolic pathway products/intermediates may not be 
evident from the genome or transcriptome. Thus, it will be important to compare the 
metabolome and proteome between the blood and ear isolate pairs when these data become 
available. Investigations could include mutational studies of candidate proteins in which 
their respective genes are either deleted, modified or over expressed, thereby testing the 
impact of highlighted factors on the ability of the pneumococcal strains to spread to specific 
sites in the body. The metabolomics data may also yield clues regarding pathways that are 
up- or down-regulated between the blood and ear isolate pairs. Important genes within these 
pathways could then be mutated in a similar fashion to the proposed proteomic 
investigations. That said, there is a possibility that some of the metabolic genes will be 
essential for pneumococcal viability, thereby limiting suitable mutations to those that do 
not involve deletion. 




Although the results from the rafR swap experiments in Chapter 2 suggested that the 
efficient utilisation of raffinose and/or downstream effects thereof, play significant roles in 
dictating where pneumococcal strains spread to around the body, the mechanisms behind 
this were not elucidated. Furthermore, these differences in raffinose operon expression 
were not picked in the in vitro transcriptomics in any of the three media, most probably 
due to catabolite repression (Iyer et al., 2005).  In fact, the most ideal conditions to perform 
transcriptomic analyses are in vivo. Thus technology and experimental techniques were 
refined during this project that allowed in vivo dual RNAseq to become viable, as detailed 
in chapter 4 and Minhas et al. (2020). 
To understand how the rafR SNP caused such a drastic switch in disease progression when 
alleles were swapped between 4559 and 947, in vivo dual RNAseq was used to examine 
pathogen and host transcriptomes in murine lung tissue 6 h post-infection.  This allowed a 
thorough investigation of how the rafR SNP affects the transcriptional cross-talk between 
host and pathogen. The dual-RNAseq data predicted that IL-17 signalling and neutrophil 
recruitment were impacted due to the rafR SNP (section 4.3.3), potentially influenced by 
corresponding changes in regulation of carbohydrate uptake and metabolism (section 
4.3.2). Flow cytometry (section 4.3.5) paired with neutrophil depletion and IL-17 
neutralisation in mice prior to I.N. challenge (section 4.3.6), confirmed the crucial 
influence of the RafR allele on the ability of the blood and ear isolates to persist in the 
lungs. Though the dual RNAseq data provided great insights into how the rafR SNP affects 
persistence in the lungs post-infection, much still needs to be elucidated. For example, 
studies on exactly how the changes in bacterial transcriptome lead to differential neutrophil 
recruitment in the host will need to be done in the future. A reasonable place to start for 
future experiments would be analysing the bacterial genes that were commonly up or down 
regulated between the strains that persisted in murine lungs (4559 and 9474559rafR) or 
between the strains that were cleared from the lungs (947 and 4559947rafR), as these may be 




determinants of the distinct virulence phenotypes of the blood and ear isolates (section 
4.3.2), as detailed in the Chapter 4 discussion.  
As the importance of IL-17 and neutrophil recruitment on pathogen clearance was already 
described in the literature (Lindén et al., 2005; McCarthy et al., 2014; Ritchie et al., 2018; 
Stoppelenburg et al., 2013), these related findings were not significant breakthroughs in 
this Chapter. However, elucidation of the influence of RafR on global pneumococcal gene 
regulation and the impact of carbohydrate metabolism on pneumococcal virulence in 
general, were significant advances for the field. The in vivo dual RNAseq and 
accompanying analyses were additionally significant breakthroughs in pneumococcal 
research, showcasing how dual RNAseq can provide mechanistic insights into host-
pathogen interactions that have real phenotypic effects in vivo. However, the precise 
mechanisms that cause the rafR SNP to alter inflammation and neutrophil infiltration into 
the lungs 6 h post-infection is not clear. Hence, future studies should focus on elucidating 
these mechanisms by analysing pneumococcal factors that were commonly upregulated in 
the strain that persisted in the lungs or commonly upregulated in the cleared strains. 
Additionally, performing in vivo dual RNAseq in murine lungs after I.N. challenge with 
the serotype 3 ST180 blood and ear isolate pair, given that they also exhibit distinct in vivo 
phenotypes. Additionally, performing dual RNAseq on RNA extracts of infected ear tissue 
using a mouse OM model would be extremely informative, if enough bacterial RNA can 
be extracted from this niche. This would provide important information on the pathogen-
host interactions that impact the translocation and subsequent persistence of pneumococci 
in the middle ear compartment.  
Results from the genomic and transcriptomic analyses in Chapters 2, 3 and 4 highlighted 
carbohydrate uptake and metabolic genes as major differentiating factors between the 
blood and ear isolate pairs. These data support the notion that carbohydrate utilisation plays 




key roles in pneumococcal disease progression and tissue tropism, which has been 
showcased throughout the literature (Buckwalter and King, 2012; Echlin et al., 2020; 
Engholm et al., 2017; Hatcher et al., 2016; Hobbs et al., 2018; Hu et al., 2019; Kahya et 
al., 2017; Motib et al., 2019; Robb et al., 2017; Trappetti et al., 2017; Yadav et al., 2018). 
A critical role of carbohydrate utilisation on pneumococcal virulence is not surprising given 
the varied constituent nutrients in distinct host niches and the ability of pneumococci to 
utilise a vast array of carbohydrates (Bidossi et al., 2012).      
This PhD project aimed to decipher the mechanisms that allow pneumococcal strains to 
spread to specific sites in the body. Instead of looking at what invasive isolates had in 
common, and risking being overwhelmed by the genomic diversity of the species, closely 
related clonal strains that nevertheless spread to different sites in the body were analysed. 
This bypassed most of the pneumococcal genetic diversity (i.e. white noise) that has 
hindered past attempts to analyse pneumococcal virulence mechanisms. Analyses of the 
omics data detailed in this thesis highlights that strains belonging to the same serotype and 
ST can exhibit significant variability, which likely influences differential tissue tropism. 
This project highlighted the importance of raffinose regulation, and carbohydrate 
metabolism in general, for pneumococcal tissue tropism. Although not all the mechanisms 
relating to the tissue tropism of the blood and ear isolate pairs were elucidated, significant 
steps were taken in uncovering how these strains spread around the body to cause disease,  








Agarwal, V., Kuchipudi, A., Fulde, M., Riesbeck, K., Bergmann, S. and Blom, A.M. (2013). 
Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- 
and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of 
host cells. J. Biol. Chem. 288: 6849–6863. 
Agarwal, V., Sroka, M., Fulde, M., Bergmann, S., Riesbeck, K. and Blom, A.M. (2014). Binding of 
Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q 
modulates the complement attack and promotes host cell adherence. J. Biol. Chem. 289:  
15833–15844. 
Ahn, D. and Prince, A. (2017). Participation of necroptosis in the host response to acute bacterial 
pneumonia. J. Innate. Immun. 9: 262–270. 
Alexander, J.E., Berry, A.M., Paton, J.C., Rubins, J.B., Andrew, P.W. and Mitchell, T.J. (1998). 
Amino acid changes affecting the activity of pneumolysin alter the behaviour of 
pneumococci in pneumonia. Microb. Pathog. 24: 167–174. 
Ali, Y.M., Lynch, N.J., Haleem, K.S., Fujita, T., Endo, Y., Hansen, S. and Holmskov, U. (2012). The 
lectin pathway of complement activation is a critical component of the innate immune 
response to pneumococcal infection. PLoS Pathog. 8: e1002793. 
Alloing, G., Granadel, C., Morrison, D.A. and Claverys, J.P. (1996). Competence pheromone, 
oligopeptide permease, and induction of competence in Streptococcus pneumoniae. 
Mol. Microbiol. 21: 471–478. 
Alloway, J.L. (1932). The transformation in vitro of R pneumococci into S forms of different 
specific types by the use of filtered pneumococcues extracts. J. Exp. Med. 55: 91–99. 
Amin, Z., Harvey, R.M., Wang, H., Hughes, C.E., Paton, A.W., Paton, J.C. and Trappetti, C. (2015). 
Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae 
strains belonging to multilocus sequence type 15. Infect. Immun. 83: 4781–90. 
Anas, A., van der Poll, T. and de Vos, A.F. (2010). Role of CD14 in lung inflammation and 
infection. Crit. Care. 14: 209. 
Andre, G.O., Converso, T.R., Politano, W.R., Ferraz, L.F.C., Ribeiro, M.L., Leite, L.C.C. and 
Darrieux, M. (2017). Role of Streptococcus pneumoniae proteins in evasion of 
complement-mediated immunity. Front. Microbiol. 8: 224. 
André, G.O., Politano, W.R., Mirza, S., Converso, T.R., Ferraz, L.F.C., Leite, L.C.C. and Darrieux, M. 
(2015). Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae 
killing. Microb. Pathog. 89: 7–17. 
Andreassen, P.R., Trappetti, C., Minhas, V., Nielsen, F.D., Pakula, K., Paton, J.C. and Jørgensen, 
M.G. (2020). Host-glycan metabolism is regulated by a species-conserved two-
component system in Streptococcus pneumoniae. PLoS Pathog. 16: e1008332. 
Andrews, S. (2010). FastQC: A quality control tool for high throughput sequence data. Babraham 
Bioinformatics. https://doi.org/citeulike-article-id:11583827. 
Antunes, M.B. and Cohen, N.A. (2007). Mucociliary clearance--A critical upper airway host 
defense mechanism and methods of assessment. Curr. Opin. Allergy CL. 7: 5–10. 
Aprianto, R., Slager, J., Holsappel, S. and Veening, J.W. (2016). Time-resolved dual RNA-seq 
reveals extensive rewiring of lung epithelial and pneumococcal transcriptomes during 
early infection. Genome Biol. 17: 198. 
Arango Duque, G. and Descoteaux, A. (2014). Macrophage cytokines: Involvement in immunity 
and infectious diseases. Front Immunol. 5: 491. 
Asmat, T.M., Agarwal, V., Saleh, M. and Hammerschmidt, S. (2014). Endocytosis of Streptococcus 
pneumoniae via the polymeric immunoglobulin receptor of epithelial cells relies on 
clathrin and caveolin dependent mechanisms. Int. J. Med. Microbiol. 304: 1233–1246. 
Attaiech, L., Olivier, A., Mortier-Barrière, I., Soulet, A.-L., Granadel, C., Martin, B. and Polard, P. 
(2011). Role of the single-stranded DNA–binding protein SsbB in pneumococcal 





Attali, C., Durmort, C., Vernet, T. and Di Guilmi, A.M. (2008). The interaction of Streptococcus 
pneumoniae with plasmin mediates transmigration across endothelial and epithelial 
monolayers by intercellular junction cleavage. Infect. Immun. 76: 5350–5356. 
Attali, C., Frolet, C., Durmort, C., Offant, J., Vernet, T. and Di Guilmi, A.M. (2008). Streptococcus 
pneumoniae choline-binding protein E interaction with plasminogen/plasmin stimulates 
migration across the extracellular matrix. Infect. Immun. 76: 466–476. 
Australian Institute of Health and Welfare. (2018). Pneumococcal disease in Australia, Australian 
Institute of Health and Welfare, available at: 
https://www.aihw.gov.au/reports/immunisation/vaccine-preventable-
diseases/contents. 
Austrian, R. (1981). Pneumococcus: The first one hundred years. Rev. Infect. Dis.3: 183–189. 
Avery, O.T., Macleod, C.M. and McCarty, M. (1944). Studies on the chemical natures of the 
substance inducing transformation of pneumococcal types: Induction of transformation 
by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 
79:  137–58. 
Ayoubi, P., Kilic, A.O. and Vijayakumar, M.N. (1991). Tn5253, the pneumococcal omega (cat tet) 
BM6001 element, is a composite structure of two conjugative transposons, Tn5251 and 
Tn5252. J. Bacteriol. 173: 1617–1622. 
Baba, H., Kawamura, I., Kohda, C., Nomura, T., Ito, Y., Kimoto, T. and Watanabe, I. (2002). 
Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks 
pore-forming activity. Infect. Immun. 70: 107–113. 
Babb, R., Chen, A., Hirst, T.R., Kara, E.E., McColl, S.R., Ogunniyi, A.D., Paton, J.C. and Alsharifi, M. 
(2016). Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell 
vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 
responses. Clin. Sci. 130: 697–710. 
Babb, R., Chen, A., Ogunniyi, A.D., Hirst, T.R., Kara, E.E., McColl, S.R., Alsharifi, M., Paton, J.C. 
(2017). Enhanced protective responses to a serotype-independent pneumococcal 
vaccine when combined with an inactivated influenza vaccine. Clin. Sci. 131: 169–180. 
Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A.I., Martínez, C.M., Amores-Iniesta, J., Compan, V., 
Barberà-Cremades, M., et al. (2014). The NLRP3 inflammasome is released as a 
particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15: 
738–748. 
Battaglia, G. (2017). Assessing cell health: Necroptosis, Bioradiations. Available at: 
https://www.bioradiations.com/assessing-cell-health-necroptosis. 
Bayle, L., Chimalapati, S., Schoehn, G., Brown, J., Vernet, T. and Durmort, C. (2011). Zinc uptake 
by Streptococcus pneumoniae depends on both AdcA and AdcAII and is essential for 
normal bacterial morphology and virulence. Mol. Microbiol. 82: 904–916. 
Bergenfelz, C. and Hakansson, A.P. (2017). Streptococcus pneumoniae otitis media pathogenesis 
and how it informs our understanding of vaccine strategies. Curr. Otorhinolayrngol. Rep. 
5: 115–124. 
Bergmann, S. and Hammerschmidt, S. (2006). Versatility of pneumococcal surface proteins. 
Microbiol. 152: 295–303. 
Bergmann, S., Rohde, M., Chhatwal, G.S. and Hammerschmidt, S. (2001). Alpha-Enolase of 
Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial 
cell surface. Mol. Microbiol. 40: 1273–1287. 
Bergmann, S., Rohde, M. and Hammerschmidt, S. (2004). Glyceraldehyde-3-phosphate 
dehydrogenase of Streptococcus pneumoniae is a surface-displayed plasminogen-
binding protein. Infect. Immun. 72: 2416–2419. 
Berry, A.M., Alexander, J.E., Mitchell, T.J., Andrew, P.W., Hansman, D. and Paton, J.C. (1995). 
Effect of defined point mutations in the pneumolysin gene on the virulence of 
Streptococcus pneumoniae. Infect. Immun. 63: 1969–1974. 
Berry, A.M., Lock, R.A., Hansman, D. and Paton, J.C. (1989). Contribution of autolysin to 




Berry, A.M., Lock, R.A. and Paton, J.C. (1996). Cloning and characterization of nanB, a second 
Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme 
from recombinant Escherichia coli. J. Bacteriol. 178: 4854–4860. 
Berry, A.M. and Paton, J.C. (1996). Sequence heterogeneity of PsaA, a 37-kilodalton putative 
adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64: 5255–
5262. 
Berry, A.M. and Paton, J.C. (2000). Additive attenuation of virulence of Streptococcus 
pneumoniae by mutation of the genes encoding pneumolysin and other putative 
pneumococcal virulence proteins. Infect. Immun. 68: 133–140. 
Bidossi, A., Mulas, L., Decorosi, F., Colomba, L., Ricci, S., Pozzi, G., Deutscher, J., et al. (2012). A 
functional genomics approach to establish the complement of carbohydrate 
transporters in Streptococcus pneumoniae. PLoS One. 7: e33320. 
Blanchette, K.A., Shenoy, A.T., Milner, J., Gilley, R.P., McClure, E., Hinojosa, C.A., Kumar, N., et al. 
(2016). Neuraminidase A-exposed galactose promotes Streptococcus pneumoniae 
biofilm formation during colonization. Infect. Immun. 84: 2922–2932. 
Blanchette-Cain, K., Hinojosa, C.A., Babu, R.A.S., Lizcano, A., Gonzalez-Juarbe, N., Munoz-
Almagro, C., Sanchez, C.J., et al. (2013). Streptococcus pneumoniae biofilm formation is 
strain dependent, multifactorial, and associated with reduced invasiveness and 
immunoreactivity during colonization. mBio. 4: e00745-13. 
Bogaert, D., De Groot, R. and Hermans, P.W.M. (2004). Streptococcus pneumoniae colonisation: 
The key to pneumococcal disease. Lancet. Infect. Dis. 4: 144–154. 
Bogaert, D., Hermans, P.W.M., Adrian, P.V., Rümke, H.C. and de Groot, R. (2004). Pneumococcal 
vaccines: an update on current strategies. Vaccine. 22: 2209–2220. 
Bolger, A.M., Lohse, M. and Usadel, B. (2014). Trimmomatic: a flexible trimmer for Illumina 
sequence data. Bioinformatics. 30: 2114–2120. 
Briles, D.E., Ades, E., Paton, J.C., Sampson, J.S., Carlone, G.M., Huebner, R.C., Virolainen, A., et al. 
(2000). Intranasal immunization of mice with a mixture of the pneumococcal proteins 
PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus 
pneumoniae. Infect. Immun. 68: 796–800. 
Brook, I. (2013). Acute Sinusitis in Children, Pediatr. Clin. North Am. 60: 409–424. 
Brooks, L.R.K. and Mias, G.I. (2018). Streptococcus pneumoniae’s virulence and host immunity: 
aging, diagnostics, and prevention. Front. Immunol. 9: 1366. 
Brown, A.O., Mann, B., Gao, G., Hankins, J.S., Humann, J., Giardina, J., Faverio, P., et al. (2014). 
Streptococcus pneumoniae translocates into the myocardium and forms unique 
microlesions that disrupt cardiac function. PLoS Pathog. 10: e1004383. 
Brown, J.S., Gilliland, S.M., Ruiz-Albert, J. and Holden, D.W. (2002). Characterization of pit, a 
Streptococcus pneumoniae iron uptake ABC transporter. Infect. Immun. 70: 4389–4398. 
Brown, J.S., Hussell, T., Gilliland, S.M., Holden, D.W., Paton, J.C., Ehrenstein, M.R., Walport, M.J., 
et al. (2002). The classical pathway is the dominant complement pathway required for 
innate immunity to Streptococcus pneumoniae infection in mice. PNAS. 99: 16969–
16974. 
Brueggemann, A.B., Harrold, C.L., Rezaei Javan, R., van Tonder, A.J., McDonnell, A.J. and 
Edwards, B.A. (2017). Pneumococcal prophages are diverse, but not without structure or 
history. Sci. Rep. 7: 42976. 
Bruinsma, N., Kristinsson, K.G., Bronzwaer, S., Schrijnemakers, P., Degener, J., Tiemersma, E., 
Hryniewicz, W., et al. (2004). Trends of penicillin and erythromycin resistance among 
invasive Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 54: 1045–1050. 
Bryant, K.A., Block, S.L., Baker, S.A., Gruber, W.C., Scott, D.A. and PCV13 Infant Study Group. 
(2010). Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. 
Pediatrics. 125: 866–875. 
Buckwalter, C.M. and King, S.J. (2012). Pneumococcal carbohydrate transport: Food for thought. 




Burkholder, K.M., Kim, K.-P., Mishra, K.K., Medina, S., Hahm, B.-K., Kim, H. and Bhunia, A.K. 
(2009). Expression of LAP, a SecA2-dependent secretory protein, is induced under 
anaerobic environment. Microbes Infect. 11: 859–867. 
Burrus, V., Pavlovic, G., Decaris, B. and Guédon, G. (2002). Conjugative transposons: The tip of 
the iceberg. Mol. Microbiol. 46: 601–610. 
Canvin, J.R., Marvin, A.P., Sivakumaran, M., Paton, J.C., Boulnois, G.J., Andrew, P.W. and 
Mitchell, T.J. (1995). The role of pneumolysin and autolysin in the pathology of 
pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Inect. Dis. 
172: 119–123. 
Carvalho, S.M., Kloosterman, T.G., Kuipers, O.P. and Neves, A.R. (2011). CcpA ensures optimal 
metabolic fitness of Streptococcus pneumoniae. PLoS One. 6: e26707. 
Carver, T.J., Rutherford, K.M., Berriman, M., Rajandream, M.-A., Barrell, B.G. and Parkhill, J. 
(2005). ACT: the Artemis comparison tool. Bioinformatics. 21: 3422–3423. 
Chai, M.H.C. (2016). Characterisation of Streptococcus pneumoniae opacity phase variation. 
Available at: https://doi.org/10.4225/55/58dc7eaca367a. 
Chancey, S.T., Agrawal, S., Schroeder, M.R., Farley, M.M., Tettelin, H. and Stephens, D.S. (2015). 
Composite mobile genetic elements disseminating macrolide resistance in Streptococcus 
pneumoniae. Front. Microbiol. 9;6: 26. 
Chen, A., Mann, B., Gao, G., Heath, R., King, J., Maissoneuve, J., Alderson, M., et al. (2015). 
Multivalent pneumococcal protein vaccines comprising pneumolysoid with 
epitopes/fragments of CbpA and/or PspA elicit strong and broad protection. Clin. 
Vaccine Immunol. 22: 1079–1089. 
Chen, S., Paterson, G.K., Tong, H.H., Mitchell, T.J. and DeMaria, T.F. (2005). Sortase A contributes 
to pneumococcal nasopharyngeal colonization in the chinchilla model. FEMS Microbiol. 
Lett. 253: 151–154. 
Cheng, W., Li, Q., Jiang, Y.-L., Zhou, C.-Z. and Chen, Y. (2013). Structures of Streptococcus 
pneumoniae piaa and its complex with ferrichrome reveal insights into the substrate 
binding and release of high affinity iron transporters. PLoS One. 12: e71451. 
Cherazard, R., Epstein, M., Doan, T.-L., Salim, T., Bharti, S. and Smith, M.A. (2017). Antimicrobial 
resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications. 
Am. J. Ther. 24: e361–e369. 
Cho, H., Jönsson, H., Campbell, K., Melke, P., Williams, J.W., Jedynak, B., Stevens, A.M., et al. 
(2007). Self-organization in high-density bacterial colonies: efficient crowd control. PLoS 
Biol. 5: e302. 
Cillóniz, C., Ewig, S., Menéndez, R., Ferrer, M., Polverino, E., Reyes, S., Gabarrús, A., et al. (2012). 
Bacterial co-infection with H1N1 infection in patients admitted with community 
acquired pneumonia. J. Infect. 65: 223–230. 
Claverys, J.-P. and Håvarstein, L.S. (2007). Cannibalism and fratricide: Mechanisms and raisons 
d’être. Nat. Rev. Microbiol. 5: 219–229. 
Claverys, J.-P., Martin, B. and Håvarstein, L.S. (2007). Competence-induced fratricide in 
streptococci. Mol. Microbiol. 64: 1423–1433. 
Cohen, R., Bingen, E., Varon, E., Rocque, F.D.L., Brahimi, N., Levy, C., Boucherat, M., et al. (1997). 
Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from 
antibiotic therapy for acute otitis media in children. Pediatr. Infect. Dis. Journal. 16: 555–
560. 
Comis, S.D., Osborne, M.P., Stephen, J., Tarlow, M.J., Hayward, T.L., Mitchell, T.J., Andrew, P.W., 
et al. (1993). Cytotoxic effects on hair cells of guinea pig cochlea produced by 
pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Oto-Laryngol. 
113: 152–159. 
Corcoran, M., Mereckiene, J., Murchan, S., McElligott, M., ’Flanagan, D., Cotter, S., Cunney, R., et 
al. (2019). Is it time to review the vaccination strategy to protect adults against invasive 
pneumococcal disease? Ir. Med. J. 112: 894. 
Costerton, J.W., Stewart, P.S. and Greenberg, E.P. (1999). Bacterial biofilms: A common cause of 




Craig, A., Mai, J., Cai, S. and Jeyaseelan, S. (2009). Neutrophil recruitment to the lungs during 
bacterial pneumonia. Infect. Immun. 77: 568–575. 
Cremers, A.J., Zomer, A.L., Gritzfeld, J.F., Ferwerda, G., van Hijum, S.A., Ferreira, D.M., Shak, J.R., 
et al. (2014). The adult nasopharyngeal microbiome as a determinant of pneumococcal 
acquisition. Microbiome. 2: 44. 
Cron, L.E., Bootsma, H.J., Noske, N., Burghout, P., Hammerschmidt, S. and Hermans, P.W.M. 
(2009). Surface-associated lipoprotein PpmA of Streptococcus pneumoniae is involved in 
colonization in a strain-specific manner. Microbiol. 155: 2401–2410. 
Croucher, N.J., Finkelstein, J.A., Pelton, S.I., Mitchell, P.K., Lee, G.M., Parkhill, J., Bentley, S.D., et 
al. (2013). Population genomics of post-vaccine changes in pneumococcal epidemiology. 
Nature Genet. 45: 656–663. 
Croucher, N.J., Mitchell, A.M., Gould, K.A., Inverarity, D., Barquist, L., Feltwell, T., Fookes, M.C., 
et al. (2013). Dominant role of nucleotide substitution in the diversification of serotype 
3 pneumococci over decades and during a single infection. PLoS Genet. 9: e1003868. 
Croucher, N.J., Walker, D., Romero, P., Lennard, N., Paterson, G.K., Bason, N.C., Mitchell, A.M., 
et al. (2009). Role of conjugative elements in the evolution of the multidrug-resistant 
pandemic clone Streptococcus pneumoniae Spain23F st81. J. Bacteriol. 191: 1480–1489. 
Cundell, D.R., Gerard, C., Idanpaan-Heikkila, I., Tuomanen, E.I. and Gerard, N.P. (1996). PAf 
receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv.  
Exp. Med. Biol. 416: 89–94. 
Cundell, D.R., Gerard, N.P., Gerard, C., Idanpaan-Heikkila, I. and Tuomanen, E.I. (1995). 
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-
activating factor. Nature. 377: 435–438. 
Dabernat, H., Geslin, P., Megraud, F., Bégué, P., Boulesteix, J., Dubreuil, C., de La Roque, F., et al. 
(1998). Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of 
Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis 
media. J. Antimicrob. Chemother. 41: 253–258. 
Dagan, R., Leibovitz, E., Greenberg, D., Yagupsky, P., Fliss, D. and Leiberman, A. (1998). Dynamics 
of pneumococcal nasopharyngeal colonization during the first days of antibiotic 
treatment in pediatric patients. Pediatr. Infect. Dis. J. 17: 880–885. 
Dalia, A.B., Standish, A.J. and Weiser, J.N. (2010). Three surface exoglycosidases from 
Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to 
opsonophagocytic killing by human neutrophils. Infect. Immun. 78: 2108–2116. 
Dalia, A.B. and Weiser, J.N. (2011). Minimization of bacterial size allows for complement evasion 
and is overcome by the agglutinating effect of antibody. Cell Host Microbe. 10: 486–496. 
Danishyar, A. and Ashurst, J. V. (2019). Otitis, Media, Acute. StatPearls. Available from: 
https://www.ncbi.nlm.nih.gov/books/NBK470332/ 
Darling, A.C.E., Mau, B., Blattner, F.R. and Perna, N.T. (2004). Mauve: Multiple alignment of 
conserved genomic sequence with rearrangements. Genome Res. 14: 1394–1403. 
Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M.K. and McDaniel, L.S. (2004). Dual roles 
of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA 
and factor H. J. Immunol. 173: 471–477. 
David Powell, Michael Milton, Andrew Perry and Kim Santos. (2019). Drpowell/Degust 4.1.1, 
Zenod. Available at: https://doi.org/10.5281/zenodo.3501067. 
David, S.C., Laan, Z., Minhas, V., Chen, A.Y., Davies, J., Hirst, T.R., McColl, S.R., et al. (2019). 
Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant 
whole-cell inactivated pneumococcal vaccine. Immunol. Cell Biol. 97: 726–739. 
Davis, K.M., Akinbi, H.T., Standish, A.J. and Weiser, J.N. (2008). Resistance to mucosal lysozyme 
compensates for the fitness deficit of peptidoglycan modifications by Streptococcus 
pneumoniae. PLoS Pathog. 4: e1000241. 
Dawid, S., Roche, A.M. and Weiser, J.N. (2007). The blp bacteriocins of Streptococcus 





Dawid, S., Sebert, M.E. and Weiser, J.N. (2009). Bacteriocin activity of Streptococcus pneumoniae 
is controlled by the serine protease HtrA via posttranscriptional regulation. J. Bacteriol. 
191: 1509–1518. 
DeBardeleben, H.K., Lysenko, E.S., Dalia, A.B. and Weiser, J.N. (2014). Tolerance of a Phage 
Element by Streptococcus pneumoniae Leads to a Fitness Defect during Colonization. J. 
Bacteriol. 196: 2670–2680. 
Dessing, M.C., Knapp, S., Florquin, S., de Vos, A.F. and van der Poll, T. (2007). CD14 facilitates 
invasive respiratory tract infection by Streptococcus pneumoniae. Am. J. Respir. Crit. 
Care Med. 175: 604–611. 
Díaz-Batalla, L., Widholm, J.M., Fahey, George C., Castaño-Tostado, E. and Paredes-López, O. 
(2006). Chemical components with health implications in wild and cultivated mexican 
common bean seeds (Phaseolus vulgaris L.). J. Agric. Food Chem. 54: 2045–2052. 
Dintilhac, A., Alloing, G., Granadel, C. and Claverys, J.-P. (1997). Competence and virulence of 
Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn 
resulting from inactivation of putative ABC metal permeases. Mol. Microbiol. 25: 727–
739. 
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., et al. (2013). 
STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29: 15–21. 
Dockrell, D.H. and Brown, J.S. (2015). Chapter 21 - Streptococcus pneumoniae interactions with 
macrophages and mechanisms of immune evasion. Academic Press, Amsterdam. pp. 
401–422. 
Domenech, A., Slager, J. and Veening, J.-W. (2018). Antibiotic-induced cell chaining triggers 
pneumococcal competence by reshaping quorum sensing to autocrine-like signaling. Cell 
Rep. 9: 2390-2400. 
Donati, C., Hiller, N.L., Tettelin, H., Muzzi, A., Croucher, N.J., Angiuoli, S.V., Oggioni, M., et al. 
(2010). Structure and dynamics of the pan-genome of Streptococcus pneumoniae and 
closely related species. Genome Biol. 11: R107. 
Donlan, R.M. and Costerton, J.W. (2002). Biofilms: Survival mechanisms of clinically relevant 
microorganisms. Clin. Microbiol. Rev. 15: 167–193. 
D’Souza, S.E., Ginsberg, M.H. and Plow, E.F. (1991). Arginyl-glycyl-aspartic acid (RGD): A cell 
adhesion motif. Trends Biochem. Sci. 16: 246–250. 
Echlin, H., Frank, M., Rock, C. and Rosch, J.W. (2020). Role of the pyruvate metabolic network on 
carbohydrate metabolism and virulence in Streptococcus pneumoniae. Mol. Microbiol. 
Available at: https://doi.org/10.1111/mmi.14557. 
Egan, J.B. and Morse, M.L. (1966). Carbohydrate transport in Staphylococcus aureus: III. Studies 
of the transport process. Biochim. Biophys. Acta. 112: 63–73. 
Ehrlich, G.D., Hu, F.Z., Shen, K., Stoodley, P. and Post, J.C. (2005). Bacterial plurality as a general 
mechanism driving persistence in chronic infections. Clin. Orthop. Relat. Res. 437: 20–
24. 
Eisen, D.P., Dean, M.M., Boermeester, M.A., Fidler, K.J., Gordon, A.C., Kronborg, G., Kun, J.F.J., et 
al. (2008). Low serum mannose-binding lectin level increases the risk of death due to 
pneumococcal infection. Clin. Infect. Dis. 47: 510–516. 
El Moujaber, G., Osman, M., Rafei, R., Dabboussi, F. and Hamze, M. (2017). Molecular 
mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle 
East region. J. Med. Microbiol. 66: 847–858. 
Eldholm, V., Johnsborg, O., Haugen, K., Ohnstad, H.S. and Håvarstein, L.S. (2009). Fratricide in 
Streptococcus pneumoniae: Contributions and role of the cell wall hydrolases CbpD, LytA 
and LytC. Microbiol. 155: 2223–2234. 
Eldholm, V., Johnsborg, O., Straume, D., Ohnstad, H.S., Berg, K.H., Hermoso, J.A. and Håvarstein, 
L.S. (2010). Pneumococcal CbpD is a murein hydrolase that requires a dual cell envelope 
binding specificity to kill target cells during fratricide. Mol. Microbiol. 4: 905–917. 
van Emmerik, L.C., Kuijper, E.J., Fijen, C.A., Dankert, J. and Thiel, S. (1994). Binding of mannan-





Engholm, D.H., Kilian, M., Goodsell, D.S., Andersen, E.S. and Kjærgaard, R.S. (2017). A visual 
review of the human pathogen Streptococcus pneumoniae. FEMS Microbiol. Rev. 41: 
854–879. 
Enright, M.C. and Spratt, B.G. (1998). A multilocus sequence typing scheme for Streptococcus 
pneumoniae: identification of clones associated with serious invasive disease. Microbiol. 
144: 3049–3060. 
Faget, J., Boivin, G., Ancey, P.-B., Gkasti, A., Mussard, J., Engblom, C., Pfirschke, C., et al. (2018). 
Efficient and specific Ly6G+ cell depletion: A change in the current practices toward 
more relevant functional analyses of neutrophils. BioRxiv. Available at: 
https://doi.org/10.1101/498881. 
Falloon, J. and Gallin, J.I. (1986). Neutrophil granules in health and disease. J. Allergy Clin. 
Immunol. 77: 653–662. 
Fasching, C.E., Grossman, T., Corthésy, B., Plaut, A.G., Weiser, J.N. and Janoff, E.N. (2007). 
Impact of the molecular form of immunoglobulin A on functional activity in defense 
against Streptococcus pneumoniae. Infect. Immun. 75: 1801–1810. 
Ferreira, D.M., Neill, D.R., Bangert, M., Gritzfeld, J.F., Green, N., Wright, A.K.A., Pennington, S.H., 
et al. (2013). Controlled human infection and rechallenge with Streptococcus 
pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. 
Crit. Care Med. 187: 855–864. 
Fiehn, O. (2016). Metabolomics by gas chromatography-mass spectrometry: combined targeted 
and untargeted profiling. Curr. Protoc. Mol. Biol. 114: 30.4.1–30.4.32 
Fine, M.J., Smith, M.A., Carson, C.A., Meffe, F., Sankey, S.S., Weissfeld, L.A., Detsky, A.S., et al. 
(1994). Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized 
controlled trials. Ann. Intern. Med. 154: 2666–2677. 
Fleming, E., Lazinski, D.W. and Camilli, A. (2015). Carbon catabolite repression by seryl 
phosphorylated HPr is essential to Streptococcus pneumoniae in carbohydrate-rich 
environments. Mol. Microbiol. 97: 360–380. 
Forrest, J., PB, M. and MA, B. (2000). Pneumococcal disease in Australia. Commun. Dis. Intell. 24:  
89–92. 
Franchi, L., Warner, N., Viani, K. and Nuñez, G. (2009). Function of Nod-like receptors in 
microbial recognition and host defense. Immunol. Rev. 227: 106–128. 
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L. and Hancock, R.E. (2013). Bacterial biofilm 
development as a multicellular adaptation: Antibiotic resistance and new therapeutic 
strategies. Curr. Opin. Microbiol. Vol. 16 No. 5, pp. 580–589. 
Ganaie, F., Saad, J.S., McGee, L., Tonder, A.J. van, Bentley, S.D., Lo, S.W., Gladstone, R.A., et al. 
(2020). A new pneumococcal capsule type, 10D, is the 100th serotype and has a large 
CPS fragment from an oral Streptococcus. mBio. 11: e00937-20. 
Gänzle, M.G. (2015). Lactic metabolism revisited: Metabolism of lactic acid bacteria in food 
fermentations and food spoilage. Curr. Opin. Food Sci. 2: 106–117. 
García-Rodríguez, J.A. and Fresnadillo Martínez, M.J. (2002). Dynamics of nasopharyngeal 
colonization by potential respiratory pathogens. J. Antimicrob. Chemother. 50: 59–73. 
García-Suárez, M. del M., Flórez, N., Astudillo, A., Vázquez, F., Villaverde, R., Fabrizio, K., Pirofski, 
L.-A., et al. (2007). The role of pneumolysin in mediating lung damage in a lethal 
pneumococcal pneumonia murine model. Respir. Res. 8: 3. 
Gardiner, E.E. and Andrews, R.K. (2012). Neutrophil extracellular traps (NETs) and infection-
related vascular dysfunction. Blood Rev. 26: 255–259. 
Geno, K.A., Gilbert, G.L., Song, J.Y., Skovsted, I.C., Klugman, K.P., Jones, C., Konradsen, H.B., et al. 
(2015). Pneumococcal capsules and their types: Past, present, and future. Clin. 
Microbiol. Rev. 28: 871–899. 
Gentile, M.A., Melchiorre, S., Emolo, C., Moschioni, M., Gianfaldoni, C., Pancotto, L., Ferlenghi, 
I., et al. (2011). Structural and functional characterization of the Streptococcus 




Ghaffar, F., Barton, T., Lozano, J., Muniz, L.S., Hicks, P., Gan, V., Ahmad, N., et al. (2004). Effect of 
the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by 
Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis.39: 930–938. 
Giammarinaro, P. and Paton, J.C. (2002). Role of RegM, a homologue of the catabolite repressor 
protein CcpA, in the virulence of Streptococcus pneumoniae. Infect. Immun. 70: 5454–
5461. 
van Gils, E.J.M., Veenhoven, R.H., Hak, E., Rodenburg, G.D., Bogaert, D., Ijzerman, E.P.F., Bruin, 
J.P., et al. (2009). Effect of reduced-dose schedules with 7-valent pneumococcal 
conjugate vaccine on nasopharyngeal pneumococcal carriage in children: A randomized 
controlled trial. JAMA. 302: 159–167. 
van Ginkel, F.W., McGhee, J.R., Watt, J.M., Campos-Torres, A., Parish, L.A. and Briles, D.E. 
(2003). Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection, 
PNAS. 100: 14363–14367. 
Gladman, S. (2018). De novo genome assembly for illumina data - bioinformatics 
documentation. Available at: 
https://www.melbournebioinformatics.org.au/tutorials/tutorials/assembly/assembly-
protocol/. 
Gladstone, R.A., Jefferies, J.M., Tocheva, A.S., Beard, K.R., Garley, D., Chong, W.W., Bentley, S.D., 
et al. (2015). Five winters of pneumococcal serotype replacement in UK carriage 
following PCV introduction. Vaccine. 33: 2015–2021. 
Gonzalez-Juarbe, N., Bradley, K.M., Riegler, A.N., Reyes, L.F., Brissac, T., Park, S.-S., Restrepo, 
M.I., et al. (2018). Bacterial pore-forming toxins promote the activation of caspases in 
parallel to necroptosis to enhance alarmin release and inflammation during pneumonia. 
Sci. Rep. 8: 5846. 
González-Juarbe, N., Gilley, R.P., Hinojosa, C.A., Bradley, K.M., Kamei, A., Gao, G., Dube, P.H., et 
al. (2015). Pore-forming toxins induce macrophage necroptosis during acute bacterial 
pneumonia. PLoS Pathog. 11: e1005337. 
von Gottberg, A., de Gouveia, L., Tempia, S., Quan, V., Meiring, S., von Mollendorf, C., Madhi, 
S.A., et al. (2014). Effects of vaccination on invasive pneumococcal disease in South 
Africa. N. Engl. J. Med. 371: 1889–1899. 
Grabenstein, J.D. and Musey, L.K. (2014). Differences in serious clinical outcomes of infection 
caused by specific pneumococcal serotypes among adults. Vaccine. 32: 2399–2405. 
Gram, C. (1884). Ueber die isolirte Farbung der Schizomyceten, Schnitt Aund Trockenpraparaten. 
Fortschr. Med. 2: 185-189. 
Gratz, N., Loh, L.N., Mann, B., Gao, G., Carter, R., Rosch, J. and Tuomanen, E.I. (2017). 
Pneumococcal neuraminidase activates TGF-β signalling. Microbiol. 163: 1198–1207. 
Grebe, K.M., Takeda, K., Hickman, H.D., Bailey, A.L., Bailey, A.M., Embry, A.C., Bennink, J.R., et al. 
(2010). Cutting edge: Sympathetic nervous system increases proinflammatory cytokines 
and exacerbates influenza A virus pathogenesis. J. Immunol. 184: 540–544. 
Griffith, F. (1928). The significance of pneumococcal types. J. Hyg.  27: 113–59. 
Grivea, I.N., Panagiotou, M., Tsantouli, A.G. and Syrogiannopoulos, G.A. (2008). Impact of 
heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-
resistant Streptococcus pneumoniae among day-care center attendees in central 
Greece. Pediatr. Infect. Dis. Journal. 27: 519–525. 
Guiral, S., Mitchell, T.J., Martin, B. and Claverys, J.-P. (2005). Competence-programmed 
predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: 
Genetic requirements. PNAS. 102: 8710–8715. 
Gutiérrez-Fernández, J., Saleh, M., Alcorlo, M., Gómez-Mejía, A., Pantoja-Uceda, D., Treviño, 
M.A., Voß, F., et al. (2016). Modular architecture and unique teichoic acid recognition 
features of choline-binding protein l (CbpL) contributing to pneumococcal pathogenesis. 
Sci. Rep. 6: 1–19. 
Hakansson, A.P. and Bergenfelz, C. (2017). Low NF-κB activation and necroptosis in alveolar 





Hall-Stoodley, L., Costerton, J.W. and Stoodley, P. (2004). Bacterial biofilms: From the natural 
environment to infectious diseases. Nat. Rev. Microbiology. 2: 95–108. 
Hamaguchi, S., Zafar, M.A., Cammer, M. and Weiser, J.N. (2018). Capsule prolongs survival of 
Streptococcus pneumoniae during starvation. Infect. Immun. 86: e00802-17. 
Hammerschmidt, S., Tillig, M.P., Wolff, S., Vaerman, J.-P. and Chhatwal, G.S. (2000). Species-
specific binding of human secretory component to SpsA protein of Streptococcus 
pneumoniae via a hexapeptide motif. Mol. Microbiol. 36: 726–736. 
Hammerschmidt, S., Wolff, S., Hocke, A., Rosseau, S., Müller, E. and Rohde, M. (2005). 
Illustration of pneumococcal polysaccharide capsule during adherence and invasion of 
epithelial cells. Infect. Immun. 73: 4653–4667. 
Hammitt, L.L., Bruden, D.L., Butler, J.C., Baggett, H.C., Hurlburt, D.A., Reasonover, A. and 
Hennessy, T.W. (2006). Indirect effect of conjugate vaccine on adult carriage of 
Streptococcus pneumoniae: An explanation of trends in invasive pneumococcal disease. 
J. Inect. Dis. 193: 1487–1494. 
Harboe, Z.B., Thomsen, R.W., Riis, A., Valentiner-Branth, P., Christensen, J.J., Lambertsen, L., 
Krogfelt, K.A., et al. (2009). Pneumococcal serotypes and mortality following invasive 
pneumococcal disease: A population-based cohort study. PLoS Med. 6: 1000081. 
Harris, R.A. and Harper, E.T. (2015). Glycolytic pathway. ELS. 1–8: e0000619. 
Härtel, T., Klein, M., Koedel, U., Rohde, M., Petruschka, L. and Hammerschmidt, S. (2011). 
Impact of glutamine transporters on pneumococcal fitness under infection-related 
conditions. Infect. Immun. 79: 44–58. 
Harvey, R.M., Hughes, C.E., Paton, A.W., Trappetti, C., Tweten, R.K. and Paton, J.C. (2014). The 
impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is 
strain-dependent. PLoS One. 9: e103625. 
Harvey, R.M., Stroeher, U.H., Ogunniyi, A.D., Smith-Vaughan, H.C., Leach, A.J. and Paton, J.C. 
(2011). A variable region within the genome of Streptococcus pneumoniae contributes 
to strain-strain variation in virulence. PLoS One. 6: e0019650. 
Harvey, R.M., Trappetti, C., Mahdi, L.K., Wang, H., McAllister, L.J., Scalvini, A., Paton, A.W., et al. 
(2016). The variable region of pneumococcal pathogenicity island 1 is responsible for 
unusually high virulence of a serotype 1 isolate. Infect. Immun. 84: 822–832. 
Hatcher, B.L., Hale, J.Y. and Briles, D.E. (2016). Free sialic acid acts as a signal that promotes 
Streptococcus pneumoniae invasion of nasal tissue and nonhematogenous invasion of 
the central nervous system. Infect. Immun. 84: 2607–2615. 
Hava, D.L. and Camilli, A. (2002). Large-scale identification of serotype 4 Streptococcus 
pneumoniae virulence factors. Mol. Microbiol. 45: 1389–1406. 
Håvarstein, L.S., Coomaraswamy, G. and Morrison, D.A. (1995). An unmodified 
heptadecapeptide pheromone induces competence for genetic transformation in 
Streptococcus pneumoniae. PNAS. 92: 11140–11144. 
Håvarstein, L.S., Martin, B., Johnsborg, O., Granadel, C. and Claverys, J.-P. (2006). New insights 
into the pneumococcal fratricide: Rto clumping and identification of a novel immunity 
factor. Mol. Microbiol. 59: 1297–1307. 
Hawkins, T., Chitale, M. and Kihara, D. (2010). Functional enrichment analyses and construction 
of functional similarity networks with high confidence function prediction by PFP. BMC 
Bioinform. 11: 265. 
Heidelberger, M. and Avery, O.T. (1923). The soluble specific substance of pneumococcus. J. Exp. 
Med. 38: 73–9. 
Heidelberger, Michael. (1927). Immunologically Specific Polysaccharides. Chem. Rev. 3: 403–423. 
Heilmann, C. (1990). Human B and T lymphocyte responses to vaccination with pneumococcal 
polysaccharides. APMIS. 15: 1–23. 
Hendriksen, W.T., Kloosterman, T.G., Bootsma, H.J., Estevão, S., de Groot, R., Kuipers, O.P. and 
Hermans, P.W.M. (2008). Site-specific contributions of glutamine-dependent regulator 
GlnR and GlnR-regulated genes to virulence of Streptococcus pneumoniae. Infect. 




Hergott, C.B., Roche, A.M., Naidu, N.A., Mesaros, C., Blair, I.A. and Weiser, J.N. (2015). Bacterial 
exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway 
infection. J. Clin. Invest. 125:  3878–3890. 
Hermans, P.W.M., Adrian, P.V., Albert, C., Estevão, S., Hoogenboezem, T., Luijendijk, I.H.T., 
Kamphausen, T., et al. (2006). The streptococcal lipoprotein rotamase A (SlrA) is a 
functional peptidyl-prolyl isomerase involved in pneumococcal colonization. The J. Biol. 
Chem. 281: 968–976. 
Hiller, N.L., Janto, B., Hogg, J.S., Boissy, R., Yu, S., Powell, E., Keefe, R., et al. (2007). Comparative 
genomic analyses of seventeen Streptococcus pneumoniae strains: Insights into the 
pneumococcal supragenome. J. Bacteriol. 189: 8186–8195. 
Hirst, R.A., Kadioglu, A., O’Callaghan, C. and Andrew, P.W. (2004). The role of pneumolysin in 
pneumococcal pneumonia and meningitis. Clin. Exp. Immunol. 138: 195–201. 
Hiss, P.H. (1905). A contribution to the physiological differentiation of pneumococcus and 
streptococcus, and to methods of staining capsules. J. Exp. Med. 6: 317–345. 
Hobbs, J.K., Pluvinage, B. and Boraston, A.B. (2018). Glycan-metabolizing enzymes in microbe-
host interactions: The Streptococcus pneumoniae paradigm. FEBS Lett. 592: 3865–3897. 
Hoe, E., Anderson, J., Nathanielsz, J., Toh, Z.Q., Marimla, R., Balloch, A. and Licciardi, P.V. (2017). 
The contrasting roles of Th17 immunity in human health and disease. Microbiol. 
Immunol. 61: 49–56. 
Hollingshead, S.K., Becker, R. and Briles, D.E. (2000). Diversity of PspA: Mosaic genes and 
evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68: 5889–
5900. 
Hoskins, J., Alborn, W.E., Arnold, J., Blaszczak, L.C., Burgett, S., DeHoff, B.S., Estrem, S.T., et al. 
(2001). Genome of the bacterium Streptococcus pneumoniae Strain R6. J. Bacteriol. 183:  
5709–5717. 
Hosseini, S.M., Poorolajal, J., Karami, M. and Ameri, P. (2015). Prevalence of nasopharyngeal 
carriage of Streptococcus pneumoniae in Iran: A meta-analysis. J. Res. Health Sci. 15: 41–
146. 
Hsieh, Y.-C., Lin, T.-L., Lin, C.-M. and Wang, J.-T. (2015). Identification of PblB mediating 
galactose-specific adhesion in a successful Streptococcus pneumoniae clone. Sci. Rep. 5: 
12265. 
Hsu, H.E., Shutt, K.A., Moore, M.R., Beall, B.W., Bennett, N.M., Craig, A.S., Farley, M.M., et al. 
(2009). Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. 
J. Med. 360: 244–256. 
Hu, F.Z., Król, J.E., Tsai, C.H.S., Eutsey, R.A., Hiller, L.N., Sen, B., Ahmed, A., et al. (2019). Deletion 
of genes involved in the ketogluconate metabolism, Entner-Doudoroff pathway, and 
glucose dehydrogenase increase local and invasive virulence phenotypes in 
Streptococcus pneumoniae. PLoS One. 14: e0209688. 
Hyams, C., Camberlein, E., Cohen, J.M., Bax, K. and Brown, J.S. (2010). The Streptococcus 
pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by 
multiple mechanisms. Infect. Immun. 78: 704–715. 
Iannelli, F., Chiavolini, D., Ricci, S., Oggioni, M.R. and Pozzi, G. (2004). Pneumococcal surface 
protein c contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect. 
Immun. 72: 3077–3080. 
Iannelli, F., Oggioni, M.R. and Pozzi, G. (2002). Allelic variation in the highly polymorphic locus 
PspC of Streptococcus pneumoniae. Gene. 284: 63–71. 
Iovino, F., Engelen-Lee, J.-Y., Brouwer, M., van de Beek, D., van der Ende, A., Valls Seron, M., 
Mellroth, P., et al. (2017). PIgR and PECAM-1 bind to pneumococcal adhesins RrgA and 
PspC mediating bacterial brain invasion. J. Exp. Med. 214: 1619–1630. 
Iroh Tam, P.-Y., Thielen, B.K., Obaro, S.K., Brearley, A.M., Kaizer, A.M., Chu, H. and Janoff, E.N. 
(2017). Childhood pneumococcal disease in Africa – A systematic review and meta-





Iyer, R., Baliga, N.S. and Camilli, A. (2005). Catabolite control protein a (CcpA) contributes to 
virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J. Bacteriol. 
187: 8340–8349. 
Iyer, R. and Camilli, A. (2007). Sucrose metabolism contributes to in vivo fitness of Streptococcus 
pneumoniae. Mol. Microbiol. 66: 1–13. 
Jagadeesan, B., Koo, O.K., Kim, K.-P., Burkholder, K.M., Mishra, K.K., Aroonnual, A. and Bhunia, 
A.K. (2010). LAP, an alcohol acetaldehyde dehydrogenase enzyme in Listeria, promotes 
bacterial adhesion to enterocyte-like Caco-2 cells only in pathogenic species. Microbiol. 
156: 2782–2795. 
Janoff, E.N., Rubins, J.B., Fasching, C., Charboneau, D., Rahkola, J.T., Plaut, A.G. and Weiser, J.N. 
(2014). Pneumococcal IgA1 protease subverts specific protection by human IgA1. 
Mucosal Immunology. 7: 249–256. 
Janulczyk, R., Iannelli, F., Sjöholm, A.G., Pozzi, G. and Björck, L. (2000). Hic, a novel surface 
protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. 
Chem. 275: 37257–37263. 
Jechlinger, W., Szostak, M.P., Witte, A. and Lubitz, W. (1999). Altered temperature induction 
sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia 
coli. FEMS Microbiol. Lett. 173: 347–352. 
Jedrzejas, M.J., Lamani, E. and Becker, R.S. (2001). Characterization of selected strains of 
pneumococcal surface protein A. J. Biol. Chem. 276: 33121–33128. 
Jedrzejas, M.J., Mello, L.V., de Groot, B.L. and Li, S. (2002). Mechanism of hyaluronan 
degradation by Streptococcus pneumoniae hyaluronate lyase. Structures of complexes 
with the substrate. J. Biol. Chem. 277: 28287–28297. 
Jensch, I., Gámez, G., Rothe, M., Ebert, S., Fulde, M., Somplatzki, D., Bergmann, S., et al. (2010). 
PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to 
nasopharyngeal colonization and airways infections. Mol. Microbiol. 77: 22–43. 
Jeong, D.-G., Seo, J.-H., Heo, S.-H., Choi, Y.-K. and Jeong, E.-S. (2015). Tumor necrosis factor-
alpha deficiency impairs host defense against Streptococcus pneumoniae. Lab. Anim. 
Res. 31: 78–85. 
Johnsborg, O., Eldholm, V., Bjørnstad, M.L. and Håvarstein, L.S. (2008). A predatory mechanism 
dramatically increases the efficiency of lateral gene transfer in Streptococcus 
pneumoniae and related commensal species. Mol. Microbiol. 69: 245–253. 
Johnson, S.E., Dykes, J.K., Jue, D.L., Sampson, J.S., Carlone, G.M. and Ades, E.W. (2002). 
Inhibition of pneumococcal carriage in mice by subcutaneous immunization with 
peptides from the common surface protein pneumococcal surface adhesin A. J. Inect. 
Dis. 185: 489–496. 
Johnston, C., Martin, B., Fichant, G., Polard, P. and Claverys, J.-P. (2014). Bacterial 
transformation: Distribution, shared mechanisms and divergent control. Nat. Rev. 
Microbiology. 12: 181–196. 
Johnston, J.W., Myers, L.E., Ochs, M.M., Benjamin, W.H., Briles, D.E. and Hollingshead, S.K. 
(2004). Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility 
and role in protection from superoxide. Infect. Immun. 72: 5858–5867. 
Jones, R.N., Sader, H.S., Mendes, R.E. and Flamm, R.K. (2013). Update on antimicrobial 
susceptibility trends among Streptococcus pneumoniae in the United States: Report of 
ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011). 
Diag. Microbiol. Infect. Dis. 75: 107–109. 
Jounblat, R., Kadioglu, A., Mitchell, T.J. and Andrew, P.W. (2003). Pneumococcal behavior and 
host responses during bronchopneumonia are affected differently by the cytolytic and 
complement-activating activities of pneumolysin. Infect. Immun. 71: 1813–1819. 
Kadioglu, A. and Andrew, P.W. (2004). The innate immune response to pneumococcal lung 
infection: The untold story. Trends Immunol. 25: 143–149. 
Kadioglu, A., Coward, W., Colston, M.J., Hewitt, C.R.A. and Andrew, P.W. (2004). CD4-T-




protective role in the host response to pneumococcal infection. Infect. Immun. 72: 
2689–2697. 
Kadioglu, A., Weiser, J.N., Paton, J.C. and Andrew, P.W. (2008). The role of Streptococcus 
pneumoniae virulence factors in host respiratory colonization and disease. Nature Rev. 
Microbiol. 6: 288–301. 
Kahya, H.F., Andrew, P.W. and Yesilkaya, H. (2017). Deacetylation of sialic acid by esterases 
potentiates pneumococcal neuraminidase activity for mucin utilization, colonization and 
virulence. PLoS Pathog. 13: e1006263. 
Kallio, A., Sepponen, K., Hermand, P., Denoël, P., Godfroid, F. and Melin, M. (2014). Role of Pht 
proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells. 
Infect. Immun. 82: 1683–1691. 
Kandasamy, R., Voysey, M., Collins, S., Berbers, G., Robinson, H., Noel, I., Hughes, H., et al. 
(2019). Persistent circulation of vaccine serotypes and serotype replacement after five 
years of UK infant immunisation with PCV13. J. Inect. Dis. 221: 1361-1370. 
Kandler, O. (1983). Carbohydrate metabolism in lactic acid bacteria. Anton. Leeuw. Int. J. 49: 
209–224. 
Kausmally, L., Johnsborg, O., Lunde, M., Knutsen, E. and Håvarstein, L.S. (2005). Choline-binding 
protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell 
lysis. J. Bacteriol. 187: 4338–4345. 
Keller, L.E., Robinson, D.A. and McDaniel, L.S. (2016). Nonencapsulated Streptococcus 
pneumoniae: Emergence and pathogenesis. mBio. 7: e01792-15. 
Kelly, T., Dillard, J.P. and Yother, J. (1994). Effect of genetic switching of capsular type on 
virulence of Streptococcus pneumoniae. Infect. Immun. 62: 1813–1819. 
Kerr, A.R., Paterson, G.K., Riboldi-Tunnicliffe, A. and Mitchell, T.J. (2005). Innate immune 
defense against pneumococcal pneumonia requires pulmonary complement component 
C3. Infect. Immun. 73: 4245–4252. 
Kharat, A.S. and Tomasz, A. (2003). Inactivation of the SrtA gene affects localization of surface 
proteins and decreases adhesion of Streptococcus pneumoniae to human pharyngeal 
cells in vitro. Infect. Immun. 71: 2758–2765. 
Kietzman, C.C., Gao, G., Mann, B., Myers, L. and Tuomanen, E.I. (2016). Dynamic capsule 
restructuring by the main pneumococcal autolysin LytA in response to the epithelium. 
Nature Commun. 7: e10859. 
Kilian, M., Poulsen, K., Blomqvist, T., Håvarstein, L.S., Bek-Thomsen, M., Tettelin, H. and 
Sørensen, U.B.S. (2008). Evolution of Streptococcus pneumoniae and its close 
commensal relatives. PLoS One. 3: e2683. 
King, S.J. (2010). Pneumococcal modification of host sugars: A major contributor to colonization 
of the human airway? Mol. Oral Microbiol. 25: 15–24. 
King, S.J., Hippe, K.R., Gould, J.M., Bae, D., Peterson, S., Cline, R.T., Fasching, C., et al. (2004). 
Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in 
vivo and protect the airway. Mol. Microbiol. 54: 159–171. 
King, S.J., Hippe, K.R. and Weiser, J.N. (2006). Deglycosylation of human glycoconjugates by the 
sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol. 
Microbiol. 59: 961–974. 
Kirkham, L.-A.S., Jefferies, J.M.C., Kerr, A.R., Jing, Y., Clarke, S.C., Smith, A. and Mitchell, T.J. 
(2006). Identification of invasive serotype 1 pneumococcal isolates that express 
nonhemolytic pneumolysin. J. Clin. Microbiol. 44: 151–159. 
Kloosterman, T.G., Bijlsma, J.J.E., Kok, J. and Kuipers, O.P. (2006). To have neighbour’s fare: 
extending the molecular toolbox for Streptococcus pneumoniae. Microbiology. 152: 
351–359. 
Knutsen, E., Ween, O. and Håvarstein, L.S. (2004). Two separate quorum-sensing systems 
upregulate transcription of the same ABC transporter in Streptococcus pneumoniae. J. 
Bacteriol. 186: 3078–3085. 
Kolaczkowska, E. and Kubes, P. (2013). Neutrophil recruitment and function in health and 




Kono, M., Zafar, M.A., Zuniga, M., Roche, A.M., Hamaguchi, S. and Weiser, J.N. (2016). Single cell 
bottlenecks in the pathogenesis of Streptococcus pneumoniae. PLoS Pathog. 12: 
e1005887. 
Kovács, M., Halfmann, A., Fedtke, I., Heintz, M., Peschel, A., Vollmer, W., Hakenbeck, R., et al. 
(2006). A functional dlt operon, encoding proteins required for incorporation of D-
alanine in teichoic acids in Gram-positive bacteria, confers resistance to cationic 
antimicrobial peptides in Streptococcus pneumoniae. J. Bacteriol. 188: 5797–5805. 
Kraal, G., van der Laan, L.J., Elomaa, O. and Tryggvason, K. (2000). The macrophage receptor 
MARCO. Microbes Infect. 2: 313–316. 
Kumar, V., Rani, A., Goyal, L., Dixit, A.K., Manjaya, J.G., Dev, J. and Swamy, M. (2010). Sucrose 
and raffinose family oligosaccharides (RFOS) in soybean seeds as influenced by genotype 
and growing location. J. Agric. Food Chem. 58: 5081–5085. 
Lacks, S. and Hotchkiss, R.D. (1960). A study of the genetic material determining an enzyme 
activity in Pneumococcus. Biochimica et Biophysica Acta. 39: 508–518. 
Langmead, B. and Salzberg, S.L. (2012). Fast gapped-read alignment with Bowtie 2. Nature 
Methods. 9: 357–359. 
Lawrence, M.C., Pilling, P.A., Epa, V.C., Berry, A.M., Ogunniyi, A.D. and Paton, J.C. (1998). The 
crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and 
a novel structure for a putative ABC-type binding protein. Structure. 6: 1553–1561. 
Leighton, M.P., Kelly, D.J., Williamson, M.P. and Shaw, J.G. (2001). An NMR and enzyme study of 
the carbon metabolism of Neisseria meningitidis. Microbiol. 147: 1473–1482. 
LeMieux, J., Hava, D.L., Basset, A. and Camilli, A. (2006). RrgA and RrgB are components of a 
multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. 
Infect. Immun. 74: 2453–2456. 
Lewis, K. (2008). Multidrug tolerance of biofilms and persister cells. Curr. Topics Microbiol. 
Immunol. 322: 107–131. 
Li, H. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM, 
ArXiv:1303.3997 [Q-Bio], available at: http://arxiv.org/abs/1303.3997. 
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., et al. (2009). The 
sequence alignment/map format and samtools. Bioinformatics. 25: 2078–2079. 
Liao, Y., Smyth, G.K. and Shi, W. (2014). FeatureCounts: An efficient general purpose program 
for assigning sequence reads to genomic features. Bioinformatics. 30: 923–930. 
Liñares, J., Ardanuy, C., Pallares, R. and Fenoll, A. (2010). Changes in antimicrobial resistance, 
serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin. 
Microbiol. Infect. 16: 402–410. 
Lindén, A., Laan, M. and Anderson, G.P. (2005). Neutrophils, interleukin-17A and lung disease. 
Europ. Resp. J. 25: 159–172. 
Lipsitch, M., O’Neill, K., Cordy, D., Bugalter, B., Trzcinski, K., Thompson, C.M., Goldstein, R., et al. 
(2007). Strain characteristics of Streptococcus pneumoniae carriage and invasive disease 
isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal 
conjugate vaccine. J. Inect. Dis. 196: 1221–1227. 
Livak, K.J. and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time 
quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25: 402–408. 
Lobley, R.W., Burrows, P.C., Warwick, R., Dawson, D.J. and Holmes, R. (1990). Simultaneous 
assessment of intestinal permeability and lactose tolerance with orally administered 
raffinose, lactose and L-arabinose. Clin. Sci. 79: 175–83. 
Lock, R.A., Zhang, Q.Y., Berry, A.M. and Paton, J.C. (1996). Sequence variation in the 
Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and 
electrophoretic mobility of the toxin. Microb. Pathog. 21: 71–83. 
Loeffler, J.M. and Fischetti, V.A. (2006). Lysogeny of Streptococcus pneumoniae with Mm1 
phage: Improved adherence and other phenotypic changes. Infect. Immun. 74: 4486–
4495. 
López, R., García, E., García, P. and García, J.L. (1997). The pneumococcal cell wall degrading 




Loughran, A.J., Orihuela, C.J. and Tuomanen, E.I. (2019). Streptococcus pneumoniae: Invasion 
and inflammation. Microbiol. Spect. 7: e30004. 
Love, M.I., Huber, W. and Anders, S. (2014). Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2. Genome Biol. 15: 550. 
Lu, L., Lamm, M.E., Li, H., Corthesy, B. and Zhang, J.-R. (2003). The human polymeric 
immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J. 
Biol. Chem. 278: 48178–48187. 
Lu, L., Ma, Y. and Zhang, J.-R. (2006). Streptococcus pneumoniae Recruits Complement Factor H 
through the Amino Terminus of CbpA. J. Biol. Chem. 281: 15464–15474. 
Lu, Y.-J., Leite, L., Gonçalves, V.M., Dias, W. de O., Liberman, C., Fratelli, F., Alderson, M., et al. 
(2010). GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects 
mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine. 28: 7468–
7475. 
Luna-Muschi, A., Castillo-Tokumori, F., Deza, M.P., Mercado, E.H., Egoavil, M., Sedano, K., 
Castillo, M.E., et al. (2019). Invasive pneumococcal disease in hospitalised children from 
Lima, Peru before and after introduction of the 7-valent conjugated vaccine. Epidemiol.  
Infect. 147: e91. 
Luong, T.T., Kim, E.-H., Bak, J.P., Nguyen, C.T., Choi, S., Briles, D.E., Pyo, S., et al. (2015). Ethanol-
induced alcohol dehydrogenase A (AdhE) potentiates pneumolysin in Streptococcus 
pneumoniae. Infect. Immun. 83: 108–119. 
Lynch, J.P. and Zhanel, G.G. (2009). Streptococcus pneumoniae: Does antimicrobial resistance 
matter? Semin. Res. Crit. Care Med. 30: 210–238. 
Lynch, J.P. and Zhanel, G.G. (2010). Streptococcus pneumoniae: Epidemiology and risk factors, 
evolution of antimicrobial resistance, and impact of vaccines. Curr. Opin. Pulmon. Med. 
16: 1. 
Lysbo Svendsen, T., Rasmussen, S., Nielsen, P.E., Hartling, O. and Trap-Jensen, J. (1979). 
Hemodynamic effects of acute and long-term treatment with labetalol. Acta Medica 
Scandin. 625: 49–53. 
Lysenko, E.S., Clarke, T.B., Shchepetov, M., Ratner, A.J., Roper, D.I., Dowson, C.G. and Weiser, 
J.N. (2007). Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic 
killing. PLoS Pathog. 3: e118. 
Macfadyen, L.P., Dorocicz, I.R., Reizer, J., Saier, M.H. and Redfield, R.J. (1996). Regulation of 
competence development and sugar utilization in Haemophilus influenzae Rd by a 
phosphoenolpyruvate:fructose phosphotransferase system. Mol. Microbiol. 21: 941–
952. 
MacLeod, C.M. and Krauss, M.R. (1950). Relation of virulence of penumococcal strains for mice 
to the quantity of capsular polysachharide formed in vitro. J. Exp. Med. 92: 1–9. 
Madeddu, G., Laura Fiori, M. and Stella Mura, M. (2010). Bacterial community-acquired 
pneumonia in HIV-infected patients. Curr. Opin. Pulmon. Med. 16: 201–7. 
Mahdi, L.K., Higgins, M.A., Day, C.J., Tiralongo, J., Hartley-Tassell, L.E., Jennings, M.P., Gordon, 
D.L., et al. (2017). The pneumococcal alpha-glycerophosphate oxidase enhances 
nasopharyngeal colonization through binding to host glycoconjugates, EBioMedicine. 18: 
236–243. 
Mahdi, L.K., Ogunniyi, A.D., LeMessurier, K.S. and Paton, J.C. (2008). Pneumococcal virulence 
gene expression and host cytokine profiles during pathogenesis of invasive disease. 
Infect. Immun. 76: 646–657. 
Mahdi, L.K., Wang, H., Van der Hoek, M.B., Paton, J.C. and Ogunniyi, A.D. (2012). Identification 
of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in 
mice. J. Clin. Invest. 122: 2208–2220. 
Majcherczyk, P.A., Langen, H., Heumann, D., Fountoulakis, M., Glauser, M.P. and Moreillon, P. 
(1999). Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan 
hydrolase releases branched stem peptides carrying proinflammatory activity. J. Biol. 




Malley, R., Henneke, P., Morse, S.C., Cieslewicz, M.J., Lipsitch, M., Thompson, C.M., Kurt-Jones, 
E., et al. (2003). Recognition of pneumolysin by Toll-like receptor 4 confers resistance to 
pneumococcal infection. PNAS. 100: 1966–1971. 
Malley, R., Lipsitch, M., Stack, A., Saladino, R., Fleisher, G., Pelton, S., Thompson, C., et al. (2001). 
Intranasal immunization with killed unencapsulated whole cells prevents colonization 
and invasive disease by capsulated pneumococci. Infect. Immun. 69: 4870–4873. 
Malley, R., Trzcinski, K., Srivastava, A., Thompson, C.M., Anderson, P.W. and Lipsitch, M. (2005). 
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal 
colonization. PNAS. 102: 4848–4853. 
Mamishi, S., Moradkhani, S., Mahmoudi, S., Hosseinpour - Sadeghi, R. and Pourakbari, B. (2014). 
Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review. 
Iran. J. Microbiol. 6: 198–210. 
Manco, S., Hernon, F., Yesilkaya, H., Paton, J.C., Andrew, P.W. and Kadioglu, A. (2006). 
Pneumococcal neuraminidases A and B both have essential roles during infection of the 
respiratory tract and sepsis. Infect. Immun. 74: 4014–4020. 
Mandigers, C.M., Diepersloot, R.J., Dessens, M., Mol, S.J. and Klingeren, B. van. (1994). A 
hospital outbreak of penicillin-resistant pneumococci in The Netherlands. Europ. Resp. J. 
7: 1635–1639. 
Mann, B., Orihuela, C., Antikainen, J., Gao, G., Sublett, J., Korhonen, T.K. and Tuomanen, E. 
(2006). Multifunctional role of choline binding protein G in pneumococcal pathogenesis. 
Infect. Immun. 74: 821–829. 
Manso, A.S., Chai, M.H., Atack, J.M., Furi, L., De Ste Croix, M., Haigh, R., Trappetti, C., et al. 
(2014). A random six-phase switch regulates pneumococcal virulence via global 
epigenetic changes. Nature Commun. 5: 1–9. 
Marion, C., Aten, A.E., Woodiga, S.A. and King, S.J. (2011). Identification of an ATPase, MsmK, 
which energizes multiple carbohydrate ABC transporters in Streptococcus pneumoniae. 
Infect. Immun. 79: 4193–4200. 
Marion, C., Stewart, J.M., Tazi, M.F., Burnaugh, A.M., Linke, C.M., Woodiga, S.A. and King, S.J. 
(2012). Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for 
growth. Infect. Immun. 80: 1390–1398. 
Marks, L.R., Davidson, B.A., Knight, P.R. and Hakansson, A.P. (2013). Interkingdom signaling 
induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic 
colonization to disease. mBio. 4: e00438-13. 
Marks, L.R., Reddinger, R.M. and Hakansson, A.P. (2012). High levels of genetic recombination 
during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae. 
mBio. 3: e00200-12. 
Marks, L.R., Reddinger, R.M. and Hakansson, A.P. (2014). Biofilm formation enhances fomite 
survival of Streptococcus pneumoniae and Streptococcus pyogenes. Infect. Immun. 82: 
1141–1146. 
Marra, A., Lawson, S., Asundi, J.S., Brigham, D. and Hromockyj, A.E. (2002). In vivo 
characterization of the psa genes from Streptococcus pneumoniae in multiple models of 
infection. Microbiology. 148: 1483–1491. 
Martin, B., Garcia, P., Castanié, M.P., Glise, B. and Claverys, J.P. (1995). The recA gene of 
Streptococcus pneumoniae is part of a competence-induced operon and controls an SOS 
regulon. Develop. Biol. Standard. 85: 293–300. 
Martin, B., Soulet, A.-L., Mirouze, N., Prudhomme, M., Mortier-Barrière, I., Granadel, C., Noirot-
Gros, M.-F., et al. (2013). ComE/ComE~P interplay dictates activation or extinction 
status of pneumococcal X-state (competence). Mol. Microbiol. 87: 394–411. 
Martner, A., Skovbjerg, S., Paton, J.C. and Wold, A.E. (2009). Streptococcus pneumoniae autolysis 
prevents phagocytosis and production of phagocyte-activating cytokines. Infect. Immun.  
77: 3826–3837. 
McAllister, L.J., Ogunniyi, A.D., Stroeher, U.H., Leach, A.J. and Paton, J.C. (2011). Contribution of 
serotype and genetic background to virulence of serotype 3 and serogroup 11 




McAllister, L.J., Tseng, H.-J., Ogunniyi, A.D., Jennings, M.P., McEwan, A.G. and Paton, J.C. (2004). 
Molecular analysis of the Psa permease complex of Streptococcus pneumoniae. Mol. 
Microbiol. 53: 889–901. 
McCarthy, M.K., Zhu, L., Procario, M.C. and Weinberg, J.B. (2014). IL-17 contributes to 
neutrophil recruitment but not to control of viral replication during acute mouse 
adenovirus type 1 respiratory infection. Virology. 456–457: 259–267. 
McCool, T.L., Cate, T.R., Moy, G. and Weiser, J.N. (2002). The immune response to 
pneumococcal proteins during experimental human carriage. J. Exp. Med. 195: 359–365. 
McKessar, S.J. and Hakenbeck, R. (2007). The two-component regulatory system TCS08 is 
involved in cellobiose metabolism of Streptococcus pneumoniae R6. J. Bacteriol. 189: 
1342–1350. 
McMillin, J.M. (1990). Blood glucose, in Walker, H.K., Hall, W.D. and Hurst, J.W. (Eds.). Clinical 
Methods: The History, Physical, and Laboratory Examinations, 3rd ed. Butterworths, 
Boston. Available at: http://www.ncbi.nlm.nih.gov/books/NBK248/. 
McNeela, E.A., Burke, A., Neill, D.R., Baxter, C., Fernandes, V.E., Ferreira, D., Smeaton, S., et al. 
(2010). Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory 
cytokines independently of TLR4. PLoS Pathog. 6: e1001191. 
Mell, J.C. and Redfield, R.J. (2014). Natural competence and the evolution of DNA uptake 
specificity. J. Bacteriol. 196: 1471–1483. 
Mellroth, P., Daniels, R., Eberhardt, A., Rönnlund, D., Blom, H., Widengren, J., Normark, S., et al. 
(2012). LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent 
peptidoglycan. The J. Biol. Chem. 287: 11018–11029. 
Minhas, V., Aprianto, R., McAllister, L.J., Wang, H., David, S.C., McLean, K.T., Comerford, I., et al. 
(2020). In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential 
tissue tropism of Streptococcus pneumoniae. Commun. Biol. 3: 1–12. 
Minhas, V., Harvey, R.M., McAllister, L.J., Seemann, T., Syme, A.E., Baines, S.L., Paton, J.C., et al. 
(2019). Capacity to utilize raffinose dictates pneumococcal disease phenotype. mBio. 10: 
e02596-18. 
Mitchell, A.J., Yau, B., McQuillan, J.A., Ball, H.J., Too, L.K., Abtin, A., Hertzog, P., et al. (2012). 
Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae 
meningitis. J. Immunol. 189: 4970–4980. 
Mitchell, T.J., Andrew, P.W., Saunders, F.K., Smith, A.N. and Boulnois, G.J. (1991). Complement 
activation and antibody binding by pneumolysin via a region of the toxin homologous to 
a human acute-phase protein. Mol. Microbiol. 5: 1883–1888. 
Mitchell, T.J. and Dalziel, C.E. (2014). The biology of pneumolysin. Subcell. Biochem. 80: 145–
160. 
Mitchell, T.J., Mendez, F., Paton, J.C., Andrew, P.W. and Boulnois, G.J. (1990). Comparison of 
pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2. Nucleic 
Acids Res. 18: 4010. 
Moffitt, K. and Malley, R. (2016). Rationale and prospects for novel pneumococcal vaccines. 
Hum. Vaccin. Immunother. 12: 383–392. 
Mook-Kanamori, B.B., Geldhoff, M., van der Poll, T. and van de Beek, D. (2011). Pathogenesis 
and pathophysiology of pneumococcal meningitis. Clin. Microbiol. Rev. 24: 557–591. 
Morens, D.M., Taubenberger, J.K. and Fauci, A.S. (2008). Predominant role of bacterial 
pneumonia as a cause of death in pandemic influenza: Implications for pandemic 
influenza preparedness. J. Inect. Dis. 198: 962–970. 
Morona, J.K., Paton, J.C., Miller, D.C. and Morona, R. (2000). Tyrosine phosphorylation of CpsD 
negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. 
Mol. Microbiol. 35: 1431–1442. 
Moscoso, M., García, E. and López, R. (2006). Biofilm formation by Streptococcus pneumoniae: 
Role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J. 




Mosser, J.L. and Tomasz, A. (1970). Choline-containing teichoic acid as a structural component 
of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J. 
Biol. Chem. 245: 287–298. 
Mostowy, R.J., Croucher, N.J., De Maio, N., Chewapreecha, C., Salter, S.J., Turner, P., Aanensen, 
D.M., et al. (2017). Pneumococcal capsule synthesis locus CPS as evolutionary hotspot 
with potential to generate novel serotypes by recombination. Mol. Biol. Evol. 34: 2537–
2554. 
Motib, A.S., Al-Bayati, F.A.Y., Manzoor, I., Shafeeq, S., Kadam, A., Kuipers, O.P., Hiller, N.L., et al. 
(2019). TprA/PhrA quorum sensing system has a major effect on pneumococcal survival 
in respiratory tract and blood, and its activity is controlled by CcpA and GlnR. Front. Cell. 
Infect. Microbiol. 9: 326. 
Mukerji, R., Mirza, S., Roche, A.M., Widener, R.W., Croney, C.M., Rhee, D.-K., Weiser, J.N., et al. 
(2012). Pneumococcal surface protein A inhibits complement deposition on the 
pneumococcal surface by competing with the binding of C-reactive protein to cell-
surface phosphocholine. J. Immunol. 189: 5327–5335. 
Muramatsu, H., Tachikui, H., Ushida, H., Song, X., Qiu, Y., Yamamoto, S. and Muramatsu, T. 
(2001). Molecular cloning and expression of endo-beta-N-acetylglucosaminidase D, 
which acts on the core structure of complex type asparagine-linked oligosaccharides. J. 
Biochem. 129: 923–928. 
Murphy, K. and Weaver, C. (2017). Chapter 02- innate immunity: The first lines of defense. 
Janeway’s Immunobiology. Available at: 
https://www.vitalsource.com/products/chapter-02-innate-immunity-the-first-lines-of-
kenneth-murphy-casey-weaver-v9781315533247ch02. 
Murray, P.J. (2009). Beyond peptidoglycan for Nod2. Nat. Immunol. 10: 1053–1054. 
Musher, D.M. (2003). How contagious are common respiratory tract infections? The N. Engl. J. 
Med. 348: 1256–1266. 
Nagasawa, R., Sato, T. and Senpuku, H. (2017). Raffinose induces biofilm formation by 
Streptococcus mutans in low concentrations of sucrose by increasing production of 
extracellular DNA and fructan. Appl. Environ. Microbiol. 83: e00869-17. 
Nakamura, S., Davis, K.M. and Weiser, J.N. (2011). Synergistic stimulation of type I interferons 
during influenza virus coinfection promotes Streptococcus pneumoniae colonization in 
mice. J. Clin. Invest. 121: 3657–3665. 
Nawrocki, K.L., Crispell, E.K. and McBride, S.M. (2014). Antimicrobial peptide resistance 
mechanisms of Gram-positive bacteria. Antibiotics. 3: 461–492. 
Nelson, A.L., Ries, J., Bagnoli, F., Dahlberg, S., Fälker, S., Rounioja, S., Tschöp, J., et al. (2007). 
RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol. Microbiol. 66: 
329–340. 
Nelson, A.L., Roche, A.M., Gould, J.M., Chim, K., Ratner, A.J. and Weiser, J.N. (2007). Capsule 
enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. 
Immun. 75: 83–90. 
Neufeld, F. (1902). Ueber die Agglutination der Pneumokokken und über die Theorieen der 
Agglutination. Zeitschrift Für Hygiene Und Infektionskrankheiten. 40: 54–72. 
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., et al. 
(2011). Active starvation responses mediate antibiotic tolerance in biofilms and 
nutrient-limited bacteria. Science. 334: 982–986. 
Note de L. Pasteur. (1881). Maison de Louis Pasteur à Arbois - Publications de Louis Pasteur dans 
les Comptes rendus. Comptes Rendus de l’Académie Des Sciences de Paris. 92: 159. 
Novick, R.P., Christie, G.E. and Penadés, J.R. (2010). The phage-related chromosomal islands of 
Gram-positive bacteria. Nature Rev. Microbiol. 8: 541–551. 
Numminen, E., Chewapreecha, C., Turner, C., Goldblatt, D., Nosten, F., Bentley, S.D., Turner, P., 
et al. (2015). Climate induces seasonality in pneumococcal transmission. Sci. Rep. 5: 
11344. 
Obert, C., Sublett, J., Kaushal, D., Hinojosa, E., Barton, T., Tuomanen, E.I. and Orihuela, C.J. 




regions of diversity correlated with invasive pneumococcal disease. Infect. Immun. 74: 
4766–4777. 
O’Brien, D.P., Briles, D.E., Szalai, A.J., Tu, A.-H., Sanz, I. and Nahm, M.H. (1999). Tumor necrosis 
factor alpha receptor I is important for survival from Streptococcus pneumoniae 
infections. Infect. Immun. 67: 595–601. 
Oggioni, M.R., Memmi, G., Maggi, T., Chiavolini, D., Iannelli, F. and Pozzi, G. (2003). 
Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 
and is a virulence factor in experimental pneumonia. Mol. Microbiol. 49: 795–805. 
Oggioni, M.R., Trappetti, C., Kadioglu, A., Cassone, M., Iannelli, F., Ricci, S., Andrew, P.W., et al. 
(2006). Switch from planktonic to sessile life: A major event in pneumococcal 
pathogenesis. Mol. Microbiol. 61: 1196–1210. 
Ogunniyi, A.D., Giammarinaro, P. and Paton, J.C. (2002). The genes encoding virulence-
associated proteins and the capsule of Streptococcus pneumoniae are upregulated and 
differentially expressed in vivo. Microbiology. 148: 2045–2053. 
Ogunniyi, A.D., Mahdi, L.K., Trappetti, C., Verhoeven, N., Mermans, D., Van der Hoek, M.B., 
Plumptre, C.D., et al. (2012). Identification of genes that contribute to the pathogenesis 
of invasive pneumococcal disease by in vivo transcriptomic analysis. Infect. Immun. 80: 
3268–3278. 
Olafsdottir, T.A., Lingnau, K., Nagy, E. and Jonsdottir, I. (2012). Novel protein-based 
pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce 
protective immunity against pneumococcal disease in neonatal mice. Infect. Immun. 80: 
461–468. 
Onishi, R.M. and Gaffen, S.L. (2010). Interleukin-17 and its target genes: Mechanisms of 
interleukin-17 function in disease. Immunology. 129: 311–321. 
Organization, W.H. (1998). Prevention of hearing impairment from chronic otitis media. Report 
of a WHO/CIBA foundation workshop, London, November 12–21, 1996, available at: 
https://apps.who.int/iris/handle/10665/63870. 
Orihuela, C.J., Gao, G., Francis, K.P., Yu, J. and Tuomanen, E.I. (2004). Tissue-specific 
contributions of pneumococcal virulence factors to pathogenesis. J. Inect. Dis. 190: 
1661–1669. 
Orihuela, C.J., Mahdavi, J., Thornton, J., Mann, B., Wooldridge, K.G., Abouseada, N., Oldfield, 
N.J., et al. (2009). Laminin receptor initiates bacterial contact with the blood brain 
barrier in experimental meningitis models. J. Clin. Invest. 119: 1638–1646. 
Orihuela, C.J., Radin, J.N., Sublett, J.E., Gao, G., Kaushal, D. and Tuomanen, E.I. (2004). 
Microarray analysis of pneumococcal gene expression during invasive disease. Infect. 
Immun. 72: 5582–5596. 
Owen, C.D., Lukacik, P., Potter, J.A., Sleator, O., Taylor, G.L. and Walsh, M.A. (2015). 
Streptococcus pneumoniae NanC structural infishts into the specificity and mechanism 
of a sialidase that produces a sialidase inhibitor. J. Biol. Chem.  290: 27736–27748. 
Paixão, L., Caldas, J., Kloosterman, T.G., Kuipers, O.P., Vinga, S. and Neves, A.R. (2015). 
Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar 
metabolism. Front. Microbiol. 6: 1041. 
Parker, D., Soong, G., Planet, P., Brower, J., Ratner, A.J. and Prince, A. (2009). The NanA 
neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect. 
Immun. 77: 3722–3730. 
Paterson, G.K. and Mitchell, T.J. (2006a). Innate immunity and the pneumococcus. Microbiol. 
152: 285–293. 
Paterson, G.K. and Mitchell, T.J. (2006b). The role of Streptococcus pneumoniae sortase A in 
colonisation and pathogenesis. Microbes Infect. 8: 145–153. 
Paton, J.C., Rowan-Kelly, B. and Ferrante, A. (1984). Activation of human complement by the 
pneumococcal toxin pneumolysin. Infect. Immun. 43: 1085–1087. 
Paton, J.C. and Trappetti, C. (2019). Streptococcus pneumoniae capsular polysaccharide. 




Peñaloza, H.F., Nieto, P.A., Muñoz‐Durango, N., Salazar‐Echegarai, F.J., Torres, J., Parga, M.J., 
Alvarez‐Lobos, M., et al. (2015). Interleukin-10 plays a key role in the modulation of 
neutrophils recruitment and lung inflammation during infection by Streptococcus 
pneumoniae. Immunology. 146: 100–112. 
Pepys, M.B. (1998). Acute phase proteins, in Delves, P.J. (Ed.). Encyclopedia of Immunology 
(Second Edition). Elsevier, Oxford, pp. 18–20. 
Pessoa, D., Hoti, F., Syrjänen, R.K., Sá-Leão, R., Kaijalainen, T.H., Gomes, M.G.M. and Auranen, K. 
(2013). Comparative analysis of Streptococcus pneumoniae transmission in Portuguese 
and Finnish day-care centres. BMC Infect. Dis. 13: 180. 
Peterson, S.N., Sung, C.K., Cline, R., Desai, B.V., Snesrud, E.C., Luo, P., Walling, J., et al. (2004). 
Identification of competence pheromone responsive genes in Streptococcus 
pneumoniae by use of DNA microarrays. Mol. Microbiol. 51: 1051–1070. 
Pettigrew, M.M., Fennie, K.P., York, M.P., Daniels, J. and Ghaffar, F. (2006). Variation in the 
presence of neuraminidase genes among Streptococcus pneumoniae isolates with 
identical sequence types. Infect. Immun. 74: 3360–3365. 
Philips, B.J., Meguer, J.-X., Redman, J. and Baker, E.H. (2003). Factors determining the 
appearance of glucose in upper and lower respiratory tract secretions. Intensive Care 
Med. 29: 2204–2210. 
Pichichero, M.E. (2017). Pneumococcal whole-cell and protein-based vaccines: Changing the 
paradigm. Expert Rev. Vaccines. 16: 1181–1190. 
Plumptre, C.D., Hughes, C.E., Harvey, R.M., Eijkelkamp, B.A., McDevitt, C.A. and Paton, J.C. 
(2014). Overlapping functionality of the Pht proteins in zinc homeostasis of 
Streptococcus pneumoniae. Infect. Immun. 82: 4315–4324. 
Polissi, A., Pontiggia, A., Feger, G., Altieri, M., Mottl, H., Ferrari, L. and Simon, D. (1998). Large-
scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 
66: 5620–5629. 
van der Poll, T., Keogh, C.V., Buurman, W.A. and Lowry, S.F. (1997). Passive immunization 
against tumor necrosis factor-alpha impairs host defense during pneumococcal 
pneumonia in mice. Am. J. Respir. Crit. Care Med. 155: 603–608. 
van der Poll, T. and Opal, S.M. (2009). Pathogenesis, treatment, and prevention of 
pneumococcal pneumonia. Lancet. 374: 1543–1556. 
Pracht, D., Elm, C., Gerber, J., Bergmann, S., Rohde, M., Seiler, M., Kim, K.S., et al. (2005). PavA 
of Streptococcus pneumoniae modulates adherence, invasion, and meningeal 
inflammation. Infect. Immun. 73: 2680–2689. 
Prager, O., Friedman, A. and Nebenzahl, Y.M. (2017). Role of neural barriers in the pathogenesis 
and outcome of Streptococcus pneumoniae meningitis (Review). Exp. Ther. Med. 13: 
799–809. 
Price, C.E., Zeyniyev, A., Kuipers, O.P. and Kok, J. (2012). From meadows to milk to mucosa - 
Adaptation of Streptococcus and Lactococcus species to their nutritional environments. 
FEMS Microbiol. Rev. 36: 949–971. 
Prudhomme, M., Attaiech, L., Sanchez, G., Martin, B. and Claverys, J.-P. (2006). Antibiotic stress 
induces genetic transformability in the human pathogen Streptococcus pneumoniae. 
Science. 313: 89–92. 
Prudhomme, M., Libante, V. and Claverys, J.-P. (2002). Homologous recombination at the 
border: Insertion-deletions and the trapping of foreign DNA in Streptococcus 
pneumoniae. PNAS. 99: 2100–2105. 
Quail, M.A., Smith, M., Coupland, P., Otto, T.D., Harris, S.R., Connor, T.R., Bertoni, A., et al. 
(2012). A tale of three next generation sequencing platforms: Comparison of Ion 
Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 13: 341. 
Quin, L.R., Carmicle, S., Dave, S., Pangburn, M.K., Evenhuis, J.P. and McDaniel, L.S. (2005). In vivo 
binding of complement regulator factor H by Streptococcus pneumoniae. J. Inect. Dis. 
192: 1996–2003. 
Quinlan, A.R. and Hall, I.M. (2010). BEDTools: A flexible suite of utilities for comparing genomic 




Rabes, A., Suttorp, N. and Opitz, B. (2016). Inflammasomes in pneumococcal infection: Innate 
immune sensing and bacterial evasion strategies. Current Topics Microbiol. Immunol. 
397: 215–227. 
Rahman, A.H., Taylor, D.K. and Turka, L.A. (2009). The contribution of direct TLR signaling to T 
cell responses. Immunologic Res. 45: 25–36. 
Ramirez, M., Severina, E. and Tomasz, A. (1999). A high incidence of prophage carriage among 
natural isolates of Streptococcus pneumoniae. J. Bacteriol. 181: 3618–3625. 
Ramos-Sevillano, E., Ercoli, G. and Brown, J.S. (2019). Mechanisms of naturally acquired 
immunity to Streptococcus pneumoniae. Front. Immunol. 10: 358. 
Rayner, C.F., Jackson, A.D., Rutman, A., Dewar, A., Mitchell, T.J., Andrew, P.W., Cole, P.J., et al. 
(1995). Interaction of pneumolysin-sufficient and -deficient isogenic variants of 
Streptococcus pneumoniae with human respiratory mucosa. Infect. Immun. 63: 442–447. 
Regev-Yochay, G., Raz, M., Dagan, R., Porat, N., Shainberg, B., Pinco, E., Keller, N., et al. (2004). 
Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in 
community and family settings. Clin. Infect. Dis. 38: 632–639. 
Regev-Yochay, G., Trzcinski, K., Thompson, C.M., Lipsitch, M. and Malley, R. (2007). SpxB is a 
suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in 
vivo competitive colonization model. J. Bacteriol. 189: 6532–6539. 
Richard, A.L., Siegel, S.J., Erikson, J. and Weiser, J.N. (2014). TLR2 signaling decreases 
transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant 
mouse Influenza A co-infection model. PLoS Pathog. 10: e1004339. 
Richards, L., Ferreira, D.M., Miyaji, E.N., Andrew, P.W. and Kadioglu, A. (2010). The immunising 
effect of pneumococcal nasopharyngeal colonisation; protection against future 
colonisation and fatal invasive disease. Immunobiology. 215: 251–263. 
Riegler, A.N., Brissac, T., Gonzalez-Juarbe, N. and Orihuela, C.J. (2019). Necroptotic cell death 
promotes adaptive immunity against colonizing pneumococci. Front. Immunol. 10: 
00615. 
Riley, I.D., Tarr, P.I., Andrews, M., Pfeiffer, M., Howard, R., Challands, P. and Jennison, G. (1977). 
Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory 
mortality in a new Guinea highlands community. Lancet. 1: 1338–1341. 
Ritchie, N.D., Ritchie, R., Bayes, H.K., Mitchell, T.J. and Evans, T.J. (2018). IL-17 can be protective 
or deleterious in murine pneumococcal pneumonia. PLoS Pathog. 14: e1007099. 
Robb, M., Hobbs, J.K., Woodiga, S.A., Shapiro-Ward, S., Suits, M.D.L., McGregor, N., Brumer, H., 
et al. (2017). Molecular characterization of N-glycan degradation and transport in 
Streptococcus pneumoniae and its contribution to virulence. PLoS Pathog. 13: e1006090. 
Roche, A.M., Richard, A.L., Rahkola, J.T., Janoff, E.N. and Weiser, J.N. (2015). Antibody blocks 
acquisition of bacterial colonization through agglutination. Mucosal Immunol. 8: 176–
185. 
Rodrigues, F., Foster, D., Nicoli, E., Trotter, C., Vipond, B., Muir, P., Gonçalves, G., et al. (2013). 
Relationships between rhinitis symptoms, respiratory viral infections and 
nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae 
and Staphylococcus aureus in children attending daycare. Pediatr. Infect. Dis. Journal. 
32: 227–232. 
Romagnani, S. (1999). Th1/Th2 cells. Inflamm. Bowel Dis. 5: 285–294. 
Rose, M.C. and Voynow, J.A. (2006). Respiratory tract mucin genes and mucin glycoproteins in 
health and disease. Physiol. Rev. 86: 245–278. 
Rosenow, C., Maniar, M. and Trias, J. (1999). Regulation of the alpha-galactosidase activity in 
Streptococcus pneumoniae: Characterization of the raffinose utilization system. Genome 
Res. 9: 1189–1197. 
Rosenow, C., Ryan, P., Weiser, J.N., Johnson, S., Fontan, P., Ortqvist, A. and Masure, H.R. (1997). 
Contribution of novel choline-binding proteins to adherence, colonization and 
immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25: 819–829. 
Rubins, J.B., Charboneau, D., Fasching, C., Berry, A.M., Paton, J.C., Alexander, J.E., Andrew, P.W., 




pathogenesis of pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 153: 1339–
1346. 
Rubins, J.B. and Pomeroy, C. (1997). Role of gamma interferon in the pathogenesis of 
bacteremic pneumococcal pneumonia. Infect. Immun. 65: 2975–2977. 
Ruoslahti, E. and Pierschbacher, M.D. (1986). Arg-Gly-Asp: A versatile cell recognition signal. Cell.  
44: 517–518. 
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M.-A. and Barrell, B. 
(2000). Artemis: Sequence visualization and annotation. Bioinformatics.16: 944–945. 
de Saizieu, A., Gardès, C., Flint, N., Wagner, C., Kamber, M., Mitchell, T.J., Keck, W., et al. (2000). 
Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled 
by an autoinduced peptide. J. Bacteriol. 182: 4696–4703. 
Saleh, M., Bartual, S.G., Abdullah, M.R., Jensch, I., Asmat, T.M., Petruschka, L., Pribyl, T., et al. 
(2013). Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold 
lipoproteins crucial for extracellular oxidative stress resistance and maintenance of 
virulence. EMBO Mol. Med. 5: 1852–1870. 
Sanchez, C.J., Kumar, N., Lizcano, A., Shivshankar, P., Hotopp, J.C.D., Jorgensen, J.H., Tettelin, H., 
et al. (2011). Streptococcus pneumoniae in biofilms are unable to cause invasive disease 
due to altered virulence determinant production. PLoS One. 6: e28738. 
Santoro, F., Iannelli, F. and Pozzi, G. (2019). Genomics and genetics of Streptococcus 
pneumoniae. Microbiol. Spect. 7: 0025. 
Seo, H.S., Michalek, S.M. and Nahm, M.H. (2008). Lipoteichoic acid is important in innate 
immune responses to gram-positive bacteria. Infect. Immun. 76: 206–213. 
Shafeeq, S., Kloosterman, T.G. and Kuipers, O.P. (2011). CelR-mediated activation of the 
cellobiose-utilization gene cluster in Streptococcus pneumoniae. Microbiol. 157: 2854–
2861. 
Shaik, M.M., Maccagni, A., Tourcier, G., Di Guilmi, A.M. and Dessen, A. (2014). Structural basis of 
pilus anchoring by the ancillary pilin RrgC of Streptococcus pneumoniae. The J. Biol. 
Chem. 289: 16988–16997. 
Shak, J.R., Vidal, J.E. and Klugman, K.P. (2013). Influence of bacterial interactions on 
pneumococcal colonization of the nasopharynx. Trends in Microbiol. 21: 129–135. 
Shakhnovich, E.A., King, S.J. and Weiser, J.N. (2002). Neuraminidase expressed by Streptococcus 
pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and 
Haemophilus influenzae: A paradigm for interbacterial competition among pathogens of 
the human respiratory tract. Infect. Immun. 70: 7161–7164. 
Shanker, E. and Federle, M.J. (2017). Quorum sensing regulation of competence and 
bacteriocins in Streptococcus pneumoniae and mutans. Genes. 8: 10015. 
Shaper, M., Hollingshead, S.K., Benjamin, W.H. and Briles, D.E. (2004). PspA protects 
Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA 
enhances killing of pneumococci by apolactoferrin. Infect. Immun. 72: 5031–5040. 
Shapiro, E.D., Berg, A.T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R.K., et al. 
(1991). The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. 
Engl. J. Med. 325: 1453–1460. 
Shelburne, S.A., Davenport, M.T., Keith, D.B. and Musser, J.M. (2008). The role of complex 
carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol. 
16: 318–325. 
Shiri, T., Nunes, M.C., Adrian, P.V., Van Niekerk, N., Klugman, K.P. and Madhi, S.A. (2013). 
Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and 
Staphylococcus aureus colonization within and between pneumococcal-vaccine naïve 
mother-child dyads. BMC Infect. Dis. 13: 483. 
Shivshankar, P., Sanchez, C., Rose, L.F. and Orihuela, C.J. (2009). The Streptococcus pneumoniae 
adhesin PsrP binds to Keratin 10 on lung cells. Mol. Microbiol. 73: 663–679. 
Shlomovitz, I., Zargarian, S., Erlich, Z., Edry-Botzer, L. and Gerlic, M. (2018). Distinguishing 




Sibold, C., Markiewicz, Z., Latorre, C. and Hakenbeck, R. (1991). Novel plasmids in clinical strains 
of Streptococcus pneumoniae. FEMS Microbiol. Lett. 77: 91–95. 
Silva, N.A., McCluskey, J., Jefferies, J.M.C., Hinds, J., Smith, A., Clarke, S.C., Mitchell, T.J., et al. 
(2006). Genomic diversity between strains of the same serotype and multilocus 
sequence type among pneumococcal clinical isolates. Infect. Immun. 74: 3513–3518. 
Singh, A.K., Pluvinage, B., Higgins, M.A., Dalia, A.B., Woodiga, S.A., Flynn, M., Lloyd, A.R., et al. 
(2014). Unravelling the multiple functions of the architecturally intricate Streptococcus 
pneumoniae β-galactosidase, BgaA. PLoS Pathog. 10: e1004364. 
Singleton, R.J., Hennessy, T.W., Bulkow, L.R., Hammitt, L.L., Zulz, T., Hurlburt, D.A., Butler, J.C., et 
al. (2007). Invasive pneumococcal disease caused by nonvaccine serotypes among 
Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine 
coverage. JAMA. 297: 1784–1792. 
Sitkiewicz, I. (2018). How to become a killer, or is it all accidental? Virulence strategies in oral 
streptococci. Mol. Oral Microbiol. 33: 1–12. 
Skov Sørensen, U.B., Blom, J., Birch-Andersen, A. and Henrichsen, J. (1988). Ultrastructural 
localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in 
pneumococci. Infect. Immun. 56: 1890–1896. 
Smith, M.D. and Guild, W.R. (1979). A plasmid in Streptococcus pneumoniae. J. Bacteriol. 137: 
735–739. 
Sørensen, U.B.S., Henrichsen, J., Chen, H.-C. and Szu, S.C. (1990). Covalent linkage between the 
capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae 
revealed by immunochemical methods. Microb. Pathog. 8: 325–334. 
Sprent, J. (1994). T and B memory cells. Cell. 76: 315–322. 
Srivastava, A., Henneke, P., Visintin, A., Morse, S.C., Martin, V., Watkins, C., Paton, J.C., et al. 
(2005). The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and 
protects against pneumococcal disease. Infect. Immun. 73: 6479–6487. 
Stahl, W.L. and O’Toole, R.D. (1972). Pneumococcal neuraminidase: Purification and properties. 
Biochimica Et Biophysica Acta. 268: 480–487. 
Standish, A.J. and Weiser, J.N. (2009). Human neutrophils kill Streptococcus pneumoniae via 
serine proteases. J. Immunol. 183: 2602–2609. 
Stanek, R.J., Norton, N.B. and Mufson, M.A. (2016). A 32-year study of the effect of 
pneumococcal vaccines on invasive Streptococcus pneumoniae disease. Am. J.Med. Sci. 
352: 563–573. 
Steinmoen, H., Knutsen, E. and Håvarstein, L.S. (2002). Induction of natural competence in 
Streptococcus pneumoniae triggers lysis and DNA release from a subfraction of the cell 
population. PNAS. 99: 7681–7686. 
Sternberg, G. (1881). A Fatal Form of Septicaemia in the Rabbit Produced by the Subcutaneous 
Injection of Human Saliva: An Experimental Research. Printed by John Murphy & Co., 
Baltimore. 
Stevens, K.E., Chang, D., Zwack, E.E. and Sebert, M.E. (2011). Competence in Streptococcus 
pneumoniae is regulated by the rate of ribosomal decoding errors. mBio. 2: e00071-11. 
Stoppelenburg, A.J., Salimi, V., Hennus, M., Plantinga, M., Veld, R.H. in ’t, Walk, J., Meerding, J., 
et al. (2013). Local IL-17A potentiates early neutrophil recruitment to the respiratory 
tract during severe RSV infection. PLoS One. 8: e78461. 
Stroeher, U.H., Paton, A.W., Ogunniyi, A.D. and Paton, J.C. (2003). Mutation of luxS of 
Streptococcus pneumoniae affects virulence in a mouse model. Infect. Immun. 71: 3206–
3212. 
Sung, C.K., Li, H., Claverys, J.P. and Morrison, D.A. (2001). An rpsl cassette, janus, for gene 
replacement through negative selection in Streptococcus pneumoniae. Appl. Environ. 
Microbiol. 67: 5190–5196. 
Swiatlo, E., Champlin, F.R., Holman, S.C., Wilson, W.W. and Watt, J.M. (2002). Contribution of 
choline-binding proteins to cell surface properties of Streptococcus pneumoniae. Infect. 




Talbot, U.M., Paton, A.W. and Paton, J.C. (1996). Uptake of Streptococcus pneumoniae by 
respiratory epithelial cells. Infect. Immun. 64: 3772–3777. 
Taylor, P.S., Faeth, I., Marks, M.K., Del Mar, C.B., Skull, S.A., Pezzullo, M.L., Havyatt, S.M., et al. 
(2009). Cost of treating otitis media in Australia. Exp. Rev. Pharmacoeconomics 
Outcomes Res. 9: 133–141. 
Tettelin, H., Nelson, K.E., Paulsen, I.T., Eisen, J.A., Read, T.D., Peterson, S., Heidelberg, J., et al. 
(2001). Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. 
Science. 293: 498–506. 
Tomlinson, G., Chimalapati, S., Pollard, T., Lapp, T., Cohen, J., Camberlein, E., Stafford, S., et al. 
(2014). TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly 
dependent on surface expression of bacterial lipoproteins. J. Immunol. 193: 3736–3745. 
Tonder, A.J. van, Bray, J.E., Jolley, K.A., Quirk, S.J., Haraldsson, G., Maiden, M.C., Bentley, S.D., et 
al. (2017). Heterogeneity among estimates of the core genome and pan-genome in 
different pneumococcal populations. BioRxiv. Available at: 
https://www.biorxiv.org/content/10.1101/133991v1. 
Tong, H.H., Blue, L.E., James, M.A. and DeMaria, T.F. (2000). Evaluation of the virulence of a 
Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal 
colonization and development of otitis media in the chinchilla model. Infect. Immun. 68: 
921–924. 
Trappetti, C., Kadioglu, A., Carter, M., Hayre, J., Iannelli, F., Pozzi, G., Andrew, P.W., et al. (2009). 
Sialic acid: A preventable signal for pneumococcal biofilm formation, colonization, and 
invasion of the host. J. Inect. Dis. 199: 1497–1505. 
Trappetti, C., Maten, E. van der, Amin, Z., Potter, A.J., Chen, A.Y., Mourik, P.M. van, Lawrence, 
A.J., et al. (2013). Site of isolation determines biofilm formation and virulence 
phenotypes of Streptococcus pneumoniae serotype 3 clinical isolates. Infect. Immun. 81:  
505–513. 
Trappetti, C., McAllister, L.J., Chen, A., Wang, H., Paton, A.W., Oggioni, M.R., McDevitt, C.A., et 
al. (2017). Autoinducer 2 signaling via the phosphotransferase frua drives galactose 
utilization by Streptococcus pneumoniae, resulting in hypervirulence. mBio. 8: e02269. 
Trappetti, C., Ogunniyi, A.D., Oggioni, M.R. and Paton, J.C. (2011). Extracellular matrix formation 
enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS One. 
6: e19844. 
Tseng, H.-J., McEwan, A.G., Paton, J.C. and Jennings, M.P. (2002). Virulence of Streptococcus 
pneumoniae: PsaA mutants are hypersensitive to oxidative stress. Infect. Immun. 70: 
1635–1639. 
Tu, A.H., Fulgham, R.L., McCrory, M.A., Briles, D.E. and Szalai, A.J. (1999). Pneumococcal surface 
protein A inhibits complement activation by Streptococcus pneumoniae. Infect. Immun. 
67: 4720–4724. 
Tuomanen, E.I. (2000). Pathogenesis of pneumococcal inflammation: Otitis media. Vaccine. 19:  
S38-40. 
Tyx, R.E., Roche-Hakansson, H. and Hakansson, A.P. (2011). Role of dihydrolipoamide 
dehydrogenase in regulation of raffinose transport in Streptococcus pneumoniae. J. 
Bacteriol. 193: 3512–3524. 
Verhagen, L.M., de Jonge, M.I., Burghout, P., Schraa, K., Spagnuolo, L., Mennens, S., Eleveld, 
M.J., et al. (2014). Genome-wide identification of genes essential for the survival of 
Streptococcus pneumoniae in human saliva. PLoS One. 9: e89541. 
de Vries, S.P.W., van Hijum, S.A.F.T., Schueler, W., Riesbeck, K., Hays, J.P., Hermans, P.W.M. and 
Bootsma, H.J. (2010). Genome analysis of Moraxella catarrhalis strain BBH18, 
[corrected] a human respiratory tract pathogen. J. Bacteriol. 192: 3574–3583. 
Waggoner, S.N., Daniels, K.A. and Welsh, R.M. (2014). Therapeutic depletion of natural killer 
cells controls persistent infection. J. Virology. 88: 1953–1960. 
Walker, C.L.F., Rudan, I., Liu, L., Nair, H., Theodoratou, E., Bhutta, Z.A., O’Brien, K.L., et al. (2013). 




Walker, J.R.L. (1992). Spectrophotometric determination of enzyme activity: Alcohol 
dehydrogenase (ADH). Biochemical Edu. 20: 42–43. 
Walsh, R.L. and Camilli, A. (2011). Streptococcus pneumoniae is desiccation tolerant and 
infectious upon rehydration. mBio. 2: e00092-00011. 
Wang, B.-Y. and Kuramitsu, H.K. (2005). Interactions between oral bacteria: Inhibition of 
Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl. Environ. 
Microbiol. 71: 354–362. 
Wang, L., Fu, J., Liang, Z. and Chen, J. (2017). Prevalence and serotype distribution of 
nasopharyngeal carriage of Streptococcus pneumoniae in China: A meta-analysis. BMC 
Infect. Dis. 17: 765. 
Watson, D.A., Musher, D.M., Jacobson, J.W. and Verhoef, J. (1993). A brief history of the 
pneumococcus in biomedical research: A panoply of scientific discovery. Clin. Infect. Dis.  
17: 913–24. 
Weber, S.E., Tian, H. and Pirofski, L. (2011). CD8+ cells enhance resistance to pulmonary 
serotype 3 Streptococcus pneumoniae infection in mice. J. Immunol. 186: 432–442. 
Weimer, K.E.D., Armbruster, C.E., Juneau, R.A., Hong, W., Pang, B. and Swords, W.E. (2010). 
Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation 
during experimental otitis media and impedes the progression of pneumococcal disease. 
J. Inect. Dis. 202: 1068–1075. 
Weinberger, D.M., Harboe, Z.B., Sanders, E.A.M., Ndiritu, M., Klugman, K.P., Rückinger, S., 
Dagan, R., et al. (2010). Association of serotype with risk of death due to pneumococcal 
pneumonia: A meta-analysis. Clin. Infect. Dis.51: 692–699. 
Weiser, J.N. (2010). The pneumococcus: Why a commensal misbehaves. J. Mol. Med.  88: 97–
102. 
Weiser, J.N., Ferreira, D.M. and Paton, J.C. (2018). Streptococcus pneumoniae: Transmission, 
colonization and invasion. Nature Rev. Microbiol. 16: 355–367. 
Wellmer, A., Gerber, J., Ragheb, J., Zysk, G., Kunst, T., Smirnov, A., Brück, W., et al. (2001). Effect 
of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus 
pneumoniae central nervous system infection and peritonitis. Infect. Immun. 69: 6881–
6886. 
Westermann, A.J., Barquist, L. and Vogel, J. (2017). Resolving host-pathogen interactions by dual 
RNA-seq. PLoS Pathog. 13: e1006033. 
Whalan, R.H., Funnell, S.G.P., Bowler, L.D., Hudson, M.J., Robinson, A. and Dowson, C.G. (2005). 
PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype 
independent antibody responses following human pneumococcal septicaemia. FEMS 
Immunol.Med. Microbiol. 43: 73–80. 
Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R., Reingold, A., et 
al. (2003). Decline in invasive pneumococcal disease after the introduction of protein-
polysaccharide conjugate vaccine. N. Engl. J. Med. 348: 1737–1746. 
Whitsett, J.A. and Alenghat, T. (2015). Respiratory epithelial cells orchestrate pulmonary innate 
immunity. Nat. Immunol. 16: 27–35. 
WHO | Pneumococcal disease. (2014). WHO, World Health Organization. 
Wholey, W.-Y., Kochan, T.J., Storck, D.N. and Dawid, S. (2016). Coordinated bacteriocin 
expression and competence in Streptococcus pneumoniae contributes to genetic 
adaptation through neighbor predation. PLoS Pathog. 12: e1005413. 
Wilson, R., Cohen, J.M., Reglinski, M., Jose, R.J., Chan, W.Y., Marshall, H., Vogel, C. de, et al. 
(2017). Naturally acquired human immunity to pneumococcus is dependent on antibody 
to protein antigens. PLoS Pathog. 13: e1006137. 
Winter, A.J., Comis, S.D., Osborne, M.P., Tarlow, M.J., Stephen, J., Andrew, P.W., Hill, J., et al. 
(1997). A role for pneumolysin but not neuraminidase in the hearing loss and cochlear 
damage induced by experimental pneumococcal meningitis in guinea pigs. Infect. 
Immun. 65: 4411–4418. 
Winzer, K., Hardie, K.R. and Williams, P. (2003). LuxS and autoinducer-2: their contribution to 




Witzenrath, M., Pache, F., Lorenz, D., Koppe, U., Gutbier, B., Tabeling, C., Reppe, K., et al. (2011). 
The NLRP3 inflammasome is differentially activated by pneumolysin variants and 
contributes to host defense in pneumococcal pneumonia. J. Immunol. 187: 434–440. 
Wolf, T., Kämmer, P., Brunke, S. and Linde, J. (2018). Two’s company: Studying interspecies 
relationships with dual RNA-seq., Curr. Opin. Microbiol. 42: 7–12. 
Wren, J.T., Blevins, L.K., Pang, B., Roy, A.B., Oliver, M.B., Reimche, J.L., Wozniak, J.E., et al. 
(2017). Pneumococcal neuraminidase A (nanA) promotes biofilm formation and 
synergizes with influenza A virus in nasal colonization and middle ear infection. Infect. 
Immun. 85: e01044-16. 
Xu, Q. and Pichichero, M.E. (2014). Co-colonization by Haemophilus influenzae with 
Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young 
children. Vaccine. 32: 706–711. 
Xu, R.-R., Yang, W.-D., Niu, K.-X., Wang, B. and Wang, W.-M. (2018). An update on the evolution 
of glucosyltransferase (gtf) genes in Streptococcus. Front. Microbiol. 9: e02979. 
Yadav, M.K., Vidal, J.E., Go, Y.Y., Kim, S.H., Chae, S.-W. and Song, J.-J. (2018). The LuxS/AI-2 
quorum-sensing system of Streptococcus pneumoniae is required to cause disease, and 
to regulate virulence- and metabolism-related genes in a rat model of middle ear 
infection. Front. Cell. Infect. Microbiol. 8: e00138. 
Yamamoto, N., Kawakami, K., Kinjo, Y., Miyagi, K., Kinjo, T., Uezu, K., Nakasone, C., et al. (2004). 
Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host 
defense against pulmonary infection with Streptococcus pneumoniae: involvement of 
interferon-gamma. Microbes Infect. 6: 1241–1249. 
Yesilkaya, H., Kadioglu, A., Gingles, N., Alexander, J.E., Mitchell, T.J. and Andrew, P.W. (2000). 
Role of manganese-containing superoxide dismutase in oxidative stress and virulence of 
Streptococcus pneumoniae. Infect. Immun. 68: 2819–2826. 
Yesilkaya, H., Spissu, F., Carvalho, S.M., Terra, V.S., Homer, K.A., Benisty, R., Porat, N., et al. 
(2009). Pyruvate formate lyase is required for pneumococcal fermentative metabolism 
and virulence. Infect. Immun. 77: 5418–5427. 
Yu, Y.-R.A., O’Koren, E.G., Hotten, D.F., Kan, M.J., Kopin, D., Nelson, E.R., Que, L., et al. (2016). A 
protocol for the comprehensive flow cytometric analysis of immune cells in normal and 
inflamed murine non-lymphoid tissues. PLoS One. 11: e0150606. 
Yun, K.W., Lee, H., Choi, E.H. and Lee, H.J. (2015). Diversity of pneumolysin and pneumococcal 
histidine triad protein D of Streptococcus pneumoniae isolated from invasive diseases in 
korean children. PLoS One. 10: e0134055. 
Yuste, J., Botto, M., Paton, J.C., Holden, D.W. and Brown, J.S. (2005). Additive inhibition of 
complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae 
septicemia. J. Immunol. 175: 1813–1819. 
Zafar, M.A., Wang, Y., Hamaguchi, S. and Weiser, J.N. (2017). Host-to-host transmission of 
Streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin. Cell Host 
Microbe. 21: 73–83. 
Zhanel, G.G., Wolter, K.D., Calciu, C., Hogan, P., Low, D.E., Weiss, K. and Karlowsky, J.A. (2014). 
Clinical cure rates in subjects treated with azithromycin for community-acquired 
respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant 
Streptococcus pneumoniae: Analysis of Phase 3 clinical trial data. J. Antimicrob. 
Chemother. 69: 2835–2840. 
Zhang, J.R., Mostov, K.E., Lamm, M.E., Nanno, M., Shimida, S., Ohwaki, M. and Tuomanen, E. 
(2000). The polymeric immunoglobulin receptor translocates pneumococci across 
human nasopharyngeal epithelial cells. Cell. 102: 827–837. 
Zimmermann, N., McBride, M.L., Yamada, Y., Hudson, S.A., Jones, C., Cromie, K.D., Crocker, P.R., 
et al. (2008). Siglec-F antibody administration to mice selectively reduces blood and 







Appendix A. Phenotype Microarray of 4559, Biolog PM1 plate. Catabolism was measured through 
the reduction of a colourless tetrazolium dye by NADH, produced during catabolic activity. A590 






Acid Succinic Acid D-Galactose 
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Acid L-Serine L-Threonine L-Alanine 
L-Alanyl-
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Acid Tyramine D-Psicose L-Lyxose 
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L-Aspartic 
Acid L-Proline D-Alanine D-Trehalose D-Mannose Dulcitol 
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Glycerol-
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Appendix B. Phenotype Microarray of 947, Biolog PM1 plate. Catabolism was measured through 
the reduction of a colourless tetrazolium dye by NADH, produced during catabolic activity. A590 
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Glyoxylic 
Acid D-Cellobiose Inosine 









Pyruvate D-Malic Acid L-Malic Acid 





















































Appendix C. Phenotype Microarray of 4559947rafR, Biolog PM1 plate. Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 






Acid Succinic Acid D-Galactose 
0.472 0.856 1.504 0.47 0.545 1.719 












Acid D-Ribose Tween 20 L-Rhamnose 








Propanediol Tween 40 
α-Keto-
Glutaric Acid 












0.444 0.442 0.523 0.576 0.647 0.51 
Glycyl-L-
Aspartic Acid Citric Acid M-Inositol D-Threonine Fumaric Acid 
Bromo 
Succinic Acid 





Acid L-Serine L-Threonine L-Alanine 
L-Alanyl-
Glycine 








Acid Tyramine D-Psicose L-Lyxose 
0.454 0.381 0.39 0.416 1.356 1.092 
L-Aspartic 
Acid L-Proline D-Alanine D-Trehalose DMannose Dulcitol 
0.499 0.492 0.51 1.634 1.612 0.611 
D,L-α-
Glycerol-
Phosphate D-Xylose L-Lactic Acid Formic Acid D-Mannitol 
L-Glutamic 
Acid 
0.573 0.978 0.946 0.557 0.784 0.493 
D-Fructose Acetic Acid α-D-Glucose Maltose D-Melibiose Thymidine 




Galactoside α-D-Lactose Lactulose Sucrose Uridine 




Glucoside Adonitol Maltotriose 
2-Deoxy 
Adenosine Adenosine 
0.494 1.339 0.54 1.577 0.546 0.778 
Propionic 
Acid Mucic Acid Glycolic Acid 
Glyoxylic 
Acid D-Cellobiose Inosine 









Pyruvate D-Malic Acid L-Malic Acid 





















































Appendix D. Phenotype Microarray of 9474559rafR, Biolog PM1 plate. Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 






Acid Succinic Acid D-Galactose 
0.488 0.748 1.094 0.443 0.457 1.262 












Acid D-Ribose Tween 20 L-Rhamnose 








Propanediol Tween 40 
α-Keto-
Glutaric Acid 












0.386 0.341 0.529 0.568 0.751 0.392 
Glycyl-L-
Aspartic Acid Citric Acid M-Inositol D-Threonine Fumaric Acid 
Bromo 
Succinic Acid 





Acid L-Serine L-Threonine L-Alanine 
L-Alanyl-
Glycine 








Acid Tyramine D-Psicose L-Lyxose 
0.428 0.195 0.217 0.258 0.733 1.067 
L-Aspartic 
Acid L-Proline D-Alanine D-Trehalose DMannose Dulcitol 
0.426 0.434 0.462 1.218 1.247 0.519 
D,L-α-
Glycerol-
Phosphate D-Xylose L-Lactic Acid Formic Acid D-Mannitol 
L-Glutamic 
Acid 
0.478 0.984 0.814 0.484 0.6 0.565 
D-Fructose Acetic Acid α-D-Glucose Maltose D-Melibiose Thymidine 




Galactoside α-D-Lactose Lactulose Sucrose Uridine 




Glucoside Adonitol Maltotriose 
2-Deoxy 
Adenosine Adenosine 
0.45 0.975 0.526 1.353 0.45 0.682 
Propionic 
Acid Mucic Acid Glycolic Acid 
Glyoxylic 
Acid D-Cellobiose Inosine 









Pyruvate D-Malic Acid L-Malic Acid 






















































Appendix E. Phenotype Microarray of 4559, Biolog PM2 plate. Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 
activity. A590 values above 0.65 were considered positive (see section 2.2.4). Values for raffinose 

















Acid β-D-Allose Amygdalin D-Arabinose  D-Arabitol 
1.134 0.669 0.664 0.669 0.841 0.515 
Gentiobiose L-Glucose Lactitol D-Melezitose Maltitol 
α-Methyl-D-
Glucoside 
0.679 0.595 0.825 0.658 0.613 0.741 
D-Raffinose Salicin  
Sedoheptulos
an L-Sorbose Stachyose D-Tagatose 
1.618 0.919 0.553 0.684 1.627 0.978 









0.404 0.681 0.429 0.547 1.458 0.368 
D-Lactic Acid 
Methyl Ester Malonic Acid 
Melibionic 
Acid Oxalic Acid 
Oxalomalic 
Acid Quinic Acid 






Acid L-Arginine Glycine L-Histidine 






Acid L-Valine D,L-Carnitine 
Sec-
Butylamine 
0.547 0.622 0.591 0.555 0.541 0.682 
Gelatin Glycogen  Inulin Laminarin Mannan  Pectin 
0.587 0.582 1.31 0.527 0.367 0.47 
L-Arabitol Arbutin 
2-Deoxy-D-

























Valeric Acid Butyric Acid 








Valeric Acid Itaconic Acid 
5-Keto-D-
Gluconic Acid 
0.42 0.54 0.518 0.39 0.526 0.841 
D-Ribono-1,4- 











Proline L-Isoleucine L-Leucine L-Lysine L-Methionine 



















































Appendix F. Phenotype Microarray of 947, Biolog PM2 plate. Catabolism was measured through 
the reduction of a colourless tetrazolium dye by NADH, produced during catabolic activity. A590 
values above 0.65 were considered positive (see section 2.2.4). Values for raffinose are 

















Acid β-D-Allose Amygdalin D-Arabinose  D-Arabitol 
1.121 0.981 0.796 0.736 0.969 0.624 
Gentiobiose L-Glucose Lactitol D-Melezitose Maltitol 
α-Methyl-D-
Glucoside 
0.801 0.67 0.881 0.679 0.735 0.897 
D-Raffinose Salicin  
Sedoheptulos
an L-Sorbose Stachyose D-Tagatose 
0.427 1.001 0.649 0.69 1.444 1.01 









0.381 0.677 0.495 0.651 1.358 0.424 
D-Lactic Acid 
Methyl Ester Malonic Acid 
Melibionic 
Acid Oxalic Acid 
Oxalomalic 
Acid Quinic Acid 






Acid L-Arginine Glycine L-Histidine 






Acid L-Valine D,L-Carnitine 
Sec-
Butylamine 
0.565 0.609 0.718 0.599 0.636 0.764 
Gelatin Glycogen  Inulin Laminarin Mannan  Pectin 
0.697 0.669 1.152 0.597 0.386 0.528 
L-Arabitol Arbutin 
2-Deoxy-D-

























Valeric Acid Butyric Acid 








Valeric Acid Itaconic Acid 
5-Keto-D-
Gluconic Acid 
0.463 0.605 0.573 0.433 0.59 0.957 
D-Ribono-1,4- 











Proline L-Isoleucine L-Leucine L-Lysine L-Methionine 



















































Appendix G. Phenotype Microarray of 4559947rafR, Biolog PM2 plate. Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 
activity. A590 values above 0.65 were considered positive (see section 2.2.4). Values for raffinose 

















Acid β-D-Allose Amygdalin D-Arabinose  D-Arabitol 
0.887 1.177 0.323 0.395 0.572 0.296 
Gentiobiose L-Glucose Lactitol D-Melezitose Maltitol 
α-Methyl-D-
Glucoside 
0.395 0.314 0.612 0.31 0.37 0.477 
D-Raffinose Salicin  
Sedoheptulos
an L-Sorbose Stachyose D-Tagatose 
0.469 0.683 0.316 0.33 0.383 0.7 









0.106 0.349 0.198 0.24 1.038 0.6 
D-Lactic Acid 
Methyl Ester Malonic Acid 
Melibionic 
Acid Oxalic Acid 
Oxalomalic 
Acid Quinic Acid 






Acid L-Arginine Glycine L-Histidine 






Acid L-Valine D,L-Carnitine 
Sec-
Butylamine 
0.237 0.281 0.304 0.277 0.266 0.427 
Gelatin Glycogen  Inulin Laminarin Mannan  Pectin 
0.329 0.343 0.871 0.304 0.173 0.262 
L-Arabitol Arbutin 
2-Deoxy-D-

























Valeric Acid Butyric Acid 








Valeric Acid Itaconic Acid 
5-Keto-D-
Gluconic Acid 
0.166 0.282 0.293 0.171 0.318 0.585 
D-Ribono-1,4- 











Proline L-Isoleucine L-Leucine L-Lysine L-Methionine 



















































Appendix H. Phenotype Microarray of 9474559rafR, Biolog PM2 plate. Catabolism was measured 
through the reduction of a colourless tetrazolium dye by NADH, produced during catabolic 
activity. A590 values above 0.65 were considered positive (see section 2.2.4). Values for raffinose 

















Acid β-D-Allose Amygdalin D-Arabinose  D-Arabitol 
1.351 0.89 0.593 0.72 0.868 0.56 
Gentiobiose L-Glucose Lactitol D-Melezitose Maltitol 
α-Methyl-D-
Glucoside 
0.776 0.602 0.933 0.596 0.695 0.84 
D-Raffinose Salicin  
Sedoheptulos
an L-Sorbose Stachyose D-Tagatose 
1.454 1.113 0.615 0.593 1.489 0.966 









0.417 0.653 0.493 0.575 1.451 0.442 
D-Lactic Acid 
Methyl Ester Malonic Acid 
Melibionic 
Acid Oxalic Acid 
Oxalomalic 
Acid Quinic Acid 






Acid L-Arginine Glycine L-Histidine 






Acid L-Valine D,L-Carnitine 
Sec-
Butylamine 
0.547 0.557 0.631 0.553 0.579 0.695 
Gelatin Glycogen  Inulin Laminarin Mannan  Pectin 
0.638 0.587 1.12 0.588 0.397 0.533 
L-Arabitol Arbutin 
2-Deoxy-D-

























Valeric Acid Butyric Acid 








Valeric Acid Itaconic Acid 
5-Keto-D-
Gluconic Acid 
0.431 0.522 0.283 0.431 0.584 0.796 
D-Ribono-1,4- 











Proline L-Isoleucine L-Leucine L-Lysine L-Methionine 



















































Appendix I: Sucrose intensity of gas chromatography mass spectrometry, selected-ion 
monitoring analysis on pneumococcal infected murine lungs 
Name  Retention Time SIM Intensity Qualifier (437.2) Ion Ratio 
Analytical standard A 13.432 4299424 15.4 
Analytical standard B 13.428 3241463 15.6 
947 A 13.428 46874 11.2 
947 B 13.428 63609 9.1 
947 C 13.428 62015 12.9 
947 D 13.428 58606 10.8 
4559 A 13.428 67667 10.8 
4559 B 13.428 32775 12.6 
4559 C 13.428 49602 11.9 
4559 D 13.428 32432 11.5 
Serum broth A 13.428 37540 11 
Serum broth B 13.428 74120 8.5 
Serum broth C 13.428 57343 8.9 























Appendix J: Raffinose intensity of gas chromatography mass spectrometry, selected-ion 
monitoring analysis on pneumococcal infected murine lungs. 
Name Retention Time SIM Intensity Qualifier (437.2) Ion Ratio 
Analytical standard 16.263 7096929 9.9 
Analytical standard 16.255 4764259 9.6 
Ear isolate 16.255 2478 26.7 
Ear isolate 16.255 1840 18.4 
Ear isolate 16.298 3100 32.7 
Ear isolate 16.255 1627 28.7 
Blood isolate 16.255 2930  N/A 
Blood isolate 16.255 802 39.9 
Blood isolate 16.298 35965 7.8 
Blood isolate 16.298 16507 13.2 
Serum broth 16.298 7043 10.9 
Serum broth 16.298 15588 8 
Serum broth 16.298 9152 7.8 























Appendix K: Differential gene expression of S. pneumoniae 4559 vs 947 in CDM+Glc (Glu), 
CDM+Gal and human serum mediums. Genes wfith fold change (FC) greater than 2 and FDR < 
0.01 are shown. FC values highlighted in blue = upregulated in 947, while values highlighted in 
red = upregulated in 4559. 
Locus tag in 947 Product Media FDR FC 
Sp947_chr_01629 
treP PTS system trehalose-specific EIIBC 
component Glu 4.99E-07 10.16 
Sp947_chr_01671 wbbI Beta-1,6-galactofuranosyltransferase Glu 3.30E-08 4.57 
Sp947_chr_01664 gtf2 Glycosyltransferase-stabilizing protein Glu 4.31E-09 4.56 
Sp947_chr_01665 gtf1 Glycosyltransferase Glu 3.36E-09 4.5 
Sp947_chr_01663 Hypothetical protein Glu 7.47E-08 4.42 
Sp947_chr_01670 
secY2 Accessory Sec system protein 
translocase subunit Glu 2.70E-08 4.34 
Sp947_chr_01666 secA_2 Protein translocase subunit  Glu 4.72E-08 4.33 
Sp947_chr_01669 Hypothetical protein Glu 4.72E-08 4.22 
Sp947_chr_01672 gspA_1 General stress protein A Glu 3.30E-08 4.2 
Sp947_chr_01668 asp2 Accessory Sec system protein  Glu 7.59E-07 4.09 
Sp947_chr_01667 Accessory Sec system protein Asp3 Glu 1.87E-05 4.05 
Sp947_chr_01662 Hypothetical protein Glu 4.72E-08 3.92 
Sp947_chr_01673 gspA_1 General stress protein A Glu 1.07E-08 3.9 
Sp947_chr_01675 Hypothetical protein Glu 3.78E-08 3.84 
Sp947_chr_01674 epsJ_4 putative glycosyltransferase  Glu 3.84E-08 3.74 
Sp947_chr_01868 Hypothetical protein Glu 0.00933 3.16 
Sp947_chr_01631 HTH-type transcriptional regulator DegA Glu 6.21E-05 2.94 
Sp947_chr_01630 scrB Sucrose-6-phosphate hydrolase Glu 0.000246 2.9 
Sp947_chr_01788 HTH-type transcriptional regulator TreR Glu 0.001066 2.61 
Sp947_chr_01600 nanA_3 Sialidase A Glu 0.001146 2.19 
Sp947_chr_01628 gmuE Putative fructokinase Glu 0.007833 2.14 
Sp947_chr_00722 Biotin transporter BioY2 Glu 0.005284 2.49 
Sp947_chr_00440 pflB Formate acetyltransferase Glu 2.96E-05 3.16 
Sp947_chr_00679 bglH_2  Aryl-phospho-beta-D-glucosidase  Glu 0.002146 3.97 
Sp947_chr_00678 Hypothetical protein Glu 3.06E-06 5.56 
Sp947_chr_00677 Hypothetical protein Glu 9.00E-07 5.57 
Sp947_chr_00676 Hypothetical protein Glu 3.84E-08 5.88 
Sp947_chr_00675 spxB Pyruvate oxidase Glu 4.72E-08 6.95 
     
Sp947_chr_01629 
treP PTS system trehalose-specific EIIBC 
component Gal 0.002858 24.5 
Sp947_chr_00499 hypothetical protein Gal 0.002594 9.25 
Sp947_chr_00498 hypothetical protein Gal 0.006684 9.2 
Sp947_chr_00500 hypothetical protein Gal 0.002442 8.36 
Sp947_chr_00502 lytA_7 Autolysin Gal 0.002688 7.4 
Sp947_chr_00501 Hypothetical protein Gal 0.005244 7.34 
Sp947_chr_00491 dus putative tRNA-dihydrouridine synthase Gal 0.004584 7.14 
Sp947_chr_00493 Hypothetical protein Gal 0.007566 6.29 
Sp947_chr_01675 Hypothetical protein Gal 0.000316 4.63 
Sp947_chr_01630 scrB Sucrose-6-phosphate hydrolase Gal 0.000152 2.85 
Sp947_chr_01631 HTH-type transcriptional regulator DegA Gal 0.000229 2.68 
Sp947_chr_00065 
acpB Capsule synthesis positive regulator 
AcpB Gal 0.002688 2.38 
Sp947_chr_00840 
nanE Putative N-acetylmannosamine-6-
phosphate 2-epimerase Gal 9.87E-05 2.25 
Sp947_chr_02095 arcC1 Carbamate kinase 1 Gal 0.002442 2.21 
Sp947_chr_00646 Hypothetical protein Gal 0.00102 2.19 
Sp947_chr_00066 
sorC PTS system sorbose-specific EIIC 
component Gal 0.004824 2.07 
Sp947_chr_00839 HTH-type transcriptional regulator RpiR Gal 0.000128 2.03 
Sp947_chr_00841 nanA N-acetylneuraminate lyase Gal 9.64E-05 2.01 





gatC_2  PTS system galactitol-specific EIIC 
component Gal 0.004291 2 
Sp947_chr_00594 Beta-galactosidase BoGH2 Gal 0.000211 2.11 
Sp947_chr_00440 pflB Formate acetyltransferase Gal 0.000229 2.21 
Sp947_chr_01097 Hypothetical protein Gal 0.001418 2.32 
Sp947_chr_01096 Hypothetical protein Gal 0.002195 2.43 
Sp947_chr_01098 Hypothetical protein Gal 0.003998 2.43 
Sp947_chr_00023 Glycosyltransferase  Gal 0.00102 2.46 
Sp947_chr_01099 Hypothetical protein Gal 0.000172 2.5 
Sp947_chr_00679 bglH_2  Aryl-phospho-beta-D-glucosidase  Gal 0.001418 2.9 
Sp947_chr_01104 lacD Tagatose 1,6-diphosphate aldolase Gal 6.09E-06 3.74 
Sp947_chr_01103 lacC Tagatose-6-phosphate kinase Gal 1.63E-05 3.93 
Sp947_chr_00116 Hypothetical protein Gal 0.000849 3.96 
Sp947_chr_00112 Hypothetical protein Gal 0.001314 4.04 
Sp947_chr_01102 lacB Galactose-6-phosphate isomerase subunit Gal 2.28E-05 4.05 
Sp947_chr_00117 dpnC Type-2 restriction enzyme DpnI Gal 0.000381 4.05 
Sp947_chr_00118 paaI Acyl-coenzyme A thioesterase Gal 0.000365 4.06 
Sp947_chr_00119 
galT Galactose-1-phosphate 
uridylyltransferase Gal 3.93E-05 4.15 
Sp947_chr_00122 adh_1 Alcohol dehydrogenase Gal 0.000805 4.16 
Sp947_chr_00114 hypothetical protein Gal 0.00102 4.16 
Sp947_chr_00115 hypothetical protein Gal 0.001218 4.24 
Sp947_chr_01101 lacA Galactose-6-phosphate isomerase subunit Gal 1.63E-05 4.24 
Sp947_chr_00120 galK_2 Galactokinase Gal 0.000211 4.28 
Sp947_chr_00121 
lacR_3 HTH-type transcriptional regulator 
LacR Gal 9.64E-05 4.42 
Sp947_chr_00111 exoA Exodeoxyribonuclease Gal 0.000229 4.58 
Sp947_chr_00113 Hypothetical protein Gal 0.005561 4.61 
Sp947_chr_00123 
adhR HTH-type transcriptional regulator 
AdhR Gal 8.98E-05 4.78 
Sp947_chr_00676 Hypothetical protein Gal 2.18E-06 5.9 
Sp947_chr_00675 spxB Pyruvate oxidase Gal 2.18E-06 6.01 
Sp947_chr_00678 Hypothetical protein Gal 2.18E-06 6.13 
Sp947_chr_00677 Hypothetical protein Gal 0.000104 6.21 
     
Sp947_chr_01629 
treP PTS system trehalose-specific EIIBC 
component Serum 1.22E-05 27.8 
Sp947_chr_01630 scrB Sucrose-6-phosphate hydrolase Serum 2.49E-08 6.66 
Sp947_chr_01631 HTH-type transcriptional regulator DegA Serum 1.26E-07 6.11 
Sp947_chr_01675 Hypothetical protein Serum 2.49E-08 5.41 
Sp947_chr_01674 epsJ_4 putative glycosyltransferase  Serum 1.26E-08 4.69 
Sp947_chr_01673 gspA_1 General stress protein A Serum 6.83E-09 4.47 
Sp947_chr_01670 
secY2 Accessory Sec system protein 
translocase subunit Serum 2.33E-07 4.25 
Sp947_chr_01672 gspA_1 General stress protein A Serum 2.49E-08 4.18 
Sp947_chr_01628 gmuE Putative fructokinase Serum 5.13E-05 4.09 
Sp947_chr_01671 wbbI Beta-1,6-galactofuranosyltransferase Serum 8.80E-08 3.98 
Sp947_chr_01663 Hypothetical protein Serum 5.88E-07 3.96 
Sp947_chr_01664 gtf2 Glycosyltransferase-stabilizing protein Serum 6.92E-08 3.9 
Sp947_chr_01665 gtf1 Glycosyltransferase Serum 2.33E-07 3.89 
Sp947_chr_01668 asp2 Accessory Sec system protein  Serum 1.22E-05 3.88 
Sp947_chr_01666 secA_2 Protein translocase subunit  Serum 6.77E-06 3.8 
Sp947_chr_01669 Hypothetical protein Serum 2.46E-06 3.74 
Sp947_chr_01667 Accessory Sec system protein Asp3 Serum 8.85E-05 3.7 
Sp947_chr_01662 Hypothetical protein Serum 5.78E-05 3.28 
Sp947_chr_00678 Hypothetical protein Serum 0.005505 3.49 
Sp947_chr_00722 Biotin transporter BioY2 Serum 1.02E-05 3.79 
Sp947_chr_00675 spxB Pyruvate oxidase Serum 2.87E-07 4.33 
Sp947_chr_00677 Hypothetical protein Serum 2.96E-05 4.72 





Appendix L: Differential gene expression of S. pneumoniae 180/15 vs 180/2 in CDM+Glc (Glu), 
CDM+Gal and human serum mediums. Genes with fold change (FC) greater than 2 and FDR < 
0.01 are shown. FC values highlighted in blue = upregulated in 180/2, while values highlighted in 
red = upregulated in 180/15. 
Locus tag in 180_2 Product Media FDR FC 
Sp180_2_chr_00600 
putative glutamine ABC transporter permease 
protein GlnP Glu 1.71E-07 6.28 
Sp180_2_chr_00603 
Glutamine transport ATP-binding protein 
GlnQ Glu 8.78E-07 5.94 
Sp180_2_chr_00601 
putative glutamine ABC transporter permease 
protein GlnM Glu 4.73E-08 5.66 
Sp180_2_chr_00602 Major cell-binding factor peb1A Glu 2.37E-07 5.58 
Sp180_2_chr_00162 Hypothetical protein Glu 0.00038 4.47 
Sp180_2_chr_00161 Hypothetical protein Glu 0.00023 4.06 
Sp180_2_chr_00513 Hypothetical protein Glu 5.1E-06 4.05 
Sp180_2_chr_01195 Arginine transport ATP-binding protein ArtM Glu 2.2E-05 3.93 
Sp180_2_chr_00813 Hypothetical protein Glu 3.1E-05 3.52 
Sp180_2_chr_01194 
Glutamine transport system permease protein 
GlnP Glu 1.6E-05 3.41 
Sp180_2_chr_00160 Hypothetical protein Glu 0.00078 3.37 
Sp180_2_chr_01196 Glucose-6-phosphate 1-dehydrogenase zwf Glu 1.3E-06 3.25 
Sp180_2_chr_00555 Hypothetical protein Glu 0.00429 3.09 
Sp180_2_chr_01980 Hypothetical protein Glu 9.1E-05 3.07 
Sp180_2_chr_00511 HTH-type transcriptional regulator GlnR Glu 8.7E-05 2.93 
Sp180_2_chr_00438 Amino-acgene_id carrier protein AlsT Glu 7.43E-07 2.92 
Sp180_2_chr_00512 Glutamine synthetase glnA Glu 0.00014 2.83 
Sp180_2_chr_00152 putative cell wall hydrolase LytN Glu 0.00266 2.76 
Sp180_2_chr_01077 Redox-sensing transcriptional repressor Rex Glu 1.7E-06 2.72 
Sp180_2_chr_01076 Putative glutamine amgene_idotransferase Glu 1.3E-06 2.65 
Sp180_2_chr_00515 Hypothetical protein Glu 9.95E-08 2.56 
Sp180_2_chr_02133 ComF operon protein 1 Glu 0.01515 2.55 
Sp180_2_chr_01822 groS 10 kDa chaperonin Glu 0.00035 2.55 
Sp180_2_chr_01821 groL 60 kDa chaperonin Glu 0.00056 2.47 
Sp180_2_chr_01434 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase metI Glu 8E-05 2.42 
Sp180_2_chr_01404 Hypothetical protein Glu 2.1E-06 2.39 
Sp180_2_chr_01435 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_1 Glu 0.00083 2.35 
Sp180_2_chr_01436 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_2 Glu 0.00076 2.32 
Sp180_2_chr_01433 Cystathionine beta-lyase PatB Glu 2.7E-05 2.31 
Sp180_2_chr_00159 Argininosuccinate synthase argG Glu 0.00826 2.3 
Sp180_2_chr_01075 Hypothetical protein Glu 1.3E-06 2.28 
Sp180_2_chr_01776 Hypothetical protein Glu 3.2E-05 2.28 
Sp180_2_chr_01437 Hypothetical protein Glu 0.0013 2.26 
Sp180_2_chr_00516 Hypothetical protein Glu 1.6E-06 2.25 
Sp180_2_chr_01347 Hypothetical protein Glu 0.0032 2.21 
Sp180_2_chr_01777 Hypothetical protein Glu 0.00015 2.18 
Sp180_2_chr_01778 Hypothetical protein Glu 6.1E-05 2.17 
Sp180_2_chr_00203 UDP-glucose 6-dehydrogenase ugd_2 Glu 0.02178 2.08 
Sp180_2_chr_00609 Hypothetical protein Glu 9.9E-06 2.06 
Sp180_2_chr_00158 Arginine-binding extracellular protein ArtP Glu 0.0087 2.05 
Sp180_2_chr_00888 Arginine decarboxylase speA Glu 0.01817 2.03 
Sp180_2_chr_01941 
PTS system oligo-beta-mannosgene_ide-
specific EIIA component gmuA Glu 0.00399 2.02 
Sp180_2_chr_01940 
PTS system cellobiose-specific EIIB 




Sp180_2_chr_01346 Hypothetical protein Glu 0.00625 2.01 
Sp180_2_chr_01125 
Dihydrolipoyllysine-resgene_idue 
acetyltransferase component of pyruvate 
dehydrogenase complex pdhC Glu 1.3E-06 2.01 
Sp180_2_chr_01183 Formate--tetrahydrofolate ligase 1 fhs1 Glu 0.00297 2.01 
Sp180_2_chr_01339 Autolysin lytA_3 Glu 3.90E-08 2.02 
Sp180_2_chr_01126 
2-oxoisovalerate dehydrogenase subunit beta 
bfmBAB Glu 1.9E-06 2.02 
Sp180_2_chr_02004 Putative glutamine amgene_idotransferase Glu 0.00279 2.03 
Sp180_2_chr_01740 Uric acgene_id permease PucK Glu 0.00032 2.04 
Sp180_2_chr_01007 
putative sgene_iderophore transport system 
ATP-binding protein YusV Glu 1.58E-07 2.05 
Sp180_2_chr_00925 ComE operon protein 1 Glu 0.00145 2.07 
Sp180_2_chr_01113 Enolase eno_2 Glu 0.00309 2.07 
Sp180_2_chr_01006 
putative sgene_iderophore transport system 
permease protein YfhA Glu 1.79E-07 2.08 
Sp180_2_chr_01928 Penicillin-binding protein 1F pbpF_1 Glu 6.29E-07 2.08 
Sp180_2_chr_00102 Bifunctional purine biosynthesis protein PurH Glu 0.02127 2.08 
Sp180_2_chr_00101 Hypothetical protein Glu 0.01241 2.14 
Sp180_2_chr_01387 FAD:protein FMN transferase apbE Glu 2.1E-05 2.16 
Sp180_2_chr_01111 Glycerate kinase glxK Glu 8.06E-07 2.19 
Sp180_2_chr_00981 Hypothetical protein Glu 9.8E-06 2.25 
Sp180_2_chr_01743 Acyl-coenzyme A thioesterase PaaI Glu 0.00011 2.26 
Sp180_2_chr_01112 Hypothetical protein Glu 1.1E-06 2.27 
Sp180_2_chr_02117 Hypothetical protein Glu 3.35E-07 2.27 
Sp180_2_chr_00100 
Phosphoribosylglycinamgene_ide 
formyltransferase purN Glu 0.0114 2.32 
Sp180_2_chr_02116 IgA FC receptor bag Glu 1.4E-06 2.33 
Sp180_2_chr_00099 
Phosphoribosylformylglycinamgene_idine 
cyclo-ligase purM Glu 0.00788 2.39 
Sp180_2_chr_02136 Hypothetical protein Glu 0.00041 2.39 
Sp180_2_chr_00598 Fructose-bisphosphate aldolase fba Glu 0.0002 2.45 
Sp180_2_chr_01340 Hypothetical protein Glu 1.44E-07 2.46 
Sp180_2_chr_01389 
NADH-dependent flavin reductase subunit 1 
nfr1 Glu 0.00017 2.47 
Sp180_2_chr_01095 Riboflavin biosynthesis protein RibF Glu 2.37E-07 2.48 
Sp180_2_chr_00979 Ferrochelatase hemH Glu 2.37E-07 2.48 
Sp180_2_chr_01124 Dihydrolipoamide dehydrogenase Glu 1.44E-07 2.52 
Sp180_2_chr_01372 Capsule biosynthesis protein CapA  Glu 3.66E-07 2.53 
Sp180_2_chr_00509 Phosphoglycerate kinase pgk Glu 0.00031 2.62 
Sp180_2_chr_00098 Amgene_idophosphoribosyltransferase purF Glu 0.00339 2.67 
Sp180_2_chr_01341 Putative ribosomal N-acetyltransferase YdaF Glu 3.90E-09 2.73 
Sp180_2_chr_01388 
NADH-dependent flavin reductase subunit 2 
nfr2 Glu 2E-05 2.83 
Sp180_2_chr_01371 Sugar phosphatase YbiV Glu 1.51E-07 2.88 
Sp180_2_chr_01123 Lipoate-protein ligase LplJ Glu 1.45E-08 2.96 
Sp180_2_chr_02121 Transcriptional regulator CtsR Glu 1.19E-09 2.97 
Sp180_2_chr_01370 Hypothetical protein Glu 6.38E-08 3.06 
Sp180_2_chr_02082 Alcohol dehydrogenase 2 adhB Glu 2.6E-05 3.24 
Sp180_2_chr_02118 Sensor histgene_idine kinase WalK Glu 2.02E-09 3.25 
Sp180_2_chr_00097 
Phosphoribosylformylglycinamgene_idine 
synthase purL Glu 0.0002 3.36 
Sp180_2_chr_02119 
Phosphate regulon transcriptional regulatory 
protein PhoB Glu 1.13E-09 3.4 
Sp180_2_chr_01942 Aldehyde-alcohol dehydrogenase adhE Glu 4.2E-05 3.51 
Sp180_2_chr_01105 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase Glu 9.7E-06 3.6 
Sp180_2_chr_01343 Nicotinate phosphoribosyltransferase pncB2 Glu 1.13E-09 3.6 
Sp180_2_chr_02120 
ATP-dependent Clp protease ATP-binding 
subunit ClpC Glu 5.31E-10 3.75 




Sp180_2_chr_00571 Hypothetical protein Glu 9.7E-06 4.29 
Sp180_2_chr_01971 Alcohol dehydrogenase adh_2 Glu 1.3E-06 4.57 
Sp180_2_chr_00096 
Phosphoribosylaminoimgene_idazole-
succinocarboxamgene_ide synthase purC Glu 5.12E-07 4.75 
Sp180_2_chr_01172 Hypothetical protein Glu 3.11E-09 5.19 
Sp180_2_chr_01266 Hypothetical protein Glu 2.3E-06 13.4 
     
Sp180_2_chr_00513 Hypothetical protein Gal 3.03E-07 4.22 
Sp180_2_chr_01194 
Glutamine transport system permease protein 
GlnP Gal 2.2E-05 3.42 
Sp180_2_chr_00602 Major cell-binding factor peb1A Gal 2.5E-05 3.42 
Sp180_2_chr_00511 HTH-type transcriptional regulator GlnR Gal 7.65E-07 3.15 
Sp180_2_chr_00813 Hypothetical protein Gal 7.65E-07 3.1 
Sp180_2_chr_00512 Glutamine synthetase glnA Gal 2.1E-06 3.08 
Sp180_2_chr_01195 Arginine transport ATP-binding protein ArtM Gal 1.9E-05 3.08 
Sp180_2_chr_00603 
Glutamine transport ATP-binding protein 
GlnQ Gal 0.00069 2.98 
Sp180_2_chr_00707 Hypothetical protein Gal 0.00304 2.91 
Sp180_2_chr_01077 Redox-sensing transcriptional repressor Rex Gal 1.3E-05 2.83 
Sp180_2_chr_00161 Hypothetical protein Gal 0.00079 2.83 
Sp180_2_chr_00708 putative copper-transporting ATPase PacS Gal 0.00375 2.71 
Sp180_2_chr_01821 groL 60 kDa chaperonin Gal 1.8E-05 2.69 
Sp180_2_chr_01076 Putative glutamine amgene_idotransferase Gal 1.5E-05 2.66 
Sp180_2_chr_00162 Hypothetical protein Gal 0.00069 2.66 
Sp180_2_chr_01404 Hypothetical protein Gal 0.0009 2.56 
Sp180_2_chr_00152 putative cell wall hydrolase LytN Gal 0.004 2.54 
Sp180_2_chr_00601 
putative glutamine ABC transporter permease 
protein GlnM Gal 8.9E-05 2.52 
Sp180_2_chr_00706 Transcriptional repressor CopY Gal 0.007 2.48 
Sp180_2_chr_01075 Hypothetical protein Gal 3.5E-05 2.46 
Sp180_2_chr_01822 groS 10 kDa chaperonin Gal 3.9E-05 2.45 
Sp180_2_chr_01437 Hypothetical protein Gal 1.4E-05 2.43 
Sp180_2_chr_01435 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_1 Gal 1.8E-05 2.37 
Sp180_2_chr_01436 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_2 Gal 2.7E-05 2.36 
Sp180_2_chr_00160 Hypothetical protein Gal 0.00443 2.32 
Sp180_2_chr_01939 Lichenan permease IIC component licC_5 Gal 0.0012 2.28 
Sp180_2_chr_01941 
PTS system oligo-beta-mannosgene_ide-
specific EIIA component gmuA Gal 0.00192 2.27 
Sp180_2_chr_01196 Glucose-6-phosphate 1-dehydrogenase zwf Gal 5.8E-05 2.24 
Sp180_2_chr_00600 
putative glutamine ABC transporter permease 
protein GlnP Gal 0.0009 2.24 
Sp180_2_chr_01940 
PTS system cellobiose-specific EIIB 
component celA_3 Gal 0.00101 2.23 
Sp180_2_chr_01980 Hypothetical protein Gal 0.00025 2.2 
Sp180_2_chr_01434 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase metI Gal 2.1E-06 2.16 
Sp180_2_chr_01938 6-phospho-beta-glucosgene_idase GmuD Gal 0.00181 2.14 
Sp180_2_chr_01433 Cystathionine beta-lyase PatB Gal 1.2E-06 2.02 
Sp180_2_chr_02141 Secreted 45 kDa protein Gal 5.8E-05 2.01 
Sp180_2_chr_00187 Hypothetical protein Gal 0.01323 2.01 
Sp180_2_chr_01929 tRNA pseudourgene_idine synthase C truC Gal 5.48E-08 2.02 
Sp180_2_chr_00980 
Large-conductance mechanosensitive channel 
mscL Gal 0.0002 2.03 
Sp180_2_chr_00509 Phosphoglycerate kinase pgk Gal 0.01028 2.03 
Sp180_2_chr_01007 
putative sgene_iderophore transport system 
ATP-binding protein YusV Gal 3.7E-05 2.05 
Sp180_2_chr_01111 Glycerate kinase glxK Gal 0.00011 2.05 
Sp180_2_chr_01928 Penicillin-binding protein 1F pbpF_1 Gal 5.48E-08 2.08 




Sp180_2_chr_00924 Putative ribosomal N-acetyltransferase YdaF Gal 7.65E-07 2.08 
Sp180_2_chr_00373 
PTS system mannose-specific EIgene_id 
component manZ_3 Gal 0.00069 2.1 
Sp180_2_chr_01595 
Putative ABC transporter substrate-binding 
protein YesO Gal 0.01301 2.11 
Sp180_2_chr_01372 Capsule biosynthesis protein CapA Gal 0.00011 2.15 
Sp180_2_chr_01095 Riboflavin biosynthesis protein RibF Gal 0.00044 2.15 
Sp180_2_chr_00598 Fructose-bisphosphate aldolase fba Gal 0.00321 2.15 
Sp180_2_chr_02116 IgA FC receptor bag Gal 3.9E-06 2.16 
Sp180_2_chr_01110 Phosphoserine phosphatase serB Gal 4.6E-05 2.19 
Sp180_2_chr_01961 
Ubiquinone/menaquinone biosynthesis C-
methyltransferase UbiE Gal 0.00167 2.19 
Sp180_2_chr_02117 Hypothetical protein Gal 2.3E-06 2.2 
Sp180_2_chr_01341 Putative ribosomal N-acetyltransferase YdaF Gal 8.9E-06 2.21 
Sp180_2_chr_01124 Dihydrolipoamide dehydrogenase Gal 0.00052 2.21 
Sp180_2_chr_01008 Hypothetical protein Gal 0.00022 2.24 
Sp180_2_chr_00372 
N-acetylgalactosamine permease IIC 
component 1 agaC Gal 0.00969 2.26 
Sp180_2_chr_01593 
Inner membrane ABC transporter permease 
protein YcjP Gal 0.04518 2.27 
Sp180_2_chr_01519 Hypothetical protein Gal 3.6E-06 2.33 
Sp180_2_chr_01371 Sugar phosphatase YbiV Gal 8.6E-05 2.37 
Sp180_2_chr_00571 Hypothetical protein Gal 0.00096 2.37 
Sp180_2_chr_00217 Hypothetical protein Gal 0.00707 2.37 
Sp180_2_chr_01518 Hypothetical protein Gal 2.8E-05 2.37 
Sp180_2_chr_02136 Hypothetical protein Gal 0.00192 2.4 
Sp180_2_chr_00490 
PTS system lactose-specific EIICB 
component lacE_1 Gal 0.00254 2.42 
Sp180_2_chr_02082 Alcohol dehydrogenase 2 adhB Gal 3.4E-06 2.45 
Sp180_2_chr_01387 FAD:protein FMN transferase apbE Gal 0.00055 2.45 
Sp180_2_chr_00489 Hypothetical protein Gal 0.00161 2.48 
Sp180_2_chr_01517 Hypothetical protein Gal 0.00144 2.49 
Sp180_2_chr_01370 Hypothetical protein Gal 2.2E-05 2.51 
Sp180_2_chr_01389 
NADH-dependent flavin reductase subunit 1 
nfr1 Gal 0.00096 2.53 
Sp180_2_chr_01749 
Cadmium%2C cobalt and zinc/H(+)-K(+) 
antiporter czcD Gal 0.02412 2.54 
Sp180_2_chr_00926 ComE operon protein 3 comEC Gal 7.47E-07 2.56 
Sp180_2_chr_01591 
scyllo-inositol 2-dehydrogenase (NAD(+)) 
iolX Gal 0.00254 2.59 
Sp180_2_chr_01123 Lipoate-protein ligase LplJ Gal 0.00013 2.6 
Sp180_2_chr_00981 Hypothetical protein Gal 5.5E-05 2.62 
Sp180_2_chr_01592 Sialgene_idase B nanB Gal 0.0018 2.64 
Sp180_2_chr_00925 ComE operon protein 1 Gal 2.05E-07 2.7 
Sp180_2_chr_01105 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase Gal 0.00037 2.73 
Sp180_2_chr_01962 Hypothetical protein Gal 0.0009 2.76 
Sp180_2_chr_01342 NH(3)-dependent NAD(+) synthetase nadE Gal 1.5E-05 2.78 
Sp180_2_chr_01596 Toxin-antitoxin biofilm protein TabA Gal 0.00399 2.81 
Sp180_2_chr_01343 Nicotinate phosphoribosyltransferase pncB2 Gal 5.5E-06 2.84 
Sp180_2_chr_01388 
NADH-dependent flavin reductase subunit 2 
nfr2 Gal 0.00101 2.89 
Sp180_2_chr_02121 Transcriptional regulator CtsR Gal 1.16E-08 2.96 
Sp180_2_chr_02118 Sensor histgene_idine kinase WalK Gal 5.48E-08 3.09 
Sp180_2_chr_02120 
ATP-dependent Clp protease ATP-binding 
subunit ClpC Gal 1.37E-08 3.21 
Sp180_2_chr_01910 Hypothetical protein Gal 2.3E-06 3.24 
Sp180_2_chr_02119 
Phosphate regulon transcriptional regulatory 
protein PhoB Gal 1.16E-08 3.3 





putative ABC transporter ATP-binding protein 
YxlF Gal 1.5E-06 3.53 
Sp180_2_chr_00979 Ferrochelatase hemH Gal 4.45E-07 4.25 
Sp180_2_chr_01942 Aldehyde-alcohol dehydrogenase adhE Gal 2.1E-06 4.64 
Sp180_2_chr_01971 Alcohol dehydrogenase adh_2 Gal 0.00714 4.84 
Sp180_2_chr_01172 Hypothetical protein Gal 1.5E-05 6.85 
Sp180_2_chr_01266 Hypothetical protein Gal 1.6E-06 11.3 
     
Sp180_2_chr_01076 Putative glutamine amgene_idotransferase Serum 4.97E-09 43.4 
Sp180_2_chr_01077 Redox-sensing transcriptional repressor Rex Serum 4.24E-08 29.8 
Sp180_2_chr_01075 Hypothetical protein Serum 2.00E-09 20.8 
Sp180_2_chr_01712 N-(5'-phosphoribosyl)anthranilate isomerase Serum 0.00044 5.21 
Sp180_2_chr_00096 
Phosphoribosylaminoimgene_idazole-
succinocarboxamgene_ide synthase purC Serum 4.27E-05 5.07 
Sp180_2_chr_00097 
Phosphoribosylformylglycinamgene_idine 
synthase purL Serum 0.00017 4.48 
Sp180_2_chr_01714 Anthranilate phosphoribosyltransferase trpD Serum 0.00014 4.34 
Sp180_2_chr_01739 Xanthine phosphoribosyltransferase xpt Serum 7.68E-05 3.97 
Sp180_2_chr_01740 Uric acgene_id permease PucK Serum 7.95E-05 3.95 
Sp180_2_chr_01716 Anthranilate synthase component 1 trpE Serum 0.00011 3.89 
Sp180_2_chr_01711 Tryptophan synthase beta chain trpB Serum 1.76E-05 3.67 
Sp180_2_chr_00045 Hypothetical protein Serum 0.00186 3.44 
Sp180_2_chr_01715 
Aminodeoxychorismate/anthranilate synthase 
component 2 pabA Serum 0.00064 3.31 
Sp180_2_chr_00040 Hypothetical protein Serum 0.00084 3.29 
Sp180_2_chr_01713 Indole-3-glycerol phosphate synthase trpC Serum 0.00037 3.18 
Sp180_2_chr_01435 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_1 Serum 0.00027 3.16 
Sp180_2_chr_00044 Single-stranded DNA-binding protein ssb_1 Serum 0.00038 3.15 
Sp180_2_chr_00042 Hypothetical protein Serum 0.00089 3.13 
Sp180_2_chr_00098 Amgene_idophosphoribosyltransferase purF Serum 0.00046 3.12 
Sp180_2_chr_01437 Hypothetical protein Serum 0.00081 3.04 
Sp180_2_chr_01436 
Multgene_idrug resistance ABC transporter 
ATP-binding and permease protein lmrA_2 Serum 0.00038 3.04 
Sp180_2_chr_00338 Hypothetical protein Serum 0.00039 2.89 
Sp180_2_chr_00041 DNA replication protein DnaC Serum 8.27E-05 2.87 
Sp180_2_chr_00159 Argininosuccinate synthase argG Serum 0.00376 2.86 
Sp180_2_chr_01718 Hypothetical protein Serum 0.0031 2.79 
Sp180_2_chr_00047 Hypothetical protein Serum 0.00437 2.77 
Sp180_2_chr_00103 Phosphoribosylamine--glycine ligase Serum 2.57E-05 2.73 
Sp180_2_chr_00054 Hypothetical protein Serum 3.20E-05 2.69 
Sp180_2_chr_00049 Tyrosine recombinase XerD Serum 0.00031 2.68 
Sp180_2_chr_00064 Chromosome partition protein Smc Serum 7.68E-05 2.64 
Sp180_2_chr_00046 Hypothetical protein Serum 0.01073 2.63 
Sp180_2_chr_00065 Hypothetical protein Serum 0.00012 2.61 
Sp180_2_chr_00106 
N5-carboxyaminoimgene_idazole 
ribonucleotgene_ide synthase purK Serum 0.00041 2.55 
Sp180_2_chr_00048 Hypothetical protein Serum 0.00024 2.54 
Sp180_2_chr_00043 Hypothetical protein Serum 0.00266 2.53 
Sp180_2_chr_00055 Hypothetical protein Serum 7.68E-05 2.53 
Sp180_2_chr_01710 Tryptophan synthase alpha chain trpA Serum 0.00294 2.52 
Sp180_2_chr_00813 Hypothetical protein Serum 7.68E-05 2.49 
Sp180_2_chr_00337 Guanine/hypoxanthine permease PbuO Serum 0.0002 2.47 
Sp180_2_chr_00053 Hypothetical protein Serum 0.0001 2.45 
Sp180_2_chr_00052 Hypothetical protein Serum 9.14E-05 2.44 
Sp180_2_chr_00050 Hypothetical protein Serum 4.06E-05 2.43 
Sp180_2_chr_00062 Hypothetical protein Serum 7.68E-05 2.42 
Sp180_2_chr_00035 Hypothetical protein Serum 0.0001 2.38 
Sp180_2_chr_00056 Hypothetical protein Serum 9.14E-05 2.36 




Sp180_2_chr_00051 Hypothetical protein Serum 0.00058 2.34 
Sp180_2_chr_01072 Hypothetical protein Serum 0.00081 2.34 
Sp180_2_chr_00066 Hypothetical protein Serum 0.00035 2.33 
Sp180_2_chr_01789 
Bifunctional alpha-galactosgene_idase/sucrose 
kinase AgaSK Serum 0.02057 2.32 
Sp180_2_chr_00032 Hypothetical protein Serum 0.00027 2.31 
Sp180_2_chr_00515 Hypothetical protein Serum 0.00035 2.27 
Sp180_2_chr_00072 Autolysin lytA_1 Serum 0.00039 2.27 
Sp180_2_chr_00063 Hypothetical protein Serum 9.11E-05 2.27 
Sp180_2_chr_00603 
Glutamine transport ATP-binding protein 
GlnQ Serum 6.15E-06 2.25 
Sp180_2_chr_00039 DNA replication protein DnaD Serum 0.00033 2.25 
Sp180_2_chr_00105 
N5-carboxyaminoimgene_idazole 
ribonucleotgene_ide mutase purE Serum 0.00111 2.24 
Sp180_2_chr_00099 
Phosphoribosylformylglycinamgene_idine 
cyclo-ligase purM Serum 0.00373 2.24 
Sp180_2_chr_00162 Hypothetical protein Serum 0.01243 2.24 
Sp180_2_chr_01521 Hypothetical protein Serum 0.01013 2.24 
Sp180_2_chr_00069 Hypothetical protein Serum 0.00148 2.23 
Sp180_2_chr_00033 Hypothetical protein Serum 0.00628 2.23 
Sp180_2_chr_00060 Hypothetical protein Serum 0.00017 2.22 
Sp180_2_chr_00161 Hypothetical protein Serum 0.01378 2.22 
Sp180_2_chr_00059 Hypothetical protein Serum 0.0004 2.22 
Sp180_2_chr_00160 Hypothetical protein Serum 0.01041 2.18 
Sp180_2_chr_00038 Hypothetical protein Serum 0.00018 2.16 
Sp180_2_chr_00031 Hypothetical protein Serum 6.75E-05 2.16 
Sp180_2_chr_00071 Hypothetical protein Serum 0.00071 2.16 
Sp180_2_chr_00034 Hypothetical protein Serum 3.75E-05 2.15 
Sp180_2_chr_00513 Hypothetical protein Serum 0.00465 2.15 
Sp180_2_chr_00036 Hypothetical protein Serum 7.68E-05 2.13 
Sp180_2_chr_00600 
putative glutamine ABC transporter permease 
protein GlnP Serum 6.15E-06 2.12 
Sp180_2_chr_00602 Major cell-binding factor peb1A Serum 3.48E-05 2.12 
Sp180_2_chr_00070 Hypothetical protein Serum 0.00041 2.12 
Sp180_2_chr_00058 Hypothetical protein Serum 0.0005 2.11 
Sp180_2_chr_01317 
Putative ABC transporter arginine-binding 
protein 2 artI Serum 0.04054 2.11 
Sp180_2_chr_00068 Hypothetical protein Serum 0.0014 2.11 
Sp180_2_chr_00100 
Phosphoribosylglycinamgene_ide 
formyltransferase purN Serum 0.01334 2.1 
Sp180_2_chr_00519 putative type I restriction enzymeP M protein Serum 6.15E-06 2.09 
Sp180_2_chr_00158 Arginine-binding extracellular protein ArtP Serum 0.00848 2.08 
Sp180_2_chr_00057 Hypothetical protein Serum 0.00037 2.08 
Sp180_2_chr_00061 Hypothetical protein Serum 0.00071 2.08 
Sp180_2_chr_00005 Peptgene_idyl-tRNA hydrolase pth Serum 0.00588 2.06 
Sp180_2_chr_01404 Hypothetical protein Serum 3.75E-05 2.05 
Sp180_2_chr_01438 Oligopeptgene_ide-binding protein SarA Serum 0.00484 2.02 
Sp180_2_chr_00728 
Inosine-5'-monophosphate dehydrogenase 
guaB_1 Serum 0.00029 2.02 
Sp180_2_chr_00006 Transcription-repair-coupling factor mfd Serum 0.01182 2.01 
Sp180_2_chr_00297 
Lichenan-specific phosphotransferase enzyme 
IIA component licA Serum 0.00064 2 
Sp180_2_chr_00295 Glucitol operon repressor srlR_1 Serum 0.0005 2.02 
Sp180_2_chr_00142 Hypothetical protein Serum 1.58E-05 2.03 
Sp180_2_chr_00228 Riboflavin biosynthesis protein RibBA Serum 0.00359 2.03 
Sp180_2_chr_00615 Hypothetical protein Serum 0.00053 2.03 
Sp180_2_chr_00450 
Malonyl CoA-acyl carrier protein transacylase 
fabD Serum 0.00027 2.04 
Sp180_2_chr_00635 Hypothetical protein Serum 0.03563 2.04 






reductase FabG Serum 0.00041 2.08 
Sp180_2_chr_01934 
putative nicotinate-nucleotgene_ide 
pyrophosphorylase [carboxylating] nadC Serum 3.48E-05 2.08 
Sp180_2_chr_00453 
Biotin carboxyl carrier protein of acetyl-CoA 
carboxylase accB Serum 0.00016 2.09 
Sp180_2_chr_00452 
3-oxoacyl-[acyl-carrier-protein] synthase 2 
fabF Serum 0.00027 2.09 
Sp180_2_chr_01136 Hypothetical protein Serum 0.00022 2.09 
Sp180_2_chr_00459 Hypothetical protein Serum 0.00075 2.1 
Sp180_2_chr_00927 ABC transporter ATP-binding protein NatA Serum 0.03044 2.1 
Sp180_2_chr_00374 Hypothetical protein Serum 0.00108 2.11 
Sp180_2_chr_00454 
3-hydroxyacyl-[acyl-carrier-protein] 
dehydratase FabZ Serum 0.00018 2.13 
Sp180_2_chr_00449 Nitronate monooxygenase Serum 7.68E-05 2.13 
Sp180_2_chr_01552 Neutral endopeptgene_idase pepO Serum 2.75E-06 2.13 
Sp180_2_chr_01932 Hypothetical protein Serum 1.41E-05 2.16 
Sp180_2_chr_00320 Pullulanase pulA Serum 0.00323 2.17 
Sp180_2_chr_00229 Riboflavin synthase ribE Serum 0.00674 2.18 
Sp180_2_chr_01904 Catabolite control protein A ccpA_2 Serum 0.00515 2.19 
Sp180_2_chr_00455 Biotin carboxylase accC Serum 0.00022 2.19 
Sp180_2_chr_01749 
Cadmium%2C cobalt and zinc/H(+)-K(+) 
antiporter czcD Serum 0.01227 2.21 
Sp180_2_chr_00804 
Pyrimgene_idine-nucleosgene_ide 
phosphorylase pdp Serum 5.78E-05 2.22 
Sp180_2_chr_00333 
PTS system sorbose-specific EIIC component 
sorA Serum 0.00422 2.24 
Sp180_2_chr_02117 Hypothetical protein Serum 0.00985 2.25 
Sp180_2_chr_00979 Ferrochelatase hemH Serum 9.11E-06 2.25 
Sp180_2_chr_00456 
Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit beta accD Serum 0.00011 2.26 
Sp180_2_chr_01933 Hypothetical protein Serum 8.27E-05 2.26 
Sp180_2_chr_00332 
PTS system mannose-specific EIgene_id 
component manZ_2 Serum 0.00515 2.26 
Sp180_2_chr_01172 Hypothetical protein  Serum 7.49E-05 2.26 
Sp180_2_chr_00227 
6%2C7-dimethyl-8-ribityllumazine synthase 
ribH Serum 0.00384 2.29 
Sp180_2_chr_00457 
Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha accA Serum 0.0001 2.32 
Sp180_2_chr_01931 
Macrolgene_ide export ATP-
binding/permease protein MacB Serum 9.51E-05 2.33 
Sp180_2_chr_00616 Hypothetical protein  Serum 0.00024 2.34 
Sp180_2_chr_02022 Hypothetical protein  Serum 0.04956 2.44 
Sp180_2_chr_01748 HTH-type transcriptional regulator AdhR Serum 0.00107 2.45 
Sp180_2_chr_00445 
Trans-2-decenoyl-[acyl-carrier-protein] 
isomerase fabM Serum 3.75E-05 2.65 
Sp180_2_chr_00973 Hypothetical protein  Serum 1.33E-05 2.76 
Sp180_2_chr_01597 Hypothetical protein  Serum 0.01541 3.44 
Sp180_2_chr_01127 
Acetoin:2%2C6-dichlorophenolindophenol 
oxgene_idoreductase subunit alpha acoA Serum 7.22E-07 3.6 
Sp180_2_chr_02116 IgA FC receptor bag Serum 0.00188 3.64 
Sp180_2_chr_02020 
Phosphate-specific transport system accessory 
protein PhoU  Serum 0.0017 4.38 
Sp180_2_chr_01266 Hypothetical protein Serum 2.01E-06 4.42 
Sp180_2_chr_02019 Phosphate import ATP-binding protein PstB 3 Serum 0.00148 4.77 
Sp180_2_chr_02018 
Phosphate transport system permease protein 
PstA 2 Serum 0.00114 4.84 
Sp180_2_chr_02017 
Phosphate transport system permease protein 
PstC 1 Serum 0.00123 4.94 





Nicotinamgene_ide ribosgene_ide transporter 
PnuC Serum 6.15E-06 5.49 
Sp180_2_chr_01126 
2-oxoisovalerate dehydrogenase subunit beta 
bfmBAB Serum 4.97E-09 6.07 
Sp180_2_chr_01123 Lipoate-protein ligase LplJ Serum 1.02E-08 6.11 
Sp180_2_chr_01125 
Dihydrolipoyllysine-resgene_idue 
acetyltransferase component of pyruvate 
dehydrogenase complex pdhC Serum 4.97E-09 6.19 

































Appendix M. Pneumococcal differential gene expression in the lungs 6 h post-infection, 947 vs 
947M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values highlighted 
in blue = upregulated in 947, while values highlighted in red = upregulated in 947M. 
Locus tag in 947 Product padj FC 
Sp947_chr_00844 Sialidase B 3.08E-10 313.9807 
Sp947_chr_02077 hypothetical protein 4.46E-10 306.9412 
Sp947_chr_00842 Sodium/glucose cotransporter 2.22E-09 243.4822 
Sp947_chr_00841 N-acetylneuraminate lyase 4.53E-09 227.7963 
Sp947_chr_00845 scyllo-inositol 2-dehydrogenase (NAD(+)) 4.36E-09 221.051 
Sp947_chr_00848 hypothetical protein 1.19E-08 202.7867 
Sp947_chr_00853 V-type sodium ATPase catalytic subunit A 1.29E-06 100.5411 
Sp947_chr_00846 Beta-glucoside kinase 3.42E-06 98.18951 
Sp947_chr_00855 V-type sodium ATPase subunit D 8.34E-06 85.94879 
Sp947_chr_00851 V-type sodium ATPase subunit C 2.50E-05 72.46612 
Sp947_chr_00843 hypothetical protein 2.17E-05 65.97758 
Sp947_chr_00839 HTH-type transcriptional regulator RpiR 3.09E-05 61.28171 
Sp947_chr_00854 V-type sodium ATPase subunit B 1.32E-06 50.86992 
Sp947_chr_00120 hypothetical protein 3.00E-04 45.77325 
Sp947_chr_02078 hypothetical protein 1.52E-04 45.42925 
Sp947_chr_00852 V-type sodium ATPase subunit G 5.34E-04 44.97311 
Sp947_chr_01964 
3-keto-L-gulonate-6-phosphate decarboxylase 
UlaD 1.36E-03 44.2113 
Sp947_chr_00850 V-type proton ATPase subunit E 9.39E-04 39.74672 
Sp947_chr_00840 
Putative N-acetylmannosamine-6-phosphate 
2-epimerase 4.32E-04 37.87573 
Sp947_chr_01963 L-ribulose-5-phosphate 3-epimerase UlaE 2.11E-03 37.77052 
Sp947_chr_01962 L-ribulose-5-phosphate 4-epimerase AraD 2.75E-03 35.23993 
Sp947_chr_00849 V-type sodium ATPase subunit K 2.25E-03 34.7923 
Sp947_chr_01960 
putative L-ascorbate-6-phosphate lactonase 
UlaG 1.16E-03 34.0495 
Sp947_chr_00847 hypothetical protein 3.85E-03 30.78829 
Sp947_chr_00118 hypothetical protein 2.13E-03 30.10216 
Sp947_chr_00631 hypothetical protein 1.22E-04 28.36211 
Sp947_chr_01965 
Ascorbate-specific PTS system EIIA 
component 8.94E-03 28.12967 
Sp947_chr_00632 ABC transporter ATP-binding protein YxdL 7.13E-03 26.82578 
Sp947_chr_00117 hypothetical protein 9.36E-03 21.85911 
Sp947_chr_00116 hypothetical protein 1.27E-02 20.39713 
Sp947_chr_02096 hypothetical protein 2.92E-07 18.61494 
Sp947_chr_01966 
Ascorbate-specific PTS system EIIB 
component 5.76E-02 18.33251 
Sp947_chr_01967 
Ascorbate-specific PTS system EIIC 
component 1.17E-02 14.29112 
Sp947_chr_00630 hypothetical protein 4.67E-02 14.26137 
Sp947_chr_01105 Transcription antiterminator LicT 5.76E-02 12.54562 
Sp947_chr_00122 hypothetical protein 5.11E-02 12.44502 
Sp947_chr_00111 
Lactococcin-G-processing and transport ATP-
binding protein LagD 8.11E-02 12.07699 
Sp947_chr_01629 
PTS system trehalose-specific EIIBC 
component 3.15E-18 11.47534 
Sp947_chr_00637 hypothetical protein 8.81E-02 11.10599 
Sp947_chr_00119 hypothetical protein 2.96E-02 10.07432 
Sp947_chr_01187 hypothetical protein 5.24E-02 8.833295 
Sp947_chr_01975 Ubiquinone biosynthesis O-methyltransferase 5.86E-02 8.275917 
Sp947_chr_00702 Maltose 6'-phosphate phosphatase 2.91E-01 8.131911 




Sp947_chr_01982 ComG operon protein 1 1.19E-04 7.374729 
Sp947_chr_00133 hypothetical protein 6.34E-04 7.228914 
Sp947_chr_02066 hypothetical protein 2.74E-01 7.180618 
Sp947_chr_01949 hypothetical protein 2.49E-01 7.107773 
Sp947_chr_02151 ComF operon protein 1 2.86E-01 6.998242 
Sp947_chr_01923 tRNA-Pro(tgg) 3.04E-01 6.979745 
Sp947_chr_01980 hypothetical protein 3.75E-02 6.946905 
Sp947_chr_02094 Ornithine carbamoyltransferase%2C catabolic 1.29E-13 6.850913 
Sp947_chr_00240 Glucitol operon repressor 2.50E-01 6.725672 
Sp947_chr_00922 ComE operon protein 1 2.64E-01 6.597975 
Sp947_chr_01978 hypothetical protein 1.39E-01 6.480978 
Sp947_chr_01277 hypothetical protein 1.43E-01 6.459624 
Sp947_chr_00112 hypothetical protein 2.91E-01 6.188522 
Sp947_chr_02128 putative glycerol uptake facilitator protein 4.20E-14 6.053371 
Sp947_chr_01120 hypothetical protein 3.51E-01 6.024365 
Sp947_chr_01977 hypothetical protein 6.78E-02 5.999717 
Sp947_chr_00794 tRNA-Gln(ttg) 3.91E-01 5.87385 
Sp947_chr_01979 hypothetical protein 2.88E-02 5.870884 
Sp947_chr_02129 Alpha-glycerophosphate oxidase 1.19E-37 5.867422 
Sp947_chr_02097 Putative dipeptidase 1.26E-04 5.831657 
Sp947_chr_00134 hypothetical protein 1.28E-02 5.621892 
Sp947_chr_00659 Aminopyrimidine aminohydrolase 3.95E-01 5.584997 
Sp947_chr_02130 Glycerol kinase 1.19E-27 5.564175 
Sp947_chr_00147 UDP-glucose 6-dehydrogenase 6.94E-02 5.536174 
Sp947_chr_02065 hypothetical protein 2.63E-01 5.252184 
Sp947_chr_01700 
Inner membrane ABC transporter permease 
protein YcjP 2.73E-01 5.193315 
Sp947_chr_02072 1-deoxy-D-xylulose-5-phosphate synthase 2.52E-02 5.114776 
Sp947_chr_01044 3-isopropylmalate dehydratase small subunit 4.14E-01 4.950902 
Sp947_chr_02093 Arginine deiminase 6.29E-05 4.916879 
Sp947_chr_00981 Queuosine precursor transporter QueT 2.91E-01 4.902071 
Sp947_chr_00135 
tRNA threonylcarbamoyladenosine 
biosynthesis protein TsaB 2.15E-01 4.652439 
Sp947_chr_02029 Phosphate-binding protein PstS 2 1.20E-06 4.568416 
Sp947_chr_01119 hypothetical protein 3.89E-01 4.33514 
Sp947_chr_00105 hypothetical protein 2.35E-06 4.320641 
Sp947_chr_01601 hypothetical protein 1.99E-01 4.317593 
Sp947_chr_01585 hypothetical protein 9.40E-06 4.244689 
Sp947_chr_02095 Carbamate kinase 1 2.88E-02 4.210313 
Sp947_chr_01582 Beta-glucoside kinase 8.39E-11 4.021705 
Sp947_chr_02074 
Ascorbate-specific PTS system EIIC 
component 4.93E-02 3.969839 
Sp947_chr_00983 asd 1.88E-02 3.920181 
Sp947_chr_02073 Transketolase 1.04E-01 3.916258 
Sp947_chr_00390 Glycine 3.47E-01 3.883027 
Sp947_chr_01611 hypothetical protein 4.51E-01 3.86601 
Sp947_chr_00146 2'-N-acetylparomamine deacetylase 1.44E-01 3.836192 
Sp947_chr_00145 hypothetical protein 2.43E-02 3.78253 
Sp947_chr_00149 hypothetical protein 1.96E-43 3.78179 
Sp947_chr_01772 Iron-uptake system permease protein FeuB 1.10E-02 3.780349 
Sp947_chr_00109 Argininosuccinate synthase 1.38E-01 3.732843 
Sp947_chr_01631 HTH-type transcriptional regulator DegA 2.19E-02 3.731615 
Sp947_chr_01262 Putative endo-beta-N-acetylglucosaminidase 8.15E-02 3.596429 
Sp947_chr_01107 
PTS system lactose-specific EIICB 
component 1.35E-02 3.562908 





putative ABC transporter ATP-binding protein 
YheS 6.78E-02 3.438094 
Sp947_chr_00108 Arginine-binding extracellular protein ArtP 1.51E-01 3.41617 
Sp947_chr_01108 6-phospho-beta-galactosidase 7.85E-02 3.360241 
Sp947_chr_00649 ABC transporter ATP-binding protein NatA 1.01E-01 3.333401 
Sp947_chr_01835 Single-stranded DNA-binding protein 7.89E-05 3.281171 
Sp947_chr_00055 hypothetical protein 2.19E-04 3.207721 
Sp947_chr_00144 hypothetical protein 2.73E-01 3.138686 
Sp947_chr_00641 Fluoroquinolones export ATP-binding protein 5.76E-02 3.109696 
Sp947_chr_01747 hypothetical protein 4.93E-01 3.109528 
Sp947_chr_01587 
L-arabinose transport system permease protein 
AraQ 5.18E-09 3.081995 
Sp947_chr_01976 hypothetical protein 1.08E-01 3.078674 
Sp947_chr_01155 Glucose-1-phosphate adenylyltransferase 1.41E-05 3.071928 
Sp947_chr_01228 Tyrosine-protein phosphatase 3.76E-02 3.048501 
Sp947_chr_01154 Glycogen biosynthesis protein GlgD 3.87E-05 2.954565 
Sp947_chr_01100 hypothetical protein 4.09E-01 2.889683 
Sp947_chr_01993 hypothetical protein 2.76E-03 2.87091 
Sp947_chr_01263 Autolysin 2.73E-01 2.870719 
Sp947_chr_01613 hypothetical protein 3.54E-01 2.855586 
Sp947_chr_01588 
Lactose transport system permease protein 
LacF 8.93E-08 2.852978 
Sp947_chr_00608 putative response regulatory protein 1.10E-09 2.84383 
Sp947_chr_01600 Sialidase A 1.33E-17 2.819847 
Sp947_chr_00173 6%2C7-dimethyl-8-ribityllumazine synthase 4.42E-01 2.814878 
Sp947_chr_00069 
Putative tagatose-6-phosphate ketose/aldose 
isomerase 5.19E-08 2.76399 
Sp947_chr_01584 hypothetical protein 1.66E-03 2.762851 
Sp947_chr_00521 hypothetical protein 3.78E-01 2.762754 
Sp947_chr_00250 hypothetical protein 4.70E-01 2.727314 
Sp947_chr_00721 hypothetical protein 3.97E-01 2.68465 
Sp947_chr_00987 2-hydroxymuconate tautomerase 4.81E-01 2.666089 
Sp947_chr_01388 hypothetical protein 1.16E-01 2.622464 
Sp947_chr_00923 ComE operon protein 3 2.15E-01 2.594794 
Sp947_chr_01013 Serine recombinase PinR 1.76E-01 2.580421 
Sp947_chr_01586 Toxin-antitoxin biofilm protein TabA 1.04E-02 2.560526 
Sp947_chr_00023 
competence protein ComW, recombinase 
RecX 3.57E-01 2.551904 
Sp947_chr_01453 hypothetical protein 2.91E-01 2.548217 
Sp947_chr_00480 hypothetical protein 2.60E-01 2.514127 
Sp947_chr_00067 
PTS system mannose-specific EIID 
component 4.61E-05 2.500185 
Sp947_chr_02076 
Mannitol-specific cryptic phosphotransferase 
enzyme IIA component 4.56E-01 2.444106 
Sp947_chr_01589 
Putative ABC transporter substrate-binding 
protein YesO 4.02E-17 2.425022 
Sp947_chr_00052 Amidophosphoribosyltransferase 2.35E-06 2.408122 
Sp947_chr_00457 hypothetical protein 3.54E-01 2.390357 
Sp947_chr_01583 N-acetylneuraminate lyase 4.63E-06 2.376665 
Sp947_chr_00925 hypothetical protein 4.93E-02 2.375513 
Sp947_chr_01278 50S ribosomal protein L7/L12 2.41E-07 2.35971 
Sp947_chr_00053 
Phosphoribosylformylglycinamidine cyclo-
ligase 1.21E-05 2.353489 
Sp947_chr_02127 hypothetical protein 4.95E-02 2.308295 
Sp947_chr_02131 hypothetical protein 3.40E-01 2.301176 
Sp947_chr_01756 Acyl-coenzyme A thioesterase PaaI 3.75E-01 2.288928 





putative ABC transporter solute-binding 
protein YclQ 1.34E-01 2.268465 
Sp947_chr_00005 Peptidyl-tRNA hydrolase 3.69E-01 2.265023 
Sp947_chr_01153 Glycogen synthase 5.10E-03 2.260835 
Sp947_chr_01101 
Galactose-6-phosphate isomerase subunit 
LacA 2.16E-01 2.243408 
Sp947_chr_00476 Protein GrpE 9.93E-04 2.233808 
Sp947_chr_00638 hypothetical protein 3.54E-01 2.218743 
Sp947_chr_02032 Phosphate import ATP-binding protein PstB 3 2.74E-02 2.215497 
Sp947_chr_01224 hypothetical protein 3.49E-01 2.207203 
Sp947_chr_01810 tRNA-Ser(tga) 4.13E-01 2.19757 
Sp947_chr_00762 Purine nucleoside phosphorylase 1 1.20E-01 2.193752 
Sp947_chr_01803 HTH-type transcriptional regulator CdhR 3.03E-01 2.193316 
Sp947_chr_02007 tRNA-Gly(tcc) 4.74E-01 2.1921 
Sp947_chr_00827 
Type-1 restriction enzyme EcoKI specificity 
protein 2.00E-01 2.190873 
Sp947_chr_01630 Sucrose-6-phosphate hydrolase 3.05E-02 2.18504 
Sp947_chr_00106 hypothetical protein 3.27E-03 2.177719 
Sp947_chr_00066 PTS system sorbose-specific EIIC component 3.08E-03 2.174249 
Sp947_chr_02030 
Phosphate transport system permease protein 
PstC 1 8.44E-02 2.167527 
Sp947_chr_00150 Nisin biosynthesis protein NisB 7.57E-23 2.163768 
Sp947_chr_01099 hypothetical protein 3.93E-01 2.157605 
Sp947_chr_01479 DegV domain-containing protein 7.47E-03 2.15692 
Sp947_chr_02062 hypothetical protein 2.49E-01 2.144907 
Sp947_chr_00607 
Peptide methionine sulfoxide reductase 
MsrA/MsrB 1.57E-06 2.132922 
Sp947_chr_00017 tRNA-Ala(tgc) 4.70E-01 2.123204 
Sp947_chr_01824 tRNA-Ala(tgc) 4.70E-01 2.123204 
Sp947_chr_01934 tRNA-Ala(tgc) 4.70E-01 2.123204 
Sp947_chr_02011 tRNA-Ala(tgc) 4.70E-01 2.123204 
Sp947_chr_00140 hypothetical protein 4.86E-01 2.122109 
Sp947_chr_01612 
Molybdenum import ATP-binding protein 
ModC 3.11E-01 2.120579 
Sp947_chr_01773 
Ferric enterobactin transport system permease 
protein FepD 2.48E-01 2.118436 
Sp947_chr_00477 Chaperone protein DnaK 3.11E-11 2.118333 
Sp947_chr_00645 hypothetical protein 1.33E-01 2.110241 
Sp947_chr_00056 Bifunctional purine biosynthesis protein PurH 2.62E-06 2.095397 
Sp947_chr_00496 Bacteriocin lactacin-F subunit LafA 4.09E-01 2.074411 
Sp947_chr_01478 4-hydroxy-tetrahydrodipicolinate reductase 1.97E-02 2.068728 
Sp947_chr_02033 
Phosphate-specific transport system accessory 
protein PhoU  3.11E-02 2.04991 
Sp947_chr_00174 Riboflavin biosynthesis protein RibBA 2.98E-01 2.047245 
Sp947_chr_01231 hypothetical protein 2.17E-01 2.042865 
Sp947_chr_00152 hypothetical protein 1.87E-20 2.035498 
Sp947_chr_02063 hypothetical protein 4.93E-01 2.032609 
Sp947_chr_00054 Phosphoribosylglycinamide formyltransferase 2.39E-02 2.031196 
Sp947_chr_01614 hypothetical protein 3.71E-01 2.028597 
Sp947_chr_02031 
Phosphate transport system permease protein 
PstA 2 7.01E-02 2.026564 
Sp947_chr_00475 Heat-inducible transcription repressor HrcA 7.89E-05 2.006056 
Sp947_chr_02088 Beta-glucoside kinase 5.00E-01 2.004401 
Sp947_chr_01317 
HTH-type transcriptional regulatory protein 
GabR 3.80E-01 2.004158 
Sp947_chr_02092 hypothetical protein 4.45E-01 2.004096 




Sp947_chr_01847 putative transcriptional regulatory protein 2.22E-05 2.113858 
Sp947_chr_01234 UTP--glucose-1-phosphate uridylyltransferase 6.67E-04 2.154403 
Sp947_chr_01238 Ribitol-5-phosphate cytidylyltransferase 1.32E-04 2.183908 
Sp947_chr_00859 Arginine regulator 4.52E-03 2.209799 
Sp947_chr_01055 Glucose-6-phosphate 1-dehydrogenase 2.31E-14 2.212385 
Sp947_chr_01293 Regulatory protein MsrR 2.28E-03 2.222293 
Sp947_chr_01640 
Ribosomal RNA small subunit 
methyltransferase B 9.93E-04 2.225681 
Sp947_chr_00191 Folylpolyglutamate synthase 3.11E-02 2.250767 
Sp947_chr_01653 hypothetical protein 1.43E-02 2.295077 
Sp947_chr_01300 3-dehydroquinate synthase 2.71E-02 2.309334 
Sp947_chr_00490 
Lactococcin-G-processing and transport ATP-
binding protein LagD 2.35E-06 2.364015 
Sp947_chr_01419 Arginine-binding extracellular protein ArtP 4.40E-07 2.398254 
Sp947_chr_01447 
Multidrug resistance ABC transporter ATP-
binding/permease protein BmrA 1.06E-02 2.404999 
Sp947_chr_00613 
2-succinyl-6-hydroxy-2%2C4-
cyclohexadiene-1-carboxylate synthase 4.54E-02 2.488993 
Sp947_chr_02091 hypothetical protein 9.36E-03 2.491938 
Sp947_chr_01850 hypothetical protein 4.99E-05 2.506163 
Sp947_chr_01236 hypothetical protein 4.88E-06 2.557541 
Sp947_chr_01851 hypothetical protein 2.43E-03 2.891242 
Sp947_chr_01237 Ribulose-5-phosphate reductase 1.55E-09 2.935155 
Sp947_chr_01235 hypothetical protein 4.67E-09 3.067205 
Sp947_chr_01848 Pneumolysin 7.93E-20 3.074683 
Sp947_chr_01445 
Multidrug resistance ABC transporter ATP-
binding and permease protein 9.93E-04 3.429428 
Sp947_chr_01421 
L-cystine transport system permease protein 
YecS 4.60E-05 3.567119 
Sp947_chr_01952 Lichenan permease IIC component 3.40E-03 3.631755 
Sp947_chr_01849 hypothetical protein 8.04E-09 3.899592 
Sp947_chr_01951 6-phospho-beta-glucosidase GmuD 6.09E-04 4.38906 
Sp947_chr_00675 Pyruvate oxidase 2.48E-78 5.288241 
Sp947_chr_00722 Biotin transporter BioY2 9.36E-03 7.135698 
Sp947_chr_01592 scyllo-inositol 2-dehydrogenase (NAD(+)) 7.65E-10 16.61538 
Sp947_chr_01596 
Inner membrane ABC transporter permease 
protein YcjO 1.70E-07 17.3257 
Sp947_chr_01598 Evolved beta-galactosidase subunit beta 7.36E-05 17.8072 
Sp947_chr_01595 
Inner membrane ABC transporter permease 
protein YcjP 1.12E-06 19.42745 
Sp947_chr_01599 hypothetical protein 2.80E-03 23.35696 
Sp947_chr_01597 
Putative ABC transporter substrate-binding 












Appendix N. Pneumococcal differential gene expression in the lungs 6 h post-infection, 947 vs 
4559. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values highlighted 
in blue = upregulated in 947, while values highlighted in red = upregulated in 4559. 
Locus tag in 947 Product padj FC 
Sp947_chr_01964 
3-keto-L-gulonate-6-phosphate decarboxylase 
UlaD 9.92E-03 24.34795 
Sp947_chr_00305 Unsaturated chondroitin disaccharide hydrolase 7.83E-03 23.54004 
Sp947_chr_01629 PTS system trehalose-specific EIIBC component 2.80E-19 18.65254 
Sp947_chr_01663 hypothetical protein 4.24E-02 17.40567 
Sp947_chr_00108 Arginine-binding extracellular protein ArtP 9.63E-03 15.89418 
Sp947_chr_00309 hypothetical protein 4.66E-02 15.73089 
Sp947_chr_01967 Ascorbate-specific PTS system EIIC component 1.09E-02 15.09351 
Sp947_chr_00109 Argininosuccinate synthase 1.64E-02 13.49916 
Sp947_chr_01318 Glutamine-binding periplasmic protein 2.64E-07 7.648698 
Sp947_chr_01667 Accessory Sec system protein Asp3 4.58E-02 7.043576 
Sp947_chr_01630 Sucrose-6-phosphate hydrolase 1.00E-06 6.702188 
Sp947_chr_02097 Putative dipeptidase 5.39E-05 6.495677 
Sp947_chr_01672 General stress protein A 3.63E-19 5.924728 
Sp947_chr_01670 
Accessory Sec system protein translocase subunit 
SecY2 3.19E-05 5.757463 
Sp947_chr_01631 HTH-type transcriptional regulator DegA 3.19E-03 5.461813 
Sp947_chr_00308 PTS system mannose-specific EIID component 3.92E-02 4.864117 
Sp947_chr_00854 V-type sodium ATPase subunit B 2.52E-06 4.860106 
Sp947_chr_01671 Beta-1%2C6-galactofuranosyltransferase WbbI 2.36E-05 4.837304 
Sp947_chr_02096 hypothetical protein 2.73E-05 4.789669 
Sp947_chr_01560 putative thiol peroxidase 6.59E-14 4.443783 
Sp947_chr_01666 Protein translocase subunit SecA 2.98E-07 4.414981 
Sp947_chr_01665 Glycosyltransferase Gtf1 2.51E-05 4.413495 
Sp947_chr_01920 
putative ABC transporter ATP-binding protein 
YxlF 1.07E-07 4.401048 
Sp947_chr_00855 V-type sodium ATPase subunit D 4.26E-03 4.394869 
Sp947_chr_01081 L-methionine gamma-lyase 3.24E-04 4.297872 
Sp947_chr_01447 
Multidrug resistance ABC transporter ATP-
binding/permease protein BmrA 4.48E-03 4.165307 
Sp947_chr_01444 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase 6.76E-04 4.10799 
Sp947_chr_01772 Iron-uptake system permease protein FeuB 6.06E-03 4.051281 
Sp947_chr_01673 General stress protein A 1.82E-06 4.024977 
Sp947_chr_01669 hypothetical protein 2.01E-04 4.019284 
Sp947_chr_01443 Cystathionine beta-lyase PatB 6.28E-04 4.001289 
Sp947_chr_01664 Glycosyltransferase-stabilizing protein Gtf2 6.80E-05 3.991404 
Sp947_chr_00104 putative cell wall hydrolase LytN 6.33E-10 3.97022 
Sp947_chr_01448 Oligopeptide-binding protein SarA 8.69E-35 3.885765 
Sp947_chr_02094 Ornithine carbamoyltransferase%2C catabolic 2.27E-09 3.843469 
Sp947_chr_02093 Arginine deiminase 1.20E-03 3.624133 
Sp947_chr_01668 Accessory Sec system protein Asp2 9.01E-04 3.57589 
Sp947_chr_01993 hypothetical protein 2.75E-04 3.5502 
Sp947_chr_00262 Alkanal monooxygenase alpha chain 4.20E-02 3.513196 
Sp947_chr_00631 hypothetical protein 6.86E-03 3.468201 
Sp947_chr_01628 Putative fructokinase 3.76E-02 3.396119 
Sp947_chr_01674 putative glycosyltransferase EpsJ 3.86E-03 3.263426 
Sp947_chr_02070 hypothetical protein 3.40E-02 3.249364 
Sp947_chr_00169 hypothetical protein 1.81E-12 3.175252 
Sp947_chr_00105 hypothetical protein 9.82E-05 3.113409 
Sp947_chr_00544 5%2C10-methylenetetrahydrofolate reductase 6.48E-07 3.063051 




Sp947_chr_01919 hypothetical protein 6.43E-04 3.008033 
Sp947_chr_00148 hypothetical protein 3.11E-03 2.944036 
Sp947_chr_00846 Beta-glucoside kinase 2.93E-02 2.853877 
Sp947_chr_01724 Tryptophan synthase beta chain 8.91E-04 2.848494 
Sp947_chr_01917 Transcriptional regulatory protein DesR 1.30E-04 2.799649 
Sp947_chr_01157 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase 5.07E-05 2.764121 
Sp947_chr_00161 Methionine import ATP-binding protein MetN 6.86E-03 2.745542 
Sp947_chr_01732 T-box 4.38E-02 2.72911 
Sp947_chr_01840 hypothetical protein 2.90E-03 2.691428 
Sp947_chr_00425 Acetolactate synthase large subunit 1.12E-15 2.650045 
Sp947_chr_00848 hypothetical protein 5.95E-04 2.637928 
Sp947_chr_00845 scyllo-inositol 2-dehydrogenase (NAD(+)) 4.49E-07 2.594575 
Sp947_chr_01918 Sensor histidine kinase DesK 1.20E-05 2.551678 
Sp947_chr_00844 Sialidase B 1.14E-08 2.530319 
Sp947_chr_00692 
Leucine-%2C isoleucine-%2C valine-%2C 
threonine-%2C and alanine-binding protein 2.08E-05 2.499057 
Sp947_chr_02160 Secreted 45 kDa protein 1.55E-13 2.495737 
Sp947_chr_00476 Protein GrpE 2.01E-04 2.420533 
Sp947_chr_00787 Branched-chain-amino-acid aminotransferase 1.35E-07 2.395717 
Sp947_chr_01424 6-phosphogluconolactonase 5.77E-04 2.345615 
Sp947_chr_01660 Serine/threonine transporter SstT 2.89E-04 2.303845 
Sp947_chr_00232 
2%2C3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 3.88E-02 2.243558 
Sp947_chr_00842 Sodium/glucose cotransporter 2.08E-05 2.238557 
Sp947_chr_01276 NADP-specific glutamate dehydrogenase 9.86E-19 2.229232 
Sp947_chr_01391 Pyridoxal 5'-phosphate synthase subunit PdxS 1.61E-04 2.172842 
Sp947_chr_00696 
High-affinity branched-chain amino acid transport 
ATP-binding protein LivF 4.48E-03 2.171266 
Sp947_chr_01661 hypothetical protein 2.04E-02 2.153858 
Sp947_chr_00853 V-type sodium ATPase catalytic subunit A 9.55E-03 2.130379 
Sp947_chr_00543 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase 2.38E-05 2.118701 
Sp947_chr_00695 
Lipopolysaccharide export system ATP-binding 
protein LptB 2.08E-02 2.098421 
Sp947_chr_00153 hypothetical protein 2.00E-19 2.013755 
Sp947_chr_01394 NADH-dependent flavin reductase subunit 2 3.48E-02 2.043274 
Sp947_chr_00205 30S ribosomal protein S19 2.68E-08 2.057637 
Sp947_chr_00489 Lactococcin A secretion protein LcnD 5.57E-07 2.137788 
Sp947_chr_00057 Phosphoribosylamine--glycine ligase 2.04E-02 2.148252 
Sp947_chr_00155 hypothetical protein 1.27E-26 2.163473 
Sp947_chr_00151 Nisin biosynthesis protein NisC 3.70E-31 2.171804 
Sp947_chr_00498 hypothetical protein 3.74E-02 2.222467 
Sp947_chr_02091 hypothetical protein 2.88E-02 2.230061 
Sp947_chr_01955 Aldehyde-alcohol dehydrogenase 3.36E-10 2.239625 
Sp947_chr_00490 
Lactococcin-G-processing and transport ATP-
binding protein LagD 1.15E-05 2.2462 
Sp947_chr_02054 Maltose transport system permease protein MalG 2.55E-03 2.250996 
Sp947_chr_00152 hypothetical protein 3.16E-35 2.253763 
Sp947_chr_02053 Maltose transport system permease protein MalF 6.34E-05 2.292191 
Sp947_chr_00157 L-cystine-binding protein TcyA 2.04E-02 2.305243 
Sp947_chr_00491 hypothetical protein 2.93E-08 2.319449 
Sp947_chr_00150 Nisin biosynthesis protein NisB 2.65E-31 2.324591 
Sp947_chr_00499 hypothetical protein 2.99E-04 2.378979 
Sp947_chr_00154 hypothetical protein 4.99E-25 2.443422 
Sp947_chr_00281 Guanine/hypoxanthine permease PbuO 5.57E-07 2.494449 




Sp947_chr_01178 NAD kinase 5.94E-03 2.564431 
Sp947_chr_00050 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 1.84E-02 2.58736 
Sp947_chr_00263 Pullulanase 6.02E-06 2.823468 
Sp947_chr_00440 Formate acetyltransferase 2.27E-52 2.85616 
Sp947_chr_00279 Alcohol dehydrogenase 1 5.38E-07 3.088478 
Sp947_chr_01753 Uric acid permease PucK 2.63E-06 3.150544 
Sp947_chr_00156 hypothetical protein 1.25E-03 3.349079 
Sp947_chr_01798 Sucrose phosphorylase 3.67E-02 3.943655 
Sp947_chr_00282 hypothetical protein 5.77E-04 5.106822 
Sp947_chr_01802 
Bifunctional alpha-galactosidase/sucrose kinase 
AgaSK 2.44E-03 5.116292 
Sp947_chr_00676 hypothetical protein 1.18E-02 6.452692 
Sp947_chr_01801 Multiple sugar-binding protein 4.56E-03 6.788077 
Sp947_chr_00675 Pyruvate oxidase 7.84E-110 6.915359 
Sp947_chr_01592 scyllo-inositol 2-dehydrogenase (NAD(+)) 8.87E-15 29.54277 
Sp947_chr_01596 
Inner membrane ABC transporter permease 
protein YcjO 2.70E-13 42.27417 
Sp947_chr_01598 Evolved beta-galactosidase subunit beta 2.11E-08 45.04628 
Sp947_chr_01595 
Inner membrane ABC transporter permease 
protein YcjP 9.79E-12 49.58462 
Sp947_chr_01599 hypothetical protein 3.26E-06 80.56657 
Sp947_chr_01597 
Putative ABC transporter substrate-binding 























Appendix O. Pneumococcal differential gene expression in the lungs 6 h post-infection, 947 vs 
4559M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values 
highlighted in blue = upregulated in 947, while values highlighted in red = upregulated in 4559M. 
Locus tag in 947 Product padj FC 
Sp947_chr_01081 L-methionine gamma-lyase 2.01E-06 6.049978 
Sp947_chr_01629 PTS system trehalose-specific EIIBC component 4.32E-17 5.71303 
Sp947_chr_01673 General stress protein A 2.68E-09 4.856349 
Sp947_chr_01318 Glutamine-binding periplasmic protein 3.42E-07 4.661576 
Sp947_chr_01448 Oligopeptide-binding protein SarA 1.19E-45 4.251728 
Sp947_chr_01671 Beta-1%2C6-galactofuranosyltransferase WbbI 5.13E-06 4.200336 
Sp947_chr_02096 hypothetical protein 1.64E-05 4.131014 
Sp947_chr_02097 Putative dipeptidase 2.74E-04 3.935156 
Sp947_chr_00544 5%2C10-methylenetetrahydrofolate reductase 4.34E-11 3.926284 
Sp947_chr_01630 Sucrose-6-phosphate hydrolase 1.32E-05 3.842564 
Sp947_chr_00105 hypothetical protein 9.16E-07 3.720141 
Sp947_chr_01674 putative glycosyltransferase EpsJ 2.97E-04 3.645955 
Sp947_chr_02093 Arginine deiminase 6.31E-04 3.638204 
Sp947_chr_02094 Ornithine carbamoyltransferase%2C catabolic 2.11E-10 3.595965 
Sp947_chr_01669 hypothetical protein 9.12E-05 3.520343 
Sp947_chr_00145 hypothetical protein 1.10E-02 3.437721 
Sp947_chr_01672 General stress protein A 3.78E-14 3.337295 
Sp947_chr_01444 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase 6.68E-04 3.323343 
Sp947_chr_01628 Putative fructokinase 1.81E-02 3.312402 
Sp947_chr_01993 hypothetical protein 1.09E-04 3.292474 
Sp947_chr_00104 putative cell wall hydrolase LytN 9.04E-10 3.274894 
Sp947_chr_01668 Accessory Sec system protein Asp2 3.58E-04 3.271471 
Sp947_chr_02070 hypothetical protein 1.33E-02 3.268113 
Sp947_chr_01631 HTH-type transcriptional regulator DegA 1.62E-02 3.241793 
Sp947_chr_01666 Protein translocase subunit SecA 1.86E-06 3.194154 
Sp947_chr_01560 putative thiol peroxidase 1.87E-11 3.156039 
Sp947_chr_00148 hypothetical protein 3.69E-04 3.143065 
Sp947_chr_00843 hypothetical protein 6.34E-04 3.140506 
Sp947_chr_01446 
Multidrug resistance ABC transporter ATP-binding 
and permease protein 2.44E-02 3.095084 
Sp947_chr_00631 hypothetical protein 5.70E-03 3.078157 
Sp947_chr_01670 
Accessory Sec system protein translocase subunit 
SecY2 6.16E-04 3.060934 
Sp947_chr_01447 
Multidrug resistance ABC transporter ATP-
binding/permease protein BmrA 6.68E-03 3.030447 
Sp947_chr_01665 Glycosyltransferase Gtf1 2.91E-04 2.877465 
Sp947_chr_00846 Beta-glucoside kinase 1.36E-02 2.854048 
Sp947_chr_01664 Glycosyltransferase-stabilizing protein Gtf2 4.96E-04 2.799165 
Sp947_chr_01660 Serine/threonine transporter SstT 1.28E-06 2.757889 
Sp947_chr_00855 V-type sodium ATPase subunit D 4.10E-02 2.573402 
Sp947_chr_01772 Iron-uptake system permease protein FeuB 3.65E-02 2.566198 
Sp947_chr_01443 Cystathionine beta-lyase PatB 1.32E-02 2.466567 
Sp947_chr_00695 
Lipopolysaccharide export system ATP-binding 
protein LptB 1.70E-03 2.4024 
Sp947_chr_00854 V-type sodium ATPase subunit B 2.76E-03 2.359804 
Sp947_chr_01157 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase 1.59E-04 2.339795 
Sp947_chr_00169 hypothetical protein 4.71E-09 2.339571 
Sp947_chr_00692 
Leucine-%2C isoleucine-%2C valine-%2C 






homocysteine methyltransferase 2.80E-07 2.29823 
Sp947_chr_01661 hypothetical protein 5.48E-03 2.245706 
Sp947_chr_00701 PTS system glucose-specific EIICBA component 2.24E-04 2.216955 
Sp947_chr_01985 N-acetylglucosamine-6-phosphate deacetylase 1.28E-06 2.199836 
Sp947_chr_00845 scyllo-inositol 2-dehydrogenase (NAD(+)) 6.36E-06 2.193442 
Sp947_chr_00967 putative amino acid permease YhdG 6.47E-03 2.175611 
Sp947_chr_00853 V-type sodium ATPase catalytic subunit A 2.93E-03 2.171867 
Sp947_chr_00747 hypothetical protein 1.16E-02 2.164988 
Sp947_chr_01984 Alcohol dehydrogenase 6.59E-05 2.143827 
Sp947_chr_02160 Secreted 45 kDa protein 5.54E-11 2.11217 
Sp947_chr_00696 
High-affinity branched-chain amino acid transport 
ATP-binding protein LivF 2.42E-03 2.088927 
Sp947_chr_00844 Sialidase B 1.59E-06 2.076986 
Sp947_chr_01840 hypothetical protein 1.72E-02 2.063451 
Sp947_chr_00842 Sodium/glucose cotransporter 4.98E-05 2.058073 
Sp947_chr_00787 Branched-chain-amino-acid aminotransferase 2.56E-06 2.038246 
Sp947_chr_02071 Dihydroxy-acid dehydratase 1.13E-06 2.036651 
Sp947_chr_00841 N-acetylneuraminate lyase 2.76E-03 2.028736 
Sp947_chr_00219 50S ribosomal protein L30 4.02E-06 2.006281 
Sp947_chr_01505 putative MFS-type transporter YhjX 1.81E-02 2.023671 
Sp947_chr_00337 Putative O-antigen transporter 1.76E-08 2.108266 
Sp947_chr_00285 GTP cyclohydrolase 1 7.38E-03 2.146718 
Sp947_chr_01309 Spermidine/putrescine-binding periplasmic protein 9.70E-03 2.183815 
Sp947_chr_00051 Phosphoribosylformylglycinamidine synthase 2.50E-18 2.248477 
Sp947_chr_00499 hypothetical protein 3.77E-04 2.270129 
Sp947_chr_00489 Lactococcin A secretion protein LcnD 4.44E-09 2.301998 
Sp947_chr_00057 Phosphoribosylamine--glycine ligase 3.82E-03 2.336422 
Sp947_chr_01178 NAD kinase 7.88E-03 2.39753 
Sp947_chr_00440 Formate acetyltransferase 4.09E-39 2.453134 
Sp947_chr_00491 hypothetical protein 2.44E-11 2.578315 
Sp947_chr_01048 GMP reductase 1.47E-04 2.657956 
Sp947_chr_00060 hypothetical protein 2.11E-02 2.684809 
Sp947_chr_00490 
Lactococcin-G-processing and transport ATP-
binding protein LagD 8.32E-10 2.783617 
Sp947_chr_00281 Guanine/hypoxanthine permease PbuO 1.01E-11 3.141839 
Sp947_chr_00050 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 8.38E-04 3.197571 
Sp947_chr_01752 Xanthine phosphoribosyltransferase 5.58E-03 3.533145 
Sp947_chr_01753 Uric acid permease PucK 1.84E-11 4.438869 
Sp947_chr_00282 hypothetical protein 5.34E-05 5.973551 
Sp947_chr_00675 Pyruvate oxidase 2.07E-119 7.278273 
Sp947_chr_00676 hypothetical protein 3.25E-03 7.516116 
Sp947_chr_01592 scyllo-inositol 2-dehydrogenase (NAD(+)) 1.85E-18 43.48026 
Sp947_chr_01598 Evolved beta-galactosidase subunit beta 4.44E-09 49.62974 
Sp947_chr_01596 
Inner membrane ABC transporter permease protein 
YcjO 1.62E-14 50.00969 
Sp947_chr_01599 hypothetical protein 1.54E-05 59.75261 
Sp947_chr_01595 
Inner membrane ABC transporter permease protein 
YcjP 4.01E-13 60.7687 
Sp947_chr_01597 
Putative ABC transporter substrate-binding protein 






Appendix P. Pneumococcal differential gene expression in the lungs 6 h post-infection, 947M vs 
4559. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values highlighted 
in blue = upregulated in 947M, while values highlighted in red = upregulated in 4559. 
Locus tag in 947 Product padj FC 
Sp947_chr_00305 Unsaturated chondroitin disaccharide hydrolase 5.14E-05 68.93754 
Sp947_chr_00306 PTS system sorbose-specific EIIB component 3.51E-04 49.45218 
Sp947_chr_00300 KHG/KDPG aldolase 3.91E-03 24.0683 
Sp947_chr_01663 hypothetical protein 4.89E-02 14.9774 
Sp947_chr_00307 N-acetylgalactosamine permease IIC component 1 1.38E-02 13.15252 
Sp947_chr_01954 
PTS system oligo-beta-mannoside-specific EIIA 
component 1.43E-02 12.11948 
Sp947_chr_01722 hypothetical protein 4.94E-02 11.94383 
Sp947_chr_00301 2-dehydro-3-deoxygluconokinase 6.47E-04 11.29777 
Sp947_chr_01447 
Multidrug resistance ABC transporter ATP-
binding/permease protein BmrA 7.75E-08 10.01756 
Sp947_chr_00308 PTS system mannose-specific EIID component 2.03E-03 7.771254 
Sp947_chr_00262 Alkanal monooxygenase alpha chain 1.33E-04 6.912513 
Sp947_chr_00193 Cardiolipin synthase 4.62E-03 6.683222 
Sp947_chr_01672 General stress protein A 1.61E-20 6.353083 
Sp947_chr_01448 Oligopeptide-binding protein SarA 2.32E-67 6.342907 
Sp947_chr_01318 Glutamine-binding periplasmic protein 8.47E-06 6.056553 
Sp947_chr_01670 
Accessory Sec system protein translocase subunit 
SecY2 3.95E-05 5.615085 
Sp947_chr_01951 6-phospho-beta-glucosidase GmuD 2.41E-04 5.149937 
Sp947_chr_01671 Beta-1%2C6-galactofuranosyltransferase WbbI 2.30E-05 4.811812 
Sp947_chr_01674 putative glycosyltransferase EpsJ 2.18E-05 4.795206 
Sp947_chr_01669 hypothetical protein 1.60E-05 4.73273 
Sp947_chr_01444 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase 1.22E-04 4.673266 
Sp947_chr_01665 Glycosyltransferase Gtf1 1.18E-05 4.600689 
Sp947_chr_01849 hypothetical protein 1.09E-09 4.492743 
Sp947_chr_01666 Protein translocase subunit SecA 2.78E-07 4.406684 
Sp947_chr_01952 Lichenan permease IIC component 9.92E-04 4.298464 
Sp947_chr_01668 Accessory Sec system protein Asp2 1.11E-04 4.155341 
Sp947_chr_01673 General stress protein A 1.46E-06 4.054469 
Sp947_chr_01445 
Multidrug resistance ABC transporter ATP-
binding and permease protein 2.20E-04 4.038759 
Sp947_chr_00104 putative cell wall hydrolase LytN 6.98E-10 3.983611 
Sp947_chr_01664 Glycosyltransferase-stabilizing protein Gtf2 8.77E-05 3.910847 
Sp947_chr_01157 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase 1.24E-08 3.804836 
Sp947_chr_01920 
putative ABC transporter ATP-binding protein 
YxlF 3.68E-06 3.759168 
Sp947_chr_01995 putative FMN/FAD exporter YeeO 4.45E-02 3.737599 
Sp947_chr_01446 
Multidrug resistance ABC transporter ATP-
binding and permease protein 2.66E-03 3.726174 
Sp947_chr_01443 Cystathionine beta-lyase PatB 2.07E-03 3.550934 
Sp947_chr_00544 5%2C10-methylenetetrahydrofolate reductase 7.79E-09 3.549207 
Sp947_chr_00161 Methionine import ATP-binding protein MetN 2.08E-04 3.538504 
Sp947_chr_01837 Phenylalanine--tRNA ligase beta subunit 3.15E-02 3.43443 
Sp947_chr_01848 Pneumolysin 9.47E-22 3.364311 
Sp947_chr_01420 Glutamine transport ATP-binding protein GlnQ 7.35E-08 3.349461 
Sp947_chr_00162 Methionine import system permease protein MetP 3.23E-03 3.322192 
Sp947_chr_01081 L-methionine gamma-lyase 8.60E-03 3.120338 
Sp947_chr_01260 Putative phosphatase 3.26E-02 3.115464 




Sp947_chr_02070 hypothetical protein 4.65E-02 2.98896 
Sp947_chr_00181 putative murein peptide carboxypeptidase 4.94E-02 2.972231 
Sp947_chr_01419 Arginine-binding extracellular protein ArtP 1.35E-09 2.930964 
Sp947_chr_00482 ABC-type transporter ATP-binding protein EcsA 2.93E-02 2.922061 
Sp947_chr_01055 Glucose-6-phosphate 1-dehydrogenase 9.29E-23 2.874562 
Sp947_chr_01918 Sensor histidine kinase DesK 6.21E-07 2.828767 
Sp947_chr_01851 hypothetical protein 2.91E-03 2.786765 
Sp947_chr_01339 Glucosamine-6-phosphate deaminase 9.28E-07 2.746131 
Sp947_chr_01850 hypothetical protein 1.10E-05 2.743522 
Sp947_chr_01732 T-box 3.58E-02 2.720698 
Sp947_chr_00543 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase 2.51E-09 2.709082 
Sp947_chr_01847 putative transcriptional regulatory protein 6.58E-08 2.646376 
Sp947_chr_01238 Ribitol-5-phosphate cytidylyltransferase 4.11E-06 2.589054 
Sp947_chr_01056 Arginine transport ATP-binding protein ArtM 2.77E-13 2.557431 
Sp947_chr_01421 L-cystine transport system permease protein YecS 2.65E-03 2.512296 
Sp947_chr_01282 putative ABC transporter ATP-binding protein 2.62E-03 2.508221 
Sp947_chr_01642 Primosomal protein N' 3.98E-04 2.500435 
Sp947_chr_00696 
High-affinity branched-chain amino acid transport 
ATP-binding protein LivF 3.30E-04 2.495921 
Sp947_chr_01919 hypothetical protein 7.59E-03 2.477463 
Sp947_chr_01917 Transcriptional regulatory protein DesR 1.19E-03 2.460707 
Sp947_chr_01724 Tryptophan synthase beta chain 6.73E-03 2.43327 
Sp947_chr_00434 hypothetical protein 1.20E-02 2.423222 
Sp947_chr_00191 Folylpolyglutamate synthase 1.37E-02 2.406573 
Sp947_chr_00787 Branched-chain-amino-acid aminotransferase 1.28E-07 2.396524 
Sp947_chr_01660 Serine/threonine transporter SstT 1.56E-04 2.365193 
Sp947_chr_00817 PTS system fructose-specific EIIABC component 3.52E-05 2.357843 
Sp947_chr_02040 N-acetyldiaminopimelate deacetylase 2.44E-03 2.31786 
Sp947_chr_00425 Acetolactate synthase large subunit 9.17E-11 2.279343 
Sp947_chr_00169 hypothetical protein 4.14E-06 2.275144 
Sp947_chr_00944 
putative S-adenosyl-L-methionine-dependent 
methyltransferase TehB 6.05E-03 2.260243 
Sp947_chr_01560 putative thiol peroxidase 4.54E-04 2.24987 
Sp947_chr_01215 putative peptidoglycan glycosyltransferase FtsW 4.18E-05 2.245616 
Sp947_chr_02018 putative ABC transporter ATP-binding protein 2.54E-04 2.232901 
Sp947_chr_00985 4-hydroxy-tetrahydrodipicolinate synthase 9.09E-04 2.211691 
Sp947_chr_01283 putative ABC transporter ATP-binding protein 9.29E-03 2.209084 
Sp947_chr_02056 HTH-type transcriptional regulator MalR 2.43E-02 2.208454 
Sp947_chr_00859 Arginine regulator 4.43E-03 2.173132 
Sp947_chr_01470 hypothetical protein 1.28E-07 2.172156 
Sp947_chr_00967 putative amino acid permease YhdG 8.74E-03 2.141793 
Sp947_chr_00695 
Lipopolysaccharide export system ATP-binding 
protein LptB 1.97E-02 2.066565 
Sp947_chr_01653 hypothetical protein 2.93E-02 2.065838 
Sp947_chr_01057 Glutamine transport system permease protein GlnP 2.03E-12 2.062275 
Sp947_chr_01661 hypothetical protein 2.78E-02 2.054099 
Sp947_chr_01640 
Ribosomal RNA small subunit methyltransferase 
B 2.91E-03 2.053249 
Sp947_chr_01281 
5-methylthioadenosine/S-adenosylhomocysteine 
deaminase 7.78E-03 2.046941 
Sp947_chr_00789 hypothetical protein 6.20E-04 2.033781 
Sp947_chr_01235 hypothetical protein 1.92E-04 2.031984 
Sp947_chr_00258 Putative zinc metalloprotease 6.05E-03 2.019156 
Sp947_chr_02160 Secreted 45 kDa protein 1.02E-07 2.017272 
Sp947_chr_00790 hypothetical protein 8.94E-06 2.016723 




Sp947_chr_00210 30S ribosomal protein S17 4.67E-07 2.011481 
Sp947_chr_01154 Glycogen biosynthesis protein GlgD 1.55E-02 2.038321 
Sp947_chr_01279 50S ribosomal protein L10 1.09E-07 2.043546 
Sp947_chr_01477 CCA-adding enzyme 4.41E-02 2.051156 
Sp947_chr_01432 ATP synthase subunit c 6.93E-03 2.052648 
Sp947_chr_00225 30S ribosomal protein S13 1.54E-08 2.076816 
Sp947_chr_00498 hypothetical protein 4.94E-02 2.116476 
Sp947_chr_00928 50S ribosomal protein L35 2.34E-03 2.124092 
Sp947_chr_00608 putative response regulatory protein 3.31E-05 2.136323 
Sp947_chr_00228 50S ribosomal protein L17 3.58E-08 2.137006 
Sp947_chr_01478 4-hydroxy-tetrahydrodipicolinate reductase 6.93E-03 2.173119 
Sp947_chr_00501 hypothetical protein 5.79E-03 2.174678 
Sp947_chr_01479 DegV domain-containing protein 3.33E-03 2.221312 
Sp947_chr_01591 
Putative N-acetylmannosamine-6-phosphate 2-
epimerase 7.35E-08 2.23104 
Sp947_chr_00059 
N5-carboxyaminoimidazole ribonucleotide 
synthase 6.69E-04 2.236367 
Sp947_chr_01589 
Putative ABC transporter substrate-binding protein 
YesO 9.43E-15 2.28675 
Sp947_chr_01584 hypothetical protein 1.07E-02 2.333389 
Sp947_chr_01590 PTS system glucose-specific EIICBA component 5.93E-17 2.346142 
Sp947_chr_00057 Phosphoribosylamine--glycine ligase 6.10E-03 2.431764 
Sp947_chr_01596 
Inner membrane ABC transporter permease 
protein YcjO 4.53E-05 2.439969 
Sp947_chr_01597 
Putative ABC transporter substrate-binding protein 
YesO 1.57E-11 2.460435 
Sp947_chr_00577 
Branched-chain amino acid transport system 2 
carrier protein 2.12E-06 2.461054 
Sp947_chr_00499 hypothetical protein 2.11E-04 2.4774 
Sp947_chr_01600 Sialidase A 1.40E-13 2.501157 
Sp947_chr_01598 Evolved beta-galactosidase subunit beta 1.08E-03 2.529667 
Sp947_chr_00925 hypothetical protein 1.77E-02 2.540488 
Sp947_chr_01595 
Inner membrane ABC transporter permease 
protein YcjP 4.13E-05 2.552297 
Sp947_chr_00282 hypothetical protein 3.15E-02 2.616579 
Sp947_chr_01586 Toxin-antitoxin biofilm protein TabA 2.91E-03 2.76266 
Sp947_chr_01101 Galactose-6-phosphate isomerase subunit LacA 4.83E-02 2.778676 
Sp947_chr_00493 hypothetical protein 1.56E-04 2.785461 
Sp947_chr_02029 Phosphate-binding protein PstS 2 2.15E-03 2.865929 
Sp947_chr_01278 50S ribosomal protein L7/L12 3.87E-12 2.996972 
Sp947_chr_00488 hypothetical protein 4.04E-02 3.028346 
Sp947_chr_01585 hypothetical protein 1.43E-03 3.034917 
Sp947_chr_01588 Lactose transport system permease protein LacF 8.20E-09 3.043549 
Sp947_chr_01587 
L-arabinose transport system permease protein 
AraQ 4.60E-09 3.098046 
Sp947_chr_02129 Alpha-glycerophosphate oxidase 2.28E-14 3.098558 
Sp947_chr_01753 Uric acid permease PucK 6.97E-06 3.127739 
Sp947_chr_01583 N-acetylneuraminate lyase 8.65E-11 3.160283 
Sp947_chr_02130 Glycerol kinase 6.99E-12 3.188476 
Sp947_chr_02128 putative glycerol uptake facilitator protein 5.65E-06 3.28419 
Sp947_chr_00056 Bifunctional purine biosynthesis protein PurH 4.99E-17 3.314739 
Sp947_chr_01233 DNA processing protein DprA 1.59E-02 3.332503 
Sp947_chr_00051 Phosphoribosylformylglycinamidine synthase 6.17E-29 3.43114 
Sp947_chr_01599 hypothetical protein 6.34E-04 3.44936 
Sp947_chr_00156 hypothetical protein 1.20E-03 3.475747 
Sp947_chr_00153 hypothetical protein 1.72E-53 3.578283 




Sp947_chr_00053 Phosphoribosylformylglycinamidine cyclo-ligase 3.79E-13 3.631123 
Sp947_chr_01107 PTS system lactose-specific EIICB component 7.51E-03 3.644307 
Sp947_chr_00154 hypothetical protein 7.99E-47 3.765825 
Sp947_chr_01835 Single-stranded DNA-binding protein 4.27E-06 3.783469 
Sp947_chr_00050 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 1.15E-03 3.934432 
Sp947_chr_00151 Nisin biosynthesis protein NisC 1.55E-88 4.039514 
Sp947_chr_00054 Phosphoribosylglycinamide formyltransferase 1.05E-08 4.05498 
Sp947_chr_01976 hypothetical protein 1.43E-02 4.070542 
Sp947_chr_00491 hypothetical protein 1.08E-16 4.148617 
Sp947_chr_00157 L-cystine-binding protein TcyA 1.27E-04 4.197553 
Sp947_chr_00052 Amidophosphoribosyltransferase 2.70E-18 4.311536 
Sp947_chr_01752 Xanthine phosphoribosyltransferase 8.75E-03 4.371717 
Sp947_chr_01035 hypothetical protein 1.51E-02 4.523322 
Sp947_chr_00152 hypothetical protein 1.47E-102 4.587529 
Sp947_chr_00496 Bacteriocin lactacin-F subunit LafA 3.41E-03 4.761852 
Sp947_chr_01582 Beta-glucoside kinase 5.11E-14 4.796863 
Sp947_chr_01979 hypothetical protein 4.17E-02 4.975354 
Sp947_chr_00150 Nisin biosynthesis protein NisB 2.28E-105 5.029877 
Sp947_chr_00149 hypothetical protein 9.98E-80 5.84338 
Sp947_chr_00055 hypothetical protein 2.54E-10 5.908767 
Sp947_chr_00923 ComE operon protein 3 6.38E-04 5.932836 
Sp947_chr_01974 
Ubiquinone/menaquinone biosynthesis C-
methyltransferase UbiE 6.02E-03 6.304239 
Sp947_chr_01982 ComG operon protein 1 1.51E-04 7.042161 
Sp947_chr_00133 hypothetical protein 5.43E-04 7.078549 
Sp947_chr_00631 hypothetical protein 3.43E-02 8.177758 
Sp947_chr_01601 hypothetical protein 1.07E-02 8.512209 
Sp947_chr_00134 hypothetical protein 4.34E-04 8.597105 
Sp947_chr_01187 hypothetical protein 3.55E-02 8.767671 
Sp947_chr_00119 hypothetical protein 2.86E-02 9.128069 
Sp947_chr_01977 hypothetical protein 3.77E-03 10.4118 
Sp947_chr_00854 V-type sodium ATPase subunit B 1.03E-02 10.46683 
Sp947_chr_01975 Ubiquinone biosynthesis O-methyltransferase 1.60E-02 10.52488 
Sp947_chr_01949 hypothetical protein 4.65E-02 12.94222 
Sp947_chr_00632 ABC transporter ATP-binding protein YxdL 2.09E-02 17.25928 
Sp947_chr_00111 
Lactococcin-G-processing and transport ATP-
binding protein LagD 1.55E-02 18.33763 
Sp947_chr_00855 V-type sodium ATPase subunit D 7.50E-03 19.55662 
Sp947_chr_00850 V-type proton ATPase subunit E 9.84E-03 19.86727 
Sp947_chr_00840 
Putative N-acetylmannosamine-6-phosphate 2-
epimerase 2.06E-03 24.75437 
Sp947_chr_00120 hypothetical protein 2.86E-03 25.71408 
Sp947_chr_00116 hypothetical protein 2.91E-03 26.96818 
Sp947_chr_00851 V-type sodium ATPase subunit C 1.83E-03 28.20511 
Sp947_chr_00843 hypothetical protein 6.39E-04 31.47893 
Sp947_chr_00117 hypothetical protein 1.32E-03 31.85973 
Sp947_chr_00846 Beta-glucoside kinase 6.62E-04 34.40566 
Sp947_chr_00118 hypothetical protein 3.54E-04 40.73953 
Sp947_chr_02078 hypothetical protein 1.92E-04 40.77519 
Sp947_chr_00839 HTH-type transcriptional regulator RpiR 1.25E-04 44.12853 
Sp947_chr_00853 V-type sodium ATPase catalytic subunit A 7.65E-05 47.19399 
Sp947_chr_00848 hypothetical protein 6.15E-06 76.87348 
Sp947_chr_00845 scyllo-inositol 2-dehydrogenase (NAD(+)) 2.21E-06 85.19736 
Sp947_chr_00842 Sodium/glucose cotransporter 4.67E-07 108.7675 
Sp947_chr_00841 N-acetylneuraminate lyase 4.39E-07 115.1438 











































Appendix Q. Pneumococcal differential gene expression in the lungs 6 h post-infection, 947M vs 
4559M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values 
highlighted in blue = upregulated in 947M, while values highlighted in red = upregulated in 
4559M. 
Locus tag in 947 Product padj FC 
Sp947_chr_00301 2-dehydro-3-deoxygluconokinase 1.17E-04 9.670733 
Sp947_chr_01712 Lichenan permease IIC component 3.56E-02 8.609312 
Sp947_chr_01445 
Multidrug resistance ABC transporter ATP-
binding and permease protein 4.16E-08 8.483181 
Sp947_chr_00306 PTS system sorbose-specific EIIB component 8.86E-03 7.513945 
Sp947_chr_01447 
Multidrug resistance ABC transporter ATP-
binding/permease protein BmrA 7.53E-09 7.288221 
Sp947_chr_01448 Oligopeptide-binding protein SarA 3.21E-85 6.940285 
Sp947_chr_00302 hypothetical protein 1.64E-02 6.743771 
Sp947_chr_01446 
Multidrug resistance ABC transporter ATP-
binding and permease protein 2.12E-05 6.075821 
Sp947_chr_00307 N-acetylgalactosamine permease IIC component 1 2.53E-02 5.42795 
Sp947_chr_01674 putative glycosyltransferase EpsJ 5.67E-07 5.357286 
Sp947_chr_00308 PTS system mannose-specific EIID component 2.24E-03 4.992152 
Sp947_chr_00305 Unsaturated chondroitin disaccharide hydrolase 9.64E-03 4.929947 
Sp947_chr_01673 General stress protein A 3.78E-09 4.891933 
Sp947_chr_00664 
Putative HMP/thiamine import ATP-binding 
protein YkoD 4.57E-02 4.859076 
Sp947_chr_00544 5%2C10-methylenetetrahydrofolate reductase 1.52E-13 4.549448 
Sp947_chr_01081 L-methionine gamma-lyase 2.58E-04 4.3924 
Sp947_chr_01802 
Bifunctional alpha-galactosidase/sucrose kinase 
AgaSK 9.20E-03 4.294223 
Sp947_chr_01671 Beta-1%2C6-galactofuranosyltransferase WbbI 7.43E-06 4.178201 
Sp947_chr_01669 hypothetical protein 6.03E-06 4.145224 
Sp947_chr_01668 Accessory Sec system protein Asp2 4.18E-05 3.801593 
Sp947_chr_01444 
Cystathionine gamma-synthase/O-
acetylhomoserine (thiol)-lyase 1.32E-04 3.780648 
Sp947_chr_01749 Exodeoxyribonuclease 1.34E-03 3.759186 
Sp947_chr_01318 Glutamine-binding periplasmic protein 4.34E-05 3.691227 
Sp947_chr_00722 Biotin transporter BioY2 3.56E-02 3.673481 
Sp947_chr_01672 General stress protein A 1.09E-15 3.578579 
Sp947_chr_01850 hypothetical protein 1.54E-08 3.371368 
Sp947_chr_00104 putative cell wall hydrolase LytN 1.48E-09 3.28594 
Sp947_chr_01711 Arylsulfatase 3.74E-02 3.285935 
Sp947_chr_01951 6-phospho-beta-glucosidase GmuD 2.12E-03 3.238088 
Sp947_chr_01952 Lichenan permease IIC component 3.22E-03 3.220857 
Sp947_chr_01157 
NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase 3.10E-08 3.220747 
Sp947_chr_01666 Protein translocase subunit SecA 2.62E-06 3.188151 
Sp947_chr_01849 hypothetical protein 3.61E-07 3.031185 
Sp947_chr_02070 hypothetical protein 2.76E-02 3.006206 
Sp947_chr_01665 Glycosyltransferase Gtf1 1.78E-04 2.99951 
Sp947_chr_01670 
Accessory Sec system protein translocase subunit 
SecY2 1.04E-03 2.985239 
Sp947_chr_00543 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase 3.12E-12 2.938637 
Sp947_chr_01731 hypothetical protein 1.04E-02 2.933719 
Sp947_chr_01851 hypothetical protein 8.59E-04 2.875592 
Sp947_chr_01339 Glucosamine-6-phosphate deaminase 2.98E-08 2.866661 
Sp947_chr_01660 Serine/threonine transporter SstT 7.70E-07 2.831328 




Sp947_chr_01848 Pneumolysin 5.90E-18 2.731212 
Sp947_chr_00967 putative amino acid permease YhdG 2.01E-04 2.694598 
Sp947_chr_01281 
5-methylthioadenosine/S-adenosylhomocysteine 
deaminase 1.08E-04 2.610116 
Sp947_chr_01238 Ribitol-5-phosphate cytidylyltransferase 5.25E-07 2.603372 
Sp947_chr_02040 N-acetyldiaminopimelate deacetylase 3.36E-04 2.491103 
Sp947_chr_01847 putative transcriptional regulatory protein 4.75E-08 2.46311 
Sp947_chr_01055 Glucose-6-phosphate 1-dehydrogenase 8.83E-19 2.41423 
Sp947_chr_00279 Alcohol dehydrogenase 1 1.79E-04 2.402247 
Sp947_chr_00696 
High-affinity branched-chain amino acid transport 
ATP-binding protein LivF 1.78E-04 2.40127 
Sp947_chr_00161 Methionine import ATP-binding protein MetN 5.07E-03 2.36814 
Sp947_chr_00695 
Lipopolysaccharide export system ATP-binding 
protein LptB 2.38E-03 2.365929 
Sp947_chr_00162 Methionine import system permease protein MetP 2.47E-02 2.354175 
Sp947_chr_01237 Ribulose-5-phosphate reductase 2.21E-07 2.347699 
Sp947_chr_00694 
High-affinity branched-chain amino acid transport 
system permease protein LivH 6.27E-04 2.285144 
Sp947_chr_02071 Dihydroxy-acid dehydratase 9.70E-09 2.2807 
Sp947_chr_01640 
Ribosomal RNA small subunit methyltransferase 
B 2.39E-04 2.277034 
Sp947_chr_00985 4-hydroxy-tetrahydrodipicolinate synthase 3.06E-04 2.222209 
Sp947_chr_01421 L-cystine transport system permease protein YecS 6.47E-03 2.19205 
Sp947_chr_01443 Cystathionine beta-lyase PatB 4.50E-02 2.188948 
Sp947_chr_01056 Arginine transport ATP-binding protein ArtM 1.14E-10 2.147633 
Sp947_chr_01661 hypothetical protein 1.13E-02 2.141693 
Sp947_chr_01287 Adapter protein MecA 6.92E-03 2.108023 
Sp947_chr_01420 Glutamine transport ATP-binding protein GlnQ 3.04E-04 2.064193 
Sp947_chr_00191 Folylpolyglutamate synthase 3.39E-02 2.058539 
Sp947_chr_01057 
Glutamine transport system permease protein 
GlnP 1.08E-13 2.054665 
Sp947_chr_00789 hypothetical protein 2.13E-04 2.044356 
Sp947_chr_00787 Branched-chain-amino-acid aminotransferase 3.56E-06 2.038933 
Sp947_chr_00403 Malonyl CoA-acyl carrier protein transacylase 1.35E-02 2.029537 
Sp947_chr_01985 N-acetylglucosamine-6-phosphate deacetylase 4.34E-05 2.007822 
Sp947_chr_01955 Aldehyde-alcohol dehydrogenase 2.78E-07 2.00535 
Sp947_chr_00283 Dihydropteroate synthase 1.34E-02 2.008932 
Sp947_chr_01500 Trehalose import ATP-binding protein SugC 3.16E-06 2.026012 
Sp947_chr_00609 Sensor histidine kinase YehU 1.74E-06 2.070439 
Sp947_chr_00083 Histidine protein kinase SaeS 5.36E-03 2.073337 
Sp947_chr_01155 Glucose-1-phosphate adenylyltransferase 8.09E-03 2.093897 
Sp947_chr_01279 50S ribosomal protein L10 1.05E-08 2.096326 
Sp947_chr_01154 Glycogen biosynthesis protein GlgD 8.29E-03 2.098713 
Sp947_chr_01590 PTS system glucose-specific EIICBA component 5.60E-14 2.138227 
Sp947_chr_00500 hypothetical protein 1.66E-06 2.139178 
Sp947_chr_00502 hypothetical protein 7.03E-05 2.147247 
Sp947_chr_01589 
Putative ABC transporter substrate-binding 
protein YesO 3.23E-13 2.149307 
Sp947_chr_00066 PTS system sorbose-specific EIIC component 1.90E-03 2.153142 
Sp947_chr_00065 PTS system sorbose-specific EIIB component 2.53E-02 2.169443 
Sp947_chr_00069 
Putative tagatose-6-phosphate ketose/aldose 
isomerase 4.34E-05 2.18834 
Sp947_chr_00925 hypothetical protein 4.99E-02 2.232677 
Sp947_chr_00067 PTS system mannose-specific EIID component 2.72E-04 2.245442 
Sp947_chr_01591 
Putative N-acetylmannosamine-6-phosphate 2-
epimerase 1.55E-08 2.259193 




Sp947_chr_00582 50S ribosomal protein L1 1.92E-11 2.266385 
Sp947_chr_01478 4-hydroxy-tetrahydrodipicolinate reductase 1.95E-03 2.316861 
Sp947_chr_00228 50S ribosomal protein L17 7.30E-11 2.339842 
Sp947_chr_00608 putative response regulatory protein 7.07E-07 2.352334 
Sp947_chr_00499 hypothetical protein 3.48E-04 2.364047 
Sp947_chr_00930 Lactoylglutathione lyase 3.61E-02 2.382768 
Sp947_chr_02030 
Phosphate transport system permease protein PstC 
1 1.96E-02 2.434936 
Sp947_chr_01479 DegV domain-containing protein 4.56E-04 2.439687 
Sp947_chr_01600 Sialidase A 1.52E-13 2.448881 
Sp947_chr_00281 Guanine/hypoxanthine permease PbuO 1.26E-07 2.458395 
Sp947_chr_00059 
N5-carboxyaminoimidazole ribonucleotide 
synthase 6.17E-05 2.458645 
Sp947_chr_01584 hypothetical protein 3.37E-03 2.507546 
Sp947_chr_01599 hypothetical protein 1.54E-02 2.558236 
Sp947_chr_01592 scyllo-inositol 2-dehydrogenase (NAD(+)) 4.91E-07 2.616868 
Sp947_chr_00285 GTP cyclohydrolase 1 1.08E-03 2.622738 
Sp947_chr_00577 
Branched-chain amino acid transport system 2 
carrier protein 1.03E-07 2.63016 
Sp947_chr_00057 Phosphoribosylamine--glycine ligase 1.46E-03 2.644768 
Sp947_chr_00493 hypothetical protein 2.13E-04 2.678999 
Sp947_chr_02032 Phosphate import ATP-binding protein PstB 3 1.01E-03 2.722278 
Sp947_chr_01598 Evolved beta-galactosidase subunit beta 1.56E-04 2.78706 
Sp947_chr_00154 hypothetical protein 2.65E-28 2.805147 
Sp947_chr_01597 
Putative ABC transporter substrate-binding 
protein YesO 1.60E-16 2.844123 
Sp947_chr_01586 Toxin-antitoxin biofilm protein TabA 1.39E-03 2.849225 
Sp947_chr_02031 
Phosphate transport system permease protein PstA 
2 5.46E-04 2.861119 
Sp947_chr_01596 
Inner membrane ABC transporter permease 
protein YcjO 2.53E-07 2.886446 
Sp947_chr_00153 hypothetical protein 1.82E-37 2.892108 
Sp947_chr_00155 hypothetical protein 1.12E-45 2.931856 
Sp947_chr_00151 Nisin biosynthesis protein NisC 7.90E-55 2.999037 
Sp947_chr_00282 hypothetical protein 6.70E-03 3.060665 
Sp947_chr_02033 
Phosphate-specific transport system accessory 
protein PhoU  2.38E-05 3.077587 
Sp947_chr_01595 
Inner membrane ABC transporter permease 
protein YcjP 1.02E-07 3.127981 
Sp947_chr_01588 Lactose transport system permease protein LacF 6.39E-10 3.167722 
Sp947_chr_01583 N-acetylneuraminate lyase 1.77E-11 3.181516 
Sp947_chr_00488 hypothetical protein 2.55E-02 3.198131 
Sp947_chr_01278 50S ribosomal protein L7/L12 2.57E-14 3.199195 
Sp947_chr_02062 hypothetical protein 1.23E-02 3.218262 
Sp947_chr_00157 L-cystine-binding protein TcyA 1.97E-03 3.281804 
Sp947_chr_02128 putative glycerol uptake facilitator protein 1.40E-06 3.376722 
Sp947_chr_00152 hypothetical protein 1.56E-66 3.408858 
Sp947_chr_01587 
L-arabinose transport system permease protein 
AraQ 2.04E-11 3.436735 
Sp947_chr_01108 6-phospho-beta-galactosidase 3.63E-02 3.572337 
Sp947_chr_00150 Nisin biosynthesis protein NisB 3.01E-67 3.640087 
Sp947_chr_00053 Phosphoribosylformylglycinamidine cyclo-ligase 7.11E-14 3.646901 
Sp947_chr_01835 Single-stranded DNA-binding protein 4.27E-06 3.681599 
Sp947_chr_02130 Glycerol kinase 5.10E-16 3.692078 
Sp947_chr_01585 hypothetical protein 2.56E-05 3.869586 
Sp947_chr_00056 Bifunctional purine biosynthesis protein PurH 3.59E-23 3.888367 




Sp947_chr_00054 Phosphoribosylglycinamide formyltransferase 8.51E-09 3.987798 
Sp947_chr_00983 asd 9.32E-03 3.997549 
Sp947_chr_02129 Alpha-glycerophosphate oxidase 3.55E-23 4.018257 
Sp947_chr_01035 hypothetical protein 2.41E-02 4.140521 
Sp947_chr_00051 Phosphoribosylformylglycinamidine synthase 2.28E-42 4.235246 
Sp947_chr_00052 Amidophosphoribosyltransferase 1.19E-18 4.268644 
Sp947_chr_02029 Phosphate-binding protein PstS 2 1.30E-06 4.397577 
Sp947_chr_01753 Uric acid permease PucK 2.01E-10 4.406739 
Sp947_chr_01976 hypothetical protein 6.51E-03 4.475349 
Sp947_chr_02096 hypothetical protein 2.68E-02 4.506143 
Sp947_chr_00491 hypothetical protein 3.28E-20 4.611629 
Sp947_chr_01582 Beta-glucoside kinase 2.18E-14 4.75467 
Sp947_chr_00050 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 7.03E-05 4.86234 
Sp947_chr_00149 hypothetical protein 9.11E-65 4.877677 
Sp947_chr_00923 ComE operon protein 3 1.39E-03 5.294791 
Sp947_chr_01752 Xanthine phosphoribosyltransferase 8.53E-04 5.746786 
Sp947_chr_00055 hypothetical protein 9.95E-11 5.925865 
Sp947_chr_01974 
Ubiquinone/menaquinone biosynthesis C-
methyltransferase UbiE 5.04E-03 6.407721 
Sp947_chr_01601 hypothetical protein 2.99E-02 6.738993 
Sp947_chr_00133 hypothetical protein 3.54E-04 7.246645 
Sp947_chr_01979 hypothetical protein 5.49E-03 7.304412 
Sp947_chr_01980 hypothetical protein 1.67E-02 7.537585 
Sp947_chr_01982 ComG operon protein 1 1.75E-05 8.446919 
Sp947_chr_00134 hypothetical protein 4.13E-04 8.447782 
Sp947_chr_00631 hypothetical protein 2.15E-02 9.213989 
Sp947_chr_01977 hypothetical protein 5.49E-03 9.600591 
Sp947_chr_00119 hypothetical protein 2.24E-02 9.657972 
Sp947_chr_01975 Ubiquinone biosynthesis O-methyltransferase 1.24E-02 11.19827 
Sp947_chr_00849 V-type sodium ATPase subunit K 4.67E-02 12.68675 
Sp947_chr_00847 hypothetical protein 4.77E-02 12.75212 
Sp947_chr_00632 ABC transporter ATP-binding protein YxdL 3.91E-02 13.87838 
Sp947_chr_00115 hypothetical protein 4.98E-02 15.08898 
Sp947_chr_00122 hypothetical protein 7.13E-03 19.74573 
Sp947_chr_00852 V-type sodium ATPase subunit G 9.01E-03 20.06019 
Sp947_chr_00843 hypothetical protein 3.51E-03 21.00858 
Sp947_chr_00854 V-type sodium ATPase subunit B 2.61E-04 21.55684 
Sp947_chr_00111 
Lactococcin-G-processing and transport ATP-
binding protein LagD 7.18E-03 22.70188 
Sp947_chr_00850 V-type proton ATPase subunit E 1.94E-03 29.81791 
Sp947_chr_00116 hypothetical protein 1.53E-03 30.65687 
Sp947_chr_00840 
Putative N-acetylmannosamine-6-phosphate 2-
epimerase 6.27E-04 31.88306 
Sp947_chr_00855 V-type sodium ATPase subunit D 7.10E-04 33.3989 
Sp947_chr_00851 V-type sodium ATPase subunit C 7.66E-04 33.41091 
Sp947_chr_00839 HTH-type transcriptional regulator RpiR 4.17E-04 33.69369 
Sp947_chr_00846 Beta-glucoside kinase 6.02E-04 34.40359 
Sp947_chr_02078 hypothetical protein 2.89E-04 37.03186 
Sp947_chr_00117 hypothetical protein 6.19E-04 37.13564 
Sp947_chr_00120 hypothetical protein 3.83E-04 39.34665 
Sp947_chr_00853 V-type sodium ATPase catalytic subunit A 8.31E-05 46.29248 
Sp947_chr_00118 hypothetical protein 1.01E-04 52.43328 
Sp947_chr_00845 scyllo-inositol 2-dehydrogenase (NAD(+)) 6.99E-07 100.7781 
Sp947_chr_00848 hypothetical protein 5.25E-07 111.61 
Sp947_chr_00841 N-acetylneuraminate lyase 4.68E-07 112.2849 




Sp947_chr_00844 Sialidase B 4.59E-08 151.1713 




































Appendix R. Pneumococcal differential gene expression in the lungs 6 h post-infection, 4559 vs 
4559M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values 
highlighted in blue = upregulated in 4559, while values highlighted in red = upregulated in 4559M. 
Locus tag in 947 Product padj FC 
Sp947_chr_00279 Alcohol dehydrogenase 1 2.23E-08 3.532144 
Sp947_chr_01955 Aldehyde-alcohol dehydrogenase 1.15E-20 3.234431 
Sp947_chr_00088 
putative multiple-sugar transport system permease 
YteP 3.50E-02 2.176402 
Sp947_chr_02054 Maltose transport system permease protein MalG 9.80E-03 2.120116 
Sp947_chr_01917 Transcriptional regulatory protein DesR 1.14E-02 2.254388 
Sp947_chr_02033 
Phosphate-specific transport system accessory 
protein PhoU  5.24E-03 2.313659 
Sp947_chr_01629 PTS system trehalose-specific EIIBC component 1.03E-02 3.264913 
Sp947_chr_01920 
putative ABC transporter ATP-binding protein 





























Appendix S. Murine differential gene expression in the lungs 6 h post-infection, 947 vs 947M. 
Genes with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in 
blue = upregulated in 947, while values highlighted in red = upregulated in 947M. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000065254 Gm23973 1.17E-08 6.0256 
ENSMUSG00000088675 Rprl1 2.45E-08 5.382293 
ENSMUSG00000106222 Rprl1 2.45E-08 5.382293 
ENSMUSG00000096269 Rpl31-ps21 6.02E-06 5.232448 
ENSMUSG00000094668 Gm24871 1.75E-06 4.724852 
ENSMUSG00000064682 Gm25813 1.04E-09 4.405394 
ENSMUSG00000065870 Rnu3a 4.31E-15 4.246867 
ENSMUSG00000106147 Rnu3a 4.31E-15 4.246867 
ENSMUSG00000095676 Gm25099 2.12E-22 4.006482 
ENSMUSG00000104896 Rnu3b4 2.62E-19 3.731483 
ENSMUSG00000105115 Rnu3b2 1.58E-19 3.730893 
ENSMUSG00000098925 Rnu3b2 1.58E-19 3.730893 
ENSMUSG00000098641 Rnu3b4 3.16E-19 3.726678 
ENSMUSG00000098943 Rnu3b1 5.09E-19 3.713982 
ENSMUSG00000105025 Rnu3b1 5.09E-19 3.713982 
ENSMUSG00000099291 Rnu3b3 1.37E-18 3.710655 
ENSMUSG00000104856 Rnu3b3 1.37E-18 3.710655 
ENSMUSG00000065232 Gm22973 7.53E-12 3.699468 
ENSMUSG00000095738 Gm25313 7.10E-11 3.614973 
ENSMUSG00000064994 Gm22422 2.64E-07 3.494379 
ENSMUSG00000065176 Rnu12 2.59E-22 3.424881 
ENSMUSG00000077254 Gm26079 7.16E-09 3.417376 
ENSMUSG00000095892 Rnu5g 1.98E-10 3.377252 
ENSMUSG00000093956 Gm24497 1.37E-09 3.358284 
ENSMUSG00000094050 Gm23472 7.29E-10 3.353025 
ENSMUSG00000080465 Gm22486 2.03E-10 3.35003 
ENSMUSG00000064856 Gm23444 1.29E-09 3.346978 
ENSMUSG00000064899 Snord118 1.39E-05 3.336753 
ENSMUSG00000093843 Gm25939 5.28E-08 3.334159 
ENSMUSG00000094655 Gm25360 1.09E-16 3.3217 
ENSMUSG00000065820 Gm26316 1.36E-09 3.301702 
ENSMUSG00000065767 Gm23849 3.38E-09 3.230541 
ENSMUSG00000064702 Gm24950 4.61E-09 3.217205 
ENSMUSG00000065251 Gm23971 4.61E-09 3.217205 
ENSMUSG00000065944 Rnu2-10 3.79E-09 3.210903 
ENSMUSG00000080538 Gm25541 1.66E-11 3.172594 
ENSMUSG00000027261 Hao1 7.14E-05 3.03458 
ENSMUSG00000094377 Gm24407 3.83E-10 3.022053 
ENSMUSG00000032494 Tdgf1 4.29E-04 3.003122 
ENSMUSG00000065911 Gm24447 3.13E-11 2.969689 
ENSMUSG00000065824 Gm26315 3.28E-11 2.966459 
ENSMUSG00000089255 Snora78 5.52E-04 2.891999 
ENSMUSG00000096243 Gm24265 9.59E-08 2.856449 
ENSMUSG00000064945 Rny3 3.87E-08 2.845147 
ENSMUSG00000085348 Myhas 3.19E-07 2.838211 
ENSMUSG00000064694 Gm24146 1.10E-06 2.83174 
ENSMUSG00000065087 Snord22 2.41E-26 2.800736 
ENSMUSG00000115207 Gm49132 4.18E-02 2.775687 
ENSMUSG00000084744 Gm25291 1.83E-05 2.768169 
ENSMUSG00000091993 B930036N10Rik 2.04E-05 2.722677 
ENSMUSG00000084708 Gm22988 4.52E-11 2.714612 




ENSMUSG00000010362 Rdm1 7.28E-09 2.661396 
ENSMUSG00000064453 Snord21 2.98E-04 2.630897 
ENSMUSG00000055170 Ifng 3.23E-05 2.609289 
ENSMUSG00000044092 C130050O18Rik 5.69E-17 2.609004 
ENSMUSG00000000386 Mx1 3.70E-72 2.588273 
ENSMUSG00000065118 Gm23297 5.39E-04 2.56856 
ENSMUSG00000064966 Snord15b 5.58E-08 2.566291 
ENSMUSG00000065701 Rny1 2.33E-06 2.562933 
ENSMUSG00000087819 Gm25117 1.86E-10 2.551007 
ENSMUSG00000111734 Gm29825 1.81E-02 2.544426 
ENSMUSG00000010342 Tex14 8.31E-10 2.529067 
ENSMUSG00000064901 Snora21 1.95E-03 2.517886 
ENSMUSG00000087775 Rprl2 4.05E-05 2.454835 
ENSMUSG00000065822 Snord15a 1.38E-04 2.451242 
ENSMUSG00000097770 Gm26776 9.57E-03 2.44156 
ENSMUSG00000020641 Rsad2 7.09E-26 2.429777 
ENSMUSG00000043681 Fam25c 1.39E-04 2.404388 
ENSMUSG00000003545 Fosb 5.64E-13 2.404057 
ENSMUSG00000025431 Crisp1 9.80E-05 2.397804 
ENSMUSG00000101133 Gm29050 8.16E-03 2.391731 
ENSMUSG00000088252 Snord13 6.50E-05 2.386827 
ENSMUSG00000077323 Rnu11 6.57E-07 2.38433 
ENSMUSG00000097131 D230017M19Rik 1.76E-08 2.381225 
ENSMUSG00000092837 Rpph1 7.69E-06 2.372261 
ENSMUSG00000071470 Ccnb1ip1 7.38E-06 2.360943 
ENSMUSG00000092819 Gm23639 7.41E-03 2.352266 
ENSMUSG00000048806 Ifnb1 7.71E-03 2.351491 
ENSMUSG00000117269 AC151275.1 2.17E-05 2.349181 
ENSMUSG00000087477 Gm13822 8.85E-05 2.342073 
ENSMUSG00000065649 Snora74a 1.06E-06 2.339372 
ENSMUSG00000105797 Gm5149 1.85E-04 2.330504 
ENSMUSG00000035692 Isg15 4.03E-49 2.315568 
ENSMUSG00000069310 Hist1h3c 2.16E-03 2.278831 
ENSMUSG00000090101 Snhg9 2.99E-03 2.269589 
ENSMUSG00000020216 Jsrp1 4.96E-03 2.263278 
ENSMUSG00000069265 Hist1h3a 8.88E-03 2.259961 
ENSMUSG00000104863 Gm49347 5.93E-05 2.258448 
ENSMUSG00000099517 Hist1h3g 1.60E-02 2.249359 
ENSMUSG00000057596 Trim30d 3.93E-09 2.247087 
ENSMUSG00000064604 Snora44 2.55E-04 2.227773 
ENSMUSG00000015437 Gzmb 1.49E-07 2.22751 
ENSMUSG00000046229 Scand1 7.61E-03 2.223718 
ENSMUSG00000077167 Gm24119 2.38E-03 2.220322 
ENSMUSG00000065126 Snord104 3.21E-09 2.21526 
ENSMUSG00000096887 Gm20594 7.60E-12 2.198159 
ENSMUSG00000080542 Gm22710 8.69E-04 2.195982 
ENSMUSG00000064999 Gm26035 2.79E-06 2.192941 
ENSMUSG00000069273 Hist1h3e 3.58E-06 2.184059 
ENSMUSG00000080365 Gm25776 1.43E-04 2.181141 
ENSMUSG00000031289 Il13ra2 4.89E-06 2.177819 
ENSMUSG00000016327 Atp1b4 1.73E-02 2.166814 
ENSMUSG00000064380 Gm26448 1.91E-09 2.16627 
ENSMUSG00000111821 Gm48545 9.69E-05 2.152735 
ENSMUSG00000097060 Gm26759 9.57E-10 2.145737 
ENSMUSG00000034855 Cxcl10 6.33E-14 2.12518 
ENSMUSG00000067455 Hist1h4j 7.47E-04 2.121665 




ENSMUSG00000096349 Gm22513 1.67E-02 2.109175 
ENSMUSG00000064655 Gm25788 7.16E-03 2.098184 
ENSMUSG00000094344 Gm11942 7.06E-20 2.094663 
ENSMUSG00000023341 Mx2 4.66E-63 2.093454 
ENSMUSG00000060093 Hist1h4a 7.15E-07 2.093403 
ENSMUSG00000030670 Cyp2r1 5.70E-03 2.090606 
ENSMUSG00000044748 Defb1 3.78E-02 2.074292 
ENSMUSG00000107722 2900060B14Rik 1.19E-03 2.067021 
ENSMUSG00000031757 Mt4 1.78E-04 2.063615 
ENSMUSG00000088025 Rprl3 1.20E-03 2.055532 
ENSMUSG00000095590 Gm24305 4.50E-02 2.053062 
ENSMUSG00000081163 Defa-ps12 2.72E-02 2.051928 
ENSMUSG00000038357 Camp 9.67E-07 2.049958 
ENSMUSG00000097457 2310031A07Rik 4.24E-02 2.038639 
ENSMUSG00000064387 Snora73a 2.52E-11 2.036576 
ENSMUSG00000031343 Gabra3 1.84E-06 2.035071 
ENSMUSG00000115420 AL732506.1 1.46E-06 2.031062 
ENSMUSG00000088088 Rmrp 1.46E-06 2.031062 
ENSMUSG00000086336 Gm12979 4.46E-02 2.029161 
ENSMUSG00000042761 Mrap2 8.11E-03 2.023479 
ENSMUSG00000066443 Gm10163 1.60E-02 2.02177 
ENSMUSG00000110421 Gm9689 8.49E-03 2.017106 
ENSMUSG00000058385 Hist1h2bg 2.16E-05 2.015475 
ENSMUSG00000069274 Hist1h4f 6.77E-04 2.001288 
ENSMUSG00000083596 Rpl21-ps15 2.72E-02 1.997761 
ENSMUSG00000020638 Cmpk2 1.22E-42 1.997189 
ENSMUSG00000046748 Tmem45a2 1.42E-06 1.980568 
ENSMUSG00000114279 Hist1h2bm 3.13E-02 1.978823 
ENSMUSG00000088948 Gm23262 5.31E-05 1.970935 
ENSMUSG00000029019 Nppb 2.19E-04 1.958092 
ENSMUSG00000102189 Gm37194 8.10E-06 1.955291 
ENSMUSG00000059230 Defb4 2.95E-05 1.953494 
ENSMUSG00000106366 Mir3069 3.60E-02 1.950774 
ENSMUSG00000065259 Snora30 2.68E-02 1.943307 
ENSMUSG00000017300 Tnnc2 1.69E-15 1.943187 
ENSMUSG00000033213 AA467197 1.20E-05 1.94194 
ENSMUSG00000065353 Snora73b 3.61E-05 1.941924 
ENSMUSG00000062461 Gm5453 2.89E-10 1.940423 
ENSMUSG00000100551 Gm19503 1.62E-07 1.936219 
ENSMUSG00000060639 Hist1h4i 6.90E-04 1.935604 
ENSMUSG00000087968 Gm25395 8.91E-07 1.934721 
ENSMUSG00000106649 Gm49349 3.20E-06 1.929867 
ENSMUSG00000068397 Gm10240 2.63E-02 1.927078 
ENSMUSG00000100210 Hist1h3f 8.72E-04 1.921571 
ENSMUSG00000004814 Ccl24 4.06E-02 1.915198 
ENSMUSG00000063001 Gm9701 1.53E-02 1.914728 
ENSMUSG00000047501 Cldn4 5.80E-05 1.913371 
ENSMUSG00000091028 Gm10722 2.29E-02 1.902823 
ENSMUSG00000065686 Snora5c 2.53E-02 1.902247 
ENSMUSG00000114456 Hist1h2bh 4.42E-03 1.899751 
ENSMUSG00000030107 Usp18 4.19E-35 1.891192 
ENSMUSG00000108332 D530033B14Rik 5.32E-17 1.887082 
ENSMUSG00000065226 Gm25791 4.61E-06 1.885368 
ENSMUSG00000027233 Patl2 4.30E-02 1.87672 
ENSMUSG00000052837 Junb 3.04E-33 1.873304 
ENSMUSG00000045027 Prss22 2.77E-08 1.873299 




ENSMUSG00000065145 Vaultrc5 1.08E-03 1.86865 
ENSMUSG00000046049 Rp1l1 1.93E-03 1.864557 
ENSMUSG00000085532 B430319H21Rik 7.16E-05 1.864074 
ENSMUSG00000069266 Hist1h4b 1.11E-02 1.861964 
ENSMUSG00000074001 Klhl40 9.93E-04 1.861333 
ENSMUSG00000085806 Gm12023 1.61E-04 1.860825 
ENSMUSG00000026535 Ifi202b 5.49E-24 1.860159 
ENSMUSG00000041827 Oasl1 1.59E-25 1.858532 
ENSMUSG00000038295 Atg9b 2.43E-03 1.857709 
ENSMUSG00000094392 Gm3788 6.33E-05 1.85749 
ENSMUSG00000058773 Hist1h1b 1.03E-03 1.854963 
ENSMUSG00000075031 Hist1h2bb 1.13E-02 1.853781 
ENSMUSG00000089542 Gm25835 2.47E-06 1.852865 
ENSMUSG00000106392 Gm5870 4.66E-02 1.852755 
ENSMUSG00000083832 Gm13771 1.90E-05 1.846272 
ENSMUSG00000074433 Lce3e 1.17E-02 1.844793 
ENSMUSG00000090293 Gm17034 3.68E-02 1.844258 
ENSMUSG00000088008 Gm25492 1.09E-02 1.841263 
ENSMUSG00000082069 Gm16242 2.24E-03 1.83945 
ENSMUSG00000107480 Gm44165 8.52E-05 1.836863 
ENSMUSG00000064288 Hist1h4k 1.54E-03 1.836703 
ENSMUSG00000091383 Hist1h2al 1.56E-06 1.834135 
ENSMUSG00000070644 Etnk2 2.72E-02 1.83037 
ENSMUSG00000034459 Ifit1 9.35E-29 1.829028 
ENSMUSG00000108414 Snhg1 1.47E-18 1.82864 
ENSMUSG00000101191 Gm28809 1.83E-02 1.825134 
ENSMUSG00000095580 Rnu1b1 1.57E-03 1.824702 
ENSMUSG00000093834 Rnu1b2 1.57E-03 1.824702 
ENSMUSG00000087090 Nctc1 3.87E-14 1.821732 
ENSMUSG00000031231 Cox7b 1.15E-18 1.818275 
ENSMUSG00000064451 Snora23 4.39E-02 1.815006 
ENSMUSG00000026418 Tnni1 8.22E-03 1.811313 
ENSMUSG00000022586 Ly6i 6.13E-15 1.806331 
ENSMUSG00000102135 Gm37108 2.29E-04 1.803613 
ENSMUSG00000057465 Saa2 2.25E-09 1.803135 
ENSMUSG00000018930 Ccl4 5.57E-23 1.800731 
ENSMUSG00000104956 4930429D17Rik 1.82E-02 1.800304 
ENSMUSG00000049173 Myoz3 2.97E-04 1.793444 
ENSMUSG00000105361 AY036118 4.61E-03 1.788552 
ENSMUSG00000104862 Gm6520 5.48E-03 1.787612 
ENSMUSG00000088529 Gm26083 3.15E-03 1.7854 
ENSMUSG00000085241 Snhg3 8.45E-07 1.784438 
ENSMUSG00000068885 Lce3f 3.45E-03 1.781149 
ENSMUSG00000085609 1700016P03Rik 1.93E-02 1.781038 
ENSMUSG00000052305 Hbb-bs 1.24E-04 1.779109 
ENSMUSG00000069306 Hist1h4m 8.36E-03 1.776996 
ENSMUSG00000074403 Hist2h3b 4.10E-02 1.775714 
ENSMUSG00000038508 Gdf15 1.58E-02 1.774828 
ENSMUSG00000111713 Gm20234 3.65E-02 1.77292 
ENSMUSG00000105826 Gm42141 1.78E-02 1.772001 
ENSMUSG00000068855 Hist2h2ac 3.41E-03 1.763701 
ENSMUSG00000064923 Gm22042 2.24E-03 1.762643 
ENSMUSG00000033196 Myh2 1.57E-05 1.760939 
ENSMUSG00000095701 Gm24830 2.16E-03 1.760782 
ENSMUSG00000096838 Gm26232 2.16E-03 1.760782 
ENSMUSG00000065773 Rnu1b6 2.16E-03 1.760782 




ENSMUSG00000031097 Tnni2 2.03E-10 1.757473 
ENSMUSG00000021768 Dusp13 1.61E-02 1.754751 
ENSMUSG00000068697 Myoz1 2.09E-06 1.754697 
ENSMUSG00000058427 Cxcl2 4.52E-11 1.754009 
ENSMUSG00000096010 Hist4h4 8.63E-04 1.751589 
ENSMUSG00000100969 1700030N03Rik 1.26E-04 1.75055 
ENSMUSG00000065037 Rn7sk 2.99E-04 1.749012 
ENSMUSG00000061482 Hist1h4d 9.27E-08 1.745652 
ENSMUSG00000081159 Gm6023 3.99E-02 1.745032 
ENSMUSG00000077714 Snord17 9.77E-04 1.74339 
ENSMUSG00000077563 Snora68 1.10E-03 1.741607 
ENSMUSG00000059434 Gckr 1.39E-05 1.737341 
ENSMUSG00000036731 Cysrt1 2.64E-02 1.736202 
ENSMUSG00000009070 Rsph14 1.51E-06 1.732995 
ENSMUSG00000038037 Socs1 3.91E-10 1.729735 
ENSMUSG00000115783 Bc1 1.91E-02 1.72912 
ENSMUSG00000095260 Gm25890 3.42E-03 1.728617 
ENSMUSG00000094812 Gm22614 3.42E-03 1.728617 
ENSMUSG00000079434 Neu2 2.66E-03 1.727284 
ENSMUSG00000066510 Ankdd1a 6.66E-07 1.722526 
ENSMUSG00000052565 Hist1h1d 6.03E-05 1.722286 
ENSMUSG00000026573 Xcl1 2.28E-02 1.721571 
ENSMUSG00000096084 Gm21850 5.20E-05 1.721306 
ENSMUSG00000076066 Mir223 1.46E-04 1.719947 
ENSMUSG00000060183 Cxcl11 1.19E-05 1.718861 
ENSMUSG00000056300 Zfp981 3.47E-08 1.717174 
ENSMUSG00000112041 9530020I12Rik 4.54E-02 1.716234 
ENSMUSG00000081642 Gm13532 2.45E-02 1.71339 
ENSMUSG00000080950 Gm7278 4.27E-03 1.71199 
ENSMUSG00000102630 Gm37289 3.32E-02 1.708678 
ENSMUSG00000073902 Gm1966 8.32E-11 1.70586 
ENSMUSG00000049734 Trex1 1.10E-13 1.705391 
ENSMUSG00000060981 Hist1h4h 1.23E-04 1.704353 
ENSMUSG00000032174 Icam5 9.90E-03 1.703716 
ENSMUSG00000088789 Scarna13 2.42E-04 1.703392 
ENSMUSG00000103308 Gm37800 1.54E-05 1.702856 
ENSMUSG00000062727 Hist1h2bk 1.47E-02 1.700599 
ENSMUSG00000088185 Scarna2 3.84E-05 1.700093 
ENSMUSG00000113198 Gm6988 1.11E-04 1.700093 
ENSMUSG00000059108 Ifitm6 1.55E-16 1.69831 
ENSMUSG00000065862 Gm24029 5.06E-03 1.697729 
ENSMUSG00000092805 Gm26461 8.64E-03 1.69729 
ENSMUSG00000070271 Gm13268 2.67E-02 1.696212 
ENSMUSG00000109052 Gm45012 1.88E-02 1.694509 
ENSMUSG00000028037 Ifi44 9.21E-19 1.693727 
ENSMUSG00000097413 A830052D11Rik 3.38E-02 1.693497 
ENSMUSG00000026358 Rgs1 1.60E-07 1.69318 
ENSMUSG00000054325 Lce3a 4.97E-03 1.691831 
ENSMUSG00000053560 Ier2 3.16E-19 1.69155 
ENSMUSG00000073940 Hbb-bt 7.55E-04 1.691523 
ENSMUSG00000051319 1500011K16Rik 1.19E-02 1.691061 
ENSMUSG00000064179 Tnnt1 3.07E-03 1.690918 
ENSMUSG00000074115 Saa1 9.38E-13 1.688411 
ENSMUSG00000069305 Hist1h4n 9.18E-03 1.688272 
ENSMUSG00000028341 Nr4a3 5.23E-35 1.683154 
ENSMUSG00000071637 Cebpd 3.66E-31 1.680871 




ENSMUSG00000057160 Gm16372 1.59E-04 1.680286 
ENSMUSG00000105790 Gm24105 9.29E-04 1.678237 
ENSMUSG00000092674 Gm24105 8.40E-04 1.675874 
ENSMUSG00000060678 Hist1h4c 3.44E-05 1.674695 
ENSMUSG00000042918 Mamstr 4.07E-16 1.672552 
ENSMUSG00000109875 Gm45456 1.06E-02 1.6722 
ENSMUSG00000030399 Ckm 1.29E-07 1.666114 
ENSMUSG00000030672 Mylpf 3.88E-04 1.662639 
ENSMUSG00000005716 Pvalb 2.77E-02 1.662341 
ENSMUSG00000042031 Lce3b 7.71E-03 1.661896 
ENSMUSG00000109905 Gm7380 1.71E-03 1.660339 
ENSMUSG00000025172 Ankrd2 2.03E-04 1.659684 
ENSMUSG00000026826 Nr4a2 3.05E-06 1.659502 
ENSMUSG00000094338 Hist1h2bl 8.49E-03 1.656315 
ENSMUSG00000029379 Cxcl3 2.23E-17 1.656114 
ENSMUSG00000035852 Misp 4.46E-09 1.656018 
ENSMUSG00000086777 Far2os2 4.90E-02 1.655464 
ENSMUSG00000053469 Tg 1.99E-19 1.649527 
ENSMUSG00000104740 Mir6516 2.80E-02 1.648462 
ENSMUSG00000071858 Gm94 2.34E-02 1.647909 
ENSMUSG00000031972 Acta1 6.98E-10 1.647593 
ENSMUSG00000029635 Cdk8 1.63E-05 1.64378 
ENSMUSG00000081684 Rps2-ps13 1.03E-05 1.64243 
ENSMUSG00000067767 Clec4b2 1.61E-03 1.642307 
ENSMUSG00000045475 Lce3c 9.18E-03 1.642182 
ENSMUSG00000017204 Gsdma 1.46E-02 1.640548 
ENSMUSG00000029378 Areg 3.84E-05 1.638461 
ENSMUSG00000085249 Gm12847 1.43E-02 1.636783 
ENSMUSG00000097122 Gm26624 4.43E-08 1.636704 
ENSMUSG00000027913 Crct1 1.49E-03 1.63647 
ENSMUSG00000050463 Krt78 8.75E-06 1.635311 
ENSMUSG00000115518 Gm10791 1.41E-03 1.634944 
ENSMUSG00000086213 A330040F15Rik 1.95E-07 1.633556 
ENSMUSG00000004885 Crabp2 2.87E-02 1.63166 
ENSMUSG00000066491 Cox6c2 3.99E-07 1.630614 
ENSMUSG00000062826 Ces2f 8.39E-04 1.627736 
ENSMUSG00000046031 Calhm6 1.04E-03 1.627261 
ENSMUSG00000064382 Gm26447 7.12E-04 1.626644 
ENSMUSG00000035653 Lrfn5 3.15E-02 1.624893 
ENSMUSG00000063739 Gm4963 8.67E-05 1.623848 
ENSMUSG00000074896 Ifit3 8.41E-19 1.622777 
ENSMUSG00000062028 Irgc1 7.95E-04 1.621717 
ENSMUSG00000063820 Arl9 3.59E-02 1.621614 
ENSMUSG00000045377 Tmem88 4.72E-06 1.619556 
ENSMUSG00000114185 Gm47662 3.98E-02 1.619275 
ENSMUSG00000041872 Il17f 1.86E-04 1.619247 
ENSMUSG00000002500 Rpl3l 2.59E-03 1.616885 
ENSMUSG00000075042 4930431P03Rik 1.10E-02 1.615685 
ENSMUSG00000044165 Bcl2l15 2.68E-05 1.615489 
ENSMUSG00000017697 Ada 9.34E-11 1.615438 
ENSMUSG00000091957 Rps2-ps10 3.10E-05 1.615002 
ENSMUSG00000025498 Irf7 2.69E-23 1.614017 
ENSMUSG00000114277 Gm48583 7.46E-04 1.611868 
ENSMUSG00000104818 Gm43661 3.64E-03 1.609404 
ENSMUSG00000063651 Cnfn 5.49E-04 1.609357 
ENSMUSG00000081700 Atp5k-ps2 3.69E-03 1.607129 




ENSMUSG00000098181 Rps12-ps24 4.51E-03 1.603992 
ENSMUSG00000056054 S100a8 3.40E-07 1.600618 
ENSMUSG00000028896 Rcc1 4.47E-11 1.599941 
ENSMUSG00000031780 Ccl17 5.39E-06 1.598957 
ENSMUSG00000109729 Gm45418 3.30E-05 1.597842 
ENSMUSG00000029862 Clcn1 1.22E-04 1.595774 
ENSMUSG00000097134 1110002J07Rik 8.36E-04 1.595135 
ENSMUSG00000094826 Gm23804 1.22E-03 1.594121 
ENSMUSG00000074149 Gm10634 2.88E-07 1.59407 
ENSMUSG00000029371 Cxcl5 5.61E-15 1.593155 
ENSMUSG00000111752 Gm38575 1.27E-10 1.593054 
ENSMUSG00000057580 Gm10012 1.95E-02 1.592497 
ENSMUSG00000114790 4921509O07Rik 4.54E-04 1.592138 
ENSMUSG00000027368 Dusp2 4.18E-09 1.591586 
ENSMUSG00000113178 Mylf-ps 1.12E-06 1.591195 
ENSMUSG00000048572 Tmem252 4.44E-31 1.589873 
ENSMUSG00000095969 Rnu1a1 1.30E-02 1.589137 
ENSMUSG00000022602 Arc 3.85E-02 1.589088 
ENSMUSG00000105145 Gm47299 1.40E-02 1.587799 
ENSMUSG00000105788 Gm47295 1.40E-02 1.587791 
ENSMUSG00000020061 Mybpc1 1.21E-11 1.587253 
ENSMUSG00000000157 Itgb2l 7.93E-11 1.586842 
ENSMUSG00000028680 Plk3 1.73E-13 1.586408 
ENSMUSG00000053553 3110082I17Rik 4.41E-10 1.586388 
ENSMUSG00000070167 Snora57 1.06E-03 1.585311 
ENSMUSG00000024430 Cabyr 2.76E-02 1.584461 
ENSMUSG00000087066 Gm15518 1.60E-08 1.584091 
ENSMUSG00000026166 Ccl20 3.82E-11 1.583687 
ENSMUSG00000014773 Dll1 1.32E-28 1.583278 
ENSMUSG00000090582 Gm17024 6.03E-07 1.582913 
ENSMUSG00000096659 Gm25679 1.19E-03 1.5829 
ENSMUSG00000093815 Gm26444 1.19E-03 1.5829 
ENSMUSG00000082838 Gm14519 5.79E-05 1.581682 
ENSMUSG00000062488 Ifit3b 7.88E-13 1.57948 
ENSMUSG00000070866 Zfp804a 2.93E-03 1.577636 
ENSMUSG00000053522 Lgals7 4.18E-02 1.57711 
ENSMUSG00000038670 Mybpc2 9.70E-09 1.576178 
ENSMUSG00000115355 4930445E18Rik 1.31E-03 1.574801 
ENSMUSG00000085434 Gm11725 3.76E-02 1.574487 
ENSMUSG00000037977 6430571L13Rik 1.13E-02 1.573903 
ENSMUSG00000089281 Scarna6 8.23E-03 1.573558 
ENSMUSG00000032327 Stra6 5.98E-03 1.572608 
ENSMUSG00000064816 Gm22357 1.73E-02 1.572211 
ENSMUSG00000008384 Sertad1 1.12E-13 1.571184 
ENSMUSG00000054582 Pabpc1l 2.99E-05 1.569168 
ENSMUSG00000026628 Atf3 3.62E-22 1.569059 
ENSMUSG00000057003 Myh4 1.65E-08 1.568031 
ENSMUSG00000113722 Snhg10 1.06E-03 1.566332 
ENSMUSG00000001014 Icam4 6.99E-03 1.565655 
ENSMUSG00000041954 Tnfrsf18 6.61E-03 1.563024 
ENSMUSG00000051439 Cd14 3.56E-27 1.562597 
ENSMUSG00000040328 Olfr56 4.75E-15 1.562502 
ENSMUSG00000096214 Gm22634 1.28E-03 1.562461 
ENSMUSG00000096206 Gm22317 1.28E-03 1.562461 
ENSMUSG00000033730 Egr3 2.40E-10 1.56174 
ENSMUSG00000116961 AC117662.4 2.23E-03 1.560197 




ENSMUSG00000109700 Gm21123 2.06E-03 1.559279 
ENSMUSG00000059741 Myl3 2.72E-06 1.558851 
ENSMUSG00000057280 Musk 2.22E-06 1.556841 
ENSMUSG00000053508 Gtsf2 6.80E-07 1.553985 
ENSMUSG00000030156 Cd69 5.45E-07 1.553384 
ENSMUSG00000089617 Scarna10 1.55E-02 1.551375 
ENSMUSG00000099587 Gm28967 1.55E-02 1.551375 
ENSMUSG00000030669 Calca 7.44E-05 1.551054 
ENSMUSG00000078616 Trim30c 4.08E-08 1.550782 
ENSMUSG00000060438 Rps10-ps1 1.39E-08 1.550238 
ENSMUSG00000024205 Rpl36-ps2 1.69E-04 1.549767 
ENSMUSG00000054169 Ceacam10 1.16E-05 1.548901 
ENSMUSG00000103313 Gm38357 3.20E-19 1.548815 
ENSMUSG00000110697 Gm31718 2.21E-17 1.548758 
ENSMUSG00000025726 Slc28a1 3.17E-02 1.545524 
ENSMUSG00000009633 G0s2 6.94E-06 1.54482 
ENSMUSG00000028435 Aqp3 1.82E-03 1.543177 
ENSMUSG00000030592 Ryr1 4.26E-06 1.541763 
ENSMUSG00000022126 Acod1 2.57E-26 1.541705 
ENSMUSG00000023034 Nr4a1 1.81E-17 1.541288 
ENSMUSG00000000982 Ccl3 6.13E-15 1.541237 
ENSMUSG00000078763 Slfn1 5.73E-17 1.541102 
ENSMUSG00000043953 Ccrl2 5.73E-17 1.540659 
ENSMUSG00000021250 Fos 1.14E-13 1.540618 
ENSMUSG00000113998 Gm40909 1.24E-05 1.539072 
ENSMUSG00000055775 Myh8 3.34E-07 1.538545 
ENSMUSG00000113778 Gm40847 4.05E-02 1.537382 
ENSMUSG00000003752 Itpkc 4.85E-21 1.537115 
ENSMUSG00000039236 Isg20 3.09E-19 1.536846 
ENSMUSG00000095891 Gm10717 4.11E-02 1.536618 
ENSMUSG00000039001 Rps21 9.90E-03 1.536396 
ENSMUSG00000082884 Gm13339 7.50E-04 1.536237 
ENSMUSG00000048003 Catsper4 8.39E-03 1.535787 
ENSMUSG00000078122 F630028O10Rik 4.20E-06 1.533738 
ENSMUSG00000026896 Ifih1 3.30E-37 1.533564 
ENSMUSG00000044162 Tnip3 1.14E-13 1.533448 
ENSMUSG00000060988 Galnt13 9.45E-06 1.532422 
ENSMUSG00000114980 4933432I03Rik 8.97E-11 1.532082 
ENSMUSG00000022026 Olfm4 2.93E-15 1.531757 
ENSMUSG00000051627 Hist1h1e 2.39E-07 1.530874 
ENSMUSG00000088835 Gm23547 1.43E-04 1.528212 
ENSMUSG00000024912 Fosl1 1.80E-06 1.524675 
ENSMUSG00000062345 Serpinb2 8.22E-08 1.524046 
ENSMUSG00000038418 Egr1 4.00E-21 1.523384 
ENSMUSG00000095280 Gm21738 2.33E-02 1.52126 
ENSMUSG00000026407 Cacna1s 4.38E-06 1.519984 
ENSMUSG00000074146 4930579C12Rik 7.58E-07 1.519858 
ENSMUSG00000099250 Rn7s2 1.74E-02 1.51752 
ENSMUSG00000099021 Rn7s1 1.74E-02 1.517472 
ENSMUSG00000059326 Csf2ra 1.63E-03 1.517321 
ENSMUSG00000089999 Gm6485 5.58E-09 1.517 
ENSMUSG00000043165 Lor 8.24E-05 1.516516 
ENSMUSG00000105195 Gm43584 5.14E-04 1.516166 
ENSMUSG00000089929 Bcl2a1b 2.06E-12 1.515751 
ENSMUSG00000081857 Gm13624 3.76E-02 1.515199 
ENSMUSG00000030787 Lyve1 1.11E-18 1.514832 




ENSMUSG00000104348 Gm37691 6.21E-04 1.514665 
ENSMUSG00000066861 Oas1g 1.81E-08 1.514221 
ENSMUSG00000020108 Ddit4 2.93E-14 1.513448 
ENSMUSG00000089762 Ier5l 3.07E-03 1.513212 
ENSMUSG00000095616 Gm26244 3.81E-02 1.513043 
ENSMUSG00000098178 Gm42418 7.46E-03 1.512104 
ENSMUSG00000081695 Rpsa-ps5 2.21E-02 1.510847 
ENSMUSG00000073402 Gm8909 3.59E-08 1.510563 
ENSMUSG00000086591 Dnah2os 1.17E-02 1.509414 
ENSMUSG00000105398 Gm47305 1.69E-02 1.508695 
ENSMUSG00000106279 Gm47287 1.69E-02 1.508691 
ENSMUSG00000087700 Gm15283 2.52E-02 1.508122 
ENSMUSG00000039070 Cpa4 3.68E-02 1.507901 
ENSMUSG00000075122 Cd80 2.72E-16 1.507703 
ENSMUSG00000069792 Wfdc17 2.78E-06 1.507287 
ENSMUSG00000069372 Ctxn3 3.67E-03 1.507089 
ENSMUSG00000087590 Epb41l4aos 1.11E-02 1.506513 
ENSMUSG00000026981 Il1rn 3.16E-19 1.505344 
ENSMUSG00000026452 Syt2 1.70E-09 1.505325 
ENSMUSG00000000204 Slfn4 4.49E-06 1.504687 
ENSMUSG00000046961 Gpr156 2.21E-03 1.504602 
ENSMUSG00000070692 Rps12-ps10 4.70E-02 1.504592 
ENSMUSG00000087881 Gm22442 1.39E-03 1.50459 
ENSMUSG00000086290 Snhg12 4.30E-06 1.504012 
ENSMUSG00000026121 Sema4c 6.49E-23 1.503955 
ENSMUSG00000087006 Gm13889 6.41E-14 1.501606 
ENSMUSG00000102496 Gm36989 8.23E-03 1.501532 
ENSMUSG00000079597 Gm5483 3.51E-09 1.500636 
ENSMUSG00000041117 Ccdc8 4.06E-05 1.500681 
ENSMUSG00000058571 Gpc6 1.32E-14 1.500895 
ENSMUSG00000036411 9530077C05Rik 6.19E-05 1.501083 
ENSMUSG00000052117 D630039A03Rik 2.45E-02 1.502702 
ENSMUSG00000104168 Gm38250 2.20E-02 1.503235 
ENSMUSG00000075410 Prcd 1.29E-02 1.506303 
ENSMUSG00000100005 B130024G19Rik 2.07E-17 1.507802 
ENSMUSG00000075592 Nynrin 6.90E-13 1.509107 
ENSMUSG00000038236 Hoxa7 4.80E-02 1.509405 
ENSMUSG00000091183 Gm5141 4.66E-03 1.509918 
ENSMUSG00000110206 Flt3l 1.03E-05 1.510135 
ENSMUSG00000078870 Gm14410 1.70E-12 1.510221 
ENSMUSG00000048402 Gli2 2.01E-16 1.510632 
ENSMUSG00000027318 Adam33 7.24E-05 1.510692 
ENSMUSG00000070867 Trabd2b 1.19E-23 1.510708 
ENSMUSG00000002346 Slc25a42 3.08E-09 1.51104 
ENSMUSG00000038119 Cdon 2.13E-13 1.511472 
ENSMUSG00000000901 Mmp11 5.59E-04 1.511928 
ENSMUSG00000030125 Lrrc23 5.32E-04 1.514186 
ENSMUSG00000021708 Rasgrf2 3.43E-12 1.514585 
ENSMUSG00000030494 Rhpn2 6.96E-09 1.515185 
ENSMUSG00000042788 Fam166b 4.27E-02 1.515671 
ENSMUSG00000024206 Rfx2 1.63E-11 1.516097 
ENSMUSG00000026494 Kif26b 4.56E-12 1.516931 
ENSMUSG00000017167 Cntnap1 8.30E-04 1.517416 
ENSMUSG00000022456 3-Sep 6.51E-04 1.518584 
ENSMUSG00000086158 Ccpg1os 2.54E-02 1.519402 
ENSMUSG00000060548 Tnfrsf19 1.99E-11 1.519979 




ENSMUSG00000020642 Rnf144a 4.31E-15 1.521445 
ENSMUSG00000085517 Gm12963 2.62E-08 1.522068 
ENSMUSG00000026785 Pkn3 1.39E-05 1.522559 
ENSMUSG00000041429 Nthl1 1.53E-02 1.522772 
ENSMUSG00000099564 Gm28729 3.26E-02 1.52279 
ENSMUSG00000050751 Pgbd5 3.26E-03 1.523024 
ENSMUSG00000024063 Lbh 1.62E-22 1.524459 
ENSMUSG00000051590 Map3k19 2.04E-03 1.524752 
ENSMUSG00000026109 Tmeff2 7.24E-05 1.524936 
ENSMUSG00000023266 Frs3 3.39E-02 1.525124 
ENSMUSG00000019945 Cabcoco1 1.24E-04 1.52674 
ENSMUSG00000026259 Ngef 2.29E-07 1.529308 
ENSMUSG00000034522 Zfp395 1.20E-09 1.531411 
ENSMUSG00000101801 1700020G17Rik 1.60E-08 1.531815 
ENSMUSG00000027656 Wisp2 1.30E-21 1.531853 
ENSMUSG00000022199 Slc22a17 3.25E-05 1.532662 
ENSMUSG00000045875 Adra1a 2.84E-04 1.533756 
ENSMUSG00000072601 Ear1 4.22E-05 1.534311 
ENSMUSG00000037492 Zmat4 1.17E-06 1.534582 
ENSMUSG00000050541 Adra1b 9.82E-06 1.535536 
ENSMUSG00000050014 Apol10b 1.20E-02 1.536867 
ENSMUSG00000059824 Dbp 3.21E-07 1.537822 
ENSMUSG00000026691 Fmo3 6.57E-08 1.538988 
ENSMUSG00000085024 C230035I16Rik 9.71E-03 1.539108 
ENSMUSG00000026347 Tmem163 2.07E-16 1.541624 
ENSMUSG00000097591 A330032B11Rik 4.27E-02 1.541666 
ENSMUSG00000075389 2810410L24Rik 2.04E-04 1.542084 
ENSMUSG00000022543 4930451G09Rik 1.75E-02 1.543206 
ENSMUSG00000106951 5930430L01Rik 7.93E-03 1.544424 
ENSMUSG00000022758 P2rx6 8.50E-04 1.545377 
ENSMUSG00000026888 Grb14 2.00E-26 1.54642 
ENSMUSG00000026824 Kcnj3 9.08E-11 1.547942 
ENSMUSG00000045555 Mettl24 1.86E-10 1.550112 
ENSMUSG00000022053 Ebf2 8.28E-10 1.550167 
ENSMUSG00000031489 Adrb3 2.08E-05 1.550335 
ENSMUSG00000074384 AI429214 2.69E-02 1.55054 
ENSMUSG00000054021 Sirt5 4.74E-06 1.551042 
ENSMUSG00000055945 Prr18 5.17E-03 1.551295 
ENSMUSG00000033595 Lgi3 1.84E-11 1.55237 
ENSMUSG00000103183 Gm37090 2.52E-03 1.5557 
ENSMUSG00000061601 Pclo 1.11E-04 1.555835 
ENSMUSG00000112714 Gm4798 2.86E-05 1.556475 
ENSMUSG00000020182 Ddc 2.94E-02 1.556886 
ENSMUSG00000030041 M1ap 4.17E-06 1.556913 
ENSMUSG00000066319 Rtp3 1.02E-03 1.559718 
ENSMUSG00000013089 Etv5 2.23E-20 1.561183 
ENSMUSG00000097805 Gm17473 3.87E-07 1.561625 
ENSMUSG00000017309 Cd300lg 4.88E-06 1.561748 
ENSMUSG00000085982 9530051G07Rik 4.48E-02 1.563023 
ENSMUSG00000029053 Prkcz 4.17E-13 1.563284 
ENSMUSG00000030607 Acan 9.06E-03 1.563675 
ENSMUSG00000046456 Tmem150b 1.36E-03 1.564973 
ENSMUSG00000093479 Gm20629 2.73E-09 1.565239 
ENSMUSG00000037610 Kcnmb2 7.66E-08 1.5685 
ENSMUSG00000086368 Gm13830 7.26E-03 1.569182 
ENSMUSG00000043088 Il17re 2.31E-04 1.569494 




ENSMUSG00000020682 Mmp28 4.74E-10 1.570816 
ENSMUSG00000084939 Gm830 1.84E-02 1.572365 
ENSMUSG00000039763 Dnajc28 3.97E-02 1.575323 
ENSMUSG00000020734 Grin2c 3.03E-02 1.577359 
ENSMUSG00000026676 Ccdc3 6.28E-11 1.578234 
ENSMUSG00000028871 Rspo1 1.42E-02 1.579214 
ENSMUSG00000017007 Rbpjl 8.03E-08 1.581836 
ENSMUSG00000019831 Wasf1 2.22E-02 1.583533 
ENSMUSG00000042793 Lgr6 1.16E-16 1.585253 
ENSMUSG00000087424 5730405O15Rik 2.20E-02 1.587279 
ENSMUSG00000078794 Dact3 2.02E-05 1.590225 
ENSMUSG00000095079 Igha 8.37E-05 1.592326 
ENSMUSG00000050022 Amz1 5.27E-05 1.593171 
ENSMUSG00000036854 Hspb6 2.04E-03 1.597689 
ENSMUSG00000021719 Rgs7bp 2.95E-09 1.59776 
ENSMUSG00000025902 Sox17 1.02E-13 1.598591 
ENSMUSG00000074219 Gm10644 2.18E-02 1.598961 
ENSMUSG00000037846 Rtkn2 5.55E-07 1.598991 
ENSMUSG00000102082 Gm28675 4.81E-02 1.599203 
ENSMUSG00000086141 9030622O22Rik 1.25E-10 1.604845 
ENSMUSG00000089941 Gm16168 1.79E-03 1.606211 
ENSMUSG00000112468 Gm47720 2.62E-06 1.608526 
ENSMUSG00000068323 Slc4a5 6.46E-08 1.609607 
ENSMUSG00000116097 Gm36738 2.28E-02 1.611492 
ENSMUSG00000019312 Grb7 8.16E-04 1.611956 
ENSMUSG00000059659 Gm10069 3.68E-05 1.612558 
ENSMUSG00000031220 Awat2 1.41E-02 1.613621 
ENSMUSG00000090206 Tepp 4.13E-03 1.616264 
ENSMUSG00000087514 Gm16076 2.99E-02 1.62071 
ENSMUSG00000041351 Rap1gap 2.36E-09 1.621611 
ENSMUSG00000069378 Prdm6 1.85E-18 1.623444 
ENSMUSG00000036923 Stox1 5.18E-07 1.623817 
ENSMUSG00000050288 Fzd2 8.28E-04 1.624159 
ENSMUSG00000086607 4930511M06Rik 6.52E-03 1.624741 
ENSMUSG00000034685 Fam171a2 6.79E-04 1.62484 
ENSMUSG00000062542 Syt9 1.57E-02 1.627124 
ENSMUSG00000007279 Scube2 2.67E-18 1.629611 
ENSMUSG00000054057 A930004D18Rik 3.30E-02 1.629982 
ENSMUSG00000066438 Plekhd1 2.77E-07 1.631307 
ENSMUSG00000085682 Gm14267 1.18E-03 1.635757 
ENSMUSG00000074793 Hspa12b 6.74E-21 1.635809 
ENSMUSG00000030495 Slc7a10 3.89E-09 1.637942 
ENSMUSG00000033590 Myo5c 1.66E-15 1.641777 
ENSMUSG00000030562 Nox4 8.94E-09 1.642642 
ENSMUSG00000083817 Gm14400 1.77E-02 1.642954 
ENSMUSG00000099553 Gm29538 1.68E-03 1.64385 
ENSMUSG00000058420 Syt17 3.26E-06 1.643854 
ENSMUSG00000054459 Vsnl1 1.48E-12 1.644077 
ENSMUSG00000037973 Ccdc129 8.09E-09 1.644828 
ENSMUSG00000059146 Ntrk3 4.47E-22 1.645531 
ENSMUSG00000056155 Nanos3 4.06E-03 1.646041 
ENSMUSG00000106749 Gm43281 3.37E-06 1.64753 
ENSMUSG00000072599 Ear-ps2 8.09E-03 1.648472 
ENSMUSG00000069518 Gm10271 4.49E-02 1.649982 
ENSMUSG00000074771 Ankef1 3.41E-04 1.656591 
ENSMUSG00000041479 Syt15 1.37E-05 1.659181 




ENSMUSG00000063430 Wscd2 1.63E-07 1.662763 
ENSMUSG00000086596 Susd5 3.88E-05 1.663486 
ENSMUSG00000011263 Exoc3l2 2.11E-02 1.671039 
ENSMUSG00000034584 Exph5 2.07E-17 1.671345 
ENSMUSG00000022840 Adcy5 1.15E-24 1.673312 
ENSMUSG00000028801 Stpg1 1.90E-04 1.675936 
ENSMUSG00000027827 Kcnab1 1.06E-12 1.685414 
ENSMUSG00000020614 Fam20a 7.24E-19 1.686889 
ENSMUSG00000021499 Catsper3 7.33E-03 1.687729 
ENSMUSG00000085171 D830026I12Rik 4.25E-02 1.689753 
ENSMUSG00000035435 Abca17 2.81E-10 1.692557 
ENSMUSG00000030043 Tacr1 7.60E-05 1.693777 
ENSMUSG00000041020 Map7d2 2.75E-02 1.695372 
ENSMUSG00000110380 Gm45332 6.76E-03 1.695675 
ENSMUSG00000105376 Gm36535 1.64E-02 1.696479 
ENSMUSG00000101605 Ace3 1.74E-05 1.696685 
ENSMUSG00000037709 Fam13a 2.63E-08 1.704891 
ENSMUSG00000109165 Gm45148 5.67E-03 1.705895 
ENSMUSG00000020169 Best3 1.46E-07 1.71572 
ENSMUSG00000048728 Zfp454 4.49E-02 1.717216 
ENSMUSG00000028755 Cda 1.99E-02 1.717754 
ENSMUSG00000085282 Gm15663 1.21E-02 1.718236 
ENSMUSG00000048096 Lmod1 9.53E-07 1.718553 
ENSMUSG00000103738 Gm37652 1.24E-03 1.722127 
ENSMUSG00000108580 Gm39094 1.47E-22 1.733461 
ENSMUSG00000027380 Acoxl 2.48E-08 1.733573 
ENSMUSG00000063535 Zfp773 3.78E-03 1.735884 
ENSMUSG00000027186 Elf5 3.75E-05 1.74138 
ENSMUSG00000029193 Cckar 1.05E-05 1.742803 
ENSMUSG00000108767 Gm29763 2.99E-02 1.742917 
ENSMUSG00000032357 Tinag 2.33E-06 1.748176 
ENSMUSG00000092515 C87198 4.36E-02 1.750226 
ENSMUSG00000070661 Rnf186 4.40E-02 1.752275 
ENSMUSG00000030380 Mzf1 1.63E-02 1.763149 
ENSMUSG00000042428 Mgat3 6.40E-12 1.763723 
ENSMUSG00000044708 Kcnj10 2.22E-02 1.767881 
ENSMUSG00000041423 Paqr6 2.72E-02 1.768799 
ENSMUSG00000089712 Gm15889 6.62E-03 1.770295 
ENSMUSG00000063730 Hsd3b2 2.08E-02 1.773821 
ENSMUSG00000101693 Gm19461 2.09E-02 1.777561 
ENSMUSG00000064294 Aox3 3.77E-15 1.778141 
ENSMUSG00000086313 Gm15940 2.10E-02 1.780429 
ENSMUSG00000044694 2010007H06Rik 1.51E-06 1.781054 
ENSMUSG00000108481 Gm33248 4.21E-13 1.784046 
ENSMUSG00000061397 Krt79 6.09E-04 1.786124 
ENSMUSG00000094786 Gm14403 1.13E-16 1.786856 
ENSMUSG00000079436 Kcnj13 4.22E-02 1.78992 
ENSMUSG00000038233 Fam198a 1.05E-06 1.790914 
ENSMUSG00000042256 Ptchd4 7.00E-05 1.791307 
ENSMUSG00000052026 Slc6a7 4.86E-05 1.792733 
ENSMUSG00000097124 A530020G20Rik 7.37E-06 1.792876 
ENSMUSG00000048988 Elfn1 1.27E-13 1.803612 
ENSMUSG00000057719 Sh3rf2 2.42E-19 1.804366 
ENSMUSG00000111761 9230112J17Rik 3.13E-04 1.810487 
ENSMUSG00000027886 1700013F07Rik 2.43E-02 1.810795 
ENSMUSG00000082292 Gm12250 3.69E-06 1.81246 




ENSMUSG00000068373 D430041D05Rik 5.87E-17 1.830741 
ENSMUSG00000020566 Atp6v1c2 1.23E-25 1.832003 
ENSMUSG00000114028 9630002D21Rik 3.96E-03 1.832354 
ENSMUSG00000102590 Mannr 1.75E-04 1.836166 
ENSMUSG00000006567 Atp7b 2.18E-17 1.836476 
ENSMUSG00000076613 Ighg2b 2.30E-02 1.837406 
ENSMUSG00000102437 Gm38048 2.54E-08 1.843504 
ENSMUSG00000025577 Cbx2 1.42E-04 1.846281 
ENSMUSG00000037279 Ovol2 2.30E-03 1.852727 
ENSMUSG00000030093 Wnt7a 1.05E-06 1.855136 
ENSMUSG00000097453 Gm26894 1.59E-03 1.856702 
ENSMUSG00000087518 Gm13561 3.22E-03 1.859076 
ENSMUSG00000044633 B530045E10Rik 8.05E-19 1.860022 
ENSMUSG00000009394 Syn2 1.55E-17 1.865441 
ENSMUSG00000085069 Gm13111 1.65E-04 1.866473 
ENSMUSG00000079173 Zan 4.11E-04 1.868008 
ENSMUSG00000030098 Grip2 4.24E-11 1.871182 
ENSMUSG00000074575 Kcng1 4.71E-02 1.871584 
ENSMUSG00000116766 AC171205.1 3.48E-02 1.87324 
ENSMUSG00000027513 Pck1 3.53E-10 1.874273 
ENSMUSG00000056824 Zfp663 6.72E-03 1.880195 
ENSMUSG00000086843 E030013I19Rik 3.55E-05 1.886677 
ENSMUSG00000108218 Olfr1372-ps1 6.73E-09 1.893798 
ENSMUSG00000087413 Gm11266 3.96E-14 1.899133 
ENSMUSG00000093550 Higd1c 3.35E-02 1.906324 
ENSMUSG00000020335 Zfp354b 1.86E-02 1.906344 
ENSMUSG00000027460 Angpt4 7.61E-09 1.918001 
ENSMUSG00000036295 Lrrn3 4.53E-05 1.925128 
ENSMUSG00000090166 Ear10 1.40E-06 1.929094 
ENSMUSG00000099338 2810030D12Rik 6.44E-05 1.935947 
ENSMUSG00000032502 Stac 6.19E-06 1.936727 
ENSMUSG00000079039 Gm11037 2.50E-02 1.940577 
ENSMUSG00000105786 Gm18957 1.48E-02 1.942241 
ENSMUSG00000117322 AC154766.4 2.55E-02 1.953694 
ENSMUSG00000022504 Ciita 2.96E-28 1.959704 
ENSMUSG00000028919 Arhgef19 2.26E-03 1.968027 
ENSMUSG00000110891 Gm40639 3.60E-02 1.972536 
ENSMUSG00000104376 Gm37516 1.20E-02 1.974628 
ENSMUSG00000029601 Iqcd 8.65E-03 1.990538 
ENSMUSG00000026870 Cutal 1.79E-04 1.994395 
ENSMUSG00000110631 Gm42047 5.59E-03 2.007803 
ENSMUSG00000085882 2610507I01Rik 5.32E-05 2.01961 
ENSMUSG00000109770 Gm30085 3.97E-02 2.026925 
ENSMUSG00000086390 1810019D21Rik 1.01E-09 2.035809 
ENSMUSG00000080797 Gm15760 2.06E-02 2.049068 
ENSMUSG00000033849 B3galt2 1.86E-03 2.059198 
ENSMUSG00000031725 Ces1f 6.83E-03 2.092553 
ENSMUSG00000087500 Gm12426 5.91E-03 2.107058 
ENSMUSG00000092004 Gm17482 9.93E-07 2.112466 
ENSMUSG00000019909 Fam162b 5.07E-04 2.116376 
ENSMUSG00000115307 Gm49313 1.84E-04 2.139641 
ENSMUSG00000060275 Nrg2 7.68E-08 2.145009 
ENSMUSG00000025789 St8sia2 1.28E-15 2.169809 
ENSMUSG00000108390 Gm39038 1.64E-03 2.192189 
ENSMUSG00000026147 Col9a1 1.56E-02 2.194131 
ENSMUSG00000053961 Ang5 2.31E-03 2.198318 




ENSMUSG00000027796 Smad9 3.65E-14 2.220367 
ENSMUSG00000103160 C130012C08Rik 2.01E-03 2.234457 
ENSMUSG00000020081 Tacr2 1.82E-02 2.253652 
ENSMUSG00000069830 Nlrp1a 2.69E-07 2.281738 
ENSMUSG00000108617 Gm31749 6.04E-03 2.285686 
ENSMUSG00000009900 Wnt3a 5.16E-09 2.298134 
ENSMUSG00000027831 Veph1 9.72E-25 2.301924 
ENSMUSG00000061171 Slc38a11 3.50E-05 2.353128 
ENSMUSG00000001494 Sost 4.34E-04 2.412139 
ENSMUSG00000026304 Rab17 1.09E-03 2.608575 
ENSMUSG00000031551 Ido1 1.39E-05 3.239545 
ENSMUSG00000092591 Gm20429 2.09E-04 3.383042 
ENSMUSG00000071679 Rtl4 6.39E-21 4.582634 






























Appendix T. Murine differential gene expression in the lungs 6 h post-infection, 947 vs 4559. 
Genes with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in 
blue = upregulated in 947, while values highlighted in red = upregulated in 4559. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000096349 Gm22513 3.77E-18 10.97464 
ENSMUSG00000094668 Gm24871 1.29E-07 6.745915 
ENSMUSG00000064899 Snord118 1.08E-09 6.570577 
ENSMUSG00000097554 Gm26825 7.25E-04 5.791676 
ENSMUSG00000109641 Gm45556 1.47E-03 5.598475 
ENSMUSG00000105361 AY036118 3.15E-13 5.461151 
ENSMUSG00000080538 Gm25541 4.06E-18 5.174635 
ENSMUSG00000093843 Gm25939 7.29E-13 4.925819 
ENSMUSG00000095676 Gm25099 9.26E-27 4.906139 
ENSMUSG00000065870 Rnu3a 1.74E-16 4.884372 
ENSMUSG00000106147 Rnu3a 1.74E-16 4.884372 
ENSMUSG00000095738 Gm25313 8.71E-14 4.857934 
ENSMUSG00000095892 Rnu5g 4.27E-14 4.78872 
ENSMUSG00000104896 Rnu3b4 9.34E-24 4.622038 
ENSMUSG00000098641 Rnu3b4 1.21E-23 4.615922 
ENSMUSG00000099291 Rnu3b3 6.68E-23 4.590292 
ENSMUSG00000104856 Rnu3b3 6.68E-23 4.590292 
ENSMUSG00000105115 Rnu3b2 7.99E-24 4.578094 
ENSMUSG00000098925 Rnu3b2 7.99E-24 4.578094 
ENSMUSG00000098943 Rnu3b1 3.21E-23 4.559078 
ENSMUSG00000105025 Rnu3b1 3.21E-23 4.559078 
ENSMUSG00000085393 Gm11280 1.04E-03 4.538932 
ENSMUSG00000064945 Rny3 1.19E-15 4.476071 
ENSMUSG00000042385 Gzmk 5.37E-03 4.35977 
ENSMUSG00000094050 Gm23472 1.36E-13 4.320851 
ENSMUSG00000093956 Gm24497 4.43E-13 4.291089 
ENSMUSG00000064856 Gm23444 2.34E-13 4.288303 
ENSMUSG00000088675 Rprl1 2.41E-06 4.192998 
ENSMUSG00000106222 Rprl1 2.41E-06 4.192998 
ENSMUSG00000065176 Rnu12 1.99E-27 4.109879 
ENSMUSG00000065701 Rny1 7.64E-13 4.069417 
ENSMUSG00000065254 Gm23973 3.03E-06 4.059083 
ENSMUSG00000032494 Tdgf1 1.92E-05 4.053171 
ENSMUSG00000065820 Gm26316 9.85E-13 4.048075 
ENSMUSG00000064682 Gm25813 9.90E-09 4.046294 
ENSMUSG00000064702 Gm24950 3.05E-12 3.981116 
ENSMUSG00000065251 Gm23971 3.05E-12 3.981116 
ENSMUSG00000065944 Rnu2-10 2.22E-12 3.976161 
ENSMUSG00000065767 Gm23849 3.07E-12 3.962822 
ENSMUSG00000077323 Rnu11 6.04E-13 3.962105 
ENSMUSG00000094377 Gm24407 2.62E-14 3.808851 
ENSMUSG00000065232 Gm22973 6.93E-12 3.795942 
ENSMUSG00000067455 Hist1h4j 3.60E-08 3.778868 
ENSMUSG00000060093 Hist1h4a 2.31E-16 3.753049 
ENSMUSG00000096243 Gm24265 2.84E-11 3.648484 
ENSMUSG00000065845 Gm25189 2.58E-03 3.636942 
ENSMUSG00000064943 Gm23240 2.39E-03 3.62003 
ENSMUSG00000069300 Hist1h2bj 2.08E-05 3.616983 
ENSMUSG00000095616 Gm26244 1.81E-09 3.585974 
ENSMUSG00000088252 Snord13 3.16E-08 3.500728 
ENSMUSG00000064941 Gm23238 2.49E-12 3.477513 




ENSMUSG00000096659 Gm25679 2.63E-16 3.411828 
ENSMUSG00000093815 Gm26444 2.63E-16 3.411828 
ENSMUSG00000063021 Hist1h2ak 2.45E-03 3.406041 
ENSMUSG00000095260 Gm25890 9.28E-10 3.34811 
ENSMUSG00000094812 Gm22614 9.28E-10 3.34811 
ENSMUSG00000064923 Gm22042 8.01E-10 3.347755 
ENSMUSG00000095580 Rnu1b1 2.34E-09 3.347511 
ENSMUSG00000093834 Rnu1b2 2.34E-09 3.347511 
ENSMUSG00000094306 Gm24924 7.72E-09 3.330976 
ENSMUSG00000095701 Gm24830 1.01E-09 3.296712 
ENSMUSG00000096838 Gm26232 1.01E-09 3.296712 
ENSMUSG00000065773 Rnu1b6 1.01E-09 3.296712 
ENSMUSG00000094826 Gm23804 3.33E-15 3.281135 
ENSMUSG00000097131 D230017M19Rik 7.32E-15 3.266318 
ENSMUSG00000069266 Hist1h4b 3.25E-06 3.259907 
ENSMUSG00000060981 Hist1h4h 4.37E-17 3.254606 
ENSMUSG00000101355 Hist1h3h 1.42E-03 3.179868 
ENSMUSG00000099517 Hist1h3g 1.06E-03 3.159837 
ENSMUSG00000010362 Rdm1 1.06E-11 3.14031 
ENSMUSG00000081684 Rps2-ps13 4.23E-24 3.13385 
ENSMUSG00000069305 Hist1h4n 4.43E-08 3.133044 
ENSMUSG00000065905 Gm26110 1.16E-04 3.130131 
ENSMUSG00000069306 Hist1h4m 5.27E-07 3.127821 
ENSMUSG00000095217 Hist1h2bn 2.95E-06 3.119423 
ENSMUSG00000064288 Hist1h4k 1.87E-08 3.117272 
ENSMUSG00000080465 Gm22486 2.90E-09 3.11249 
ENSMUSG00000047061 Gm9817 3.14E-02 3.110749 
ENSMUSG00000087963 Gm25394 2.00E-03 3.095042 
ENSMUSG00000115420 AL732506.1 2.92E-15 3.080505 
ENSMUSG00000088088 Rmrp 2.92E-15 3.080505 
ENSMUSG00000096205 Gm22068 3.77E-09 3.06075 
ENSMUSG00000094655 Gm25360 1.37E-14 3.058749 
ENSMUSG00000060678 Hist1h4c 2.01E-18 3.058247 
ENSMUSG00000065824 Gm26315 1.04E-11 3.053521 
ENSMUSG00000092837 Rpph1 4.58E-09 3.031887 
ENSMUSG00000088025 Rprl3 2.03E-07 3.027158 
ENSMUSG00000099583 Hist1h3d 3.33E-04 3.01984 
ENSMUSG00000071470 Ccnb1ip1 4.41E-09 3.011385 
ENSMUSG00000065911 Gm24447 2.34E-11 2.998729 
ENSMUSG00000064694 Gm24146 5.78E-07 2.99441 
ENSMUSG00000092805 Gm26461 4.04E-09 2.980919 
ENSMUSG00000069274 Hist1h4f 2.64E-07 2.963294 
ENSMUSG00000096214 Gm22634 3.07E-14 2.955618 
ENSMUSG00000096206 Gm22317 3.07E-14 2.955618 
ENSMUSG00000087775 Rprl2 5.59E-07 2.949971 
ENSMUSG00000061482 Hist1h4d 5.96E-25 2.947909 
ENSMUSG00000092819 Gm23639 1.31E-03 2.911866 
ENSMUSG00000023467 Tulp2 8.88E-03 2.887985 
ENSMUSG00000010342 Tex14 2.11E-12 2.887178 
ENSMUSG00000092702 Gm24514 3.30E-08 2.857933 
ENSMUSG00000105790 Gm24105 1.12E-10 2.857786 
ENSMUSG00000087943 Gm24245 4.70E-13 2.854799 
ENSMUSG00000100210 Hist1h3f 1.45E-07 2.846879 
ENSMUSG00000090625 Gm20721 5.27E-04 2.822061 
ENSMUSG00000092674 Gm24105 1.19E-10 2.820054 
ENSMUSG00000046242 Nme9 4.34E-05 2.796067 




ENSMUSG00000114279 Hist1h2bm 1.67E-03 2.777077 
ENSMUSG00000058385 Hist1h2bg 2.78E-09 2.77039 
ENSMUSG00000064901 Snora21 9.99E-04 2.75448 
ENSMUSG00000101972 Hist1h3i 1.08E-03 2.745319 
ENSMUSG00000070167 Snora57 2.32E-12 2.741946 
ENSMUSG00000069265 Hist1h3a 1.82E-03 2.720348 
ENSMUSG00000064451 Snora23 9.44E-04 2.713527 
ENSMUSG00000091383 Hist1h2al 5.55E-14 2.672474 
ENSMUSG00000114456 Hist1h2bh 2.26E-05 2.669249 
ENSMUSG00000068855 Hist2h2ac 1.06E-06 2.662418 
ENSMUSG00000088008 Gm25492 6.86E-05 2.660852 
ENSMUSG00000105145 Gm47299 1.14E-08 2.652374 
ENSMUSG00000105788 Gm47295 1.14E-08 2.652269 
ENSMUSG00000105399 Mir1843b 7.66E-03 2.649552 
ENSMUSG00000065686 Snora5c 9.51E-04 2.647534 
ENSMUSG00000062727 Hist1h2bk 1.21E-05 2.647047 
ENSMUSG00000090208 Gm15851 4.93E-02 2.646 
ENSMUSG00000096992 Gm26788 1.53E-02 2.640965 
ENSMUSG00000092386 Gm20536 1.21E-02 2.615154 
ENSMUSG00000057596 Trim30d 2.24E-12 2.613284 
ENSMUSG00000064999 Gm26035 7.18E-09 2.608373 
ENSMUSG00000069267 Hist1h3b 1.04E-03 2.564833 
ENSMUSG00000093355 Snora26 1.95E-02 2.562115 
ENSMUSG00000069273 Hist1h3e 5.25E-08 2.556766 
ENSMUSG00000064994 Gm22422 9.17E-05 2.54989 
ENSMUSG00000060988 Galnt13 1.31E-22 2.547254 
ENSMUSG00000081342 Gm11434 1.83E-02 2.528216 
ENSMUSG00000065649 Snora74a 1.80E-07 2.526072 
ENSMUSG00000064655 Gm25788 1.04E-03 2.525134 
ENSMUSG00000097799 Gm26899 2.35E-02 2.488561 
ENSMUSG00000065145 Vaultrc5 2.35E-06 2.476147 
ENSMUSG00000085465 Gm15347 1.42E-02 2.4729 
ENSMUSG00000075031 Hist1h2bb 2.05E-04 2.467707 
ENSMUSG00000087819 Gm25117 1.17E-09 2.467012 
ENSMUSG00000074403 Hist2h3b 1.52E-03 2.454729 
ENSMUSG00000077254 Gm26079 1.78E-05 2.438855 
ENSMUSG00000115783 Bc1 1.63E-04 2.432863 
ENSMUSG00000098178 Gm42418 3.40E-10 2.426788 
ENSMUSG00000065087 Snord22 4.68E-20 2.423107 
ENSMUSG00000094338 Hist1h2bl 5.96E-06 2.421661 
ENSMUSG00000096010 Hist4h4 1.32E-07 2.421203 
ENSMUSG00000076614 Ighg1 3.86E-02 2.417765 
ENSMUSG00000089536 Scarna3a 8.57E-03 2.411926 
ENSMUSG00000069268 Hist1h2bf 6.11E-03 2.41015 
ENSMUSG00000076258 Gm23935 6.42E-13 2.406898 
ENSMUSG00000097346 Gm26619 2.89E-02 2.388088 
ENSMUSG00000080365 Gm25776 3.68E-05 2.383555 
ENSMUSG00000076281 Gm24270 1.12E-10 2.373892 
ENSMUSG00000097815 Gm26809 2.33E-02 2.371395 
ENSMUSG00000114969 Hba-ps3 9.14E-04 2.369228 
ENSMUSG00000065778 Gm22154 1.68E-02 2.34964 
ENSMUSG00000105448 Gm25820 1.08E-02 2.348821 
ENSMUSG00000105288 Gm25820 1.08E-02 2.348821 
ENSMUSG00000064966 Snord15b 1.44E-06 2.333139 
ENSMUSG00000069308 Hist1h2bp 3.62E-03 2.322081 
ENSMUSG00000035299 Mid1 4.01E-07 2.316383 




ENSMUSG00000088529 Gm26083 2.80E-05 2.314116 
ENSMUSG00000113512 Gm9063 3.83E-02 2.306271 
ENSMUSG00000069310 Hist1h3c 2.34E-03 2.302294 
ENSMUSG00000115432 D130009I18Rik 2.70E-03 2.300679 
ENSMUSG00000004814 Ccl24 9.80E-03 2.290894 
ENSMUSG00000091957 Rps2-ps10 1.37E-12 2.275718 
ENSMUSG00000077611 Gm23946 4.84E-02 2.264088 
ENSMUSG00000088609 Gm24187 3.72E-12 2.233571 
ENSMUSG00000099250 Rn7s2 5.82E-07 2.228017 
ENSMUSG00000099021 Rn7s1 5.82E-07 2.227961 
ENSMUSG00000095590 Gm24305 2.92E-02 2.221176 
ENSMUSG00000060639 Hist1h4i 5.98E-05 2.218385 
ENSMUSG00000082755 Gm8692 3.31E-04 2.214971 
ENSMUSG00000112246 Gm40761 4.75E-02 2.182331 
ENSMUSG00000105398 Gm47305 8.24E-07 2.175963 
ENSMUSG00000106279 Gm47287 8.24E-07 2.175954 
ENSMUSG00000063954 Hist2h2aa2 3.09E-07 2.164586 
ENSMUSG00000052305 Hbb-bs 1.32E-07 2.16149 
ENSMUSG00000104863 Gm49347 2.14E-04 2.145847 
ENSMUSG00000064380 Gm26448 4.40E-09 2.145839 
ENSMUSG00000088246 Gm25911 7.67E-12 2.145126 
ENSMUSG00000089255 Snora78 1.36E-02 2.137569 
ENSMUSG00000085297 Gm11651 5.25E-03 2.127159 
ENSMUSG00000058773 Hist1h1b 8.95E-05 2.120617 
ENSMUSG00000064220 Hist2h2aa1 3.10E-04 2.117751 
ENSMUSG00000104740 Mir6516 9.92E-04 2.113466 
ENSMUSG00000046229 Scand1 1.44E-02 2.111608 
ENSMUSG00000064387 Snora73a 7.47E-12 2.088608 
ENSMUSG00000085261 Gm13814 1.41E-02 2.077594 
ENSMUSG00000080542 Gm22710 2.43E-03 2.074884 
ENSMUSG00000091993 B930036N10Rik 2.07E-03 2.07144 
ENSMUSG00000112831 AC167229.1 2.82E-02 2.068995 
ENSMUSG00000091405 Hist2h4 9.28E-10 2.052495 
ENSMUSG00000046031 Calhm6 1.74E-06 2.048611 
ENSMUSG00000084708 Gm22988 5.06E-06 2.038794 
ENSMUSG00000031289 Il13ra2 4.46E-05 2.025167 
ENSMUSG00000088185 Scarna2 2.45E-08 2.024717 
ENSMUSG00000029635 Cdk8 3.25E-10 2.022129 
ENSMUSG00000088789 Scarna13 1.73E-06 2.017749 
ENSMUSG00000026573 Xcl1 3.45E-03 2.016054 
ENSMUSG00000100992 Gm23925 3.22E-02 2.01348 
ENSMUSG00000102189 Gm37194 5.60E-06 2.000652 
ENSMUSG00000077167 Gm24119 9.88E-03 1.997643 
ENSMUSG00000065637 Gm26397 4.01E-07 1.997637 
ENSMUSG00000084744 Gm25291 4.03E-03 1.99723 
ENSMUSG00000106649 Gm49349 1.43E-06 1.993359 
ENSMUSG00000064405 Gm23925 3.66E-02 1.98704 
ENSMUSG00000082516 Gm13342 1.02E-02 1.981125 
ENSMUSG00000027233 Patl2 3.08E-02 1.979645 
ENSMUSG00000092746 Rn7s6 1.82E-05 1.965498 
ENSMUSG00000073940 Hbb-bt 8.75E-06 1.965051 
ENSMUSG00000103336 Gm37993 4.98E-02 1.954663 
ENSMUSG00000100831 Gm17847 1.84E-02 1.954622 
ENSMUSG00000081058 Hist2h3c2 2.98E-03 1.954493 
ENSMUSG00000065118 Gm23297 1.62E-02 1.944291 
ENSMUSG00000030670 Cyp2r1 1.52E-02 1.939325 




ENSMUSG00000001983 Taco1 6.95E-08 1.933656 
ENSMUSG00000065226 Gm25791 3.01E-06 1.926078 
ENSMUSG00000062461 Gm5453 8.46E-10 1.924129 
ENSMUSG00000104690 Gm47304 3.05E-05 1.920177 
ENSMUSG00000065037 Rn7sk 2.04E-05 1.917124 
ENSMUSG00000069917 Hba-a2 3.52E-13 1.915594 
ENSMUSG00000055170 Ifng 5.97E-03 1.914606 
ENSMUSG00000064841 Gm26205 1.80E-02 1.910409 
ENSMUSG00000090101 Snhg9 2.49E-02 1.888943 
ENSMUSG00000065353 Snora73b 9.17E-05 1.888933 
ENSMUSG00000113136 Gm19951 1.01E-03 1.888218 
ENSMUSG00000113465 Gm40271 5.45E-03 1.872958 
ENSMUSG00000066629 Rpl36-ps3 5.45E-03 1.872958 
ENSMUSG00000024205 Rpl36-ps2 1.48E-07 1.856283 
ENSMUSG00000089617 Scarna10 3.70E-04 1.856044 
ENSMUSG00000099587 Gm28967 3.70E-04 1.856044 
ENSMUSG00000022658 Tagln3 3.59E-03 1.852149 
ENSMUSG00000117074 AC121299.1 4.22E-02 1.849145 
ENSMUSG00000087968 Gm25395 7.59E-06 1.841096 
ENSMUSG00000052565 Hist1h1d 8.37E-06 1.839687 
ENSMUSG00000091955 Gm9844 3.52E-18 1.837563 
ENSMUSG00000086196 Gm13571 3.25E-04 1.836858 
ENSMUSG00000064853 Gm23442 2.97E-04 1.832979 
ENSMUSG00000077714 Snord17 3.52E-04 1.822824 
ENSMUSG00000069919 Hba-a1 8.16E-13 1.822782 
ENSMUSG00000020641 Rsad2 3.37E-12 1.822486 
ENSMUSG00000049539 Hist1h1a 7.38E-03 1.821165 
ENSMUSG00000069307 Hist1h2bq 4.15E-05 1.818275 
ENSMUSG00000035528 Npffr2 7.77E-03 1.814241 
ENSMUSG00000027220 Syt13 1.11E-02 1.812055 
ENSMUSG00000067321 Gm7931 3.36E-02 1.81009 
ENSMUSG00000085348 Myhas 3.50E-03 1.803894 
ENSMUSG00000065822 Snord15a 1.55E-02 1.803286 
ENSMUSG00000063234 Gpr84 1.21E-08 1.800134 
ENSMUSG00000085241 Snhg3 6.58E-07 1.798898 
ENSMUSG00000085573 Gm15418 4.34E-02 1.79681 
ENSMUSG00000065304 Gm23245 2.53E-02 1.794865 
ENSMUSG00000003545 Fosb 2.44E-06 1.793447 
ENSMUSG00000089762 Ier5l 3.00E-05 1.79236 
ENSMUSG00000057465 Saa2 5.73E-09 1.789508 
ENSMUSG00000053553 3110082I17Rik 9.75E-15 1.769663 
ENSMUSG00000109875 Gm45456 4.92E-03 1.768914 
ENSMUSG00000069303 Hist1h2br 8.01E-05 1.766683 
ENSMUSG00000100969 1700030N03Rik 1.27E-04 1.764586 
ENSMUSG00000053626 Tll1 3.72E-29 1.754673 
ENSMUSG00000037190 Cyb561d2 9.84E-03 1.753648 
ENSMUSG00000046470 Sox18 1.23E-13 1.751676 
ENSMUSG00000044092 C130050O18Rik 1.22E-06 1.748316 
ENSMUSG00000062778 Chia1 4.57E-20 1.747009 
ENSMUSG00000035852 Misp 1.80E-10 1.74205 
ENSMUSG00000025946 Pth2r 3.71E-02 1.730767 
ENSMUSG00000113722 Snhg10 6.72E-05 1.728473 
ENSMUSG00000020638 Cmpk2 9.44E-27 1.721661 
ENSMUSG00000089281 Scarna6 1.62E-03 1.712381 
ENSMUSG00000077563 Snora68 2.00E-03 1.708197 
ENSMUSG00000114234 Gm3131 3.41E-02 1.706159 




ENSMUSG00000028461 Ccdc107 1.38E-06 1.705554 
ENSMUSG00000102349 Gm37376 1.71E-02 1.701801 
ENSMUSG00000024810 Il33 4.65E-23 1.70107 
ENSMUSG00000070473 Cldn3 2.42E-10 1.696455 
ENSMUSG00000048709 Gm8666 3.20E-02 1.694683 
ENSMUSG00000028678 Kif2c 3.69E-02 1.693279 
ENSMUSG00000095098 Ccdc85b 4.36E-03 1.690404 
ENSMUSG00000074576 Mocs3 1.14E-02 1.689861 
ENSMUSG00000088948 Gm23262 2.79E-03 1.686819 
ENSMUSG00000075268 Gm10819 1.05E-04 1.686108 
ENSMUSG00000078141 Gm2399 4.75E-03 1.685731 
ENSMUSG00000022595 Lypd2 4.45E-03 1.685708 
ENSMUSG00000063171 Rps4l 2.87E-03 1.683014 
ENSMUSG00000110528 Gm1943 4.81E-02 1.681924 
ENSMUSG00000015880 Ncapg 1.05E-02 1.677303 
ENSMUSG00000056758 Hmga2 3.94E-02 1.676199 
ENSMUSG00000084783 Gm15419 2.22E-02 1.674643 
ENSMUSG00000116694 AC154667.2 1.48E-03 1.671371 
ENSMUSG00000083737 Prdx6-ps2 1.28E-02 1.666943 
ENSMUSG00000085431 4930440I19Rik 1.34E-03 1.66478 
ENSMUSG00000097971 Gm26917 1.21E-04 1.66206 
ENSMUSG00000094344 Gm11942 4.89E-10 1.661048 
ENSMUSG00000092267 Gm20417 6.05E-04 1.651296 
ENSMUSG00000042737 Dpm3 1.76E-02 1.647963 
ENSMUSG00000087247 Alkal1 1.04E-10 1.64795 
ENSMUSG00000064382 Gm26447 5.42E-04 1.647264 
ENSMUSG00000083337 Gm11539 4.30E-05 1.643919 
ENSMUSG00000025226 Fbxl15 3.44E-02 1.64349 
ENSMUSG00000082241 Gng5-ps 3.89E-02 1.641179 
ENSMUSG00000105827 Hist2h2bb 2.20E-03 1.637237 
ENSMUSG00000057160 Gm16372 4.55E-04 1.635812 
ENSMUSG00000106767 Gm42727 1.77E-02 1.635709 
ENSMUSG00000020493 Prr11 1.30E-02 1.633632 
ENSMUSG00000092116 Gm10320 3.42E-03 1.631539 
ENSMUSG00000117037 CT010433.2 2.53E-02 1.628923 
ENSMUSG00000024401 Tnf 3.17E-19 1.627752 
ENSMUSG00000057863 Rpl36 9.70E-06 1.626087 
ENSMUSG00000047370 Gm7367 9.82E-04 1.625595 
ENSMUSG00000020895 Tmem107 4.41E-02 1.624311 
ENSMUSG00000114304 Gm48099 1.30E-06 1.623936 
ENSMUSG00000028896 Rcc1 1.44E-11 1.622009 
ENSMUSG00000107349 Gm6655 8.45E-03 1.614486 
ENSMUSG00000080006 Rps19-ps7 3.14E-03 1.611362 
ENSMUSG00000060438 Rps10-ps1 9.88E-10 1.610232 
ENSMUSG00000080811 Gm14513 7.39E-05 1.609441 
ENSMUSG00000104862 Gm6520 2.83E-02 1.607007 
ENSMUSG00000028540 Dph2 7.43E-05 1.606169 
ENSMUSG00000022769 Sdf2l1 7.63E-04 1.604934 
ENSMUSG00000090942 F830016B08Rik 7.69E-06 1.603028 
ENSMUSG00000007892 Rplp1 2.35E-11 1.602848 
ENSMUSG00000022097 Sftpc 3.79E-08 1.601389 
ENSMUSG00000040936 Ulk4 1.79E-13 1.600562 
ENSMUSG00000097060 Gm26759 2.92E-04 1.600487 
ENSMUSG00000091845 Rpl36-ps12 6.25E-04 1.600167 
ENSMUSG00000030329 Pianp 8.93E-03 1.596449 
ENSMUSG00000035202 Lars2 9.76E-08 1.596336 




ENSMUSG00000082662 Gm15516 4.17E-02 1.594564 
ENSMUSG00000063586 Gm5513 6.64E-03 1.592966 
ENSMUSG00000097679 Rps19-ps5 1.49E-02 1.590111 
ENSMUSG00000108414 Snhg1 2.93E-11 1.588096 
ENSMUSG00000085401 Slc39a1-ps 5.90E-10 1.587829 
ENSMUSG00000060183 Cxcl11 2.63E-04 1.587297 
ENSMUSG00000027447 Cst3 8.64E-19 1.585854 
ENSMUSG00000069515 Lyz1 3.15E-15 1.584793 
ENSMUSG00000071419 Rps15-ps2 2.45E-08 1.583911 
ENSMUSG00000102135 Gm37108 5.48E-03 1.582546 
ENSMUSG00000065126 Snord104 8.14E-04 1.581336 
ENSMUSG00000052837 Junb 4.96E-18 1.580061 
ENSMUSG00000117187 CT033749.1 1.02E-02 1.579981 
ENSMUSG00000000386 Mx1 2.32E-17 1.579725 
ENSMUSG00000036114 Rpp25l 1.62E-03 1.578918 
ENSMUSG00000079505 Gm11131 3.63E-03 1.576721 
ENSMUSG00000114321 Gm8971 3.66E-04 1.576165 
ENSMUSG00000046240 Hepacam 5.51E-04 1.575183 
ENSMUSG00000083669 Gm10169 5.08E-03 1.573737 
ENSMUSG00000094955 Gm3699 5.08E-03 1.573303 
ENSMUSG00000029410 Ppef2 5.25E-03 1.572807 
ENSMUSG00000068606 Gm4841 3.38E-02 1.572259 
ENSMUSG00000106352 5033403H07Rik 4.74E-06 1.571858 
ENSMUSG00000098534 Gm27167 3.43E-06 1.571239 
ENSMUSG00000111897 Gm19810 1.29E-04 1.568539 
ENSMUSG00000117269 AC151275.1 3.31E-02 1.567532 
ENSMUSG00000112290 Gm33782 4.90E-03 1.563678 
ENSMUSG00000015437 Gzmb 5.18E-03 1.561612 
ENSMUSG00000024165 Jpt2 9.07E-16 1.560746 
ENSMUSG00000047443 Erfe 1.12E-03 1.559959 
ENSMUSG00000089542 Gm25835 9.96E-04 1.558194 
ENSMUSG00000080747 Gm14016 4.05E-03 1.557656 
ENSMUSG00000064063 BC048507 1.80E-02 1.554995 
ENSMUSG00000117046 AC122746.1 2.71E-02 1.552568 
ENSMUSG00000021070 Bdkrb2 5.92E-05 1.552425 
ENSMUSG00000060419 Rps16-ps2 4.73E-10 1.551902 
ENSMUSG00000086324 Gm15564 3.09E-05 1.551082 
ENSMUSG00000086420 Gm8865 4.69E-03 1.548083 
ENSMUSG00000041378 Cldn5 1.39E-15 1.546994 
ENSMUSG00000027496 Aurka 4.17E-02 1.546663 
ENSMUSG00000095478 Gm9824 9.03E-03 1.546072 
ENSMUSG00000079330 Lemd1 1.45E-03 1.544978 
ENSMUSG00000076036 Gm22133 4.18E-13 1.544169 
ENSMUSG00000082062 Ftl2-ps 7.57E-11 1.542066 
ENSMUSG00000032425 Zfp949 7.47E-12 1.541584 
ENSMUSG00000070284 Gmppb 4.20E-05 1.539971 
ENSMUSG00000081382 Rpl18-ps1 1.43E-03 1.538547 
ENSMUSG00000099060 Mir7025 4.48E-02 1.53617 
ENSMUSG00000082609 Gm15464 3.50E-02 1.535836 
ENSMUSG00000030744 Rps3 6.04E-11 1.535727 
ENSMUSG00000037169 Mycn 3.45E-04 1.535438 
ENSMUSG00000094111 Nutf2-ps2 4.80E-02 1.534662 
ENSMUSG00000087006 Gm13889 3.61E-15 1.533387 
ENSMUSG00000113212 Gm47435 1.57E-02 1.532655 
ENSMUSG00000007872 Id3 6.85E-12 1.530174 
ENSMUSG00000015092 Edf1 3.80E-08 1.530159 




ENSMUSG00000073144 4930599N23Rik 1.03E-03 1.528627 
ENSMUSG00000087060 Eldr 9.87E-03 1.527571 
ENSMUSG00000028179 Cth 1.62E-04 1.52673 
ENSMUSG00000058900 Rsl1 9.35E-05 1.526622 
ENSMUSG00000053508 Gtsf2 3.10E-06 1.522863 
ENSMUSG00000050796 B3galt6 1.56E-02 1.522466 
ENSMUSG00000050370 Ch25h 2.02E-21 1.521802 
ENSMUSG00000059835 Rpl13-ps3 7.89E-04 1.521415 
ENSMUSG00000112003 Gm4864 3.60E-02 1.520838 
ENSMUSG00000043099 Hic1 1.04E-03 1.518516 
ENSMUSG00000033368 Trim69 4.03E-03 1.516764 
ENSMUSG00000046731 Kctd11 1.05E-14 1.516698 
ENSMUSG00000070392 Gm20634 2.49E-03 1.515844 
ENSMUSG00000093674 Rpl41 1.91E-12 1.515683 
ENSMUSG00000096942 Rps19-ps6 1.09E-06 1.515244 
ENSMUSG00000104560 Gm8115 7.31E-03 1.514801 
ENSMUSG00000070462 Tlnrd1 1.52E-09 1.513754 
ENSMUSG00000036992 Nxt1 1.64E-03 1.513731 
ENSMUSG00000061848 Gm5805 1.54E-10 1.512703 
ENSMUSG00000099544 Gm18699 2.13E-03 1.511865 
ENSMUSG00000059434 Gckr 1.64E-03 1.511175 
ENSMUSG00000042842 Serpinb6b 2.39E-16 1.510922 
ENSMUSG00000068240 Gm11808 9.62E-10 1.510582 
ENSMUSG00000109658 Gm45660 3.74E-05 1.510374 
ENSMUSG00000044197 Gpr146 8.83E-19 1.510371 
ENSMUSG00000105472 Gm43024 2.61E-02 1.509917 
ENSMUSG00000075020 Mir670hg 8.54E-03 1.509891 
ENSMUSG00000008140 Emc10 3.81E-09 1.509274 
ENSMUSG00000029371 Cxcl5 1.04E-11 1.507055 
ENSMUSG00000024925 Rnaseh2c 3.97E-02 1.506518 
ENSMUSG00000110275 Gm5905 2.92E-15 1.506379 
ENSMUSG00000115143 Fkbp1a-ps1 3.40E-04 1.504907 
ENSMUSG00000074115 Saa1 4.30E-08 1.504478 
ENSMUSG00000091639 Gm3756 5.43E-10 1.504454 
ENSMUSG00000101449 Gm17791 1.23E-02 1.504151 
ENSMUSG00000098181 Rps12-ps24 1.77E-02 1.503082 
ENSMUSG00000116358 Gm49450 2.31E-13 1.502451 
ENSMUSG00000059461 Gm7331 1.06E-06 1.502048 
ENSMUSG00000091269 Gm6682 9.38E-11 1.501853 
ENSMUSG00000022408 Fam83f 1.13E-02 1.500479 
ENSMUSG00000027843 Ptpn22 4.55E-11 1.500715 
ENSMUSG00000026414 Tnnt2 2.59E-14 1.500887 
ENSMUSG00000046961 Gpr156 7.92E-04 1.503034 
ENSMUSG00000030468 Siglecg 1.69E-05 1.503144 
ENSMUSG00000059900 Tmem40 3.18E-02 1.503359 
ENSMUSG00000015568 Lpl 1.57E-32 1.503627 
ENSMUSG00000048794 Cfap100 1.97E-05 1.504035 
ENSMUSG00000043789 Vwce 1.10E-02 1.504138 
ENSMUSG00000021751 Acox2 2.40E-04 1.504181 
ENSMUSG00000050600 Zfp831 4.21E-09 1.504376 
ENSMUSG00000020892 Aloxe3 1.83E-02 1.504792 
ENSMUSG00000078234 Klhdc7a 7.85E-04 1.505376 
ENSMUSG00000114937 Gm30054 1.87E-05 1.505389 
ENSMUSG00000046186 Cd109 2.33E-05 1.505728 
ENSMUSG00000038167 Plekhg6 2.51E-03 1.506016 
ENSMUSG00000028017 Egf 4.01E-07 1.506454 




ENSMUSG00000025271 Pfkfb1 7.66E-13 1.507316 
ENSMUSG00000029123 Stk32b 1.69E-02 1.507913 
ENSMUSG00000024049 Myom1 1.17E-21 1.508449 
ENSMUSG00000007122 Casq1 6.70E-07 1.509955 
ENSMUSG00000003476 Crhr2 1.35E-04 1.511069 
ENSMUSG00000056366 Fabp3-ps1 2.81E-06 1.512819 
ENSMUSG00000108955 Gm44775 3.93E-02 1.513353 
ENSMUSG00000111907 Gm48202 6.46E-03 1.514782 
ENSMUSG00000002007 Srpk3 3.83E-03 1.514899 
ENSMUSG00000006345 Ggt1 1.00E-04 1.514981 
ENSMUSG00000073968 Trim68 1.66E-08 1.515157 
ENSMUSG00000112230 Ifngas1 3.52E-02 1.515642 
ENSMUSG00000090124 Ugt1a7c 1.52E-11 1.516108 
ENSMUSG00000089943 Ugt1a5 7.03E-06 1.516142 
ENSMUSG00000090165 Ugt1a10 6.59E-12 1.516306 
ENSMUSG00000097579 Gm26799 2.23E-03 1.517356 
ENSMUSG00000112023 Lilr4b 1.77E-04 1.517729 
ENSMUSG00000005951 Shpk 1.11E-04 1.51779 
ENSMUSG00000035296 Sgcg 1.16E-09 1.517805 
ENSMUSG00000032925 Itgbl1 1.02E-17 1.518245 
ENSMUSG00000043873 Chil5 7.73E-03 1.518859 
ENSMUSG00000109371 Gm44626 2.32E-02 1.519236 
ENSMUSG00000090175 Ugt1a9 7.00E-12 1.519384 
ENSMUSG00000060275 Nrg2 6.87E-03 1.52007 
ENSMUSG00000089675 Ugt1a8 6.80E-12 1.520697 
ENSMUSG00000041608 Entpd3 1.12E-10 1.520924 
ENSMUSG00000069808 Fam57a 1.25E-06 1.521054 
ENSMUSG00000100510 AV026068 5.30E-03 1.521178 
ENSMUSG00000086607 4930511M06Rik 2.52E-02 1.521734 
ENSMUSG00000040247 Tbc1d10c 6.96E-07 1.522149 
ENSMUSG00000041642 Kif21b 3.24E-10 1.522398 
ENSMUSG00000090799 Klhl33 8.11E-05 1.522621 
ENSMUSG00000070498 Tmem132b 3.43E-08 1.523157 
ENSMUSG00000018796 Acsl1 8.24E-30 1.523655 
ENSMUSG00000078937 Cpt1b 5.04E-08 1.523826 
ENSMUSG00000034570 Inpp5j 8.55E-03 1.523892 
ENSMUSG00000044551 9930012K11Rik 7.95E-04 1.524065 
ENSMUSG00000032053 Pou2af1 6.57E-06 1.524753 
ENSMUSG00000089804 Gm16136 3.66E-02 1.525379 
ENSMUSG00000031958 Ldhd 1.14E-03 1.526 
ENSMUSG00000073988 Ttpa 2.43E-06 1.52693 
ENSMUSG00000043639 Rbm20 4.76E-16 1.527208 
ENSMUSG00000046971 Pla2g4f 1.67E-05 1.527252 
ENSMUSG00000058207 Serpina3k 5.08E-04 1.5276 
ENSMUSG00000062257 Opcml 5.34E-11 1.527897 
ENSMUSG00000066108 Muc5b 2.76E-21 1.528023 
ENSMUSG00000020256 Aldh1l2 1.82E-04 1.530481 
ENSMUSG00000031303 Map3k15 1.02E-08 1.532052 
ENSMUSG00000006014 Prg4 3.62E-08 1.532224 
ENSMUSG00000007107 Atp1a4 2.62E-06 1.53242 
ENSMUSG00000038777 Sema6c 8.09E-05 1.533598 
ENSMUSG00000030470 Csrp3 6.81E-10 1.534077 
ENSMUSG00000024039 Cbs 3.49E-02 1.534538 
ENSMUSG00000000686 Abhd15 8.63E-05 1.535291 
ENSMUSG00000051910 Sox6 9.77E-26 1.536789 
ENSMUSG00000002997 Prkar2b 2.00E-17 1.537187 




ENSMUSG00000110397 Gm45540 4.65E-06 1.537736 
ENSMUSG00000029228 Lnx1 1.73E-19 1.537867 
ENSMUSG00000031382 Asb11 2.82E-04 1.538155 
ENSMUSG00000020303 Stc2 3.41E-05 1.538946 
ENSMUSG00000026824 Kcnj3 2.07E-10 1.539467 
ENSMUSG00000054545 Ugt1a6a 9.67E-10 1.539483 
ENSMUSG00000097193 Gm26664 1.10E-02 1.539627 
ENSMUSG00000032066 Bco2 3.66E-02 1.539965 
ENSMUSG00000090145 Ugt1a6b 6.45E-12 1.540465 
ENSMUSG00000030098 Grip2 2.01E-05 1.541304 
ENSMUSG00000030650 Tmc5 3.57E-04 1.543931 
ENSMUSG00000113165 Gm47863 4.70E-02 1.547216 
ENSMUSG00000096981 Gm16845 7.49E-05 1.547297 
ENSMUSG00000058498 Rnf207 5.23E-03 1.547335 
ENSMUSG00000104094 Gm37314 4.58E-03 1.547567 
ENSMUSG00000087172 Gm12153 2.27E-09 1.547691 
ENSMUSG00000000197 Nalcn 4.06E-06 1.549339 
ENSMUSG00000097885 5031434O11Rik 4.83E-03 1.549511 
ENSMUSG00000085779 Atcayos 8.31E-10 1.550724 
ENSMUSG00000038583 Pln 3.75E-10 1.550962 
ENSMUSG00000047940 Stpg2 3.85E-03 1.55183 
ENSMUSG00000032495 Lrrc2 1.65E-06 1.553009 
ENSMUSG00000046818 Ddit4l 1.98E-02 1.554266 
ENSMUSG00000031808 Slc27a1 6.93E-12 1.555141 
ENSMUSG00000027796 Smad9 1.44E-04 1.555153 
ENSMUSG00000064368 mt-Nd6 4.83E-18 1.555459 
ENSMUSG00000074497 A430078G23Rik 5.03E-17 1.557086 
ENSMUSG00000087579 Hectd2os 3.22E-07 1.557447 
ENSMUSG00000097917 Gm26839 3.13E-02 1.55764 
ENSMUSG00000113184 AC125351.1 6.09E-05 1.558477 
ENSMUSG00000043531 Sorcs1 2.00E-07 1.560471 
ENSMUSG00000112947 Gm47493 2.90E-03 1.560632 
ENSMUSG00000042474 Fcmr 3.47E-04 1.561669 
ENSMUSG00000039521 Foxp3 3.68E-03 1.562481 
ENSMUSG00000030219 Erp27 2.46E-02 1.563639 
ENSMUSG00000029158 Yipf7 1.40E-02 1.563821 
ENSMUSG00000079015 Serpina1c 2.41E-03 1.56468 
ENSMUSG00000038132 Rbm24 4.06E-11 1.564762 
ENSMUSG00000028116 Myoz2 2.18E-12 1.566472 
ENSMUSG00000114138 Gm36423 1.97E-02 1.566955 
ENSMUSG00000044938 Klhl31 1.10E-08 1.567813 
ENSMUSG00000012705 Retn 1.11E-02 1.567825 
ENSMUSG00000030278 Cidec 1.15E-06 1.56902 
ENSMUSG00000075307 Klhl41 1.95E-09 1.569759 
ENSMUSG00000043165 Lor 7.00E-06 1.56992 
ENSMUSG00000060962 Dmkn 6.45E-08 1.570534 
ENSMUSG00000038242 Aox4 5.04E-03 1.571204 
ENSMUSG00000091712 Sec14l5 1.06E-03 1.572691 
ENSMUSG00000013523 Bcas1 3.93E-02 1.572801 
ENSMUSG00000092201 A530058N18Rik 1.98E-06 1.572952 
ENSMUSG00000083120 Gm15854 3.07E-03 1.573014 
ENSMUSG00000034009 Rxfp1 2.53E-03 1.573695 
ENSMUSG00000029499 Pxmp2 6.54E-04 1.574213 
ENSMUSG00000097062 Gm17586 4.09E-02 1.574318 
ENSMUSG00000078486 Perm1 7.00E-10 1.575601 
ENSMUSG00000053024 Cntn2 3.82E-02 1.576448 




ENSMUSG00000101640 Gm28376 4.52E-02 1.576948 
ENSMUSG00000093938 Evi2b 2.47E-13 1.577235 
ENSMUSG00000029838 Ptn 3.62E-03 1.578484 
ENSMUSG00000074433 Lce3e 4.14E-02 1.579193 
ENSMUSG00000113178 Mylf-ps 5.90E-07 1.579344 
ENSMUSG00000043629 1700019D03Rik 8.68E-03 1.58036 
ENSMUSG00000099966 2810402E24Rik 1.76E-03 1.580758 
ENSMUSG00000026989 Dapl1 4.53E-02 1.581376 
ENSMUSG00000030598 Fbxo17 3.90E-05 1.582412 
ENSMUSG00000054598 9130230L23Rik 5.99E-08 1.582807 
ENSMUSG00000033508 Asprv1 6.88E-04 1.583878 
ENSMUSG00000038295 Atg9b 1.40E-02 1.58412 
ENSMUSG00000096351 Samd11 9.99E-04 1.584324 
ENSMUSG00000039084 Chad 9.78E-06 1.586243 
ENSMUSG00000076617 Ighm 5.17E-12 1.586353 
ENSMUSG00000086968 4933431E20Rik 3.14E-02 1.586354 
ENSMUSG00000040086 Tnni3k 4.57E-09 1.587296 
ENSMUSG00000035606 Ky 2.23E-04 1.588323 
ENSMUSG00000038170 Pde4dip 3.86E-39 1.588667 
ENSMUSG00000029055 Plch2 6.80E-08 1.588932 
ENSMUSG00000061013 Mkx 2.08E-04 1.589186 
ENSMUSG00000041782 Lad1 1.14E-06 1.589714 
ENSMUSG00000027456 Sdcbp2 1.49E-07 1.5906 
ENSMUSG00000020836 Coro6 8.35E-11 1.591197 
ENSMUSG00000060180 Myh13 3.21E-04 1.591427 
ENSMUSG00000053093 Myh7 2.88E-07 1.593422 
ENSMUSG00000109510 Gm42417 7.99E-14 1.595001 
ENSMUSG00000057092 Fxyd3 3.96E-03 1.596509 
ENSMUSG00000117297 CT571247.2 9.90E-03 1.597064 
ENSMUSG00000090173 Fbxw10 2.39E-04 1.598188 
ENSMUSG00000054889 Dsp 3.20E-46 1.598377 
ENSMUSG00000041616 Nppa 1.28E-03 1.59881 
ENSMUSG00000056271 Lman1l 4.16E-02 1.599281 
ENSMUSG00000057280 Musk 5.50E-08 1.600621 
ENSMUSG00000031377 Bmx 1.66E-10 1.601368 
ENSMUSG00000064340 mt-Tl1 1.92E-09 1.601856 
ENSMUSG00000027559 Car3 1.93E-38 1.60232 
ENSMUSG00000061462 Obscn 1.92E-25 1.602458 
ENSMUSG00000102305 Gm38192 2.46E-02 1.603866 
ENSMUSG00000038173 Enpp6 2.21E-02 1.604535 
ENSMUSG00000028150 Rorc 9.93E-07 1.604951 
ENSMUSG00000029167 Ppargc1a 2.14E-18 1.605113 
ENSMUSG00000092397 C130080G10Rik 7.30E-06 1.605123 
ENSMUSG00000103984 Gm37447 3.69E-02 1.605238 
ENSMUSG00000040055 Gjb6 2.24E-03 1.605389 
ENSMUSG00000024347 Psd2 2.70E-02 1.606216 
ENSMUSG00000068885 Lce3f 8.58E-03 1.607541 
ENSMUSG00000037989 Wnk2 1.81E-14 1.608343 
ENSMUSG00000085184 4933439K11Rik 3.15E-03 1.608853 
ENSMUSG00000031097 Tnni2 2.26E-08 1.6098 
ENSMUSG00000017400 Stac2 4.29E-02 1.612166 
ENSMUSG00000024673 Ms4a1 8.11E-06 1.612963 
ENSMUSG00000033544 Angptl1 1.17E-02 1.613351 
ENSMUSG00000097652 Mhrt 2.82E-07 1.613894 
ENSMUSG00000085971 Gm15411 3.02E-05 1.613896 
ENSMUSG00000075289 Carns1 1.74E-06 1.615629 




ENSMUSG00000040694 Apobec2 6.16E-08 1.620042 
ENSMUSG00000043008 Klhl6 3.96E-14 1.62231 
ENSMUSG00000018893 Mb 2.71E-08 1.623243 
ENSMUSG00000027861 Casq2 1.05E-11 1.623312 
ENSMUSG00000020067 Mypn 1.05E-14 1.623658 
ENSMUSG00000028115 Bnipl 1.13E-02 1.623683 
ENSMUSG00000054659 Pm20d2 1.90E-02 1.623767 
ENSMUSG00000055415 Atp10b 9.65E-03 1.624498 
ENSMUSG00000039891 Txlnb 6.59E-16 1.625928 
ENSMUSG00000020169 Best3 3.97E-06 1.62632 
ENSMUSG00000085194 Platr32 1.32E-02 1.628265 
ENSMUSG00000063297 Luzp2 9.47E-06 1.63024 
ENSMUSG00000025815 Dhtkd1 2.73E-06 1.630385 
ENSMUSG00000021123 Rdh12 1.62E-12 1.631252 
ENSMUSG00000046056 Sbsn 8.20E-05 1.631281 
ENSMUSG00000076275 Mir675 3.45E-04 1.631535 
ENSMUSG00000036560 Lgi4 6.45E-08 1.632499 
ENSMUSG00000111818 Gm17749 8.46E-06 1.632708 
ENSMUSG00000052496 Pkdrej 1.85E-02 1.635592 
ENSMUSG00000085417 Gm13919 1.14E-02 1.637562 
ENSMUSG00000031700 Gpt2 2.20E-10 1.638222 
ENSMUSG00000086564 Cd101 2.04E-15 1.638923 
ENSMUSG00000067149 Jchain 6.64E-03 1.639225 
ENSMUSG00000049123 Catsperg2 3.63E-02 1.639878 
ENSMUSG00000057719 Sh3rf2 1.37E-13 1.640066 
ENSMUSG00000027887 Sypl2 7.30E-06 1.641809 
ENSMUSG00000066510 Ankdd1a 8.15E-07 1.642186 
ENSMUSG00000102191 Gm36569 1.33E-02 1.642411 
ENSMUSG00000022523 Fgf12 9.16E-19 1.642983 
ENSMUSG00000058470 Gm8369 1.21E-10 1.644013 
ENSMUSG00000096646 CR974586.6 4.85E-02 1.647968 
ENSMUSG00000079853 Klra1 4.74E-04 1.648672 
ENSMUSG00000029862 Clcn1 3.16E-06 1.649099 
ENSMUSG00000007279 Scube2 3.52E-19 1.651431 
ENSMUSG00000032564 Cpne4 1.36E-05 1.651458 
ENSMUSG00000043487 Acot6 1.05E-02 1.65192 
ENSMUSG00000014453 Blk 1.77E-09 1.652393 
ENSMUSG00000059857 Ntng1 2.28E-05 1.653485 
ENSMUSG00000057246 BC051142 2.48E-04 1.653565 
ENSMUSG00000033569 Adgrb3 4.62E-07 1.653669 
ENSMUSG00000041538 H2-Ob 1.37E-05 1.653876 
ENSMUSG00000029361 Nos1 1.56E-11 1.653885 
ENSMUSG00000106547 B230303O12Rik 1.21E-08 1.654582 
ENSMUSG00000072720 Myo18b 4.14E-27 1.655567 
ENSMUSG00000086962 Gm12248 3.67E-04 1.656171 
ENSMUSG00000020374 Rasgef1c 1.48E-09 1.656757 
ENSMUSG00000033182 Kbtbd12 1.02E-07 1.656789 
ENSMUSG00000105646 Gm30211 1.89E-10 1.657828 
ENSMUSG00000054582 Pabpc1l 1.93E-07 1.660152 
ENSMUSG00000047228 A2ml1 2.62E-03 1.660287 
ENSMUSG00000098381 Mir7225 3.46E-03 1.660541 
ENSMUSG00000085532 B430319H21Rik 1.21E-03 1.661812 
ENSMUSG00000079764 AC087559.1 4.29E-02 1.662417 
ENSMUSG00000108436 Gm44851 1.77E-02 1.663035 
ENSMUSG00000078817 Nlrp12 1.01E-15 1.663158 
ENSMUSG00000110195 Pde2a 7.09E-18 1.665411 




ENSMUSG00000037572 Wdhd1 5.63E-09 1.666104 
ENSMUSG00000021506 Pitx1 2.48E-02 1.668955 
ENSMUSG00000026564 Dusp27 2.96E-09 1.67013 
ENSMUSG00000037188 Grhl3 5.01E-04 1.670721 
ENSMUSG00000028834 Trim63 5.36E-07 1.67122 
ENSMUSG00000038077 Kcna6 3.83E-05 1.672132 
ENSMUSG00000063651 Cnfn 3.01E-05 1.673857 
ENSMUSG00000031245 Hmgn5 1.75E-06 1.674099 
ENSMUSG00000028544 Slc5a9 4.27E-03 1.67494 
ENSMUSG00000058966 Fam57b 2.45E-04 1.676352 
ENSMUSG00000022416 Cacna1i 7.73E-05 1.678167 
ENSMUSG00000036731 Cysrt1 1.69E-02 1.678982 
ENSMUSG00000046352 Gjb2 7.16E-07 1.679256 
ENSMUSG00000028459 Cd72 3.05E-05 1.679816 
ENSMUSG00000045534 Kcna5 2.06E-03 1.681084 
ENSMUSG00000000244 Tspan32 1.65E-11 1.681161 
ENSMUSG00000108985 A930030B08Rik 2.28E-02 1.682419 
ENSMUSG00000032942 Ucp3 6.10E-07 1.684317 
ENSMUSG00000087336 Gm15860 2.35E-02 1.684872 
ENSMUSG00000002831 Plin4 1.20E-31 1.686763 
ENSMUSG00000020848 Doc2b 1.14E-10 1.686804 
ENSMUSG00000052726 Kcnt2 2.57E-21 1.687119 
ENSMUSG00000024105 Themis3 1.57E-02 1.68772 
ENSMUSG00000112707 D830005E20Rik 1.41E-09 1.688501 
ENSMUSG00000030317 Timp4 1.18E-08 1.688584 
ENSMUSG00000095438 Mir133a-1hg 2.49E-05 1.688705 
ENSMUSG00000034308 Sdr42e1 1.55E-04 1.688804 
ENSMUSG00000070385 Ampd1 9.23E-08 1.689044 
ENSMUSG00000086405 9330198N18Rik 9.76E-07 1.689856 
ENSMUSG00000029660 Tex26 5.91E-07 1.690097 
ENSMUSG00000032262 Elovl4 6.32E-05 1.690396 
ENSMUSG00000031461 Myom2 2.01E-27 1.69079 
ENSMUSG00000040740 Slc25a34 2.14E-05 1.690811 
ENSMUSG00000000049 Apoh 2.58E-02 1.69197 
ENSMUSG00000023019 Gpd1 5.00E-16 1.693018 
ENSMUSG00000030510 Cers3 7.37E-07 1.693354 
ENSMUSG00000076937 Iglc2 2.70E-03 1.693807 
ENSMUSG00000038763 Alpk3 6.16E-26 1.693831 
ENSMUSG00000067889 Sptbn2 2.00E-07 1.694539 
ENSMUSG00000106245 Gm43824 1.15E-02 1.694809 
ENSMUSG00000042567 Nek10 1.91E-12 1.695091 
ENSMUSG00000048764 Tmprss11f 8.49E-03 1.696489 
ENSMUSG00000022878 Adipoq 5.10E-07 1.69666 
ENSMUSG00000026527 Rgs7 1.36E-33 1.696693 
ENSMUSG00000090206 Tepp 1.43E-03 1.696892 
ENSMUSG00000002500 Rpl3l 1.67E-04 1.698266 
ENSMUSG00000054057 A930004D18Rik 1.98E-02 1.699027 
ENSMUSG00000079644 Gm1110 1.53E-02 1.699165 
ENSMUSG00000059201 Lep 5.30E-03 1.70052 
ENSMUSG00000061816 Myl1 3.42E-12 1.701209 
ENSMUSG00000043366 Olfr78 4.74E-03 1.701217 
ENSMUSG00000039092 Sptlc3 1.10E-03 1.702114 
ENSMUSG00000053964 Lgals4 6.56E-05 1.702508 
ENSMUSG00000025892 Gria4 3.55E-03 1.703464 
ENSMUSG00000019906 Lin7a 1.80E-05 1.704483 
ENSMUSG00000041020 Map7d2 2.72E-02 1.705429 




ENSMUSG00000028773 Fabp3 1.13E-08 1.706932 
ENSMUSG00000031385 Plxnb3 2.72E-03 1.709339 
ENSMUSG00000110411 Gm45457 9.03E-03 1.710479 
ENSMUSG00000034282 Evpl 1.07E-08 1.710621 
ENSMUSG00000087628 Gm13028 1.40E-03 1.71063 
ENSMUSG00000036960 Clca2 2.27E-02 1.712431 
ENSMUSG00000052013 Btla 1.86E-06 1.713815 
ENSMUSG00000025754 Agbl1 1.29E-20 1.714057 
ENSMUSG00000034634 Ly6d 7.90E-04 1.715269 
ENSMUSG00000061126 Cyp4f39 3.92E-03 1.718439 
ENSMUSG00000035580 Kcnh8 9.67E-06 1.718443 
ENSMUSG00000021340 Gpld1 5.88E-10 1.718732 
ENSMUSG00000040350 Trim7 7.94E-08 1.718782 
ENSMUSG00000116987 AC150035.3 1.76E-02 1.719502 
ENSMUSG00000038204 Asb10 2.36E-02 1.719976 
ENSMUSG00000020334 Slc22a4 1.93E-07 1.720261 
ENSMUSG00000064346 mt-Tw 2.44E-04 1.721955 
ENSMUSG00000007033 Hspa1l 2.73E-02 1.722982 
ENSMUSG00000038239 Hrc 6.28E-14 1.724801 
ENSMUSG00000073492 Gm10521 2.63E-03 1.725675 
ENSMUSG00000020279 Il9r 3.97E-02 1.726651 
ENSMUSG00000040899 Ccr6 4.51E-09 1.728272 
ENSMUSG00000073985 Gm10602 5.77E-04 1.7291 
ENSMUSG00000069733 Ube2u 5.69E-03 1.72999 
ENSMUSG00000036123 Slc9a3 8.61E-03 1.729994 
ENSMUSG00000019787 Trdn 2.22E-33 1.730141 
ENSMUSG00000099364 5730419F03Rik 1.15E-02 1.732264 
ENSMUSG00000093577 Gm20632 4.01E-02 1.733244 
ENSMUSG00000027077 Smtnl1 4.61E-06 1.734518 
ENSMUSG00000057003 Myh4 3.19E-14 1.734608 
ENSMUSG00000000031 H19 5.10E-18 1.735173 
ENSMUSG00000003271 Sult2b1 1.84E-03 1.735974 
ENSMUSG00000038354 Ankrd35 3.79E-03 1.736278 
ENSMUSG00000015879 Fam184b 6.83E-03 1.737161 
ENSMUSG00000079243 Xirp1 1.34E-16 1.737887 
ENSMUSG00000079588 Tmem182 9.64E-13 1.738319 
ENSMUSG00000031376 Atp2b3 9.23E-04 1.73926 
ENSMUSG00000042010 Acacb 9.27E-37 1.739339 
ENSMUSG00000022871 Fetub 5.57E-05 1.739701 
ENSMUSG00000010066 Cacna2d2 4.85E-04 1.74003 
ENSMUSG00000027831 Veph1 7.22E-11 1.743301 
ENSMUSG00000005268 Prlr 1.86E-05 1.743362 
ENSMUSG00000038665 Dgki 7.51E-11 1.743848 
ENSMUSG00000040536 Necab1 6.32E-03 1.744057 
ENSMUSG00000062713 Sim2 3.32E-09 1.745706 
ENSMUSG00000037139 Myom3 3.04E-14 1.746519 
ENSMUSG00000014030 Pax5 3.89E-07 1.746801 
ENSMUSG00000031626 Sorbs2 8.87E-27 1.746865 
ENSMUSG00000048142 Nat8l 3.69E-04 1.747147 
ENSMUSG00000067341 H2-Eb2 8.84E-03 1.748009 
ENSMUSG00000025172 Ankrd2 1.45E-06 1.749393 
ENSMUSG00000096974 Gm26881 1.04E-02 1.749441 
ENSMUSG00000020000 Moxd1 4.65E-03 1.750501 
ENSMUSG00000070423 Olfr558 4.01E-02 1.750691 
ENSMUSG00000099449 Gm28401 4.06E-02 1.754089 
ENSMUSG00000067653 Ankrd23 1.06E-15 1.754635 




ENSMUSG00000027868 Tbx15 4.21E-14 1.755594 
ENSMUSG00000051747 Ttn 1.12E-46 1.757967 
ENSMUSG00000032033 Barx2 1.39E-07 1.759194 
ENSMUSG00000022622 Acr 1.21E-08 1.760657 
ENSMUSG00000057054 Inca1 1.12E-04 1.76172 
ENSMUSG00000115610 Gm31251 3.90E-14 1.761914 
ENSMUSG00000061259 Tmprss11d 1.42E-02 1.761956 
ENSMUSG00000069830 Nlrp1a 1.11E-03 1.76325 
ENSMUSG00000110010 Gm45629 1.53E-03 1.764151 
ENSMUSG00000038663 Fsd2 1.08E-14 1.765708 
ENSMUSG00000100627 A830008E24Rik 1.45E-02 1.766465 
ENSMUSG00000001095 Slc13a2 5.92E-04 1.767172 
ENSMUSG00000024827 Gldc 3.59E-02 1.767944 
ENSMUSG00000027913 Crct1 4.51E-05 1.768545 
ENSMUSG00000013483 Card14 4.06E-05 1.769133 
ENSMUSG00000030592 Ryr1 3.35E-10 1.769178 
ENSMUSG00000102759 Gm10463 4.04E-02 1.770039 
ENSMUSG00000074254 Cyp2a4 3.39E-02 1.770248 
ENSMUSG00000058975 Kcnc1 6.09E-05 1.770841 
ENSMUSG00000054325 Lce3a 5.92E-04 1.771249 
ENSMUSG00000022040 Ephx2 1.34E-07 1.77423 
ENSMUSG00000069670 Nkain2 1.14E-30 1.775621 
ENSMUSG00000099994 1700024B18Rik 3.27E-02 1.775772 
ENSMUSG00000039873 Neurl2 3.62E-03 1.776821 
ENSMUSG00000086765 Gm11827 4.14E-05 1.779138 
ENSMUSG00000093765 Gm20658 4.32E-02 1.779401 
ENSMUSG00000044708 Kcnj10 2.20E-02 1.780045 
ENSMUSG00000010476 Ebf3 2.43E-10 1.782939 
ENSMUSG00000043681 Fam25c 5.16E-03 1.783067 
ENSMUSG00000026220 Slc16a14 1.02E-02 1.783575 
ENSMUSG00000048078 Tenm4 8.65E-33 1.786182 
ENSMUSG00000074625 Arhgap40 1.61E-05 1.786986 
ENSMUSG00000024334 H2-Oa 2.83E-02 1.78792 
ENSMUSG00000005373 Mlxipl 1.48E-14 1.792638 
ENSMUSG00000031757 Mt4 1.02E-03 1.792943 
ENSMUSG00000104927 Gm43388 8.61E-03 1.794412 
ENSMUSG00000031594 Fgl1 3.86E-02 1.796159 
ENSMUSG00000017300 Tnnc2 5.41E-14 1.797829 
ENSMUSG00000087307 Gm12925 4.11E-02 1.79825 
ENSMUSG00000100199 Gm20324 5.05E-04 1.800659 
ENSMUSG00000109754 Gm39214 4.56E-02 1.800915 
ENSMUSG00000040490 Lrfn2 2.65E-03 1.803413 
ENSMUSG00000110631 Gm42047 2.58E-02 1.804324 
ENSMUSG00000111809 Gm49334 5.99E-03 1.805073 
ENSMUSG00000048070 Pirt 4.90E-02 1.805324 
ENSMUSG00000111299 4930540M03Rik 3.88E-02 1.805841 
ENSMUSG00000026489 Coq8a 5.21E-32 1.80787 
ENSMUSG00000085171 D830026I12Rik 1.96E-02 1.808535 
ENSMUSG00000000673 Haao 2.83E-04 1.808707 
ENSMUSG00000037661 Gpr160 1.16E-06 1.8137 
ENSMUSG00000074215 Gm10643 2.95E-02 1.814076 
ENSMUSG00000096449 Gm4076 4.29E-02 1.815678 
ENSMUSG00000022383 Ppara 2.50E-24 1.817544 
ENSMUSG00000109157 Gm44829 3.21E-05 1.818829 
ENSMUSG00000020698 Cct6b 6.42E-04 1.823548 
ENSMUSG00000049336 Tenm2 1.31E-16 1.8238 




ENSMUSG00000005547 Cyp2a5 1.12E-09 1.826543 
ENSMUSG00000027261 Hao1 1.24E-02 1.82689 
ENSMUSG00000037446 Tulp1 5.73E-03 1.828912 
ENSMUSG00000086547 Gm11755 1.77E-02 1.832213 
ENSMUSG00000087090 Nctc1 7.99E-18 1.832231 
ENSMUSG00000047419 Cmya5 3.32E-33 1.832861 
ENSMUSG00000031425 Plp1 8.47E-11 1.833127 
ENSMUSG00000067616 Klk11 1.67E-03 1.835648 
ENSMUSG00000079025 Gsdmc 4.96E-03 1.835798 
ENSMUSG00000085479 9430073C21Rik 4.93E-02 1.836068 
ENSMUSG00000027674 Pex5l 3.20E-11 1.836523 
ENSMUSG00000001027 Scn4a 8.93E-13 1.838172 
ENSMUSG00000038020 Rapgefl1 3.35E-07 1.842817 
ENSMUSG00000037509 Arhgef4 1.01E-11 1.84526 
ENSMUSG00000056569 Mpz 2.39E-15 1.845464 
ENSMUSG00000018862 Otop3 2.40E-03 1.847993 
ENSMUSG00000027022 Xirp2 2.79E-35 1.849448 
ENSMUSG00000116508 Gm49463 1.89E-02 1.850853 
ENSMUSG00000044788 Fads6 2.44E-04 1.85333 
ENSMUSG00000031372 Trex2 3.78E-02 1.854308 
ENSMUSG00000028573 Fggy 2.26E-05 1.854817 
ENSMUSG00000029683 Lmod2 1.32E-16 1.857354 
ENSMUSG00000022491 Glycam1 8.74E-05 1.858915 
ENSMUSG00000030724 Cd19 1.17E-10 1.860844 
ENSMUSG00000087242 C78197 4.25E-02 1.86137 
ENSMUSG00000040340 Tex45 7.93E-03 1.861819 
ENSMUSG00000021613 Hapln1 2.16E-04 1.864932 
ENSMUSG00000112895 Gm47567 7.34E-05 1.86531 
ENSMUSG00000085743 8430419K02Rik 6.18E-22 1.866081 
ENSMUSG00000101930 Gm5441 1.11E-09 1.866612 
ENSMUSG00000042251 Pm20d1 6.12E-05 1.867473 
ENSMUSG00000103965 Gm30173 2.07E-04 1.869946 
ENSMUSG00000028996 Rbp7 6.66E-03 1.871717 
ENSMUSG00000042031 Lce3b 1.73E-04 1.872678 
ENSMUSG00000042895 Abra 1.62E-09 1.874549 
ENSMUSG00000026697 Myoc 1.02E-02 1.875415 
ENSMUSG00000026100 Mstn 8.60E-03 1.877754 
ENSMUSG00000091119 Ccdc152 2.42E-05 1.879304 
ENSMUSG00000062515 Fabp4 8.53E-23 1.879539 
ENSMUSG00000062372 Otof 6.43E-03 1.881054 
ENSMUSG00000021622 Ckmt2 1.81E-18 1.882596 
ENSMUSG00000096960 A230028O05Rik 2.40E-09 1.883268 
ENSMUSG00000104453 Gm37829 6.61E-05 1.884749 
ENSMUSG00000039496 Cdnf 4.66E-03 1.887309 
ENSMUSG00000034645 Zyg11a 2.17E-02 1.88839 
ENSMUSG00000074862 BC025920 2.90E-03 1.888707 
ENSMUSG00000030577 Cd22 5.61E-10 1.888805 
ENSMUSG00000046480 Scn4b 2.33E-10 1.889073 
ENSMUSG00000061723 Tnnt3 3.36E-12 1.895792 
ENSMUSG00000073602 Serpinb3b 8.46E-04 1.896022 
ENSMUSG00000042250 Pglyrp4 1.68E-02 1.896106 
ENSMUSG00000037977 6430571L13Rik 1.82E-05 1.897294 
ENSMUSG00000071858 Gm94 1.11E-03 1.898142 
ENSMUSG00000043461 Sptssb 3.69E-04 1.8982 
ENSMUSG00000027470 Mylk2 8.39E-14 1.898313 
ENSMUSG00000084929 Foxo6os 1.25E-02 1.898699 




ENSMUSG00000020061 Mybpc1 4.60E-23 1.903022 
ENSMUSG00000000223 Drp2 6.47E-08 1.90562 
ENSMUSG00000042514 Klhl14 9.78E-05 1.906063 
ENSMUSG00000097286 Gm26684 2.80E-02 1.914855 
ENSMUSG00000038602 Slc35f1 6.46E-23 1.915687 
ENSMUSG00000029602 Rasal1 7.61E-04 1.918457 
ENSMUSG00000025431 Crisp1 6.65E-04 1.918683 
ENSMUSG00000047586 Nccrp1 3.55E-02 1.920616 
ENSMUSG00000086980 Gm13791 1.98E-02 1.922479 
ENSMUSG00000049134 Nrap 2.40E-35 1.926123 
ENSMUSG00000044737 Klk14 1.25E-07 1.926874 
ENSMUSG00000071540 3425401B19Rik 1.95E-20 1.927593 
ENSMUSG00000039763 Dnajc28 1.34E-03 1.92807 
ENSMUSG00000041423 Paqr6 9.00E-03 1.931307 
ENSMUSG00000045475 Lce3c 5.69E-05 1.931506 
ENSMUSG00000032311 Nrg4 1.59E-17 1.932314 
ENSMUSG00000039269 2300002M23Rik 5.11E-03 1.934349 
ENSMUSG00000050840 Cdh20 3.44E-04 1.936624 
ENSMUSG00000032278 Paqr5 8.26E-10 1.937115 
ENSMUSG00000039376 Synpo2l 3.96E-21 1.938741 
ENSMUSG00000007653 Gabrb2 6.55E-03 1.938974 
ENSMUSG00000056328 Myh1 2.30E-34 1.944869 
ENSMUSG00000032503 Arpp21 1.12E-06 1.948018 
ENSMUSG00000090118 Gm16163 7.49E-08 1.950295 
ENSMUSG00000005355 Casp14 2.78E-02 1.950333 
ENSMUSG00000019851 Perp 2.82E-14 1.951709 
ENSMUSG00000026950 Neb 2.63E-19 1.958489 
ENSMUSG00000041476 Smpx 7.49E-08 1.958962 
ENSMUSG00000055333 Fat2 8.85E-09 1.964371 
ENSMUSG00000032281 Acsbg1 6.04E-11 1.96499 
ENSMUSG00000026450 Chit1 3.30E-03 1.966851 
ENSMUSG00000110580 D830024N08Rik 3.00E-09 1.967915 
ENSMUSG00000039070 Cpa4 2.42E-05 1.968184 
ENSMUSG00000021223 Papln 5.90E-05 1.970017 
ENSMUSG00000050808 Muc15 3.15E-02 1.970166 
ENSMUSG00000096169 Olfr1564 4.84E-02 1.970537 
ENSMUSG00000067242 Lgi1 1.81E-04 1.972543 
ENSMUSG00000001497 Pax9 7.05E-07 1.973159 
ENSMUSG00000041737 Tmem45b 1.68E-09 1.973324 
ENSMUSG00000055561 Spink5 1.65E-11 1.975498 
ENSMUSG00000037129 Tmprss13 2.20E-05 1.978708 
ENSMUSG00000112471 Gm5779 6.88E-03 1.980462 
ENSMUSG00000027833 Shox2 1.87E-02 1.981285 
ENSMUSG00000043286 Pnpla1 1.95E-03 1.981508 
ENSMUSG00000105986 Gm43065 5.52E-04 1.983525 
ENSMUSG00000030935 Acsm3 9.82E-03 1.984411 
ENSMUSG00000059742 Kcnh7 1.36E-03 1.986178 
ENSMUSG00000050650 Mrgpra1 3.24E-02 1.986835 
ENSMUSG00000034730 Adgrb1 1.54E-02 1.986876 
ENSMUSG00000050663 Trhde 2.20E-03 1.987786 
ENSMUSG00000034774 Dsg1c 2.60E-02 1.98819 
ENSMUSG00000030178 Klra13-ps 3.18E-03 1.989497 
ENSMUSG00000030730 Atp2a1 2.28E-32 1.98969 
ENSMUSG00000027376 Prom2 3.25E-06 1.991537 
ENSMUSG00000025105 Bnc1 5.33E-04 1.99208 
ENSMUSG00000039956 Mrap 5.20E-09 1.993265 




ENSMUSG00000024331 Dsc2 6.73E-10 1.997784 
ENSMUSG00000103243 Lce1d 3.79E-03 1.999738 
ENSMUSG00000050463 Krt78 3.05E-12 2.000453 
ENSMUSG00000021359 Tfap2a 1.09E-03 2.000592 
ENSMUSG00000025329 Padi1 1.62E-02 2.00394 
ENSMUSG00000031204 Asb12 4.92E-02 2.004544 
ENSMUSG00000039518 Cdsn 8.05E-07 2.005848 
ENSMUSG00000031844 Hsd17b2 1.89E-04 2.007414 
ENSMUSG00000099906 Gm28653 1.27E-02 2.010149 
ENSMUSG00000075296 Aldh3b2 1.77E-03 2.010847 
ENSMUSG00000031936 Hephl1 1.35E-02 2.013642 
ENSMUSG00000102590 Mannr 1.14E-05 2.01519 
ENSMUSG00000026834 Acvr1c 4.87E-08 2.015446 
ENSMUSG00000030834 Abcc6 6.84E-03 2.015784 
ENSMUSG00000025425 St8sia5 2.17E-02 2.018317 
ENSMUSG00000036854 Hspb6 1.10E-06 2.019132 
ENSMUSG00000019853 Hebp2 4.55E-03 2.019308 
ENSMUSG00000050359 Sprr1a 4.50E-07 2.019357 
ENSMUSG00000110390 Gm45869 4.89E-02 2.02195 
ENSMUSG00000090356 Teddm3 1.30E-03 2.026459 
ENSMUSG00000050296 Abca12 8.96E-08 2.026805 
ENSMUSG00000047746 Fbxo40 8.92E-18 2.029312 
ENSMUSG00000032726 Bmp8a 5.87E-03 2.030065 
ENSMUSG00000029154 Cwh43 1.88E-02 2.030933 
ENSMUSG00000055489 Ano5 8.68E-17 2.033201 
ENSMUSG00000017204 Gsdma 3.20E-05 2.033369 
ENSMUSG00000044086 Lmod3 3.08E-06 2.045815 
ENSMUSG00000110843 Gm35552 4.00E-02 2.047718 
ENSMUSG00000033579 Fa2h 3.55E-03 2.048412 
ENSMUSG00000028989 Angptl7 3.95E-11 2.049447 
ENSMUSG00000114493 Gm47071 9.81E-10 2.052629 
ENSMUSG00000074489 Bglap3 1.66E-03 2.058281 
ENSMUSG00000060621 Nkpd1 1.03E-02 2.065488 
ENSMUSG00000062826 Ces2f 1.92E-08 2.067273 
ENSMUSG00000030546 Plin1 8.52E-14 2.067798 
ENSMUSG00000109311 AI314278 4.74E-04 2.069279 
ENSMUSG00000023473 Celsr3 1.86E-12 2.073428 
ENSMUSG00000096001 2610528A11Rik 3.36E-02 2.073506 
ENSMUSG00000089941 Gm16168 2.39E-07 2.073697 
ENSMUSG00000074647 Fam83c 2.18E-02 2.076138 
ENSMUSG00000067081 Asb18 2.76E-08 2.077407 
ENSMUSG00000044594 Serpinb3a 5.80E-06 2.079432 
ENSMUSG00000044499 Hs3st5 3.23E-11 2.080027 
ENSMUSG00000030713 Klk7 1.62E-02 2.081978 
ENSMUSG00000043472 Lce3d 2.62E-02 2.084031 
ENSMUSG00000045019 Acer1 2.71E-02 2.084468 
ENSMUSG00000047976 Kcna1 2.86E-12 2.088442 
ENSMUSG00000032013 Trim29 1.72E-10 2.088868 
ENSMUSG00000026327 Serpinb11 1.47E-04 2.090204 
ENSMUSG00000026592 Tex35 4.71E-09 2.091662 
ENSMUSG00000047216 Cdh19 9.22E-24 2.093022 
ENSMUSG00000050830 Vwc2 6.27E-05 2.093227 
ENSMUSG00000078907 Fam186b 4.10E-02 2.094674 
ENSMUSG00000016179 Camk1g 3.72E-02 2.098511 
ENSMUSG00000026407 Cacna1s 4.35E-21 2.098587 
ENSMUSG00000059994 Fcrl1 2.55E-10 2.10039 




ENSMUSG00000010064 Slc38a3 3.35E-10 2.106878 
ENSMUSG00000031448 Adprhl1 1.43E-16 2.1087 
ENSMUSG00000045776 Lrtm1 1.67E-11 2.109699 
ENSMUSG00000053522 Lgals7 5.24E-05 2.111441 
ENSMUSG00000069873 4930438A08Rik 3.96E-05 2.11536 
ENSMUSG00000022053 Ebf2 2.57E-28 2.116937 
ENSMUSG00000049598 Vsig8 5.27E-03 2.118056 
ENSMUSG00000056966 Gjc3 1.05E-02 2.118632 
ENSMUSG00000094814 Gm21973 5.63E-03 2.122571 
ENSMUSG00000026621 Mar1 2.60E-02 2.123251 
ENSMUSG00000021255 Esrrb 5.97E-07 2.124457 
ENSMUSG00000109293 Dcst2 1.99E-02 2.125564 
ENSMUSG00000026147 Col9a1 2.36E-02 2.125738 
ENSMUSG00000067001 Serpinb7 1.24E-02 2.128035 
ENSMUSG00000024076 Vit 7.49E-08 2.128736 
ENSMUSG00000048399 Tprg 5.27E-05 2.129159 
ENSMUSG00000048721 Fndc9 4.81E-02 2.129168 
ENSMUSG00000028865 Cd164l2 6.80E-05 2.131367 
ENSMUSG00000029195 Klb 1.90E-02 2.135638 
ENSMUSG00000032401 Lctl 4.28E-02 2.141541 
ENSMUSG00000051965 Nanos2 2.43E-02 2.142158 
ENSMUSG00000028736 Pax7 1.19E-02 2.142682 
ENSMUSG00000044041 Krt13 2.13E-07 2.145789 
ENSMUSG00000035686 Thrsp 1.00E-21 2.14587 
ENSMUSG00000059956 Serpinb12 6.27E-06 2.148141 
ENSMUSG00000030484 Lypd5 1.18E-07 2.149653 
ENSMUSG00000057454 Lypd3 8.72E-05 2.150403 
ENSMUSG00000025479 Cyp2e1 2.34E-37 2.150779 
ENSMUSG00000097768 2310043M15Rik 2.17E-03 2.151001 
ENSMUSG00000020007 Il20ra 8.82E-04 2.163851 
ENSMUSG00000027359 Slc27a2 3.11E-04 2.163887 
ENSMUSG00000045539 Sprr3 1.12E-09 2.16411 
ENSMUSG00000032807 Alox12b 2.37E-06 2.164244 
ENSMUSG00000032454 Rbp2 2.18E-02 2.166851 
ENSMUSG00000050108 Bpifc 6.18E-03 2.167485 
ENSMUSG00000043460 Elfn2 2.40E-02 2.16877 
ENSMUSG00000041984 Rptn 1.76E-11 2.170781 
ENSMUSG00000043468 Adam30 5.96E-03 2.173031 
ENSMUSG00000073601 Serpinb3c 2.50E-03 2.175747 
ENSMUSG00000024471 Myot 2.51E-26 2.176575 
ENSMUSG00000065445 Mir143 2.74E-02 2.17762 
ENSMUSG00000005716 Pvalb 2.86E-05 2.18435 
ENSMUSG00000022510 Trp63 1.40E-18 2.189235 
ENSMUSG00000026984 Il1f6 3.02E-03 2.189606 
ENSMUSG00000062044 Lmtk3 3.45E-02 2.190846 
ENSMUSG00000052581 Lrrtm4 1.15E-11 2.192309 
ENSMUSG00000045569 Mc2r 3.78E-02 2.192408 
ENSMUSG00000017309 Cd300lg 6.73E-18 2.195374 
ENSMUSG00000024526 Cidea 2.31E-06 2.199377 
ENSMUSG00000081689 Gm9166 4.77E-02 2.201972 
ENSMUSG00000102574 Gm33206 1.64E-02 2.204692 
ENSMUSG00000025064 Col17a1 1.23E-11 2.208855 
ENSMUSG00000074445 Sprr2a3 3.39E-03 2.210458 
ENSMUSG00000116659 AC158985.1 1.19E-02 2.215346 
ENSMUSG00000027401 Tgm3 2.06E-08 2.229316 
ENSMUSG00000026985 Il1f8 3.43E-03 2.233766 




ENSMUSG00000041991 Hrnr 2.86E-07 2.235634 
ENSMUSG00000024972 Lgals12 4.44E-07 2.236885 
ENSMUSG00000054146 Krt15 4.97E-10 2.240443 
ENSMUSG00000021509 Slc25a48 9.46E-04 2.243699 
ENSMUSG00000044322 Dsc1 1.20E-04 2.247548 
ENSMUSG00000059668 Krt4 3.30E-08 2.252859 
ENSMUSG00000102698 Gm37777 4.88E-02 2.254948 
ENSMUSG00000031725 Ces1f 2.39E-03 2.264564 
ENSMUSG00000028396 2310002L09Rik 6.45E-05 2.264786 
ENSMUSG00000105128 Gm42870 1.67E-03 2.265372 
ENSMUSG00000117222 AC060761.1 1.12E-09 2.268436 
ENSMUSG00000039238 Zfp750 1.91E-05 2.270028 
ENSMUSG00000028148 Them5 4.51E-09 2.271649 
ENSMUSG00000027966 Col11a1 1.37E-12 2.271918 
ENSMUSG00000117029 CT030155.1 3.50E-04 2.274179 
ENSMUSG00000085615 A330035P11Rik 3.82E-03 2.27617 
ENSMUSG00000097364 Gm26719 1.09E-03 2.281662 
ENSMUSG00000046764 A530053G22Rik 3.40E-04 2.285877 
ENSMUSG00000069441 Dsg1a 1.19E-12 2.293298 
ENSMUSG00000106871 Gm3289 3.38E-02 2.300456 
ENSMUSG00000026413 Pkp1 1.59E-11 2.301027 
ENSMUSG00000043430 Psapl1 6.34E-09 2.302115 
ENSMUSG00000026983 Il1f5 7.17E-04 2.303818 
ENSMUSG00000044359 P2ry4 3.22E-04 2.308913 
ENSMUSG00000023041 Krt6b 2.05E-02 2.310622 
ENSMUSG00000094335 Igkv1-117 4.70E-02 2.317249 
ENSMUSG00000040154 Wfdc5 1.56E-04 2.317891 
ENSMUSG00000044505 Lingo4 4.11E-02 2.324002 
ENSMUSG00000086155 9430041J12Rik 1.78E-02 2.328883 
ENSMUSG00000051596 Otop1 5.62E-03 2.333939 
ENSMUSG00000040283 Btnl9 4.98E-05 2.341489 
ENSMUSG00000071019 Sdr16c6 6.69E-04 2.347186 
ENSMUSG00000061928 Dsg1b 2.79E-10 2.356478 
ENSMUSG00000044453 Ffar1 6.83E-03 2.359339 
ENSMUSG00000074771 Ankef1 3.32E-11 2.367063 
ENSMUSG00000102713 Gm29994 4.96E-02 2.37116 
ENSMUSG00000033268 Duox1 1.02E-07 2.373757 
ENSMUSG00000087382 Ctcflos 3.00E-06 2.374574 
ENSMUSG00000022860 Chodl 2.17E-03 2.383702 
ENSMUSG00000097335 Gm26563 3.11E-04 2.388002 
ENSMUSG00000074113 Gm10629 2.59E-02 2.396626 
ENSMUSG00000061527 Krt5 1.53E-10 2.400635 
ENSMUSG00000102788 Gm38255 2.20E-02 2.411338 
ENSMUSG00000063130 Calml3 1.42E-10 2.41536 
ENSMUSG00000027761 Aadac 1.39E-02 2.416545 
ENSMUSG00000021565 Slc6a19 1.11E-07 2.422981 
ENSMUSG00000017607 Tns4 1.21E-08 2.42721 
ENSMUSG00000086584 Gm12002 9.27E-09 2.431887 
ENSMUSG00000056078 Lipm 3.36E-06 2.434023 
ENSMUSG00000048455 Sprr1b 7.22E-04 2.435726 
ENSMUSG00000074623 Gm826 2.01E-05 2.447222 
ENSMUSG00000117322 AC154766.4 1.42E-03 2.450311 
ENSMUSG00000074652 Myh7b 3.23E-04 2.464603 
ENSMUSG00000097074 4833428L15Rik 3.94E-03 2.46861 
ENSMUSG00000044748 Defb1 6.87E-04 2.475512 
ENSMUSG00000109656 Gm45548 1.18E-02 2.476315 




ENSMUSG00000030972 Acsm5 4.43E-02 2.484046 
ENSMUSG00000082141 Gm11212 1.17E-02 2.488085 
ENSMUSG00000114898 Gm49390 2.70E-02 2.494279 
ENSMUSG00000043795 Prr33 9.14E-05 2.508198 
ENSMUSG00000095079 Igha 3.83E-18 2.559163 
ENSMUSG00000070719 Pla2g4d 2.65E-03 2.562518 
ENSMUSG00000057913 Gm10032 3.14E-02 2.585521 
ENSMUSG00000023176 Cpn2 4.45E-03 2.587907 
ENSMUSG00000068893 Sprr2a2 1.16E-09 2.589158 
ENSMUSG00000042662 Dusp15 9.84E-03 2.602635 
ENSMUSG00000067006 Serpinb5 9.95E-09 2.602844 
ENSMUSG00000086032 Gm15929 3.41E-02 2.608879 
ENSMUSG00000092222 Gm20506 6.46E-03 2.617156 
ENSMUSG00000055301 Adh7 5.78E-18 2.63083 
ENSMUSG00000102762 4930403P22Rik 1.44E-03 2.635338 
ENSMUSG00000028427 Aqp7 2.36E-05 2.650459 
ENSMUSG00000078664 Sprr2a1 9.93E-05 2.651024 
ENSMUSG00000019936 Epyc 2.77E-02 2.652037 
ENSMUSG00000046095 Krt32 1.20E-03 2.667941 
ENSMUSG00000114091 Gm40655 5.12E-07 2.678247 
ENSMUSG00000099798 Gm29168 1.20E-02 2.686459 
ENSMUSG00000027048 Abcb11 3.96E-02 2.686539 
ENSMUSG00000032373 Car12 1.07E-30 2.712374 
ENSMUSG00000035861 Tmprss11b 5.06E-03 2.728767 
ENSMUSG00000097850 4631405K08Rik 6.26E-04 2.731215 
ENSMUSG00000030046 Bmp10 2.22E-02 2.748688 
ENSMUSG00000079451 Tmprss11g 2.47E-07 2.766776 
ENSMUSG00000033765 Calm4 2.29E-07 2.770286 
ENSMUSG00000074156 Ces1h 1.20E-08 2.790568 
ENSMUSG00000078964 Ces1b 7.10E-05 2.800191 
ENSMUSG00000029019 Nppb 4.80E-12 2.809285 
ENSMUSG00000074183 Gsta1 1.83E-03 2.825282 
ENSMUSG00000045545 Krt14 8.07E-21 2.845235 
ENSMUSG00000033849 B3galt2 1.28E-06 2.854439 
ENSMUSG00000037942 Crp 4.26E-04 2.872187 
ENSMUSG00000032852 Rspo4 3.66E-02 2.874898 
ENSMUSG00000028011 Tdo2 5.25E-03 2.883112 
ENSMUSG00000053675 Tgm5 1.57E-02 2.88705 
ENSMUSG00000114922 Ppifos 6.49E-06 2.892979 
ENSMUSG00000092586 Ly6g6c 8.58E-10 2.894076 
ENSMUSG00000075217 4833423E24Rik 5.12E-09 2.895953 
ENSMUSG00000016327 Atp1b4 2.46E-06 2.972894 
ENSMUSG00000028356 Ambp 1.17E-04 3.000966 
ENSMUSG00000031710 Ucp1 1.67E-14 3.002674 
ENSMUSG00000116482 Gm34152 1.61E-02 3.020639 
ENSMUSG00000033196 Myh2 1.40E-20 3.128999 
ENSMUSG00000013936 Myl2 1.78E-08 3.151791 
ENSMUSG00000111709 Gm3776 1.40E-03 3.198663 
ENSMUSG00000059898 Dsc3 1.21E-15 3.210725 
ENSMUSG00000111556 Gm19299 4.63E-06 3.219853 
ENSMUSG00000058354 Krt6a 5.91E-07 3.268707 
ENSMUSG00000004872 Pax3 4.21E-04 3.300239 
ENSMUSG00000106056 4930500L23Rik 1.18E-03 3.320195 
ENSMUSG00000115207 Gm49132 2.01E-04 3.358344 
ENSMUSG00000028001 Fga 2.45E-06 3.395634 
ENSMUSG00000056632 Dsg3 1.17E-26 3.443911 




ENSMUSG00000017950 Hnf4a 3.71E-04 3.786185 
ENSMUSG00000025003 Cyp2c39 1.57E-03 4.069422 
ENSMUSG00000102098 2310016D03Rik 8.49E-06 4.610042 
ENSMUSG00000056656 Apol8 1.42E-18 4.685594 
ENSMUSG00000033860 Fgg 2.32E-12 4.837005 
ENSMUSG00000022875 Kng1 3.51E-06 4.98915 
ENSMUSG00000025194 Abcc2 1.51E-05 5.208255 
ENSMUSG00000054422 Fabp1 9.90E-07 5.384976 
ENSMUSG00000021364 Elovl2 1.66E-05 5.766093 
ENSMUSG00000001670 Tat 8.99E-06 8.225412 
ENSMUSG00000030131 Mug2 4.90E-08 8.940782 
ENSMUSG00000030359 Pzp 5.53E-19 10.7158 
ENSMUSG00000028307 Aldob 4.66E-11 13.80692 
ENSMUSG00000020609 Apob 3.96E-21 14.75844 
ENSMUSG00000085154 C130046K22Rik 5.61E-09 14.96049 
ENSMUSG00000022868 Ahsg 1.17E-21 15.70773 
ENSMUSG00000035540 Gc 1.39E-15 17.68534 
ENSMUSG00000019932 Kera 9.46E-13 17.79842 
ENSMUSG00000003053 Cyp2c29 3.02E-11 21.15165 
ENSMUSG00000059481 Plg 1.20E-08 22.09324 
ENSMUSG00000056035 Cyp3a11 1.28E-13 54.83161 
ENSMUSG00000032083 Apoa1 5.63E-16 55.84116 
ENSMUSG00000061808 Ttr 6.66E-07 82.413 
ENSMUSG00000059908 Mug1 1.60E-17 99.55708 
ENSMUSG00000029630 Cyp3a25 1.25E-06 123.9654 
ENSMUSG00000029368 Alb 2.26E-43 153.3651 
ENSMUSG00000025991 Cps1 2.28E-07 180.3232 






















Appendix U. Murine differential gene expression in the lungs 6 h post-infection, 947 vs 4559M. 
Genes with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in 
blue = upregulated in 947, while values highlighted in red = upregulated in 4559M. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000096349 Gm22513 4.55E-03 2.606374 
ENSMUSG00000045932 Ifit2 6.67E-41 2.120213 
ENSMUSG00000003545 Fosb 1.28E-08 2.101081 
ENSMUSG00000094392 Gm3788 2.89E-05 2.057367 
ENSMUSG00000057596 Trim30d 5.07E-06 1.986075 
ENSMUSG00000000386 Mx1 2.11E-34 1.933773 
ENSMUSG00000020641 Rsad2 1.35E-13 1.923719 
ENSMUSG00000059434 Gckr 5.94E-06 1.899378 
ENSMUSG00000097312 Gm26870 9.81E-06 1.880663 
ENSMUSG00000060183 Cxcl11 4.50E-06 1.864222 
ENSMUSG00000035852 Misp 1.64E-10 1.805939 
ENSMUSG00000015437 Gzmb 7.02E-04 1.803683 
ENSMUSG00000108289 Gm44174 1.88E-06 1.793558 
ENSMUSG00000048003 Catsper4 2.11E-03 1.765394 
ENSMUSG00000052353 Cemip 5.51E-17 1.762085 
ENSMUSG00000084823 Gm17216 1.45E-02 1.726759 
ENSMUSG00000020638 Cmpk2 4.84E-24 1.693086 
ENSMUSG00000103824 Gm38177 1.68E-02 1.688716 
ENSMUSG00000031757 Mt4 3.02E-02 1.675168 
ENSMUSG00000037962 Rflna 2.29E-02 1.671596 
ENSMUSG00000114553 Gm7644 1.01E-02 1.623832 
ENSMUSG00000026826 Nr4a2 1.18E-04 1.600445 
ENSMUSG00000059832 Kprp 2.90E-03 1.592978 
ENSMUSG00000014543 Klra17 2.61E-06 1.58641 
ENSMUSG00000063651 Cnfn 4.88E-03 1.573752 
ENSMUSG00000116660 CT030736.1 1.20E-05 1.572765 
ENSMUSG00000028031 Dkk2 3.03E-04 1.572515 
ENSMUSG00000059230 Defb4 2.16E-02 1.569063 
ENSMUSG00000086196 Gm13571 2.78E-02 1.568524 
ENSMUSG00000067767 Clec4b2 1.74E-02 1.568218 
ENSMUSG00000073902 Gm1966 8.80E-07 1.554048 
ENSMUSG00000111229 Gm39323 1.70E-02 1.52393 
ENSMUSG00000034855 Cxcl10 3.16E-04 1.523329 
ENSMUSG00000070866 Zfp804a 2.31E-02 1.521761 
ENSMUSG00000097134 1110002J07Rik 1.21E-02 1.519142 
ENSMUSG00000032502 Stac 4.38E-02 1.517901 
ENSMUSG00000043664 Tmem221 3.80E-02 1.516904 
ENSMUSG00000086213 A330040F15Rik 1.39E-04 1.503579 
ENSMUSG00000096349 Gm22513 4.55E-03 2.606374 
ENSMUSG00000045932 Ifit2 6.67E-41 2.120213 
ENSMUSG00000003545 Fosb 1.28E-08 2.101081 
ENSMUSG00000094392 Gm3788 2.89E-05 2.057367 
ENSMUSG00000057596 Trim30d 5.07E-06 1.986075 
ENSMUSG00000000386 Mx1 2.11E-34 1.933773 
ENSMUSG00000020641 Rsad2 1.35E-13 1.923719 
ENSMUSG00000059434 Gckr 5.94E-06 1.899378 
ENSMUSG00000097312 Gm26870 9.81E-06 1.880663 
ENSMUSG00000060183 Cxcl11 4.50E-06 1.864222 
ENSMUSG00000035852 Misp 1.64E-10 1.805939 
ENSMUSG00000015437 Gzmb 7.02E-04 1.803683 
ENSMUSG00000108289 Gm44174 1.88E-06 1.793558 




ENSMUSG00000052353 Cemip 5.51E-17 1.762085 
ENSMUSG00000084823 Gm17216 1.45E-02 1.726759 
ENSMUSG00000020638 Cmpk2 4.84E-24 1.693086 
ENSMUSG00000103824 Gm38177 1.68E-02 1.688716 
ENSMUSG00000031757 Mt4 3.02E-02 1.675168 
ENSMUSG00000037962 Rflna 2.29E-02 1.671596 
ENSMUSG00000114553 Gm7644 1.01E-02 1.623832 
ENSMUSG00000026826 Nr4a2 1.18E-04 1.600445 
ENSMUSG00000059832 Kprp 2.90E-03 1.592978 
ENSMUSG00000014543 Klra17 2.61E-06 1.58641 
ENSMUSG00000063651 Cnfn 4.88E-03 1.573752 
ENSMUSG00000116660 CT030736.1 1.20E-05 1.572765 
ENSMUSG00000028031 Dkk2 3.03E-04 1.572515 
ENSMUSG00000059230 Defb4 2.16E-02 1.569063 
ENSMUSG00000086196 Gm13571 2.78E-02 1.568524 
ENSMUSG00000067767 Clec4b2 1.74E-02 1.568218 
ENSMUSG00000073902 Gm1966 8.80E-07 1.554048 
ENSMUSG00000111229 Gm39323 1.70E-02 1.52393 
ENSMUSG00000034855 Cxcl10 3.16E-04 1.523329 
ENSMUSG00000070866 Zfp804a 2.31E-02 1.521761 
ENSMUSG00000097134 1110002J07Rik 1.21E-02 1.519142 
ENSMUSG00000032502 Stac 4.38E-02 1.517901 
ENSMUSG00000043664 Tmem221 3.80E-02 1.516904 
ENSMUSG00000086213 A330040F15Rik 1.39E-04 1.503579 
ENSMUSG00000101930 Gm5441 8.04E-04 1.501768 
ENSMUSG00000116031 D030024E09Rik 1.14E-03 1.505026 
ENSMUSG00000109157 Gm44829 2.31E-02 1.513042 
ENSMUSG00000047976 Kcna1 1.32E-03 1.515831 
ENSMUSG00000098708 Gm27252 9.38E-03 1.516922 
ENSMUSG00000066510 Ankdd1a 2.65E-04 1.517129 
ENSMUSG00000096084 Gm21850 3.46E-03 1.51884 
ENSMUSG00000021259 Cyp46a1 4.91E-02 1.520911 
ENSMUSG00000056569 Mpz 1.47E-06 1.521436 
ENSMUSG00000092267 Gm20417 4.50E-03 1.523107 
ENSMUSG00000030350 Prmt8 2.14E-06 1.527589 
ENSMUSG00000108929 Cc2d2b 2.94E-02 1.536074 
ENSMUSG00000000197 Nalcn 3.23E-05 1.543563 
ENSMUSG00000089844 A530032D15Rik 2.07E-05 1.544398 
ENSMUSG00000054582 Pabpc1l 5.95E-05 1.549878 
ENSMUSG00000090877 Hspa1b 1.31E-04 1.554299 
ENSMUSG00000094125 Gm13698 1.01E-02 1.558384 
ENSMUSG00000094336 Gm13693 1.01E-02 1.558384 
ENSMUSG00000096484 Gm13696 1.01E-02 1.558384 
ENSMUSG00000096337 Gm13694 1.01E-02 1.558384 
ENSMUSG00000095824 Gm13697 1.01E-02 1.558384 
ENSMUSG00000079247 Gm13691 1.01E-02 1.558384 
ENSMUSG00000020698 Cct6b 4.95E-02 1.558508 
ENSMUSG00000097071 4930544I03Rik 2.71E-03 1.558902 
ENSMUSG00000111818 Gm17749 3.50E-04 1.559008 
ENSMUSG00000096729 Gm13695 9.65E-03 1.560095 
ENSMUSG00000000157 Itgb2l 1.35E-10 1.563713 
ENSMUSG00000102590 Mannr 3.05E-02 1.566127 
ENSMUSG00000100457 D830032E09Rik 4.66E-02 1.566802 
ENSMUSG00000069830 Nlrp1a 3.96E-02 1.567104 
ENSMUSG00000027513 Pck1 9.84E-05 1.579451 
ENSMUSG00000109002 Gm38405 3.97E-02 1.583287 




ENSMUSG00000019577 Pdk4 7.99E-35 1.589981 
ENSMUSG00000109032 Gm7972 1.78E-03 1.592848 
ENSMUSG00000017309 Cd300lg 1.27E-05 1.593726 
ENSMUSG00000042895 Abra 1.07E-04 1.59373 
ENSMUSG00000093482 Gm20619 4.17E-04 1.595111 
ENSMUSG00000025038 Efhc2 1.41E-03 1.595115 
ENSMUSG00000028989 Angptl7 2.82E-04 1.597595 
ENSMUSG00000028573 Fggy 6.11E-03 1.598726 
ENSMUSG00000096351 Samd11 2.77E-03 1.599425 
ENSMUSG00000001482 Def8 1.63E-08 1.601844 
ENSMUSG00000103620 Gm37359 6.80E-03 1.602521 
ENSMUSG00000034755 Pcdh11x 2.76E-04 1.607959 
ENSMUSG00000112707 D830005E20Rik 3.55E-07 1.612262 
ENSMUSG00000025716 Myo3a 1.00E-02 1.616705 
ENSMUSG00000039376 Synpo2l 3.29E-10 1.617835 
ENSMUSG00000043487 Acot6 4.05E-02 1.619862 
ENSMUSG00000040740 Slc25a34 5.61E-04 1.620673 
ENSMUSG00000083898 Gm7340 2.52E-05 1.62131 
ENSMUSG00000047216 Cdh19 3.15E-09 1.621717 
ENSMUSG00000087436 Gm16156 3.54E-02 1.622122 
ENSMUSG00000046748 Tmem45a2 5.95E-04 1.63198 
ENSMUSG00000042451 Mybph 3.29E-11 1.633192 
ENSMUSG00000112895 Gm47567 9.03E-03 1.63877 
ENSMUSG00000031626 Sorbs2 2.96E-20 1.6396 
ENSMUSG00000030607 Acan 1.15E-02 1.640047 
ENSMUSG00000004668 Abca13 4.50E-22 1.64663 
ENSMUSG00000025892 Gria4 2.09E-02 1.648351 
ENSMUSG00000079243 Xirp1 1.13E-12 1.649967 
ENSMUSG00000025172 Ankrd2 1.14E-04 1.655491 
ENSMUSG00000032496 Ltf 1.64E-24 1.662871 
ENSMUSG00000087353 Gm13727 9.58E-05 1.669227 
ENSMUSG00000084783 Gm15419 2.41E-02 1.67799 
ENSMUSG00000043789 Vwce 2.45E-03 1.682827 
ENSMUSG00000092397 C130080G10Rik 3.31E-06 1.687017 
ENSMUSG00000052581 Lrrtm4 1.05E-04 1.698365 
ENSMUSG00000041476 Smpx 1.39E-04 1.709086 
ENSMUSG00000103288 Gm37273 2.47E-03 1.713415 
ENSMUSG00000091971 Hspa1a 2.89E-05 1.735291 
ENSMUSG00000027014 Cwc22 4.55E-06 1.737258 
ENSMUSG00000038357 Camp 1.72E-04 1.743837 
ENSMUSG00000086354 Gm13938 1.32E-12 1.744173 
ENSMUSG00000048388 Fam171b 3.75E-15 1.772987 
ENSMUSG00000091119 Ccdc152 7.27E-04 1.775671 
ENSMUSG00000092201 A530058N18Rik 3.96E-09 1.775799 
ENSMUSG00000027966 Col11a1 1.22E-05 1.791424 
ENSMUSG00000087362 Gm13710 7.49E-07 1.797954 
ENSMUSG00000028865 Cd164l2 7.33E-03 1.840898 
ENSMUSG00000026592 Tex35 4.20E-06 1.902222 
ENSMUSG00000050830 Vwc2 2.01E-03 1.925254 
ENSMUSG00000020848 Doc2b 7.33E-16 1.935334 
ENSMUSG00000021071 Trim9 7.02E-07 1.951751 
ENSMUSG00000031710 Ucp1 7.62E-05 1.957941 
ENSMUSG00000042567 Nek10 5.83E-20 1.985917 
ENSMUSG00000105361 AY036118 2.16E-04 2.072411 
ENSMUSG00000032484 Ngp 7.92E-53 2.07311 
ENSMUSG00000096960 A230028O05Rik 1.84E-11 2.079473 




ENSMUSG00000020609 Apob 5.06E-03 2.792234 
ENSMUSG00000056656 Apol8 3.96E-09 3.055558 
ENSMUSG00000013936 Myl2 4.89E-18 5.494857 




































Appendix V. Murine differential gene expression in the lungs 6 h post-infection, 947M vs 4559. 
Genes with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in 
blue = upregulated in 947M, while values highlighted in red = upregulated in 4559. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000096349 Gm22513 4.24E-09 5.203286 
ENSMUSG00000086468 Etaa1os 3.06E-03 4.383019 
ENSMUSG00000071679 Rtl4 2.82E-18 4.145063 
ENSMUSG00000097554 Gm26825 3.15E-02 3.419807 
ENSMUSG00000031551 Ido1 1.65E-05 3.222093 
ENSMUSG00000085465 Gm15347 7.57E-04 3.20346 
ENSMUSG00000089874 9230117E06Rik 4.64E-02 3.119926 
ENSMUSG00000112246 Gm40761 1.67E-03 3.067346 
ENSMUSG00000046242 Nme9 5.99E-06 3.059333 
ENSMUSG00000105361 AY036118 7.94E-06 3.053392 
ENSMUSG00000001494 Sost 8.97E-05 2.742959 
ENSMUSG00000030114 Klrg1 6.18E-03 2.73067 
ENSMUSG00000092591 Gm20429 2.74E-03 2.725606 
ENSMUSG00000102608 Gm37267 3.18E-02 2.662128 
ENSMUSG00000064941 Gm23238 4.50E-07 2.561069 
ENSMUSG00000091694 Apol11b 3.42E-02 2.557668 
ENSMUSG00000076612 Ighg2c 1.66E-02 2.526225 
ENSMUSG00000117074 AC121299.1 9.05E-04 2.484582 
ENSMUSG00000063594 Gng8 1.64E-02 2.483359 
ENSMUSG00000102795 Gm6236 3.35E-02 2.457189 
ENSMUSG00000095616 Gm26244 1.72E-04 2.370041 
ENSMUSG00000025578 Cbx8 3.26E-04 2.32664 
ENSMUSG00000086843 E030013I19Rik 1.04E-07 2.322747 
ENSMUSG00000094306 Gm24924 2.98E-04 2.262227 
ENSMUSG00000115432 D130009I18Rik 4.24E-03 2.229274 
ENSMUSG00000070530 Wfdc16 2.71E-02 2.177114 
ENSMUSG00000095969 Rnu1a1 3.65E-04 2.169236 
ENSMUSG00000101603 Gm28730 4.48E-02 2.160864 
ENSMUSG00000115307 Gm49313 2.36E-04 2.155958 
ENSMUSG00000096659 Gm25679 1.87E-06 2.155429 
ENSMUSG00000093815 Gm26444 1.87E-06 2.155429 
ENSMUSG00000090667 Gm765 4.68E-02 2.133759 
ENSMUSG00000082292 Gm12250 2.39E-09 2.123222 
ENSMUSG00000080797 Gm15760 1.81E-02 2.120402 
ENSMUSG00000108481 Gm33248 1.01E-19 2.098355 
ENSMUSG00000070720 Tmem200b 5.47E-05 2.088404 
ENSMUSG00000069300 Hist1h2bj 3.40E-02 2.08459 
ENSMUSG00000065778 Gm22154 4.98E-02 2.079887 
ENSMUSG00000094826 Gm23804 9.42E-06 2.058273 
ENSMUSG00000091956 C2cd4b 2.21E-02 2.046617 
ENSMUSG00000052026 Slc6a7 1.35E-06 2.03982 
ENSMUSG00000114969 Hba-ps3 8.89E-03 2.039639 
ENSMUSG00000109491 Gm15396 4.44E-03 2.0348 
ENSMUSG00000046470 Sox18 7.42E-22 2.034619 
ENSMUSG00000087943 Gm24245 4.06E-06 2.030591 
ENSMUSG00000112831 AC167229.1 4.48E-02 1.969926 
ENSMUSG00000044952 Kctd21 6.08E-12 1.954796 
ENSMUSG00000116809 AC122538.1 1.49E-02 1.952285 
ENSMUSG00000072599 Ear-ps2 4.25E-04 1.942615 
ENSMUSG00000095260 Gm25890 2.93E-03 1.936872 
ENSMUSG00000094812 Gm22614 2.93E-03 1.936872 




ENSMUSG00000104965 Gm43437 2.42E-02 1.930614 
ENSMUSG00000071661 Zbtb3 1.99E-02 1.929765 
ENSMUSG00000035299 Mid1 1.10E-04 1.921743 
ENSMUSG00000079330 Lemd1 3.53E-07 1.913457 
ENSMUSG00000060981 Hist1h4h 2.00E-05 1.909585 
ENSMUSG00000068696 Gpr88 1.30E-02 1.908856 
ENSMUSG00000081684 Rps2-ps13 6.39E-08 1.908057 
ENSMUSG00000064063 BC048507 1.73E-04 1.907851 
ENSMUSG00000096205 Gm22068 2.30E-03 1.907755 
ENSMUSG00000082192 Gm14719 7.60E-03 1.90406 
ENSMUSG00000092118 Fancf 3.09E-02 1.903835 
ENSMUSG00000050578 Mmp13 1.52E-03 1.899788 
ENSMUSG00000064923 Gm22042 3.99E-03 1.899281 
ENSMUSG00000055945 Prr18 4.95E-05 1.895915 
ENSMUSG00000096214 Gm22634 3.91E-05 1.891642 
ENSMUSG00000096206 Gm22317 3.91E-05 1.891642 
ENSMUSG00000063681 Crb1 3.96E-02 1.887394 
ENSMUSG00000116097 Gm36738 2.84E-03 1.876667 
ENSMUSG00000095701 Gm24830 4.71E-03 1.8723 
ENSMUSG00000096838 Gm26232 4.71E-03 1.8723 
ENSMUSG00000065773 Rnu1b6 4.71E-03 1.8723 
ENSMUSG00000107794 Gm44095 1.32E-03 1.871248 
ENSMUSG00000083737 Prdx6-ps2 1.41E-03 1.870411 
ENSMUSG00000035435 Abca17 1.48E-13 1.866967 
ENSMUSG00000038233 Fam198a 3.68E-07 1.865708 
ENSMUSG00000069305 Hist1h4n 9.20E-03 1.855769 
ENSMUSG00000041479 Syt15 1.78E-07 1.853036 
ENSMUSG00000112969 Gm48496 9.76E-03 1.84879 
ENSMUSG00000032357 Tinag 3.44E-07 1.84595 
ENSMUSG00000085154 C130046K22Rik 1.34E-02 1.844771 
ENSMUSG00000114028 9630002D21Rik 4.31E-03 1.844134 
ENSMUSG00000036264 Fstl4 3.58E-03 1.839891 
ENSMUSG00000108580 Gm39094 5.20E-27 1.83939 
ENSMUSG00000095580 Rnu1b1 9.28E-03 1.834552 
ENSMUSG00000093834 Rnu1b2 9.28E-03 1.834552 
ENSMUSG00000060678 Hist1h4c 1.39E-05 1.826151 
ENSMUSG00000045410 Akr1e1 8.33E-04 1.825984 
ENSMUSG00000085297 Gm11651 3.62E-02 1.823187 
ENSMUSG00000110634 Gm45895 4.27E-02 1.812488 
ENSMUSG00000035528 Npffr2 8.19E-03 1.809944 
ENSMUSG00000088246 Gm25911 1.52E-07 1.809528 
ENSMUSG00000086368 Gm13830 4.51E-04 1.80628 
ENSMUSG00000042988 Notum 1.04E-02 1.800697 
ENSMUSG00000087247 Alkal1 1.02E-14 1.799935 
ENSMUSG00000037279 Ovol2 4.81E-03 1.799681 
ENSMUSG00000060093 Hist1h4a 1.67E-03 1.792799 
ENSMUSG00000088609 Gm24187 7.72E-07 1.790795 
ENSMUSG00000085982 9530051G07Rik 8.90E-03 1.790428 
ENSMUSG00000029193 Cckar 6.00E-06 1.790204 
ENSMUSG00000086822 5330413P13Rik 2.14E-02 1.781756 
ENSMUSG00000067455 Hist1h4j 4.84E-02 1.781086 
ENSMUSG00000009900 Wnt3a 7.74E-05 1.780263 
ENSMUSG00000092240 Gm4246 6.92E-04 1.769107 
ENSMUSG00000084998 Gm16279 3.51E-03 1.767919 
ENSMUSG00000053961 Ang5 3.61E-02 1.764068 
ENSMUSG00000027070 Lrp2 5.22E-34 1.760968 




ENSMUSG00000085882 2610507I01Rik 1.69E-03 1.759883 
ENSMUSG00000092805 Gm26461 4.98E-03 1.756282 
ENSMUSG00000024925 Rnaseh2c 2.34E-03 1.756123 
ENSMUSG00000031831 Dnaaf1 3.63E-02 1.748301 
ENSMUSG00000052117 D630039A03Rik 1.92E-03 1.746534 
ENSMUSG00000031220 Awat2 4.93E-03 1.738885 
ENSMUSG00000101605 Ace3 9.36E-06 1.738835 
ENSMUSG00000106229 Gm19409 3.20E-02 1.738286 
ENSMUSG00000030043 Tacr1 5.14E-05 1.733899 
ENSMUSG00000101674 4930444A19Rik 4.33E-02 1.733428 
ENSMUSG00000103160 C130012C08Rik 4.54E-02 1.730458 
ENSMUSG00000047085 Lrrc4b 2.55E-04 1.729971 
ENSMUSG00000086596 Susd5 1.35E-05 1.729874 
ENSMUSG00000070167 Snora57 5.72E-04 1.729595 
ENSMUSG00000050188 Lsm10 1.05E-03 1.72668 
ENSMUSG00000037649 H2-DMa 1.45E-08 1.723012 
ENSMUSG00000086390 1810019D21Rik 4.92E-06 1.722576 
ENSMUSG00000020734 Grin2c 9.25E-03 1.722135 
ENSMUSG00000106373 Gm6522 1.37E-03 1.721283 
ENSMUSG00000100041 Gm5702 2.41E-02 1.71842 
ENSMUSG00000040936 Ulk4 1.20E-17 1.714171 
ENSMUSG00000046240 Hepacam 2.58E-05 1.711621 
ENSMUSG00000030041 M1ap 2.40E-08 1.711292 
ENSMUSG00000035504 Reep6 3.13E-04 1.70748 
ENSMUSG00000036295 Lrrn3 1.27E-03 1.70554 
ENSMUSG00000105790 Gm24105 3.99E-03 1.70285 
ENSMUSG00000053318 Slamf8 2.80E-02 1.700939 
ENSMUSG00000082571 Gm8737 7.77E-03 1.698276 
ENSMUSG00000034324 Tmem132c 9.33E-22 1.697915 
ENSMUSG00000064288 Hist1h4k 2.67E-02 1.697211 
ENSMUSG00000117037 CT010433.2 1.34E-02 1.69681 
ENSMUSG00000037628 Cdkn3 2.99E-02 1.696525 
ENSMUSG00000037962 Rflna 3.78E-03 1.692265 
ENSMUSG00000061482 Hist1h4d 3.50E-06 1.688716 
ENSMUSG00000050288 Fzd2 3.65E-04 1.688423 
ENSMUSG00000076258 Gm23935 4.28E-05 1.682922 
ENSMUSG00000092674 Gm24105 4.53E-03 1.682736 
ENSMUSG00000034532 Fbxo16 1.50E-02 1.679353 
ENSMUSG00000032502 Stac 5.86E-04 1.678126 
ENSMUSG00000072601 Ear1 1.06E-06 1.671809 
ENSMUSG00000105145 Gm47299 5.17E-03 1.670472 
ENSMUSG00000105788 Gm47295 5.18E-03 1.670415 
ENSMUSG00000035910 Dcdc2a 2.61E-02 1.666406 
ENSMUSG00000097399 Gm26555 2.67E-02 1.664266 
ENSMUSG00000060988 Galnt13 6.00E-07 1.662241 
ENSMUSG00000077323 Rnu11 3.05E-02 1.661727 
ENSMUSG00000039672 Kcne2 2.18E-02 1.658794 
ENSMUSG00000070873 Lilra5 5.27E-04 1.658722 
ENSMUSG00000030093 Wnt7a 1.03E-04 1.65745 
ENSMUSG00000022504 Ciita 2.11E-16 1.65614 
ENSMUSG00000042985 Upk3b 4.24E-09 1.655501 
ENSMUSG00000033053 1700028P14Rik 1.36E-02 1.654074 
ENSMUSG00000058057 Mettl7a3 3.23E-02 1.653564 
ENSMUSG00000049511 Htr1b 3.81E-04 1.649535 
ENSMUSG00000076281 Gm24270 3.95E-04 1.648636 
ENSMUSG00000079505 Gm11131 1.20E-03 1.646768 




ENSMUSG00000027186 Elf5 3.61E-04 1.63763 
ENSMUSG00000106416 Gm5857 3.80E-02 1.636649 
ENSMUSG00000110380 Gm45332 1.47E-02 1.634963 
ENSMUSG00000097453 Gm26894 1.65E-02 1.633469 
ENSMUSG00000020493 Prr11 1.30E-02 1.633102 
ENSMUSG00000061171 Slc38a11 2.46E-02 1.631519 
ENSMUSG00000114566 Gm48500 2.22E-02 1.631147 
ENSMUSG00000080538 Gm25541 4.24E-02 1.631042 
ENSMUSG00000041431 Ccnb1 3.24E-02 1.628007 
ENSMUSG00000025789 St8sia2 7.94E-07 1.627729 
ENSMUSG00000090166 Ear10 5.45E-04 1.627571 
ENSMUSG00000063779 Chil4 4.43E-04 1.627486 
ENSMUSG00000062545 Tlr12 1.63E-02 1.627004 
ENSMUSG00000092702 Gm24514 2.88E-02 1.625445 
ENSMUSG00000030800 Prss8 1.50E-08 1.624743 
ENSMUSG00000060969 Irx1 1.52E-09 1.623286 
ENSMUSG00000027656 Wisp2 1.04E-26 1.618407 
ENSMUSG00000042210 Abhd14a 9.45E-03 1.615522 
ENSMUSG00000022097 Sftpc 1.49E-08 1.614898 
ENSMUSG00000037190 Cyb561d2 3.40E-02 1.614444 
ENSMUSG00000056665 Them6 2.04E-02 1.61301 
ENSMUSG00000085069 Gm13111 5.74E-03 1.611789 
ENSMUSG00000038094 Atp13a4 5.04E-06 1.611226 
ENSMUSG00000112468 Gm47720 4.04E-06 1.61105 
ENSMUSG00000106352 5033403H07Rik 1.21E-06 1.61053 
ENSMUSG00000023147 Wrb 8.63E-06 1.609411 
ENSMUSG00000043719 Col6a6 5.13E-12 1.607024 
ENSMUSG00000097805 Gm17473 1.31E-07 1.60527 
ENSMUSG00000099338 2810030D12Rik 6.11E-03 1.605182 
ENSMUSG00000098178 Gm42418 1.65E-03 1.604909 
ENSMUSG00000024810 Il33 1.71E-18 1.603739 
ENSMUSG00000026870 Cutal 1.49E-02 1.601874 
ENSMUSG00000036114 Rpp25l 1.15E-03 1.599792 
ENSMUSG00000074480 Mex3a 4.38E-02 1.598909 
ENSMUSG00000013089 Etv5 2.42E-22 1.598533 
ENSMUSG00000042766 Trim46 1.71E-03 1.598267 
ENSMUSG00000075020 Mir670hg 2.15E-03 1.596736 
ENSMUSG00000087424 5730405O15Rik 2.37E-02 1.595889 
ENSMUSG00000040841 Six5 3.01E-05 1.595572 
ENSMUSG00000027380 Acoxl 3.11E-06 1.593887 
ENSMUSG00000108218 Olfr1372-ps1 4.02E-05 1.592729 
ENSMUSG00000041380 Htr2c 1.13E-06 1.592272 
ENSMUSG00000019909 Fam162b 4.28E-02 1.591414 
ENSMUSG00000090704 Trp53-ps 2.03E-07 1.591127 
ENSMUSG00000022844 Pdia5 8.24E-13 1.590662 
ENSMUSG00000033595 Lgi3 2.28E-12 1.588201 
ENSMUSG00000065701 Rny1 4.19E-02 1.587797 
ENSMUSG00000037610 Kcnmb2 5.28E-08 1.587617 
ENSMUSG00000043895 S1pr2 1.57E-16 1.586409 
ENSMUSG00000102175 Gm6119 1.44E-02 1.583275 
ENSMUSG00000037846 Rtkn2 8.92E-07 1.58299 
ENSMUSG00000030329 Pianp 1.03E-02 1.58274 
ENSMUSG00000027932 Slc27a3 3.43E-03 1.582304 
ENSMUSG00000030732 Chrdl2 4.82E-02 1.581585 
ENSMUSG00000094786 Gm14403 1.30E-10 1.579975 
ENSMUSG00000107290 Gm43282 3.94E-02 1.578205 




ENSMUSG00000075389 2810410L24Rik 1.42E-04 1.575503 
ENSMUSG00000091780 Sco2 3.28E-03 1.574907 
ENSMUSG00000064945 Rny3 3.69E-02 1.573231 
ENSMUSG00000009114 2610028H24Rik 8.71E-05 1.569539 
ENSMUSG00000074283 Zfp109 6.83E-04 1.567793 
ENSMUSG00000019295 Tmem129 8.45E-07 1.564808 
ENSMUSG00000026941 Mamdc4 2.12E-05 1.563251 
ENSMUSG00000086549 Gm13648 7.89E-03 1.559935 
ENSMUSG00000055134 9130017K11Rik 1.15E-02 1.55658 
ENSMUSG00000033952 Aspm 2.58E-05 1.55636 
ENSMUSG00000003779 Kif20a 3.46E-02 1.556308 
ENSMUSG00000025035 Arl3 2.31E-07 1.556136 
ENSMUSG00000044030 Irf2bp1 2.69E-06 1.55373 
ENSMUSG00000093327 Mir5107 5.85E-09 1.552336 
ENSMUSG00000107349 Gm6655 1.81E-02 1.551154 
ENSMUSG00000106633 Gm43431 4.58E-02 1.551081 
ENSMUSG00000078794 Dact3 8.48E-05 1.549569 
ENSMUSG00000027954 Efna1 1.86E-10 1.54683 
ENSMUSG00000021700 Rab3c 3.56E-05 1.5459 
ENSMUSG00000025902 Sox17 9.62E-12 1.5454 
ENSMUSG00000078772 Gm12353 3.08E-08 1.545118 
ENSMUSG00000070473 Cldn3 4.38E-07 1.5441 
ENSMUSG00000069515 Lyz1 8.64E-14 1.543848 
ENSMUSG00000030796 Tead2 4.76E-10 1.543617 
ENSMUSG00000040809 Chil3 4.58E-05 1.543465 
ENSMUSG00000037101 Ttc29 7.26E-06 1.542686 
ENSMUSG00000040289 Hey1 6.55E-13 1.542366 
ENSMUSG00000022595 Lypd2 2.36E-02 1.542217 
ENSMUSG00000051817 Sox12 2.88E-02 1.54192 
ENSMUSG00000029053 Prkcz 4.18E-12 1.538465 
ENSMUSG00000113212 Gm47435 1.47E-02 1.538088 
ENSMUSG00000049625 Tifab 1.51E-07 1.537426 
ENSMUSG00000032224 Fam81a 6.07E-03 1.535556 
ENSMUSG00000112343 Sfta3-ps 1.96E-21 1.534461 
ENSMUSG00000027849 Syt6 2.09E-04 1.533147 
ENSMUSG00000024206 Rfx2 7.51E-12 1.530804 
ENSMUSG00000006567 Atp7b 5.51E-09 1.529838 
ENSMUSG00000073424 Cyp4f15 1.31E-02 1.529096 
ENSMUSG00000044081 Zfp85os 2.57E-02 1.528554 
ENSMUSG00000058396 Gpr182 1.82E-07 1.527896 
ENSMUSG00000086141 9030622O22Rik 1.39E-08 1.526052 
ENSMUSG00000029651 Mtus2 1.31E-14 1.524294 
ENSMUSG00000040009 Gnaz 1.48E-02 1.522347 
ENSMUSG00000089694 Nat8f7 3.13E-02 1.518666 
ENSMUSG00000034685 Fam171a2 4.78E-03 1.518575 
ENSMUSG00000041261 Car8 9.86E-22 1.517297 
ENSMUSG00000057123 Gja5 2.89E-12 1.517113 
ENSMUSG00000115420 AL732506.1 8.45E-03 1.516697 
ENSMUSG00000088088 Rmrp 8.45E-03 1.516697 
ENSMUSG00000081093 Gm12565 3.28E-02 1.515801 
ENSMUSG00000117046 AC122746.1 3.96E-02 1.515479 
ENSMUSG00000104114 Gm37297 5.73E-04 1.515439 
ENSMUSG00000021496 Pcbd2 8.78E-13 1.515151 
ENSMUSG00000028540 Dph2 7.17E-04 1.514882 
ENSMUSG00000043668 Tox3 3.57E-13 1.513681 
ENSMUSG00000111409 Gm49380 3.92E-07 1.511921 




ENSMUSG00000103738 Gm37652 2.01E-02 1.50916 
ENSMUSG00000044217 Aqp5 2.95E-15 1.509144 
ENSMUSG00000027490 E2f1 4.24E-02 1.508243 
ENSMUSG00000001444 Tbx21 2.37E-04 1.504887 
ENSMUSG00000066319 Rtp3 3.35E-03 1.504256 
ENSMUSG00000025512 Chid1 8.49E-12 1.504081 
ENSMUSG00000009394 Syn2 4.75E-08 1.503605 
ENSMUSG00000115143 Fkbp1a-ps1 3.78E-04 1.502351 
ENSMUSG00000033282 Rpgrip1l 6.03E-09 1.502144 
ENSMUSG00000036192 Rorb 1.76E-04 1.50102 
ENSMUSG00000099553 Gm29538 1.36E-02 1.500991 
ENSMUSG00000072596 Ear2 2.39E-06 1.500831 
ENSMUSG00000090737 Gm6788 2.53E-03 1.500806 
ENSMUSG00000085043 Gm13184 3.64E-02 1.500172 
ENSMUSG00000030428 Ttyh1 1.19E-02 1.502203 
ENSMUSG00000050357 Carmil2 4.60E-05 1.502416 
ENSMUSG00000032089 Il10ra 4.81E-21 1.502903 
ENSMUSG00000030107 Usp18 1.51E-14 1.502976 
ENSMUSG00000001014 Icam4 1.79E-02 1.502992 
ENSMUSG00000030785 Cox6a2 2.61E-07 1.503108 
ENSMUSG00000079434 Neu2 3.87E-02 1.503483 
ENSMUSG00000105677 Gm43328 4.53E-05 1.503833 
ENSMUSG00000101751 Gm2427 5.37E-05 1.503916 
ENSMUSG00000113668 Gm47451 1.42E-03 1.50528 
ENSMUSG00000052374 Actn2 3.36E-22 1.50534 
ENSMUSG00000057897 Camk2b 6.39E-04 1.505487 
ENSMUSG00000105337 1700094M23Rik 2.95E-06 1.505662 
ENSMUSG00000042678 Myo15 2.07E-03 1.506355 
ENSMUSG00000033107 Rnf125 1.82E-24 1.50685 
ENSMUSG00000036390 Gadd45a 1.65E-09 1.507699 
ENSMUSG00000058470 Gm8369 1.45E-07 1.507965 
ENSMUSG00000032369 Plscr1 5.18E-17 1.508682 
ENSMUSG00000105355 Gm40117 4.51E-02 1.508939 
ENSMUSG00000040899 Ccr6 1.50E-05 1.509044 
ENSMUSG00000011305 Plin5 1.11E-03 1.509246 
ENSMUSG00000102343 Gm37381 4.52E-02 1.509423 
ENSMUSG00000078937 Cpt1b 1.25E-07 1.509518 
ENSMUSG00000021250 Fos 1.72E-12 1.509638 
ENSMUSG00000006763 Saal1 3.57E-13 1.509651 
ENSMUSG00000074452 Pate2 1.01E-06 1.509912 
ENSMUSG00000109700 Gm21123 5.59E-03 1.510051 
ENSMUSG00000030433 Sbk2 7.43E-06 1.510461 
ENSMUSG00000053040 Aph1c 2.31E-08 1.510621 
ENSMUSG00000101344 Gm29183 7.91E-11 1.510713 
ENSMUSG00000035208 Slfn8 1.32E-11 1.510878 
ENSMUSG00000024778 Fas 1.01E-25 1.5111 
ENSMUSG00000028862 Map3k6 1.35E-20 1.511475 
ENSMUSG00000034833 Tespa1 1.65E-09 1.512576 
ENSMUSG00000115344 Gm49364 3.50E-09 1.512709 
ENSMUSG00000057092 Fxyd3 1.24E-02 1.513268 
ENSMUSG00000034959 Rubcnl 4.29E-14 1.514234 
ENSMUSG00000034842 Art3 1.48E-18 1.514796 
ENSMUSG00000003134 Tbc1d8 2.32E-15 1.51505 
ENSMUSG00000048004 Tmem196 1.46E-02 1.516581 
ENSMUSG00000012123 Crybg2 6.60E-05 1.516896 
ENSMUSG00000112808 Gm4739 1.85E-05 1.516929 




ENSMUSG00000091412 Gm2895 1.63E-06 1.518936 
ENSMUSG00000026535 Ifi202b 5.15E-11 1.518943 
ENSMUSG00000044244 Il20rb 2.54E-19 1.519567 
ENSMUSG00000056755 Grm7 9.05E-05 1.519614 
ENSMUSG00000085908 Gm14209 7.71E-04 1.519669 
ENSMUSG00000029377 Ereg 1.71E-06 1.520092 
ENSMUSG00000024590 Lmnb1 2.04E-16 1.521965 
ENSMUSG00000071342 Lsmem1 5.96E-06 1.522759 
ENSMUSG00000069808 Fam57a 1.08E-06 1.522864 
ENSMUSG00000109371 Gm44626 2.28E-02 1.523263 
ENSMUSG00000051650 B3gnt2 2.04E-28 1.524523 
ENSMUSG00000033065 Pfkm 5.41E-13 1.52463 
ENSMUSG00000087589 D430040D24Rik 2.69E-06 1.524663 
ENSMUSG00000092201 A530058N18Rik 1.19E-05 1.524752 
ENSMUSG00000030077 Chl1 1.64E-18 1.526046 
ENSMUSG00000038665 Dgki 1.02E-06 1.526881 
ENSMUSG00000032661 Oas3 2.11E-10 1.526922 
ENSMUSG00000104010 Gm37366 8.49E-03 1.527991 
ENSMUSG00000032338 Hcn4 1.08E-07 1.528197 
ENSMUSG00000021125 Arg2 6.25E-15 1.528694 
ENSMUSG00000109279 Gm45220 7.04E-07 1.52872 
ENSMUSG00000025804 Ccr1 1.42E-12 1.528934 
ENSMUSG00000058498 Rnf207 6.72E-03 1.530495 
ENSMUSG00000074625 Arhgap40 2.06E-03 1.530634 
ENSMUSG00000108929 Cc2d2b 1.62E-02 1.532023 
ENSMUSG00000014198 Zfp385c 4.22E-02 1.532252 
ENSMUSG00000035818 Plekhs1 3.36E-03 1.532308 
ENSMUSG00000035580 Kcnh8 6.34E-04 1.532597 
ENSMUSG00000051748 Wfdc21 7.29E-08 1.53281 
ENSMUSG00000038663 Fsd2 8.48E-09 1.533131 
ENSMUSG00000022523 Fgf12 2.76E-14 1.533583 
ENSMUSG00000037904 Ankrd9 6.45E-03 1.535904 
ENSMUSG00000104406 Gm38014 4.26E-03 1.536295 
ENSMUSG00000109764 Klkb1 2.91E-02 1.53632 
ENSMUSG00000026628 Atf3 2.70E-20 1.537981 
ENSMUSG00000029915 Clec5a 1.81E-14 1.538051 
ENSMUSG00000042254 Cilp 4.11E-06 1.538166 
ENSMUSG00000078963 Hsbp1l1 4.27E-02 1.538173 
ENSMUSG00000004360 9330159F19Rik 2.37E-04 1.53843 
ENSMUSG00000073489 Ifi204 9.86E-22 1.540317 
ENSMUSG00000024481 Lvrn 2.04E-11 1.541111 
ENSMUSG00000057246 BC051142 1.99E-03 1.541414 
ENSMUSG00000086564 Cd101 4.69E-12 1.541652 
ENSMUSG00000064340 mt-Tl1 4.10E-08 1.54264 
ENSMUSG00000032125 Robo4 1.62E-20 1.542785 
ENSMUSG00000044405 Adig 4.27E-02 1.543087 
ENSMUSG00000052212 Cd177 4.55E-16 1.543341 
ENSMUSG00000032355 Mlip 2.15E-13 1.543416 
ENSMUSG00000042828 Trim72 5.22E-08 1.543717 
ENSMUSG00000056300 Zfp981 1.45E-05 1.543885 
ENSMUSG00000004864 Mapk13 6.25E-10 1.546096 
ENSMUSG00000063129 Aldoart2 1.66E-05 1.54623 
ENSMUSG00000042010 Acacb 3.59E-23 1.54649 
ENSMUSG00000070354 Evi2 8.63E-14 1.546718 
ENSMUSG00000034990 Otoa 4.05E-03 1.547561 
ENSMUSG00000049093 Il23r 5.93E-07 1.54799 




ENSMUSG00000022026 Olfm4 7.52E-16 1.548559 
ENSMUSG00000026452 Syt2 1.23E-10 1.548817 
ENSMUSG00000061578 Ksr2 1.01E-03 1.54969 
ENSMUSG00000032816 Igdcc4 5.80E-05 1.549734 
ENSMUSG00000104728 Gm42462 1.51E-06 1.55063 
ENSMUSG00000098702 1500015A07Rik 1.10E-03 1.552174 
ENSMUSG00000064147 Rab44 7.19E-18 1.55308 
ENSMUSG00000092397 C130080G10Rik 3.48E-05 1.554863 
ENSMUSG00000003849 Nqo1 1.35E-03 1.555535 
ENSMUSG00000057054 Inca1 3.20E-03 1.557038 
ENSMUSG00000009292 Trpm2 8.56E-13 1.558139 
ENSMUSG00000001943 Vsig2 1.50E-12 1.560479 
ENSMUSG00000025701 Alox5 2.14E-20 1.561191 
ENSMUSG00000105053 Gm43064 2.35E-10 1.564013 
ENSMUSG00000068794 Col28a1 4.53E-05 1.564183 
ENSMUSG00000021950 Anxa8 2.41E-06 1.565581 
ENSMUSG00000113918 Gm6566 7.52E-03 1.565835 
ENSMUSG00000055027 Smyd1 9.41E-12 1.566011 
ENSMUSG00000047746 Fbxo40 6.40E-08 1.566184 
ENSMUSG00000016349 Eef1a2 2.02E-12 1.566216 
ENSMUSG00000034308 Sdr42e1 1.45E-03 1.566555 
ENSMUSG00000029204 Rhoh 1.15E-21 1.56695 
ENSMUSG00000021061 Sptb 7.50E-20 1.567256 
ENSMUSG00000020698 Cct6b 1.31E-02 1.567908 
ENSMUSG00000045102 Poln 7.37E-20 1.567926 
ENSMUSG00000020077 Srgn 3.93E-19 1.568811 
ENSMUSG00000090582 Gm17024 1.32E-06 1.570766 
ENSMUSG00000017830 Dhx58 5.45E-13 1.571673 
ENSMUSG00000044716 Dok7 1.96E-05 1.57206 
ENSMUSG00000070604 Vsig10l 5.39E-07 1.572936 
ENSMUSG00000053338 Tarm1 1.01E-19 1.573966 
ENSMUSG00000005800 Mmp8 2.88E-22 1.574036 
ENSMUSG00000113778 Gm40847 2.80E-02 1.574565 
ENSMUSG00000037572 Wdhd1 2.94E-07 1.574592 
ENSMUSG00000032561 Acpp 2.04E-16 1.575351 
ENSMUSG00000053914 Kdm4d 6.99E-07 1.57607 
ENSMUSG00000002769 Gnmt 4.11E-02 1.576947 
ENSMUSG00000021579 Lrrc14b 1.53E-02 1.577637 
ENSMUSG00000031452 1700029H14Rik 4.92E-11 1.578495 
ENSMUSG00000112707 D830005E20Rik 1.67E-07 1.578937 
ENSMUSG00000024517 Grp 1.13E-02 1.579229 
ENSMUSG00000030577 Cd22 1.23E-05 1.580173 
ENSMUSG00000051351 Zfp46 5.74E-27 1.580489 
ENSMUSG00000000204 Slfn4 1.72E-07 1.580569 
ENSMUSG00000062007 Hsh2d 6.70E-05 1.580819 
ENSMUSG00000070000 Fcho1 1.23E-04 1.580984 
ENSMUSG00000105572 Gm43300 8.23E-05 1.581967 
ENSMUSG00000027360 Hdc 5.77E-25 1.582111 
ENSMUSG00000024803 Ankrd1 1.68E-14 1.582117 
ENSMUSG00000031872 Bean1 2.56E-09 1.582908 
ENSMUSG00000108313 Gm45052 3.46E-02 1.583486 
ENSMUSG00000024210 Ip6k3 2.10E-09 1.583691 
ENSMUSG00000037849 Ifi206 8.40E-04 1.584723 
ENSMUSG00000050663 Trhde 4.90E-02 1.585677 
ENSMUSG00000039891 Txlnb 2.06E-14 1.58583 
ENSMUSG00000024593 Megf10 6.07E-05 1.585923 




ENSMUSG00000053024 Cntn2 3.57E-02 1.587941 
ENSMUSG00000071561 BC100530 2.30E-07 1.588282 
ENSMUSG00000114138 Gm36423 1.66E-02 1.589727 
ENSMUSG00000043789 Vwce 3.78E-03 1.5899 
ENSMUSG00000042851 Zc3h6 1.02E-14 1.590111 
ENSMUSG00000116604 AC087898.2 3.16E-02 1.590457 
ENSMUSG00000010476 Ebf3 5.07E-07 1.590556 
ENSMUSG00000004609 Cd33 3.48E-28 1.592001 
ENSMUSG00000098875 Gm27211 1.13E-06 1.592609 
ENSMUSG00000029205 Chrna9 2.74E-02 1.592947 
ENSMUSG00000050840 Cdh20 1.45E-02 1.593388 
ENSMUSG00000006457 Actn3 7.83E-07 1.59497 
ENSMUSG00000104348 Gm37691 1.06E-04 1.595263 
ENSMUSG00000024076 Vit 1.11E-03 1.595268 
ENSMUSG00000024972 Lgals12 4.52E-03 1.595515 
ENSMUSG00000040055 Gjb6 2.71E-03 1.595537 
ENSMUSG00000049336 Tenm2 1.62E-10 1.596005 
ENSMUSG00000104213 Ighd 3.47E-05 1.596239 
ENSMUSG00000022383 Ppara 2.03E-15 1.597777 
ENSMUSG00000054169 Ceacam10 2.78E-06 1.598518 
ENSMUSG00000109232 Gm44577 1.35E-02 1.598735 
ENSMUSG00000035692 Isg15 6.47E-15 1.601526 
ENSMUSG00000032523 Hhatl 3.08E-03 1.601819 
ENSMUSG00000040747 Cd53 9.31E-18 1.602191 
ENSMUSG00000053469 Tg 4.33E-17 1.602498 
ENSMUSG00000059974 Ntm 1.81E-26 1.602733 
ENSMUSG00000018425 Dhx40 3.14E-21 1.604037 
ENSMUSG00000075122 Cd80 1.39E-21 1.605419 
ENSMUSG00000002831 Plin4 3.11E-26 1.606197 
ENSMUSG00000095079 Igha 1.40E-05 1.607185 
ENSMUSG00000078902 Gm14443 1.56E-02 1.607245 
ENSMUSG00000115855 Gm34643 1.33E-02 1.60811 
ENSMUSG00000073492 Gm10521 1.01E-02 1.608342 
ENSMUSG00000058818 Pirb 1.25E-16 1.608386 
ENSMUSG00000071562 Stfa1 1.20E-02 1.608568 
ENSMUSG00000058755 Osm 9.87E-06 1.608663 
ENSMUSG00000025479 Cyp2e1 1.75E-15 1.608811 
ENSMUSG00000116975 AC097366.1 4.70E-02 1.609642 
ENSMUSG00000061126 Cyp4f39 1.24E-02 1.611491 
ENSMUSG00000086756 Gm14051 4.26E-03 1.612421 
ENSMUSG00000054383 Pnma1 1.58E-02 1.612439 
ENSMUSG00000084788 Gm11342 1.75E-08 1.6151 
ENSMUSG00000102776 Gm38162 1.33E-04 1.615539 
ENSMUSG00000104453 Gm37829 3.14E-03 1.616164 
ENSMUSG00000049709 Nlrp10 1.69E-03 1.616218 
ENSMUSG00000047798 Cd300lf 2.12E-26 1.616545 
ENSMUSG00000093938 Evi2b 9.87E-15 1.61906 
ENSMUSG00000031303 Map3k15 8.44E-11 1.619429 
ENSMUSG00000110195 Pde2a 3.98E-16 1.622023 
ENSMUSG00000109819 B930018H19Rik 2.50E-04 1.622025 
ENSMUSG00000028860 Sytl1 2.85E-04 1.623336 
ENSMUSG00000034570 Inpp5j 2.35E-03 1.623616 
ENSMUSG00000026220 Slc16a14 3.53E-02 1.625516 
ENSMUSG00000116290 Gm49518 1.89E-02 1.626577 
ENSMUSG00000096957 E230013L22Rik 7.49E-09 1.626815 
ENSMUSG00000003153 Slc2a3 1.50E-16 1.627617 




ENSMUSG00000067577 A430093F15Rik 6.34E-09 1.628234 
ENSMUSG00000079597 Gm5483 5.40E-13 1.628886 
ENSMUSG00000018507 Trpv2 5.02E-19 1.629285 
ENSMUSG00000032023 Jhy 7.50E-07 1.630081 
ENSMUSG00000042567 Nek10 7.69E-11 1.630143 
ENSMUSG00000022876 Samsn1 1.31E-21 1.6304 
ENSMUSG00000113998 Gm40909 5.76E-07 1.630854 
ENSMUSG00000022454 Nell2 1.66E-02 1.631056 
ENSMUSG00000107480 Gm44165 2.95E-03 1.631572 
ENSMUSG00000115355 4930445E18Rik 5.26E-04 1.631708 
ENSMUSG00000040287 Stac3 6.79E-06 1.632241 
ENSMUSG00000116747 AC144408.2 2.16E-02 1.633409 
ENSMUSG00000056071 S100a9 5.19E-11 1.634188 
ENSMUSG00000066800 Rnasel 7.15E-19 1.63539 
ENSMUSG00000000386 Mx1 3.52E-19 1.638433 
ENSMUSG00000030669 Calca 6.86E-06 1.640644 
ENSMUSG00000099364 5730419F03Rik 2.51E-02 1.642235 
ENSMUSG00000041754 Trem3 2.37E-12 1.64293 
ENSMUSG00000048416 Mlf1 3.35E-12 1.64339 
ENSMUSG00000056054 S100a8 5.09E-08 1.644216 
ENSMUSG00000011148 Adssl1 5.36E-13 1.645005 
ENSMUSG00000052726 Kcnt2 2.51E-19 1.645058 
ENSMUSG00000029228 Lnx1 2.29E-25 1.645255 
ENSMUSG00000116031 D030024E09Rik 2.72E-05 1.645676 
ENSMUSG00000099092 Mir7062 3.90E-02 1.646838 
ENSMUSG00000109096 Gm44888 1.16E-02 1.647995 
ENSMUSG00000038132 Rbm24 2.05E-13 1.648088 
ENSMUSG00000000673 Haao 2.61E-03 1.648454 
ENSMUSG00000026073 Il1r2 8.70E-09 1.64854 
ENSMUSG00000037731 Themis2 6.62E-24 1.649889 
ENSMUSG00000091438 Gm17088 1.47E-02 1.650306 
ENSMUSG00000064346 mt-Tw 8.31E-04 1.65172 
ENSMUSG00000034855 Cxcl10 1.23E-06 1.652425 
ENSMUSG00000031312 Itgb1bp2 3.28E-08 1.652551 
ENSMUSG00000059657 Stfa2l1 1.02E-14 1.652763 
ENSMUSG00000024379 Tslp 1.96E-07 1.652917 
ENSMUSG00000032648 Pygm 1.27E-25 1.653929 
ENSMUSG00000064360 mt-Nd3 6.22E-34 1.653955 
ENSMUSG00000005686 Ampd3 5.07E-44 1.654326 
ENSMUSG00000036067 Slc2a6 2.22E-21 1.655183 
ENSMUSG00000110125 Gm33148 4.23E-02 1.655315 
ENSMUSG00000021071 Trim9 4.06E-04 1.655679 
ENSMUSG00000012819 Cdh23 5.33E-08 1.655851 
ENSMUSG00000029602 Rasal1 1.09E-02 1.6569 
ENSMUSG00000038204 Asb10 3.79E-02 1.657364 
ENSMUSG00000034755 Pcdh11x 2.75E-05 1.65877 
ENSMUSG00000038067 Csf3 2.30E-17 1.659219 
ENSMUSG00000029059 Fam213b 2.03E-02 1.659422 
ENSMUSG00000032033 Barx2 2.86E-06 1.659698 
ENSMUSG00000034686 Prr7 4.58E-13 1.660366 
ENSMUSG00000101939 Gm28438 1.42E-34 1.661494 
ENSMUSG00000100510 AV026068 6.71E-04 1.66215 
ENSMUSG00000046610 Oacyl 7.18E-05 1.662776 
ENSMUSG00000028834 Trim63 7.79E-07 1.663212 
ENSMUSG00000003863 Ppfia3 3.09E-02 1.664438 
ENSMUSG00000031626 Sorbs2 1.22E-22 1.665918 




ENSMUSG00000087579 Hectd2os 4.33E-09 1.666956 
ENSMUSG00000022821 Hgd 9.49E-04 1.667405 
ENSMUSG00000020067 Mypn 2.91E-16 1.668111 
ENSMUSG00000074071 Fam169b 1.03E-40 1.669004 
ENSMUSG00000093806 Asmt 3.89E-02 1.669364 
ENSMUSG00000031258 Xkrx 2.29E-02 1.669615 
ENSMUSG00000040435 Ppp1r15a 1.10E-25 1.669806 
ENSMUSG00000097643 A130051J06Rik 3.09E-02 1.669883 
ENSMUSG00000079644 Gm1110 2.01E-02 1.67036 
ENSMUSG00000042717 Ppp1r3a 8.51E-16 1.670789 
ENSMUSG00000075042 4930431P03Rik 6.43E-03 1.670913 
ENSMUSG00000054717 Hmgb2 8.73E-07 1.670984 
ENSMUSG00000082179 Gm11407 1.60E-02 1.671338 
ENSMUSG00000056133 Unc93a2 1.34E-02 1.672597 
ENSMUSG00000101640 Gm28376 2.21E-02 1.673873 
ENSMUSG00000030156 Cd69 2.53E-09 1.674983 
ENSMUSG00000113185 Gm47127 3.62E-10 1.675362 
ENSMUSG00000038239 Hrc 1.25E-12 1.67644 
ENSMUSG00000078486 Perm1 3.53E-12 1.677159 
ENSMUSG00000059741 Myl3 2.68E-08 1.677439 
ENSMUSG00000027843 Ptpn22 1.42E-17 1.677529 
ENSMUSG00000098670 Gm27818 6.52E-03 1.678782 
ENSMUSG00000003476 Crhr2 1.34E-06 1.679035 
ENSMUSG00000091712 Sec14l5 1.80E-04 1.679152 
ENSMUSG00000103308 Gm37800 3.21E-05 1.680186 
ENSMUSG00000026358 Rgs1 3.15E-07 1.680205 
ENSMUSG00000109864 Eid3 9.84E-08 1.682789 
ENSMUSG00000073771 Btbd19 4.74E-06 1.683039 
ENSMUSG00000090439 Gm17455 2.54E-02 1.683429 
ENSMUSG00000035653 Lrfn5 2.04E-02 1.684683 
ENSMUSG00000086335 Gm12107 4.07E-02 1.684829 
ENSMUSG00000111809 Gm49334 1.68E-02 1.687123 
ENSMUSG00000006724 Cyp27b1 2.49E-02 1.688563 
ENSMUSG00000097028 Ptgs2os 4.00E-03 1.688812 
ENSMUSG00000027966 Col11a1 6.48E-06 1.689108 
ENSMUSG00000042251 Pm20d1 9.34E-04 1.689267 
ENSMUSG00000104554 Gm4610 2.85E-03 1.689388 
ENSMUSG00000028544 Slc5a9 3.63E-03 1.690419 
ENSMUSG00000027861 Casq2 1.46E-13 1.690798 
ENSMUSG00000087684 1200007C13Rik 9.26E-19 1.692709 
ENSMUSG00000046223 Plaur 3.12E-25 1.69343 
ENSMUSG00000086727 4931428L18Rik 4.68E-02 1.694028 
ENSMUSG00000018470 Kcnab3 4.44E-02 1.695106 
ENSMUSG00000020722 Cacng1 3.42E-03 1.695444 
ENSMUSG00000050966 Lin28a 3.70E-02 1.696226 
ENSMUSG00000031245 Hmgn5 1.10E-06 1.696266 
ENSMUSG00000084760 Gm15472 4.94E-02 1.699259 
ENSMUSG00000029379 Cxcl3 3.14E-19 1.699755 
ENSMUSG00000106741 4930513D17Rik 2.78E-04 1.700156 
ENSMUSG00000033676 Gabrb3 9.53E-03 1.700516 
ENSMUSG00000111827 Gm8131 2.03E-02 1.701357 
ENSMUSG00000026989 Dapl1 1.87E-02 1.702816 
ENSMUSG00000021298 Gpr132 1.17E-13 1.705667 
ENSMUSG00000005373 Mlxipl 2.58E-12 1.705754 
ENSMUSG00000022651 Retnlg 1.15E-21 1.705788 
ENSMUSG00000036557 Stpg4 7.22E-03 1.706336 




ENSMUSG00000092134 Gm17089 2.08E-03 1.708295 
ENSMUSG00000115610 Gm31251 8.64E-13 1.708416 
ENSMUSG00000027824 Vmn2r1 3.39E-02 1.71058 
ENSMUSG00000057580 Gm10012 5.95E-03 1.711245 
ENSMUSG00000090785 Gm17116 3.94E-02 1.712965 
ENSMUSG00000109005 Gm45221 9.18E-13 1.713519 
ENSMUSG00000097652 Mhrt 5.45E-09 1.713729 
ENSMUSG00000039376 Synpo2l 2.08E-14 1.714714 
ENSMUSG00000030935 Acsm3 4.85E-02 1.714851 
ENSMUSG00000085792 Gm15414 4.12E-02 1.715017 
ENSMUSG00000032845 Alpk2 8.22E-25 1.71506 
ENSMUSG00000024215 Spdef 3.57E-05 1.715667 
ENSMUSG00000040490 Lrfn2 6.64E-03 1.717782 
ENSMUSG00000067049 Unc93a 3.95E-04 1.719453 
ENSMUSG00000020836 Coro6 4.06E-14 1.719576 
ENSMUSG00000025236 Adpgk 9.28E-08 1.720655 
ENSMUSG00000069670 Nkain2 2.61E-27 1.720935 
ENSMUSG00000054204 Alkal2 9.31E-03 1.721026 
ENSMUSG00000050439 Enthd1 1.61E-03 1.722314 
ENSMUSG00000058966 Fam57b 1.21E-04 1.722847 
ENSMUSG00000039521 Foxp3 3.73E-04 1.722974 
ENSMUSG00000042451 Mybph 4.32E-14 1.725736 
ENSMUSG00000025746 Il6 5.63E-08 1.726006 
ENSMUSG00000087382 Ctcflos 3.89E-03 1.729287 
ENSMUSG00000024521 Pmaip1 5.17E-21 1.731247 
ENSMUSG00000113321 Gm8075 1.52E-03 1.732541 
ENSMUSG00000028125 Abca4 1.40E-15 1.733301 
ENSMUSG00000109510 Gm42417 2.03E-18 1.733587 
ENSMUSG00000056643 Chst13 3.89E-02 1.737568 
ENSMUSG00000109002 Gm38405 3.68E-03 1.738016 
ENSMUSG00000066366 Serpina1a 4.81E-04 1.739086 
ENSMUSG00000030144 Clec4d 1.24E-21 1.739304 
ENSMUSG00000074899 Sptbn5 8.93E-15 1.741636 
ENSMUSG00000019933 Mrln 6.47E-04 1.74233 
ENSMUSG00000117297 CT571247.2 2.12E-03 1.742747 
ENSMUSG00000029838 Ptn 3.58E-04 1.745315 
ENSMUSG00000110626 Gm45805 3.93E-03 1.746875 
ENSMUSG00000114638 Gm31834 1.32E-02 1.748994 
ENSMUSG00000004902 Slc25a18 9.40E-11 1.748994 
ENSMUSG00000021886 Gpr65 1.38E-16 1.751875 
ENSMUSG00000111334 AC162938.1 2.19E-03 1.751922 
ENSMUSG00000090141 Gm614 1.79E-07 1.752594 
ENSMUSG00000028116 Myoz2 1.41E-18 1.753998 
ENSMUSG00000024912 Fosl1 4.81E-11 1.757523 
ENSMUSG00000047281 Sfn 1.96E-12 1.758427 
ENSMUSG00000048489 Depp1 5.70E-10 1.75859 
ENSMUSG00000052769 Gm9889 3.49E-03 1.758749 
ENSMUSG00000038242 Aox4 3.63E-04 1.759686 
ENSMUSG00000047940 Stpg2 1.76E-04 1.761496 
ENSMUSG00000067242 Lgi1 2.15E-03 1.76182 
ENSMUSG00000079015 Serpina1c 9.81E-05 1.762405 
ENSMUSG00000028573 Fggy 9.93E-05 1.763622 
ENSMUSG00000106547 B230303O12Rik 1.91E-10 1.763742 
ENSMUSG00000110010 Gm45629 1.72E-03 1.764186 
ENSMUSG00000106478 Gm36551 2.69E-03 1.766268 
ENSMUSG00000034919 Ttc22 1.21E-03 1.767889 




ENSMUSG00000026564 Dusp27 4.71E-11 1.770954 
ENSMUSG00000079429 Mroh2a 4.95E-02 1.771987 
ENSMUSG00000030510 Cers3 8.43E-08 1.773692 
ENSMUSG00000094334 Fabp5l2 1.94E-02 1.773759 
ENSMUSG00000030235 Slco1c1 6.91E-16 1.775853 
ENSMUSG00000037989 Wnk2 2.70E-20 1.777419 
ENSMUSG00000027674 Pex5l 4.64E-10 1.777644 
ENSMUSG00000004668 Abca13 5.69E-29 1.778516 
ENSMUSG00000062713 Sim2 1.19E-09 1.779309 
ENSMUSG00000116961 AC117662.4 3.90E-05 1.7808 
ENSMUSG00000026669 Mcm10 2.70E-08 1.780809 
ENSMUSG00000049598 Vsig8 3.66E-02 1.781692 
ENSMUSG00000051747 Ttn 1.20E-50 1.787185 
ENSMUSG00000085417 Gm13919 2.58E-03 1.789173 
ENSMUSG00000033544 Angptl1 2.01E-03 1.789715 
ENSMUSG00000020000 Moxd1 3.38E-03 1.789741 
ENSMUSG00000001249 Hpn 8.32E-15 1.79272 
ENSMUSG00000034648 Lrrn1 4.21E-04 1.792909 
ENSMUSG00000090173 Fbxw10 4.07E-06 1.793362 
ENSMUSG00000110580 D830024N08Rik 3.86E-07 1.79383 
ENSMUSG00000027559 Car3 1.14E-58 1.794165 
ENSMUSG00000049173 Myoz3 3.68E-04 1.794511 
ENSMUSG00000097579 Gm26799 1.22E-05 1.798591 
ENSMUSG00000108322 5430431A17Rik 9.26E-04 1.79877 
ENSMUSG00000041954 Tnfrsf18 1.91E-04 1.798838 
ENSMUSG00000086236 5830418P13Rik 3.97E-02 1.799096 
ENSMUSG00000107667 C530044C16Rik 2.55E-03 1.799886 
ENSMUSG00000032484 Ngp 7.22E-33 1.802514 
ENSMUSG00000097543 Gm805 3.14E-03 1.804272 
ENSMUSG00000042045 Sln 1.59E-14 1.805054 
ENSMUSG00000031382 Asb11 5.07E-07 1.807798 
ENSMUSG00000039653 Baat 1.72E-02 1.807968 
ENSMUSG00000109921 Gm33326 4.27E-02 1.808594 
ENSMUSG00000046818 Ddit4l 1.37E-03 1.809116 
ENSMUSG00000044083 Efcab8 1.54E-22 1.80916 
ENSMUSG00000101639 Gm8597 2.68E-02 1.810383 
ENSMUSG00000000223 Drp2 8.23E-07 1.810905 
ENSMUSG00000085584 Rtl9 4.99E-02 1.814506 
ENSMUSG00000006345 Ggt1 2.21E-08 1.817124 
ENSMUSG00000086448 9330162012Rik 3.73E-02 1.817998 
ENSMUSG00000067889 Sptbn2 4.24E-09 1.818248 
ENSMUSG00000038763 Alpk3 1.96E-32 1.81872 
ENSMUSG00000085194 Platr32 2.24E-03 1.819714 
ENSMUSG00000030470 Csrp3 2.08E-18 1.819847 
ENSMUSG00000043008 Klhl6 2.15E-21 1.820648 
ENSMUSG00000019987 Arg1 2.20E-03 1.822152 
ENSMUSG00000039264 Gimap3 3.51E-14 1.824217 
ENSMUSG00000060470 Adgrg3 1.14E-17 1.824816 
ENSMUSG00000025488 Cox8b 1.08E-07 1.825697 
ENSMUSG00000097071 4930544I03Rik 5.59E-06 1.830008 
ENSMUSG00000028680 Plk3 8.61E-23 1.830772 
ENSMUSG00000020007 Il20ra 1.06E-02 1.831433 
ENSMUSG00000074340 Ovgp1 2.09E-12 1.832669 
ENSMUSG00000112148 Lilrb4a 1.06E-12 1.832695 
ENSMUSG00000034145 Tmem63c 7.44E-03 1.833488 
ENSMUSG00000031837 Necab2 4.40E-02 1.833535 




ENSMUSG00000021255 Esrrb 6.95E-05 1.835067 
ENSMUSG00000092008 Cyp2c69 1.42E-02 1.83538 
ENSMUSG00000103485 Gm38001 2.57E-02 1.836426 
ENSMUSG00000029660 Tex26 9.36E-09 1.837627 
ENSMUSG00000086405 9330198N18Rik 1.69E-08 1.837669 
ENSMUSG00000037509 Arhgef4 1.46E-11 1.84023 
ENSMUSG00000041737 Tmem45b 8.44E-08 1.840717 
ENSMUSG00000027359 Slc27a2 5.04E-03 1.841241 
ENSMUSG00000047419 Cmya5 5.22E-34 1.843129 
ENSMUSG00000033182 Kbtbd12 1.30E-10 1.843376 
ENSMUSG00000044938 Klhl31 4.21E-15 1.843504 
ENSMUSG00000109675 Nxpe1-ps 2.49E-02 1.843549 
ENSMUSG00000000049 Apoh 9.36E-03 1.843946 
ENSMUSG00000105107 Gm43412 3.93E-05 1.845797 
ENSMUSG00000023341 Mx2 2.68E-43 1.846495 
ENSMUSG00000053641 Dennd4a 7.82E-42 1.846884 
ENSMUSG00000029158 Yipf7 5.09E-04 1.849072 
ENSMUSG00000032278 Paqr5 1.41E-08 1.850269 
ENSMUSG00000031098 Syt8 9.62E-03 1.851676 
ENSMUSG00000090118 Gm16163 8.91E-07 1.853032 
ENSMUSG00000024526 Cidea 2.58E-04 1.853747 
ENSMUSG00000115919 Gm31583 2.47E-02 1.853826 
ENSMUSG00000114372 2310067P03Rik 2.35E-03 1.854639 
ENSMUSG00000081700 Atp5k-ps2 8.27E-05 1.855005 
ENSMUSG00000066491 Cox6c2 5.55E-11 1.856124 
ENSMUSG00000031461 Myom2 1.24E-37 1.857642 
ENSMUSG00000104956 4930429D17Rik 1.29E-02 1.859359 
ENSMUSG00000041616 Nppa 8.40E-06 1.859817 
ENSMUSG00000030834 Abcc6 1.85E-02 1.86125 
ENSMUSG00000044367 Slc16a13 1.02E-23 1.863682 
ENSMUSG00000026100 Mstn 1.03E-02 1.863901 
ENSMUSG00000058975 Kcnc1 1.48E-05 1.864086 
ENSMUSG00000044086 Lmod3 5.83E-05 1.864089 
ENSMUSG00000032262 Elovl4 1.84E-06 1.865299 
ENSMUSG00000022824 Muc13 2.46E-06 1.871007 
ENSMUSG00000105986 Gm43065 1.82E-03 1.871109 
ENSMUSG00000091119 Ccdc152 3.30E-05 1.87189 
ENSMUSG00000109198 D7Bwg0826e 6.88E-03 1.872806 
ENSMUSG00000087187 Gm13431 2.85E-04 1.873198 
ENSMUSG00000106245 Gm43824 2.54E-03 1.874635 
ENSMUSG00000110411 Gm45457 2.24E-03 1.87632 
ENSMUSG00000025069 Gsto2 7.14E-04 1.878743 
ENSMUSG00000090066 1110002E22Rik 4.80E-18 1.881563 
ENSMUSG00000110498 A630001O12Rik 2.05E-05 1.881948 
ENSMUSG00000032174 Icam5 1.60E-03 1.884311 
ENSMUSG00000040350 Trim7 3.16E-10 1.886702 
ENSMUSG00000063001 Gm9701 2.00E-02 1.886992 
ENSMUSG00000028017 Egf 2.98E-15 1.887283 
ENSMUSG00000070498 Tmem132b 7.38E-17 1.887425 
ENSMUSG00000028427 Aqp7 6.69E-03 1.888129 
ENSMUSG00000038508 Gdf15 6.53E-03 1.888853 
ENSMUSG00000027513 Pck1 9.43E-13 1.890906 
ENSMUSG00000059900 Tmem40 4.20E-04 1.893524 
ENSMUSG00000115518 Gm10791 1.65E-05 1.895648 
ENSMUSG00000090293 Gm17034 2.96E-02 1.897849 
ENSMUSG00000025004 Cyp2c40 1.94E-02 1.898265 




ENSMUSG00000031958 Ldhd 4.49E-07 1.899952 
ENSMUSG00000022582 Ly6g 4.01E-07 1.902278 
ENSMUSG00000062077 Trim54 1.10E-15 1.902342 
ENSMUSG00000024617 Camk2a 4.89E-09 1.903979 
ENSMUSG00000007122 Casq1 2.89E-15 1.904008 
ENSMUSG00000069733 Ube2u 1.19E-03 1.904037 
ENSMUSG00000024430 Cabyr 1.01E-03 1.904429 
ENSMUSG00000056569 Mpz 1.14E-16 1.905577 
ENSMUSG00000032942 Ucp3 9.12E-10 1.909391 
ENSMUSG00000044165 Bcl2l15 4.24E-09 1.911503 
ENSMUSG00000079588 Tmem182 5.78E-17 1.91235 
ENSMUSG00000007877 Tcap 1.05E-20 1.912751 
ENSMUSG00000025473 Adam8 9.12E-15 1.913184 
ENSMUSG00000031376 Atp2b3 1.10E-04 1.915267 
ENSMUSG00000099760 Gm28800 1.04E-02 1.918089 
ENSMUSG00000085249 Gm12847 6.44E-04 1.921004 
ENSMUSG00000105826 Gm42141 5.75E-03 1.921732 
ENSMUSG00000112082 Gm35035 1.26E-03 1.922335 
ENSMUSG00000033213 AA467197 2.17E-05 1.926523 
ENSMUSG00000046764 A530053G22Rik 5.14E-03 1.927384 
ENSMUSG00000074623 Gm826 1.94E-03 1.931273 
ENSMUSG00000030399 Ckm 2.68E-12 1.931828 
ENSMUSG00000101930 Gm5441 1.33E-10 1.932682 
ENSMUSG00000027456 Sdcbp2 5.13E-14 1.933121 
ENSMUSG00000086765 Gm11827 2.95E-06 1.933308 
ENSMUSG00000027505 Fam209 8.82E-04 1.935233 
ENSMUSG00000054905 Stfa3 8.40E-04 1.935879 
ENSMUSG00000062515 Fabp4 8.09E-25 1.936282 
ENSMUSG00000024223 Armc12 3.96E-02 1.94095 
ENSMUSG00000026068 Il18rap 6.22E-34 1.941935 
ENSMUSG00000026489 Coq8a 2.76E-39 1.94642 
ENSMUSG00000105542 Gm34248 2.05E-02 1.947483 
ENSMUSG00000022468 Endou 3.09E-13 1.95126 
ENSMUSG00000062372 Otof 4.14E-03 1.953074 
ENSMUSG00000060962 Dmkn 4.46E-16 1.954338 
ENSMUSG00000075307 Klhl41 3.80E-19 1.954528 
ENSMUSG00000013936 Myl2 8.34E-04 1.957148 
ENSMUSG00000074218 Cox7a1 4.66E-09 1.957494 
ENSMUSG00000103965 Gm30173 8.23E-05 1.957865 
ENSMUSG00000015879 Fam184b 9.58E-04 1.958074 
ENSMUSG00000030236 Slco1b2 6.11E-03 1.958235 
ENSMUSG00000116641 AC165271.1 3.93E-02 1.960352 
ENSMUSG00000029683 Lmod2 2.29E-19 1.962142 
ENSMUSG00000058427 Cxcl2 7.52E-16 1.965001 
ENSMUSG00000097468 Mdrl 1.18E-02 1.9652 
ENSMUSG00000085739 Gm15862 4.50E-02 1.966473 
ENSMUSG00000099906 Gm28653 1.68E-02 1.966573 
ENSMUSG00000097622 A330033J07Rik 9.21E-03 1.967677 
ENSMUSG00000025929 Il17a 6.98E-03 1.968258 
ENSMUSG00000101969 Gm20125 7.68E-08 1.970172 
ENSMUSG00000109881 Gm45507 3.61E-02 1.972472 
ENSMUSG00000025892 Gria4 1.74E-04 1.973108 
ENSMUSG00000028786 Tmem54 2.69E-02 1.973491 
ENSMUSG00000037188 Grhl3 3.13E-06 1.976128 
ENSMUSG00000028736 Pax7 2.68E-02 1.978015 
ENSMUSG00000117029 CT030155.1 3.35E-03 1.980083 




ENSMUSG00000001027 Scn4a 1.63E-15 1.982106 
ENSMUSG00000020848 Doc2b 7.17E-17 1.983107 
ENSMUSG00000071540 3425401B19Rik 1.11E-21 1.983567 
ENSMUSG00000059108 Ifitm6 1.39E-27 1.986147 
ENSMUSG00000026166 Ccl20 1.87E-24 1.988087 
ENSMUSG00000032021 Crtam 1.62E-20 1.988346 
ENSMUSG00000048939 Atp13a5 8.98E-03 1.988773 
ENSMUSG00000027961 Lrrc39 1.97E-07 1.989628 
ENSMUSG00000050211 Pla2g4e 2.57E-15 1.990622 
ENSMUSG00000050612 Txndc2 9.64E-03 1.991405 
ENSMUSG00000097476 Gm26583 2.67E-02 1.992121 
ENSMUSG00000018893 Mb 2.96E-16 1.995476 
ENSMUSG00000001497 Pax9 5.45E-07 1.99584 
ENSMUSG00000022871 Fetub 5.14E-07 1.996529 
ENSMUSG00000040536 Necab1 6.95E-04 1.9986 
ENSMUSG00000109831 Gm36431 7.50E-03 1.99936 
ENSMUSG00000102762 4930403P22Rik 2.46E-02 2.001551 
ENSMUSG00000041782 Lad1 3.08E-13 2.002946 
ENSMUSG00000043873 Chil5 7.40E-06 2.00396 
ENSMUSG00000085806 Gm12023 2.03E-05 2.005786 
ENSMUSG00000035686 Thrsp 3.08E-18 2.008526 
ENSMUSG00000067653 Ankrd23 7.18E-23 2.012683 
ENSMUSG00000021622 Ckmt2 2.18E-22 2.016924 
ENSMUSG00000046480 Scn4b 3.61E-12 2.018601 
ENSMUSG00000114656 2810403G07Rik 2.60E-02 2.018932 
ENSMUSG00000022525 Hrasls 1.48E-02 2.019224 
ENSMUSG00000070644 Etnk2 8.41E-03 2.020491 
ENSMUSG00000042306 S100a14 4.36E-12 2.021351 
ENSMUSG00000098132 Rassf10 1.04E-02 2.021448 
ENSMUSG00000062593 Gm49339 1.64E-14 2.024042 
ENSMUSG00000111299 4930540M03Rik 1.34E-02 2.024137 
ENSMUSG00000021340 Gpld1 6.91E-16 2.028941 
ENSMUSG00000046352 Gjb2 1.21E-11 2.030651 
ENSMUSG00000103620 Gm37359 4.58E-06 2.031625 
ENSMUSG00000085743 8430419K02Rik 1.91E-27 2.032356 
ENSMUSG00000089854 Gm16133 2.61E-06 2.035203 
ENSMUSG00000006204 5430419D17Rik 3.20E-02 2.035247 
ENSMUSG00000021509 Slc25a48 4.04E-03 2.035611 
ENSMUSG00000061462 Obscn 5.68E-58 2.038968 
ENSMUSG00000059994 Fcrl1 1.30E-09 2.039878 
ENSMUSG00000076275 Mir675 1.77E-07 2.041447 
ENSMUSG00000069372 Ctxn3 3.18E-08 2.043908 
ENSMUSG00000037129 Tmprss13 8.77E-06 2.050404 
ENSMUSG00000021223 Papln 2.43E-05 2.052027 
ENSMUSG00000085779 Atcayos 9.38E-24 2.05238 
ENSMUSG00000031231 Cox7b 6.58E-27 2.052756 
ENSMUSG00000049100 Pcdh10 8.51E-03 2.052949 
ENSMUSG00000085996 A830012C17Rik 1.30E-03 2.057668 
ENSMUSG00000034282 Evpl 8.05E-15 2.062518 
ENSMUSG00000027887 Sypl2 3.80E-11 2.066455 
ENSMUSG00000032503 Arpp21 1.46E-07 2.066522 
ENSMUSG00000047976 Kcna1 7.38E-12 2.070587 
ENSMUSG00000032066 Bco2 2.78E-04 2.073257 
ENSMUSG00000044359 P2ry4 1.91E-03 2.076374 
ENSMUSG00000093577 Gm20632 6.14E-03 2.077013 
ENSMUSG00000013483 Card14 1.31E-07 2.078412 




ENSMUSG00000043029 Trpv3 1.44E-02 2.081377 
ENSMUSG00000039238 Zfp750 1.47E-04 2.082281 
ENSMUSG00000110752 D730003K21Rik 4.64E-02 2.082774 
ENSMUSG00000028778 Hcrtr1 3.59E-02 2.085093 
ENSMUSG00000058207 Serpina3k 1.26E-09 2.085453 
ENSMUSG00000067081 Asb18 2.65E-08 2.090381 
ENSMUSG00000086628 Gm16157 1.73E-02 2.090745 
ENSMUSG00000024105 Themis3 5.35E-04 2.093314 
ENSMUSG00000061259 Tmprss11d 1.09E-03 2.098869 
ENSMUSG00000090698 Apold1 9.53E-29 2.09911 
ENSMUSG00000019102 Aldh3a1 7.05E-13 2.102843 
ENSMUSG00000083832 Gm13771 1.13E-07 2.104884 
ENSMUSG00000102630 Gm37289 1.55E-03 2.105392 
ENSMUSG00000110278 Gm5608 5.85E-19 2.108069 
ENSMUSG00000034768 Asb16 1.07E-02 2.111324 
ENSMUSG00000039956 Mrap 4.45E-10 2.112034 
ENSMUSG00000103923 Gm37896 8.60E-03 2.11783 
ENSMUSG00000097335 Gm26563 2.10E-03 2.118682 
ENSMUSG00000078907 Fam186b 3.97E-02 2.120724 
ENSMUSG00000059742 Kcnh7 5.20E-04 2.121118 
ENSMUSG00000069581 Tspear 4.61E-03 2.12407 
ENSMUSG00000111582 Gm47347 3.71E-02 2.125209 
ENSMUSG00000110101 Gm6249 2.05E-02 2.12537 
ENSMUSG00000114838 Gm48703 2.07E-02 2.125697 
ENSMUSG00000110622 Iqcn 5.56E-03 2.126382 
ENSMUSG00000032013 Trim29 7.42E-11 2.126553 
ENSMUSG00000019787 Trdn 6.78E-61 2.127457 
ENSMUSG00000103502 9330121J05Rik 4.80E-02 2.127771 
ENSMUSG00000059201 Lep 5.78E-05 2.128026 
ENSMUSG00000072573 Gm10369 3.96E-02 2.129896 
ENSMUSG00000035923 Myf6 2.65E-02 2.130758 
ENSMUSG00000028989 Angptl7 5.47E-12 2.131128 
ENSMUSG00000055775 Myh8 4.26E-21 2.138598 
ENSMUSG00000108436 Gm44851 3.51E-04 2.138805 
ENSMUSG00000100551 Gm19503 1.04E-09 2.138828 
ENSMUSG00000038670 Mybpc2 7.68E-24 2.148925 
ENSMUSG00000079243 Xirp1 5.72E-30 2.150145 
ENSMUSG00000104340 Gm10522 2.43E-02 2.151948 
ENSMUSG00000031448 Adprhl1 2.72E-17 2.153714 
ENSMUSG00000021359 Tfap2a 3.33E-04 2.154076 
ENSMUSG00000021702 Thbs4 2.51E-18 2.160411 
ENSMUSG00000082884 Gm13339 7.91E-11 2.160938 
ENSMUSG00000072845 Tmprss11a 1.18E-02 2.165947 
ENSMUSG00000025370 Cdh9 1.48E-02 2.168399 
ENSMUSG00000028356 Ambp 6.80E-03 2.16969 
ENSMUSG00000019851 Perp 7.61E-19 2.171313 
ENSMUSG00000108985 A930030B08Rik 5.86E-04 2.171742 
ENSMUSG00000089948 Far2os1 3.02E-02 2.174011 
ENSMUSG00000024973 Hrasls5 6.29E-03 2.174329 
ENSMUSG00000038751 Ptk6 2.90E-04 2.175162 
ENSMUSG00000055489 Ano5 2.65E-19 2.176035 
ENSMUSG00000036960 Clca2 8.46E-04 2.179341 
ENSMUSG00000064371 mt-Tt 3.00E-02 2.180972 
ENSMUSG00000111514 E230014E18Rik 6.75E-12 2.182891 
ENSMUSG00000086777 Far2os2 7.84E-04 2.185863 
ENSMUSG00000020892 Aloxe3 1.75E-06 2.187315 




ENSMUSG00000117092 AC166110.1 2.83E-03 2.190222 
ENSMUSG00000023176 Cpn2 2.07E-02 2.192113 
ENSMUSG00000027196 Alkbh3os1 3.46E-02 2.193943 
ENSMUSG00000032292 Nr2e3 4.12E-03 2.196921 
ENSMUSG00000042918 Mamstr 1.20E-37 2.197597 
ENSMUSG00000046056 Sbsn 2.83E-10 2.198103 
ENSMUSG00000027902 Chil6 1.73E-02 2.200008 
ENSMUSG00000091238 Gm17103 7.14E-04 2.200115 
ENSMUSG00000096351 Samd11 9.26E-09 2.20062 
ENSMUSG00000109157 Gm44829 6.38E-08 2.201996 
ENSMUSG00000042250 Pglyrp4 3.18E-03 2.203176 
ENSMUSG00000102759 Gm10463 4.03E-03 2.205769 
ENSMUSG00000007653 Gabrb2 1.16E-03 2.208491 
ENSMUSG00000047216 Cdh19 1.60E-26 2.20978 
ENSMUSG00000096887 Gm20594 7.85E-12 2.211799 
ENSMUSG00000045027 Prss22 4.56E-13 2.221258 
ENSMUSG00000041872 Il17f 3.11E-11 2.222913 
ENSMUSG00000104314 Gm37907 4.45E-02 2.226011 
ENSMUSG00000025754 Agbl1 1.47E-44 2.226428 
ENSMUSG00000019853 Hebp2 1.26E-03 2.230586 
ENSMUSG00000111818 Gm17749 3.92E-13 2.231279 
ENSMUSG00000047686 Rtl3 3.27E-02 2.237085 
ENSMUSG00000017607 Tns4 2.61E-07 2.237262 
ENSMUSG00000028435 Aqp3 1.87E-10 2.240723 
ENSMUSG00000034683 Ppp1r1c 4.89E-04 2.242066 
ENSMUSG00000031936 Hephl1 4.37E-03 2.253413 
ENSMUSG00000087477 Gm13822 2.34E-04 2.260881 
ENSMUSG00000046961 Gpr156 1.14E-11 2.261469 
ENSMUSG00000068890 Lce1a2 5.61E-03 2.26277 
ENSMUSG00000112023 Lilr4b 2.80E-15 2.264239 
ENSMUSG00000038020 Rapgefl1 7.31E-12 2.268906 
ENSMUSG00000042662 Dusp15 2.80E-02 2.282184 
ENSMUSG00000036123 Slc9a3 7.66E-05 2.282388 
ENSMUSG00000070385 Ampd1 2.67E-16 2.283597 
ENSMUSG00000111765 Gm10635 3.06E-03 2.287427 
ENSMUSG00000042895 Abra 4.53E-15 2.29493 
ENSMUSG00000040340 Tex45 2.95E-04 2.297836 
ENSMUSG00000027022 Xirp2 1.00E-64 2.303434 
ENSMUSG00000032281 Acsbg1 1.63E-15 2.307473 
ENSMUSG00000106746 2900064F13Rik 3.81E-02 2.307491 
ENSMUSG00000085564 Gm12198 3.19E-02 2.309238 
ENSMUSG00000000031 H19 9.37E-41 2.316057 
ENSMUSG00000017697 Ada 2.19E-32 2.316335 
ENSMUSG00000108964 Gm18600 2.02E-02 2.316741 
ENSMUSG00000040258 Nxph4 1.61E-02 2.322015 
ENSMUSG00000034634 Ly6d 7.55E-08 2.32215 
ENSMUSG00000085434 Gm11725 1.18E-05 2.32389 
ENSMUSG00000041827 Oasl1 1.27E-48 2.333376 
ENSMUSG00000046049 Rp1l1 8.88E-06 2.335651 
ENSMUSG00000029361 Nos1 2.34E-29 2.336301 
ENSMUSG00000022860 Chodl 3.02E-03 2.338522 
ENSMUSG00000025329 Padi1 3.46E-03 2.339451 
ENSMUSG00000004885 Crabp2 2.14E-05 2.342472 
ENSMUSG00000097076 Platr7 7.34E-03 2.342649 
ENSMUSG00000073602 Serpinb3b 7.91E-06 2.343508 
ENSMUSG00000049134 Nrap 7.61E-59 2.345431 




ENSMUSG00000056966 Gjc3 3.67E-03 2.35148 
ENSMUSG00000068697 Myoz1 3.99E-14 2.351495 
ENSMUSG00000009070 Rsph14 5.67E-15 2.352471 
ENSMUSG00000022622 Acr 2.57E-18 2.353769 
ENSMUSG00000114457 Gm36346 1.55E-02 2.357304 
ENSMUSG00000037469 Acp7 6.67E-04 2.357911 
ENSMUSG00000096084 Gm21850 1.15E-11 2.358208 
ENSMUSG00000031972 Acta1 3.59E-28 2.359297 
ENSMUSG00000026983 Il1f5 5.52E-04 2.359573 
ENSMUSG00000059832 Kprp 5.63E-13 2.360512 
ENSMUSG00000043286 Pnpla1 1.03E-04 2.366505 
ENSMUSG00000033508 Asprv1 8.12E-12 2.36952 
ENSMUSG00000085511 Gm11738 1.72E-03 2.370938 
ENSMUSG00000044737 Klk14 4.19E-12 2.372258 
ENSMUSG00000111556 Gm19299 6.49E-04 2.375603 
ENSMUSG00000024771 Lipk 3.83E-03 2.37619 
ENSMUSG00000027376 Prom2 7.96E-09 2.376333 
ENSMUSG00000021123 Rdh12 6.55E-37 2.378531 
ENSMUSG00000043165 Lor 6.90E-19 2.380809 
ENSMUSG00000097069 Gm16998 3.57E-02 2.384026 
ENSMUSG00000060180 Myh13 2.82E-11 2.384598 
ENSMUSG00000026621 Mar1 1.07E-02 2.385001 
ENSMUSG00000024331 Dsc2 7.84E-15 2.385649 
ENSMUSG00000095438 Mir133a-1hg 5.55E-12 2.386779 
ENSMUSG00000069873 4930438A08Rik 2.56E-06 2.387168 
ENSMUSG00000041476 Smpx 1.20E-12 2.388318 
ENSMUSG00000097281 Gm26685 4.14E-02 2.39049 
ENSMUSG00000022510 Trp63 1.37E-22 2.394718 
ENSMUSG00000034730 Adgrb1 2.15E-03 2.399098 
ENSMUSG00000108448 Gm21269 1.77E-02 2.402324 
ENSMUSG00000081619 Gm13351 4.66E-02 2.402361 
ENSMUSG00000097850 4631405K08Rik 3.02E-03 2.406628 
ENSMUSG00000109372 Gm19410 2.96E-02 2.407345 
ENSMUSG00000092222 Gm20506 1.38E-02 2.407749 
ENSMUSG00000064179 Tnnt1 6.04E-08 2.41389 
ENSMUSG00000050808 Muc15 4.42E-03 2.423088 
ENSMUSG00000030672 Mylpf 4.00E-11 2.425658 
ENSMUSG00000037942 Crp 3.22E-03 2.427037 
ENSMUSG00000075296 Aldh3b2 7.70E-05 2.42977 
ENSMUSG00000044499 Hs3st5 1.87E-15 2.429999 
ENSMUSG00000038357 Camp 4.41E-10 2.437799 
ENSMUSG00000081163 Defa-ps12 4.11E-03 2.439291 
ENSMUSG00000097413 A830052D11Rik 6.08E-05 2.440113 
ENSMUSG00000040283 Btnl9 2.24E-05 2.447538 
ENSMUSG00000074695 Il22 2.53E-04 2.451827 
ENSMUSG00000026592 Tex35 3.15E-12 2.456187 
ENSMUSG00000109311 AI314278 2.12E-05 2.458668 
ENSMUSG00000042092 Lce1c 1.91E-03 2.46598 
ENSMUSG00000061816 Myl1 1.65E-32 2.468997 
ENSMUSG00000027868 Tbx15 3.60E-32 2.473286 
ENSMUSG00000067001 Serpinb7 2.67E-03 2.476115 
ENSMUSG00000043461 Sptssb 4.59E-07 2.477048 
ENSMUSG00000067616 Klk11 2.13E-06 2.484335 
ENSMUSG00000032807 Alox12b 2.99E-08 2.487194 
ENSMUSG00000050830 Vwc2 9.16E-07 2.489155 
ENSMUSG00000057280 Musk 7.35E-26 2.491914 




ENSMUSG00000026984 Il1f6 6.08E-04 2.49812 
ENSMUSG00000075394 Hoxc4 3.49E-02 2.499153 
ENSMUSG00000042761 Mrap2 3.01E-04 2.502625 
ENSMUSG00000027077 Smtnl1 6.53E-14 2.503067 
ENSMUSG00000023153 Tmem52 1.52E-03 2.503879 
ENSMUSG00000028865 Cd164l2 1.88E-06 2.505749 
ENSMUSG00000100147 1700047M11Rik 1.89E-21 2.506465 
ENSMUSG00000045019 Acer1 5.56E-03 2.51065 
ENSMUSG00000050359 Sprr1a 6.00E-11 2.511127 
ENSMUSG00000113178 Mylf-ps 7.37E-25 2.513042 
ENSMUSG00000028186 Uox 5.38E-03 2.521096 
ENSMUSG00000021506 Pitx1 4.13E-05 2.524928 
ENSMUSG00000100410 2310020H05Rik 5.52E-04 2.525092 
ENSMUSG00000099798 Gm29168 1.95E-02 2.530757 
ENSMUSG00000023473 Celsr3 5.94E-19 2.534816 
ENSMUSG00000042124 Lce1f 2.44E-03 2.541445 
ENSMUSG00000027470 Mylk2 2.72E-26 2.549178 
ENSMUSG00000044322 Dsc1 5.79E-06 2.554197 
ENSMUSG00000037139 Myom3 1.14E-36 2.554969 
ENSMUSG00000026327 Serpinb11 1.65E-06 2.557138 
ENSMUSG00000096960 A230028O05Rik 1.73E-18 2.567768 
ENSMUSG00000057609 Lce1a1 1.62E-04 2.572862 
ENSMUSG00000025064 Col17a1 5.34E-16 2.577045 
ENSMUSG00000024365 Cyp21a1 1.60E-02 2.581649 
ENSMUSG00000025317 Car5a 3.01E-02 2.589695 
ENSMUSG00000026418 Tnni1 3.68E-06 2.58989 
ENSMUSG00000061928 Dsg1b 2.34E-12 2.593438 
ENSMUSG00000114493 Gm47071 2.06E-15 2.5951 
ENSMUSG00000081689 Gm9166 1.74E-02 2.598563 
ENSMUSG00000028148 Them5 1.44E-11 2.59946 
ENSMUSG00000048455 Sprr1b 3.10E-04 2.603137 
ENSMUSG00000054582 Pabpc1l 3.75E-22 2.605057 
ENSMUSG00000047586 Nccrp1 1.96E-03 2.608167 
ENSMUSG00000103382 Gm37755 1.50E-03 2.610909 
ENSMUSG00000021768 Dusp13 4.51E-06 2.617201 
ENSMUSG00000021565 Slc6a19 1.45E-08 2.620258 
ENSMUSG00000069441 Dsg1a 1.77E-16 2.627138 
ENSMUSG00000029862 Clcn1 1.98E-18 2.631589 
ENSMUSG00000066897 Olfr872 7.98E-03 2.634158 
ENSMUSG00000038354 Ankrd35 3.43E-07 2.634991 
ENSMUSG00000016942 Tmprss6 2.91E-02 2.635952 
ENSMUSG00000074199 Krtdap 1.84E-07 2.63948 
ENSMUSG00000026450 Chit1 2.83E-05 2.645391 
ENSMUSG00000034774 Dsg1c 1.69E-03 2.648044 
ENSMUSG00000055561 Spink5 2.81E-21 2.649507 
ENSMUSG00000049593 Lce1h 1.12E-02 2.651785 
ENSMUSG00000087410 2310065F04Rik 1.84E-02 2.652839 
ENSMUSG00000031710 Ucp1 8.66E-12 2.653905 
ENSMUSG00000074001 Klhl40 2.22E-08 2.659211 
ENSMUSG00000031343 Gabra3 8.60E-12 2.660099 
ENSMUSG00000040154 Wfdc5 1.24E-05 2.663952 
ENSMUSG00000112041 9530020I12Rik 3.40E-05 2.669075 
ENSMUSG00000116482 Gm34152 3.36E-02 2.674711 
ENSMUSG00000059956 Serpinb12 2.21E-09 2.67661 
ENSMUSG00000060621 Nkpd1 5.88E-04 2.680095 
ENSMUSG00000063651 Cnfn 1.68E-15 2.693832 




ENSMUSG00000040127 Sdr9c7 7.30E-03 2.70979 
ENSMUSG00000059230 Defb4 4.63E-11 2.713218 
ENSMUSG00000053675 Tgm5 2.41E-02 2.71792 
ENSMUSG00000112471 Gm5779 8.23E-05 2.719729 
ENSMUSG00000057003 Myh4 8.95E-42 2.71992 
ENSMUSG00000097768 2310043M15Rik 6.60E-05 2.725258 
ENSMUSG00000100781 Gm29481 3.64E-04 2.726074 
ENSMUSG00000026950 Neb 4.90E-43 2.726723 
ENSMUSG00000030592 Ryr1 3.70E-30 2.727653 
ENSMUSG00000034362 Csta1 4.08E-04 2.728502 
ENSMUSG00000111821 Gm48545 1.08E-07 2.729446 
ENSMUSG00000050296 Abca12 2.65E-14 2.739696 
ENSMUSG00000002500 Rpl3l 1.16E-12 2.745902 
ENSMUSG00000084228 Gm8080 1.10E-02 2.75149 
ENSMUSG00000041991 Hrnr 4.02E-11 2.752579 
ENSMUSG00000091376 Aadacl2 1.73E-03 2.759068 
ENSMUSG00000028011 Tdo2 8.06E-03 2.760958 
ENSMUSG00000084929 Foxo6os 9.14E-05 2.765202 
ENSMUSG00000090356 Teddm3 5.80E-06 2.767835 
ENSMUSG00000074489 Bglap3 9.79E-06 2.770307 
ENSMUSG00000061762 Tac1 9.92E-03 2.773699 
ENSMUSG00000031844 Hsd17b2 7.25E-08 2.776301 
ENSMUSG00000027401 Tgm3 2.87E-13 2.777067 
ENSMUSG00000041984 Rptn 1.46E-19 2.778259 
ENSMUSG00000048806 Ifnb1 9.77E-04 2.781116 
ENSMUSG00000058260 Serpina9 4.93E-03 2.790483 
ENSMUSG00000045539 Sprr3 1.26E-16 2.802851 
ENSMUSG00000030484 Lypd5 2.30E-12 2.803817 
ENSMUSG00000028396 2310002L09Rik 8.35E-07 2.810987 
ENSMUSG00000061723 Tnnt3 7.78E-31 2.811141 
ENSMUSG00000108371 Gm38832 4.21E-03 2.817575 
ENSMUSG00000074113 Gm10629 9.39E-03 2.826311 
ENSMUSG00000066510 Ankdd1a 1.97E-24 2.828707 
ENSMUSG00000031097 Tnni2 5.06E-35 2.82918 
ENSMUSG00000039518 Cdsn 2.66E-13 2.831018 
ENSMUSG00000043468 Adam30 2.93E-04 2.837999 
ENSMUSG00000106056 4930500L23Rik 4.77E-03 2.840989 
ENSMUSG00000045776 Lrtm1 1.50E-19 2.850709 
ENSMUSG00000043460 Elfn2 2.64E-03 2.850978 
ENSMUSG00000057454 Lypd3 1.13E-07 2.855151 
ENSMUSG00000018862 Otop3 4.00E-07 2.861507 
ENSMUSG00000068885 Lce3f 3.57E-09 2.863271 
ENSMUSG00000032401 Lctl 5.17E-03 2.865397 
ENSMUSG00000032373 Car12 2.44E-33 2.866191 
ENSMUSG00000046748 Tmem45a2 3.29E-15 2.875771 
ENSMUSG00000116659 AC158985.1 1.03E-03 2.879651 
ENSMUSG00000111555 Gm47326 4.82E-02 2.882505 
ENSMUSG00000079025 Gsdmc 9.10E-07 2.885077 
ENSMUSG00000056328 Myh1 2.08E-87 2.886996 
ENSMUSG00000027913 Crct1 2.20E-14 2.894169 
ENSMUSG00000020216 Jsrp1 1.18E-04 2.896039 
ENSMUSG00000071019 Sdr16c6 3.06E-05 2.897926 
ENSMUSG00000025172 Ankrd2 3.28E-18 2.90344 
ENSMUSG00000074433 Lce3e 9.33E-07 2.913285 
ENSMUSG00000036731 Cysrt1 8.18E-07 2.915053 
ENSMUSG00000010064 Slc38a3 5.21E-18 2.918093 




ENSMUSG00000085479 9430073C21Rik 5.71E-04 2.934549 
ENSMUSG00000059668 Krt4 4.18E-14 2.937284 
ENSMUSG00000114163 Gm32296 5.99E-04 2.941019 
ENSMUSG00000038295 Atg9b 6.02E-09 2.942834 
ENSMUSG00000099449 Gm28401 1.09E-04 2.950106 
ENSMUSG00000026413 Pkp1 5.96E-19 2.956086 
ENSMUSG00000028386 Slc46a2 8.03E-03 2.960449 
ENSMUSG00000039070 Cpa4 3.59E-11 2.967827 
ENSMUSG00000037977 6430571L13Rik 1.15E-12 2.986157 
ENSMUSG00000110426 Gm45757 2.83E-02 2.990865 
ENSMUSG00000032454 Rbp2 9.49E-04 2.991761 
ENSMUSG00000073601 Serpinb3c 2.89E-05 2.992627 
ENSMUSG00000029154 Cwh43 3.21E-04 2.995754 
ENSMUSG00000054325 Lce3a 3.84E-11 2.996653 
ENSMUSG00000105160 A530030E21Rik 7.94E-03 3.00639 
ENSMUSG00000074183 Gsta1 1.18E-03 3.011134 
ENSMUSG00000068889 Lce1e 3.36E-03 3.016024 
ENSMUSG00000020061 Mybpc1 4.58E-66 3.020577 
ENSMUSG00000027048 Abcb11 2.16E-02 3.040284 
ENSMUSG00000039269 2300002M23Rik 1.76E-06 3.045743 
ENSMUSG00000117222 AC060761.1 8.51E-16 3.048258 
ENSMUSG00000025129 Ppp1r27 6.54E-04 3.050154 
ENSMUSG00000020908 Myh3 2.90E-04 3.053928 
ENSMUSG00000097364 Gm26719 2.09E-05 3.072513 
ENSMUSG00000054422 Fabp1 5.44E-04 3.078014 
ENSMUSG00000044041 Krt13 2.04E-15 3.079995 
ENSMUSG00000063821 Dupd1 1.16E-02 3.080693 
ENSMUSG00000043430 Psapl1 2.65E-14 3.082218 
ENSMUSG00000044594 Serpinb3a 5.68E-13 3.087602 
ENSMUSG00000085532 B430319H21Rik 1.32E-14 3.09774 
ENSMUSG00000042031 Lce3b 1.13E-11 3.112196 
ENSMUSG00000005355 Casp14 2.13E-04 3.113601 
ENSMUSG00000087038 2900079G21Rik 4.50E-03 3.1195 
ENSMUSG00000114922 Ppifos 2.43E-06 3.120941 
ENSMUSG00000031372 Trex2 1.04E-04 3.124283 
ENSMUSG00000086584 Gm12002 6.34E-13 3.127654 
ENSMUSG00000071858 Gm94 2.60E-09 3.127964 
ENSMUSG00000092586 Ly6g6c 8.86E-11 3.133452 
ENSMUSG00000101133 Gm29050 2.40E-04 3.136949 
ENSMUSG00000048399 Tprg 1.51E-09 3.169198 
ENSMUSG00000045475 Lce3c 3.14E-12 3.171884 
ENSMUSG00000110735 Gm47173 8.51E-03 3.184631 
ENSMUSG00000054146 Krt15 8.74E-19 3.18484 
ENSMUSG00000103243 Lce1d 2.93E-06 3.187473 
ENSMUSG00000026407 Cacna1s 1.08E-45 3.18982 
ENSMUSG00000024471 Myot 5.42E-54 3.196349 
ENSMUSG00000030713 Klk7 1.82E-04 3.197459 
ENSMUSG00000097214 Gm19791 2.77E-02 3.223603 
ENSMUSG00000068893 Sprr2a2 2.58E-13 3.229494 
ENSMUSG00000050108 Bpifc 5.73E-05 3.240719 
ENSMUSG00000028236 Sdr16c5 1.03E-04 3.243863 
ENSMUSG00000078664 Sprr2a1 4.79E-06 3.253984 
ENSMUSG00000033268 Duox1 2.09E-12 3.257037 
ENSMUSG00000063130 Calml3 1.60E-17 3.258145 
ENSMUSG00000050463 Krt78 7.67E-32 3.271363 
ENSMUSG00000096269 Rpl31-ps21 2.93E-03 3.274694 




ENSMUSG00000061527 Krt5 7.51E-19 3.292118 
ENSMUSG00000030155 Clec2e 8.29E-03 3.314901 
ENSMUSG00000047884 Klk9 1.29E-04 3.323011 
ENSMUSG00000114091 Gm40655 1.54E-09 3.328511 
ENSMUSG00000053522 Lgals7 1.35E-10 3.329974 
ENSMUSG00000017204 Gsdma 4.28E-12 3.335837 
ENSMUSG00000087090 Nctc1 2.38E-59 3.337836 
ENSMUSG00000096001 2610528A11Rik 4.77E-04 3.356603 
ENSMUSG00000062826 Ces2f 1.27E-20 3.364975 
ENSMUSG00000031344 Gabrq 9.36E-03 3.374101 
ENSMUSG00000085257 Gm13264 2.59E-02 3.380709 
ENSMUSG00000082141 Gm11212 1.11E-03 3.415103 
ENSMUSG00000067006 Serpinb5 3.69E-13 3.437795 
ENSMUSG00000074156 Ces1h 2.13E-11 3.444764 
ENSMUSG00000046676 Lce1l 1.08E-02 3.449777 
ENSMUSG00000021364 Elovl2 1.25E-03 3.464127 
ENSMUSG00000074445 Sprr2a3 8.74E-06 3.468969 
ENSMUSG00000078964 Ces1b 2.78E-06 3.472679 
ENSMUSG00000045545 Krt14 4.41E-27 3.472881 
ENSMUSG00000059898 Dsc3 2.86E-17 3.473919 
ENSMUSG00000033765 Calm4 5.17E-10 3.476147 
ENSMUSG00000105961 Gm40123 8.89E-03 3.493003 
ENSMUSG00000048721 Fndc9 1.16E-03 3.493393 
ENSMUSG00000017300 Tnnc2 2.61E-56 3.493517 
ENSMUSG00000101840 Gm28294 1.22E-02 3.494083 
ENSMUSG00000046095 Krt32 6.38E-05 3.511431 
ENSMUSG00000043795 Prr33 3.14E-07 3.513074 
ENSMUSG00000074647 Fam83c 1.30E-04 3.523902 
ENSMUSG00000091172 Gm17120 7.31E-03 3.529014 
ENSMUSG00000110207 Gm33586 2.10E-02 3.530274 
ENSMUSG00000051965 Nanos2 3.22E-04 3.536107 
ENSMUSG00000051431 Gpr87 7.37E-05 3.549606 
ENSMUSG00000025229 Pitx3 6.86E-03 3.553927 
ENSMUSG00000005716 Pvalb 2.81E-11 3.631134 
ENSMUSG00000031757 Mt4 1.87E-13 3.699945 
ENSMUSG00000058354 Krt6a 8.73E-08 3.701633 
ENSMUSG00000026985 Il1f8 4.85E-06 3.747629 
ENSMUSG00000055301 Adh7 9.72E-31 3.762133 
ENSMUSG00000097770 Gm26776 2.69E-05 3.767514 
ENSMUSG00000115270 5430430K15Rik 1.03E-02 3.813184 
ENSMUSG00000075217 4833423E24Rik 7.79E-13 3.828324 
ENSMUSG00000043472 Lce3d 9.57E-05 3.852596 
ENSMUSG00000030244 Gys2 3.13E-03 3.866888 
ENSMUSG00000056078 Lipm 5.55E-12 3.878651 
ENSMUSG00000047428 Dlk2 6.06E-04 3.942878 
ENSMUSG00000013766 Ly6g6e 6.75E-03 3.95354 
ENSMUSG00000017950 Hnf4a 2.61E-04 4.02923 
ENSMUSG00000025194 Abcc2 1.91E-04 4.03213 
ENSMUSG00000030046 Bmp10 5.70E-04 4.173749 
ENSMUSG00000056632 Dsg3 2.00E-33 4.176681 
ENSMUSG00000030237 Slco1a4 4.96E-03 4.192899 
ENSMUSG00000028001 Fga 1.73E-08 4.260873 
ENSMUSG00000109685 Gm45912 2.62E-03 4.273195 
ENSMUSG00000111709 Gm3776 1.46E-04 4.284462 
ENSMUSG00000043681 Fam25c 7.65E-12 4.287186 
ENSMUSG00000079451 Tmprss11g 6.62E-12 4.355436 




ENSMUSG00000025431 Crisp1 1.13E-13 4.600625 
ENSMUSG00000023041 Krt6b 7.88E-05 4.619968 
ENSMUSG00000011632 Pinlyp 1.13E-03 4.658043 
ENSMUSG00000022875 Kng1 9.90E-06 4.667574 
ENSMUSG00000035031 C8a 2.65E-03 4.905581 
ENSMUSG00000044748 Defb1 2.48E-08 5.134939 
ENSMUSG00000102098 2310016D03Rik 3.16E-06 5.282878 
ENSMUSG00000035861 Tmprss11b 1.93E-05 5.434747 
ENSMUSG00000027761 Aadac 2.12E-05 5.483728 
ENSMUSG00000029019 Nppb 2.05E-26 5.500836 
ENSMUSG00000033196 Myh2 1.31E-45 5.509976 
ENSMUSG00000027261 Hao1 4.23E-11 5.543845 
ENSMUSG00000070719 Pla2g4d 3.51E-07 5.701431 
ENSMUSG00000025003 Cyp2c39 1.58E-04 6.085577 
ENSMUSG00000004872 Pax3 1.87E-06 6.162959 
ENSMUSG00000016327 Atp1b4 4.64E-12 6.441707 
ENSMUSG00000027249 F2 5.25E-04 6.44469 
ENSMUSG00000033860 Fgg 1.30E-15 6.79552 
ENSMUSG00000056656 Apol8 2.35E-27 6.857002 
ENSMUSG00000073375 Lrrc30 2.39E-04 7.131156 
ENSMUSG00000024512 Dynap 2.79E-05 7.653523 
ENSMUSG00000001670 Tat 1.65E-05 8.104061 
ENSMUSG00000029671 Wnt16 5.12E-05 8.122169 
ENSMUSG00000019932 Kera 9.32E-11 9.197208 
ENSMUSG00000115207 Gm49132 6.77E-08 9.321712 
ENSMUSG00000030131 Mug2 3.68E-08 10.01166 
ENSMUSG00000020609 Apob 1.70E-16 10.07445 
ENSMUSG00000003053 Cyp2c29 1.58E-09 11.55749 
ENSMUSG00000022868 Ahsg 1.79E-19 12.68437 
ENSMUSG00000035540 Gc 2.58E-14 14.12206 
ENSMUSG00000030359 Pzp 3.60E-20 14.37129 
ENSMUSG00000059481 Plg 3.52E-08 19.5621 
ENSMUSG00000057400 Ces1c 8.80E-07 19.90682 
ENSMUSG00000028307 Aldob 1.46E-10 20.84021 
ENSMUSG00000005681 Apoa2 3.99E-05 38.11525 
ENSMUSG00000059908 Mug1 1.99E-19 49.75901 
ENSMUSG00000029630 Cyp3a25 3.05E-06 60.85914 
ENSMUSG00000056035 Cyp3a11 2.89E-12 61.11608 
ENSMUSG00000025991 Cps1 1.52E-07 68.002 
ENSMUSG00000061808 Ttr 9.12E-07 72.79417 
ENSMUSG00000033831 Fgb 2.27E-10 80.34186 
ENSMUSG00000032083 Apoa1 1.86E-13 85.92226 











Appendix W. Murine differential gene expression in the lungs 6 h post-infection, 947M vs 4559M. 
Genes with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in 
blue = upregulated in 947M, while values highlighted in red = upregulated in 4559M. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000085261 Gm13814 1.01E-05 5.162232 
ENSMUSG00000031551 Ido1 1.63E-07 4.116956 
ENSMUSG00000071679 Rtl4 1.67E-17 4.081086 
ENSMUSG00000063594 Gng8 7.78E-04 3.837051 
ENSMUSG00000009900 Wnt3a 3.97E-16 3.498319 
ENSMUSG00000092591 Gm20429 6.56E-04 3.202419 
ENSMUSG00000115574 Gm49245 6.79E-04 3.163799 
ENSMUSG00000115307 Gm49313 7.11E-07 2.940982 
ENSMUSG00000032502 Stac 7.16E-13 2.939761 
ENSMUSG00000085982 9530051G07Rik 4.37E-06 2.908872 
ENSMUSG00000085235 Gm12576 1.23E-05 2.830949 
ENSMUSG00000030114 Klrg1 5.25E-03 2.807412 
ENSMUSG00000068428 Gmnc 8.48E-03 2.716893 
ENSMUSG00000001494 Sost 1.53E-04 2.681953 
ENSMUSG00000020081 Tacr2 7.50E-03 2.609488 
ENSMUSG00000105402 Gm3716 8.05E-03 2.563662 
ENSMUSG00000108617 Gm31749 3.03E-03 2.550466 
ENSMUSG00000060275 Nrg2 1.89E-11 2.543613 
ENSMUSG00000114028 9630002D21Rik 2.18E-05 2.514966 
ENSMUSG00000048485 Zbtb8b 1.10E-02 2.476257 
ENSMUSG00000076613 Ighg2b 8.81E-04 2.473764 
ENSMUSG00000053961 Ang5 8.04E-04 2.455475 
ENSMUSG00000092389 Gm20483 1.60E-02 2.454367 
ENSMUSG00000090166 Ear10 5.22E-10 2.447762 
ENSMUSG00000114566 Gm48500 3.34E-05 2.443691 
ENSMUSG00000087500 Gm12426 1.87E-03 2.430623 
ENSMUSG00000086843 E030013I19Rik 9.29E-08 2.368294 
ENSMUSG00000061171 Slc38a11 6.50E-05 2.368149 
ENSMUSG00000087355 Gm13187 2.64E-02 2.35886 
ENSMUSG00000076612 Ighg2c 2.96E-02 2.329747 
ENSMUSG00000079436 Kcnj13 3.92E-03 2.327287 
ENSMUSG00000052026 Slc6a7 2.97E-08 2.315711 
ENSMUSG00000070530 Wfdc16 1.76E-02 2.314729 
ENSMUSG00000109056 A630009H07Rik 2.27E-02 2.292291 
ENSMUSG00000056824 Zfp663 6.59E-04 2.279782 
ENSMUSG00000072599 Ear-ps2 2.14E-05 2.246685 
ENSMUSG00000009394 Syn2 3.23E-27 2.246363 
ENSMUSG00000051969 Tlr11 1.09E-02 2.239618 
ENSMUSG00000086313 Gm15940 1.71E-03 2.238922 
ENSMUSG00000036295 Lrrn3 1.33E-06 2.227998 
ENSMUSG00000085882 2610507I01Rik 1.42E-05 2.211385 
ENSMUSG00000116097 Gm36738 2.22E-04 2.2066 
ENSMUSG00000030041 M1ap 6.18E-16 2.204481 
ENSMUSG00000011263 Exoc3l2 4.87E-04 2.194716 
ENSMUSG00000086822 5330413P13Rik 1.81E-03 2.193201 
ENSMUSG00000102082 Gm28675 9.97E-04 2.179205 
ENSMUSG00000099338 2810030D12Rik 7.38E-06 2.170948 
ENSMUSG00000030495 Slc7a10 8.33E-20 2.14737 
ENSMUSG00000087042 Gm11611 2.21E-02 2.145158 
ENSMUSG00000099553 Gm29538 2.37E-06 2.13579 
ENSMUSG00000066319 Rtp3 5.27E-08 2.127259 




ENSMUSG00000110427 4933406B17Rik 1.98E-02 2.10939 
ENSMUSG00000025789 St8sia2 8.02E-14 2.104873 
ENSMUSG00000028755 Cda 1.82E-03 2.099281 
ENSMUSG00000026304 Rab17 1.54E-02 2.091565 
ENSMUSG00000029193 Cckar 1.80E-08 2.087954 
ENSMUSG00000019909 Fam162b 9.91E-04 2.085813 
ENSMUSG00000039179 Tekt5 3.66E-03 2.083175 
ENSMUSG00000044633 B530045E10Rik 2.46E-24 2.082099 
ENSMUSG00000108084 Gm7932 3.36E-02 2.079352 
ENSMUSG00000060615 Ang4 3.19E-02 2.073621 
ENSMUSG00000000901 Mmp11 1.21E-09 2.071062 
ENSMUSG00000051920 Rspo2 3.77E-02 2.060566 
ENSMUSG00000024968 Rcor2 7.64E-03 2.054541 
ENSMUSG00000048988 Elfn1 2.26E-18 2.049999 
ENSMUSG00000028919 Arhgef19 1.84E-03 2.045006 
ENSMUSG00000085282 Gm15663 1.26E-03 2.042585 
ENSMUSG00000101605 Ace3 1.64E-08 2.033861 
ENSMUSG00000063730 Hsd3b2 4.33E-03 2.031267 
ENSMUSG00000037962 Rflna 9.51E-05 2.029917 
ENSMUSG00000048455 Sprr1b 4.70E-02 2.029009 
ENSMUSG00000054622 D730045B01Rik 3.09E-03 2.018059 
ENSMUSG00000092353 Gm20539 1.07E-02 2.004409 
ENSMUSG00000029601 Iqcd 9.80E-03 2.001456 
ENSMUSG00000026109 Tmeff2 3.23E-11 1.998603 
ENSMUSG00000009114 2610028H24Rik 2.03E-09 1.997699 
ENSMUSG00000029477 Morn3 2.44E-03 1.99663 
ENSMUSG00000074505 Fat3 3.95E-40 1.986612 
ENSMUSG00000108481 Gm33248 9.66E-17 1.983101 
ENSMUSG00000026494 Kif26b 6.07E-29 1.976902 
ENSMUSG00000103857 Gm37249 2.44E-02 1.97662 
ENSMUSG00000055945 Prr18 2.04E-05 1.976009 
ENSMUSG00000087142 Gm12454 1.40E-03 1.974069 
ENSMUSG00000022491 Glycam1 9.58E-05 1.972925 
ENSMUSG00000070720 Tmem200b 2.56E-04 1.963692 
ENSMUSG00000116660 CT030736.1 1.35E-13 1.960853 
ENSMUSG00000020218 Wif1 3.37E-14 1.957565 
ENSMUSG00000047085 Lrrc4b 1.22E-05 1.939777 
ENSMUSG00000027656 Wisp2 6.19E-47 1.938229 
ENSMUSG00000027380 Acoxl 1.13E-11 1.935006 
ENSMUSG00000017007 Rbpjl 2.17E-14 1.933213 
ENSMUSG00000033533 Acsm1 1.08E-07 1.933132 
ENSMUSG00000079039 Gm11037 3.17E-02 1.927416 
ENSMUSG00000092004 Gm17482 3.73E-05 1.925619 
ENSMUSG00000052353 Cemip 1.08E-23 1.921299 
ENSMUSG00000067714 Lpar5 4.75E-02 1.916894 
ENSMUSG00000086368 Gm13830 1.34E-04 1.915922 
ENSMUSG00000107230 Gm19265 2.82E-03 1.914934 
ENSMUSG00000022504 Ciita 3.98E-26 1.914004 
ENSMUSG00000050288 Fzd2 1.07E-05 1.912167 
ENSMUSG00000086585 Gm16126 3.81E-02 1.91092 
ENSMUSG00000040841 Six5 6.58E-09 1.910496 
ENSMUSG00000084998 Gm16279 9.76E-04 1.908554 
ENSMUSG00000072596 Ear2 7.41E-14 1.907457 
ENSMUSG00000063681 Crb1 3.66E-02 1.90717 
ENSMUSG00000026870 Cutal 7.86E-04 1.907001 
ENSMUSG00000105547 Iglc3 3.49E-02 1.904731 




ENSMUSG00000034324 Tmem132c 6.54E-30 1.893682 
ENSMUSG00000108390 Gm39038 1.42E-02 1.893336 
ENSMUSG00000097591 A330032B11Rik 2.92E-03 1.889618 
ENSMUSG00000108195 Gm44415 1.81E-02 1.887889 
ENSMUSG00000038233 Fam198a 3.94E-07 1.883042 
ENSMUSG00000103839 Gm37607 3.89E-02 1.879446 
ENSMUSG00000030043 Tacr1 4.32E-06 1.878906 
ENSMUSG00000074480 Mex3a 5.57E-03 1.877201 
ENSMUSG00000063260 Syt10 2.50E-02 1.87586 
ENSMUSG00000072601 Ear1 3.55E-09 1.87466 
ENSMUSG00000025577 Cbx2 1.79E-04 1.874541 
ENSMUSG00000043110 Lrrn4 8.40E-06 1.874015 
ENSMUSG00000045087 S1pr5 2.29E-03 1.872791 
ENSMUSG00000085069 Gm13111 2.88E-04 1.871815 
ENSMUSG00000014543 Klra17 1.24E-12 1.871249 
ENSMUSG00000092515 C87198 2.73E-02 1.870875 
ENSMUSG00000114161 Gm48662 1.37E-02 1.868726 
ENSMUSG00000108289 Gm44174 3.34E-08 1.868318 
ENSMUSG00000034467 Dynlrb2 1.07E-04 1.864633 
ENSMUSG00000030125 Lrrc23 3.21E-07 1.862472 
ENSMUSG00000037492 Zmat4 1.44E-11 1.858985 
ENSMUSG00000089713 Gm16564 3.70E-02 1.858329 
ENSMUSG00000110380 Gm45332 2.12E-03 1.856669 
ENSMUSG00000026616 Cr2 1.36E-07 1.856455 
ENSMUSG00000027831 Veph1 6.53E-14 1.85639 
ENSMUSG00000108580 Gm39094 9.91E-27 1.847514 
ENSMUSG00000085419 Gm11734 9.18E-03 1.8441 
ENSMUSG00000024440 Pcdh12 1.29E-20 1.843863 
ENSMUSG00000044952 Kctd21 5.91E-10 1.842085 
ENSMUSG00000116609 AC122141.1 1.30E-02 1.840951 
ENSMUSG00000086154 Gm16196 1.33E-02 1.840383 
ENSMUSG00000046242 Nme9 1.23E-02 1.838804 
ENSMUSG00000063320 1190007I07Rik 1.48E-02 1.836405 
ENSMUSG00000086390 1810019D21Rik 4.43E-07 1.836126 
ENSMUSG00000087518 Gm13561 5.48E-03 1.835776 
ENSMUSG00000100041 Gm5702 1.11E-02 1.835727 
ENSMUSG00000102175 Gm6119 1.10E-03 1.833252 
ENSMUSG00000087514 Gm16076 7.80E-03 1.831068 
ENSMUSG00000079355 Ackr4 1.42E-05 1.830347 
ENSMUSG00000021234 Fam161b 1.93E-04 1.828797 
ENSMUSG00000097339 Gm26671 6.23E-05 1.828632 
ENSMUSG00000046182 Gsg1l 2.43E-05 1.826043 
ENSMUSG00000047787 Flrt1 4.73E-02 1.825861 
ENSMUSG00000021708 Rasgrf2 7.04E-24 1.822346 
ENSMUSG00000029651 Mtus2 3.04E-27 1.820688 
ENSMUSG00000079173 Zan 1.05E-03 1.82063 
ENSMUSG00000042256 Ptchd4 8.22E-05 1.819936 
ENSMUSG00000063430 Wscd2 1.07E-09 1.81492 
ENSMUSG00000104168 Gm38250 8.48E-04 1.810521 
ENSMUSG00000103738 Gm37652 6.73E-04 1.809033 
ENSMUSG00000056155 Nanos3 8.78E-04 1.806709 
ENSMUSG00000044338 Aplnr 1.37E-34 1.806317 
ENSMUSG00000038402 Foxf2 1.43E-09 1.806283 
ENSMUSG00000110660 Gm5362 1.46E-02 1.804937 
ENSMUSG00000020642 Rnf144a 4.67E-29 1.804772 
ENSMUSG00000086283 2810433D01Rik 4.15E-02 1.804678 




ENSMUSG00000105376 Gm36535 8.45E-03 1.797718 
ENSMUSG00000030098 Grip2 2.83E-09 1.795977 
ENSMUSG00000027796 Smad9 7.70E-08 1.788007 
ENSMUSG00000052563 D930048N14Rik 1.75E-06 1.786953 
ENSMUSG00000045555 Mettl24 4.87E-17 1.786089 
ENSMUSG00000039037 St6galnac5 9.72E-33 1.782983 
ENSMUSG00000084866 A930006K02Rik 7.02E-03 1.779173 
ENSMUSG00000050022 Amz1 1.30E-06 1.779075 
ENSMUSG00000115333 Gm34590 6.00E-03 1.77317 
ENSMUSG00000091415 Ak9 7.15E-10 1.77086 
ENSMUSG00000036923 Stox1 1.49E-08 1.769288 
ENSMUSG00000025902 Sox17 1.61E-18 1.76508 
ENSMUSG00000026301 Iqca 1.77E-05 1.764688 
ENSMUSG00000079330 Lemd1 1.10E-05 1.764372 
ENSMUSG00000057123 Gja5 5.68E-21 1.76359 
ENSMUSG00000112468 Gm47720 6.31E-08 1.762303 
ENSMUSG00000027932 Slc27a3 3.01E-04 1.757901 
ENSMUSG00000027318 Adam33 5.00E-08 1.756879 
ENSMUSG00000034584 Exph5 9.73E-20 1.754362 
ENSMUSG00000042359 Osbpl6 1.37E-20 1.752867 
ENSMUSG00000086141 9030622O22Rik 6.75E-14 1.748517 
ENSMUSG00000087413 Gm11266 1.49E-10 1.7464 
ENSMUSG00000043088 Il17re 8.79E-06 1.745302 
ENSMUSG00000073877 Gm13306 1.50E-02 1.741028 
ENSMUSG00000058420 Syt17 5.21E-07 1.739965 
ENSMUSG00000054966 Lmntd1 3.10E-21 1.739876 
ENSMUSG00000044156 Hepacam2 8.78E-03 1.7394 
ENSMUSG00000112343 Sfta3-ps 6.02E-35 1.73883 
ENSMUSG00000025578 Cbx8 2.05E-02 1.738267 
ENSMUSG00000049420 Tmem200a 4.62E-16 1.737708 
ENSMUSG00000094786 Gm14403 2.31E-14 1.73598 
ENSMUSG00000052516 Robo2 3.01E-29 1.732225 
ENSMUSG00000052117 D630039A03Rik 2.49E-03 1.730316 
ENSMUSG00000095247 Ccl27a 1.67E-02 1.729601 
ENSMUSG00000035829 Ppp1r26 4.19E-05 1.727533 
ENSMUSG00000031489 Adrb3 1.72E-07 1.727349 
ENSMUSG00000022844 Pdia5 7.32E-17 1.727186 
ENSMUSG00000030732 Chrdl2 1.63E-02 1.727151 
ENSMUSG00000034685 Fam171a2 2.13E-04 1.726734 
ENSMUSG00000063535 Zfp773 5.88E-03 1.725168 
ENSMUSG00000030302 Atp2b2 1.69E-08 1.723946 
ENSMUSG00000024063 Lbh 4.98E-36 1.722771 
ENSMUSG00000068246 Apol9b 3.02E-02 1.721537 
ENSMUSG00000027849 Syt6 2.77E-06 1.721018 
ENSMUSG00000023011 Faim2 1.27E-05 1.718468 
ENSMUSG00000037709 Fam13a 1.35E-08 1.718152 
ENSMUSG00000037973 Ccdc129 1.14E-09 1.717358 
ENSMUSG00000030093 Wnt7a 3.68E-05 1.717134 
ENSMUSG00000054459 Vsnl1 3.49E-14 1.71657 
ENSMUSG00000106749 Gm43281 1.17E-06 1.71649 
ENSMUSG00000038453 Srcin1 3.73E-09 1.71294 
ENSMUSG00000020169 Best3 4.21E-07 1.7127 
ENSMUSG00000070802 Pnmal2 2.73E-03 1.712669 
ENSMUSG00000108767 Gm29763 4.23E-02 1.712211 
ENSMUSG00000106617 Gm36266 4.87E-02 1.708878 
ENSMUSG00000037846 Rtkn2 5.59E-09 1.707006 




ENSMUSG00000020734 Grin2c 1.11E-02 1.70189 
ENSMUSG00000020135 Apc2 5.57E-05 1.700572 
ENSMUSG00000029510 Gpc2 3.36E-02 1.699228 
ENSMUSG00000011658 Fuz 2.30E-07 1.696259 
ENSMUSG00000028871 Rspo1 5.07E-03 1.694801 
ENSMUSG00000059323 Tonsl 8.20E-04 1.693202 
ENSMUSG00000051727 Kctd14 3.92E-02 1.692769 
ENSMUSG00000021496 Pcbd2 5.81E-19 1.692202 
ENSMUSG00000024206 Rfx2 4.60E-17 1.691263 
ENSMUSG00000034771 Tle2 8.58E-09 1.690916 
ENSMUSG00000105637 Gm42480 4.36E-02 1.690621 
ENSMUSG00000110206 Flt3l 3.41E-08 1.689626 
ENSMUSG00000020566 Atp6v1c2 6.88E-19 1.689203 
ENSMUSG00000026347 Tmem163 2.61E-23 1.688979 
ENSMUSG00000038422 Hdhd3 1.93E-02 1.688234 
ENSMUSG00000110893 Gm47392 3.19E-02 1.684205 
ENSMUSG00000020546 Stxbp4 8.52E-19 1.682897 
ENSMUSG00000031147 Magix 1.99E-02 1.682316 
ENSMUSG00000097399 Gm26555 2.40E-02 1.681825 
ENSMUSG00000057719 Sh3rf2 5.96E-15 1.681035 
ENSMUSG00000078794 Dact3 3.49E-06 1.680713 
ENSMUSG00000026676 Ccdc3 9.32E-13 1.678664 
ENSMUSG00000113585 Gm19605 3.31E-04 1.676504 
ENSMUSG00000112714 Gm4798 2.16E-06 1.675832 
ENSMUSG00000082192 Gm14719 3.57E-02 1.675599 
ENSMUSG00000104244 2900018N21Rik 2.55E-02 1.67496 
ENSMUSG00000098022 Zfp82 2.20E-02 1.672994 
ENSMUSG00000040543 Pitpnm3 2.42E-15 1.670307 
ENSMUSG00000040009 Gnaz 2.72E-03 1.670102 
ENSMUSG00000074282 Zfp94 1.02E-04 1.669767 
ENSMUSG00000041431 Ccnb1 2.46E-02 1.668727 
ENSMUSG00000037101 Ttc29 1.48E-07 1.668254 
ENSMUSG00000044694 2010007H06Rik 4.57E-05 1.664324 
ENSMUSG00000074283 Zfp109 1.27E-04 1.664311 
ENSMUSG00000042750 Bex2 2.12E-02 1.660556 
ENSMUSG00000037610 Kcnmb2 3.48E-09 1.660213 
ENSMUSG00000029206 Nsun7 8.95E-03 1.65966 
ENSMUSG00000048096 Lmod1 4.51E-06 1.658969 
ENSMUSG00000087424 5730405O15Rik 1.41E-02 1.658718 
ENSMUSG00000043664 Tmem221 1.85E-03 1.657821 
ENSMUSG00000036962 Cfap221 1.50E-04 1.657207 
ENSMUSG00000104658 Gm30275 9.01E-04 1.656842 
ENSMUSG00000059588 Calcrl 5.46E-25 1.656551 
ENSMUSG00000032606 Nicn1 4.61E-05 1.655171 
ENSMUSG00000042988 Notum 3.14E-02 1.651852 
ENSMUSG00000090135 Gm15809 7.06E-05 1.651829 
ENSMUSG00000026785 Pkn3 3.37E-07 1.651277 
ENSMUSG00000036864 Proser3 1.85E-04 1.650066 
ENSMUSG00000021573 Tppp 1.72E-15 1.64999 
ENSMUSG00000047146 Tet1 9.98E-15 1.649532 
ENSMUSG00000022763 Aifm3 4.57E-02 1.648956 
ENSMUSG00000029074 Ttll10 4.54E-08 1.648169 
ENSMUSG00000106951 5930430L01Rik 2.79E-03 1.648167 
ENSMUSG00000066129 Kndc1 1.48E-05 1.648069 
ENSMUSG00000036218 Pdzrn4 1.20E-13 1.64797 
ENSMUSG00000049349 Gm5105 4.33E-02 1.647966 




ENSMUSG00000004996 Mri1 6.19E-05 1.646009 
ENSMUSG00000030209 Grin2b 1.06E-03 1.644894 
ENSMUSG00000083640 Gm8876 2.25E-02 1.644745 
ENSMUSG00000022199 Slc22a17 2.43E-06 1.644577 
ENSMUSG00000097115 1810019N24Rik 4.68E-02 1.644237 
ENSMUSG00000053730 Tmem39b 5.53E-05 1.642946 
ENSMUSG00000022615 Tymp 9.68E-04 1.641539 
ENSMUSG00000038605 Samd10 3.89E-05 1.640188 
ENSMUSG00000028801 Stpg1 5.81E-04 1.639582 
ENSMUSG00000024579 Pcyox1l 2.73E-06 1.639339 
ENSMUSG00000109394 A230057D06Rik 1.24E-15 1.639166 
ENSMUSG00000038576 Susd4 5.59E-13 1.639016 
ENSMUSG00000097453 Gm26894 1.64E-02 1.637894 
ENSMUSG00000027186 Elf5 3.99E-04 1.637037 
ENSMUSG00000067629 Syngap1 1.04E-10 1.636623 
ENSMUSG00000042474 Fcmr 1.58E-04 1.636419 
ENSMUSG00000049625 Tifab 3.19E-09 1.636014 
ENSMUSG00000102437 Gm38048 9.87E-06 1.635702 
ENSMUSG00000032357 Tinag 5.76E-05 1.635216 
ENSMUSG00000033952 Aspm 3.64E-06 1.635025 
ENSMUSG00000106993 Gm43417 1.87E-02 1.634425 
ENSMUSG00000085682 Gm14267 1.56E-03 1.633309 
ENSMUSG00000050705 2310061I04Rik 1.46E-05 1.632802 
ENSMUSG00000035504 Reep6 1.13E-03 1.631873 
ENSMUSG00000029521 Chek2 1.57E-03 1.62588 
ENSMUSG00000085237 Gm15406 4.19E-08 1.6257 
ENSMUSG00000031220 Awat2 1.51E-02 1.624394 
ENSMUSG00000054555 Adam12 2.00E-23 1.623831 
ENSMUSG00000112694 Gm33037 1.78E-02 1.620917 
ENSMUSG00000042826 Fgf11 1.79E-03 1.618808 
ENSMUSG00000040282 BC052040 2.59E-16 1.618536 
ENSMUSG00000032064 Dixdc1 5.04E-09 1.617751 
ENSMUSG00000111229 Gm39323 1.15E-03 1.617613 
ENSMUSG00000052921 Arhgef15 1.73E-18 1.61749 
ENSMUSG00000031870 Pgr 3.58E-10 1.617384 
ENSMUSG00000051811 Cox6b2 1.16E-02 1.617084 
ENSMUSG00000035435 Abca17 2.04E-08 1.615687 
ENSMUSG00000022179 4931414P19Rik 3.70E-05 1.615439 
ENSMUSG00000028031 Dkk2 2.04E-05 1.613944 
ENSMUSG00000049811 Fam161a 3.97E-06 1.611627 
ENSMUSG00000097805 Gm17473 1.63E-07 1.610565 
ENSMUSG00000027560 Dok5 1.58E-03 1.609425 
ENSMUSG00000045875 Adra1a 3.66E-05 1.608373 
ENSMUSG00000074793 Hspa12b 3.94E-19 1.607954 
ENSMUSG00000068551 Zfp467 5.27E-10 1.605012 
ENSMUSG00000022442 Ttll1 1.44E-05 1.604733 
ENSMUSG00000058396 Gpr182 6.53E-09 1.603606 
ENSMUSG00000001496 Nkx2-1 1.73E-11 1.599734 
ENSMUSG00000116116 Gm671 1.39E-07 1.599663 
ENSMUSG00000030796 Tead2 3.21E-11 1.599608 
ENSMUSG00000057060 Slc35f3 1.38E-03 1.599499 
ENSMUSG00000046806 Cyren 2.91E-05 1.5994 
ENSMUSG00000003779 Kif20a 2.39E-02 1.599212 
ENSMUSG00000066235 Pomgnt2 2.51E-04 1.597016 
ENSMUSG00000055333 Fat2 2.60E-04 1.596568 
ENSMUSG00000030873 Scnn1b 2.04E-20 1.594799 




ENSMUSG00000020614 Fam20a 1.16E-14 1.594492 
ENSMUSG00000062542 Syt9 2.52E-02 1.59351 
ENSMUSG00000068263 Efcc1 1.34E-09 1.593299 
ENSMUSG00000097124 A530020G20Rik 5.09E-04 1.593002 
ENSMUSG00000078607 1810010H24Rik 7.09E-07 1.592582 
ENSMUSG00000043668 Tox3 5.03E-16 1.591389 
ENSMUSG00000022676 Snai2 1.80E-03 1.591354 
ENSMUSG00000042210 Abhd14a 1.25E-02 1.591316 
ENSMUSG00000024403 Atp6v1g2 5.74E-03 1.591076 
ENSMUSG00000026860 Sh3glb2 5.11E-12 1.590949 
ENSMUSG00000027217 Tspan18 4.38E-21 1.590887 
ENSMUSG00000082292 Gm12250 3.96E-04 1.59078 
ENSMUSG00000105135 Gm43667 1.64E-02 1.589917 
ENSMUSG00000031665 Sall1 9.47E-03 1.589292 
ENSMUSG00000108207 1810059H22Rik 2.37E-02 1.589229 
ENSMUSG00000087013 2610027K06Rik 5.70E-14 1.589185 
ENSMUSG00000044548 Dact1 2.47E-07 1.587675 
ENSMUSG00000110279 Gm45552 1.29E-02 1.585905 
ENSMUSG00000115301 Gm6330 2.91E-02 1.585784 
ENSMUSG00000055150 Zfp78 2.68E-03 1.584768 
ENSMUSG00000057751 Megf6 1.53E-14 1.584688 
ENSMUSG00000054517 Trim65 3.34E-06 1.584269 
ENSMUSG00000002771 Grin2d 3.01E-05 1.583762 
ENSMUSG00000107736 Gm44148 4.72E-09 1.583468 
ENSMUSG00000030680 Pagr1a 7.90E-04 1.5832 
ENSMUSG00000037025 Foxa2 1.28E-03 1.582839 
ENSMUSG00000103766 Gm38392 2.13E-04 1.580705 
ENSMUSG00000033233 Trim45 1.95E-02 1.578751 
ENSMUSG00000046240 Hepacam 4.39E-04 1.578062 
ENSMUSG00000098465 Mir1668 3.82E-05 1.577691 
ENSMUSG00000089769 Gm16574 3.22E-02 1.577572 
ENSMUSG00000029790 Cep41 1.21E-04 1.576274 
ENSMUSG00000046470 Sox18 1.24E-09 1.57479 
ENSMUSG00000036598 Ccdc113 2.12E-02 1.574563 
ENSMUSG00000084939 Gm830 2.06E-02 1.573865 
ENSMUSG00000069378 Prdm6 2.91E-16 1.572953 
ENSMUSG00000042766 Trim46 2.68E-03 1.572774 
ENSMUSG00000034848 Ttc21b 1.51E-11 1.572038 
ENSMUSG00000064284 Cdpf1 2.94E-03 1.571986 
ENSMUSG00000115095 Gm49311 8.92E-03 1.571257 
ENSMUSG00000020182 Ddc 2.97E-02 1.571232 
ENSMUSG00000032492 Pth1r 1.36E-04 1.570378 
ENSMUSG00000027574 Nkain4 3.42E-06 1.570249 
ENSMUSG00000021684 Pde8b 6.66E-17 1.570207 
ENSMUSG00000039552 Rsph4a 1.53E-02 1.570094 
ENSMUSG00000102305 Gm38192 4.40E-02 1.56988 
ENSMUSG00000041117 Ccdc8 7.59E-06 1.569825 
ENSMUSG00000033590 Myo5c 7.37E-13 1.569346 
ENSMUSG00000043932 Klri2 2.44E-03 1.5688 
ENSMUSG00000108218 Olfr1372-ps1 8.01E-05 1.567865 
ENSMUSG00000055134 9130017K11Rik 1.04E-02 1.567643 
ENSMUSG00000038725 Pkhd1l1 2.18E-08 1.56719 
ENSMUSG00000037279 Ovol2 3.58E-02 1.566143 
ENSMUSG00000050947 Amigo1 1.16E-07 1.566084 
ENSMUSG00000022416 Cacna1i 1.45E-03 1.565741 
ENSMUSG00000038379 Ttk 3.20E-02 1.564059 




ENSMUSG00000078772 Gm12353 1.41E-08 1.563774 
ENSMUSG00000115157 Gm49397 8.53E-23 1.563261 
ENSMUSG00000079164 Tlr5 3.12E-06 1.563178 
ENSMUSG00000068323 Slc4a5 5.95E-07 1.56313 
ENSMUSG00000054967 Zfp647 3.16E-03 1.563113 
ENSMUSG00000086533 Mypopos 8.00E-09 1.560072 
ENSMUSG00000064294 Aox3 2.44E-09 1.560014 
ENSMUSG00000025933 Tmem14a 2.01E-02 1.559242 
ENSMUSG00000061397 Krt79 1.26E-02 1.559113 
ENSMUSG00000062861 Zfp28 1.43E-05 1.558974 
ENSMUSG00000114553 Gm7644 7.76E-03 1.558629 
ENSMUSG00000039577 Nphp4 5.79E-05 1.558615 
ENSMUSG00000085936 2610307P16Rik 1.35E-26 1.558192 
ENSMUSG00000041429 Nthl1 1.26E-02 1.55773 
ENSMUSG00000030351 Tspan11 1.91E-24 1.555549 
ENSMUSG00000017167 Cntnap1 5.58E-04 1.555233 
ENSMUSG00000030800 Prss8 4.00E-07 1.554977 
ENSMUSG00000026824 Kcnj3 1.18E-10 1.55393 
ENSMUSG00000022759 Lrrc74b 1.13E-02 1.553927 
ENSMUSG00000102691 Gm37780 9.59E-03 1.553868 
ENSMUSG00000027424 Mgme1 8.77E-03 1.553739 
ENSMUSG00000038797 Zscan2 3.13E-04 1.553465 
ENSMUSG00000112121 C230072F16Rik 1.48E-06 1.553102 
ENSMUSG00000039304 Tnfsf10 1.86E-18 1.552207 
ENSMUSG00000054074 Skida1 4.97E-02 1.551638 
ENSMUSG00000074646 6430550D23Rik 3.75E-02 1.550595 
ENSMUSG00000051550 Zfp579 4.82E-05 1.549596 
ENSMUSG00000029053 Prkcz 2.72E-12 1.549462 
ENSMUSG00000045410 Akr1e1 1.81E-02 1.547976 
ENSMUSG00000108365 Gm44951 3.56E-03 1.547705 
ENSMUSG00000083817 Gm14400 4.50E-02 1.547364 
ENSMUSG00000024299 Adamts10 6.54E-19 1.546832 
ENSMUSG00000029603 Dtx1 4.99E-03 1.546727 
ENSMUSG00000075592 Nynrin 8.46E-14 1.546558 
ENSMUSG00000031517 Gpm6a 1.10E-11 1.546528 
ENSMUSG00000099564 Gm28729 2.89E-02 1.546472 
ENSMUSG00000022701 Ccdc191 1.34E-10 1.546372 
ENSMUSG00000039058 Ak5 3.48E-05 1.546267 
ENSMUSG00000048498 Cd300e 4.94E-02 1.545969 
ENSMUSG00000106633 Gm43431 4.81E-02 1.544944 
ENSMUSG00000066438 Plekhd1 9.20E-06 1.544901 
ENSMUSG00000060548 Tnfrsf19 5.99E-12 1.544576 
ENSMUSG00000020682 Mmp28 3.42E-09 1.544554 
ENSMUSG00000042073 Abhd14b 8.46E-08 1.543843 
ENSMUSG00000074384 AI429214 3.33E-02 1.543505 
ENSMUSG00000082264 Gm12799 1.72E-04 1.543452 
ENSMUSG00000048897 Zfp710 6.90E-19 1.542688 
ENSMUSG00000109165 Gm45148 3.20E-02 1.542583 
ENSMUSG00000022543 4930451G09Rik 2.13E-02 1.542361 
ENSMUSG00000032609 Klhdc8b 1.78E-05 1.541974 
ENSMUSG00000062785 Kcnc3 7.41E-09 1.541955 
ENSMUSG00000034532 Fbxo16 4.66E-02 1.5419 
ENSMUSG00000020513 Tubd1 2.22E-06 1.541575 
ENSMUSG00000035547 Capn5 1.06E-11 1.541062 
ENSMUSG00000020268 Lyrm7 1.22E-03 1.541004 
ENSMUSG00000106758 Gm42731 3.30E-02 1.540776 




ENSMUSG00000041460 Cacna2d4 2.80E-02 1.540666 
ENSMUSG00000037813 D630003M21Rik 1.59E-03 1.540376 
ENSMUSG00000037892 Pcdh18 2.52E-14 1.540206 
ENSMUSG00000078552 Dcdc2b 3.72E-02 1.539768 
ENSMUSG00000113543 Gm36264 2.91E-02 1.539705 
ENSMUSG00000029335 Bmp3 1.77E-12 1.539659 
ENSMUSG00000107068 Gm42742 4.89E-06 1.538758 
ENSMUSG00000095987 Gm13104 1.34E-02 1.538362 
ENSMUSG00000046456 Tmem150b 2.91E-03 1.538263 
ENSMUSG00000106247 Gm43720 4.73E-02 1.538062 
ENSMUSG00000070873 Lilra5 3.76E-03 1.53778 
ENSMUSG00000022818 Cyp2ab1 2.94E-02 1.537532 
ENSMUSG00000058656 Samd12 1.10E-19 1.536867 
ENSMUSG00000059851 Kmt5c 1.85E-08 1.536592 
ENSMUSG00000104114 Gm37297 4.16E-04 1.536347 
ENSMUSG00000018740 Slc25a35 2.79E-05 1.536163 
ENSMUSG00000103845 Gm19026 3.48E-03 1.536156 
ENSMUSG00000112627 4933412E12Rik 2.50E-08 1.535554 
ENSMUSG00000035863 Palm 2.73E-10 1.535105 
ENSMUSG00000033763 Mtss1l 3.13E-14 1.535088 
ENSMUSG00000024787 Snx15 1.16E-06 1.534706 
ENSMUSG00000028088 Fmo5 1.52E-06 1.534518 
ENSMUSG00000106892 Gm42791 4.56E-09 1.534363 
ENSMUSG00000051359 Ncald 1.38E-26 1.534218 
ENSMUSG00000049532 Sall2 6.86E-05 1.534187 
ENSMUSG00000112164 Gm19990 4.48E-02 1.533334 
ENSMUSG00000026888 Grb14 1.31E-24 1.5329 
ENSMUSG00000026586 Prrx1 1.15E-18 1.532838 
ENSMUSG00000023147 Wrb 8.70E-05 1.531827 
ENSMUSG00000022941 Ripply3 1.87E-10 1.531256 
ENSMUSG00000021055 Esr2 9.86E-08 1.531097 
ENSMUSG00000050069 Grem2 2.17E-14 1.53098 
ENSMUSG00000042784 Muc1 1.74E-15 1.530839 
ENSMUSG00000030361 Klrb1a 1.98E-02 1.530589 
ENSMUSG00000036278 Macrod1 1.31E-10 1.530463 
ENSMUSG00000027500 Stmn2 5.55E-12 1.529312 
ENSMUSG00000079671 2610203C22Rik 1.17E-16 1.529211 
ENSMUSG00000070737 Tmem35b 1.01E-03 1.528272 
ENSMUSG00000026443 Lrrn2 3.23E-03 1.52766 
ENSMUSG00000036882 Arhgap33 2.72E-04 1.527118 
ENSMUSG00000076431 Sox4 1.22E-10 1.526384 
ENSMUSG00000049107 Ntf3 3.97E-10 1.526123 
ENSMUSG00000097354 2310001H17Rik 1.98E-27 1.525662 
ENSMUSG00000102326 Gm37788 2.52E-02 1.525393 
ENSMUSG00000115970 8430426J06Rik 1.78E-06 1.52498 
ENSMUSG00000000627 Sema4f 1.29E-05 1.524743 
ENSMUSG00000051855 Mest 2.70E-08 1.524224 
ENSMUSG00000019312 Grb7 4.43E-03 1.524165 
ENSMUSG00000041361 Myzap 3.12E-18 1.523261 
ENSMUSG00000036983 Tfb1m 1.77E-06 1.521731 
ENSMUSG00000024673 Ms4a1 3.20E-04 1.521639 
ENSMUSG00000019945 Cabcoco1 2.38E-04 1.52083 
ENSMUSG00000026748 Plxdc2 3.63E-19 1.520549 
ENSMUSG00000107499 Ccdc142 4.86E-02 1.520041 
ENSMUSG00000029456 Acad10 4.39E-07 1.520036 
ENSMUSG00000023949 Tcte1 3.76E-02 1.5199 




ENSMUSG00000060862 Zbtb40 1.39E-13 1.517839 
ENSMUSG00000027490 E2f1 3.92E-02 1.517055 
ENSMUSG00000032680 6820408C15Rik 1.89E-02 1.516845 
ENSMUSG00000022103 Gfra2 1.63E-10 1.516841 
ENSMUSG00000000402 Egfl6 8.17E-08 1.516514 
ENSMUSG00000026390 Marco 1.23E-08 1.516135 
ENSMUSG00000107794 Gm44095 3.87E-02 1.515819 
ENSMUSG00000111761 9230112J17Rik 1.69E-02 1.51564 
ENSMUSG00000056228 Cars2 3.79E-12 1.514966 
ENSMUSG00000079003 Samd1 1.24E-04 1.514814 
ENSMUSG00000038302 Afg1l 7.32E-25 1.514245 
ENSMUSG00000022309 Angpt1 1.03E-07 1.514084 
ENSMUSG00000045114 Prrt2 9.94E-04 1.51398 
ENSMUSG00000037922 Bank1 1.10E-03 1.512972 
ENSMUSG00000034800 Zfp661 9.55E-03 1.512619 
ENSMUSG00000036411 9530077C05Rik 8.03E-05 1.512568 
ENSMUSG00000035459 Stab2 1.02E-04 1.512457 
ENSMUSG00000062960 Kdr 3.63E-21 1.511554 
ENSMUSG00000050936 Gm42743 1.63E-07 1.511039 
ENSMUSG00000021719 Rgs7bp 4.17E-07 1.510943 
ENSMUSG00000031802 Phxr4 1.18E-04 1.510821 
ENSMUSG00000085207 Gm11767 2.22E-03 1.50959 
ENSMUSG00000057396 Zfp759 1.29E-03 1.509269 
ENSMUSG00000031736 Crnde 1.62E-06 1.509225 
ENSMUSG00000027977 Ndst3 7.76E-05 1.508506 
ENSMUSG00000025395 Prim1 4.62E-03 1.507443 
ENSMUSG00000030551 Nr2f2 3.20E-10 1.507264 
ENSMUSG00000028003 Lrat 1.08E-05 1.507135 
ENSMUSG00000100707 Gm28523 2.77E-03 1.50701 
ENSMUSG00000050222 Il17d 1.67E-02 1.506503 
ENSMUSG00000056185 Snx32 3.36E-07 1.506257 
ENSMUSG00000098318 Lockd 1.28E-03 1.50611 
ENSMUSG00000031775 Pllp 1.05E-06 1.506048 
ENSMUSG00000002346 Slc25a42 8.80E-09 1.506014 
ENSMUSG00000007207 Stx1a 7.57E-06 1.5059 
ENSMUSG00000030084 Plxna1 1.91E-16 1.505539 
ENSMUSG00000059146 Ntrk3 4.22E-15 1.504398 
ENSMUSG00000073424 Cyp4f15 1.80E-02 1.503825 
ENSMUSG00000039062 Anpep 4.19E-13 1.503782 
ENSMUSG00000001288 Rarg 2.33E-13 1.503681 
ENSMUSG00000051817 Sox12 4.13E-02 1.502765 
ENSMUSG00000076609 Igkc 4.41E-05 1.502726 
ENSMUSG00000013033 Adgrl1 1.28E-14 1.502317 
ENSMUSG00000033948 Zswim5 6.73E-05 1.501944 
ENSMUSG00000079620 Muc4 1.41E-14 1.501612 
ENSMUSG00000024018 Ccdc167 3.57E-09 1.501095 
ENSMUSG00000045441 Gprin3 3.83E-11 1.500851 
ENSMUSG00000036959 Bcorl1 3.46E-14 1.500655 
ENSMUSG00000044701 Il27 1.05E-02 1.500073 
ENSMUSG00000028773 Fabp3 3.89E-05 1.501682 
ENSMUSG00000070031 Sp140 3.17E-21 1.501904 
ENSMUSG00000105053 Gm43064 1.55E-08 1.501933 
ENSMUSG00000029552 Tes 1.46E-22 1.502499 
ENSMUSG00000047976 Kcna1 4.87E-04 1.502872 
ENSMUSG00000045349 Sh2d5 1.76E-02 1.502987 
ENSMUSG00000058755 Osm 1.79E-04 1.503113 




ENSMUSG00000113041 Gm48302 4.83E-03 1.503595 
ENSMUSG00000100969 1700030N03Rik 9.26E-03 1.503827 
ENSMUSG00000030595 Nfkbib 5.68E-12 1.503921 
ENSMUSG00000090141 Gm614 3.44E-04 1.504654 
ENSMUSG00000035208 Slfn8 3.12E-11 1.504893 
ENSMUSG00000004951 Hspb1 3.20E-15 1.505858 
ENSMUSG00000059498 Fcgr3 5.02E-25 1.506788 
ENSMUSG00000043953 Ccrl2 2.05E-15 1.507145 
ENSMUSG00000041754 Trem3 1.95E-08 1.507303 
ENSMUSG00000112707 D830005E20Rik 3.83E-06 1.507644 
ENSMUSG00000084208 Gm12792 3.21E-02 1.508358 
ENSMUSG00000053560 Ier2 6.51E-12 1.508916 
ENSMUSG00000021886 Gpr65 5.04E-09 1.509174 
ENSMUSG00000105337 1700094M23Rik 2.68E-06 1.510638 
ENSMUSG00000075042 4930431P03Rik 3.69E-02 1.511896 
ENSMUSG00000101969 Gm20125 2.94E-03 1.51201 
ENSMUSG00000039005 Tlr4 9.61E-33 1.512543 
ENSMUSG00000102476 Gm37245 3.69E-08 1.512732 
ENSMUSG00000036557 Stpg4 4.97E-02 1.513017 
ENSMUSG00000108368 Gm45053 8.49E-05 1.513592 
ENSMUSG00000034640 Tiparp 3.82E-23 1.514228 
ENSMUSG00000004609 Cd33 1.53E-22 1.514366 
ENSMUSG00000097558 Gm26902 2.40E-02 1.514485 
ENSMUSG00000030069 Prok2 3.12E-09 1.51466 
ENSMUSG00000079012 Serpina3m 9.97E-15 1.515028 
ENSMUSG00000037833 Sh2d4b 1.28E-10 1.515452 
ENSMUSG00000036181 Hist1h1c 8.16E-07 1.515838 
ENSMUSG00000032942 Ucp3 2.72E-04 1.515872 
ENSMUSG00000078915 Hsp25-ps1 1.89E-14 1.515918 
ENSMUSG00000045763 Basp1 8.22E-23 1.516202 
ENSMUSG00000023964 Calcr 2.13E-09 1.51776 
ENSMUSG00000074449 Gm15319 1.18E-02 1.518175 
ENSMUSG00000027748 Trpc4 4.48E-02 1.518209 
ENSMUSG00000084093 Gm16418 4.51E-02 1.518297 
ENSMUSG00000025716 Myo3a 1.15E-02 1.518517 
ENSMUSG00000019787 Trdn 5.00E-18 1.51858 
ENSMUSG00000089281 Scarna6 1.66E-02 1.519358 
ENSMUSG00000090248 Gm14027 1.67E-02 1.519727 
ENSMUSG00000086320 Gm12840 2.45E-10 1.519868 
ENSMUSG00000028573 Fggy 5.40E-03 1.520122 
ENSMUSG00000033730 Egr3 6.03E-09 1.520144 
ENSMUSG00000089716 Gm6264 6.83E-06 1.520708 
ENSMUSG00000051650 B3gnt2 7.54E-28 1.520857 
ENSMUSG00000104108 Gm37876 2.97E-03 1.520932 
ENSMUSG00000051439 Cd14 2.28E-24 1.521574 
ENSMUSG00000020732 Rab37 4.19E-04 1.521864 
ENSMUSG00000037904 Ankrd9 7.83E-03 1.522534 
ENSMUSG00000105195 Gm43584 5.16E-04 1.522603 
ENSMUSG00000027360 Hdc 4.67E-21 1.522604 
ENSMUSG00000001014 Icam4 1.36E-02 1.522651 
ENSMUSG00000022126 Acod1 4.82E-25 1.523696 
ENSMUSG00000031448 Adprhl1 1.56E-05 1.524028 
ENSMUSG00000056328 Myh1 4.72E-14 1.524211 
ENSMUSG00000087593 Gm16174 6.08E-03 1.524313 
ENSMUSG00000020275 Rel 1.32E-22 1.524463 
ENSMUSG00000016559 H3f3b 1.21E-21 1.524786 




ENSMUSG00000099250 Rn7s2 1.32E-02 1.526701 
ENSMUSG00000099021 Rn7s1 1.32E-02 1.526715 
ENSMUSG00000023067 Cdkn1a 1.39E-25 1.527143 
ENSMUSG00000095294 Gm21119 1.32E-02 1.527698 
ENSMUSG00000026073 Il1r2 1.36E-06 1.527927 
ENSMUSG00000031231 Cox7b 1.64E-09 1.528049 
ENSMUSG00000025161 Slc16a3 3.55E-18 1.528109 
ENSMUSG00000097543 Gm805 4.90E-02 1.528998 
ENSMUSG00000059974 Ntm 4.19E-21 1.529013 
ENSMUSG00000103288 Gm37273 8.69E-03 1.529304 
ENSMUSG00000052769 Gm9889 3.93E-02 1.529381 
ENSMUSG00000024590 Lmnb1 8.45E-17 1.529562 
ENSMUSG00000114277 Gm48583 4.03E-03 1.529671 
ENSMUSG00000106497 Gm43195 3.51E-02 1.529948 
ENSMUSG00000085147 Gm12609 2.37E-02 1.529985 
ENSMUSG00000068697 Myoz1 6.25E-04 1.530719 
ENSMUSG00000029660 Tex26 1.65E-04 1.530841 
ENSMUSG00000046480 Scn4b 9.28E-05 1.530902 
ENSMUSG00000115946 Mirt2 7.87E-13 1.531478 
ENSMUSG00000021622 Ckmt2 1.46E-08 1.531721 
ENSMUSG00000039753 Fbxl5 8.84E-17 1.532351 
ENSMUSG00000108486 Gm44836 8.76E-04 1.533293 
ENSMUSG00000082057 Gm15789 2.89E-02 1.533491 
ENSMUSG00000028862 Map3k6 6.29E-22 1.534354 
ENSMUSG00000061462 Obscn 6.82E-21 1.535088 
ENSMUSG00000029204 Rhoh 1.11E-19 1.535236 
ENSMUSG00000072620 Slfn2 1.20E-17 1.535662 
ENSMUSG00000098670 Gm27818 3.10E-02 1.536024 
ENSMUSG00000107029 Gm43123 2.37E-04 1.536945 
ENSMUSG00000087066 Gm15518 2.95E-07 1.537162 
ENSMUSG00000031682 1700011L22Rik 6.64E-04 1.537235 
ENSMUSG00000078763 Slfn1 2.40E-16 1.537518 
ENSMUSG00000074149 Gm10634 4.40E-06 1.540107 
ENSMUSG00000030669 Calca 1.35E-04 1.540221 
ENSMUSG00000030088 Aldh1l1 8.07E-17 1.541343 
ENSMUSG00000030107 Usp18 3.01E-16 1.541655 
ENSMUSG00000071342 Lsmem1 3.17E-06 1.541988 
ENSMUSG00000027861 Casq2 2.44E-09 1.542362 
ENSMUSG00000074419 Gm15448 1.08E-08 1.542588 
ENSMUSG00000062077 Trim54 3.72E-07 1.543231 
ENSMUSG00000031289 Il13ra2 2.50E-02 1.544205 
ENSMUSG00000094344 Gm11942 5.03E-07 1.545029 
ENSMUSG00000055602 Tcp10b 1.12E-04 1.545251 
ENSMUSG00000022902 Stfa2 2.23E-06 1.546076 
ENSMUSG00000097579 Gm26799 2.14E-03 1.546157 
ENSMUSG00000028116 Myoz2 3.48E-11 1.546592 
ENSMUSG00000029915 Clec5a 1.27E-14 1.546688 
ENSMUSG00000087135 Gm16096 3.13E-02 1.547248 
ENSMUSG00000026669 Mcm10 6.49E-05 1.547768 
ENSMUSG00000026358 Rgs1 2.94E-05 1.548109 
ENSMUSG00000114790 4921509O07Rik 1.41E-03 1.54851 
ENSMUSG00000115855 Gm34643 2.49E-02 1.548911 
ENSMUSG00000097062 Gm17586 4.91E-02 1.549771 
ENSMUSG00000037139 Myom3 5.04E-08 1.550368 
ENSMUSG00000028012 Rrh 5.89E-04 1.551343 
ENSMUSG00000052270 Fpr2 8.89E-17 1.551885 




ENSMUSG00000042680 Garem1 2.43E-28 1.553264 
ENSMUSG00000083500 Gm15470 2.33E-02 1.553699 
ENSMUSG00000089617 Scarna10 1.33E-02 1.554248 
ENSMUSG00000099587 Gm28967 1.33E-02 1.554248 
ENSMUSG00000061723 Tnnt3 3.59E-06 1.554618 
ENSMUSG00000101930 Gm5441 4.71E-05 1.554924 
ENSMUSG00000047281 Sfn 1.18E-07 1.554958 
ENSMUSG00000003134 Tbc1d8 2.31E-17 1.555831 
ENSMUSG00000095098 Ccdc85b 1.46E-02 1.556789 
ENSMUSG00000105572 Gm43300 1.75E-04 1.557092 
ENSMUSG00000007877 Tcap 8.03E-10 1.557367 
ENSMUSG00000028896 Rcc1 6.05E-10 1.558192 
ENSMUSG00000104093 A330015K06Rik 2.94E-04 1.558524 
ENSMUSG00000049515 Espnl 1.85E-06 1.558599 
ENSMUSG00000105145 Gm47299 1.61E-02 1.559865 
ENSMUSG00000105788 Gm47295 1.61E-02 1.560047 
ENSMUSG00000030470 Csrp3 2.57E-10 1.560127 
ENSMUSG00000086350 B230369F24Rik 3.44E-02 1.561156 
ENSMUSG00000092134 Gm17089 1.34E-02 1.562976 
ENSMUSG00000087684 1200007C13Rik 1.65E-13 1.563081 
ENSMUSG00000031626 Sorbs2 1.55E-17 1.563623 
ENSMUSG00000109279 Gm45220 1.65E-07 1.564122 
ENSMUSG00000031780 Ccl17 2.29E-05 1.565128 
ENSMUSG00000110251 Gm2996 4.56E-09 1.565506 
ENSMUSG00000021591 Glrx 1.01E-19 1.565524 
ENSMUSG00000079597 Gm5483 5.00E-11 1.565997 
ENSMUSG00000097282 5031415H12Rik 2.32E-03 1.566965 
ENSMUSG00000086554 9530034E10Rik 1.85E-02 1.567387 
ENSMUSG00000109005 Gm45221 4.72E-09 1.567699 
ENSMUSG00000050439 Enthd1 1.23E-02 1.568498 
ENSMUSG00000020644 Id2 5.12E-18 1.570106 
ENSMUSG00000086584 Gm12002 1.57E-02 1.570339 
ENSMUSG00000079190 AC133103.1 6.72E-04 1.570523 
ENSMUSG00000107352 Gm43660 2.34E-04 1.570886 
ENSMUSG00000056569 Mpz 2.72E-08 1.570995 
ENSMUSG00000069873 4930438A08Rik 3.36E-02 1.571682 
ENSMUSG00000085249 Gm12847 2.96E-02 1.571826 
ENSMUSG00000052212 Cd177 3.33E-17 1.571901 
ENSMUSG00000031382 Asb11 2.67E-04 1.571915 
ENSMUSG00000087597 Gm15345 5.12E-03 1.573455 
ENSMUSG00000101751 Gm2427 5.74E-06 1.573571 
ENSMUSG00000024774 Ankrd22 7.98E-10 1.573578 
ENSMUSG00000078122 F630028O10Rik 7.10E-07 1.57378 
ENSMUSG00000104801 Gm43834 1.91E-08 1.574775 
ENSMUSG00000095260 Gm25890 2.05E-02 1.575215 
ENSMUSG00000094812 Gm22614 2.05E-02 1.575215 
ENSMUSG00000044997 E130304I02Rik 4.00E-02 1.575721 
ENSMUSG00000098702 1500015A07Rik 6.89E-04 1.576298 
ENSMUSG00000019933 Mrln 7.38E-03 1.577435 
ENSMUSG00000055972 2810407A14Rik 3.65E-09 1.577756 
ENSMUSG00000104406 Gm38014 2.17E-03 1.5782 
ENSMUSG00000046223 Plaur 3.97E-19 1.578531 
ENSMUSG00000031452 1700029H14Rik 7.05E-11 1.578888 
ENSMUSG00000044639 Gm11507 3.21E-02 1.580159 
ENSMUSG00000047604 Frat2 6.81E-03 1.580191 
ENSMUSG00000086765 Gm11827 2.45E-03 1.580289 




ENSMUSG00000029377 Ereg 1.30E-07 1.581718 
ENSMUSG00000005686 Ampd3 3.84E-36 1.582624 
ENSMUSG00000055639 Dach1 2.45E-49 1.582772 
ENSMUSG00000048572 Tmem252 2.15E-30 1.583456 
ENSMUSG00000106741 4930513D17Rik 2.31E-03 1.583518 
ENSMUSG00000104449 Gm37255 6.66E-04 1.583657 
ENSMUSG00000034226 Rhov 1.51E-03 1.583825 
ENSMUSG00000034990 Otoa 2.27E-03 1.584135 
ENSMUSG00000038059 Smim3 2.50E-27 1.584279 
ENSMUSG00000064288 Hist1h4k 2.55E-02 1.584323 
ENSMUSG00000067049 Unc93a 3.55E-03 1.584342 
ENSMUSG00000114662 Gm31683 3.36E-03 1.584857 
ENSMUSG00000071561 BC100530 2.75E-07 1.585823 
ENSMUSG00000056025 Clca3a1 1.39E-09 1.586042 
ENSMUSG00000064923 Gm22042 1.82E-02 1.586766 
ENSMUSG00000087362 Gm13710 3.87E-05 1.588172 
ENSMUSG00000115764 Gm18811 4.77E-02 1.588766 
ENSMUSG00000102135 Gm37108 6.83E-03 1.589787 
ENSMUSG00000018930 Ccl4 3.25E-14 1.592018 
ENSMUSG00000092920 Mirt2 2.33E-03 1.593218 
ENSMUSG00000003484 Cyp4f18 1.28E-11 1.594494 
ENSMUSG00000068855 Hist2h2ac 2.26E-02 1.595197 
ENSMUSG00000077192 Snora17 1.22E-02 1.595366 
ENSMUSG00000112148 Lilrb4a 6.29E-08 1.595991 
ENSMUSG00000053914 Kdm4d 3.47E-07 1.598458 
ENSMUSG00000078905 Gm14393 2.09E-02 1.598898 
ENSMUSG00000055301 Adh7 3.36E-04 1.599546 
ENSMUSG00000025804 Ccr1 2.69E-15 1.600075 
ENSMUSG00000025236 Adpgk 4.54E-06 1.600129 
ENSMUSG00000028747 Htr6 3.61E-02 1.600441 
ENSMUSG00000026452 Syt2 4.75E-12 1.600466 
ENSMUSG00000095438 Mir133a-1hg 8.40E-04 1.60088 
ENSMUSG00000107092 Gm7993 3.05E-09 1.601292 
ENSMUSG00000099061 Gm28050 3.42E-06 1.601401 
ENSMUSG00000100182 1810006J02Rik 2.34E-03 1.601528 
ENSMUSG00000080845 Gm9115 9.28E-06 1.602056 
ENSMUSG00000021702 Thbs4 5.37E-07 1.602758 
ENSMUSG00000094733 Gm5416 2.35E-02 1.603974 
ENSMUSG00000044719 E230025N22Rik 7.14E-03 1.604274 
ENSMUSG00000031538 Plat 1.12E-27 1.6045 
ENSMUSG00000071562 Stfa1 1.25E-02 1.604593 
ENSMUSG00000116760 AC164314.1 1.55E-18 1.605019 
ENSMUSG00000062028 Irgc1 1.27E-03 1.605428 
ENSMUSG00000020108 Ddit4 3.87E-18 1.605556 
ENSMUSG00000097168 C230088H06Rik 1.53E-07 1.607501 
ENSMUSG00000059657 Stfa2l1 4.70E-13 1.608177 
ENSMUSG00000054383 Pnma1 1.59E-02 1.609741 
ENSMUSG00000030235 Slco1c1 8.01E-11 1.610186 
ENSMUSG00000079800 AC125149.3 5.67E-04 1.610687 
ENSMUSG00000047330 Kcne4 1.72E-12 1.611245 
ENSMUSG00000011179 Odc1 6.77E-19 1.611702 
ENSMUSG00000088185 Scarna2 2.29E-04 1.611916 
ENSMUSG00000029635 Cdk8 2.85E-05 1.613325 
ENSMUSG00000040747 Cd53 2.71E-18 1.613354 
ENSMUSG00000104740 Mir6516 3.89E-02 1.613694 
ENSMUSG00000086275 1700121C08Rik 1.98E-03 1.614578 




ENSMUSG00000046101 Mcmdc2 2.24E-02 1.615786 
ENSMUSG00000114980 4933432I03Rik 3.86E-13 1.617126 
ENSMUSG00000112105 Rps7-ps2 2.09E-03 1.617464 
ENSMUSG00000024215 Spdef 3.27E-04 1.617571 
ENSMUSG00000087436 Gm16156 1.33E-02 1.618843 
ENSMUSG00000095701 Gm24830 1.23E-02 1.619865 
ENSMUSG00000096838 Gm26232 1.23E-02 1.619865 
ENSMUSG00000065773 Rnu1b6 1.23E-02 1.619865 
ENSMUSG00000029378 Areg 8.57E-05 1.620274 
ENSMUSG00000030144 Clec4d 1.13E-16 1.621129 
ENSMUSG00000089999 Gm6485 1.16E-11 1.621898 
ENSMUSG00000097060 Gm26759 2.64E-04 1.622397 
ENSMUSG00000043613 Mmp3 2.40E-04 1.624738 
ENSMUSG00000106607 Gm43178 2.36E-02 1.625189 
ENSMUSG00000064941 Gm23238 2.37E-03 1.625244 
ENSMUSG00000045102 Poln 6.51E-23 1.627181 
ENSMUSG00000074146 4930579C12Rik 9.25E-09 1.627321 
ENSMUSG00000061878 Sphk1 2.13E-23 1.628004 
ENSMUSG00000067555 Gm10212 4.20E-03 1.628146 
ENSMUSG00000086993 Rsf1os2 1.93E-02 1.629504 
ENSMUSG00000116747 AC144408.2 2.19E-02 1.630024 
ENSMUSG00000069273 Hist1h3e 8.64E-03 1.630123 
ENSMUSG00000085743 8430419K02Rik 5.99E-13 1.63082 
ENSMUSG00000053338 Tarm1 1.27E-22 1.63113 
ENSMUSG00000024471 Myot 2.74E-09 1.631316 
ENSMUSG00000046610 Oacyl 1.57E-04 1.631988 
ENSMUSG00000114125 1700037F03Rik 1.56E-02 1.632073 
ENSMUSG00000027832 Ptx3 2.36E-34 1.633264 
ENSMUSG00000092397 C130080G10Rik 3.11E-06 1.634192 
ENSMUSG00000099803 Gm28863 4.44E-02 1.634596 
ENSMUSG00000100779 Gm29292 5.73E-14 1.635041 
ENSMUSG00000032523 Hhatl 1.82E-03 1.63623 
ENSMUSG00000028125 Abca4 1.97E-12 1.637562 
ENSMUSG00000038037 Socs1 4.73E-08 1.638886 
ENSMUSG00000031872 Bean1 1.38E-10 1.639807 
ENSMUSG00000049734 Trex1 2.49E-11 1.640014 
ENSMUSG00000095580 Rnu1b1 1.33E-02 1.641977 
ENSMUSG00000093834 Rnu1b2 1.33E-02 1.641977 
ENSMUSG00000009633 G0s2 2.23E-07 1.642205 
ENSMUSG00000002847 Pla1a 3.33E-22 1.642753 
ENSMUSG00000043008 Klhl6 7.14E-15 1.642823 
ENSMUSG00000062461 Gm5453 8.90E-06 1.643537 
ENSMUSG00000045455 Gm9797 4.46E-02 1.644519 
ENSMUSG00000082884 Gm13339 5.60E-05 1.644853 
ENSMUSG00000052477 C130026I21Rik 6.00E-27 1.645118 
ENSMUSG00000040490 Lrfn2 1.41E-02 1.645149 
ENSMUSG00000113701 B230303A05Rik 4.29E-04 1.645667 
ENSMUSG00000104560 Gm8115 6.75E-04 1.645915 
ENSMUSG00000028396 2310002L09Rik 4.23E-02 1.649697 
ENSMUSG00000024521 Pmaip1 2.02E-17 1.652637 
ENSMUSG00000066361 Serpina3c 4.62E-21 1.652992 
ENSMUSG00000091971 Hspa1a 3.82E-05 1.65332 
ENSMUSG00000027014 Cwc22 6.70E-06 1.653834 
ENSMUSG00000085779 Atcayos 1.32E-11 1.655658 
ENSMUSG00000079462 Gm15737 4.27E-02 1.655772 
ENSMUSG00000069305 Hist1h4n 1.34E-02 1.65667 




ENSMUSG00000023341 Mx2 6.24E-29 1.656679 
ENSMUSG00000096957 E230013L22Rik 2.31E-09 1.657441 
ENSMUSG00000082838 Gm14519 1.01E-05 1.657928 
ENSMUSG00000095500 AC132444.5 1.55E-02 1.658094 
ENSMUSG00000035692 Isg15 5.98E-17 1.659027 
ENSMUSG00000031972 Acta1 2.51E-10 1.660693 
ENSMUSG00000115518 Gm10791 1.14E-03 1.661218 
ENSMUSG00000028989 Angptl7 1.47E-05 1.661267 
ENSMUSG00000030592 Ryr1 3.10E-08 1.662936 
ENSMUSG00000087968 Gm25395 3.29E-04 1.663115 
ENSMUSG00000074218 Cox7a1 2.46E-05 1.664493 
ENSMUSG00000097927 Gm6999 1.40E-06 1.664539 
ENSMUSG00000024481 Lvrn 1.55E-15 1.664843 
ENSMUSG00000051748 Wfdc21 6.59E-11 1.665772 
ENSMUSG00000056133 Unc93a2 1.42E-02 1.666035 
ENSMUSG00000022821 Hgd 9.91E-04 1.666819 
ENSMUSG00000077391 Gm24336 9.21E-03 1.667557 
ENSMUSG00000112895 Gm47567 1.94E-03 1.668933 
ENSMUSG00000097414 B130046B21Rik 5.30E-06 1.670513 
ENSMUSG00000057003 Myh4 1.07E-10 1.67121 
ENSMUSG00000096010 Hist4h4 2.64E-03 1.673569 
ENSMUSG00000113960 4933412O06Rik 5.41E-03 1.673653 
ENSMUSG00000041616 Nppa 2.60E-04 1.674788 
ENSMUSG00000108436 Gm44851 2.65E-02 1.675059 
ENSMUSG00000052496 Pkdrej 8.35E-03 1.675102 
ENSMUSG00000032845 Alpk2 2.46E-22 1.67545 
ENSMUSG00000006345 Ggt1 2.80E-06 1.675688 
ENSMUSG00000030672 Mylpf 2.51E-04 1.677392 
ENSMUSG00000075122 Cd80 1.39E-25 1.678083 
ENSMUSG00000100301 6030407O03Rik 1.46E-17 1.678651 
ENSMUSG00000091952 Gm17709 3.50E-11 1.679019 
ENSMUSG00000022876 Samsn1 2.79E-24 1.680546 
ENSMUSG00000113178 Mylf-ps 3.93E-08 1.680637 
ENSMUSG00000095620 2010005H15Rik 3.96E-03 1.680691 
ENSMUSG00000054258 Gm5082 3.59E-02 1.681204 
ENSMUSG00000070498 Tmem132b 3.01E-11 1.68225 
ENSMUSG00000056856 Jakmip3 3.89E-03 1.683214 
ENSMUSG00000111324 Gm31410 6.04E-03 1.68436 
ENSMUSG00000054204 Alkal2 1.32E-02 1.6846 
ENSMUSG00000078902 Gm14443 6.61E-03 1.684691 
ENSMUSG00000076135 Gm24276 3.81E-02 1.685494 
ENSMUSG00000000204 Slfn4 1.36E-09 1.686 
ENSMUSG00000005800 Mmp8 3.48E-29 1.686464 
ENSMUSG00000001249 Hpn 7.62E-12 1.687075 
ENSMUSG00000041827 Oasl1 9.65E-18 1.687086 
ENSMUSG00000074452 Pate2 1.83E-10 1.688618 
ENSMUSG00000045551 Fpr1 1.35E-39 1.689129 
ENSMUSG00000053641 Dennd4a 2.32E-30 1.689402 
ENSMUSG00000104818 Gm43661 1.29E-03 1.689966 
ENSMUSG00000109232 Gm44577 4.63E-03 1.690024 
ENSMUSG00000048489 Depp1 1.22E-08 1.690058 
ENSMUSG00000093378 Gm20663 1.10E-02 1.691727 
ENSMUSG00000049134 Nrap 6.44E-22 1.692374 
ENSMUSG00000051832 E230016K23Rik 8.52E-07 1.694895 
ENSMUSG00000052837 Junb 1.10E-23 1.695927 
ENSMUSG00000069274 Hist1h4f 1.44E-02 1.701594 




ENSMUSG00000028680 Plk3 1.48E-17 1.701976 
ENSMUSG00000032174 Icam5 1.01E-02 1.705483 
ENSMUSG00000087113 Gm11714 3.79E-04 1.706526 
ENSMUSG00000111514 E230014E18Rik 7.88E-06 1.708494 
ENSMUSG00000064382 Gm26447 1.31E-04 1.709249 
ENSMUSG00000107667 C530044C16Rik 6.95E-03 1.709767 
ENSMUSG00000057580 Gm10012 5.96E-03 1.711919 
ENSMUSG00000062593 Gm49339 8.13E-09 1.712107 
ENSMUSG00000047216 Cdh19 5.39E-12 1.712183 
ENSMUSG00000092626 9130230N09Rik 3.71E-02 1.712613 
ENSMUSG00000109032 Gm7972 5.34E-05 1.712639 
ENSMUSG00000087159 Gm15246 5.79E-06 1.712843 
ENSMUSG00000071637 Cebpd 2.78E-33 1.713579 
ENSMUSG00000027737 Slc7a11 7.04E-24 1.713985 
ENSMUSG00000109729 Gm45418 1.79E-06 1.714339 
ENSMUSG00000026068 Il18rap 1.63E-22 1.714997 
ENSMUSG00000097263 Gm26804 1.62E-02 1.715908 
ENSMUSG00000109052 Gm45012 1.67E-02 1.716023 
ENSMUSG00000029862 Clcn1 8.39E-06 1.716184 
ENSMUSG00000022582 Ly6g 3.58E-05 1.718298 
ENSMUSG00000042918 Mamstr 7.60E-18 1.719004 
ENSMUSG00000027505 Fam209 8.93E-03 1.720522 
ENSMUSG00000092201 A530058N18Rik 6.08E-09 1.721383 
ENSMUSG00000102349 Gm37376 7.33E-03 1.722299 
ENSMUSG00000102051 I830127L07Rik 2.66E-06 1.722921 
ENSMUSG00000094306 Gm24924 3.54E-03 1.723532 
ENSMUSG00000027470 Mylk2 8.88E-09 1.72462 
ENSMUSG00000088008 Gm25492 2.74E-02 1.727829 
ENSMUSG00000029384 2010109A12Rik 9.32E-06 1.729412 
ENSMUSG00000104010 Gm37366 3.43E-04 1.729563 
ENSMUSG00000031710 Ucp1 4.71E-04 1.730521 
ENSMUSG00000064841 Gm26205 3.76E-02 1.732023 
ENSMUSG00000087059 Gm12339 3.57E-10 1.73504 
ENSMUSG00000059741 Myl3 2.57E-09 1.735257 
ENSMUSG00000030399 Ckm 6.58E-09 1.737508 
ENSMUSG00000072720 Myo18b 2.53E-31 1.738448 
ENSMUSG00000100733 4932411K12Rik 8.48E-06 1.74245 
ENSMUSG00000013483 Card14 1.29E-04 1.743775 
ENSMUSG00000026407 Cacna1s 4.58E-10 1.743939 
ENSMUSG00000085241 Snhg3 2.11E-06 1.74396 
ENSMUSG00000097122 Gm26624 2.89E-10 1.744094 
ENSMUSG00000032661 Oas3 1.63E-17 1.74446 
ENSMUSG00000060639 Hist1h4i 6.34E-03 1.746403 
ENSMUSG00000092539 Gm20468 3.84E-02 1.747708 
ENSMUSG00000100147 1700047M11Rik 3.91E-08 1.748016 
ENSMUSG00000070524 Fcrlb 1.24E-02 1.748075 
ENSMUSG00000095616 Gm26244 3.02E-03 1.749841 
ENSMUSG00000069306 Hist1h4m 1.13E-02 1.750899 
ENSMUSG00000101191 Gm28809 3.20E-02 1.7511 
ENSMUSG00000097358 Gm26773 2.59E-03 1.753117 
ENSMUSG00000061816 Myl1 1.60E-12 1.754682 
ENSMUSG00000054169 Ceacam10 9.98E-09 1.754693 
ENSMUSG00000105826 Gm42141 2.16E-02 1.754897 
ENSMUSG00000105790 Gm24105 3.07E-04 1.75526 
ENSMUSG00000092674 Gm24105 2.58E-04 1.75676 
ENSMUSG00000056071 S100a9 2.01E-14 1.760172 




ENSMUSG00000022651 Retnlg 1.87E-24 1.766124 
ENSMUSG00000023473 Celsr3 3.06E-07 1.767531 
ENSMUSG00000101344 Gm29183 4.83E-20 1.767788 
ENSMUSG00000050931 Sgms2 5.11E-55 1.768559 
ENSMUSG00000091119 Ccdc152 2.18E-04 1.768666 
ENSMUSG00000097413 A830052D11Rik 2.01E-02 1.771034 
ENSMUSG00000091383 Hist1h2al 9.26E-06 1.771647 
ENSMUSG00000064853 Gm23442 3.06E-04 1.773453 
ENSMUSG00000099092 Mir7062 1.37E-02 1.773986 
ENSMUSG00000052767 Gm12703 5.22E-04 1.775187 
ENSMUSG00000111752 Gm38575 1.61E-15 1.776614 
ENSMUSG00000043789 Vwce 1.79E-04 1.778777 
ENSMUSG00000109831 Gm36431 3.33E-02 1.779631 
ENSMUSG00000039653 Baat 2.08E-02 1.779818 
ENSMUSG00000050553 Gk2 1.02E-02 1.780074 
ENSMUSG00000022824 Muc13 2.08E-05 1.781872 
ENSMUSG00000027855 Sycp1 2.52E-02 1.785086 
ENSMUSG00000102343 Gm37381 2.22E-03 1.785986 
ENSMUSG00000058427 Cxcl2 6.05E-12 1.786152 
ENSMUSG00000031097 Tnni2 6.59E-11 1.786684 
ENSMUSG00000072875 Gpr27 2.99E-05 1.787666 
ENSMUSG00000026100 Mstn 1.84E-02 1.787836 
ENSMUSG00000090698 Apold1 1.30E-17 1.788991 
ENSMUSG00000027824 Vmn2r1 1.85E-02 1.78902 
ENSMUSG00000116508 Gm49463 2.15E-02 1.789422 
ENSMUSG00000088529 Gm26083 3.34E-03 1.790452 
ENSMUSG00000081857 Gm13624 1.87E-03 1.79269 
ENSMUSG00000077323 Rnu11 2.17E-03 1.793382 
ENSMUSG00000022602 Arc 6.32E-03 1.79405 
ENSMUSG00000044367 Slc16a13 8.06E-21 1.795745 
ENSMUSG00000109096 Gm44888 2.17E-03 1.796222 
ENSMUSG00000085792 Gm15414 2.28E-02 1.796476 
ENSMUSG00000115432 D130009I18Rik 1.25E-02 1.7966 
ENSMUSG00000074001 Klhl40 2.39E-03 1.804207 
ENSMUSG00000024827 Gldc 2.59E-02 1.808096 
ENSMUSG00000110626 Gm45805 1.93E-03 1.809283 
ENSMUSG00000102759 Gm10463 4.37E-02 1.811725 
ENSMUSG00000108929 Cc2d2b 3.12E-04 1.814541 
ENSMUSG00000048388 Fam171b 3.36E-17 1.816202 
ENSMUSG00000089844 A530032D15Rik 3.03E-10 1.816284 
ENSMUSG00000043795 Prr33 4.01E-02 1.817973 
ENSMUSG00000027456 Sdcbp2 1.73E-11 1.818137 
ENSMUSG00000095969 Rnu1a1 7.72E-04 1.823663 
ENSMUSG00000041872 Il17f 1.92E-06 1.828096 
ENSMUSG00000001482 Def8 2.17E-14 1.828763 
ENSMUSG00000006724 Cyp27b1 7.32E-03 1.82998 
ENSMUSG00000101279 Gm18342 1.51E-05 1.831412 
ENSMUSG00000109157 Gm44829 8.56E-05 1.83179 
ENSMUSG00000056300 Zfp981 3.27E-10 1.83268 
ENSMUSG00000077714 Snord17 2.21E-04 1.835137 
ENSMUSG00000034683 Ppp1r1c 1.37E-02 1.836685 
ENSMUSG00000087700 Gm15283 3.63E-04 1.838693 
ENSMUSG00000096214 Gm22634 4.41E-06 1.840548 
ENSMUSG00000096206 Gm22317 4.41E-06 1.840548 
ENSMUSG00000110411 Gm45457 3.21E-03 1.842368 
ENSMUSG00000115420 AL732506.1 3.41E-05 1.84363 




ENSMUSG00000070167 Snora57 6.49E-06 1.843722 
ENSMUSG00000044083 Efcab8 8.89E-24 1.847127 
ENSMUSG00000096205 Gm22068 4.44E-04 1.848083 
ENSMUSG00000034755 Pcdh11x 1.69E-07 1.849981 
ENSMUSG00000064655 Gm25788 3.42E-02 1.850018 
ENSMUSG00000112082 Gm35035 2.70E-03 1.850562 
ENSMUSG00000096659 Gm25679 6.20E-06 1.851418 
ENSMUSG00000093815 Gm26444 6.20E-06 1.851418 
ENSMUSG00000044092 C130050O18Rik 4.16E-07 1.85322 
ENSMUSG00000060093 Hist1h4a 6.83E-05 1.854758 
ENSMUSG00000112023 Lilr4b 3.87E-09 1.856512 
ENSMUSG00000030730 Atp2a1 2.57E-25 1.856765 
ENSMUSG00000113185 Gm47127 2.52E-14 1.857191 
ENSMUSG00000087203 Gm13986 9.23E-38 1.857802 
ENSMUSG00000017300 Tnnc2 2.32E-13 1.860495 
ENSMUSG00000005716 Pvalb 5.17E-03 1.862103 
ENSMUSG00000064179 Tnnt1 3.30E-04 1.865691 
ENSMUSG00000103907 Gm37498 2.41E-19 1.868144 
ENSMUSG00000094826 Gm23804 6.28E-06 1.870232 
ENSMUSG00000107480 Gm44165 6.63E-05 1.871722 
ENSMUSG00000050304 Slc25a2 1.14E-02 1.87573 
ENSMUSG00000065862 Gm24029 6.61E-04 1.875777 
ENSMUSG00000064453 Snord21 3.67E-02 1.876243 
ENSMUSG00000096972 Gm26883 3.02E-04 1.878023 
ENSMUSG00000002500 Rpl3l 4.07E-05 1.878812 
ENSMUSG00000065145 Vaultrc5 9.73E-04 1.881338 
ENSMUSG00000097052 Snora43 4.79E-02 1.882312 
ENSMUSG00000025473 Adam8 3.65E-14 1.883209 
ENSMUSG00000025929 Il17a 1.27E-02 1.884795 
ENSMUSG00000069733 Ube2u 1.49E-03 1.885786 
ENSMUSG00000060988 Galnt13 6.96E-12 1.886176 
ENSMUSG00000064387 Snora73a 4.95E-09 1.88777 
ENSMUSG00000110125 Gm33148 6.45E-03 1.888934 
ENSMUSG00000082069 Gm16242 1.52E-03 1.890196 
ENSMUSG00000042451 Mybph 7.08E-19 1.89042 
ENSMUSG00000074071 Fam169b 1.22E-62 1.892733 
ENSMUSG00000062393 Dgkk 3.95E-02 1.894875 
ENSMUSG00000104554 Gm4610 1.51E-04 1.897808 
ENSMUSG00000032021 Crtam 1.06E-17 1.89973 
ENSMUSG00000092805 Gm26461 7.94E-04 1.903632 
ENSMUSG00000060470 Adgrg3 5.50E-20 1.903686 
ENSMUSG00000097081 Gm10425 2.22E-02 1.906599 
ENSMUSG00000032066 Bco2 1.74E-03 1.906705 
ENSMUSG00000092267 Gm20417 5.68E-07 1.908725 
ENSMUSG00000025892 Gria4 4.06E-04 1.909271 
ENSMUSG00000042567 Nek10 1.49E-18 1.909826 
ENSMUSG00000115426 Gm19510 3.61E-02 1.911947 
ENSMUSG00000116641 AC165271.1 4.77E-02 1.912683 
ENSMUSG00000108332 D530033B14Rik 3.38E-17 1.912716 
ENSMUSG00000038067 Csf3 5.24E-28 1.912958 
ENSMUSG00000043681 Fam25c 9.06E-03 1.913562 
ENSMUSG00000064999 Gm26035 1.27E-04 1.915529 
ENSMUSG00000084929 Foxo6os 2.44E-02 1.916095 
ENSMUSG00000113321 Gm8075 1.08E-04 1.9166 
ENSMUSG00000080542 Gm22710 9.10E-03 1.916605 
ENSMUSG00000097622 A330033J07Rik 1.30E-02 1.916889 




ENSMUSG00000065353 Snora73b 4.31E-05 1.92082 
ENSMUSG00000079451 Tmprss11g 1.05E-02 1.922677 
ENSMUSG00000057280 Musk 4.21E-13 1.924024 
ENSMUSG00000026166 Ccl20 6.82E-22 1.924662 
ENSMUSG00000043873 Chil5 3.16E-05 1.926813 
ENSMUSG00000099470 Gm29340 6.43E-03 1.928433 
ENSMUSG00000038508 Gdf15 4.48E-03 1.930522 
ENSMUSG00000085434 Gm11725 1.19E-03 1.931465 
ENSMUSG00000049173 Myoz3 4.24E-05 1.93273 
ENSMUSG00000097417 Gm26669 3.24E-02 1.932952 
ENSMUSG00000052581 Lrrtm4 1.64E-07 1.934282 
ENSMUSG00000116975 AC097366.1 2.80E-03 1.934645 
ENSMUSG00000107722 2900060B14Rik 4.30E-03 1.93608 
ENSMUSG00000044165 Bcl2l15 2.49E-09 1.936183 
ENSMUSG00000104728 Gm42462 3.00E-14 1.936263 
ENSMUSG00000022622 Acr 4.06E-11 1.941514 
ENSMUSG00000065226 Gm25791 1.83E-06 1.942482 
ENSMUSG00000109002 Gm38405 2.93E-04 1.943877 
ENSMUSG00000055523 Gucy2g 2.09E-02 1.944978 
ENSMUSG00000024912 Fosl1 4.08E-15 1.946069 
ENSMUSG00000049100 Pcdh10 1.63E-02 1.947579 
ENSMUSG00000100334 C230024C17Rik 1.73E-02 1.947699 
ENSMUSG00000102416 4933424G06Rik 2.21E-02 1.951006 
ENSMUSG00000042895 Abra 1.14E-09 1.951135 
ENSMUSG00000102630 Gm37289 5.47E-03 1.953604 
ENSMUSG00000037705 Tecta 1.30E-02 1.953664 
ENSMUSG00000085750 Gm14009 2.26E-02 1.959056 
ENSMUSG00000106392 Gm5870 2.74E-02 1.959897 
ENSMUSG00000116961 AC117662.4 7.69E-07 1.970064 
ENSMUSG00000029379 Cxcl3 5.85E-31 1.970535 
ENSMUSG00000056054 S100a8 2.08E-14 1.971878 
ENSMUSG00000009070 Rsph14 1.08E-09 1.971919 
ENSMUSG00000106649 Gm49349 1.69E-06 1.97517 
ENSMUSG00000115355 4930445E18Rik 3.15E-07 1.98206 
ENSMUSG00000084783 Gm15419 3.73E-04 1.984549 
ENSMUSG00000048806 Ifnb1 4.47E-02 1.985866 
ENSMUSG00000112683 Gm18904 5.10E-03 1.988548 
ENSMUSG00000103626 Gm37358 4.92E-04 1.992354 
ENSMUSG00000087090 Nctc1 3.78E-18 1.993635 
ENSMUSG00000110498 A630001O12Rik 2.63E-06 1.993703 
ENSMUSG00000097643 A130051J06Rik 1.72E-03 1.997776 
ENSMUSG00000024430 Cabyr 3.39E-04 1.999224 
ENSMUSG00000065701 Rny1 7.04E-04 2.000426 
ENSMUSG00000104956 4930429D17Rik 4.22E-03 2.000856 
ENSMUSG00000046049 Rp1l1 5.00E-04 2.002651 
ENSMUSG00000089647 Gm2245 4.25E-03 2.00392 
ENSMUSG00000034145 Tmem63c 1.54E-03 2.004762 
ENSMUSG00000097300 Gm26835 2.99E-02 2.005741 
ENSMUSG00000058740 Kcnt1 1.78E-11 2.006095 
ENSMUSG00000032496 Ltf 1.13E-45 2.006145 
ENSMUSG00000065126 Snord104 6.05E-07 2.006554 
ENSMUSG00000097071 4930544I03Rik 1.01E-07 2.006732 
ENSMUSG00000077167 Gm24119 1.08E-02 2.009462 
ENSMUSG00000110622 Iqcn 1.16E-02 2.011367 
ENSMUSG00000071470 Ccnb1ip1 2.89E-04 2.016759 
ENSMUSG00000037977 6430571L13Rik 2.38E-05 2.018356 




ENSMUSG00000080950 Gm7278 9.59E-05 2.024914 
ENSMUSG00000092837 Rpph1 2.95E-04 2.025336 
ENSMUSG00000040340 Tex45 2.80E-03 2.026678 
ENSMUSG00000086754 Gm16098 3.57E-02 2.033401 
ENSMUSG00000088025 Rprl3 1.21E-03 2.034205 
ENSMUSG00000116031 D030024E09Rik 3.10E-10 2.034724 
ENSMUSG00000079243 Xirp1 1.63E-25 2.041369 
ENSMUSG00000054905 Stfa3 2.46E-04 2.044116 
ENSMUSG00000032292 Nr2e3 1.06E-02 2.046336 
ENSMUSG00000089854 Gm16133 2.44E-06 2.047282 
ENSMUSG00000116606 AC163633.2 3.18E-02 2.047702 
ENSMUSG00000103382 Gm37755 2.66E-02 2.049867 
ENSMUSG00000077563 Snora68 1.19E-05 2.052854 
ENSMUSG00000106224 Gm43823 1.06E-02 2.054673 
ENSMUSG00000103308 Gm37800 1.61E-09 2.055329 
ENSMUSG00000115151 Gm19276 5.37E-03 2.055894 
ENSMUSG00000086649 Gm15286 3.26E-02 2.064189 
ENSMUSG00000020216 Jsrp1 1.65E-02 2.064977 
ENSMUSG00000097036 1110036E04Rik 2.16E-02 2.065813 
ENSMUSG00000089536 Scarna3a 2.33E-02 2.0728 
ENSMUSG00000113447 Gm48538 3.67E-05 2.078097 
ENSMUSG00000087477 Gm13822 1.26E-03 2.082278 
ENSMUSG00000041476 Smpx 3.41E-09 2.083676 
ENSMUSG00000065824 Gm26315 1.20E-05 2.084426 
ENSMUSG00000103485 Gm38001 4.48E-03 2.088313 
ENSMUSG00000109311 AI314278 8.28E-04 2.092515 
ENSMUSG00000065911 Gm24447 1.06E-05 2.092602 
ENSMUSG00000108985 A930030B08Rik 1.21E-03 2.092679 
ENSMUSG00000094088 Ighv1-64 4.84E-02 2.093497 
ENSMUSG00000093577 Gm20632 5.25E-03 2.099577 
ENSMUSG00000097468 Mdrl 4.60E-03 2.100337 
ENSMUSG00000103923 Gm37896 9.28E-03 2.102126 
ENSMUSG00000112471 Gm5779 5.98E-03 2.104841 
ENSMUSG00000093908 Gm5784 1.59E-06 2.105369 
ENSMUSG00000047501 Cldn4 3.24E-06 2.10583 
ENSMUSG00000108677 Gm44759 1.85E-02 2.11069 
ENSMUSG00000087775 Rprl2 7.23E-04 2.112469 
ENSMUSG00000033213 AA467197 7.56E-07 2.116442 
ENSMUSG00000117092 AC166110.1 4.57E-03 2.122036 
ENSMUSG00000110278 Gm5608 4.80E-19 2.124723 
ENSMUSG00000033196 Myh2 2.12E-09 2.129399 
ENSMUSG00000021123 Rdh12 1.23E-27 2.13007 
ENSMUSG00000111818 Gm17749 1.56E-11 2.130559 
ENSMUSG00000022026 Olfm4 1.74E-47 2.133503 
ENSMUSG00000097131 D230017M19Rik 8.10E-07 2.14415 
ENSMUSG00000113998 Gm40909 1.98E-16 2.150507 
ENSMUSG00000090101 Snhg9 6.89E-03 2.150509 
ENSMUSG00000074398 Gm15441 1.46E-03 2.151127 
ENSMUSG00000035653 Lrfn5 2.00E-04 2.153773 
ENSMUSG00000086220 Gm16599 1.86E-03 2.158383 
ENSMUSG00000116237 Gm30339 3.53E-03 2.162938 
ENSMUSG00000028865 Cd164l2 1.12E-04 2.164257 
ENSMUSG00000114457 Gm36346 3.31E-02 2.164377 
ENSMUSG00000064604 Snora44 5.26E-04 2.16931 
ENSMUSG00000084708 Gm22988 4.87E-07 2.171425 
ENSMUSG00000089542 Gm25835 1.60E-09 2.171658 




ENSMUSG00000103620 Gm37359 3.97E-07 2.173343 
ENSMUSG00000093355 Snora26 4.17E-02 2.191494 
ENSMUSG00000043468 Adam30 1.06E-02 2.195772 
ENSMUSG00000101845 Gm28198 4.01E-02 2.207421 
ENSMUSG00000064380 Gm26448 9.55E-10 2.208699 
ENSMUSG00000025431 Crisp1 6.59E-04 2.208969 
ENSMUSG00000111867 Gm31013 2.68E-02 2.214693 
ENSMUSG00000087819 Gm25117 1.67E-07 2.214707 
ENSMUSG00000091366 Gm17040 4.44E-02 2.216824 
ENSMUSG00000064694 Gm24146 4.82E-04 2.217621 
ENSMUSG00000009551 6330409D20Rik 4.87E-02 2.221007 
ENSMUSG00000096351 Samd11 6.92E-09 2.221597 
ENSMUSG00000080365 Gm25776 1.17E-04 2.222028 
ENSMUSG00000065259 Snora30 5.73E-03 2.223572 
ENSMUSG00000107841 Gm44185 1.38E-02 2.224563 
ENSMUSG00000046961 Gpr156 4.17E-11 2.227765 
ENSMUSG00000026592 Tex35 1.15E-09 2.233732 
ENSMUSG00000103502 9330121J05Rik 3.03E-02 2.239685 
ENSMUSG00000086354 Gm13938 8.15E-26 2.24405 
ENSMUSG00000114697 Gm30806 2.67E-02 2.246899 
ENSMUSG00000004668 Abca13 2.61E-57 2.24728 
ENSMUSG00000085573 Gm15418 3.19E-04 2.250028 
ENSMUSG00000092819 Gm23639 1.25E-02 2.258412 
ENSMUSG00000104863 Gm49347 6.55E-05 2.266581 
ENSMUSG00000096887 Gm20594 2.13E-12 2.268158 
ENSMUSG00000113868 Gm34719 1.46E-03 2.270756 
ENSMUSG00000096243 Gm24265 3.92E-05 2.270994 
ENSMUSG00000085599 Gm13449 3.60E-04 2.273353 
ENSMUSG00000020848 Doc2b 4.53E-24 2.275294 
ENSMUSG00000088948 Gm23262 4.47E-07 2.276029 
ENSMUSG00000092702 Gm24514 2.89E-06 2.276899 
ENSMUSG00000109921 Gm33326 2.14E-03 2.281901 
ENSMUSG00000111765 Gm10635 3.03E-03 2.28596 
ENSMUSG00000053615 Gm9913 3.32E-02 2.288715 
ENSMUSG00000050830 Vwc2 1.21E-05 2.28941 
ENSMUSG00000045027 Prss22 4.65E-14 2.295806 
ENSMUSG00000059108 Ifitm6 3.62E-40 2.296863 
ENSMUSG00000111639 1700019L13Rik 1.07E-02 2.297301 
ENSMUSG00000006764 Tph2 1.53E-02 2.300399 
ENSMUSG00000099760 Gm28800 5.16E-04 2.300754 
ENSMUSG00000108171 Gm43915 1.82E-02 2.304507 
ENSMUSG00000051965 Nanos2 3.15E-02 2.309161 
ENSMUSG00000065649 Snora74a 1.83E-06 2.319528 
ENSMUSG00000111821 Gm48545 1.45E-05 2.341304 
ENSMUSG00000074652 Myh7b 2.41E-03 2.354961 
ENSMUSG00000023153 Tmem52 3.20E-03 2.37334 
ENSMUSG00000113778 Gm40847 2.82E-06 2.385725 
ENSMUSG00000102189 Gm37194 2.59E-09 2.389093 
ENSMUSG00000091238 Gm17103 1.31E-04 2.395524 
ENSMUSG00000110237 Gm18258 2.84E-02 2.417341 
ENSMUSG00000088252 Snord13 5.28E-05 2.418714 
ENSMUSG00000098975 Gm27177 1.24E-02 2.419022 
ENSMUSG00000097346 Gm26619 8.29E-03 2.422694 
ENSMUSG00000054582 Pabpc1l 8.18E-19 2.43202 
ENSMUSG00000094377 Gm24407 5.41E-07 2.44395 
ENSMUSG00000090625 Gm20721 5.29E-04 2.452874 




ENSMUSG00000033860 Fgg 1.06E-03 2.454493 
ENSMUSG00000043460 Elfn2 1.29E-02 2.455388 
ENSMUSG00000110114 Gm45471 1.99E-02 2.456678 
ENSMUSG00000064945 Rny3 2.32E-06 2.465394 
ENSMUSG00000085297 Gm11651 3.64E-05 2.473195 
ENSMUSG00000089655 Gm16004 2.40E-03 2.475649 
ENSMUSG00000108720 Gm44672 7.98E-03 2.479163 
ENSMUSG00000000157 Itgb2l 5.28E-41 2.481365 
ENSMUSG00000086980 Gm13791 1.78E-03 2.484391 
ENSMUSG00000024729 1700017D01Rik 1.57E-02 2.495512 
ENSMUSG00000069310 Hist1h3c 5.35E-04 2.501758 
ENSMUSG00000065087 Snord22 1.02E-20 2.504791 
ENSMUSG00000077254 Gm26079 5.09E-05 2.508432 
ENSMUSG00000023467 Tulp2 3.92E-03 2.545698 
ENSMUSG00000084744 Gm25291 1.27E-04 2.547348 
ENSMUSG00000080538 Gm25541 1.65E-07 2.547886 
ENSMUSG00000086628 Gm16157 1.31E-03 2.549909 
ENSMUSG00000116657 AC127341.3 6.32E-03 2.552284 
ENSMUSG00000085532 B430319H21Rik 2.25E-10 2.571664 
ENSMUSG00000095590 Gm24305 5.01E-03 2.571674 
ENSMUSG00000040258 Nxph4 5.24E-03 2.575445 
ENSMUSG00000097069 Gm16998 1.82E-02 2.578575 
ENSMUSG00000010362 Rdm1 1.63E-08 2.583826 
ENSMUSG00000107179 Gm43069 7.95E-03 2.585741 
ENSMUSG00000064966 Snord15b 2.43E-08 2.605397 
ENSMUSG00000066510 Ankdd1a 1.64E-20 2.613295 
ENSMUSG00000031343 Gabra3 2.60E-11 2.613416 
ENSMUSG00000096084 Gm21850 1.82E-14 2.614388 
ENSMUSG00000090208 Gm15851 1.89E-02 2.614614 
ENSMUSG00000074113 Gm10629 1.77E-02 2.621575 
ENSMUSG00000064901 Snora21 1.20E-03 2.626929 
ENSMUSG00000090293 Gm17034 1.90E-04 2.681395 
ENSMUSG00000037942 Crp 7.71E-04 2.683734 
ENSMUSG00000111582 Gm47347 3.20E-03 2.685612 
ENSMUSG00000085511 Gm11738 1.89E-04 2.70767 
ENSMUSG00000064371 mt-Tt 2.94E-03 2.714465 
ENSMUSG00000114649 3110006O06Rik 8.08E-03 2.716208 
ENSMUSG00000065822 Snord15a 1.62E-05 2.722509 
ENSMUSG00000085806 Gm12023 8.06E-11 2.725972 
ENSMUSG00000021071 Trim9 6.06E-15 2.732965 
ENSMUSG00000025172 Ankrd2 4.58E-16 2.747592 
ENSMUSG00000064899 Snord118 3.85E-04 2.765016 
ENSMUSG00000110790 Gm47079 8.78E-03 2.791718 
ENSMUSG00000016327 Atp1b4 7.76E-04 2.794331 
ENSMUSG00000096960 A230028O05Rik 2.22E-22 2.835285 
ENSMUSG00000089255 Snora78 7.85E-04 2.851741 
ENSMUSG00000032484 Ngp 3.65E-107 2.860267 
ENSMUSG00000064943 Gm23240 8.10E-03 2.878259 
ENSMUSG00000114922 Ppifos 1.68E-05 2.879757 
ENSMUSG00000022249 Ttc23l 3.38E-03 2.910968 
ENSMUSG00000030359 Pzp 1.62E-03 2.922478 
ENSMUSG00000065118 Gm23297 4.76E-05 2.968259 
ENSMUSG00000111734 Gm29825 3.88E-03 2.997991 
ENSMUSG00000115532 Gm41206 2.62E-03 3.003723 
ENSMUSG00000106056 4930500L23Rik 2.55E-03 3.004773 
ENSMUSG00000093843 Gm25939 6.49E-07 3.015148 




ENSMUSG00000094050 Gm23472 2.00E-08 3.0215 
ENSMUSG00000064856 Gm23444 2.61E-08 3.025159 
ENSMUSG00000093956 Gm24497 3.05E-08 3.03474 
ENSMUSG00000059908 Mug1 4.53E-02 3.062787 
ENSMUSG00000064994 Gm22422 7.84E-06 3.063734 
ENSMUSG00000109464 Gm34350 1.03E-02 3.073399 
ENSMUSG00000042761 Mrap2 4.40E-06 3.081864 
ENSMUSG00000089948 Far2os1 4.72E-04 3.104791 
ENSMUSG00000065944 Rnu2-10 7.80E-09 3.107609 
ENSMUSG00000064702 Gm24950 9.28E-09 3.114592 
ENSMUSG00000065251 Gm23971 9.28E-09 3.114592 
ENSMUSG00000065767 Gm23849 7.91E-09 3.116902 
ENSMUSG00000087038 2900079G21Rik 4.45E-03 3.117026 
ENSMUSG00000091993 B930036N10Rik 9.73E-07 3.120615 
ENSMUSG00000022868 Ahsg 3.12E-04 3.161068 
ENSMUSG00000095892 Rnu5g 3.38E-09 3.162782 
ENSMUSG00000065820 Gm26316 3.08E-09 3.189586 
ENSMUSG00000046748 Tmem45a2 1.25E-18 3.232248 
ENSMUSG00000097554 Gm26825 1.50E-03 3.233552 
ENSMUSG00000095738 Gm25313 4.08E-09 3.26894 
ENSMUSG00000110735 Gm47173 6.45E-03 3.273965 
ENSMUSG00000099291 Rnu3b3 2.67E-15 3.306299 
ENSMUSG00000104856 Rnu3b3 2.67E-15 3.306299 
ENSMUSG00000105115 Rnu3b2 5.42E-16 3.31235 
ENSMUSG00000098925 Rnu3b2 5.42E-16 3.31235 
ENSMUSG00000104896 Rnu3b4 7.98E-16 3.316405 
ENSMUSG00000098641 Rnu3b4 8.89E-16 3.316683 
ENSMUSG00000027233 Patl2 9.28E-06 3.317931 
ENSMUSG00000098943 Rnu3b1 9.63E-16 3.32264 
ENSMUSG00000105025 Rnu3b1 9.63E-16 3.32264 
ENSMUSG00000085348 Myhas 2.21E-09 3.342376 
ENSMUSG00000065254 Gm23973 3.63E-04 3.375179 
ENSMUSG00000088675 Rprl1 9.25E-05 3.390244 
ENSMUSG00000106222 Rprl1 9.25E-05 3.390244 
ENSMUSG00000086777 Far2os2 8.53E-09 3.410703 
ENSMUSG00000013936 Myl2 1.38E-11 3.412107 
ENSMUSG00000065870 Rnu3a 8.20E-11 3.438606 
ENSMUSG00000106147 Rnu3a 8.20E-11 3.438606 
ENSMUSG00000094655 Gm25360 9.25E-18 3.476566 
ENSMUSG00000099449 Gm28401 3.66E-06 3.512495 
ENSMUSG00000080465 Gm22486 3.79E-11 3.525781 
ENSMUSG00000097770 Gm26776 7.15E-05 3.556066 
ENSMUSG00000095676 Gm25099 1.48E-18 3.569557 
ENSMUSG00000038357 Camp 2.10E-20 3.574791 
ENSMUSG00000110588 Gm45774 2.37E-05 3.651499 
ENSMUSG00000105361 AY036118 4.75E-13 3.706614 
ENSMUSG00000114163 Gm32296 1.06E-05 3.753819 
ENSMUSG00000097815 Gm26809 4.14E-06 3.770845 
ENSMUSG00000101133 Gm29050 4.66E-06 3.935451 
ENSMUSG00000094668 Gm24871 3.50E-05 3.990369 
ENSMUSG00000065232 Gm22973 1.47E-13 4.080121 
ENSMUSG00000096269 Rpl31-ps21 1.07E-04 4.321736 
ENSMUSG00000029019 Nppb 3.13E-19 4.33994 
ENSMUSG00000097364 Gm26719 2.54E-09 4.440093 
ENSMUSG00000056656 Apol8 1.21E-16 4.471575 
ENSMUSG00000064682 Gm25813 4.91E-11 4.908819 




ENSMUSG00000028307 Aldob 2.14E-03 5.215422 
ENSMUSG00000027261 Hao1 2.14E-10 5.270442 
ENSMUSG00000056035 Cyp3a11 1.02E-03 8.674899 
ENSMUSG00000025991 Cps1 9.04E-03 9.941545 
ENSMUSG00000032083 Apoa1 5.02E-04 10.21736 
ENSMUSG00000029368 Alb 1.23E-11 11.41724 



































Appendix X. Murine differential gene expression in the lungs 6 h post-infection, 4559 vs 4559M. Genes 
with fold change (FC) greater than 1.5 and p < 0.05 are shown. FC values highlighted in blue = upregulated 
in 4559, while values highlighted in red = upregulated in 4559M. 
Gene Stable ID Gene Name padj FC 
ENSMUSG00000029630 Cyp3a25 1.75E-05 49.7977 
ENSMUSG00000059908 Mug1 3.28E-16 16.2463 
ENSMUSG00000061808 Ttr 2.84E-06 14.48 
ENSMUSG00000032083 Apoa1 1.40E-09 8.40944 
ENSMUSG00000029368 Alb 7.42E-10 7.88269 
ENSMUSG00000056035 Cyp3a11 2.46E-09 7.04516 
ENSMUSG00000003053 Cyp2c29 1.29E-06 6.94961 
ENSMUSG00000025991 Cps1 1.02E-02 6.84018 
ENSMUSG00000059481 Plg 5.17E-05 6.64669 
ENSMUSG00000035540 Gc 4.99E-09 6.39712 
ENSMUSG00000019932 Kera 1.93E-07 5.71283 
ENSMUSG00000058354 Krt6a 2.39E-09 5.47428 
ENSMUSG00000020609 Apob 7.58E-09 5.28553 
ENSMUSG00000048455 Sprr1b 8.94E-08 5.28178 
ENSMUSG00000030131 Mug2 7.90E-05 4.9728 
ENSMUSG00000030359 Pzp 5.04E-10 4.9175 
ENSMUSG00000074647 Fam83c 3.54E-05 4.88673 
ENSMUSG00000033831 Fgb 8.00E-03 4.77839 
ENSMUSG00000023041 Krt6b 6.28E-04 4.23661 
ENSMUSG00000046095 Krt32 6.56E-05 4.06888 
ENSMUSG00000022875 Kng1 1.83E-04 4.04028 
ENSMUSG00000022868 Ahsg 6.92E-08 4.01269 
ENSMUSG00000028307 Aldob 4.31E-05 3.99588 
ENSMUSG00000068888 Lce1i 1.87E-03 3.93124 
ENSMUSG00000035861 Tmprss11b 9.18E-04 3.92883 
ENSMUSG00000025194 Abcc2 8.61E-04 3.90941 
ENSMUSG00000027761 Aadac 1.07E-03 3.88939 
ENSMUSG00000092586 Ly6g6c 2.26E-12 3.86378 
ENSMUSG00000074445 Sprr2a3 1.99E-05 3.71115 
ENSMUSG00000059898 Dsc3 2.90E-17 3.70907 
ENSMUSG00000054422 Fabp1 3.27E-04 3.66856 
ENSMUSG00000053675 Tgm5 1.06E-02 3.59152 
ENSMUSG00000032373 Car12 2.24E-43 3.56925 
ENSMUSG00000021364 Elovl2 3.03E-03 3.52501 
ENSMUSG00000026450 Chit1 1.24E-06 3.51671 
ENSMUSG00000033268 Duox1 7.07E-12 3.43887 
ENSMUSG00000056632 Dsg3 8.74E-24 3.40573 
ENSMUSG00000067006 Serpinb5 8.21E-12 3.40296 
ENSMUSG00000017950 Hnf4a 3.10E-03 3.39187 
ENSMUSG00000040127 Sdr9c7 3.52E-03 3.33689 
ENSMUSG00000045545 Krt14 1.09E-22 3.26379 
ENSMUSG00000061527 Krt5 1.31E-17 3.25295 
ENSMUSG00000097850 4631405K08Rik 3.80E-04 3.17772 
ENSMUSG00000026985 Il1f8 1.88E-04 3.17313 
ENSMUSG00000078664 Sprr2a1 4.06E-05 3.14672 
ENSMUSG00000054146 Krt15 8.77E-17 3.1094 
ENSMUSG00000028236 Sdr16c5 5.99E-04 3.09328 
ENSMUSG00000026413 Pkp1 2.42E-19 3.08859 
ENSMUSG00000102098 2310016D03Rik 2.45E-03 3.03012 
ENSMUSG00000059832 Kprp 2.49E-18 3.02836 
ENSMUSG00000068893 Sprr2a2 5.63E-11 3.01925 




ENSMUSG00000038295 Atg9b 3.71E-08 3.00088 
ENSMUSG00000097768 2310043M15Rik 6.14E-05 2.99467 
ENSMUSG00000048399 Tprg 8.10E-08 2.97043 
ENSMUSG00000071858 Gm94 8.27E-08 2.95766 
ENSMUSG00000042031 Lce3b 8.70E-10 2.94911 
ENSMUSG00000085261 Gm13814 1.65E-02 2.93578 
ENSMUSG00000075217 4833423E24Rik 3.24E-08 2.93359 
ENSMUSG00000041984 Rptn 2.63E-20 2.90552 
ENSMUSG00000033765 Calm4 4.66E-07 2.90141 
ENSMUSG00000005355 Casp14 1.53E-03 2.89567 
ENSMUSG00000026327 Serpinb11 7.21E-07 2.86034 
ENSMUSG00000044748 Defb1 4.03E-04 2.84373 
ENSMUSG00000079025 Gsdmc 6.93E-06 2.8424 
ENSMUSG00000053522 Lgals7 1.41E-07 2.82395 
ENSMUSG00000043472 Lce3d 5.15E-03 2.80644 
ENSMUSG00000045539 Sprr3 1.03E-15 2.79819 
ENSMUSG00000018862 Otop3 4.58E-06 2.79571 
ENSMUSG00000114091 Gm40655 1.03E-06 2.79416 
ENSMUSG00000071019 Sdr16c6 2.08E-04 2.79341 
ENSMUSG00000099906 Gm28653 9.77E-04 2.78803 
ENSMUSG00000004872 Pax3 6.22E-03 2.78741 
ENSMUSG00000045019 Acer1 5.37E-03 2.78363 
ENSMUSG00000057609 Lce1a1 1.99E-04 2.77319 
ENSMUSG00000056078 Lipm 6.48E-07 2.76931 
ENSMUSG00000033860 Fgg 1.23E-05 2.7686 
ENSMUSG00000047428 Dlk2 1.85E-02 2.76136 
ENSMUSG00000025064 Col17a1 6.87E-17 2.75765 
ENSMUSG00000034774 Dsg1c 3.15E-03 2.75484 
ENSMUSG00000017607 Tns4 1.32E-09 2.74798 
ENSMUSG00000030484 Lypd5 7.90E-11 2.74454 
ENSMUSG00000074156 Ces1h 1.86E-07 2.73844 
ENSMUSG00000026983 Il1f5 2.08E-04 2.73336 
ENSMUSG00000059668 Krt4 1.06E-11 2.72465 
ENSMUSG00000050359 Sprr1a 2.66E-11 2.71649 
ENSMUSG00000105160 A530030E21Rik 3.10E-02 2.71344 
ENSMUSG00000050808 Muc15 3.46E-03 2.71087 
ENSMUSG00000050463 Krt78 1.01E-21 2.70916 
ENSMUSG00000029154 Cwh43 3.03E-03 2.6846 
ENSMUSG00000044041 Krt13 1.85E-11 2.68386 
ENSMUSG00000103243 Lce1d 2.22E-04 2.66703 
ENSMUSG00000078964 Ces1b 5.60E-04 2.66571 
ENSMUSG00000070719 Pla2g4d 4.58E-03 2.66266 
ENSMUSG00000027224 Duoxa1 1.53E-02 2.65474 
ENSMUSG00000062826 Ces2f 5.60E-13 2.64193 
ENSMUSG00000074199 Krtdap 6.33E-07 2.64017 
ENSMUSG00000050108 Bpifc 2.11E-03 2.63956 
ENSMUSG00000055561 Spink5 2.42E-19 2.63531 
ENSMUSG00000063651 Cnfn 1.48E-13 2.63424 
ENSMUSG00000042124 Lce1f 4.49E-03 2.6302 
ENSMUSG00000044594 Serpinb3a 3.67E-09 2.62271 
ENSMUSG00000028001 Fga 6.07E-04 2.61124 
ENSMUSG00000074489 Bglap3 1.19E-04 2.60397 
ENSMUSG00000017204 Gsdma 1.43E-07 2.603 
ENSMUSG00000033196 Myh2 4.95E-14 2.58757 
ENSMUSG00000030834 Abcc6 1.07E-03 2.57913 
ENSMUSG00000081163 Defa-ps12 6.10E-03 2.57856 




ENSMUSG00000061928 Dsg1b 3.62E-11 2.56262 
ENSMUSG00000106871 Gm3289 3.48E-02 2.55403 
ENSMUSG00000022491 Glycam1 5.93E-08 2.552 
ENSMUSG00000057454 Lypd3 9.96E-06 2.54396 
ENSMUSG00000084228 Gm8080 3.66E-02 2.53954 
ENSMUSG00000061259 Tmprss11d 1.47E-04 2.53596 
ENSMUSG00000027376 Prom2 7.87E-09 2.53276 
ENSMUSG00000022860 Chodl 3.30E-03 2.53009 
ENSMUSG00000036960 Clca2 3.16E-04 2.52337 
ENSMUSG00000045475 Lce3c 9.57E-08 2.52299 
ENSMUSG00000063130 Calml3 1.43E-10 2.51428 
ENSMUSG00000040154 Wfdc5 1.42E-04 2.51022 
ENSMUSG00000117222 AC060761.1 1.75E-10 2.50439 
ENSMUSG00000059956 Serpinb12 1.32E-07 2.48356 
ENSMUSG00000021506 Pitx1 2.41E-04 2.46822 
ENSMUSG00000043029 Trpv3 6.01E-03 2.45237 
ENSMUSG00000034362 Csta1 4.02E-03 2.44214 
ENSMUSG00000099146 0610031O16Rik 1.31E-02 2.42834 
ENSMUSG00000044499 Hs3st5 4.61E-14 2.42328 
ENSMUSG00000116659 AC158985.1 1.31E-02 2.41132 
ENSMUSG00000027401 Tgm3 1.67E-09 2.41084 
ENSMUSG00000037188 Grhl3 1.79E-08 2.41062 
ENSMUSG00000093385 A330044P14Rik 4.33E-02 2.40792 
ENSMUSG00000030713 Klk7 9.32E-03 2.40587 
ENSMUSG00000043430 Psapl1 1.18E-08 2.40429 
ENSMUSG00000044628 Rnf208 3.62E-02 2.40152 
ENSMUSG00000039238 Zfp750 2.57E-05 2.39905 
ENSMUSG00000037129 Tmprss13 4.41E-07 2.39884 
ENSMUSG00000032013 Trim29 1.24E-12 2.39013 
ENSMUSG00000109656 Gm45548 3.25E-02 2.38688 
ENSMUSG00000051431 Gpr87 1.20E-02 2.38474 
ENSMUSG00000044322 Dsc1 7.89E-05 2.38231 
ENSMUSG00000069441 Dsg1a 1.65E-12 2.37371 
ENSMUSG00000032807 Alox12b 8.10E-07 2.37178 
ENSMUSG00000039269 2300002M23Rik 6.30E-04 2.36131 
ENSMUSG00000055301 Adh7 2.74E-13 2.352 
ENSMUSG00000022510 Trp63 3.19E-20 2.34287 
ENSMUSG00000092222 Gm20506 3.27E-02 2.34271 
ENSMUSG00000038020 Rapgefl1 1.54E-11 2.33861 
ENSMUSG00000028148 Them5 1.43E-08 2.32907 
ENSMUSG00000032454 Rbp2 2.18E-02 2.32839 
ENSMUSG00000054325 Lce3a 1.60E-06 2.31499 
ENSMUSG00000016327 Atp1b4 9.25E-04 2.30528 
ENSMUSG00000047884 Klk9 1.51E-02 2.29768 
ENSMUSG00000041991 Hrnr 2.88E-07 2.29503 
ENSMUSG00000010064 Slc38a3 9.74E-11 2.28605 
ENSMUSG00000027913 Crct1 1.33E-08 2.2855 
ENSMUSG00000050296 Abca12 2.98E-09 2.27557 
ENSMUSG00000039518 Cdsn 3.75E-08 2.27368 
ENSMUSG00000079451 Tmprss11g 1.35E-04 2.2653 
ENSMUSG00000073602 Serpinb3b 7.22E-05 2.25697 
ENSMUSG00000027513 Pck1 7.41E-18 2.24387 
ENSMUSG00000043681 Fam25c 2.27E-04 2.24042 
ENSMUSG00000047586 Nccrp1 1.89E-02 2.24009 
ENSMUSG00000026984 Il1f6 6.03E-03 2.23995 
ENSMUSG00000039070 Cpa4 3.31E-06 2.23183 




ENSMUSG00000060621 Nkpd1 1.11E-02 2.2285 
ENSMUSG00000048764 Tmprss11f 1.97E-04 2.22505 
ENSMUSG00000076613 Ighg2b 8.46E-03 2.22301 
ENSMUSG00000025329 Padi1 1.34E-02 2.22281 
ENSMUSG00000044359 P2ry4 2.00E-03 2.21873 
ENSMUSG00000079644 Gm1110 8.55E-04 2.19573 
ENSMUSG00000059230 Defb4 1.15E-06 2.17928 
ENSMUSG00000112267 Gm47903 3.79E-02 2.17842 
ENSMUSG00000021359 Tfap2a 8.96E-04 2.17337 
ENSMUSG00000031844 Hsd17b2 1.45E-04 2.16161 
ENSMUSG00000067714 Lpar5 2.70E-02 2.15751 
ENSMUSG00000068885 Lce3f 5.02E-05 2.15408 
ENSMUSG00000031372 Trex2 1.77E-02 2.15218 
ENSMUSG00000073601 Serpinb3c 7.40E-03 2.14657 
ENSMUSG00000024331 Dsc2 6.87E-11 2.14446 
ENSMUSG00000090356 Teddm3 1.75E-03 2.13866 
ENSMUSG00000032281 Acsbg1 5.63E-12 2.13831 
ENSMUSG00000021509 Slc25a48 5.40E-03 2.13414 
ENSMUSG00000086448 9330162012Rik 1.57E-02 2.12691 
ENSMUSG00000047787 Flrt1 1.70E-02 2.12205 
ENSMUSG00000068890 Lce1a2 2.23E-02 2.12041 
ENSMUSG00000046818 Ddit4l 1.82E-04 2.11443 
ENSMUSG00000045776 Lrtm1 3.90E-10 2.10474 
ENSMUSG00000038242 Aox4 1.01E-05 2.10471 
ENSMUSG00000027923 Lce1b 2.48E-02 2.10373 
ENSMUSG00000055333 Fat2 2.95E-09 2.09985 
ENSMUSG00000091376 Aadacl2 4.12E-02 2.09943 
ENSMUSG00000086585 Gm16126 2.80E-02 2.08292 
ENSMUSG00000074625 Arhgap40 4.55E-07 2.08272 
ENSMUSG00000025431 Crisp1 3.94E-04 2.0827 
ENSMUSG00000003271 Sult2b1 1.40E-04 2.07941 
ENSMUSG00000074771 Ankef1 1.86E-07 2.06756 
ENSMUSG00000030577 Cd22 9.58E-12 2.0664 
ENSMUSG00000042092 Lce1c 2.56E-02 2.06455 
ENSMUSG00000075296 Aldh3b2 3.22E-03 2.06241 
ENSMUSG00000048078 Tenm4 4.36E-46 2.05431 
ENSMUSG00000043165 Lor 1.66E-12 2.053 
ENSMUSG00000046056 Sbsn 6.79E-08 2.04981 
ENSMUSG00000049336 Tenm2 1.73E-20 2.03138 
ENSMUSG00000020061 Mybpc1 1.29E-26 2.0298 
ENSMUSG00000038354 Ankrd35 5.87E-04 2.02604 
ENSMUSG00000021255 Esrrb 2.34E-05 2.00726 
ENSMUSG00000106245 Gm43824 2.26E-03 2.00651 
ENSMUSG00000026616 Cr2 8.19E-09 2.0019 
ENSMUSG00000087500 Gm12426 3.86E-02 1.99964 
ENSMUSG00000074433 Lce3e 3.42E-03 1.99487 
ENSMUSG00000086584 Gm12002 3.67E-05 1.99171 
ENSMUSG00000104927 Gm43388 4.85E-03 1.99016 
ENSMUSG00000033849 B3galt2 3.89E-03 1.98493 
ENSMUSG00000035606 Ky 1.89E-07 1.98363 
ENSMUSG00000100781 Gm29481 2.81E-02 1.98361 
ENSMUSG00000049598 Vsig8 2.47E-02 1.98235 
ENSMUSG00000028544 Slc5a9 3.70E-04 1.97676 
ENSMUSG00000036731 Cysrt1 3.63E-03 1.97512 
ENSMUSG00000038115 Ano2 1.53E-17 1.96639 
ENSMUSG00000027833 Shox2 3.91E-02 1.96557 




ENSMUSG00000022416 Cacna1i 1.15E-06 1.96482 
ENSMUSG00000032278 Paqr5 5.13E-09 1.96334 
ENSMUSG00000043461 Sptssb 5.50E-04 1.96325 
ENSMUSG00000026109 Tmeff2 5.04E-10 1.96288 
ENSMUSG00000024471 Myot 1.16E-18 1.95937 
ENSMUSG00000115919 Gm31583 2.72E-02 1.95861 
ENSMUSG00000037469 Acp7 1.65E-02 1.95823 
ENSMUSG00000056966 Gjc3 4.48E-02 1.95084 
ENSMUSG00000005716 Pvalb 1.10E-03 1.95002 
ENSMUSG00000055489 Ano5 1.63E-13 1.94962 
ENSMUSG00000043286 Pnpla1 6.54E-03 1.94448 
ENSMUSG00000015879 Fam184b 2.97E-03 1.94 
ENSMUSG00000001497 Pax9 7.64E-06 1.93926 
ENSMUSG00000021565 Slc6a19 2.86E-04 1.93609 
ENSMUSG00000114493 Gm47071 1.55E-07 1.93539 
ENSMUSG00000043795 Prr33 1.22E-02 1.93241 
ENSMUSG00000024972 Lgals12 1.56E-04 1.92981 
ENSMUSG00000037157 Il22ra1 2.63E-02 1.92792 
ENSMUSG00000085184 4933439K11Rik 1.66E-04 1.92699 
ENSMUSG00000031936 Hephl1 4.23E-02 1.92403 
ENSMUSG00000024673 Ms4a1 1.09E-08 1.92013 
ENSMUSG00000111556 Gm19299 2.18E-02 1.91814 
ENSMUSG00000030178 Klra13-ps 1.23E-02 1.91485 
ENSMUSG00000000673 Haao 2.01E-04 1.91426 
ENSMUSG00000019102 Aldh3a1 2.82E-09 1.90858 
ENSMUSG00000104213 Ighd 1.37E-08 1.90673 
ENSMUSG00000034282 Evpl 4.31E-11 1.90263 
ENSMUSG00000021223 Papln 5.43E-04 1.89985 
ENSMUSG00000041782 Lad1 1.90E-10 1.89447 
ENSMUSG00000067889 Sptbn2 3.18E-09 1.89422 
ENSMUSG00000056328 Myh1 5.41E-31 1.89409 
ENSMUSG00000048142 Nat8l 2.19E-04 1.88665 
ENSMUSG00000116290 Gm49518 4.80E-03 1.88407 
ENSMUSG00000027359 Slc27a2 8.34E-03 1.88103 
ENSMUSG00000061126 Cyp4f39 1.85E-03 1.87931 
ENSMUSG00000019853 Hebp2 2.38E-02 1.8788 
ENSMUSG00000024347 Psd2 6.76E-03 1.8787 
ENSMUSG00000049123 Catsperg2 1.49E-02 1.87815 
ENSMUSG00000017300 Tnnc2 5.40E-15 1.87774 
ENSMUSG00000026950 Neb 1.41E-16 1.87734 
ENSMUSG00000032033 Barx2 3.20E-08 1.87675 
ENSMUSG00000046182 Gsg1l 2.78E-05 1.8741 
ENSMUSG00000044737 Klk14 2.20E-06 1.87252 
ENSMUSG00000046971 Pla2g4f 1.78E-09 1.87121 
ENSMUSG00000044086 Lmod3 1.84E-04 1.86547 
ENSMUSG00000084162 Gm11251 4.13E-02 1.86137 
ENSMUSG00000033508 Asprv1 4.71E-06 1.85815 
ENSMUSG00000034579 Pla2g3 9.27E-03 1.85233 
ENSMUSG00000106617 Gm36266 3.40E-02 1.85212 
ENSMUSG00000037509 Arhgef4 9.74E-11 1.8494 
ENSMUSG00000028435 Aqp3 6.38E-06 1.84168 
ENSMUSG00000060180 Myh13 1.20E-05 1.8367 
ENSMUSG00000030935 Acsm3 4.56E-02 1.83384 
ENSMUSG00000028031 Dkk2 1.01E-07 1.83252 
ENSMUSG00000039092 Sptlc3 6.41E-04 1.83181 
ENSMUSG00000026407 Cacna1s 2.79E-13 1.82909 




ENSMUSG00000073492 Gm10521 2.31E-03 1.81983 
ENSMUSG00000087382 Ctcflos 3.63E-03 1.81593 
ENSMUSG00000014030 Pax5 1.30E-07 1.81402 
ENSMUSG00000030724 Cd19 4.30E-09 1.8132 
ENSMUSG00000029361 Nos1 2.87E-14 1.81035 
ENSMUSG00000069808 Fam57a 1.84E-11 1.80929 
ENSMUSG00000061723 Tnnt3 3.90E-10 1.80825 
ENSMUSG00000054966 Lmntd1 3.80E-23 1.80655 
ENSMUSG00000003863 Ppfia3 2.28E-02 1.80404 
ENSMUSG00000060275 Nrg2 1.27E-04 1.80254 
ENSMUSG00000085235 Gm12576 4.86E-02 1.79966 
ENSMUSG00000039809 Gabbr2 3.16E-02 1.79942 
ENSMUSG00000102305 Gm38192 1.07E-02 1.79922 
ENSMUSG00000030510 Cers3 3.38E-07 1.79054 
ENSMUSG00000037922 Bank1 5.44E-06 1.7892 
ENSMUSG00000027077 Smtnl1 6.91E-06 1.78907 
ENSMUSG00000049349 Gm5105 2.80E-02 1.78388 
ENSMUSG00000072591 5930412G12Rik 3.66E-02 1.78195 
ENSMUSG00000042306 S100a14 9.20E-08 1.77984 
ENSMUSG00000042474 Fcmr 2.09E-05 1.77414 
ENSMUSG00000067616 Klk11 7.10E-03 1.77343 
ENSMUSG00000040283 Btnl9 1.58E-02 1.77128 
ENSMUSG00000001095 Slc13a2 1.63E-03 1.76877 
ENSMUSG00000095079 Igha 6.91E-07 1.76823 
ENSMUSG00000071540 3425401B19Rik 2.42E-14 1.76757 
ENSMUSG00000042514 Klhl14 1.86E-03 1.76512 
ENSMUSG00000032502 Stac 1.48E-03 1.75181 
ENSMUSG00000004885 Crabp2 1.22E-02 1.74533 
ENSMUSG00000022871 Fetub 2.02E-04 1.74369 
ENSMUSG00000025754 Agbl1 7.55E-21 1.74292 
ENSMUSG00000057802 Gm10030 2.61E-02 1.74044 
ENSMUSG00000032564 Cpne4 7.97E-06 1.73707 
ENSMUSG00000013523 Bcas1 2.19E-02 1.73402 
ENSMUSG00000030546 Plin1 1.25E-07 1.73097 
ENSMUSG00000085417 Gm13919 1.02E-02 1.72944 
ENSMUSG00000079853 Klra1 3.86E-04 1.72252 
ENSMUSG00000105646 Gm30211 5.74E-11 1.72189 
ENSMUSG00000033182 Kbtbd12 8.41E-08 1.72084 
ENSMUSG00000038751 Ptk6 2.49E-02 1.71998 
ENSMUSG00000026989 Dapl1 3.16E-02 1.71791 
ENSMUSG00000112041 9530020I12Rik 4.23E-02 1.71514 
ENSMUSG00000019851 Perp 5.28E-09 1.71321 
ENSMUSG00000026418 Tnni1 1.91E-02 1.71016 
ENSMUSG00000062515 Fabp4 9.13E-16 1.70935 
ENSMUSG00000026834 Acvr1c 1.49E-04 1.70449 
ENSMUSG00000028396 2310002L09Rik 2.22E-02 1.70394 
ENSMUSG00000060962 Dmkn 1.01E-09 1.69805 
ENSMUSG00000074862 BC025920 2.99E-02 1.69659 
ENSMUSG00000091712 Sec14l5 4.66E-04 1.69507 
ENSMUSG00000025479 Cyp2e1 3.83E-17 1.69172 
ENSMUSG00000029055 Plch2 9.19E-09 1.68869 
ENSMUSG00000087514 Gm16076 4.55E-02 1.68559 
ENSMUSG00000038167 Plekhg6 3.73E-04 1.6825 
ENSMUSG00000076617 Ighm 3.37E-14 1.68243 
ENSMUSG00000076275 Mir675 4.98E-04 1.68125 
ENSMUSG00000021768 Dusp13 2.66E-02 1.68064 




ENSMUSG00000014543 Klra17 3.90E-08 1.67493 
ENSMUSG00000086564 Cd101 3.09E-15 1.6748 
ENSMUSG00000087090 Nctc1 3.84E-12 1.67425 
ENSMUSG00000022053 Ebf2 5.76E-13 1.67262 
ENSMUSG00000097312 Gm26870 4.70E-04 1.67024 
ENSMUSG00000044788 Fads6 6.63E-03 1.66957 
ENSMUSG00000067081 Asb18 4.14E-04 1.66683 
ENSMUSG00000067242 Lgi1 1.29E-02 1.66527 
ENSMUSG00000025330 Padi4 2.91E-05 1.65776 
ENSMUSG00000079015 Serpina1c 1.52E-03 1.65711 
ENSMUSG00000040536 Necab1 2.89E-02 1.65665 
ENSMUSG00000029603 Dtx1 2.06E-03 1.65369 
ENSMUSG00000032311 Nrg4 1.05E-09 1.65365 
ENSMUSG00000038457 Tmem255b 1.95E-03 1.65304 
ENSMUSG00000098488 Pla2g4b 8.22E-03 1.65198 
ENSMUSG00000066366 Serpina1a 4.02E-03 1.64939 
ENSMUSG00000029120 Ppp2r2c 3.19E-03 1.64868 
ENSMUSG00000027022 Xirp2 1.28E-22 1.64858 
ENSMUSG00000037139 Myom3 8.53E-11 1.64798 
ENSMUSG00000033544 Angptl1 1.83E-02 1.64513 
ENSMUSG00000024136 Dnase1l2 3.42E-03 1.64394 
ENSMUSG00000030592 Ryr1 1.75E-07 1.64026 
ENSMUSG00000103824 Gm38177 1.79E-02 1.6397 
ENSMUSG00000006411 Nectin4 3.58E-05 1.63718 
ENSMUSG00000096974 Gm26881 4.82E-02 1.63547 
ENSMUSG00000005547 Cyp2a5 4.57E-06 1.63304 
ENSMUSG00000113543 Gm36264 2.07E-02 1.63225 
ENSMUSG00000026494 Kif26b 2.39E-14 1.63132 
ENSMUSG00000070802 Pnmal2 1.50E-02 1.62883 
ENSMUSG00000057003 Myh4 1.66E-10 1.62751 
ENSMUSG00000028017 Egf 1.08E-08 1.62681 
ENSMUSG00000082674 Gm11914 2.98E-02 1.62365 
ENSMUSG00000059994 Fcrl1 1.55E-04 1.62354 
ENSMUSG00000020169 Best3 2.24E-05 1.62346 
ENSMUSG00000046352 Gjb2 1.75E-05 1.62257 
ENSMUSG00000058498 Rnf207 4.30E-03 1.6175 
ENSMUSG00000033533 Acsm1 5.95E-04 1.61748 
ENSMUSG00000017697 Ada 1.08E-10 1.61747 
ENSMUSG00000005373 Mlxipl 2.73E-09 1.61612 
ENSMUSG00000056755 Grm7 2.64E-05 1.6147 
ENSMUSG00000082179 Gm11407 4.66E-02 1.61227 
ENSMUSG00000001027 Scn4a 1.74E-07 1.60993 
ENSMUSG00000050600 Zfp831 3.33E-11 1.60941 
ENSMUSG00000056155 Nanos3 2.00E-02 1.60734 
ENSMUSG00000025105 Bnc1 3.90E-02 1.60648 
ENSMUSG00000075555 Gm10863 1.79E-03 1.6055 
ENSMUSG00000054889 Dsp 3.74E-45 1.60391 
ENSMUSG00000074604 Mgst2 1.19E-07 1.60185 
ENSMUSG00000036218 Pdzrn4 1.90E-11 1.60165 
ENSMUSG00000058975 Kcnc1 3.09E-03 1.60068 
ENSMUSG00000000244 Tspan32 1.03E-08 1.5999 
ENSMUSG00000031937 Vstm5 6.27E-03 1.5993 
ENSMUSG00000034648 Lrrn1 1.12E-02 1.59815 
ENSMUSG00000030495 Slc7a10 2.96E-07 1.59742 
ENSMUSG00000017639 Rab11fip4 7.16E-06 1.59393 
ENSMUSG00000029602 Rasal1 3.67E-02 1.59345 




ENSMUSG00000034308 Sdr42e1 2.38E-03 1.5912 
ENSMUSG00000059900 Tmem40 2.36E-02 1.59117 
ENSMUSG00000089941 Gm16168 3.31E-03 1.59041 
ENSMUSG00000020892 Aloxe3 1.31E-02 1.58477 
ENSMUSG00000115095 Gm49311 1.45E-02 1.58455 
ENSMUSG00000031097 Tnni2 2.64E-07 1.58348 
ENSMUSG00000031245 Hmgn5 9.24E-05 1.58329 
ENSMUSG00000067653 Ankrd23 7.42E-10 1.58165 
ENSMUSG00000039264 Gimap3 5.32E-08 1.58068 
ENSMUSG00000030730 Atp2a1 4.52E-14 1.57945 
ENSMUSG00000083834 Gm12577 3.00E-02 1.57726 
ENSMUSG00000076609 Igkc 1.26E-05 1.5742 
ENSMUSG00000021579 Lrrc14b 3.06E-02 1.57311 
ENSMUSG00000030598 Fbxo17 1.83E-04 1.57292 
ENSMUSG00000008999 Bmp7 9.10E-03 1.5718 
ENSMUSG00000036214 Znrd1as 3.27E-02 1.57078 
ENSMUSG00000030468 Siglecg 7.97E-06 1.56997 
ENSMUSG00000085971 Gm15411 3.59E-04 1.56795 
ENSMUSG00000024617 Camk2a 1.83E-04 1.56649 
ENSMUSG00000021340 Gpld1 1.71E-06 1.56545 
ENSMUSG00000031933 Izumo1r 4.04E-02 1.56461 
ENSMUSG00000090799 Klhl33 9.45E-05 1.56433 
ENSMUSG00000036854 Hspb6 5.71E-03 1.56314 
ENSMUSG00000047419 Cmya5 1.22E-17 1.56238 
ENSMUSG00000114014 Gm48350 2.45E-03 1.56063 
ENSMUSG00000063522 2010109I03Rik 1.10E-02 1.56032 
ENSMUSG00000037661 Gpr160 1.12E-03 1.56002 
ENSMUSG00000055775 Myh8 2.99E-07 1.55915 
ENSMUSG00000097899 Gm16894 8.00E-03 1.55851 
ENSMUSG00000039521 Foxp3 9.57E-03 1.55602 
ENSMUSG00000070385 Ampd1 4.23E-05 1.55169 
ENSMUSG00000050106 Tmc8 7.90E-05 1.5508 
ENSMUSG00000035686 Thrsp 2.97E-07 1.54774 
ENSMUSG00000041460 Cacna2d4 4.52E-02 1.5477 
ENSMUSG00000026824 Kcnj3 9.29E-10 1.54542 
ENSMUSG00000020758 Itgb4 4.89E-09 1.54438 
ENSMUSG00000032503 Arpp21 4.76E-03 1.54437 
ENSMUSG00000043110 Lrrn4 7.92E-03 1.5421 
ENSMUSG00000014453 Blk 1.27E-06 1.54192 
ENSMUSG00000027419 Pcsk2 5.87E-03 1.54191 
ENSMUSG00000034656 Cacna1a 7.55E-12 1.54042 
ENSMUSG00000015702 Anxa9 7.23E-03 1.5397 
ENSMUSG00000062713 Sim2 2.58E-05 1.53934 
ENSMUSG00000068697 Myoz1 5.79E-04 1.5362 
ENSMUSG00000038602 Slc35f1 8.70E-10 1.53615 
ENSMUSG00000079110 Capn3 9.20E-06 1.5356 
ENSMUSG00000036856 Wnt4 2.59E-06 1.53379 
ENSMUSG00000000223 Drp2 1.32E-03 1.53365 
ENSMUSG00000031710 Ucp1 7.53E-03 1.53359 
ENSMUSG00000056656 Apol8 4.49E-02 1.53347 
ENSMUSG00000029862 Clcn1 2.78E-04 1.5334 
ENSMUSG00000024526 Cidea 2.67E-02 1.53274 
ENSMUSG00000042251 Pm20d1 1.64E-02 1.5326 
ENSMUSG00000079055 Slc8a3 2.56E-06 1.53124 
ENSMUSG00000031377 Bmx 4.19E-08 1.5308 
ENSMUSG00000034570 Inpp5j 1.71E-02 1.52977 




ENSMUSG00000057719 Sh3rf2 1.60E-09 1.52797 
ENSMUSG00000035189 Ano4 1.29E-06 1.52212 
ENSMUSG00000043932 Klri2 1.09E-02 1.51956 
ENSMUSG00000024112 Cacna1h 1.02E-02 1.51951 
ENSMUSG00000072812 Ahnak2 2.64E-06 1.51917 
ENSMUSG00000024669 Cd5 8.63E-04 1.51847 
ENSMUSG00000037989 Wnk2 1.82E-10 1.51835 
ENSMUSG00000074497 A430078G23Rik 3.97E-14 1.51676 
ENSMUSG00000054708 Ankrd24 3.01E-04 1.51618 
ENSMUSG00000032243 Itga11 6.65E-04 1.51519 
ENSMUSG00000087150 BC064078 4.96E-03 1.51421 
ENSMUSG00000044461 Shisa2 4.62E-02 1.50751 
ENSMUSG00000114937 Gm30054 6.11E-05 1.50651 
ENSMUSG00000038605 Samd10 2.26E-03 1.50622 
ENSMUSG00000040350 Trim7 2.15E-04 1.50563 
ENSMUSG00000100551 Gm19503 3.16E-03 1.5047 
ENSMUSG00000015314 Slamf6 1.76E-09 1.50457 
ENSMUSG00000032262 Elovl4 5.29E-03 1.50436 
ENSMUSG00000090166 Ear10 2.48E-02 1.50393 
ENSMUSG00000058207 Serpina3k 2.37E-03 1.50282 
ENSMUSG00000040694 Apobec2 2.65E-05 1.50189 
ENSMUSG00000113447 Gm48538 4.54E-02 1.50191 
ENSMUSG00000026646 Suv39h2 4.57E-02 1.5074 
ENSMUSG00000030744 Rps3 1.27E-09 1.50807 
ENSMUSG00000085025 Gm13715 3.50E-02 1.50829 
ENSMUSG00000059835 Rpl13-ps3 2.53E-03 1.51027 
ENSMUSG00000032496 Ltf 3.04E-16 1.51096 
ENSMUSG00000084104 Gm13578 2.62E-05 1.51286 
ENSMUSG00000091845 Rpl36-ps12 7.00E-03 1.51322 
ENSMUSG00000100969 1700030N03Rik 1.54E-02 1.51588 
ENSMUSG00000082062 Ftl2-ps 3.39E-09 1.51711 
ENSMUSG00000076036 Gm22133 2.46E-11 1.51828 
ENSMUSG00000083337 Gm11539 1.80E-03 1.52589 
ENSMUSG00000040809 Chil3 1.62E-04 1.52703 
ENSMUSG00000024774 Ankrd22 3.56E-08 1.53049 
ENSMUSG00000052565 Hist1h1d 7.00E-03 1.53071 
ENSMUSG00000024026 Glo1 8.15E-12 1.53202 
ENSMUSG00000057863 Rpl36 4.20E-04 1.53263 
ENSMUSG00000080811 Gm14513 1.25E-03 1.5339 
ENSMUSG00000109658 Gm45660 4.65E-05 1.53887 
ENSMUSG00000097366 Gm8177 1.12E-02 1.54012 
ENSMUSG00000094955 Gm3699 1.48E-02 1.5463 
ENSMUSG00000094125 Gm13698 6.40E-03 1.55008 
ENSMUSG00000094336 Gm13693 6.40E-03 1.55008 
ENSMUSG00000096484 Gm13696 6.40E-03 1.55008 
ENSMUSG00000096337 Gm13694 6.40E-03 1.55008 
ENSMUSG00000095824 Gm13697 6.40E-03 1.55008 
ENSMUSG00000079247 Gm13691 6.40E-03 1.55008 
ENSMUSG00000096729 Gm13695 5.93E-03 1.55266 
ENSMUSG00000112908 Gm7392 3.88E-04 1.5528 
ENSMUSG00000022097 Sftpc 6.96E-07 1.55295 
ENSMUSG00000046031 Calhm6 1.49E-02 1.5541 
ENSMUSG00000082978 Rpsa-ps11 2.04E-02 1.55812 
ENSMUSG00000085264 Gm15581 3.86E-02 1.56146 
ENSMUSG00000028179 Cth 1.60E-04 1.56198 
ENSMUSG00000080950 Gm7278 2.72E-02 1.56602 




ENSMUSG00000114304 Gm48099 2.47E-05 1.56873 
ENSMUSG00000065968 Ifitm7 3.54E-02 1.57151 
ENSMUSG00000077391 Gm24336 3.92E-02 1.57527 
ENSMUSG00000073940 Hbb-bt 7.22E-03 1.57539 
ENSMUSG00000028896 Rcc1 7.42E-10 1.57968 
ENSMUSG00000085401 Slc39a1-ps 5.82E-09 1.58067 
ENSMUSG00000049932 H2afx 6.34E-03 1.58133 
ENSMUSG00000087968 Gm25395 2.95E-03 1.58263 
ENSMUSG00000032484 Ngp 5.93E-21 1.58682 
ENSMUSG00000083898 Gm7340 3.68E-05 1.58939 
ENSMUSG00000097971 Gm26917 8.77E-04 1.59222 
ENSMUSG00000050796 B3galt6 1.23E-02 1.59236 
ENSMUSG00000048388 Fam171b 2.37E-10 1.59429 
ENSMUSG00000024205 Rpl36-ps2 4.35E-04 1.59832 
ENSMUSG00000007892 Rplp1 5.42E-11 1.61046 
ENSMUSG00000052305 Hbb-bs 3.42E-03 1.61115 
ENSMUSG00000065037 Rn7sk 4.20E-03 1.61406 
ENSMUSG00000079505 Gm11131 4.60E-03 1.61438 
ENSMUSG00000087700 Gm15283 1.12E-02 1.61608 
ENSMUSG00000096972 Gm26883 1.24E-02 1.62189 
ENSMUSG00000063779 Chil4 1.09E-03 1.62825 
ENSMUSG00000062461 Gm5453 4.23E-05 1.62974 
ENSMUSG00000083836 Ldha-ps2 2.54E-03 1.63004 
ENSMUSG00000084708 Gm22988 4.90E-03 1.63084 
ENSMUSG00000106373 Gm6522 8.32E-03 1.64441 
ENSMUSG00000075391 Gm13443 5.63E-08 1.6457 
ENSMUSG00000077192 Snora17 1.41E-02 1.64917 
ENSMUSG00000021071 Trim9 2.44E-04 1.65066 
ENSMUSG00000089281 Scarna6 7.09E-03 1.6534 
ENSMUSG00000025716 Myo3a 4.50E-03 1.65551 
ENSMUSG00000030329 Pianp 7.04E-03 1.66575 
ENSMUSG00000097168 C230088H06Rik 6.39E-08 1.67154 
ENSMUSG00000063586 Gm5513 4.76E-03 1.67361 
ENSMUSG00000070473 Cldn3 4.42E-09 1.67916 
ENSMUSG00000083737 Prdx6-ps2 2.04E-02 1.6846 
ENSMUSG00000088789 Scarna13 1.82E-03 1.68485 
ENSMUSG00000035299 Mid1 3.52E-03 1.71244 
ENSMUSG00000070524 Fcrlb 2.80E-02 1.72336 
ENSMUSG00000064382 Gm26447 2.21E-04 1.73092 
ENSMUSG00000032425 Zfp949 1.91E-18 1.74133 
ENSMUSG00000013936 Myl2 4.07E-03 1.74341 
ENSMUSG00000104560 Gm8115 3.84E-04 1.74573 
ENSMUSG00000089762 Ier5l 2.27E-04 1.74658 
ENSMUSG00000087353 Gm13727 7.20E-06 1.75524 
ENSMUSG00000085241 Snhg3 4.49E-06 1.75809 
ENSMUSG00000113960 4933412O06Rik 4.05E-03 1.76721 
ENSMUSG00000075268 Gm10819 4.64E-05 1.77825 
ENSMUSG00000106497 Gm43195 7.66E-03 1.77886 
ENSMUSG00000044117 2900011O08Rik 6.16E-03 1.78002 
ENSMUSG00000086420 Gm8865 2.40E-04 1.78093 
ENSMUSG00000027014 Cwc22 5.52E-07 1.781 
ENSMUSG00000077254 Gm26079 1.93E-02 1.79018 
ENSMUSG00000062464 Cyp4f37 2.53E-04 1.80716 
ENSMUSG00000082755 Gm8692 2.33E-02 1.80988 
ENSMUSG00000080542 Gm22710 3.28E-02 1.81091 
ENSMUSG00000107722 2900060B14Rik 2.04E-02 1.81334 




ENSMUSG00000089542 Gm25835 8.85E-06 1.82629 
ENSMUSG00000085599 Gm13449 1.80E-02 1.82911 
ENSMUSG00000084744 Gm25291 2.45E-02 1.83791 
ENSMUSG00000029372 Ppbp 1.41E-06 1.83838 
ENSMUSG00000095098 Ccdc85b 1.56E-03 1.84033 
ENSMUSG00000088609 Gm24187 4.85E-07 1.84671 
ENSMUSG00000001482 Def8 5.29E-14 1.84897 
ENSMUSG00000089617 Scarna10 6.74E-04 1.85948 
ENSMUSG00000099587 Gm28967 6.74E-04 1.85948 
ENSMUSG00000088246 Gm25911 1.03E-07 1.86065 
ENSMUSG00000001983 Taco1 8.81E-07 1.86641 
ENSMUSG00000065353 Snora73b 2.44E-04 1.8684 
ENSMUSG00000086354 Gm13938 1.03E-15 1.8767 
ENSMUSG00000091405 Hist2h4 4.81E-07 1.88798 
ENSMUSG00000091957 Rps2-ps10 4.59E-07 1.89014 
ENSMUSG00000069273 Hist1h3e 1.12E-03 1.9083 
ENSMUSG00000104690 Gm47304 5.92E-05 1.91679 
ENSMUSG00000077714 Snord17 1.66E-04 1.91875 
ENSMUSG00000088185 Scarna2 7.71E-07 1.9197 
ENSMUSG00000049097 Ankrd34a 1.63E-02 1.91985 
ENSMUSG00000036264 Fstl4 2.89E-03 1.92434 
ENSMUSG00000114456 Hist1h2bh 1.82E-02 1.92447 
ENSMUSG00000098178 Gm42418 1.34E-05 1.92525 
ENSMUSG00000058385 Hist1h2bg 1.06E-03 1.92534 
ENSMUSG00000064387 Snora73a 5.40E-09 1.936 
ENSMUSG00000094338 Hist1h2bl 3.08E-03 1.94362 
ENSMUSG00000088948 Gm23262 1.49E-04 1.94793 
ENSMUSG00000064220 Hist2h2aa1 3.69E-03 1.95446 
ENSMUSG00000028461 Ccdc107 1.54E-09 1.96853 
ENSMUSG00000065226 Gm25791 3.14E-06 1.98442 
ENSMUSG00000029635 Cdk8 2.29E-09 1.98467 
ENSMUSG00000092746 Rn7s6 2.46E-05 1.98632 
ENSMUSG00000065259 Snora30 3.24E-02 1.99136 
ENSMUSG00000060639 Hist1h4i 1.64E-03 2.00154 
ENSMUSG00000065822 Snord15a 5.99E-03 2.00285 
ENSMUSG00000063954 Hist2h2aa2 1.91E-05 2.0103 
ENSMUSG00000077563 Snora68 6.54E-05 2.01347 
ENSMUSG00000074398 Gm15441 7.12E-03 2.02986 
ENSMUSG00000069308 Hist1h2bp 3.32E-02 2.03521 
ENSMUSG00000106649 Gm49349 2.06E-06 2.04015 
ENSMUSG00000116237 Gm30339 1.38E-02 2.04542 
ENSMUSG00000089655 Gm16004 2.91E-02 2.05643 
ENSMUSG00000076281 Gm24270 2.24E-07 2.06413 
ENSMUSG00000104740 Mir6516 3.24E-03 2.06889 
ENSMUSG00000097263 Gm26804 2.12E-03 2.10305 
ENSMUSG00000089255 Snora78 2.81E-02 2.10781 
ENSMUSG00000065911 Gm24447 2.25E-05 2.11307 
ENSMUSG00000062727 Hist1h2bk 3.23E-03 2.11378 
ENSMUSG00000093378 Gm20663 7.20E-04 2.11505 
ENSMUSG00000085348 Myhas 2.48E-04 2.12433 
ENSMUSG00000064841 Gm26205 8.37E-03 2.1269 
ENSMUSG00000081684 Rps2-ps13 5.49E-10 2.13212 
ENSMUSG00000101972 Hist1h3i 3.84E-02 2.13658 
ENSMUSG00000064231 Gm5321 1.89E-02 2.13892 
ENSMUSG00000087819 Gm25117 2.03E-06 2.14179 
ENSMUSG00000065824 Gm26315 1.47E-05 2.1456 




ENSMUSG00000105398 Gm47305 2.67E-06 2.14661 
ENSMUSG00000097300 Gm26835 3.09E-02 2.15296 
ENSMUSG00000104863 Gm49347 5.00E-04 2.15358 
ENSMUSG00000065087 Snord22 1.78E-14 2.16707 
ENSMUSG00000100210 Hist1h3f 5.03E-04 2.17714 
ENSMUSG00000069265 Hist1h3a 3.80E-02 2.18419 
ENSMUSG00000064380 Gm26448 7.15E-09 2.18787 
ENSMUSG00000064853 Gm23442 3.71E-06 2.1894 
ENSMUSG00000065304 Gm23245 2.59E-03 2.20662 
ENSMUSG00000110588 Gm45774 1.44E-02 2.22306 
ENSMUSG00000064655 Gm25788 1.17E-02 2.22647 
ENSMUSG00000064994 Gm22422 2.44E-03 2.23564 
ENSMUSG00000099250 Rn7s2 9.79E-07 2.24149 
ENSMUSG00000099021 Rn7s1 9.79E-07 2.24153 
ENSMUSG00000105460 Gm42671 4.96E-02 2.24303 
ENSMUSG00000065118 Gm23297 4.50E-03 2.24685 
ENSMUSG00000065254 Gm23973 2.55E-02 2.27365 
ENSMUSG00000064999 Gm26035 2.23E-06 2.27841 
ENSMUSG00000065686 Snora5c 1.32E-02 2.28658 
ENSMUSG00000117074 AC121299.1 6.16E-03 2.29666 
ENSMUSG00000086220 Gm16599 1.82E-03 2.30969 
ENSMUSG00000096010 Hist4h4 2.23E-06 2.31336 
ENSMUSG00000076258 Gm23935 1.76E-11 2.31549 
ENSMUSG00000103626 Gm37358 6.88E-05 2.31983 
ENSMUSG00000088529 Gm26083 7.90E-05 2.32066 
ENSMUSG00000112246 Gm40761 4.60E-02 2.33454 
ENSMUSG00000064694 Gm24146 5.87E-04 2.34501 
ENSMUSG00000114969 Hba-ps3 2.31E-03 2.35684 
ENSMUSG00000086649 Gm15286 2.21E-02 2.36528 
ENSMUSG00000064966 Snord15b 1.96E-06 2.36869 
ENSMUSG00000091993 B930036N10Rik 3.93E-04 2.3742 
ENSMUSG00000053615 Gm9913 4.61E-02 2.38787 
ENSMUSG00000108866 Gm35082 4.48E-02 2.40681 
ENSMUSG00000068855 Hist2h2ac 5.77E-05 2.40805 
ENSMUSG00000099517 Hist1h3g 3.11E-02 2.42777 
ENSMUSG00000080365 Gm25776 6.97E-05 2.42824 
ENSMUSG00000102189 Gm37194 5.60E-09 2.44452 
ENSMUSG00000061482 Hist1h4d 2.67E-16 2.45181 
ENSMUSG00000043340 6530409C15Rik 1.55E-02 2.46462 
ENSMUSG00000099583 Hist1h3d 9.81E-03 2.47409 
ENSMUSG00000105448 Gm25820 1.07E-02 2.49056 
ENSMUSG00000105288 Gm25820 1.07E-02 2.49056 
ENSMUSG00000065145 Vaultrc5 5.90E-06 2.49296 
ENSMUSG00000088008 Gm25492 6.25E-04 2.49693 
ENSMUSG00000064451 Snora23 6.01E-03 2.49877 
ENSMUSG00000095217 Hist1h2bn 8.20E-04 2.50304 
ENSMUSG00000065649 Snora74a 9.27E-07 2.50464 
ENSMUSG00000092267 Gm20417 2.33E-11 2.5151 
ENSMUSG00000069274 Hist1h4f 6.17E-05 2.51954 
ENSMUSG00000093650 Gm20631 3.45E-02 2.52141 
ENSMUSG00000069310 Hist1h3c 1.27E-03 2.52752 
ENSMUSG00000087775 Rprl2 4.48E-05 2.53855 
ENSMUSG00000071470 Ccnb1ip1 1.51E-06 2.57238 
ENSMUSG00000091383 Hist1h2al 3.90E-12 2.58142 
ENSMUSG00000092837 Rpph1 1.54E-06 2.5885 
ENSMUSG00000092386 Gm20536 2.30E-02 2.58947 




ENSMUSG00000102349 Gm37376 5.22E-06 2.59474 
ENSMUSG00000060678 Hist1h4c 1.34E-12 2.602 
ENSMUSG00000097417 Gm26669 3.90E-03 2.60481 
ENSMUSG00000105145 Gm47299 4.92E-08 2.60571 
ENSMUSG00000105788 Gm47295 4.92E-08 2.60593 
ENSMUSG00000089536 Scarna3a 6.53E-03 2.6208 
ENSMUSG00000101355 Hist1h3h 1.95E-02 2.63462 
ENSMUSG00000088675 Rprl1 4.46E-03 2.64112 
ENSMUSG00000106222 Rprl1 4.46E-03 2.64112 
ENSMUSG00000069266 Hist1h4b 5.61E-04 2.64927 
ENSMUSG00000069267 Hist1h3b 1.36E-03 2.66856 
ENSMUSG00000060981 Hist1h4h 3.18E-11 2.67747 
ENSMUSG00000064288 Hist1h4k 6.70E-06 2.68893 
ENSMUSG00000064604 Snora44 4.05E-05 2.70815 
ENSMUSG00000093355 Snora26 1.76E-02 2.76757 
ENSMUSG00000095590 Gm24305 5.74E-03 2.78226 
ENSMUSG00000092819 Gm23639 4.60E-03 2.79569 
ENSMUSG00000115420 AL732506.1 1.91E-12 2.79623 
ENSMUSG00000088088 Rmrp 1.91E-12 2.79623 
ENSMUSG00000086953 Aknaos 4.22E-02 2.79896 
ENSMUSG00000010342 Tex14 2.50E-11 2.80189 
ENSMUSG00000067455 Hist1h4j 1.31E-04 2.80961 
ENSMUSG00000084783 Gm15419 5.16E-07 2.81003 
ENSMUSG00000111971 Gm48678 1.46E-04 2.81027 
ENSMUSG00000064901 Snora21 1.28E-03 2.87377 
ENSMUSG00000087943 Gm24245 1.66E-12 2.89193 
ENSMUSG00000087963 Gm25394 8.18E-03 2.89624 
ENSMUSG00000096243 Gm24265 1.61E-07 2.90069 
ENSMUSG00000065905 Gm26110 9.26E-04 2.91055 
ENSMUSG00000105399 Mir1843b 5.37E-03 2.9215 
ENSMUSG00000097131 D230017M19Rik 5.32E-12 2.94112 
ENSMUSG00000092674 Gm24105 7.90E-11 2.95616 
ENSMUSG00000077323 Rnu11 1.61E-07 2.98011 
ENSMUSG00000096992 Gm26788 9.33E-03 2.98078 
ENSMUSG00000117227 AC105304.3 2.95E-02 2.9812 
ENSMUSG00000065778 Gm22154 2.44E-03 2.9846 
ENSMUSG00000105790 Gm24105 8.13E-11 2.98894 
ENSMUSG00000088025 Rprl3 6.04E-07 2.99575 
ENSMUSG00000095580 Rnu1b1 3.38E-07 3.01229 
ENSMUSG00000093834 Rnu1b2 3.38E-07 3.01229 
ENSMUSG00000064923 Gm22042 1.44E-07 3.01372 
ENSMUSG00000095701 Gm24830 9.14E-08 3.03287 
ENSMUSG00000096838 Gm26232 9.14E-08 3.03287 
ENSMUSG00000065773 Rnu1b6 9.14E-08 3.03287 
ENSMUSG00000010362 Rdm1 9.37E-11 3.04878 
ENSMUSG00000095260 Gm25890 1.10E-07 3.05099 
ENSMUSG00000094812 Gm22614 1.10E-07 3.05099 
ENSMUSG00000069300 Hist1h2bj 7.93E-04 3.06257 
ENSMUSG00000069305 Hist1h4n 3.36E-07 3.0744 
ENSMUSG00000094377 Gm24407 6.03E-10 3.08024 
ENSMUSG00000069306 Hist1h4m 2.82E-06 3.08188 
ENSMUSG00000060988 Galnt13 9.80E-33 3.13528 
ENSMUSG00000065701 Rny1 1.52E-08 3.17627 
ENSMUSG00000070167 Snora57 1.98E-15 3.18889 
ENSMUSG00000094655 Gm25360 5.67E-15 3.20136 
ENSMUSG00000108563 Gm44686 1.39E-02 3.23591 




ENSMUSG00000091165 Gm17036 1.50E-02 3.27618 
ENSMUSG00000060093 Hist1h4a 1.46E-12 3.32521 
ENSMUSG00000092805 Gm26461 1.31E-10 3.34331 
ENSMUSG00000096214 Gm22634 5.90E-18 3.48166 
ENSMUSG00000096206 Gm22317 5.90E-18 3.48166 
ENSMUSG00000027233 Patl2 1.67E-05 3.4999 
ENSMUSG00000065845 Gm25189 7.04E-03 3.50714 
ENSMUSG00000096205 Gm22068 8.03E-11 3.52569 
ENSMUSG00000088252 Snord13 8.10E-08 3.5475 
ENSMUSG00000065176 Rnu12 1.76E-21 3.61877 
ENSMUSG00000097799 Gm26899 1.05E-03 3.63697 
ENSMUSG00000092702 Gm24514 7.15E-12 3.70097 
ENSMUSG00000064943 Gm23240 3.63E-03 3.72556 
ENSMUSG00000085573 Gm15418 1.61E-07 3.75952 
ENSMUSG00000110790 Gm47079 2.36E-03 3.78383 
ENSMUSG00000065767 Gm23849 2.98E-11 3.82342 
ENSMUSG00000065944 Rnu2-10 1.90E-11 3.84825 
ENSMUSG00000094826 Gm23804 1.21E-18 3.84945 
ENSMUSG00000064702 Gm24950 2.50E-11 3.85414 
ENSMUSG00000065251 Gm23971 2.50E-11 3.85414 
ENSMUSG00000064856 Gm23444 3.12E-11 3.87597 
ENSMUSG00000093956 Gm24497 6.05E-11 3.87768 
ENSMUSG00000064945 Rny3 1.84E-12 3.87863 
ENSMUSG00000094050 Gm23472 2.54E-11 3.89363 
ENSMUSG00000094306 Gm24924 1.54E-10 3.89902 
ENSMUSG00000108171 Gm43915 7.23E-04 3.89946 
ENSMUSG00000065820 Gm26316 9.58E-12 3.91062 
ENSMUSG00000097346 Gm26619 2.86E-04 3.94457 
ENSMUSG00000065870 Rnu3a 1.51E-11 3.95478 
ENSMUSG00000106147 Rnu3a 1.51E-11 3.95478 
ENSMUSG00000095969 Rnu1a1 1.19E-11 3.95595 
ENSMUSG00000096659 Gm25679 1.03E-19 3.9906 
ENSMUSG00000093815 Gm26444 1.03E-19 3.9906 
ENSMUSG00000115432 D130009I18Rik 1.17E-07 4.00512 
ENSMUSG00000105115 Rnu3b2 3.78E-19 4.06451 
ENSMUSG00000098925 Rnu3b2 3.78E-19 4.06451 
ENSMUSG00000098943 Rnu3b1 6.81E-19 4.07869 
ENSMUSG00000105025 Rnu3b1 6.81E-19 4.07869 
ENSMUSG00000099291 Rnu3b3 1.50E-18 4.09008 
ENSMUSG00000104856 Rnu3b3 1.50E-18 4.09008 
ENSMUSG00000104896 Rnu3b4 3.78E-19 4.1079 
ENSMUSG00000098641 Rnu3b4 4.19E-19 4.1081 
ENSMUSG00000095616 Gm26244 5.63E-11 4.1472 
ENSMUSG00000080538 Gm25541 1.15E-12 4.15571 
ENSMUSG00000064941 Gm23238 2.71E-15 4.16236 
ENSMUSG00000065232 Gm22973 6.24E-13 4.18652 
ENSMUSG00000085393 Gm11280 4.14E-03 4.19886 
ENSMUSG00000096349 Gm22513 1.18E-06 4.21069 
ENSMUSG00000090625 Gm20721 7.53E-07 4.26306 
ENSMUSG00000095676 Gm25099 1.09E-21 4.3711 
ENSMUSG00000095738 Gm25313 2.50E-11 4.39293 
ENSMUSG00000093843 Gm25939 6.33E-11 4.45452 
ENSMUSG00000095892 Rnu5g 3.84E-12 4.48461 
ENSMUSG00000064682 Gm25813 1.88E-09 4.50868 
ENSMUSG00000085297 Gm11651 8.54E-10 4.5091 
ENSMUSG00000085465 Gm15347 3.44E-06 4.85263 




ENSMUSG00000023467 Tulp2 2.27E-05 5.12205 
ENSMUSG00000064899 Snord118 2.09E-07 5.44474 
ENSMUSG00000094668 Gm24871 6.67E-06 5.69726 
ENSMUSG00000097815 Gm26809 9.27E-08 5.9877 
ENSMUSG00000047061 Gm9817 3.07E-05 7.37847 
ENSMUSG00000097554 Gm26825 2.08E-06 11.0581 





















Appendix Y. Gating strategy 1. Contour plots of windows and gating strategy used for the 
identification of major immune cell populations in pneumococcal infected mouse lungs. Cells were 
first gated for size and singularity, followed by exclusion of dead cells. Gates containing multiple 
cell populations other than single cell gates are numbered G1-G6. Gates containing single cell 
populations are labelled with the cell types that include: T cells, B cells, natural killer cells, 
neutrophils, eosinophils, inflammatory monocytes, resident monocytes, alveolar macrophages, 

































Appendix Z. Gating strategy 2. Contour plots of windows and gating strategy used to validate anti-
Ly6G mediated neutrophil depletion. Cells were first gated for size and singularity, followed by 
gating for leukocytes. CD11b+ cells were then gated for, and subsequently neutrophils were 
detected as GR1int/hi and Ly6Cint.  
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Capacity To Utilize Raffinose Dictates Pneumococcal Disease
Phenotype
Vikrant Minhas,a Richard M. Harvey,a Lauren J. McAllister,a Torsten Seemann,b,c Anna E. Syme,b Sarah L. Baines,c
James C. Paton,a Claudia Trappettia
aResearch Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia
bMelbourne Bioinformatics, The University of Melbourne, Melbourne, Australia
cDepartment of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
ABSTRACT Streptococcus pneumoniae is commonly carried asymptomatically in the
human nasopharynx, but it also causes serious and invasive diseases such as pneu-
monia, bacteremia, and meningitis, as well as less serious but highly prevalent
infections such as otitis media. We have previously shown that closely related
pneumococci (of the same capsular serotype and multilocus sequence type [ST])
can display distinct pathogenic profiles in mice that correlate with clinical isola-
tion site (e.g., blood versus ear), suggesting stable niche adaptation within a
clonal lineage. This has provided an opportunity to identify determinants of dis-
ease tropism. Genomic analysis identified 17 and 27 single nucleotide polymor-
phisms (SNPs) or insertions/deletions in protein coding sequences between
blood and ear isolates of serotype 14 ST15 and serotype 3 ST180, respectively.
SNPs in raffinose uptake and utilization genes (rafR or rafK) were detected in
both serotypes/lineages. Ear isolates were consistently defective in growth in
media containing raffinose as the sole carbon source, as well as in expression of
raffinose pathway genes aga, rafG, and rafK, relative to their serotype/ST-
matched blood isolates. Similar differences were also seen between serotype 23F
ST81 blood and ear isolates. Analysis of rafR allelic exchange mutants of the se-
rotype 14 ST15 blood and ear isolates demonstrated that the SNP in rafR was
entirely responsible for their distinct in vitro phenotypes and was also the deter-
minant of differential tropism for the lungs versus ear and brain in a mouse in-
tranasal challenge model. These data suggest that the ability of pneumococci to
utilize raffinose determines the nature of disease.
IMPORTANCE S. pneumoniae is a component of the commensal nasopharyngeal mi-
croflora of humans, but from this reservoir, it can progress to localized or invasive
disease with a frequency that translates into massive global morbidity and mortality.
However, the factors that govern the switch from commensal to pathogen, as well
as those that determine disease tropism, are poorly understood. Here we show that
capacity to utilize raffinose can determine the nature of the disease caused by a
given pneumococcal strain. Moreover, our findings provide an interesting example
of convergent evolution, whereby pneumococci belonging to two unrelated sero-
types/lineages exhibit SNPs in separate genes affecting raffinose uptake and utiliza-
tion that correlate with distinct pathogenic profiles in vivo. This further underscores
the critical role of differential carbohydrate metabolism in the pathogenesis of local-
ized versus invasive pneumococcal disease.
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Streptococcus pneumoniae (the pneumococcus) is one of the world’s foremost bac-terial pathogens, killing 1 to 2 million people each year. In spite of this, it is
considered part of the “normal” nasopharyngeal microflora, asymptomatically coloniz-
ing up to 65% of individuals; these carriers are the principal reservoirs for transmission
of S. pneumoniae in the community (1, 2). In a small proportion of carriers, which
nevertheless translates into globally significant numbers, S. pneumoniae invades from
its nasopharyngeal reservoir to cause disease: e.g., by aspiration into the lungs to cause
pneumonia, by direct or indirect invasion of the blood (bacteremia) or central nervous
system (meningitis), or by ascension of the eustachian tube to access the middle ear
and cause otitis media (OM) (1, 2). However, the molecular mechanisms whereby
pneumococci transition from a commensal lifestyle to cause either localized or invasive
disease are poorly understood.
The pneumococcus is a genetically plastic and diverse species, comprising at least
98 capsular serotypes, superimposed on more than 12,000 clonal lineages (sequence
types [STs]) recognizable by multilocus sequence typing (3). It has a core genome of
roughly 1,500 genes, with the remaining 30% of the genome present as accessory
regions (ARs), present in some but not all clonal lineages. Individual S. pneumoniae
strains can differ markedly in their virulence phenotypes, including their capacity to
colonize the nasopharynx, spread from person to person, or progress to either localized
or invasive infections. Capsule switching experiments have shown that both serotype
and genetic background (i.e., ST) influence virulence (4, 5), but strain complexity has
complicated attempts to examine whether there is any association between a given
clonal lineage or serotype and propensity to cause localized rather than invasive
infections.
Previous studies in our laboratory have shown that S. pneumoniae clinical isolates
belonging to the same serotype and ST may display distinct virulence phenotypes in
mice, in accordance with their original site of isolation in humans (blood versus ear).
After intranasal (i.n.) challenge, serotype 3 blood isolates belonging to ST180, ST232,
and ST233 did not stably colonize the nasopharynx, but spread to the blood in the
majority of mice; none spread to the ear. In contrast, ear isolates colonized the
nasopharynx at higher levels than the respective ST-matched blood isolates and also
spread to the ear compartment; none caused bacteremia (6). In a separate study,
serotype 14 (ST15) blood and ear isolates all exhibited a similar capacity to colonize the
nasopharynx, but significant differences were observed between bacterial loads in
other host niches. Blood isolates caused pneumonia in most animals, whereas ear
isolates were not detected in the lungs of any of the mice 24 h post-intranasal
challenge. Conversely, ST15 ear isolates, but not blood isolates, were able to spread to
the brain, and in the ear compartment, the bacterial load and proportion of infected
mice were significantly greater for mice challenged with ear rather than blood isolates
(7). Thus, strains within a clonal lineage appear to be exhibiting stable niche adaptation.
Although members of the same serotype and ST type have very closely related
genetic backbones, they are not necessarily identical and may have acquired distinct
ARs or other genetic changes, such as single nucleotide polymorphisms (SNPs) or
insertions or deletions (indels). In the present study, we have compared the genomes
of representative serotype 14 ST15 and serotype 3 ST180 blood and ear isolates to
determine whether such differences can account for their distinct virulence pheno-
types. We show that SNPs in loci responsible for uptake and utilization of the trisac-
charide raffinose are the ultimate determinant of disease progression.
RESULTS
Genetic differences between serotype/ST-matched blood and ear isolates. In
the first instance, draft genomes of serotype 14 ST15 strains 4559 (blood isolate) and
947 (ear isolate) were assembled from PacBio and MiSeq data and then compared (see
Materials and Methods). The only differences in ARs were the presence of a 35-kb
prophage and a 3.2-kb plasmid in 4559 and not 947, but these ARs were not present
in other serotype 14 ST15 blood isolates in our collection (results not shown). Seven-
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teen SNPs and indels present within protein coding sequences of 4559 and 947
resulting in a change in the predicted amino acid sequence are listed in Table 1. The
genes affected included those predicted to be involved in metabolism and energy
production, transcriptional regulation, transporters, and putative virulence factors.
Among the latter category, an SNP resulting in a L43P substitution was identified in
cpsE, which encodes the glycosyl transferase that initiates assembly of the capsular
polysaccharide (CPS) repeat unit. However, we have previously shown that there is no
difference in total CPS production between 4559 and 947 (7). The SNP in the putative
plasmin and fibronectin-binding protein gene pfbA is also a conservative T318M
substitution. The protein encoded by iga is truncated in 4559 compared to 947, but
only by four amino acids. On the other hand, the nanB sequence in 947 has a premature
stop codon that truncates the protein by 330 amino acids (47% of the 4559 protein),
presumably inactivating the gene product. Mutagenesis studies have previously shown
that NanB contributes to colonization of both the upper and lower respiratory tract of
mice, albeit to a lesser extent than the major neuraminidase NanA (8). Nevertheless,
4559 and 947 colonize the nasopharynx equally well (7). Interestingly, SNPs were
identified in two metabolic genes, coding for ATP-dependent 6-phosphofructokinase
(pfkA) and a glycogen synthase (glgA), as well as in two helix-turn-helix (HTH)-type
transcriptional regulators, scrR and rafR, involved in metabolism of sucrose and raffin-
ose, respectively. Given the importance of carbohydrate metabolism to S. pneumoniae
(9), we employed a phenotypic microarray to compare the capacity of 4559 and 947 to
metabolize over 100 different carbohydrates (see Materials and Methods). The only
difference observed between the ear and blood isolates was a reduced capacity of the
former (947) to grow in medium containing raffinose as the sole carbon source (data
not shown).
Genetic differences between ear/blood isolate pairs that are common to two
unrelated serotypes/ST lineages would be strong candidates for determinants of tissue
tropism. Genomic comparisons were therefore also made between two serotype 3
ST180 ear and blood isolates (strains 180/2 and 180/15, respectively), which like the
serotype 14 ST15 isolates, have previously been shown to exhibit distinct tissue tropism
in mice in accordance with clinical isolation site (6). There were no differences in ARs
between the two strains, while SNPs and indels impacting the deduced amino acid
sequence for 27 genes were identified (Table 2). Interestingly, there were no affected
genes in common with those in Table 1. However, an I227T SNP was detected in the
serotype 3 rafK gene, encoding the ATP-binding protein component of the raffinose
TABLE 1 Genes containing indels or SNPs that led to amino acid changes, identified from the whole-genome variant calling analysis
between 4559 and 947a
Locus tag
in 947 Gene Product Change in aa sequence in 4559 relative to 947
0862 pfkA ATP-dependent 6-phosphofructokinase S212G
1153 glgA Glycogen synthase E174G
1345 pncB Nicotinate phosphoribosyltransferase N434D
1631 scrR HTH-type transcriptional regulator ΔL27-G28
1803 rafR HTH-type transcriptional regulator D249G
1255 pyrP Uracil permease V65A
1737 piuA Fe3 import ATP-binding protein G141V
2020 ABC transporter ATP-binding protein Y508N
0330 cpsE CPS glycosyltransferase L43P
1139 iga Immunoglobulin A1 protease Premature stop 1905 (4559) due to indel
1594 nanB Sialidase B Premature stop 362 (947) due to indel
1741 pfbA Plasmin and fibronectin-binding protein A T318M
0945 coiA Competence protein E78K
1141 addA ATP-dependent helicase/nuclease subunit A I980M
1060 Acetyl transferase C101G
1194 Cytosolic protein containing multiple CBS domains Premature stop 104 (947) due to SNP
1731 Hypothetical protein (no Pfam match) H32P
aResults for the raffinose pathway gene rafR are in boldface.
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ABC transporter. RafK is known to be essential for activation of other raf operon genes,
and the SNP identified in ST180 isolates is located in the conserved regulatory domain
motif 1 (10). Thus, potential defects in raffinose uptake/metabolism appear to be a
common feature of ear isolates from both serotypes/lineages.
Blood isolates utilize raffinose more efficiently than ear isolates. In view of the
SNPs in genes associated with raffinose metabolism between ear and blood isolates in
two unrelated serotypes/STs and the fact that the serotype 14 ear and blood isolates
differed only in their ability to metabolize raffinose on phenotypic microarray analysis,
in vitro growth phenotypes were further investigated. Strains 4559 and 947, as well as
another pair of serotype 14 ST15 blood and ear isolates (4534 and 51742, respectively),
were grown in a chemically defined medium (CDM) with either glucose or raffinose as
the sole carbon source (designated CDMGlc and CDMRaf, respectively) (Fig. 1). In
CDMGlc, there were no significant differences in growth rates between blood and ear
isolates. However, in CDMRaf, the two blood isolates grew at a higher rate and to a
higher final culture density (optical density at 600 nm [OD600]) than either of the
serotype 14 ST15 ear isolates. Similarly, there was no significant difference in growth
rates of the serotype 3 ST180 ear and blood isolates (180/15 and 180/2, respectively) in
CDMGlc, but the blood isolate grew better than the ear isolate in CDMRaf (Fig. 1).
Thus, defective growth in raffinose appears to be a common defect in ear isolates
relative to serotype/ST-matched blood isolates.
The raffinose uptake/utilization operon in S. pneumoniae comprises genes encoding
transcriptional regulators (rafR and rafS), an -galactosidase (aga), the ABC transporter
substrate-binding protein and two cognate permeases (rafE, rafF, and rafG), a sucrose
phosphorylase (gtfA), and a protein of unknown function (rafX), as well as the ATP
binding protein component of the transporter (rafK), which is independently located in
the genome (11) (Fig. 2). To determine if the difference in ability to utilize raffinose
TABLE 2 Genes containing indels or SNPs that led to amino acid changes, identified from the whole-genome variant calling analysis
between 180/2 and 180/15a
Locus tag
in 180/2 Gene Productb Change in aa sequence of 180/15 relative to 180/2
100 purN Phosphoribosyl-glycinamide G81A
254 rpsJ 30S ribosomal protein S10 Y58D
285 Hypothetical protein A81S
314 cdsA Phosphatidate cytidylyltransferase M14I
335 adhP Alcohol dehydrogenase 1 M210V
403 fabK Enoyl-[acyl-carrier-protein] reductase I1029T
449 Nitronate monooxygenase I55M
512 glnA Glutamine synthetase F22L
645 nhaK Sodium, potassium, lithium and rubidium/H antiporter G190D
741 VanZ family protein C149W
996 Hypothetical protein H38R
1121 clcA H/Cl exchange transporter M131I
1138 ptsH Phosphocarrier protein HPr I14V
1172 Formate/nitrate transporter A211E
1194 glnP Glutamine transport system permease protein S662A
1234 SpF43_sRNA Y31C
1306 alaS Alanine-tRNA ligase E18A
1387 apbE FAD:protein FMN transferase M52I
1404 LPXTG cell wall anchor domain-containing protein ΔK112-Q119; G125K, E126T, P127E, E130V,
K131N, I133D; ΔQ135-P178
1491 rafK Raffinose import ATP-binding protein I227T
1616 dnaB DNA helicase C375R
1760 fepD_2 Ferric enterobactin transport system permease protein S248G
1863 rpoC DNA-directed RNA polymerase subunit beta D76E
1878 acyP Acylphosphatase V4I
1887 rsgA Small ribosomal subunit biogenesis G40S
2045 aspS Aspartate tRNA ligase E51V
2100 dltD D-Alanyl-lipoteichoic acid biosynthesis protein D151E
aResults for the raffinose pathway gene rafK are in boldface.
bFAD, flavin adenine dinucleotide; FMN, flavin mononucleotide.
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between the blood and ear isolates corresponded with raffinose operon gene expres-
sion, S. pneumoniae serotype 14 ST15 strains 4559, 947, 4534, and 51742 and serotype
3 ST180 strains 180/2 and 180/15 were grown to the same OD600 (0.2) in CDMGlc and
then washed and resuspended in CDMRaf and incubated for a further 30 min. RNA
FIG 1 Differential growth of blood and ear isolates in raffinose. S. pneumoniae serotype 14 ST15 blood isolates 4559 and 4534 and ear isolates
947 and 51742 were grown in 200 l CDM supplemented with 0.5% glucose (CDMGlc) or 0.5% raffinose (CDMRaf). Similar growth studies were
also performed for serotype 3 ST180 strains 180/15 (blood isolate) and 180/2 (ear isolate). OD600 was measured every hour for 12 h. Data are mean
OD600  standard deviation (SD) from triplicate assays.
FIG 2 Genetic loci encoding raffinose uptake and utilization in S. pneumoniae. The numbers below each gene refer to the locus tags in the
serotype 14 ST15 947 genome. The locations of SNPs in serotype 14 ST15 and serotype 3 ST180 isolates are indicated with asterisks; horizontal
arrows show the locations of promoters.
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was then extracted, and levels of aga, rafG, and rafK mRNA, representative of each of
the three rafR-regulated transcriptional units, were then measured relative to 16S rRNA
by quantitative real-time reverse transcription-PCR (qRT-PCR). In every case, expression
levels for all three genes were significantly greater in the blood isolates than in the
respective ear isolates (Fig. 3).
As further confirmation, blood and ear isolates belonging to serotype 23F ST81 were
also tested for growth in CDMGlc and CDMRaf, as well as for expression of aga, rafG,
and rafK (Fig. 4). Again, the blood isolate grew to a higher OD600 than the ear isolate
in CDMRaf, but not in CDMGlc. Moreover, expression of all three raf genes was
significantly higher in the blood isolate than in the ear isolate.
The SNP in 947 rafR is responsible for its raffinose phenotype. In order to test
whether the distinct in vitro and in vivo phenotype of 947 relative to 4559 was
attributable to the SNP in rafR, allelic-exchange mutagenesis was performed in 4559
and 947, generating a 4559 derivative with its rafR allele replaced by that from 947
(designated 4559947rafR) and a 947 derivative expressing the 4559 rafR allele
(9474559rafR) (see Materials and Methods). Growth assays in CDMGlc showed no
significant differences in growth rates between 4559, 947, 4559947rafR, and 9474559rafR.
However, in CDMRaf, growth of 4559947rafR was at least as poor as that of 947, while
growth of 9474559rafR was similar to that of 4559 (Fig. 5A). Expression of aga, rafG, and
rafK was then examined in 4559, 947, 4559947rafR, and 9474559rafR by qRT-PCR after
30 min of growth in CDMRaf. For all three genes, expression levels in 9474559rafR were
indistinguishable from those in 4559, while expression in 4559947rafR was essentially the
same as that in 947 (Fig. 5B). Thus, exchange of rafR alleles between 4559 and 947
significantly impacts both growth phenotype and raf operon gene expression in
CDMRaf.
Virulence phenotypes of 4559 and 947 and their rafR exchange mutants. In
order to determine whether the marked difference in virulence phenotypes of 4559 and
FIG 3 Expression of raffinose pathway genes by serotype 14 and 3 blood and ear isolates. The indicated strains were grown in CDMGlc to an OD600 of 0.2,
washed and resuspended in CDMRaf, and then incubated at 37°C for a further 30 min. RNA was then extracted, and levels of aga, rafG, and rafK mRNA were
analyzed by qRT-PCR using 16S rRNA as an internal control (see Materials and Methods). The data presented are the means  SD from three independent
experiments. *, P  0.05, **, P  0.01, and ****, P  0.0001, by unpaired t test.
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947 is also directly attributable to the SNP in rafR, 4559, 947, 4559947rafR, and 9474559rafR
were tested in a murine intranasal challenge model. Groups of Swiss mice were
challenged with 108 CFU of each strain, and bacterial loads were quantitated in various
tissues 24 h postchallenge (Fig. 6). No significant differences in bacterial numbers in the
nasopharynx were seen between any groups (Fig. 6), and no bacteria were detected in
the blood of any mice (data not presented). However, 4559 was better able than 947
to persist in the lungs of infected mice, with significantly higher geometric mean (GM)
bacterial load (P  0.0001) and a significantly greater proportion of infected animals
(14/16 versus 6/16; P  0.01) (Fig. 6). On the other hand, bacterial loads of 947 in the
ear were significantly greater than that for mice challenged with 4559 (P  0.01), and
the proportion of infected mice was also significantly greater (16/16 versus 7/16;
P  0.001) (Fig. 6). A similar trend was also seen in the brain (Fig. 6), in accordance with
our previous report (4).
Exchanging the rafR alleles has a striking impact on virulence phenotype. In the
lungs, both the GM CFU and proportion of infected mice for the group challenged with
4559947rafR were significantly lower than those for the 4559 group (P  0.0001 and
P  0.001, respectively). Indeed, the virulence phenotype of 4559947rafR was indistin-
guishable from that of 947. Conversely, the GM bacterial load and proportion of
infected mice for the 9474559rafR group were significantly greater than those for the 947
group (P  0.01 and P  0.05, respectively); there were no significant differences in
these parameters between the 9474559rafR and 4559 groups. In the ear, both the GM
FIG 4 Growth phenotype and raffinose pathway gene expression in serotype 23F ST81 blood and ear isolates. (A) Growth of blood isolate 5076 and ear isolate
9725241 in CDMGlc or CDMRaf was monitored by OD600 for 12 h. Data are mean OD600  SD from triplicate assays. (B) The indicated strains were grown
in CDMGlc to an OD600 of 0.2, washed and resuspended in CDMRaf, and then incubated at 37°C for a further 30 min. RNA was then extracted, and levels
of aga, rafG, and rafK mRNA were analyzed by qRT-PCR using 16S rRNA as an internal control. The data presented are the means  SD from three independent
experiments. ***, P  0.001 by unpaired t test.
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CFU and proportion of infected mice for the group challenged with 4559947rafR were
significantly greater than those for the 4559 group (P  0.05 and P  0.01, respectively).
Conversely, both the GM CFU and proportion of infected mice for the group challenged
with 9474559rafR were significantly lower than those for the 947 group (P  0.01 in both
cases). Moreover, there was no significant difference in either GM bacterial loads or
proportions of infected mice between the 4559947rafR and 947 groups or between the
9474559rafR and 4559 groups (Fig. 6). A similar pattern is seen in the brain; the GM CFU
for the 4559947rafR group was significantly greater than those for either the 4559 or
9474559rafR groups (P  0.01 in both cases). Moreover, there was no significant differ-
ence in either GM bacterial loads or proportions of infected mice between the
4559947rafR and 947 groups or between the 9474559rafR and 4559 group (Fig. 6).
Collectively, these data show that swapping the rafR allele between 4559 and 947 leads
to a switch in their respective virulence profiles, and thus, the D49G SNP in rafR is
entirely responsible for the observed difference in tissue tropisms between the sero-
type 14 ST15 blood and ear isolates.
Mutagenesis of rafK in serotype 3 ST180 blood and ear isolates. Attempts to
construct rafK exchange mutants of serotype 3 ST180 blood and ear isolates (180/15
and 180/2, respectively) analogous to the rafR exchange mutants constructed for the
serotype 14 strains were not successful. Thus, the impact of the SNP in RafK could not
be directly tested. However, we were able to delete the native rafK genes from both
type 3 strains (designated 180/15 ΔrafK and 180/2 ΔrafK, respectively). Both mutants
FIG 5 Growth phenotype and raffinose operon gene expression in rafR exchange mutants. (A) S. pneumoniae strains 4559, 947, 4559947rafR, and 9474559rafR were
grown in CDMGlc or CDMRaf, and OD600 was monitored for 12 h. Data are mean OD600  SD from triplicate assays. (B) The indicated strains were grown
in CDMGlc to an OD600 of 0.2, washed and resuspended in CDMRaf, and then incubated at 37°C for a further 30 min. RNA was then extracted, and levels
of aga, rafG, and rafK mRNA were analyzed by qRT-PCR. Data are the means  SD from three independent experiments. *, P  0.05, ***, P  0.001, and ****,
P  0.0001, by unpaired t test.
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were incapable of growth in CDMRaf, and expression of aga and rafG was virtually
undetectable by qRT-PCR; rafK expression was also undetectable, as expected (Fig. 7).
Thus, the ear isolate 180/2 exhibits a phenotype that is intermediate between that of
the blood isolate 180/15 and either of the two ΔrafK mutants, consistent with partial
functionality of the ear isolate RafK. S. pneumoniae rafK deletion mutants have previ-
ously been shown to be outcompeted by the wild type in the murine lung and
nasopharynx (10, 12). Similarly, in the present study, bacterial loads in the lungs, blood,
ear, and brain were also lower for mice challenged with the 180/2 and 180/15 ΔrafK
mutants relative to those challenged with the respective wild types at 48 h after
intranasal challenge (result not presented). This indicates that even the intermediate
level of raffinose pathway gene expression exhibited by ear isolate 180/2 contributes to
virulence.
DISCUSSION
Pneumococci are strictly fermentative bacteria, relying solely on carbohydrate me-
tabolism for energy and growth (13). However, carbohydrate availability differs be-
tween host niches, and so the ability to respond to and utilize distinct carbohydrates
is crucial for pneumococcal fitness in vivo. The S. pneumoniae genome encodes 21
phosphotransferase systems (PTSs) and up to 8 ATP binding cassette (ABC) transporters
for the import of carbohydrates (9, 14), accounting for roughly 30% of all transport
systems. Previous studies have shown that several of these carbohydrate transporters,
present in both the core and accessory genome, impact pneumococcal virulence. For
example, a sucrose PTS and ABC transporter system of serotype 4 pneumococci have
been shown to play roles in murine colonization and pneumonia, respectively (15),
FIG 6 Virulence phenotype of rafR exchange mutants. Groups of 16 mice were infected intranasally with
108 CFU of the indicated strain. At 24 h, all mice from each group were euthanized and numbers of
pneumococci in the indicated tissues/sites were quantitated (see Materials and Methods). Viable counts
(total CFU per tissue) are shown for each mouse at each site; horizontal bars indicate the geometric mean
(GM) CFU for each group; the broken line indicates the threshold for detection. Differences in GM
bacterial loads between groups are indicated by asterisks: *, P  0.05, **, P  0.01, and ****, P  0.0001,
by unpaired t test.
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while transporters for carbohydrates such as glucose, galactose, and mannose were
shown to impact invasive pneumococcal disease (16–18).
The present study further underscores the critical role played by differential carbo-
hydrate metabolism in pneumococcal pathogenesis. It demonstrates that reduced
capacity to utilize raffinose does not simply reduce pneumococcal virulence, but rather
changes the nature of disease caused. In multiple serotypes/ST lineages, ear isolates
had defective growth in CDMRaf and reduced expression of raffinose pathway genes
relative to their serotype/ST-matched blood isolates. Exchange of rafR alleles between
ear and blood isolates of serotype 14 ST15 reversed these in vitro phenotypes. More-
over, rafR exchange caused blood isolates to now cause otitis media and meningitis
rather than pneumonia, after intranasal challenge, and conversely cause ear isolates to
now target the lungs. This striking switch in in vitro and in vivo behaviors was
attributable to a single, nonconservative SNP (D249G) in RafR, identifying this residue
as one of critical functional importance. Significantly, the region of RafR from amino
acids 226 to 268 comprises a conserved signature sequence for the AraC/XylS family of
transcriptional regulators (11).
Interestingly, in spite of exhibiting similarly distinct in vitro and in vivo phenotypes,
the serotype 3 ST180 blood and ear isolates did not share the SNP in rafR, but rather
had an SNP in rafK, which encodes the ATPase required for raffinose uptake via the ABC
transport system encoded by rafEFG. RafK-mediated uptake of raffinose has previously
been shown to be essential for induction of the raf operons in S. pneumoniae D39 (10).
Attempts to construct rafK exchange mutants in this lineage (analogous to the serotype
FIG 7 Growth phenotype and raffinose operon gene expression in ΔrafK mutants. (A) S. pneumoniae serotype 3 strains 180/15, 180/2, 180/15ΔrafK, and
180/2ΔrafK were grown in CDMGlc or CDMRaf, and OD600 was monitored for 12 h. Data are mean OD600  SD from triplicate assays. (B) The indicated strains
were grown in CDMGlc to an OD600 of 0.2, washed and resuspended in CDMRaf, and then incubated at 37°C for a further 30 min. RNA was then extracted,
and levels of aga, rafG, and rafK mRNA were analyzed by qRT-PCR. Data are the means  SD from three independent experiments. *, P  0.05, **, P  0.01, and
***, P  0.001, by unpaired t test.
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14 ST15 rafR exchange mutants) were not successful. However, rafK deletion mutants
of both 180/2 and 180/15 were obtained. Whereas the wild-type ear isolate 180/2
exhibited reduced growth in CDMRaf and expression of aga, rafG, and rafK relative to
the wild-type blood isolate 180/15, both rafK deletion mutants were unable to grow in
CDMRaf at all, and expression of any of the raf operon transcripts was undetectable.
Clearly, the RafK allele carried by 180/2 retains partial function. The I227T SNP that
distinguishes the RafK alleles of 180/2 and 180/15 is located in the conserved regulatory
domain motif 1. This domain is believed to be involved in the interaction between RafK
and the enzyme dihydrolipoamide dehydrogenase (DLDH), which has been shown to
modulate raffinose uptake and raf operon expression in S. pneumoniae D39 (10). In the
murine model, both rafK deletion mutants exhibited reduced bacterial loads in multiple
host niches relative to their respective wild-type strains, consistent with previous
reports (10, 12).
Our findings provide an interesting example of convergent evolution, whereby
pneumococci belonging to two unrelated serotypes/lineages exhibit SNPs in separate
genes, each affecting raffinose uptake and utilization, which in turn correlate with
distinct pathogenic profiles in both mice and humans (the latter by inference from the
clinical isolation site). In S. pneumoniae D39, induction of expression of the raf operon
gene aga required the presence of raffinose; reduced but nevertheless significant aga
expression also occurred in a rafR knockout mutant (11). Thus, raf operon expression in
pneumococci can be impacted either by defects in raffinose import (e.g., due to a
defective RafK), such that insufficient exogenous raffinose (if present) is internalized to
induce raf expression, or by functional defects in the transcriptional activator RafR, such
that baseline levels of expression induced by the presence of raffinose are not further
upregulated. The raf operons are part of the core genome of S. pneumoniae, and
BLASTX analysis of available genomes shows that there is between 1% and 3% deduced
amino acid sequence variation within any of the raf genes. Thus, SNPs are widespread,
but it is not known which (if any) of these other SNPs impact the capacity to import or
utilize raffinose or the virulence phenotype.
Notwithstanding the results presented above, the precise mechanism whereby
differential raffinose uptake/utilization determines the virulence phenotype is uncer-
tain. Raffinose is a plant-derived trisaccharide present in many staple foods, particularly
beans and soy (19, 20). Although humans are unable to metabolize it, dietary raffinose
is known to be absorbed by the intestinal epithelium (21), raising the possibility of at
least small amounts being present on mucosal surfaces. As part of the present study,
we confirmed that expression of aga, rafG, and rafK was not detectable by qRT-PCR
when pneumococci are grown in vitro in media lacking raffinose. However, expression of all
three genes was detected in RNA extracts of mouse lung tissue 6 h after intranasal
challenge with either of the serotype 14 ST15 blood or ear isolates (results not shown).
Since raffinose is the only known inducer of the raf operon in S. pneumoniae, this finding
is strongly indicative of the presence of bioavailable raffinose in the murine lung. A
potential complicating factor is that RafEFG is reported to be also capable of importing
stachyose (14), while RafK has been reported to also energize uptake of sialic acid and
maltotetraose via unrelated transporters (12). Thus, the SNPs observed in the present study
could have pleiotropic effects. However, no differences in metabolism of these sugars
between the serotype 14 ST15 blood and ear isolates were observed using phenotypic
microarray analysis, and the serotype 3 ST180 strains were unable to grow in CDM with
stachyose or sialic acid as the sole carbon source. Moreover, there was no significant
difference in the growth rates of the ST180 blood and ear isolates when grown in CDM with
maltotetraose (results not presented). A particularly intriguing finding of the present study
was that lower raffinose uptake/utilization by the ear isolates provided an advantage over
blood isolates in the ear compartment. Interestingly, exogenous raffinose has recently
been shown to promote biofilm formation by Streptococcus mutans by promoting aggre-
gation of extracellular DNA into the biofilm matrix. Biofilm formation was unaffected by
deletion of the -galactosidase gene agaL, indicating that the effect was unrelated to
metabolism of any internalized raffinose (22). Thus, it is conceivable that the reduced
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capacity of S. pneumoniae ear isolates to assimilate (and thereby deplete) raffinose from the
middle ear mucosa may similarly promote pneumococcal biofilm formation in that niche,
leading to otitis media. Further studies are in progress in our laboratory to elucidate the
precise molecular mechanism whereby fine-tuning of levels of expression of raffinose
uptake and utilization genes can have such a profound impact on pathogenic profiles of
clinical isolates of S. pneumoniae.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The S. pneumoniae strains used in this study are listed in
Table 3. Cells were routinely grown in casein-based, semisynthetic liquid medium (CY) (23) or serum
broth (SB) as required. Growth assays were performed using a chemically medium (CDM) comprising
RPMI 1640 medium (Sigma), supplemented with amino acids, vitamins, choline, and catalase as described
previously (24), with either 0.5% glucose or 0.5% raffinose. Bacteria were plated on Columbia agar
supplemented with 5% (vol/vol) horse blood (BA) with or without gentamicin (40 g/ml), kanamycin
(500 g/ml), or streptomycin (150 g/ml) (as required) and incubated at 37°C in 5% CO2 overnight. For
gene expression analyses, strains were grown in CDMGlc medium to an OD600 of 0.2, before being
incubated in CDMRaf for 30 min.
Genome sequencing. S. pneumoniae strains were grown to mid-exponential phase in Todd-Hewitt
broth supplemented with 1% yeast extract. Genomic DNA (gDNA) was extracted using the Qiagen
genomic DNA buffer set with 100/g Genomic Tips according to the manufacturer’s instructions, except
mutanolysin (20 U) and sodium deoxycholate (0.1%) were included to aid cell lysis. The gDNA was
sequenced at the Ramaciotti Centre for Genomics (University of New South Wales, Sydney, Australia) on
an Illumina MiSeq (250-bp paired-end reads), as well as a PacBio RSII instrument using one SMRT cell per
strain, a 20-kb insert library, and the P6 polymerase and C4 sequencing chemistry.
Bioinformatic analyses. The Artemis Comparison Tool was used to compare genomes (25). MiSeq
reads of 4559 and 947 and 180/15 and 180/2 were mapped to the assembled reference genome of the
opposing strain with BOWTIE2 version 2.2.6 (26). Variant calling was then performed using SAMTools
version 0.1.18 (27), and variants were mapped to coding sequences of the reference strain using
BEDTools version 2.25.0 (28). Single nucleotide polymorphisms (SNPs) and insertions/deletions (indels)
were filtered for those with scores of 100 or greater. Artemis was used to visualize SNPs and indels (29).
Sanger sequencing was performed to confirm the SNPs in rafR and rafK (Australian Genome Research
Facility, Adelaide).
Phenotypic microarrays. Carbon phenotype microarray analysis was performed on the serotype 14
ST 15 strains, using the PM microplates PM1 and PM2A (Biolog, Inc.), which tested for the catabolism of
190 different carbon sources. Each well of the microarrays contained a different carbon source. Briefly,
cells were suspended in the provided buffer (as per the manufacturer’s instructions) to an A590 of 0.37.
One hundred microliters of this suspension was added to the wells, and the A590 was measured after 17
h of incubation at 37°C. Catabolism was measured through the reduction of a colorless tetrazolium dye
by NADH, produced during catabolic activity. Absorbance values above 0.65 after subtraction of that for
the zero carbon source blank were considered positive.
Growth assays. Each tested strain was grown in CDM supplemented with either 0.5% Glc
(CDMGlc), 0.5% Raf (CDMRaf), or no sugar (CDM) and then incubated at 37°C for 12 h in 96-well flat
bottom plates (Costar). The OD600 was measured every 15 min using a SPECTRAmax M2 spectropho-
tometer (Millennium Science). All experiments were conducted in triplicate and repeated at least two
times.
qRT-PCR. Differences in levels of gene expression were assayed by one-step relative quantitative
real-time RT-PCR (qRT-PCR) in a Roche LC480 real-time cycler essentially as described previously (30). The
specific primers used for the various genes are listed in Table 4 and were used at a final concentration
of 200 nM per reaction. As an internal control, primers specific for 16S rRNA were employed. Amplifica-
tion data were analyzed using the comparative critical threshold cycle (2ΔΔCT) method (31).
Mutagenesis. The rafR gene swap between serotype 14 ST15 4559 and 947 strains, to produce
4559947rafR and 9474559rafR, was achieved via allelic exchange mutagenesis utilizing the Janus cassette, as
described previously (32, 33). This involved a three-step process in which endogenous rpsL (which confers
TABLE 3 S. pneumoniae strains used in this study
Strain Description Source Reference
4559 Serotype 14 ST15 Blood 7
947 Serotype 14 ST15 Ear 7
4534 Serotype 14 ST15 Blood 7
51742 Serotype 14 ST15 Ear 7
4559947rafR 4559 expressing 947 rafR gene This study
9474559rafR 947 expressing 4559 rafR gene This study
180/15 Serotype 3 ST180 Blood 6
180/2 Serotype 3 ST180 Ear 6
5076 Serotype 23F ST81 Blood This study
9725241 Serotype 23F ST81 Ear This study
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streptomycin sensitivity) was first replaced with the streptomycin-resistant rpsL1 allele by direct transforma-
tion of the blood and ear isolates. The Janus cassette (comprising a kanamycin resistance marker and a
dominant counterselectable rpsL marker) was then used to replace the native rafR gene by direct transfor-
mation with a linear PCR product comprising the Janus cassette flanked by sequences 5= and 3= to rafR
(selecting on kanamycin). In the final step, the Janus cassette in Kanr/Streps transformants is replaced by
transformation with the alternative rafR allele and flanking sequences, counterselecting on streptomycin (loss
of the Janus cassette reinstates the Strepr phenotype). Gene swap constructs were confirmed by Sanger DNA
sequencing (AGRF, Adelaide). The rafK gene was also deleted from serotype 3 ST180/2 and ST180/15 by direct
transformation with a linear DNA fragment comprising an erythromycin resistance cassette flanked by
sequences 5= and 3= to rafK generated by overlap PCR, essentially as previously described (34). The primers
used are listed in Table 4. Mutant constructs were confirmed by PCR.
Animal studies. Animal experiments were approved by the University of Adelaide Animal Ethics
Committee. Groups of outbred 6-week-old female Swiss (CD-1) mice were anesthetized by intraperito-
neal injection of pentobarbital sodium (Nembutal; Rhone-Merieux) and challenged intranasally (i.n.) with
50 l of bacterial suspension containing approximately 1  108 CFU in SB (7). The challenge dose was
confirmed retrospectively by serial dilution and plating on BA. Mice were euthanized by CO2 asphyxiation
at 24 h, and then tissue samples (lungs, nasopharynx, brain, ear, and blood) were harvested and
pneumococci enumerated in tissue homogenates as described previously via serial dilution and plating
on plates containing BA plus gentamicin (35).
Data availability. Genome sequences have been deposited with ENA under accession no.
SAMEA5092021, SAMEA5092022, SAMEA5092023, and SAMEA5092024, for strains 947, 4559, 180/2, and
180/15, respectively.
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In vivo dual RNA-seq reveals that neutrophil
recruitment underlies differential tissue tropism
of Streptococcus pneumoniae
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Streptococcus pneumoniae is a genetically diverse human-adapted pathogen commonly carried
asymptomatically in the nasopharynx. We have recently shown that a single nucleotide
polymorphism (SNP) in the raffinose pathway regulatory gene rafR accounts for a difference
in the capacity of clonally-related strains to cause localised versus systemic infection. Using
dual RNA-seq, we show that this SNP affects expression of bacterial genes encoding multiple
sugar transporters, and fine-tunes carbohydrate metabolism, along with extensive rewiring of
host transcriptional responses to infection, particularly expression of genes encoding cytokine
and chemokine ligands and receptors. The data predict a crucial role for differential neutrophil
recruitment (confirmed by in vivo neutrophil depletion and IL-17 neutralization) indicating
that early detection of bacteria by the host in the lung environment is crucial for effective
clearance. Thus, dual RNA-seq provides a powerful tool for understanding complex host-
pathogen interactions and reveals how a single bacterial SNP can drive differential disease
outcomes.
https://doi.org/10.1038/s42003-020-1018-x OPEN
1 Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia. 2 Department
of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland. 3 Department of Molecular and
Biomedical Science, University of Adelaide, Adelaide 5005, Australia. 4These authors contributed equally: Vikrant Minhas, Rieza Aprianto. 5These authors
jointly supervised this work: James C. Paton, Jan-Willem Veening, Claudia Trappetti. ✉email: james.paton@adelaide.edu.au









S treptococcus pneumoniae is a major human pathogenresponsible for massive global morbidity and mortality.Despite this, the pneumococcus makes up the part of the
commensal human nasopharyngeal flora, colonizing up to 65% of
individuals1,2. S. pneumoniae can invade from this reservoir to
cause disease, for example, by aspiration into the lungs to cause
pneumonia, by invasion of the blood (bacteremia) or central
nervous system (meningitis), or by ascension of the eustachian
tube to cause otitis media (OM)1,2. S. pneumoniae is an extremely
heterogeneous species, comprising at least 98 capsular serotypes
and over 12,000 clonal lineages (sequence types; ST) recognizable
by multi-locus sequence typing3,4. Unsurprisingly, S. pneumoniae
strains differ markedly in their capacity to progress from carriage
to disease and/or the nature of the disease that they cause1,2.
We have previously reported marked differences in virulence
in a murine intranasal (IN) challenge model between S. pneu-
moniae strains belonging to the same serotype and ST, which
correlated with clinical isolation site in humans (ear versus
blood). In serotype 3 ST180, ST232, and ST233, and in serotype
14 ST15, human ear isolates had greater capacity to cause OM
in mice relative to their respective serotype-/ST-matched blood
isolates, while blood isolates preferentially caused pneumonia
or sepsis in mice, suggesting stable niche adaptation within a
clonal lineage5,6. Recently we have shown that although the
genomes of serotype-/ST-matched blood and ear isolates differ
by several single nucleotide polymorphisms (SNPs), the distinct
virulence phenotypes correlated with single SNPs in genes
encoding uptake and utilization of the sugar raffinose7. In
serotype 14 ST15, the SNP was in the regulatory gene rafR,
while in serotype 3 ST180, the SNP was in rafK, which encodes
the raffinose ABC transporter ATPase7. Both SNPs result in
non-conservative amino acid changes in functionally critical
domains of the respective gene product (D249G for RafR; I227T
for RafK). Moreover, in both serotypes/lineages, ear isolates had
in vitro growth defects in a chemically-defined medium with
raffinose as sole carbon source, correlating with defective
transcription of raffinose pathway operons. Remarkably, in
serotype 14 ST15, exchanging the rafR alleles between blood
and ear isolates reversed both the in vitro and in vivo pheno-
types7. Thus, the D249G SNP in rafR appears to be the deter-
minant of differential virulence phenotype between the blood
and ear isolates of this lineage, which may reflect differential
engagement of innate host defenses and/or differential bacterial
nutritional fitness in distinct host niches (Fig. 1).
Dual RNA-seq applies deep sequencing to simultaneously
quantify genome-wide transcriptional responses of host and
pathogen8,9. This approach offers higher efficiency and more
restricted technical bias compared to conventional approaches,
such as assaying single species or array-based methods. Here, we
have used dual RNA-seq analysis to examine host-pathogen
transcriptional cross-talk in the blood and ear isolates and rafR-
swapped derivatives thereof, during the early stages of infection.
Our data strongly suggest that the rafR SNP interacts with the
pneumococcal genetic background in the different clinical iso-
lates, which in turn, induces variegated transcriptional responses
in the pathogen; this response, in turn, initiates a diverging host
response that determines the outcome of infection.
Results
Comparative host/pathogen transcriptomics. Our previous
studies have shown that at 6 h after IN challenge with serotype 14
ST15 S. pneumoniae, numbers of blood and ear isolates (strains
4559-Blood and 9–47-Ear, respectively) in murine lungs are
similar (106–107 CFU per lung). However, by 24 h, the ear isolate
had been cleared from the lungs, instead spreading to the ear and
brain. In contrast, the blood isolate persisted in the lungs at 24 h,
but did not spread to the ear or brain6. Thus, 6 h post infection is
a critical decision point in the pathogenic process, and the similar
bacterial loads in the lung at this time enables examination of
host/pathogen transcriptional cross-talk without the complication
of bacterial dose effects. Accordingly, groups of 12 mice were
anaesthetized and challenged IN with 108 CFU of 4559-Blood,
9–47-Ear or their respective rafR-swapped mutants; at 6 h, mice
were euthanized and total RNA was extracted from perfused
lungs and purified. RNA from lungs of four mice was pooled for
dual RNA-seq analysis in triplicate (see “Methods” section).
Within the sequencing libraries, an overwhelming majority of
reads originate from the host genome (average 99.5%; range
99.1–99.7%), which translates into an average depth of 1.3 times
(range 0.8–1.8 times). Conversely, 0.52% of the total reads
originated from the pathogen genome (0.33–0.93%) (Supplemen-
tary Table 1). Of these pneumococcal reads, 64.5% (61.4–67.3%)
mapped onto rRNA genes and 35.5% (32.7–38.6%) mapped onto
non-rRNA genes. Previous data indicate that non-depleted
libraries only contain 5% non-ribosomal RNA reads; thus, this
treatment enriched the non-ribosomal RNAs sevenfold. Non-
ribosomal read depth was 2.7 times (1.4–4.6 times) for the
pathogen genome. Further downstream analysis, including
Fig. 1 Impact of rafR SNP. A SNP in rafR between the serotype 14 sequence type 15 clonal isolates 4559-Blood and 947-Ear leads to a non-conservative
G249D amino acid substitution in the raffinose pathway regulator RafR. RafRG249 results in upregulation of raf operons (horizontal arrows denote
transcriptional start sites) in 4559-Blood relative to 947-Ear, favouring persistence in the lung after intranasal challenge. Lower raf pathway expression
mediated by RafRD249 facilitates clearance of 947-Ear from the lung, but promotes spread to and/or persistence in the ear and brain. The location of the
SNP in rafR is indicated by an asterisk7.
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differential gene expression, excluded ribosomal reads from the
pathogen library. Supplementary Data 1–6 list pneumococcal
genes that are significantly differentially expressed (fold change
(FC) > 2, p < 0.05) for each of the six pairwise comparisons
between the four strains. Supplementary Data 7–12 list murine
genes that are significantly differentially expressed (FC > 1.5, p <
0.05) for the same pairwise comparisons. The lower FC cut-off for
murine genes was chosen to strike a balance between simplicity of
analysis and sensitivity. Heat maps displaying the top 50 murine
and top 50 pneumococcal genes (Fig. 2) showcase the breadth of
transcriptomic rewiring due to the rafR SNP.
RafR fine tunes carbohydrate metabolism during infection. In
order to directly compare pathogen transcriptional responses in
murine lung, we listed homologous genes between the wild type
ear and blood isolates and used these to visualize the transcrip-
tional response in a principal component analysis (PCA) plot
(Fig. 3a). Here, the pneumococcal transcriptional response of the
ear isolate (strain 9–47-Ear, dark orange) to murine lung infec-
tion diverges considerably from the response of the blood isolate
(strain 4559-Blood, dark purple). Specifically, 76 homologous
genes are upregulated in the ear isolate, while 40 are upregulated
in the blood isolate. Upregulated genes in strain 9–47-Ear include
genes involved in carbohydrate metabolism, general stress
response and nutrient transporters, while upregulated genes in
the blood isolate include genes encoding small molecule per-
meases and nisin biosynthesis orthologous proteins.
Furthermore, replacing rafR of 9–47-Ear with the allele from
the 4559-Blood (designated strain 9–47M) dissociates its
transcriptional response considerably from its parental strain
(Fig. 3a; 9–47-Ear, dark orange to 9–47M, light orange). These
large scale transcriptomic differences between 9–47-Ear and
9–47M may explain the impact of the rafR SNP on in vivo tissue
tropism. Specifically, 87 genes are upregulated in the wild type
strain (9–47-Ear) while 36 genes are upregulated in the otherwise
isogenic rafR swap strain (9–47M, Fig. 3b), with differentially
expressed genes spread across the pneumococcal genome.
Presence of the blood isolate rafR allele in 9–47-Ear activates
the expression of major genes pertaining to carbohydrate
metabolism, including adhA (alcohol dehydrogenase) and spxB
(pyruvate oxidase), as well as genes encoding permeases,
including glnH6P6 (transporting arginine, cysteine) and ycjOP-
yesO (transporting multiple sugars). Also, a subset of genes with
function in carbohydrate metabolism are repressed in the rafR-
swap strain, such as glycogen synthesis (glgACD), sucrose
metabolism (scrB) and ribulose metabolism (ulaDEF). Expression
of seven genes encoding ATPase subunits (ntpABCDEGK) and
genes for iron (piuB) and sugar (scrA, satABC, and gadEW)
permeases are also repressed.
On the other hand, replacing the blood isolate rafR with the ear
allele (strain 4559M) does not noticeably interrupt pneumococcal
transcriptional response to murine lung (Fig. 3a; 4559-Blood,
dark purple to 4559M, light purple), despite the different in vivo
behaviors of 4559-Blood and 4559M. Essentially, the rafR swap
activates only two genes: yxlF, encoding a putative subunit of an
ABC transporter and phoU1 encoding a phosphate transporter;
and represses 35 genes, mostly contained in a single genomic
island (Fig. 3c, upregulated in 4559-Blood). The genomic island
consists of 28 consecutive genes encoding subunits of bacter-
iophage(s), interspaced by dnaC, encoding a DNA replication
protein and lytA, encoding autolysin. The activation of
bacteriophage-associated genes indicates that the original isolate
(strain 4559-Blood) endures host-derived stress, unlike the rafR
swap mutant (strain 4559M). Other genes repressed in 4559M
include adhAE (alcohol dehydrogenases), gtfA (sucrose
phosphorylase) and rafEG (raffinose transporter). Conversely,
9–47M and 4559-Blood showcase similar in vivo behaviors yet
display varied transcriptomes in murine lungs post-infection
(Fig. 3a). Hence, transcriptional profiling was unable to predict
tissue tropism in this case. Taken together, the single D249G SNP
in rafR interferes with global gene expression within the already
transcriptionally-distinct parental clinical isolates. This effect is
more pronounced in 9–47-Ear than 4559-Blood.
Next, we performed quantified enrichment analyses on specific
gene functions. Carbohydrate metabolism is enriched in the
differentially expressed genes between the strains, particularly
when comparing the ear isolate to its cognate rafR swap (Fig. 3d;
comparison A, 9–47-Ear versus 9–47M, p= 0.03), comparing the
two clinical isolates (comparison B, 9–47-Ear versus 4559-Blood,
p= 0.017) and comparing the swap cognates (comparison E,
9–47M versus 4559M, p= 0.041). Another function, ABC
transporters, is also enriched in the comparison within the ear
isolates (Fig. 3e; comparison A, 9–47-Ear versus 9–47M, p=
0.049), between the original isolates (comparison B, 9–47-Ear
versus 4559-Blood, p= 0.014), between ear isolate and rafR 746G
in the blood isolate background (comparison C, 9–47-Ear versus
4559M, p= 0.01) and between the rafR cognates (comparison E,
9–47M versus 4559M, p= 1.8 × 10−4).
Additionally, since the pneumococcal genome has an excep-
tionally high number of sugar transporters10, we quantified
enrichment for this function (Fig. 3f). Sugar transporters are
enriched in almost all comparisons (except between 4559-Blood
and 4559M), highlighting the role of rafR in the widespread
regulation of pneumococcal sugar importers. Specifically, ear and
blood isolates behave differently in regard to sugar transporter
expression (9–47-Ear versus 4559-Blood; Fig. 3f, comparison B).
The ear isolate upregulates scrA (encoding a mannose and
trehalose transporter) and ulaA (ascorbate transporter), while the
blood isolate upregulates ycjOP-yesO (alternative sugar transpor-
ters), rafE (raffinose transporter) and malFG (maltose transpor-
ter). Furthermore, rafR swap in the ear isolate background (9–47-
Ear versus 9–47M; Fig. 3f, comparison A) reduces the expression
of gadEW (encoding sorbose and mannose transporter), satABC
(arabinose and lactose transporter), ulaAC and glpF (glycerol
transporter), while the swap activates the expression of ycjOP-
yesO and bguD (encoding complex polysaccharide transporters).
In contrast, rafR swap in the blood isolate background (4559-
Blood versus 4559M; Fig. 3f, comparison F) downregulates the
expression of rafEG and malD (maltose transporter). The
enrichment analysis reveals that the D249G SNP in rafR directly
and indirectly affects the expression of genes encoding sugar
transporters, other (ABC) transporters and carbohydrate
metabolism.
We also identified genes that were commonly up or down-
regulated between the strains with a given virulence phenotype
(Supplementary Table 2). adhP (Sp947_00279) was upregulated
in both strains that persisted in lungs (9–47M and 4559-Blood),
while eight genes from the genomic region Sp947_0842 to
Sp947_0855, as well as Sp947_00631 and Sp947_02096, were
upregulated in strains that were cleared from lungs by 24 h (9–47-
Ear and 4559M). These genes include neuraminidase nanB, and
alpha-glycerophosphate oxidase glpO (Supplementary Table 2).
All other differentially expressed pneumococcal genes are listed in
Supplementary Data 1–6.
RafR-specific rewiring of host transcriptional responses. The
measured murine transcriptional response represents aggregate
gene expression of all (host) cells present during pneumococcal
lung infection. These include epithelial cells, endothelial cells of
lung vasculature, smooth muscle cells, fibroblasts, activated, and
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Fig. 2 Heat maps displaying differentially expressed genes from the dual RNA-seq data in murine lungs 6 h after infection with either 9–47-Ear,
4559-Blood, 9–47M, or 4559M. Purple indicates relatively low expression, while orange indicates relatively higher expression values. Top 50 differentially
expressed pneumococcal (a) and murine (b) genes are shown. Fold change values of all statistically significantly expressed genes can be found
in Supplementary Data 1–12.
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non-activated immune cells. The host transcriptional response
was specific to the infecting pneumococcal strain (Fig. 4a). Spe-
cifically, there was a diverging host response to the ear isolate
(9–47-Ear, dark orange) and blood isolate (4559-Blood, dark
purple). Interestingly, rafR swap in blood isolate background
(4559M, light purple) mimics the lung response to the wild type
ear isolate (9–47-Ear, dark orange); these two strains harbor the
D249 rafR allele. Surprisingly, the rafR swap in the 9–47-Ear
background (9–47M, light orange) which harbors the G249 allele,
does not drive the host response to mimic those of the wild type
4559-Blood strain (dark purple) that also has the G249 allele, but
rather towards a new, third position of genome-wide expression.
Genome-wide plotting of murine transcriptional responses to
S. pneumoniae strains 9–47-Ear and 4559-Blood shows extensive
rewiring of gene expression across the murine chromosomes,
consistent with their different tissue tropisms in vivo (Fig. 4b).
Specifically, 433 murine genes are activated upon infection by
9–47-Ear (FC > 1.5, p < 0.05), while 787 genes are activated by
infection with 4559-Blood (FC > 1.5, p < 0.05). Of the 9–47-Ear-
upregulated murine genes, only 37% were protein-coding, with
the majority encoding pseudogenes and small RNAs. Conversely,
of the 787 4559-Blood-upregulated murine genes, 80% were
protein-coding, while the rest encoded small RNAs. The 4559-
Blood-upregulated genes encode proteins involved in multiple
pathways such as general metabolism, peroxisome proliferator-
activated receptor (PPAR) signaling, steroid hormone biosynth-
esis and cAMP signaling. Although both strains belong to the
same capsular serotype and ST6, our data strongly suggest wildly
diverging isolate-specific host responses during early infection,
with the rafR SNP varying the host response considerably.
Interestingly, the host transcriptional response to 4559M closely
resembles that of 9–47-Ear (Fig. 4a), suggesting that the rafR SNP
plays a crucial role in the distinct response to 9–47-Ear versus
4559-Blood. However, the host transcriptional response to 4559-
Blood does not closely resemble the response to 9–47M, despite
the similar in vivo tissue tropism these strains display. This
suggests, unsurprisingly, that the host transcriptional response to
pneumococcal infection does not perfectly correlate with in vivo
outcomes.
In addition, rafR swap in the ear isolate background (9–47M)
expressing the G249 rafR allele activates 271 murine genes (FC >
1.5, p < 0.05), while it represses 479 genes. The G249 rafR-
activated genes include those involved in the Wnt signaling
pathway (Fzd2, Lgr6, Rspo1, Sost, Sox17, Wnt3a, Wnt7a) and
9-47 9-47M 4559 4559M
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Fig. 3 Pathogen transcriptional responses in murine lung. a PCA plot showing divergence of transcriptional response to lung infection within the ear
(9–47-Ear) and blood isolates (4559-Blood). rafR swap (9–47M) rewires pneumococcal transcriptional response only in the ear isolate background but not
in the blood isolate. b Differential expression due to the rafR swap in the ear isolate background is spread throughout the pneumococcal genome.
c Differential expression due to the rafR swap in the blood isolate background is limited to a genomic island. d–f Functional enrichment showed specific
function being differentially expressed, including carbohydrate metabolism (d), ABC transporters (e), and sugar transporters (f). A: comparison of 9–47-
Ear to 9–47M; B: 9–47-Ear to 4559-Blood; C: 9–47-Ear to 4559M; D: 9–47M to 4559-Blood; E: 9–47M to 4559M and F: 4559-Blood to 4559M. Asterisk
(*) denotes statistically significant functional enrichment for the indicated strain–strain comparison.
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general calcium signaling pathway (Adra1a, Adra1b, Adrb3,
Cckar, Grin2c, P2rx6, Tacr1, Tacr2). Conversely, 52% of the G249
rafR-repressed genes in lungs infected with 9–47M encode RNA
features and 18 chemokines, chemokine ligands, interferons and
interleukins. On the other hand, rafR swap in the blood isolate
background (4559M) expressing the D249 rafR allele activates
328 murine genes (FC > 1.5, p < 0.05), and represses 472 genes.
Seventy-three percent of the D249 rafR-activated murine genes
encode RNA features and 33 encode histone proteins. The
activation of these histone proteins suggests a massive reorgani-
zation of gene regulation with numerous potential downstream
impacts. In contrast, D249 rafR-repressed genes include genes
encoding calmodulins (Calm4, Calm13, and Camk2a) and
phospholipases A2 (Pla2g4b, Pla2g4d, and Pla2g4f).
Moreover, there are only 132 differentially expressed host
genes in response to wild type 9–47-Ear compared to the
response to strain 4559M (both having the D249 rafR allele), with
38 genes upregulated in strain 9–47-Ear and 94 in strain 4559M.
Intriguingly, the D249 rafR allele (strains 9–47-Ear and 4559M) is
associated with a upregulation of RNA features, including
antisense, intronic, long intergenic non-coding RNAs (lincRNAs)
and micro RNAs (miRNAs). The resulting abundance of RNA
species in murine cells upon pneumococcal infection has the
potential for even more widespread transcriptional rewiring and
fine-tuning of gene products later in the infection.
A quantified functional enrichment showed that certain gene
functions are enriched in the murine response to pneumococcal
strains. In particular, cytokine-cytokine receptor interaction is
enriched in differentially expressed host genes because of rafR
swap in the ear isolate background (Fig. 4c, comparison A, 9–47-
Ear versus 9–47M, p= 9.5 × 10−4). Concurrently, the function is
enriched in differentially expressed genes between mice infected
with 9–47M and those infected with 4559-Blood (comparison D,
p= 1.8 × 10−4). Since both strains harbor the G249 rafR allele,
the differentially expressed genes encoding cytokines and
cytokine receptors are most likely attributable to unrelated
genetic differences between the clinical isolates. Interestingly,
this function is not enriched in differentially expressed genes
9-47 9-47M 4559 4559M
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Fig. 4 The SNP in pneumococcal rafR drives diverging host response. a PCA plot illustrates murine lung response to the pneumococcal strains.
Interestingly, host transcriptional response to rafR swap in blood isolate (4559M, light purple) is similar to the murine response to the original ear strain
(9–47-Ear, dark orange). b Differential gene expression of transcriptional response to pneumococcal ear and blood isolates shows a widespread
transcriptional rewiring. Specifically, 433 genes are activated in response to infection by ear isolate (9–47-Ear) while 787 genes are activated (FC > 1.5, p <
0.05) by blood isolate (4559-Blood). c–e Specific gene ontology terms are enriched in differentially expressed host genes in response to pneumococcal
infection: cytokine–cytokine receptor interaction (c), interleukin-17 signaling pathway (d), and necroptosis (e). A: comparison between 9–47-Ear to 9–47M;
B: 9–47-Ear to 4559-Blood; C: 9–47-Ear to 4559M; D: 9–47M to 4559-Blood; E: 9–47M to 4559M and F: 4559-Blood to 4559M. Asterisk (*) denotes
statistically significant functional enrichment for the indicated strain–strain comparison.
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between the rafR swap in the blood isolate background (4559M)
and the wild type 9–47-Ear (comparison C), both of which have
the D249 rafR allele. Genes encoding chemokine ligands (Cxcl2,
Cxcl3, Cxcl10, and Ccl20), interleukin 17F (Il17f), interferon beta
(Ifnb1) and a receptor of TNF (Tnfrsf18) are the common
differentially expressed genes in lungs of mice infected with 9–47-
Ear, 9–47M, and 4559-Blood, with ascending expression from
responses to 9–47M, 9–47-Ear and 4559-Blood. Other genes
encoding chemokine ligands (Ccl3, Ccl4, Ccl17, Ccl24, Cxcl5,
Cxcl11, and Xcl1), interleukins (Il1rn and Il13ra2) and interferon
gamma (Ifng) are more highly expressed in the ear isolate-
infected lung (9–47-Ear) than in lungs infected by the rafR swap
ear isolate (9–47M). Finally, genes encoding chemokine receptors
(Ccr1 and Ccr6), interleukin receptors (Il1r2, Il10ra, Il17a,
Il18rap, Il20ra, Il20rb, Il22, and Il23r), and interleukins (Il1f5,
Il1f6, Il1f8, and Il6) are more highly expressed in lungs infected by
4559-Blood compared to the rafR swap in the ear isolate
background (9–47M).
Interleukin 17, as part of the cytokine response, activates
multitudes of downstream targets in defense against infectious
agents11, and thus plays a central role in host response to
pneumococcal infection. Here, we observe the same pattern of
diverging activation among murine responses to the pneumococ-
cal strains (Fig. 4d), with IL-17-associated genes being enriched in
differentially expressed genes among the host transcriptional
response to the rafR swap in the ear isolate background
(comparison A, 9–47-Ear versus 9–47M, p= 9.5 × 10−4). These
genes are also enriched amongst the host response to pneumo-
coccal strains with the G249 rafR allele (comparison D, 9–47M
versus 4559-Blood, p= 7.5×10−4) and to the rafR swap cognates
(comparison E, 9–47M versus 4559M, p= 0.022). However, there
was no enrichment of IL-17 associated genes amongst the host
response to pneumococcal strains with the D249 rafR allele
(comparison C, 9–47-Ear versus 4559M). Common differentially
expressed genes of this function include genes encoding
interleukin 17F (Il17f) and chemokine ligands (Cxcl2, Cxcl3 and
Ccl20), with ascending expression level of response to 9–47M,
9–47-Ear, and 4559-Blood. Specifically, the products of these
genes regulate the recruitment of neutrophils and activate immune
responses to extracellular pathogens.
In addition to the above, necroptosis, a programmed cell death,
exhibits a trend for its enrichment (p= 0.07) in differentially
expressed murine genes because of the rafR swap in the blood
isolate background (Fig. 4e, comparison F, 4559-Blood versus
4559M). Genes encoding histone cluster 2 (Hist2h2ac, Hisr2-
h2aa1, Hist2h2aa2, and H2afx) are more highly expressed in
murine lungs infected with 4559-Blood, while those encoding
phospholipases A2 (Pla2g4b, Pla2g4f, and Pla2g4d) and a subunit
of calcium/calmodulin-dependent protein kinase II (Camk2a) are
more highly expressed in the transcriptional response to the rafR
swap in the blood isolate background (4559M).
Validation of host/pathogen transcriptomics. To validate the
findings from the dual RNA-seq, quantitative real time RT-PCR
was performed on the same RNA samples from the lungs 6 h
post-infection. 19 pneumococcal and 18 murine genes were
chosen for this validation, with the primers used listed in Sup-
plementary Table 3. A total of 76 pneumococcal and 72 murine
gene Log2 FC comparisons were performed, with a high degree of
correlation observed for both pneumococcal (R2 > 0.73, Pearson)
and murine genes (R2 > 0.81, Pearson) (Fig. 5a). To validate the
reproducibility of the dual RNA-seq data, lung RNA samples 6 h
post-infection from a different experiment were analysed with
qRT-PCR. Here, 6 pneumococcal and 6 murine genes were
chosen, and 24 pneumococcal and 24 murine gene log2 FC
comparisons were performed. A high degree of correlation was
also observed here, for both pneumococcal (R2 > 0.77, Pearson)
and murine genes (R2 > 0.73, Pearson) (Fig. 5b).
Immune cell subsets present in infected lung tissue. The host
RNA-seq data represent the pooled transcriptional responses of
all cell types present in the lungs at the time of RNA extraction.
Thus, some of the transcriptomic differences may be attributable
to alterations in the relative abundance of given cell types, for
example by differential recruitment of immune cell subsets to the
site of infection. Accordingly, flow cytometry was used to quan-
tify immune cell subsets present in lung tissue 6 h after infection
with either 9–47-Ear, 4559-Blood, 9–47M or 4559M. The surface
marker staining panel used (Supplementary Table 4) and
appropriate gating strategy (Supplementary Fig. 1) allowed the
identification and enumeration of natural killer (NK) cells, neu-
trophils, eosinophils, inflammatory monocytes (iMono), resident
monocytes (rMono), alveolar macrophages (AMФ), interstitial
macrophages (iMФ), CD11b-negative dendritic cells (CD11b-
DC), CD11b-positive dendritic cells (CD11b+DC), T cells and B
cells12. Of these, neutrophils, by far the most abundant cell type,
were present in significantly higher numbers in murine lungs
infected with 9–47-Ear (versus 4559-Blood, p < 0.01; versus
9–47M, p < 0.05) and 4559M (versus 4559-Blood, p < 0.05)
(Fig. 6), both of which have the D249 rafR allele and were cleared
from the lungs 24 h post-infection. NK cells were also found to be
significantly higher in lungs infected with 9–47-Ear (versus 4559-
Blood, p < 0.01; versus 9–47M, p < 0.05), while eosinophils were
raised in 4559M infected lungs (versus 4559-Blood, p < 0.05)
(Fig. 6). However, since the numbers of NK cells and eosinophils
were much lower than neutrophils, their contribution to total
lung mRNA and their impact on tissue tropism may be less
pronounced. Moreover, the large difference in neutrophil
recruitment to the lungs at 6 h post-infection aligns with the
differential IL-17 response highlighted in the dual RNA-seq data.
The higher number of neutrophils in murine lungs infected with
9–47-Ear and 4559M is likely to facilitate their clearance from
this niche.
Impact of neutrophil depletion and IL-17A neutralization. The
greater abundance of neutrophils in lungs infected with strains
containing the D249 rafR allele that are cleared from the lungs by
24 h suggests that the recruitment and presence of neutrophils is
crucial for bacterial clearance from the lung. Thus, differential
neutrophil recruitment might be the underlying mechanism for
the observed RafR-dependent tropism. To test this, we investi-
gated the importance of neutrophils for persistence of pneumo-
cocci in the lungs in the IN challenge model. Injection of anti-
mouse Ly6G was used to deplete neutrophils in 32 mice, along-
side an isotype control group treated with rat IgG2a. Neutrophil
depletion was confirmed in the blood prior to challenge using
flow cytometry (Supplementary Fig. 2), with a 76.35% decrease in
neutrophils in the anti-mouse ly6G treated mice, relative to the
isotype control-treated group (p < 0.0001) (Supplementary
Fig. 3A). Mice were then challenged with 108 CFU of each strain,
for both treatment groups. Bacterial loads were quantified in the
nasopharynx and lungs 24 h post-challenge. No significant dif-
ferences in bacterial numbers in the nasopharynx were seen
between strains within each treatment group (Fig. 7a). Also, for
both treatments, the numbers of bacteria in the lungs infected
with 4559-Blood and 9–47M were higher than 9–47-Ear and
4559M (Fig. 7b), which is consistent with our previous findings7.
However, the anti-Ly6G-treated groups showed significantly
higher lung bacterial loads compared to their respective
isotype controls: 4559-Blood anti-Ly6G versus 4559-Blood
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control (p < 0.001), 947-Blood anti-Ly6G versus 947-Blood con-
trol (p < 0.01), 4559M anti-Ly6G versus 4559M control (p < 0.01),
and 947M anti-Ly6G versus 947M control (p < 0.05) (Fig. 7b).
Importantly, the lung bacterial loads of anti-Ly6G-treated 9–47-
Ear and 4559M groups were not significantly different to the
isotype control-treated 4559-Blood group (Fig. 7b). Thus,
restriction of neutrophil infiltration into the lungs by depleting
circulating neutrophils in mice challenged with the strains
expressing the D249 rafR allele resulted in enhanced lung bac-
terial loads at 24 h similar to that seen in untreated mice chal-
lenged with the strains expressing the G249 rafR allele.
Given the known involvement of IL-17 in neutrophil
recruitment into the lungs after infection13–16, we also investi-
gated the in vivo significance of the rafR-mediated differential
expression of IL-17-associated genes between the various S.
pneumoniae strains. Groups of mice were injected with anti-
mouse IL-17A, or a control murine IgG1 antibody, before and
after pneumococcal challenge. IL-17A depletion was confirmed
by ELISA on separate 9–47-infected bronchoalveolar lavage
(BAL) samples, with a 55.63% reduction in IL-17A levels seen in
anti-mouse IL-17A treated mice relative to the isotype control
group (p < 0.0001) (Supplementary Fig. 3b). The effect of this IL-
17A depletion on neutrophil levels was also tested using flow
cytometry on infected 9–47 lung tissue, with a 22.23% decrease in
neutrophils seen in the anti-mouse IL-17A-treated mice, relative
to the isotype control-treated group (p < 0.05) (Supplementary
Fig. 3C). Bacterial loads were quantified in the nasopharynx and
lungs for 24 h of post-challenge. Again, no significant differences
between strains in bacterial numbers in the nasopharynx were
seen within each treatment group (Fig. 7c). However, similar to
the results obtained using anti-Ly6G, groups treated with anti-IL-
17A showed significantly higher bacterial numbers in the lungs
compared to their respective isotype controls; 4559-Blood anti-
IL-17A versus 4559-Blood control (p < 0.05); 947-Blood anti-IL-
17A versus 947-Blood control (p < 0.05); 4559M anti-IL-17A
versus 4559M control (p < 0.05); and 947M anti-IL-17A versus
947M control (p < 0.01) (Fig. 7d). Nevertheless, the impact of
anti-IL-17 treatment on lung bacterial loads was not quite as
dramatic as that of anti-Ly6G, as the number of bacteria in the
lungs of anti-IL-17A-treated 9–47-Ear and 4559M groups
remained significantly lower relative to the isotype control
treated 4559-Blood group (both p < 0.05) (Fig. 7d). Together,
these results show that pneumococcal strains carrying the D249
rafR allele cause a rapid influx of neutrophils, partly controlled by
IL-17 expression in the host, leading to clearance from the lung,
while the G249 rafR strains manage to remain “stealthy” and
hence can persist.
Discussion
In this study, we have used a dual RNA-seq approach, validated
by qRT-PCR, to elucidate the complex interspecies interactions
between murine lung cells and infecting S. pneumoniae blood and
ear isolates that are closely related (same capsular serotype and ST
type), but exhibit distinct virulence phenotypes in accordance
with their original clinical isolation site. These differences are
largely, but not completely, driven by a D249G SNP in the raf-
finose pathway transcriptional regulator gene rafR, which exten-
sively impacts the bacterial transcriptome in the lung
environment. The SNP affects expression of genes encoding
multiple transmembrane transporters, including those for various
sugars, and fine-tunes pneumococcal carbohydrate metabolism.
This indicates that the differential expression of sugar catabolism
pathways provides specific advantages in distinct host niches,
implying differential niche-specific availability of one carbohy-
drate source versus another. Free sugars are in low abundance in
the upper respiratory tract, but S. pneumoniae expresses a range
of surface-associated exoglycosidases enabling it to scavenge
constituent sugars (including galactose, N-acetylglucosamine,
sialic acid, and mannose) from complex host glycans present in
respiratory secretions and on the epithelial surface17–21. On the
other hand, glucose is readily available in the blood and also in
inflamed tissues, implying a marked alteration in the availability
of this preferred carbohydrate source as invasive disease pro-
gresses22. All these variations, and the downstream consequences
thereof, are ultimately sensed by host cells, including epithelial
and immune cells, resulting in the observed divergence of host
response to the various strains, particularly with respect to
expression of genes encoding cytokine and chemokine ligands
and receptors, as well as those associated with programmed
cell death.
Examination of the nature of the host response has provided
important clues regarding the mechanism whereby the rafR SNP
impacts virulence phenotype. By way of example, the dual RNA-
seq data showed that expression of IL-17-related genes was
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Fig. 5 Validation of transcriptomic data. Gene expression values from the dual RNA-seq were confirmed by qRT-PCR, using a the same isolated RNA used
for the dual RNA-seq or b isolated RNA from a repeated experiment. a 18 murine and 19 pneumococcal genes were chosen as experimental validation
targets. Log2 fold changes were plotted from qRT-PCR against dual RNA-seq log fold changes for 9–47-Ear versus 4559-Blood, 9–47-Ear versus 9–47M,
9–47M versus 4559M, and 4559-Blood versus 4559M comparisons. A total of 72 murine and 76 pneumococcal comparisons were plotted, with a high
degree of correlation observed for both species (R2 > 0.73, Pearson). b 6 murine and 6 pneumococcal genes were chosen as targets to test the
reproducibility of the dual RNA-seq data. Log2 fold changes were plotted from qRT-PCR against dual RNA-seq log fold changes for 9–47-Ear versus 4559-
Blood, 9–47-Ear versus 9–47M, 9–47M versus 4559M and 4559-Blood versus 4559M comparisons. A total of 24 murine and 24 pneumococcal
comparisons were plotted, with a high degree of correlation observed for both species (R2 > 0.73, Pearson).
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enriched in mice infected with 9–47-Ear and 4559M, the strains
that express the D249 rafR allele and which are cleared from the
lungs after 24 h of post-challenge. It is well known that IL-17
drives neutrophil recruitment into the lungs after infection13–16.
Additionally, neutrophil extravasation genes were shown to be
upregulated in murine lungs for 48 h of post pneumococcal
challenge23. Indeed, we have shown here that neutrophils were
present in the lungs at 6 h of post challenge at higher numbers in
mice infected with 9–47-Ear and 4559M compared with the
strains expressing the G249 rafR allele (Fig. 6), as predicted by the
dual RNA-seq data. Moreover, we went on to show that neu-
trophil depletion by treatment with anti-Ly6G increased bacterial
numbers in the lungs of mice, relative to the isotype controls.
Strikingly, pneumococcal numbers in the lungs of anti-Ly6G
treated mice infected with 9–47-Ear and 4559M were not sig-
nificantly different to that for isotype control-treated 4559-Blood-
infected mice (Fig. 7b). In vivo neutralization of IL-17A also
resulted in an increase in bacterial loads in the lungs of mice,
relative to the isotype controls, for all challenge strains (Fig. 7d),
although not to the same extent as seen with for neutrophil-
depleted mice (Fig. 7b). The difference between the impact of IL-
17A neutralization versus neutrophil depletion is likely due to the
action of alternative neutrophil recruitment pathways24,25. Our
findings demonstrate that the rafR SNP examined in this study
has a wide spread effect on both the bacterial and host tran-
scriptomes, with the strains expressing the G249 allele triggering a
strong pro-inflammatory IL-17 response in the lungs post-
infection. This response leads to an influx of neutrophils to the
Fig. 6 Quantification of immune cell subsets in murine lungs 6 h post infection. Groups of 8 mice per strain were challenged with either 9–47-Ear, 4559-
Blood, 9–47M or 4559M. Single cell lung suspensions were prepared and stained with antibodies against various surface markers (Supplementary Table 4)
then analyzed by flow cytometry. Populations enumerated include: NK natural killer cells, iMono neutrophils, eosinophils, inflammatory monocytes, rMono
resident monocytes, AMФ alveolar macrophages, iMФ interstitial macrophages, CD11b−DC CD11b-negative dendritic cells, CD11b+DC CD11b-positive
dendritic cells, T cells and B cells. Graphs shown represent pooled data from two independent experiments. All quantitative data are presented as mean ±
S.E.M (n= 16 for each group), analyzed by one-way ANOVA (*p < 0.05; **p < 0.01).
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lungs, resulting in the clearance of bacteria. Conversely, expres-
sion of the D249 rafR allele results in a more subdued IL-17 host
response, allowing for bacterial persistence in the lungs. Thus, our
findings clearly indicate that modulation of neutrophil recruit-
ment during the early stage of infection plays a key role in the
capacity of a given S. pneumoniae strain to persist in the lungs,
and the nature of disease ultimately caused by it.
Our previous studies have shown that in spite of early clear-
ance from the lung, strains 9–47 Ear and 4559M, expressing the
G249 rafR allele, have an enhanced capacity to spread to and/or
proliferate in the ear and brain compartments6,7. It is not known
whether differential carbohydrate metabolism better adapts these
strains to available carbohydrate sources in these niches, or
whether altered host pro-inflammatory responses contribute to
ascension of the Eustachian tube or penetration of the blood-
brain barrier. Unfortunately, the total numbers of pneumococci
present in these niches are too low for pathogen–host tran-
scriptomic analyses using available technologies.
Intra-species variation in virulence phenotype is a common
feature of pathogenic microorganisms, which by nature are
genetically diverse. S. pneumoniae is an exemplar of such diversity
comprising at least 98 capsular serotypes superimposed on over
12,000 MLST types, and with a core genome that accounts for
only 70% of genes2. Nevertheless, stark differences in pathogenic
profile can result from the smallest of genetic differences between
strains, as exemplified by the profound impact of a single SNP on
both bacterial and host transcriptomes reported in this study.
Methods
Bacterial strains and growth conditions. S. pneumoniae strains used in this study
are listed in Supplementary Table 4. Cells were routinely grown in serum broth
(SB) as required. Bacteria were plated on Columbia agar supplemented with 5%
(vol/vol) horse blood (BA) and incubated at 37 °C in 5% CO2 overnight.
Intranasal challenge of mice and extraction of RNA. Animal experiments were
approved by the University of Adelaide Animal Ethics Committee. Groups of 12
outbred 5–6-week-old female Swiss (CD-1) mice (48 in total), were anesthetized by
intraperitoneal injection of pentobarbital sodium (Nembutal) and challenged
intranasally (IN) with 50 µl of bacterial suspension containing approximately 1 ×
108 CFU in SB of 4559-Blood, 9–47-Ear, 4559M or 9–47M. The challenge dose was
confirmed retrospectively by serial dilution and plating on BA. Mice were eutha-
nized by CO2 asphyxiation at 6 h and lungs placed in 1 ml TRIzol (Thermo Fisher).
RNA was then extracted using acid-phenol-chloroform-isoamyl alcohol (125:21:1;
pH 4.5; Ambion) and purified using the RNeasy minikit (Qiagen). For subsequent
dual RNA-seq analyses, there were three replicates per strain, with each replicate
derived from the lungs of four mice.
RNA library preparation and sequencing. RNA quality was checked using chip-






















































































































































Fig. 7 Impact of neutrophil depletion or IL-17A neutralization on pneumococcal virulence. Groups of eight mice were treated with either 350 μg of rat
anti-mouse Ly6G or rat IgG2a isotype control, one and two days prior to pneumococcal challenge (a, b), or with anti-IL-17A or mouse IgG1 isotype control
(c, d), one day before, 2 h before and 6 h after intranasal challenge (see “Methods” section). Twenty-four hours of post-infection, numbers of pneumococci
in the nasopharynx and lungs were quantitated (see “Methods” section). NB: n is <8 for some groups because some mice didn’t survive the challenge
procedure, or until the time of harvest. Viable counts (total CFU per tissue) are shown for each mouse at each site; horizontal bars indicate the geometric
mean (GM) CFU for each group; the broken line indicates the threshold for detection. Differences in GM bacterial loads between groups are indicated by
asterisks: *p < 0.05, **p < 0.01, ***p < 0.001, by unpaired t-test.
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murine and pneumococcal ribosomal RNAs by dual rRNA-depletion as previously
described26. Stranded cDNA library preparation was performed according to the
prescribed protocol (Illumina, US). Sequencing was performed for twelve samples
in one lane of an Illumina NextSeq 500, High Output Flowcell in 85 single end
mode. Libraries were demultiplexed and analyzed further. Raw libraries are
accessible at https://www.ncbi.nlm.nih.gov/geo/ with the accession number
GSE123982.
Sequence data analysis. Quality of raw libraries was checked (FastQC v0.11.8,
Babraham Bioinformatics, UK)27. In order to improve the quality of alignment, we
trimmed the reads using the following criteria: (i) removal of adapter sequence, if
any, based on TruSeq3-SE library, (ii) removal of low quality leading and trailing
nucleotides, (iii) a five-nucleotide sliding window was created for surviving reads,
in which the average quality score must be above 20 and (iv) minimum remaining
length must be above 50 (Trimmomatic v0.38)28. The quality of trimmed reads was
confirmed using FastQC27.
As reference genomes, we created chimeric genomes by concatenating the in-
house generated S. pneumoniae strain 9–47-Ear or 4559-Blood circular genomes7
into the genome of Mus musculus (ENSEMBL, release 94, downloaded 9 October
2018). The corresponding annotation file was downloaded at the same time. The
chimeric mouse/9–47-Ear genome was used as reference to align libraries from
lungs infected by strain 9–47-Ear (and its corresponding swap mutant 9–47M)
while the mouse/4559-Blood chimeric genome was used to align 4559-Blood and
4559M libraries. Notably, the genome of S. pneumoniae isolate 4559-Blood has a
plasmid. Alignment was performed by RNA-STAR (v2.6.0a)29 with the following
options: (i) alignIntronMax 1 and (ii) sjdbOverhang 84. The aligned reads were
then summarized (featureCount v1.6.3) according to the chimeric annotation file in
stranded, multimapping (-M), fractionized (--fraction) and overlapping (-O)
modes30. In order to compare gene expression between strains from ear and blood
isolate backgrounds, we prepared a common pneumococcal annotation file using
Mauve v2015022631. Common genes between 9–47-Ear and 4559-Blood were
defined as having common coverage at least 90% and identity at least 90%. This
single-pass alignment was selected to minimize false discovery rate. However, due
to this approach, we had to adjust the summarizing process, taking into account the
overlapping nature of bacterial genes and its organization into operon structures.
We then analyzed host and pathogen libraries separately in R (R v3.5.2). Since
reads coming from pneumococcal genes encoding bacterial rRNA dominate the
pathogen libraries (average 64.5%; range 61.4–67.3%), we excluded these
pneumococcal ribosomal RNA reads from downstream analysis, but we did not do
the same exclusion to reads from murine ribosomal RNA genes due to effective
rRNA depletion. Differential gene analysis was performed by DESeq2 v1.22.132 and
genome-wide fold change was calculated within host and pathogen libraries for
every two possible comparisons: strains 9–47-Ear to 9–47M, strains 9–47-Ear to
4559-Blood, strains 9–47-Ear to 4559M, strains 9–47M to 4559-Blood, strains
9–47M to 4559M and strains 4559-Blood to 4559M. Value of fold change was set to
zero if the corresponding adjusted p-value (padj) is reported to be NA.
Quantitative real time RT-PCR. Differences in levels of gene expression observed
in the dual RNA-seq data were validated by one-step relative quantitative real-time
RT-PCR (qRT-PCR) in a Roche LC480 real-time cycler essentially as previously
described33. The same RNA that was used for the dual RNA-seq was used in the
qRT-PCR experimental validation. 19 pneumococcal genes and 18 murine genes
were chosen for the experimental validation. The murine intranasal challenge and
RNA isolation was repeated to test the reproducibility of the dual RNA-seq data. 6
pneumococcal and 6 murine genes were chosen for the reproducibility validation.
The specific primers used for the various genes are listed in Supplementary Table 3
and were used at a final concentration of 200 nM per reaction. As an internal
control, primers specific for gyrA for pneumococcal genes, and GAPDH for murine
genes, were employed. Amplification data were analysed using the comparative
critical threshold (2−ΔΔCT) method34.
Flow cytometry analysis of infected murine lungs. Groups of 8 outbred 6-week-
old female Swiss (CD-1) mice (32 in total) were anesthetized and challenged with
the bacterial suspension as outlined above in the total RNA extraction method.
Mice were euthanized by CO2 asphyxiation at 6 h, then lungs were finely macerated
in 1 mL prewarmed digestion medium (DMEM+ 5% FCS, 10 mM HEPES, 2.5 mM
CaCl2, 0.2 U mL−1 penicillin/gentamicin, 1 mg mL−1 collagenase IA, 30 U mL−1
DNase) and incubated at 37 °C for 1 h with mixing every 20 min. Single cells were
then prepared for acquisition on a BD LSRFortessa X20 flow cytometer as pre-
viously described35. The single cell suspensions were stained using antibodies
against surface markers listed in Supplementary Table 4, allowing the enumeration
of a number of immune cell subsets, as previously described12.
Neutrophil depletion, IL-17A blockade and bacterial loads. Groups of 8 outbred
6-week-old female Swiss (CD-1) mice (64 in total) were intraperitoneally admi-
nistered with either 350 μg of rat anti-mouse Ly6G or rat IgG2a isotype control
antibodies, one and two days prior to pneumococcal challenge, or 200 μg of either
monoclonal anti-mouse IL-17A or mouse IgG1 isotype control antibodies one day
prior to, 2 h before and 6 h after pneumococcal challenge. Mice were also cheek
bled on the day of challenge for confirmation of depletion of Ly6G-positive cells via
flow cytometry, as previously described36. Mice were then anesthetized and chal-
lenged with the bacterial suspension as outlined above in the total RNA extraction
method, for each treatment group. Mice were euthanized by CO2 asphyxiation at
24 h, then nasopharynx and lung tissue samples were harvested and pneumococci
enumerated in tissue homogenates as described previously via serial dilution and
plating on BA containing gentamicin37.
Neutrophil and IL-17A levels after IL-17A neutralization. Groups of three
outbred 6-week-old female Swiss (CD-1) mice were intraperitoneally administered
with 200 μg of either monoclonal anti-mouse IL-17A or mouse IgG1 isotype
control antibodies one day prior to and 2 h before intranasal challenge with 9–47,
as described above. Six hours of post-infection, lung tissue and bronchoalveolar
lavage (BAL) were harvested. To quantify IL-17 levels, a mouse IL-17 DuoSet®
ELISA (R&D Systems) was performed on BAL samples in duplicate, according to
the manufacturer’s instructions. Flow cytometry was performed on lung tissue
samples, as described above, to quantify neutrophil levels after anti-mouse IL-17A
treatment.
Statistics and reproducibility. For the RNA-seq data, enrichment tests to assess
enrichment were performed by the built-in function, fisher.test(). Corresponding p-
values of the enrichment test were adjusted by Bonferroni correction. Resultant
figures encompass data derived from three replicates per group, with each replicate
derived from lungs of four mice. All other data are presented as mean ± standard
error of mean (SEM) or geometric mean, and were analyzed by two-tailed unpaired
Student’s t-test, one way ANOVA or Pearson correlation coefficient, using Prism
v8.0d (GraphPad). Statistical significance was defined as p < 0.05. Data presented in
figures are representative of at least two independent in vivo experiments, or at
least 3 independent in vitro experiments.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Raw RNA libraries are accessible at https://www.ncbi.nlm.nih.gov/geo/ with the accession
number GSE123982. Source data for Figs. 2–7 are provided in Supplementary Data 13.
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